Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6245288873075724,-2.4895139972119753,0.0,0.0,0.0,54/87,20.52%,RPL41;RPS12;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;RPS13;RPL21;RPL7;RPL18;RPL27;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;RPL30;RPS23;RPL36;RPLP1;RPS29;RPL37;RPS9;RPS5;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;RPL7A;RPL19;RPS20;RPL14;RPL13;RPL32;RPL5;RPSA;RPLP0;RPS6;RPL22;ZFAND2B;RPS21;RPL37A;RPLP2;RPL17;RPL23
prerank,protein targeting to ER (GO:0045047),-0.6102902550906442,-2.4501494228585217,0.0,0.0,0.0,78/99,31.20%,RPL41;RPS12;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;RPS13;RPL21;RPL7;RPL18;RPL27;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;RPL30;RPS23;RPL36;RPLP1;RPS29;RPL37;RPS9;RPS5;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;RPL7A;RPL19;RPS20;RPL14;RPL13;RPL32;RPL5;RPSA;RPLP0;RPS6;RPL22;ZFAND2B;RPS21;RPL37A;SGTB;RPLP2;SPCS1;RPL17;RPL23;RPL28;RPL31;CHMP4B;CHMP4A;EDEM1;RPS10;SGTA;RPS11;RPS27;RPS16;SRPRA;RPL10;RPL15;RPL12;RPL9;RPS8;SEC61G;GET3;SEC63;RPS27A;RPL10A;RPS17
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.6068951530666669,-2.440501628955383,0.0,0.0,0.0,54/91,20.52%,RPL41;RPS12;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;RPS13;RPL21;RPL7;RPL18;RPL27;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;RPL30;RPS23;RPL36;RPLP1;RPS29;RPL37;RPS9;RPS5;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;RPL7A;RPL19;RPS20;ARL6IP1;RPL14;RPL13;RPL32;RPL5;RPSA;RPLP0;RPS6;RPL22;RPS21;RPL37A;RPLP2;RPL17;RPL23
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.5650796814652833,-2.374691167668601,0.0,0.0,0.0,58/110,20.52%,RPL41;RPS12;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;RPS13;RPL21;RPL7;RPL18;RPL27;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;RPL30;RPS23;PABPC1;PNRC2;RPL36;RPLP1;RPS29;RPL37;PPP2R2A;RPS9;RBM8A;RPS5;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;RPL7A;RPL19;RPS20;RPL14;RPL13;RPL32;RPL5;RPSA;SMG7;RPLP0;RPS6;RPL22;RPS21;RPL37A;RPLP2;RPL17;RPL23
prerank,cytoplasmic translation (GO:0002181),-0.5944382236515245,-2.3605429657939627,0.0,0.0,0.0,53/91,20.52%,RPL41;RPS12;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;RPS13;RPL21;RPL7;RPL18;RPL27;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;RPL30;RPS23;RPL36;RPLP1;RPS29;RPL37;RPS9;RPS5;EIF4A1;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;RPL7A;RPL19;RPS20;RPL14;RPL13;RPL32;RPL5;RPSA;RPLP0;RPS6;RPL22;RPS21;RPL37A;RPL17;RPL23
prerank,peptide biosynthetic process (GO:0043043),-0.5306592796386886,-2.280852977085655,0.0,0.0,0.0,77/153,23.08%,RPL41;RPS12;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;WARS1;RPS13;RPL21;RPL7;RPL18;RPL27;GGT5;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;MRRF;RPL30;RPS23;RPL36;RPLP1;RPS29;RPL37;RPS9;RPS5;YARS2;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;MRPS18A;RPL13A;MRPS5;GGTA1;RPL7A;RPL19;RPS20;RPL14;EEF1A1;RPL13;RPL32;MRPS12;RPL5;RPSA;MRPS33;RPLP0;MRPL55;RPS6;RPS6KB2;RPL22;MRPS18B;MRPL42;RPS21;GGT1;RPL37A;RPLP2;MRPS21;MRPS7;RPL17;RPL23;PCSK1;MRPL34;EIF4EBP2;RPL28;PABPC4;RPL31;EEF1A2
prerank,extracellular structure organization (GO:0043062),0.6382865607092023,2.12658534499359,0.0,0.0010139173072901053,0.001,54/204,5.48%,ITGA9;ADAMTS6;COL4A4;ADAMTS12;COL4A5;ADAMTSL3;LAMA1;COL4A6;FBN1;COL1A2;COL1A1;DDR2;FBLN5;COL4A3;THSD4;COL22A1;ELN;ADAMTS10;ADAMTS5;LOXL1;MATN3;LUM;SPARC;COL5A1;COL8A2;LOX;DAG1;DCN;BGN;LAMA2;FBN2;SERPINE1;COL11A1;HSPG2;ITGA11;ADAMTS2;ADAMTSL2;RECK;LAMC1;ITGA3;MMP2;MFAP5;MMP19;NID1;NID2;COL13A1;TGFBR1;VTN;COL9A2;ITGB8;MMP11;SMOC2;ECM2;ITGB5
prerank,external encapsulating structure organization (GO:0045229),0.6351520906371871,2.1207297099224194,0.0,0.0005069586536450526,0.001,53/205,5.48%,ITGA9;ADAMTS6;COL4A4;ADAMTS12;COL4A5;ADAMTSL3;LAMA1;COL4A6;FBN1;COL1A2;COL1A1;DDR2;FBLN5;COL4A3;THSD4;COL22A1;ELN;ADAMTS10;ADAMTS5;LOXL1;MATN3;LUM;SPARC;COL5A1;COL8A2;LOX;DAG1;DCN;BGN;LAMA2;FBN2;SERPINE1;COL11A1;HSPG2;ITGA11;ADAMTS2;ADAMTSL2;RECK;LAMC1;ITGA3;MMP2;MFAP5;MMP19;NID1;NID2;COL13A1;VTN;COL9A2;ITGB8;MMP11;SMOC2;ECM2;ITGB5
prerank,translation (GO:0006412),-0.46868290304127613,-2.1106146708835953,0.0,0.003332257893647041,0.022,91/208,23.08%,RPL41;RPS12;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;WARS1;RPS13;RPL21;RPL7;RPL18;RPL27;EEF2;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;WARS2;MRRF;RPL30;RPS23;RPL36;RPLP1;RPS29;RPL37;NOA1;GTPBP1;LARS1;RPS9;YARS1;RPS5;GFM2;YARS2;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;MRPS18A;QARS1;RPL13A;MRPS5;RPL7A;RPL19;RPS20;RPL14;EEF1A1;RPL13;EEF1B2;RPL32;MRPS12;RPL5;KARS1;NDUFA7;RPSA;FASTKD2;MRPS33;FARS2;RPLP0;AIMP1;MRPL55;MRPL57;RPS6;RPS6KB2;RPL22;MRPS18B;MRPL42;MARS2;RPS21;RPL37A;RPLP2;MRPS21;AIMP2;MRPS7;RPL17;RPL23;MRPL34;EIF4EBP2;TARS1;RPL28;PABPC4;RPL31;EEF1A2
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.8145399216639717,-2.0949250240565163,0.0,0.0032396951743790675,0.028,4/14,3.20%,ABCG2;HMOX2;SLCO2B1;ABCC1
prerank,heme catabolic process (GO:0042167),-0.8145399216639717,-2.0949250240565163,0.0,0.0032396951743790675,0.028,4/14,3.20%,ABCG2;HMOX2;SLCO2B1;ABCC1
prerank,retinoid metabolic process (GO:0001523),0.6762064193255822,1.9996294047770096,0.0,0.022644153196145683,0.058,15/71,7.29%,ALDH1A1;RBP4;GPC6;AKR1B1;CYP26B1;LRP1;HSPG2;DHRS3;RBP1;APOE;APOA1;CYP1B1;ALDH1A2;SDC1;ADH1A
prerank,regulation of exocytosis (GO:0017157),-0.5772262203366955,-1.9914107296077481,0.0,0.022062324137521447,0.182,20/46,19.34%,STXBP6;IL1RAPL1;RAB27A;STXBP5L;RAB21;RAB3C;RIMS2;SYT1;CADPS;RAB12;RAB8B;RAB27B;LGI3;NSF;CPLX1;CFTR;RAB15;RAB3A;CLASP1;ANXA1
prerank,diterpenoid metabolic process (GO:0016101),0.6938445961809143,1.986749925778278,0.0,0.02458749470178505,0.083,10/55,4.31%,ALDH1A1;RBP4;GPC6;AKR1B1;LRP1;HSPG2;DHRS3;RBP1;APOE;APOA1
prerank,extracellular matrix organization (GO:0030198),0.5826409759191283,1.9825101531129667,0.0,0.02169783037600825,0.092,68/276,7.82%,ITGA9;ADAMTS6;COL4A4;ADAMTS12;COL4A5;ADAMTSL3;LAMA1;COL4A6;FBN1;COL1A2;COL1A1;DDR2;FBLN5;COL4A3;THSD4;COL22A1;ELN;ADAMTS10;ADAMTS5;LOXL1;MATN3;LUM;GSN;SPARC;COL5A1;COL8A2;LOX;DAG1;DCN;BGN;LAMA2;FBN2;SERPINE1;COL11A1;HSPG2;ITGA11;DPT;ADAMTS2;ADAMTSL2;RECK;LAMC1;ITGA3;MMP2;MFAP5;MMP19;NID1;NID2;GAS6;COL13A1;TGFBR1;VTN;COL9A2;SH3PXD2B;ITGB8;MMP11;SMOC2;COL20A1;ECM2;ITGB5;CYP1B1;ADAMTS9;SERPINH1;TNC;SMOC1;TIMP2;COLQ;SCUBE1;FLRT2
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.7167070171002726,1.982046259409604,0.0,0.018588483966985266,0.095,15/43,8.96%,IGF1;NELL1;BMP6;DDR2;FBN2;IL6R;BMPR1A;CCN1;WNT4;YAP1;RUNX2;ACVR1;WWTR1;BMP2;CCN4
prerank,skeletal system development (GO:0001501),0.5996733007772478,1.9667786101538447,0.0,0.023754634056511036,0.134,28/148,5.51%,IGF1;RBP4;BMP6;FBN1;COL1A2;IGF2;COL1A1;GJA1;TRPS1;CDH11;MATN3;AHSG;SOX5;GLI2;SULF2;FGFR1;ANKH;FGFR2;GNAS;COL13A1;TGFBR1;NPR3;COL9A2;SULF1;SH3PXD2B;ITGB8;CREB3L2;TBX3
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.8328239635796628,1.964394243944571,0.0,0.022306180760382315,0.143,9/17,9.53%,IGF1;NRP1;DOCK4;PDGFRB;VTN;IGFBP5;DOCK5;CCN4;S100A11
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.8801824875544931,1.9556312766381367,0.0,0.02343275554626021,0.166,5/13,4.06%,LTBP1;GREM2;FBN1;FBN2;FSTL1
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.8276440970074775,1.9499630524235376,0.001644736842105263,0.024739582297878565,0.193,3/18,0.46%,IGF1;IGFBP2;IGF2
prerank,regulation of activated T cell proliferation (GO:0046006),0.7440372634053067,1.9485614139364478,0.0,0.022767052263696002,0.196,3/30,0.46%,IGF1;IGFBP2;IGF2
prerank,collagen fibril organization (GO:0030199),0.6303458421696753,1.933985421235401,0.0,0.029995053673998948,0.256,22/88,6.33%,COL4A4;COL4A5;COL4A6;COL1A2;COL1A1;DDR2;COL4A3;COL22A1;LOXL1;LUM;COL5A1;COL8A2;LOX;COL11A1;DPT;ADAMTS2;COL13A1;TGFBR1;COL9A2;COL20A1;CYP1B1;SERPINH1
prerank,negative regulation of reproductive process (GO:2000242),0.830772965343302,1.915221803000969,0.0,0.04274051418422904,0.369,3/17,4.16%,IGF1;GJA1;SULF1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.7189189802038489,-1.908734210251844,0.0,0.07678077563278389,0.536,7/15,6.82%,KCNJ2;ATP1A1;KCNJ3;KCND3;KCNN2;KCNQ1;ATP1B1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.818080276200479,1.8935075650927762,0.0016835016835016834,0.06452859434253455,0.516,6/16,5.13%,IGF1;IGFBP2;CILP;IGFBP4;PHIP;IGFBP5
prerank,cell junction assembly (GO:0034329),-0.46170735511787575,-1.892094477570596,0.0,0.08933459443350278,0.615,28/100,6.25%,PKP4;DNM3;FN1;ADGRL3;SHANK3;CTNND2;CLDN5;CDH2;GPM6A;ITGA6;NLGN1;LIMS2;CDH1;ACTB;SPOCK2;KIRREL3;TJP1;GJC1;NRCAM;MYO9A;DNER;CDH12;CDH6;NRXN1;CDH8;CDH9;OPHN1;CDK5
prerank,positive regulation of nuclear division (GO:0051785),0.7574046340121046,1.8863972388176664,0.0015384615384615385,0.06887878240857448,0.548,13/25,13.25%,IGF1;IGF2;TGFA;EPGN;PDGFRB;PHIP;CD28;NPM2;SIRT2;DRD3;RGCC;INSR;EGF
prerank,eye development (GO:0001654),0.6544550263206586,1.8779186793143883,0.0,0.07610716787846353,0.59,12/54,6.98%,RBP4;LAMA1;FBN1;PBX1;COL5A1;FBN2;SHROOM2;SH3PXD2B;CPAMD8;SKI;CACNA1C;SMOC1
prerank,regulation of phospholipase activity (GO:0010517),0.8913246758382852,1.8738398468056636,0.0,0.07795234827224513,0.617,4/10,3.03%,PDPK1;LRP1;FGFR1;FGFR2
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.5324295223233185,-1.8709438773693863,0.003703703703703704,0.10900328225180031,0.726,22/46,17.45%,GRM7;MEF2C;SHANK3;GRM3;CDH2;NLGN1;PTK2B;GRIK1;TSHZ3;NRXN1;GRM5;OPHN1;CDK5;SYT1;TPRG1L;GRM8;HOMER1;NLGN3;CACNG3;CACNG4;GRM1;DGKZ
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.7837350157278087,1.8682266771376048,0.0,0.0812260420617962,0.66,5/19,4.69%,DAPK2;CAMK1D;RIPOR2;CCL19;MCU
prerank,glutamate receptor signaling pathway (GO:0007215),-0.5604556662150182,-1.8673748219186466,0.0,0.10684051871505824,0.745,20/37,19.53%,GRM7;GRID2;GRM3;GRIA4;PTK2B;GRIK1;GRIK2;GRIN2A;GRM5;GRIN2B;GRIN3A;GRIA2;GRM8;HOMER1;APP;CDK5R1;HOMER3;GRM1;GRIN1;DAGLB
prerank,positive regulation of neutrophil migration (GO:1902624),0.7909839531182463,1.864874889946948,0.0,0.08143356899603688,0.683,5/18,4.69%,DAPK2;CAMK1D;RIPOR2;CCL19;MCU
prerank,regulation of epithelial cell proliferation (GO:0050678),0.6044599306444456,1.8615212835469779,0.0,0.08167103910221798,0.708,18/85,8.61%,IGF1;TCF7L2;BMP6;MTSS1;ANGPT1;TGFBR3;MCC;TGFA;LAMC1;EPGN;FGFR2;YAP1;NUPR1;SFRP1;ZFP36L1;NR1D1;OSR1;EGFR
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.7734851750183898,-1.8614456364432195,0.0,0.10639158952660857,0.77,6/11,6.82%,KCNJ2;ATP1A1;KCNJ3;KCND3;KCNQ1;ATP1B1
prerank,negative regulation of peptidase activity (GO:0010466),0.660884225060872,1.8561519249431226,0.0013966480446927375,0.08695547954426092,0.742,13/47,7.14%,TIMP3;LRP1;AHSG;SERPINE1;SERPING1;VTN;FETUB;SERPIND1;SERPINF1;CST3;SERPINH1;CRB2;TIMP2
prerank,actin cytoskeleton reorganization (GO:0031532),0.6256075714198285,1.849950593688358,0.0,0.09300386936870148,0.776,13/63,5.11%,NRP1;AUTS2;PHACTR1;NRK;ANTXR1;GSN;NEDD9;PARVA;KIT;DTNBP1;THSD7A;MCU;PTK7
prerank,cellular response to zinc ion (GO:0071294),-0.7115708198269621,-1.8483424625591955,0.002364066193853428,0.11705423626928368,0.823,10/15,5.93%,GLRA1;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;GLRA2
prerank,chloride transport (GO:0006821),-0.48809239937487015,-1.845990952765064,0.0,0.11308441861626696,0.833,27/74,14.00%,SLC4A10;SLC12A2;SLC26A7;SLC12A7;CLIC4;GABRG3;ANO1;ANO4;CLCN3;CLIC5;GABRA2;GABRB3;GLRA1;GABRB1;GABRG2;SLC1A1;GLRA2;SLC12A6;CLIC1;GABRB2;SLC4A8;GABRA3;SLC26A6;ANO3;ANO2;CFTR;SLC12A5
prerank,primary alcohol metabolic process (GO:0034308),0.7440244462837478,1.84521007925444,0.0,0.09689522788798482,0.802,5/25,7.29%,IGF1;RBP4;DHRS3;CYP1B1;ADH1A
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.7945241056381771,1.8447051676386375,0.0,0.09366061126092348,0.806,5/17,4.69%,DAPK2;CAMK1D;RIPOR2;CCL19;MCU
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.6096768886836726,1.8425250146705328,0.0012422360248447205,0.09356428911673091,0.819,15/74,6.32%,IGF1;TCF7L2;EYA2;GDNF;AR;EYA1;SERPINE1;BCL2;SH3RF1;CFLAR;TGFBR1;RFFL;ACVR1;PHIP;SRC
prerank,establishment of endothelial barrier (GO:0061028),-0.57939816686708,-1.8307661076641333,0.0,0.13055971552747642,0.88,13/29,10.46%,PDE4D;PECAM1;RAP1A;F11R;PPP1R16B;TJP2;TJP1;RDX;PDE2A;RAP1B;ROBO4;SOX18;MSN
prerank,synapse assembly (GO:0007416),-0.48040335422915953,-1.8303130553486073,0.0,0.12414852928765258,0.882,18/67,6.25%,DNM3;ADGRL3;GRID2;SHANK3;CDH2;GPM6A;NLGN1;CDH1;SPOCK2;KIRREL3;NRCAM;GABRA2;GABRB3;DNER;NRXN1;GABRG2;LRRTM3;CDK5
prerank,regulation of glucose import (GO:0046324),0.6892567492822439,1.8251511226282315,0.0030816640986132513,0.120773150026056,0.893,11/30,12.56%,IGF1;ENPP1;PID1;PIK3R1;PRKAG2;APPL2;OSBPL8;CREBL2;RHOQ;SELENOS;INSR
prerank,regulation of smooth muscle cell migration (GO:0014910),0.752559706009265,1.8244260025186756,0.0032520325203252032,0.117539302659927,0.893,11/20,11.08%,IGF1;NRP1;LRP1;SERPINE1;BMPR1A;PDGFRB;VTN;IGFBP5;CCN4;S100A11;IGFBP3
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.7319934893234387,1.8238665020974754,0.004658385093167702,0.11460886705618512,0.897,8/23,5.92%,NREP;TGFBR3;SMAD3;ITGA3;SMURF2;ENG;DKK3;BCL9
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.6159379339090685,1.8234046596229925,0.0,0.11132112780729983,0.898,18/65,10.37%,LTBP1;PDPK1;FBN1;SMAD3;LDLRAD4;FBN2;ADAMTSL2;NKX2-1;PMEPA1;TGFBR1;SLC2A10;SMURF2;SKI;EMILIN1;SPRY2;LEMD3;FAM89B;SPRED3
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.6015682387662872,1.8149483660798307,0.0,0.12376550597654551,0.934,29/74,15.88%,EPHA3;PHLDB2;COL1A1;SMAD3;LDLRAD4;DAG1;OLFM1;NKX2-1;TGFBR1;AXIN2;SFRP1;PDPN;CRB2;WWTR1;DAB2;BMP2;SPRY2;USF3;FOXA1;SPRED3;RGCC;VASN;PTEN;MDK;HPN;GLIPR2;SPRED1;BMP5;SDHAF2
prerank,neurotransmitter uptake (GO:0001504),0.8161216168853016,1.8057728046145056,0.0,0.1391029131582199,0.952,4/12,4.20%,SLC1A3;GLUL;ATP1A2;SLC22A2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.7458481247282402,1.8053692573320577,0.001594896331738437,0.1354847001866403,0.952,5/21,5.13%,IGF1;GJA1;BMPR1A;MMP2;IGFBP5
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.6905754448272712,1.8047751091304862,0.0014749262536873156,0.133099690156992,0.957,10/30,5.92%,NREP;TGFBR3;SMAD3;ITGA3;FSTL1;TWSG1;SMURF2;ENG;DKK3;BCL9
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.49400059681864383,-1.804226769097131,0.004048582995951417,0.1604621019869952,0.945,23/54,21.54%,NSA2;RPL3;RPL7;RPL35A;PAK1IP1;RPL11;MAK16;RPL26;RPL6;MALSU1;RPL7A;NVL;PPAN;SNU13;RPL14;RPL5;RPLP0;NPM1;RRP15;NOP16;RPF1;RRS1;RPF2
prerank,positive regulation of phospholipase activity (GO:0010518),0.7286744150853794,1.804137640363055,0.0,0.1304374794731447,0.96,11/22,10.17%,PDPK1;FGFR1;FGFR2;KIT;PDGFRA;PDGFRB;NTF3;AGTR1;NTRK3;ARL1;FGF2
prerank,regulation of osteoblast proliferation (GO:0033688),0.7804540003959137,1.7990680841541684,0.0,0.13624151703386755,0.966,7/17,8.76%,NELL1;MN1;CCN1;FGFR2;NPR3;SFRP1;BMP2
prerank,regulation of stress fiber assembly (GO:0051492),0.6026922349439259,1.7942295559324999,0.0,0.14296234032790484,0.97,21/74,7.55%,NRP1;PHLDB2;CCN2;ROCK2;PPM1E;PIK3R1;CGNL1;ARHGAP6;DLC1;TPM1;ARHGAP28;ARHGEF10L;TGFBR1;ASAP3;APOA1;SFRP1;CDC42;ALMS1;ARHGEF18;LPAR1;CARMIL1
prerank,regulation of bone mineralization (GO:0030500),0.6256190741227154,1.7919169844695582,0.001326259946949602,0.14416807982846605,0.97,18/55,9.41%,NELL1;BMP6;DDR2;ENPP1;SLC8A1;ADGRV1;AHSG;FBN2;BMPR1A;CCN1;ANKH;KL;WNT4;ACVR1;BCOR;OSR1;BMP2;TRPM4
prerank,neuron cell-cell adhesion (GO:0007158),-0.6911418936552557,-1.7913931051848977,0.004796163069544364,0.1762394174862213,0.964,9/14,21.03%,NLGN1;NRXN3;NCAM2;CNTN4;NRXN1;RET;NLGN3;CDK5R1;ASTN1
prerank,membrane repolarization during action potential (GO:0086011),-0.7164052972119497,-1.7888328863283478,0.0022935779816513763,0.1740158085256247,0.969,5/13,6.82%,KCNJ2;ATP1A1;KCND3;KCNQ1;ATP1B1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.7661172863984542,-1.783653484386454,0.00211864406779661,0.17561964971373137,0.974,3/10,1.90%,CAV1;ANK3;KCNAB1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.7245495531499351,1.7829648609185997,0.004862236628849271,0.15642924199909136,0.981,4/21,1.86%,EYA2;GDNF;EYA1;BCL2
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.7245495531499351,1.7829648609185997,0.004862236628849271,0.15642924199909136,0.981,4/21,1.86%,EYA2;GDNF;EYA1;BCL2
prerank,positive regulation of biomineral tissue development (GO:0070169),0.646758804226407,1.7820565419137306,0.002758620689655172,0.15472378109247006,0.981,11/40,4.67%,NELL1;BMP6;SLC8A1;ADGRV1;FBN2;BMPR1A;CCN1;KL;WNT4;WNT6;ACVR1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6980840298855926,1.7783613914026732,0.0061068702290076335,0.15980325950508925,0.985,5/26,2.08%,EYA2;GDNF;EYA1;BCL2;FGFR1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.62960433285769,-1.7782974102847071,0.007894736842105263,0.17992457074707746,0.977,10/18,23.02%,SHANK3;NLGN1;PTK2B;TSHZ3;NRXN1;NLGN3;CACNG3;CACNG4;RELN;CCL2
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.8026510913645559,1.777115238731234,0.001692047377326565,0.1592091581328153,0.988,3/13,4.04%,IGF1;CCL19;SLC2A10
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.8453304763211911,1.7734235052515588,0.0035842293906810036,0.16397165011384635,0.989,5/10,4.71%,LYN;GAS6;CCL19;RAPGEF2;AXL
prerank,positive regulation of protein processing (GO:0010954),0.7504224853700068,1.7707689646389901,0.0,0.16637461269624002,0.99,3/19,1.20%,CCBE1;CLEC3B;GSN
prerank,negative regulation of endopeptidase activity (GO:0010951),0.6324548215508113,1.7703921477187805,0.0027397260273972603,0.16360119040518786,0.99,13/47,7.14%,TIMP3;AHSG;SERPINE1;SERPING1;RECK;VTN;FETUB;MT3;SERPIND1;SERPINF1;SERPINH1;CRB2;TIMP2
prerank,regulation of AMPA receptor activity (GO:2000311),-0.5754828230631646,-1.7688437666164563,0.005847953216374269,0.19201025359509855,0.988,12/25,22.69%,MEF2C;SHANK3;NLGN1;SHANK1;ADRB2;GSG1L;NLGN3;CACNG3;CACNG4;SHISA9;MINK1;RELN
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.7260996215551724,-1.7683111971596885,0.002207505518763797,0.1858214389827501,0.988,6/12,10.37%,PDE4D;CAV1;GJD3;CAMK2D;CALM1;CALM3
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.6343149280246875,1.7631236692581027,0.0027100271002710027,0.17783227902644716,0.995,9/46,6.81%,IGF1;TCF7L2;OGN;ELN;IL6R;PDGFRB;IGFBP5;VIP;IL12B
prerank,regulation of osteoblast differentiation (GO:0045667),0.5833045223943829,1.7623419468016088,0.00125,0.17603330271249484,0.995,27/82,15.03%,IGF1;NELL1;BMP6;DDR2;FBN2;IL6R;BMPR1A;CCN1;FGFR2;WNT4;YAP1;RUNX2;ACVR1;SKI;SMOC1;WWTR1;BMP2;CCN4;TRPM4;DNAI3;REST;TMEM64;LRP3;TMEM119;TWIST2;BMP4;SUFU
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.7534720692580644,1.7598506710023247,0.003189792663476874,0.1791465142318205,0.995,8/17,14.66%,ADRA1B;ADCY9;RAPGEF2;ADRA2C;ADRB3;DRD3;ADRA2A;AKAP13
prerank,regulation of steroid metabolic process (GO:0019218),0.7054432030014501,1.7581926423633416,0.0031545741324921135,0.18027035879819178,0.996,6/23,6.59%,RORA;EPHX2;APOE;STAR;GNB3;NR5A1
prerank,regulation of smooth muscle contraction (GO:0006940),-0.6241386922505902,-1.757689016162728,0.0028089887640449437,0.20219297549430246,0.994,7/20,16.47%,PLCE1;CAV1;KCNB2;CHRM3;ADRB2;CHRM2;CTTN
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.6638133920070478,1.7555093007467104,0.0014771048744460858,0.18353931096565484,0.997,12/33,6.96%,TCF7L2;PDPK1;ANGPT1;SERPINE1;YAP1;GAS6;NUPR1;SEMA5A;CAST;NEUROD1;CDH5;NFE2L2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.613023668841055,1.751158716694913,0.0027624309392265192,0.19035800426083838,0.998,9/49,7.08%,IGF1;GHR;IL31RA;LYN;IL6R;KIT;PIBF1;IL12B;TSLP
prerank,positive regulation of bone mineralization (GO:0030501),0.6532417848109601,1.7502905459461835,0.0014044943820224719,0.18944654918520504,0.998,10/35,4.67%,NELL1;BMP6;SLC8A1;ADGRV1;FBN2;BMPR1A;CCN1;KL;WNT4;ACVR1
prerank,positive regulation of T cell proliferation (GO:0042102),0.5940066675324011,1.7461186620497016,0.001358695652173913,0.19840257346991852,0.998,6/55,7.10%,IGF1;IGFBP2;IGF2;CCL19;IL12B;CD28
prerank,cellular response to copper ion (GO:0071280),-0.6746171138506174,-1.7451907923583425,0.0024752475247524753,0.22183812706560666,0.997,8/16,4.62%,MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.7938831987526067,1.74413129218896,0.0070052539404553416,0.1999858007397576,0.998,2/13,0.46%,IGF1;IGF2
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.7991830014284458,1.743703889923616,0.005338078291814947,0.19734517771891957,0.998,3/11,1.19%,IGF1;GHR;PIK3R1
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.6671916492303634,1.7424449879325459,0.0,0.19702585960590938,0.998,12/34,13.25%,IGF1;IGF2;TGFA;EPGN;PDGFRB;PHIP;CD28;DRD3;ANAPC5;RGCC;INSR;EGF
prerank,regulation of neuroinflammatory response (GO:0150077),0.7310414845280562,1.7417717396298467,0.0031847133757961785,0.19520576368774764,0.998,5/19,8.69%,IGF1;DAGLA;NUPR1;NR1D1;CD200
prerank,positive regulation of protein secretion (GO:0050714),0.5859444105257012,1.7411927177290674,0.0,0.19320369103741797,0.998,9/69,4.69%,IGF1;TCF7L2;RBP4;BMP6;WLS;SLC30A8;MYO18A;MYH10;MCU
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.5478791786102118,1.7392191587206545,0.0012224938875305623,0.19489552850808617,0.998,23/113,10.17%,IGF1;TCF7L2;NRP1;BMP6;AREG;TGFA;LAMC1;EPGN;FGFR2;VASH2;YAP1;TGFBR1;SEMA5A;NOTCH2;SFRP1;VIP;AKT3;OSR1;EGFR;BMP2;ITGB3;ARNT;FGF2
prerank,cAMP biosynthetic process (GO:0006171),0.8336595069708946,1.7381106373630524,0.006837606837606838,0.19406377261532615,0.998,5/10,3.53%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.7208229827828988,-1.7376371895328993,0.004576659038901602,0.2319174890348601,0.997,7/10,23.02%,KDR;IL33;NAMPT;JAK2;NOD2;TLR4;CCL2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.5095063604241874,1.7365873673914838,0.0,0.1948882037373194,0.998,57/248,13.40%,IGFBP2;TCF7L2;LYPD6;WLS;BICC1;LRRK1;COL1A1;RNF220;DAAM2;CDK14;TBL1XR1;RBMS3;MCC;ZEB2;IGFBP4;LGR4;DACT1;NKD1;KANK1;GLI3;FGFR2;APOE;SEMA5A;TMEM170B;TLE1;SMURF2;PRICKLE1;PSME4;AXIN2;MLLT3;SFRP1;PTK7;DKK3;USP47;ZNRF3;ADGRA2;LRRK2;WWTR1;STK4;DAB2;EGFR;BMP2;PRKN;TRPM4;STK11;INVS;DDX3X;LZTS2;JADE1;TMEM64;WNK1;GLI1;BTRC;UBAC2;KLHL12;EGF;TNKS2
prerank,response to copper ion (GO:0046688),-0.6293722665869527,-1.7301013261513178,0.005194805194805195,0.2417136569604222,0.999,8/20,4.62%,MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H
prerank,protein oxidation (GO:0018158),0.8089099054144904,1.7272697139089432,0.0017211703958691911,0.21562096284871027,0.999,3/11,4.31%,LOXL1;LOX;APOA1
prerank,regulation of small molecule metabolic process (GO:0062012),0.6699695290959029,1.7252548550107618,0.006097560975609756,0.21758987292955909,0.999,7/28,10.78%,PDK1;RORA;EPHX2;APOE;GNB3;PRKN;NCOR2
prerank,angiogenesis involved in wound healing (GO:0060055),-0.7200273364716451,-1.7242314713417703,0.011210762331838564,0.2490594045025869,0.999,7/11,9.51%,ADIPOR2;CD34;KDR;PRCP;GATA2;MCAM;VEGFA
prerank,response to histamine (GO:0034776),-0.724815958733552,-1.721614113532621,0.00909090909090909,0.24750258727514082,0.999,6/10,11.62%,DIAPH1;GABRB3;GABRB1;GABRG2;GABRB2;HRH1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.8001114986408279,1.7215317548446496,0.005309734513274336,0.22428167686415657,1.0,2/12,0.46%,IGF1;IGF2
prerank,lung development (GO:0030324),0.6442905700816023,1.7206322477650744,0.004437869822485207,0.22338938088771687,1.0,14/33,14.90%,RBP4;ERRFI1;GLI2;ITGA3;NKX2-1;FGFR2;PDPN;CEBPA;DNAAF1;FGF2;RCN3;CCDC40;ABCA3;BMP4
prerank,regulation of mitotic nuclear division (GO:0007088),0.5958064139748042,1.7194281923553334,0.004076086956521739,0.22312325713759829,1.0,15/55,13.25%,IGF1;IGF2;TGFA;OBSL1;EPGN;PDGFRB;TOM1L2;PHIP;CD28;DRD3;L3MBTL1;RGCC;NME6;INSR;EGF
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.6929242901673941,1.718487467334577,0.0031847133757961785,0.22251701621483141,1.0,3/24,0.63%,IGF1;IGF2;ENPP1
prerank,retinol metabolic process (GO:0042572),0.7727709005150325,1.7169959312317158,0.006666666666666667,0.22328546583337242,1.0,4/14,7.29%,RBP4;DHRS3;CYP1B1;ADH1A
prerank,positive regulation of ATP metabolic process (GO:1903580),0.6453753235275467,1.7112014745689994,0.008849557522123894,0.23569903781062737,1.0,6/32,5.20%,IGF1;ZBTB20;PID1;PFKFB4;NUPR1;PRKAA2
prerank,defense response to tumor cell (GO:0002357),0.8209312673905765,1.709523338268435,0.007104795737122558,0.23751737149918778,1.0,3/10,1.83%,DAPK1;RBMS3;DLEC1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.5259671456353964,1.7092925639800918,0.0,0.23494320478220862,1.0,28/152,6.62%,LYPD6;WLS;LRRK1;COL1A1;RNF220;DAAM2;TBL1XR1;ZEB2;LGR4;DACT1;SULF2;SALL1;KANK1;MACF1;FGFR2;SEMA5A;LBX2;SULF1;SMURF2;PSME4;AXIN2;SFRP1;PTK7;USP47;SKI;ADGRA2;LRRK2;WNT5B
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.4147615426498528,-1.7090480334481077,0.0,0.27213439464784167,0.999,33/107,11.60%,GRM7;SLC12A2;GRID2;MEF2C;MCTP1;GRM3;CDH2;NRG3;NLGN1;RIMS1;NGF;GRIK1;GRIK2;PXK;DLGAP2;GRM5;OPHN1;CDK5;RIMS2;SYT1;TMEM108;CLSTN2;LRP8;SLC4A8;TPRG1L;LRRC4C;BCR;SYN3;GRID1;CLSTN3;GRM8;CX3CR1;HOMER1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.8031569231569686,1.7083601902253494,0.008865248226950355,0.2343134732777786,1.0,3/10,4.30%,NELL1;EPHA4;CDK5RAP3
prerank,myoblast differentiation (GO:0045445),0.7781874220840326,1.7037259649931291,0.008460236886632826,0.2435623822005381,1.0,5/14,7.41%,IGF1;TCF7L2;EPAS1;SDC1;DDX17
prerank,regulation of protein processing (GO:0070613),0.692893465594641,1.7033967715772116,0.015384615384615385,0.24128491596457774,1.0,8/21,15.33%,CCBE1;RUNX1;LRRK2;RNF139;SNX12;CLN3;GAS1;NLRC4
prerank,regulation of dendrite extension (GO:1903859),-0.6192142633437959,-1.7026143606654336,0.005141388174807198,0.28211075008188546,0.999,6/18,7.82%,SMURF1;RIMS1;NEDD4L;RIMS2;SYT1;ITSN2
prerank,positive regulation of dendrite extension (GO:1903861),-0.6273028362717712,-1.7010669020834013,0.007731958762886598,0.2780769212248455,0.999,6/17,7.82%,SMURF1;RIMS1;NEDD4L;RIMS2;SYT1;ITSN2
prerank,organic anion transport (GO:0015711),-0.4364362379317826,-1.6995843336380132,0.005747126436781609,0.27361925493609873,0.999,19/76,13.10%,SLC4A10;ABCG2;SLC26A7;LRRC8C;ABCC4;SLCO2A1;SLCO1C1;LRRC8D;SLCO2B1;CA4;SLC22A6;SLC39A8;ABCC6;SLC4A8;SLC26A6;SLC52A3;SLC35A2;SLC25A4;CFTR
prerank,positive regulation of stress fiber assembly (GO:0051496),0.6139738746426435,1.6981800091071795,0.008321775312066574,0.25274930636127746,1.0,15/44,11.52%,NRP1;CCN2;ROCK2;PPM1E;TPM1;ARHGEF10L;TGFBR1;APOA1;SFRP1;CDC42;LPAR1;CARMIL1;SYNPO2L;ARHGEF10;RGCC
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.7530192488306043,1.6967620798700513,0.022847100175746926,0.25381285225255595,1.0,5/13,10.17%,PDPK1;IGF2;FGFR1;AKT3;FGF2
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.526571552982883,1.6932302703526017,0.0,0.26060308348803213,1.0,21/129,6.60%,LYPD6;WLS;LRRK1;COL1A1;RNF220;DAAM2;TBL1XR1;ZEB2;LGR4;DACT1;KANK1;FGFR2;SEMA5A;SMURF2;PSME4;AXIN2;SFRP1;PTK7;USP47;ADGRA2;LRRK2
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.5469585914142171,-1.6921448781287192,0.008547008547008548,0.28558350758796663,1.0,7/27,7.81%,UTRN;NEDD4L;YWHAH;CAMK2D;FGF12;NOS1;ATP2B4
prerank,regulation of membrane repolarization (GO:0060306),-0.6791814361000404,-1.6874479859074376,0.007263922518159807,0.2900635497839448,1.0,7/13,14.78%,CAV1;KCNJ2;NEDD4L;KCNQ1;AKAP6;CASQ2;CACNA2D1
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.37046826985095027,-1.6842519450923592,0.0,0.29222050472899186,1.0,84/224,23.35%,GRM7;DLG2;SLC12A7;EXOC4;UNC13B;GRM3;GRIA4;RIT2;NLGN1;GABRG3;KCND2;GRIK1;GRIK2;GRIN2A;SDCBP;GABRA2;GABRB3;SYPL1;AMPH;GLRA1;GABRB1;NRXN1;GABRG2;PRKACB;SLC1A1;LRP6;CHRM3;GLRA2;GRM5;CDK5;SLC12A6;GRIN2B;PRKAR1A;SYT1;CAMK4;HCRTR2;GABRB2;GRIA2;PRKAR2B;PAFAH1B1;HTR2A;RPS6KA1;GABRA3;KCNQ3;PRKAR1B;CALM1;PRKAR2A;HOMER1;HRH1;CPLX1;SYN2;PCDHB14;SLC12A5;GPR176;CHRM2;PLP1;GIPC1;NLGN3;GRM1;CACNA1A;SYNJ2BP;APBA2;SLC1A2;SYN1;KIF5A;KCNIP2;GRIN1;CACNB3;GABRA4;GABRG1;GAD1;PNOC;NPY5R;HAP1;CAMKK1;GABARAP;KCNC4;PTCHD1;MAPK1;GABRR2;MINK1;GLRA3;SYT5;CHRM1
prerank,cell-matrix adhesion (GO:0007160),0.5381358264043703,1.6835107648301901,0.0012077294685990338,0.2859636774753208,1.0,25/95,11.27%,ITGBL1;ADAMTS12;FBLN5;ACTN2;DLC1;ITGA11;RHOD;ITGA3;NID2;COL13A1;VTN;ITGB8;ECM2;ITGB5;ADAMTS9;SRC;EMILIN1;VCL;CD63;ITGB6;ITGB3;ITGAV;LYVE1;TRIP6;SGCE
prerank,activation of protein kinase B activity (GO:0032148),0.6502885049686132,1.6831318536283493,0.005847953216374269,0.2835759861338592,1.0,8/29,8.17%,IGF1;PDPK1;GAS6;MT3;NTF3;OSBPL8;ADRA2C;NTRK3
prerank,modulation by symbiont of entry into host (GO:0052372),-0.6288640722451428,-1.6791436698604738,0.01990049751243781,0.29874039126742974,1.0,9/16,21.76%,CAV1;TRIM14;HS3ST5;TRIM25;EXOC2;TRIM68;TRIM6;TRIM62;NECTIN2
prerank,respiratory system development (GO:0060541),0.6336858190688325,1.6784955993175277,0.014858841010401188,0.2956456128394535,1.0,15/32,16.72%,RBP4;GLI2;ITGA3;NKX2-1;FGFR2;PDPN;CEBPA;DNAAF1;FGF2;CCDC40;ABCA3;BMP4;SPEF2;SMCHD1;SHH
prerank,negative regulation of protein catabolic process (GO:0042177),0.6137703237913598,1.6715098848911645,0.0071633237822349575,0.3152281425862558,1.0,13/40,14.43%,NELL1;TIMP3;CDK5RAP3;SNRNP70;CST3;TIMP2;SIRT2;IRAK3;EGFR;SNX12;PTPN3;BANP;FLNA
prerank,rRNA processing (GO:0006364),-0.38469270249579457,-1.6711716183460759,0.0,0.31319160471143587,1.0,65/172,20.65%,NSA2;RPL41;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;RPL21;RPL7;RPL18;RIOK1;RPL27;RPL35A;RPL38;RPS15;RPL39;RPS7;RPL11;WDR36;RPL30;RPL36;RPLP1;RPL37;MAK16;RPS9;UTP4;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;LSM6;RPL7A;NVL;RPL19;RRP1;SNU13;POP4;RPL14;RPL13;RPL32;RPL5;NOL9;PRKDC;RPLP0;MPHOSPH10;KRR1;RPS6;RPL22;UTP15;RRP36;IMP4;FCF1;EXOSC5;RRP15;RRP12;RPL37A;RPLP2;RPL17;RPL23;RPF1
prerank,epidermis development (GO:0008544),0.5793981103030674,1.6697930157279077,0.007863695937090432,0.3178878055258697,1.0,5/56,4.52%,SVEP1;CCN2;FGFR2;TGM5;EDAR
prerank,diol biosynthetic process (GO:0034312),-0.6372480444078238,-1.669244386648723,0.009708737864077669,0.31112644013947544,1.0,6/15,10.72%,ACER3;ACER2;GCH1;DHFR;SPTLC2;SPR
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.5684870080183224,1.6688424217920743,0.008962868117797696,0.3175271393782133,1.0,12/63,6.42%,IGF1;TCF7L2;AR;FGFR1;SH3RF1;SP100;CFLAR;TGFBR1;ACVR1;PHIP;SRC;PML
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5151568471292873,-1.6683838439204852,0.0033112582781456954,0.305608733391484,1.0,10/37,3.96%,HMCN1;GRID2;CADM1;NLGN1;IL1RAPL1;TENM2;TENM3;TENM4;PTPRD;NECTIN1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.7467762946040862,1.6680936408022733,0.017684887459807074,0.316318058986244,1.0,4/14,8.69%,IGF1;LDLR;NR1D1;CD200
prerank,respiratory tube development (GO:0030323),0.6434657264357337,1.666463030946255,0.01775147928994083,0.31810760883308853,1.0,12/28,14.90%,RBP4;GLI2;ITGA3;NKX2-1;FGFR2;PDPN;CEBPA;DNAAF1;FGF2;CCDC40;ABCA3;BMP4
prerank,response to iron ion (GO:0010039),0.7661074452669602,1.6658339811637612,0.010273972602739725,0.3166369432777949,1.0,4/12,6.50%,BMP6;BCL2;SLC11A2;ACO1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.5908741207095055,1.6649178033278562,0.00816326530612245,0.31609746121413246,1.0,16/51,11.52%,NRP1;CCN2;ROCK2;PPM1E;TPM1;ARHGEF10L;TGFBR1;APOA1;SYNPO2;SFRP1;CDC42;LPAR1;CARMIL1;SYNPO2L;ARHGEF10;RGCC
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.5154385235925366,1.6645758316237964,0.002352941176470588,0.31365762336771064,1.0,21/121,7.08%,IGF1;NRP1;BMP6;IGF2;ANGPT1;GHR;IL31RA;LYN;NEDD9;EPHA4;IL6R;IL34;KIT;GAS6;VTN;ACVR1;NTF3;PIBF1;SRC;IL12B;TSLP
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.7365341747663403,1.6645212760386288,0.008503401360544218,0.3102473037014768,1.0,2/15,0.75%,IGF1;ROCK2
prerank,activation of adenylate cyclase activity (GO:0007190),0.6200666707163621,1.6644083619509646,0.012413793103448275,0.307160615369608,1.0,8/35,6.10%,ADCY1;ADCY2;ADCY7;LGR4;ADCY5;ADCY9;LHCGR;ADRB3
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.7649013124589155,1.664021137847679,0.02586206896551724,0.3049105607835277,1.0,1/12,0.15%,RBP4
prerank,pigment granule transport (GO:0051904),-0.6021845182439945,-1.6622148854759153,0.013123359580052493,0.3086781562148376,1.0,8/18,19.54%,RAB27A;RAB11A;RAB27B;ARL6;MLPH;BLOC1S5;BBS7;MREG
prerank,melanosome transport (GO:0032402),-0.6021845182439945,-1.6622148854759153,0.013123359580052493,0.3086781562148376,1.0,8/18,19.54%,RAB27A;RAB11A;RAB27B;ARL6;MLPH;BLOC1S5;BBS7;MREG
prerank,ethanol metabolic process (GO:0006067),0.7667602487822884,1.6616831652449155,0.013513513513513514,0.30939907048763493,1.0,3/12,8.59%,ALDH1A1;ADH1A;ALDH2
prerank,sympathetic nervous system development (GO:0048485),0.7554507993189497,1.659981300530665,0.008305647840531562,0.31197036288286406,1.0,3/15,3.21%,NRP1;GDNF;ASCL1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.5693352824349825,1.6566113032993315,0.004166666666666667,0.3193515927333845,1.0,9/57,7.08%,IGF1;GHR;IL31RA;LYN;IL6R;KIT;PIBF1;IL12B;TSLP
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.701086478583736,1.6561964828475964,0.01694915254237288,0.317558900643261,1.0,8/19,8.91%,ROBO1;CCBE1;DCN;SMOC2;IL12B;MYO1C;CD63;SPRY2
prerank,positive regulation of protein maturation (GO:1903319),0.7636771252089862,1.6560623355542925,0.024263431542461005,0.3146734609729312,1.0,1/11,0.21%,CCBE1
prerank,sulfur compound catabolic process (GO:0044273),0.6217423454133109,1.6532364897082283,0.010294117647058823,0.3205755659513426,1.0,11/38,8.05%,FMOD;OGN;LUM;DCN;BGN;GALNS;CHAC2;NUDT7;DPEP1;OMD;CSPG5
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.5474704332127747,-1.65272709305115,0.008310249307479225,0.32996295351050803,1.0,12/28,18.87%,OCLN;NAV3;MET;RPS3;MECP2;PAK1;FES;GIT1;DCTN1;CDK5RAP2;CDK5R1;CLASP1
prerank,inorganic anion transmembrane transport (GO:0098661),-0.4538466071615265,-1.652390722012059,0.004310344827586207,0.324038447122468,1.0,26/63,14.00%,SLC12A2;SLC12A7;SLC26A2;GABRG3;ANO1;ANO4;CLCN3;SLC5A6;GABRA2;GABRB3;GLRA1;GABRB1;GABRG2;SLC1A1;GLRA2;SLC12A6;GABRB2;SLC37A3;SLC4A8;SLC25A30;GABRA3;ANO3;ANO2;CFTR;SLC25A11;SLC12A5
prerank,rRNA metabolic process (GO:0016072),-0.3826718994572961,-1.6522331279104236,0.0,0.3177128561323872,1.0,78/160,28.34%,RPL41;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;RPL21;RPL7;RPL18;RPL27;RPL35A;RPL38;RPS15;RPL39;RPS7;RPL11;WDR36;RPL30;RPL36;RPLP1;RPL37;NIFK;RPS9;UTP4;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;RPL7A;NVL;RPL19;RRP1;SNU13;POP4;RPL14;RPL13;DEDD2;RPL32;RPL5;NOL9;RPLP0;MPHOSPH10;KRR1;RPS6;RPL22;UTP15;RRP36;IMP4;FCF1;EXOSC5;RRP12;RPL37A;RPLP2;RPL17;RPL23;RPF1;WDR46;RPL28;RPL31;NOL8;PDCD11;EXOSC4;NOP56;RPS27;NOLC1;NOC4L;RPS16;PIH1D1;RPL10;RPL15;WDR18;RPL12;RPL9
prerank,eye morphogenesis (GO:0048592),0.7071312368610274,1.6517328646412353,0.01740506329113924,0.32261193342775574,1.0,8/19,5.82%,FBN1;COL5A1;FBN2;NKD1;SHROOM2;MFAP5;RARG;SKI
prerank,lipid oxidation (GO:0034440),-0.6593138762640011,-1.6508191678287145,0.022113022113022112,0.31507688476537643,1.0,4/12,16.45%,ADIPOR2;PLA2G7;PPARGC1A;ACOX1
prerank,cellular biogenic amine catabolic process (GO:0042402),0.8021807274679877,1.649228797941385,0.0051813471502590676,0.3281405103593431,1.0,7/10,11.59%,SMOX;SLC44A1;COMT;HNMT;ALDH7A1;LRTOMT;SARDH
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.6704634825075149,1.6490461248463326,0.019077901430842606,0.3255080123324154,1.0,7/24,9.70%,CCBE1;RORA;SULF2;SULF1;CYP1B1;EIF2AK3;ARNT
prerank,regulation of multicellular organism growth (GO:0040014),0.7287125461589209,1.6471028593978818,0.01839464882943144,0.3283887421393458,1.0,2/15,1.00%,IGF1;GHR
prerank,negative regulation of receptor binding (GO:1900121),-0.7089723914263989,-1.6470493105991941,0.0117096018735363,0.31995229542167664,1.0,3/10,6.54%,B2M;ADAM15;ATP2A3
prerank,outflow tract septum morphogenesis (GO:0003148),0.6554947866519512,1.6462248205579604,0.019938650306748466,0.32822093695501947,1.0,7/24,5.70%,NRP1;ROBO1;BMPR1A;PARVA;FGFR2;ACVR1;ENG
prerank,acylglycerol metabolic process (GO:0006639),-0.49397689911229403,-1.6455424667924277,0.012578616352201259,0.3178712676978991,1.0,16/37,20.81%,CAV1;MGLL;ABHD2;DGKB;DGKH;DGKK;PGS1;PLAAT3;PNPLA3;DGKG;DGKQ;PNPLA2;ABHD6;DGKZ;LYPLA2;DGKI
prerank,positive regulation of ossification (GO:0045778),0.6062023666659209,1.64477716671311,0.016666666666666666,0.3299956300221961,1.0,10/39,4.67%,NELL1;BMP6;SLC8A1;ADGRV1;FBN2;BMPR1A;CCN1;KL;WNT4;ACVR1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.6639301609065045,1.644317725611442,0.0125,0.3283532202839494,1.0,4/23,5.20%,IGF1;ZBTB20;PFKFB4;PRKAA2
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.7942127395819898,1.6441371756507097,0.028021015761821366,0.3257861153652721,1.0,2/10,2.73%,RUNX1;SH3RF1
prerank,melanocyte differentiation (GO:0030318),0.7657291303146133,1.6441345110999954,0.015817223198594025,0.32272222670434775,1.0,5/11,6.53%,ENPP1;LRMDA;MITF;KIT;SLC24A5
prerank,positive regulation of glycolytic process (GO:0045821),0.6856510623994216,1.6440664725263194,0.00964630225080386,0.31690548726745177,1.0,4/20,5.20%,IGF1;ZBTB20;PFKFB4;PRKAA2
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.6856510623994216,1.6440664725263194,0.00964630225080386,0.31690548726745177,1.0,4/20,5.20%,IGF1;ZBTB20;PFKFB4;PRKAA2
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.6774929314259011,1.6437994444355783,0.01437699680511182,0.3148166729167552,1.0,8/22,14.46%,SH3D19;TIMP3;APOE;SNX33;TIMP2;ADRA2A;PTPN3;SNX9
prerank,regulation of protein autophosphorylation (GO:0031952),0.6119705384945537,1.6429457058112173,0.008915304606240713,0.31468306246258354,1.0,10/36,13.64%,EPHA7;ENPP1;ERRFI1;PDGFD;ENG;DDX3X;IMPACT;PPP2R5D;RAP2A;MVP
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.6942018618036732,1.6427848753373908,0.0078125,0.31226826186504086,1.0,9/21,9.78%,BMP6;CILP;BMPR1A;TGFBR1;SLC2A10;WWTR1;DAB2;RBPMS;FAM89B
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.6585037212197747,1.6424228708202349,0.02365930599369085,0.310638915021006,1.0,7/26,9.70%,CCBE1;RORA;SULF2;SULF1;CYP1B1;EIF2AK3;ARNT
prerank,positive regulation of behavior (GO:0048520),-0.7140773686310538,-1.6405679956698238,0.022675736961451247,0.3254772217305985,1.0,3/10,1.44%,MEF2C;SGIP1;NLGN1
prerank,proteoglycan metabolic process (GO:0006029),0.6638810151166228,1.6401123719814754,0.00906344410876133,0.31523855537188733,1.0,5/26,4.16%,IGF1;ADAMTS12;GAL3ST3;SULF2;SULF1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.7098219250414155,1.637890681156939,0.023333333333333334,0.3192327536014364,1.0,4/16,9.33%,PDK1;RORA;GNB3;PRKN
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.5133967127136329,-1.637014406347256,0.006666666666666667,0.32947699923435114,1.0,13/33,11.16%,GRID2;NRG3;NLGN1;NGF;GRIK1;GRIK2;PXK;LRP8;SLC4A8;LRRC4C;BCR;GRID1;CX3CR1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5685485282260524,1.6363319311653597,0.006622516556291391,0.3213941530664888,1.0,14/55,10.17%,GPC6;FMOD;OGN;CEMIP;LUM;DCN;BGN;HSPG2;GALNS;SDC1;OMD;CSPG5;LYVE1;FGF2
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.5821591487751376,1.6357045045286362,0.014864864864864866,0.32070379242914876,1.0,7/43,5.13%,IGF1;GJA1;IL6R;BMPR1A;MMP2;PDGFRB;IGFBP5
prerank,regulation of axon guidance (GO:1902667),0.7631170160877956,1.6355731129139182,0.014035087719298246,0.31843936216822394,1.0,2/10,0.51%,NRP1;MYCBP2
prerank,positive regulation of phosphorylation (GO:0042327),0.47936240668535585,1.634674116205554,0.0,0.31856766243881907,1.0,47/240,10.18%,IGF1;EPHA3;NRP1;EPHA7;ZBTB20;IGF2;DDR2;ROCK2;ANGPT1;AR;LYN;FGFR1;EPHA4;LEPR;IL34;PELI2;EPHA8;CCN1;FGFR2;KIT;FGFR4;PFKFB4;GAS6;PDGFRA;PDGFRB;MT3;AXL;AXIN2;PRKAA2;MUSK;SLCO3A1;ROR1;ENG;LRRK2;NTRK3;STK4;DAB2;DSCAM;ARRB1;EGFR;EPHB2;BMP2;ITGB3;LMO4;ARNT;FGF2;RYK
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.4570993577289909,-1.6340708821513972,0.0,0.3314388146455029,1.0,19/54,15.08%,CAV1;DPP10;FHL1;KCNIP4;KCNJ2;KCNAB1;NEDD4L;KCNJ3;KCNMA1;KCNN2;KCNQ1;AKAP6;KCNMB2;DPP6;KCNJ15;GNB1;KCNJ10;GNG2;CACNA1D
prerank,regulation of cell differentiation (GO:0045595),0.5011064139140415,1.6323346500101459,0.0,0.32323513350138416,1.0,27/148,7.79%,EPHA3;PHLDB2;IGF2;CCN2;NREP;TRPS1;GDNF;AR;DAG1;RUNX1;FGFR1;FGFR2;RUNX2;TGFBR1;CSF1;CDK5RAP3;NEUROD4;NTF3;NEUROD1;GNB3;BCL6;ZFP36L1;SIK1;SMOC1;DDX17;PPP1R13L;NR1D1
prerank,activation of protein kinase activity (GO:0032147),0.5221340723067306,1.6320530336761354,0.00851581508515815,0.3214286850327515,1.0,28/106,12.56%,IGF1;PDPK1;ADCY1;NRK;ANGPT1;ADCY2;GHR;ADCY7;ADCY5;GAS6;ADCY9;MT3;NTF3;OSBPL8;ADRA2C;PIBF1;TLR6;NTRK3;STK4;PRRC1;MAP4K4;ITGB3;STK11;TAOK3;ADRA2A;TNFSF15;STRADA;INSR
prerank,intestinal absorption (GO:0050892),-0.6452092667599113,-1.6316500305878745,0.023696682464454975,0.3334529887665436,1.0,5/13,10.27%,F11R;TJP2;KCNQ1;SLC26A6;UGCG
prerank,energy reserve metabolic process (GO:0006112),0.6882848927170754,1.6315002453141376,0.035541195476575124,0.32059059718687716,1.0,9/19,10.94%,PID1;PHKB;LEPR;PRKAG2;MT3;ADRB3;GFPT1;PYGM;PPP1R3C
prerank,positive regulation of dendrite development (GO:1900006),-0.6880191512922298,-1.6299238786327757,0.020689655172413793,0.33232330285184136,1.0,8/10,20.82%,COBL;LRP8;PTN;ALK;ZDHHC15;PACSIN1;VLDLR;DAB2IP
prerank,keratan sulfate catabolic process (GO:0042340),0.7793802078405023,1.6297172610015442,0.014519056261343012,0.32378036372717384,1.0,5/11,7.98%,FMOD;OGN;LUM;GALNS;OMD
prerank,neurotransmitter biosynthetic process (GO:0042136),0.7086072898542319,1.62954897917899,0.046357615894039736,0.32160138070419647,1.0,3/14,4.20%,MOXD1;DAGLA;SLC22A2
prerank,regulation of Wnt signaling pathway (GO:0030111),0.514121422114631,1.628917869955627,0.0035629453681710215,0.320831236985015,1.0,25/108,9.33%,WLS;TRABD2B;DAAM2;CDK14;LRP1;DACT1;SULF2;RUNX1;SALL1;NKD1;KANK1;ITGA3;MACF1;FGFR2;MDFI;TLE1;SULF1;SFRP1;PTK7;SKI;LRRK2;TCF7L1;BMP2;CBY1;PRKN
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.627888956692589,1.6288499754226495,0.023734177215189875,0.3184754818890512,1.0,7/26,12.56%,IGF1;PIK3R1;OSBPL8;CREBL2;BRAF;RHOQ;INSR
prerank,bicellular tight junction assembly (GO:0070830),-0.4680547970055902,-1.6285392382270745,0.0,0.3305171118955992,1.0,12/46,12.65%,MPP7;OCLN;PECAM1;CLDN5;ESAM;F11R;CLDN11;RAMP2;PDCD6IP;PATJ;STRN;PAK2
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.6860806105411534,1.6260384119652758,0.019417475728155338,0.3250972953533353,1.0,4/18,2.08%,PDPK1;IGF2;COL4A3;FGFR1
prerank,camera-type eye development (GO:0043010),0.6605601332812281,1.6253027688076054,0.01757188498402556,0.32483675117338423,1.0,7/25,6.67%,LAMA1;FBN1;FBN2;SHROOM2;CYP1B1;SKI;CACNA1C
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.6304049735906577,1.6233980591377366,0.019756838905775075,0.3280973036559075,1.0,13/29,15.88%,LDLRAD4;NKX2-1;SFRP1;SPRY2;USF3;FOXA1;SPRED3;VASN;PTEN;HPN;SPRED1;BMP5;SDHAF2
prerank,tight junction assembly (GO:0120192),-0.4612620766736771,-1.622856503525094,0.0037313432835820895,0.34073773280598596,1.0,9/49,4.01%,MPP7;OCLN;PECAM1;CLDN5;ESAM;F11R;LSR;CLDN11;RAMP2
prerank,positive regulation of signal transduction (GO:0009967),0.478989749148711,1.6227238971040494,0.0,0.32765248673645436,1.0,51/238,9.70%,IGF1;NRP1;ROBO1;CCBE1;BMP6;PTGIS;WLS;IGF2;ESM1;MN1;PIK3R1;SASH1;DACT1;SULF2;SALL1;KANK1;MACF1;FGFR2;YAP1;GAS6;MAML3;TGFBR1;SMO;VTN;SULF1;MT3;AXL;NTF3;PHIP;SFRP1;SMOC2;CUX2;SKI;ENHO;SRC;LRRK2;ING5;TSLP;TRAF7;MYO1C;CD63;RBPJ;NTRK3;DRD3;TEDC1;BMP2;ZMIZ1;KAT2B;ITGB3;ITGAV;ARNT
prerank,cAMP metabolic process (GO:0046058),0.72942396531935,1.6224255064960214,0.023961661341853034,0.32615379966352015,1.0,5/13,3.53%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9
prerank,regulation of macrophage cytokine production (GO:0010935),-0.6345339767779036,-1.6222962906012448,0.02364066193853428,0.33670865778461767,1.0,8/13,20.01%,SEMA7A;PLCG2;TGFB2;TGFB1;GPRC5B;SIRT1;CUEDC2;TGFB3
prerank,positive regulation of cell differentiation (GO:0045597),0.4822471794869011,1.620931602641912,0.0,0.328470508428128,1.0,47/237,8.96%,IGF1;TCF4;NELL1;BMP6;RIN2;COL1A1;GJA1;DDR2;CCN2;GDNF;SMAD3;AR;SOX5;FBN2;FGFR1;IL6R;SP7;BMPR1A;OLFM1;CCN1;ZEB1;MEDAG;WNT4;RIPOR2;ASCL1;YAP1;RUNX2;TGFBR1;CSF1;RAPGEF2;NEUROD4;ACVR1;NEUROD1;AXIN2;SFRP1;PDPN;ZFP36L1;ADRA2C;CDC42;CRB2;AGTR1;WWTR1;PPP1R13L;DAB2;CREBL2;BMP2;CCN4
prerank,determination of bilateral symmetry (GO:0009855),-0.5458356601906335,-1.620075980174945,0.011730205278592375,0.33746284783919556,1.0,11/24,23.28%,NOTCH1;TBX1;ZIC3;GALNT11;DNAH11;STIL;ARL6;CITED2;BBS7;DLL1;ODAD3
prerank,bicarbonate transport (GO:0015701),-0.535147556452486,-1.619630144004913,0.008746355685131196,0.333205304172735,1.0,7/25,13.10%,SLC4A10;SLC26A7;CA4;SLC39A8;SLC4A8;SLC26A6;CFTR
prerank,neurotransmitter secretion (GO:0007269),-0.4706544838854393,-1.6190716526079012,0.0,0.32897536901380214,1.0,21/44,22.90%,RIMS1;LIN7A;HSPA8;NRXN1;CDK5;RIMS2;LIN7C;SYT1;NAAA;SYN3;PCLO;CPLX1;SYN2;RAB3A;STX1A;DVL1;SYN1;GAD1;OTOF;STXBP2;SNPH
prerank,lipid phosphorylation (GO:0046834),-0.6941670241083713,-1.6178062032297604,0.021141649048625793,0.3275331821297237,1.0,7/10,20.81%,DGKB;DGKH;DGKK;DGKG;DGKQ;DGKZ;DGKI
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.6455552408304592,1.6160934270054115,0.020958083832335328,0.34129839177894883,1.0,5/26,2.87%,ERRFI1;CBLB;AREG;TGFA;EPGN
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.7793335870142407,1.6159329820968658,0.02697841726618705,0.3391439041309392,1.0,6/10,13.25%,AREG;TGFA;EPGN;HBEGF;ADRA2A;EGF
prerank,negative regulation of interleukin-1 production (GO:0032692),0.6655160160183776,1.614998650584649,0.019696969696969695,0.33933693641820406,1.0,3/23,4.31%,IGF1;GAS6;APOA1
prerank,ERK1 and ERK2 cascade (GO:0070371),0.6733980236878825,1.6137963807814641,0.022082018927444796,0.34057857876803255,1.0,7/21,9.63%,IGF1;APOA1;MT3;CTSH;ZFP36L1;MAP2K1;ITGAV
prerank,negative regulation of cell development (GO:0010721),0.6470451418240811,1.613594488481462,0.019938650306748466,0.3387303886523965,1.0,3/25,4.43%,IGF1;FBN1;APPL2
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.6511238502641864,1.6106531665896844,0.014778325123152709,0.3455015735294253,1.0,5/23,6.35%,TGFBR3;TPM1;FGFR2;ADAMTS9;TNNC1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.5259829539613311,1.6103061554618985,0.005069708491761723,0.3441588007832109,1.0,14/86,6.81%,IGF1;NRP1;EPHA7;BMP6;IGF2;ANGPT1;GHR;IL6R;VTN;ACVR1;NTF3;SFRP1;SRC;IL12B
prerank,chordate embryonic development (GO:0043009),0.5601485033425724,1.6093549862518421,0.012096774193548387,0.3449215380756828,1.0,12/55,6.07%,RBP4;IGF2;COL1A1;ARNT2;DACT1;SULF2;FGFR1;FGFR2;TGFBR1;SULF1;LIG4;ALDH1A2
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.638652470221336,1.6091951373084703,0.019230769230769232,0.3429720137238394,1.0,5/27,5.01%,IGF1;DDR2;GAS6;PDGFRA;LIG4
prerank,dorsal/ventral pattern formation (GO:0009953),0.6619827932641916,1.6057027797696248,0.026729559748427674,0.35161357854300906,1.0,6/20,5.06%,GLI2;BMPR1A;WNT8B;MDFI;ACVR1;SFRP1
prerank,positive regulation of glucose import (GO:0046326),0.645224976423193,1.6031071377941157,0.027868852459016394,0.3577200223797674,1.0,6/21,12.56%,IGF1;PIK3R1;OSBPL8;CREBL2;RHOQ;INSR
prerank,cellular response to BMP stimulus (GO:0071773),0.5456616117950314,1.6020584747199447,0.011494252873563218,0.3586856555328101,1.0,19/66,15.58%,BMP6;ADAMTS12;TGFBR3;SMAD3;BMPR1A;RUNX2;ACVR1;SFRP1;ENG;RGMA;BMP2;SMAD1;BMP15;USP9Y;PDCD4;USP9X;HIVEP1;BMP4;BMP5
prerank,regulation of histone modification (GO:0031056),0.7153687863491165,1.5986200927182754,0.03770197486535009,0.36742532532166355,1.0,6/13,14.65%,IGF2;NNMT;HPF1;MTHFR;SETD5;AKAP8L
prerank,triglyceride catabolic process (GO:0019433),-0.5739898646939927,-1.5984399456206755,0.015267175572519083,0.3794088011094685,1.0,10/19,37.14%,PNPLA3;PNPLA2;FABP7;FABP3;LIPH;LIPC;LPL;FABP4;FABP12;FABP5
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.7319100150966237,1.595884479541366,0.03327495621716287,0.3735131509393673,1.0,4/12,6.81%,LYN;IL34;CSF1;IL12B
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.5871555936965006,1.5955234847313096,0.014986376021798364,0.37211459641455963,1.0,4/39,4.69%,TCF7L2;RBP4;SLC30A8;MCU
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.6710121022317679,1.5939781310249346,0.02607361963190184,0.37452863799899805,1.0,2/19,4.31%,IGF1;APOA1
prerank,response to organophosphorus (GO:0046683),-0.5930867788920946,-1.5936727204424885,0.03155339805825243,0.38838960994382893,1.0,6/16,13.12%,TRPC3;ABCC9;P2RX7;TRIM16;DGKQ;TYMS
prerank,mRNA destabilization (GO:0061157),0.5841073327921998,1.59321692092566,0.02282453637660485,0.37438896571687136,1.0,14/38,20.49%,POLR2D;ROCK2;ZFP36L1;CPEB3;TUT7;METTL14;TUT4;PLEKHN1;RC3H2;RC3H1;METTL3;YTHDF2;FTO;ZFP36L2
prerank,protein secretion (GO:0009306),0.5505089645023038,1.5931763873652809,0.013262599469496022,0.37199877474918236,1.0,19/56,16.12%,WLS;STEAP3;ABCA1;SLC30A8;NEUROD1;TVP23B;VIP;FAM3B;ARFGAP3;LTBP2;MIA2;MIA3;RCN3;MTTP;CYB5R4;TVP23A;TANGO2;MAFA;GOLPH3
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.5987190647395831,1.5924821395806061,0.019746121297602257,0.37183727382685794,1.0,6/37,5.13%,IGF1;GJA1;TPM1;BMPR1A;MMP2;IGFBP5
prerank,supramolecular fiber organization (GO:0097435),0.4610219119798758,1.5916738454035664,0.0,0.3721277958279313,1.0,51/333,7.68%,COL4A4;COL4A5;MFAP4;COL4A6;COL1A2;COL1A1;DDR2;FBLN5;RHOH;COL4A3;COL22A1;LOXL1;LUM;GSN;COL5A1;COL8A2;CGNL1;FIGN;LOX;COL11A1;HSPG2;BFSP1;DPT;RHOD;ADAMTS2;TPM1;TMOD4;SHROOM2;NCKAP5;RHOBTB1;COL13A1;TGFBR1;COL9A2;MYO1B;APOA1;CLIP4;COL20A1;RHOBTB3;DES;CYP1B1;DYNC1H1;CST3;CDC42;SERPINH1;EMILIN1;RHOBTB2;LTBP2;LTBP3;SNCAIP;CARMIL1;MYO1C
prerank,chemical synaptic transmission (GO:0007268),-0.34346825788760443,-1.5914799531080375,0.0,0.38961752238055164,1.0,101/284,23.35%,GRM7;DLG2;GRID2;SLC12A7;EXOC4;UNC13B;GRM3;GRIA4;RIT2;NLGN1;GABRG3;RIMS1;KCND2;LIN7A;GRIK1;GRIK2;GRIN2A;HSPA8;SDCBP;GABRA2;GABRB3;SYPL1;AMPH;GLRA1;GABRB1;DLGAP2;NRXN1;GABRG2;PRKACB;SLC1A1;CDH8;LRP6;CHRM3;GLRA2;GRM5;CDK5;LIN7C;SLC12A6;GRIN2B;PRKAR1A;SYT1;CAMK4;HCRTR2;GABRB2;NAAA;GRIA2;PRKAR2B;PAFAH1B1;HTR2A;RPS6KA1;GABRA3;KCNQ3;SYN3;GRID1;PRKAR1B;CALM1;PRKAR2A;HOMER1;HRH1;CPLX1;SYN2;PCDHB14;SLC1A4;SLC12A5;GPR176;CHRM2;PLP1;GIPC1;NLGN3;RAB3A;STX1A;CBLN2;GRM1;CACNA1A;SYNJ2BP;APBA2;SLC1A2;DVL1;SYN1;KIF5A;KCNIP2;GRIN1;CACNB3;GABRA4;GABRG1;GAD1;PNOC;NPY5R;HAP1;CAMKK1;GABARAP;KCNC4;PTCHD1;MAPK1;GABRR2;MINK1;STXBP2;SNPH;GLRA3;SYT5;CHRM1
prerank,anterior/posterior axis specification (GO:0009948),0.694282798751536,1.588538098910828,0.04,0.37995884039836636,1.0,3/15,5.82%,WLS;TBX3;SKI
prerank,positive regulation of protein export from nucleus (GO:0046827),0.6928379159332914,1.5853206717452712,0.032758620689655175,0.3885158821862549,1.0,4/15,12.17%,TCF7L2;GAS6;RBM22;YWHAE
prerank,muscle cell differentiation (GO:0042692),-0.486147501317997,-1.5846051075027896,0.025157232704402517,0.40631579925831796,1.0,8/32,6.41%,NEBL;SYNE1;MRTFB;SGCZ;MEF2C;TBX1;KDM1A;HEY2
prerank,adherens junction organization (GO:0034332),-0.4564994237989837,-1.5832984526634304,0.008,0.40487137590280514,1.0,18/48,12.65%,CADM2;CDH2;CADM1;CDH1;ACTB;TJP1;NECTIN1;RAMP2;CDH12;CDH6;CDH8;CDH9;CDH13;JUP;CDH10;CSK;PVR;PAK2
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.5236632947010595,1.5816710829513958,0.013836477987421384,0.3987131052739057,1.0,10/77,6.32%,IGF1;TCF7L2;AR;BCL2;SH3RF1;CFLAR;TGFBR1;ACVR1;PHIP;SRC
prerank,phosphate ion homeostasis (GO:0055062),0.7559947777195202,1.5794286063600296,0.047285464098073555,0.403970820832308,1.0,2/10,3.10%,ENPP1;FGFR4
prerank,potassium ion homeostasis (GO:0055075),-0.5359631518700835,-1.5793843950280098,0.013888888888888888,0.41142720151494855,1.0,7/23,6.82%,SLC12A2;SLC12A7;KCNJ2;ATP1A1;KCNMA1;SLC12A6;ATP1B1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.7282554395255755,1.579162327929301,0.033783783783783786,0.3997611161692025,1.0,2/12,6.11%,IGF1;LMCD1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.7282554395255755,1.579162327929301,0.033783783783783786,0.3997611161692025,1.0,2/12,6.11%,IGF1;LMCD1
prerank,GPI anchor metabolic process (GO:0006505),-0.5071001639570346,-1.57815082217984,0.03869047619047619,0.40936788223453896,1.0,11/26,18.79%,DPM1;PIGP;PGAP2;GPLD1;PIGB;PIGL;DPM3;PIGU;DPM2;PIGO;PIGV
prerank,cardiac conduction system development (GO:0003161),0.642126934174581,1.5770334637290853,0.02631578947368421,0.40432198647544537,1.0,9/24,14.90%,GJA1;GJB6;BMPR1A;NOTCH2;MSC;SMAD1;CACNA1G;GATA6;BMP4
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.5029356224819332,1.57605630512304,0.006119951040391677,0.4051141673888874,1.0,24/95,10.37%,PDPK1;NREP;TGFBR3;SMAD3;LDLRAD4;ZEB2;ADAMTSL2;ITGA3;NKX2-1;PMEPA1;TGFBR1;SLC2A10;SMURF2;ENG;DKK3;SKI;BCL9;EMILIN1;DAB2;SPRY2;LEMD3;FAM89B;STK11;SPRED3
prerank,chloride transmembrane transport (GO:1902476),-0.4579543044445606,-1.5760179002232881,0.011583011583011582,0.4107614074546169,1.0,21/48,14.00%,SLC12A2;SLC12A7;GABRG3;ANO1;ANO4;CLCN3;GABRA2;GABRB3;GLRA1;GABRB1;GABRG2;SLC1A1;GLRA2;SLC12A6;GABRB2;SLC4A8;GABRA3;ANO3;ANO2;CFTR;SLC12A5
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.6115092443320178,-1.5750733794893996,0.048426150121065374,0.4081880932418693,1.0,8/13,23.02%,KDR;IL33;NAMPT;JAK2;EDN1;NOD2;TLR4;CCL2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.6171970061706565,1.5749248996609448,0.028189910979228485,0.4062513170984629,1.0,4/26,7.80%,IGF1;FHL2;LMCD1;RCAN1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.6088206032785874,-1.5745427489557429,0.030973451327433628,0.40434058539407786,1.0,5/13,13.49%,ELOVL7;ELOVL5;TECR;TECRL;HACD2
prerank,negative regulation of proteolysis (GO:0045861),0.5879066285355127,1.574178840397313,0.024745269286754003,0.4063541257943729,1.0,13/34,16.33%,TIMP3;DNAJC1;EPHA4;CST3;LRRK2;TIMP2;SNX12;F2;CLN3;TM4SF20;PTPN3;GAS1;AKT1
prerank,sensory perception of sound (GO:0007605),0.5108059174329286,1.572556329854882,0.004895960832313341,0.4095725221547191,1.0,18/88,11.09%,ATP6V0A4;COL1A1;CEMIP;COL4A3;ADGRV1;EYA1;GRXCR1;COL11A1;EML2;KIT;RIPOR2;ROR1;USH2A;ALDH7A1;TIMM9;LRTOMT;COL11A2;GSDME
prerank,C4-dicarboxylate transport (GO:0015740),-0.6182630516056848,-1.5719335935614007,0.023923444976076555,0.40707207662718164,1.0,11/14,30.26%,LRRC8D;SLC25A13;SLC25A12;SLC1A1;SLC25A30;SLC25A11;SLC1A2;SLC25A22;SLC25A10;LRRC8E;SLC25A14
prerank,signal release from synapse (GO:0099643),-0.4583793307345672,-1.5714019492765015,0.003401360544217687,0.4032513377453113,1.0,20/43,22.90%,RIMS1;LIN7A;HSPA8;NRXN1;CDK5;LIN7C;SYT1;NAAA;SYN3;PCLO;CPLX1;SYN2;RAB3A;STX1A;DVL1;SYN1;GAD1;OTOF;STXBP2;SNPH
prerank,regulation of gastrulation (GO:0010470),0.6866801511882709,1.5708166674135913,0.041666666666666664,0.41311220938072246,1.0,4/14,7.90%,PHLDB2;DAG1;CRB2;OSR1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.6020916377599373,-1.56885337562723,0.032663316582914576,0.40568230269800193,1.0,7/15,18.22%,REEP1;RTN3;TMEM33;ATL2;ARL6IP1;ZFYVE27;REEP2
prerank,regulation of epidermal cell differentiation (GO:0045604),0.6328887150873396,1.5688110616091002,0.038461538461538464,0.4176597415322582,1.0,7/21,14.95%,ERRFI1;ROCK2;RUNX1;ZFP36L1;CTSL;BMP4;SFRP4
prerank,cardiac muscle tissue development (GO:0048738),0.5508938804163507,1.568084589909872,0.019021739130434784,0.4178076700440535,1.0,17/50,15.58%,RBP4;GJA1;GJB6;BMPR1A;NOTCH2;MSC;ADAMTS9;SIK1;BMP2;CBY1;SMAD1;CSRP3;CACNA1G;AKAP13;GATA6;BMP4;BMP5
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.5623525213585009,1.5676107422337815,0.02390998593530239,0.416848279943541,1.0,6/43,2.39%,IGF2;ENPP1;PID1;AHSG;OGT;KANK1
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.6381873341579375,1.5674805704274273,0.03475513428120063,0.41478324909847547,1.0,5/23,4.69%,DAPK2;CAMK1D;RIPOR2;CCL19;MCU
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.47860062973983697,1.565917531721101,0.005773672055427252,0.4178908463772706,1.0,25/150,7.10%,TCF7L2;PDPK1;IGF2;ANGPT1;PIK3R1;AREG;TGFA;FGFR1;EPGN;KL;FGFR2;KIT;FGFR4;GAS6;PDGFRA;PDGFRB;TGFBR1;SEMA5A;CCL19;AXL;OSBPL8;FRS2;ENG;SRC;CD28
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.5393964021873168,1.565101830881396,0.014435695538057743,0.4180639036916947,1.0,13/61,9.90%,IGF1;ROBO1;AUTS2;LYN;NOTCH2;APOA1;LPAR1;ALS2;ARRB1;MAP4K4;RAPGEF1;MAPRE2;SYNPO2L
prerank,microtubule anchoring at centrosome (GO:0034454),0.7613324726963765,1.5637681837536088,0.03460207612456748,0.4202806523106579,1.0,2/10,2.59%,CCDC68;NINL
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.6389157304402269,1.5627189763271319,0.03129890453834116,0.4214990621247468,1.0,7/21,6.95%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9;GUCY2C;GUCY2D
prerank,axonal fasciculation (GO:0007413),0.706652927259608,1.5613952068335797,0.03880070546737213,0.42392943694051116,1.0,6/12,11.56%,EPHA3;EPHA4;SEMA5A;ARHGAP35;EPHB2;EPHB3
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.4812806767442272,1.5610806012113896,0.0034965034965034965,0.42270974444103376,1.0,32/138,8.62%,EPHA3;EPHA7;MTSS1;DDR2;ANGPTL1;IL31RA;LYN;NEDD9;FGFR1;EPHA4;GFRA2;EPHA8;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;CD7;POLR1G;CSF1;AXL;NTF3;FRS2;GUCY2C;MUSK;ROR1;SRC;BDKRB2;GUCY2D;NTRK3;EGFR;EPHB2
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.6326631053290428,-1.5608264272352876,0.027586206896551724,0.4256075905904719,1.0,3/11,6.57%,SLIT2;CCN3;RIN3
prerank,T cell differentiation (GO:0030217),0.573090677328276,1.5587025278102018,0.027417027417027416,0.4289394649823674,1.0,11/40,9.44%,RHOH;LEPR;GLI3;KIT;LIG4;ZFP36L1;TCF7;CD28;NHEJ1;GPR89A;GPR89B
prerank,cytoskeleton organization (GO:0007010),0.4855997477676415,1.5567795342911286,0.007202881152460984,0.4332613499380232,1.0,28/114,8.38%,SH3D19;MICAL3;RHOH;RHOD;NEDD9;OBSL1;TPM1;MARK1;ANK1;RHOBTB1;APOE;PALLD;CNN2;WDPCP;FGD1;BRWD1;PHIP;FGD4;RHOBTB3;DES;ARHGAP10;RANBP9;RHOBTB2;CSPG5;WTIP;PLD2;MAST2;CAPZB
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.46417471790502696,-1.5561687519436609,0.010033444816053512,0.4351409033833299,1.0,16/39,20.17%,RPS24;RPS14;RPS19;RIOK1;RPS15;RPS7;UTP4;RPS5;METTL17;LSM6;SNU13;RPSA;RPS6;RRP36;NPM1;MRPS7
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.5245277258066695,-1.5557780464451432,0.014204545454545454,0.43075233091342136,1.0,5/24,5.29%,MEF2C;CDH2;SPAG9;CDON;TCF3
prerank,purine nucleotide catabolic process (GO:0006195),-0.613913848413647,-1.5557006436534415,0.02962962962962963,0.4254894153460428,1.0,7/13,18.50%,NT5E;NT5C2;NT5C1A;GDA;NT5C;PNP;GPX1
prerank,regulation of MAPK cascade (GO:0043408),0.473240265727122,1.5549862688759803,0.002280501710376283,0.43699259854824396,1.0,33/157,11.33%,IGF1;EPHA7;IGF2;ADRA1B;NRK;ROCK2;TGFBR3;KSR1;DAG1;LYN;FGFR1;PELI2;EPHA8;CCN1;FGFR2;KIT;LBH;ROR1;ADRA2C;ADRB3;LPAR1;MAP2K1;TRAF7;NTRK3;STK4;EGFR;BMP2;MAP4K4;FGF2;RYK;TAOK3;GSDME;ADRA2A
prerank,carbohydrate homeostasis (GO:0033500),0.5207866288568963,1.554136666283021,0.01675257731958763,0.4375482806934469,1.0,14/67,12.78%,TCF7L2;RBP4;LEPR;SLC30A8;FGFR4;APPL2;MCU;NEUROD1;PRKAA2;CEBPA;STK11;ADRA2A;INSR;CYB5R4
prerank,myofibril assembly (GO:0030239),0.5656551433348975,1.5520269117694758,0.015827338129496403,0.4427173087483233,1.0,12/42,10.14%,ACTN2;OBSL1;TPM1;TMOD4;TNNT1;PDGFRA;CFLAR;PDGFRB;CSRP2;CSRP3;SYNPO2L;TNNT3
prerank,cellular response to organonitrogen compound (GO:0071417),-0.39012188625035465,-1.5507691524471483,0.005714285714285714,0.4361829591815846,1.0,28/99,13.10%,SLIT2;MEF2C;RAP1A;CDH1;ACTB;DIAPH1;SH3BP4;GABRB3;P2RX7;GLRA1;GABRB1;GABRG2;PDE2A;KCNQ1;GLRA2;AKAP6;SPAAR;RAP1B;TAF1;INPP5K;GABRB2;LARS1;IPO5;SLC26A6;JUP;HRH1;MTOR;CFTR
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.4629475043096239,1.5503505915913773,0.002207505518763797,0.4461972516601311,1.0,44/186,15.29%,IGFBP2;TCF7L2;BICC1;TRABD2B;RBMS3;MCC;LRP1;IGFBP4;DACT1;NKD1;GLI3;MDFI;APOE;TMEM170B;TLE1;PRICKLE1;PSME4;RNF213;AXIN2;MLLT3;SFRP1;DKK3;ZNRF3;WWTR1;STK4;DAB2;BMP2;CBY1;PRKN;STK11;TAX1BP3;INVS;LZTS2;JADE1;TMEM64;GLI1;UBAC2;KLHL12;TSC2;MDK;AMFR;CXXC4;SFRP4;GRB10
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.35710181914922323,-1.550170300640549,0.011627906976744186,0.43290229225251603,1.0,71/168,20.52%,RPL41;RPS12;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;CNOT6L;RPL34;RPS13;RPL21;RPL7;RPL18;RPL27;CSDE1;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;PAN3;RPL30;RPS23;PABPC1;PNRC2;RPL36;RPLP1;RPS29;RPL37;PPP2R2A;RPS9;RBM8A;RPS5;RPL4;PNLDC1;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;RPL7A;THRAP3;RPL19;RPS20;RPL14;RPL13;DIS3L2;RPL32;RPL5;RPSA;SMG7;RPLP0;NBAS;RPS6;RPL22;AGO1;EXOSC5;CNOT7;RPS21;DDX5;DCP2;RPL37A;RPLP2;TENT2;RPL17;RPL23
prerank,Rho protein signal transduction (GO:0007266),0.5424352951872281,1.549355697182006,0.027548209366391185,0.4474022775896177,1.0,15/53,12.41%,COL1A2;ROCK2;ARHGAP6;RHOD;CTNNAL1;ARHGAP29;CDC42EP4;PDPN;CDC42;AGTR1;NTN1;ARHGEF11;TAX1BP3;ADRA2A;ARHGAP5
prerank,regulation of acute inflammatory response (GO:0002673),0.6490181784283527,1.547639407433226,0.04333868378812199,0.45124361752180736,1.0,2/18,2.52%,PTGES;OSMR
prerank,embryonic organ morphogenesis (GO:0048562),0.5631066411492249,1.5474538205023698,0.01904761904761905,0.4494104899950153,1.0,9/42,5.01%,RBP4;FBN1;FBN2;MFAP5;FGFR2;PDGFRA;ACVR1;NEUROD1;RARG
prerank,iron ion transport (GO:0006826),0.5521753365790464,1.5465995955070746,0.025245441795231416,0.4504119867696274,1.0,6/47,6.48%,ATP6V0A4;CP;STEAP3;SCARA5;HEPH;SLC11A2
prerank,renal system development (GO:0072001),0.54750516146063,1.5464221875145105,0.026525198938992044,0.44864187721542653,1.0,10/52,7.26%,RBP4;GLI2;SULF2;SALL1;WNT4;TGFBR1;SULF1;GREB1L;AGTR1;IFT27
prerank,cellular response to ketone (GO:1901655),0.5791729652712576,1.545830032882393,0.03281027104136947,0.44841452025871253,1.0,8/35,7.21%,ADCY1;ROCK2;ADCY2;AR;ADCY5;SFRP1;SRC;SPHK2
prerank,regulation of plasminogen activation (GO:0010755),0.7210030808125663,1.545256848646443,0.05244122965641953,0.44797701243602606,1.0,7/12,15.65%,CLEC3B;SERPINE1;RUNX1;PLGRKT;CTSZ;HPN;MELTF
prerank,positive regulation of MAPK cascade (GO:0043410),0.45338044005603517,1.5449364518851278,0.0032502708559046588,0.4465627986402158,1.0,48/245,11.33%,IGF1;NRP1;ROBO1;IGF2;ADRA1B;CCN2;ROCK2;ANGPT1;PDGFD;KSR1;FGFR1;IL34;PELI2;EPHA8;EPGN;FGFR2;KIT;FGFR4;GAS6;PDGFRA;APOE;PDGFRB;CCL19;NOTCH2;RAPGEF2;MT3;ROR1;ADRA2C;ADRB3;CCL4;LRRK2;LPAR1;MAP2K1;TRAF7;MTURN;NTRK3;SLC30A10;ARRB1;EGFR;BMP2;SPRY2;FGF2;RYK;CARD9;BRAF;TAOK3;GSDME;ADRA2A
prerank,sphingolipid catabolic process (GO:0030149),-0.5869729591551114,-1.5425576386063176,0.03931203931203931,0.4519374768258799,1.0,4/15,3.32%,ACER3;ENPP2;ACER2;PPT1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.6646318012394637,1.542300088793072,0.03697749196141479,0.453479908862666,1.0,7/18,11.52%,DDR2;SMAD3;RUNX1;PDPN;EMILIN1;BMP2;RGCC
prerank,metal ion homeostasis (GO:0055065),-0.46944256344676893,-1.5419432662569863,0.013245033112582781,0.44872092233131783,1.0,7/40,6.65%,TMTC2;SLC12A2;SLC12A7;CAV1;ANK3;LETM1;SLC12A6
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.4652947154349232,-1.5410860694024031,0.013377926421404682,0.44628897300419784,1.0,11/38,15.08%,CAV1;KCNJ2;CTNNA3;KCNJ3;KCND3;CAMK2D;KCNQ1;JUP;DSG2;CACNA2D1;CACNA1D
prerank,smooth muscle cell differentiation (GO:0051145),-0.6199930529138069,-1.5410160613513966,0.04100227790432802,0.4412690852749014,1.0,6/12,14.87%,MRTFB;MEF2C;HEY2;APLNR;HEY1;EDNRB
prerank,epithelial structure maintenance (GO:0010669),0.7131577449288153,1.5409498914201203,0.05604203152364273,0.45615549544379713,1.0,2/11,8.42%,RBP4;PIWIL4
prerank,embryonic limb morphogenesis (GO:0030326),0.5757244695730357,1.5407024040470583,0.028189910979228485,0.4546938846576879,1.0,11/34,8.19%,CYP26B1;SALL1;GLI3;WDPCP;RARG;TBX3;MAP3K20;SKI;CACNA1C;OSR1;AFF3
prerank,regulation of biomineral tissue development (GO:0070167),0.6197982991613472,1.5401118461873804,0.04361370716510903,0.45450568551241627,1.0,6/26,3.44%,DDR2;ENPP1;ROCK2;AHSG;ANKH;GAS6
prerank,regulation of catabolic process (GO:0009894),-0.5563987025169882,-1.5390761260891903,0.04371584699453552,0.4424194758308076,1.0,4/18,4.22%,FAP;ZDHHC2;NEDD4L;FAF1
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.6669182514304441,1.5380314075125836,0.04088586030664395,0.459484088058917,1.0,2/17,3.47%,IGF1;APOE
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.6935365214316296,1.5369623776481924,0.05799648506151142,0.46075974794396873,1.0,2/13,0.18%,NRP1;PLXNA2
prerank,odontogenesis (GO:0042476),0.5688981984123275,1.53693610161656,0.037900874635568516,0.4584787724985422,1.0,9/35,8.76%,COL1A2;GLI2;FGFR2;WNT6;AXIN2;BCOR;OSR1;AQP6;BMP2
prerank,chondrocyte differentiation (GO:0002062),0.5769874783708532,1.5365717161817896,0.0344311377245509,0.4573962958343383,1.0,11/32,8.76%,SOX5;SULF2;RUNX1;NFIB;RUNX2;SULF1;CREB3L2;WNT5B;EIF2AK3;OSR1;BMP2
prerank,positive regulation of cell cycle process (GO:0090068),0.5014104383160438,1.5361358926918536,0.011138613861386138,0.4565679980822316,1.0,16/91,8.21%,IGF1;IGF2;SVIL;TGFA;EPGN;PDGFRB;PHIP;MAP3K20;DYNC1H1;CDC42;INO80;CD28;NPM2;SIRT2;UBXN2B;DRD3
prerank,negative regulation of cellular protein localization (GO:1903828),0.5677151624617409,1.533636547438652,0.04437869822485207,0.462984493881161,1.0,9/34,10.56%,ROCK2;ACTN2;LEPROT;RIPOR2;SNX33;UBXN2B;PICALM;COMMD1;TAX1BP3
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.44010024345387755,1.5334837531782868,0.0010204081632653062,0.46114290542119113,1.0,68/390,10.18%,IGF1;EPHA3;NRP1;POLR2D;ATP6V0A4;EPHA7;COL4A6;IGF2;MTSS1;COL1A1;DDR2;ROCK2;ANGPT1;GHR;ANGPTL1;PIK3R1;PDGFD;IL31RA;LYN;SULF2;NEDD9;FGFR1;EPHA4;GFRA2;EPHA8;MMP2;KL;FGFR2;KIT;FGFR4;RBFOX2;PDGFRA;EFNB2;PDGFRB;ANGPT2;CD7;SULF1;POLR1G;CSF1;RAPGEF2;AXL;NTF3;PHIP;FRS2;MUSK;ROR1;CDC42;SRC;BDKRB2;EFNA2;SIRT2;EIF2AK3;FLRT2;NTRK3;AAMP;FOXC2;ZNF106;EGFR;EPHB2;HNRNPA1;EFNB1;RAPGEF1;ITGB3;POLR2C;ITGAV;ATP6V1E1;FGF2;RYK
prerank,negative regulation of cell migration (GO:0030336),0.47851172054958163,1.5333974053852168,0.002285714285714286,0.4591873537799671,1.0,27/137,7.44%,ROBO1;PHLDB2;GJA1;MCC;LDLRAD4;LRP1;DAG1;MITF;SERPINE1;DLC1;PODN;TPM1;EPHA4;BMPR1A;KANK1;RECK;NKX2-1;DPYSL3;SULF1;SFRP1;IGFBP5;CYP1B1;ENG;VCL;ATP1B2;DPEP1;AFDN
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.5809917590018302,-1.5329446536032632,0.0325,0.4577357948936606,1.0,8/15,17.75%,TEC;PTK2B;KDR;BMX;AATK;MAPK3;IGF1R;TXK
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.5637783108569224,-1.5326529013459187,0.03655352480417755,0.4535318436645069,1.0,5/17,10.27%,PDE3B;SORL1;MFSD2A;ALK;GPLD1
prerank,regulation of extracellular matrix organization (GO:1903053),0.6891337265589501,1.5320132637452493,0.03872053872053872,0.46174301132645035,1.0,6/15,4.04%,DDR2;LRP1;RUNX1;AEBP1;FGFR4;SLC2A10
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.6455312882838462,1.5314995647840162,0.04552845528455285,0.461191132605037,1.0,2/20,4.82%,IGF1;NEUROD1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.48757211712979065,1.531083928905895,0.011933174224343675,0.46051421382151136,1.0,26/112,9.24%,CILP;COL1A2;CLEC3B;TGFBR3;SMAD3;SOX5;BMPR1A;WNT4;TGFBR1;TWSG1;PDCD5;APOA1;APPL2;ACVR1;SFRP1;ITGB5;PDE3A;CDH5;ENG;ZFP36L1;SKI;SRC;LTBP2;ARHGEF18;ZMIZ1;SMAD1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.6355058036492998,1.5309262680704498,0.059113300492610835,0.4588550202139639,1.0,2/19,3.47%,IGF1;APOE
prerank,negative regulation of stress fiber assembly (GO:0051497),0.6090006940452736,1.5303202396003204,0.058823529411764705,0.4586782971596796,1.0,6/24,2.15%,PHLDB2;PIK3R1;CGNL1;ARHGAP6;DLC1;ARHGAP28
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.6653305867038201,1.5294731013920446,0.044142614601018676,0.4596557018064059,1.0,2/16,0.75%,IGF1;ROCK2
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.508759474519957,-1.5285965504076255,0.03978779840848806,0.46147297962246897,1.0,11/26,18.87%,OCLN;NAV3;MET;RPS3;PAK1;FES;DCTN1;TRPV4;CDK5RAP2;CDK5R1;CLASP1
prerank,detection of mechanical stimulus (GO:0050982),-0.5507095275477515,-1.5264074592724715,0.05234159779614325,0.46340813380593415,1.0,3/19,1.56%,PIEZO2;CDH2;PIEZO1
prerank,regulation of smoothened signaling pathway (GO:0008589),0.5357142044513575,1.5261230084656738,0.031767955801104975,0.46966027813707,1.0,23/50,18.68%,RORA;ZIC1;GLI3;FGFR2;MGRN1;SMO;FBXL17;SFRP1;TULP3;TEDC1;IFT81;GLIS2;TTC23;PTCH2;GLI1;BTRC;SUFU;GAS1;SHH;INTU;HHIP;EVC;PDCL
prerank,wound healing (GO:0042060),0.5259262956423417,1.5253323064008355,0.020860495436766623,0.4703743620114787,1.0,14/62,10.49%,IGF1;SMAD3;TPM1;PPP3CA;MACF1;PPL;PDGFRA;CFLAR;TGFBR1;FUT10;ITGB3;MIA3;FGF2;ANXA6
prerank,hematopoietic stem cell differentiation (GO:0060218),0.7353655254963344,1.524810442511266,0.04838709677419355,0.47005303858018055,1.0,5/10,11.49%,SP7;MLLT3;SFRP1;BATF;UFL1
prerank,positive regulation of kinase activity (GO:0033674),0.48652113134534736,1.5248009316963103,0.009445100354191263,0.4678816014430345,1.0,31/107,12.56%,EPHA3;EPHA7;DDR2;FGFR1;EPHA4;EPHA8;CCN1;FGFR2;KIT;FGFR4;PRKAG2;GAS6;PDGFRA;PDGFRB;CCL19;CSF1;RAPGEF2;AXL;MUSK;ROR1;ALS2;NTRK3;EGFR;EPHB2;LMO4;RYK;MRNIP;EPHB3;F2;DUSP19;INSR
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.6790951070972951,1.5240428975935527,0.05253940455341506,0.46836220148087593,1.0,2/15,3.64%,MOXD1;SMOX
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.6612755782160042,1.5227104223642791,0.06310679611650485,0.47121686723925255,1.0,2/17,1.34%,BMP6;SASH1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.705061881444689,1.5221078640449908,0.06174957118353345,0.471117633358109,1.0,2/11,4.09%,RUNX1;TWSG1
prerank,ketone body metabolic process (GO:1902224),0.7100308791909862,1.5219310922825642,0.070298769771529,0.46954843712865385,1.0,4/10,3.16%,SLC27A5;ACSS3;OXCT1;HMGCLL1
prerank,catecholamine metabolic process (GO:0006584),0.6715237816620346,1.5209230795772262,0.04965753424657534,0.47092668578551405,1.0,5/14,10.21%,COMT;SNCAIP;DRD3;PRKN;LRTOMT
prerank,regulation of amyloid-beta formation (GO:1902003),0.5700933843093486,1.520804956938693,0.0377906976744186,0.4691183165580953,1.0,4/34,3.47%,IGF1;ROCK2;EPHA4;APOE
prerank,positive regulation of axon extension (GO:0045773),0.612274647655836,1.519629403639193,0.046224961479198766,0.47114296357735125,1.0,6/22,8.66%,NRP1;MACF1;SEMA5A;GOLGA4;DSCAM;NTN1
prerank,artery development (GO:0060840),0.6160284017316953,1.5189965760587387,0.04538087520259319,0.4713453922802361,1.0,5/23,5.70%,NRP1;ROBO1;TGFBR1;SLC2A10;ENG
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.6802974067620998,1.5189773366765607,0.03819444444444445,0.46926697539606627,1.0,4/16,3.57%,NRP1;PDGFD;PDGFRA;PDGFRB
prerank,embryonic organ development (GO:0048568),0.5156222835158452,1.5179429282576984,0.028683181225554105,0.47092523628140476,1.0,13/61,4.82%,RBP4;TEAD1;GDNF;PBX1;GLI2;SALL1;BMPR1A;GLI3;FGFR2;KIT;COL13A1;RARB;NEUROD1
prerank,axon guidance (GO:0007411),0.44662458534063193,1.5176733686609767,0.003329633740288568,0.46977554075770456,1.0,41/201,10.38%,EPHA3;NRP1;ROBO1;PLXNA2;EPHA7;LAMA1;RHOH;GDNF;PIK3R1;DAG1;SEMA3D;LAMA2;GLI2;EPHA4;GFRA2;EPHA8;NFIB;EFNB2;SMO;PALLD;SEMA5A;NOTCH2;NCAM1;LRTM1;FRS2;SRC;ALCAM;RANBP9;EFNA2;ARHGAP35;SPTAN1;DSCAM;EPHB2;NTN1;EFNB1;GFRA4;SLIT3;SLIT1;RYK;PTPRM;NEXN
prerank,embryonic digestive tract development (GO:0048566),0.6500391776741108,1.5176201589649223,0.05422647527910686,0.46782878616144485,1.0,6/18,3.69%,GLI2;SALL1;GLI3;FGFR2;PDGFRA;RARB
prerank,protein kinase B signaling (GO:0043491),0.6286831438170712,1.5164146139400623,0.04134762633996937,0.46991413436834073,1.0,5/23,7.38%,IGF1;GAS6;MT3;ZFP36L1;SIRT2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.45800572965294767,1.5162842045174068,0.008998875140607425,0.46822064710643513,1.0,32/161,12.91%,IGFBP2;TCF7L2;BICC1;RBMS3;MCC;IGFBP4;DACT1;NKD1;GLI3;APOE;TMEM170B;TLE1;PRICKLE1;PSME4;AXIN2;MLLT3;SFRP1;DKK3;ZNRF3;WWTR1;STK4;DAB2;BMP2;PRKN;STK11;INVS;LZTS2;JADE1;TMEM64;GLI1;UBAC2;KLHL12
prerank,cell-cell junction organization (GO:0045216),-0.3898597881027707,-1.5158450092752391,0.005025125628140704,0.4941098566175796,1.0,27/79,14.09%,PKP4;CTNND2;OCLN;CADM2;CLDN5;CDH2;CADM1;LIMS2;CDH1;TJP2;TJP1;GJC1;TGFB2;NECTIN1;CDH12;CDH6;CDH8;CDH9;CDH13;JUP;CDH10;CSK;TGFB1;CXADR;PVR;TRPV4;DSG2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.621315160711568,1.515323281843234,0.044189852700491,0.46952518877322597,1.0,2/22,0.75%,IGF1;ROCK2
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.7246184927094103,1.5151442795904502,0.04591836734693878,0.4680873172331217,1.0,2/11,5.54%,PDK1;CYP1B1
prerank,regulation of endopeptidase activity (GO:0052548),0.5183973348442388,1.514919657209148,0.02557200538358008,0.46681470645199125,1.0,13/59,10.93%,TIMP3;AHSG;SERPINE1;SERPING1;VTN;FETUB;SERPIND1;SERPINF1;SERPINH1;CRB2;TIMP2;PICALM;APH1B
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6894734587560277,1.5148278287227819,0.07131011608623548,0.46509771530178,1.0,2/13,1.03%,ERRFI1;CBLB
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.681518937865713,1.512671510286417,0.05734767025089606,0.4707244509266325,1.0,4/12,3.19%,MYCBP2;GLI2;EPHA4;NFIB
prerank,potassium ion import across plasma membrane (GO:1990573),-0.4448187494453958,-1.5123757928666446,0.034129692832764506,0.500940478995762,1.0,12/41,14.00%,SLC12A2;SLC12A7;KCNJ2;ATP1A1;KCNJ3;ABCC9;SLC12A6;ATP1B1;KCNJ15;ATP1A3;KCNJ10;SLC12A5
prerank,sprouting angiogenesis (GO:0002040),0.5338367404383365,1.5122051207886882,0.02021563342318059,0.4702451064308624,1.0,12/51,6.39%,NRP1;ROBO1;CCBE1;ESM1;ANGPT1;RECK;PARVA;EFNB2;SEMA5A;RNF213;ENG;ADGRA2
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.5209918166579056,1.5087596303237663,0.023166023166023165,0.4800501699767969,1.0,14/66,6.06%,ROBO1;MTSS1;TGFBR3;SPARC;MCC;NR2F2;FGFR2;NFIB;APOE;NUPR1;SULF1;SFRP1;CASK;ATOH8
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5674985201681709,1.508665996119214,0.04888888888888889,0.478296835391354,1.0,11/34,14.43%,NRP1;NEDD9;APOA1;CDC42;DOCK5;CARMIL1;CSPG5;MYADM;P4HB;MDK;FLNA
prerank,response to amyloid-beta (GO:1904645),0.5450969764906852,1.5079230437526066,0.03977272727272727,0.47885741103352086,1.0,7/44,7.77%,IGF1;GJA1;LRP1;EPHA4;MMP2;CACNB1;TLR6
prerank,regulation of kinase activity (GO:0043549),0.4863101026761062,1.5074646293651013,0.01824817518248175,0.478486289088833,1.0,22/89,10.59%,EPHA3;EPHA7;LDB2;DDR2;FGFR1;EPHA4;EPHA8;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;TSPYL2;AXL;MUSK;ROR1;NTRK3;EGFR;EPHB2;LMO4;RYK;RBL2
prerank,positive regulation of phosphatase activity (GO:0010922),-0.5184927631983444,-1.5059594439629302,0.04071246819338423,0.5183787997744752,1.0,10/21,12.39%,MEF2C;ITGA1;HSP90AB1;PPP1R15B;CALM1;MTMR9;GPLD1;CALM3;PLEK;MTOR
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.6649331208087605,1.5045705358591053,0.052805280528052806,0.4869836160954484,1.0,5/15,5.93%,DDR2;LRP1;FGFR4;PDPN;CST3
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.670635320808031,1.5043901036996814,0.052969502407704656,0.48552832485649955,1.0,1/15,0.01%,IGF1
prerank,aorta development (GO:0035904),0.6653729593852693,1.504292341248159,0.05326460481099656,0.483814702228223,1.0,4/14,6.17%,ROBO1;LRP1;PDGFRB;ADAMTS9
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.5476287083807865,-1.5040083569927094,0.04473684210526316,0.5200017673368608,1.0,8/18,11.31%,SHANK3;NLGN1;PTK2B;RIMS1;NRXN1;RIMS2;SHANK1;PRKCZ
prerank,regulation of protein export from nucleus (GO:0046825),0.593254569675439,1.5030178429228294,0.06339144215530904,0.48626532868571826,1.0,6/23,12.17%,TCF7L2;SP100;GAS6;RBM22;IFI27;YWHAE
prerank,embryonic eye morphogenesis (GO:0048048),0.7050171750371329,1.5028529797954806,0.06914893617021277,0.48478453774402314,1.0,4/11,5.01%,FBN1;FBN2;MFAP5;RARG
prerank,amide transport (GO:0042886),-0.48812597934601504,-1.5005626304883566,0.03932584269662921,0.5270882808240543,1.0,6/26,6.74%,CERT1;ABCG2;PLTP;SLC5A6;SLC38A5;PLEKHA3
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.6430089515830435,-1.5003503649196286,0.045871559633027525,0.5224960337886965,1.0,7/10,20.74%,GABRG3;GABRA2;GABRG2;GABRB2;GABRA3;GABRA4;GABRG1
prerank,nucleotide catabolic process (GO:0009166),-0.5564850418173704,-1.500260248315774,0.04177545691906005,0.5174817995018123,1.0,8/16,23.83%,NT5E;NT5C2;NT5C1A;GDA;NT5C;PNP;GPX1;VCP
prerank,sarcomere organization (GO:0045214),0.5779026936052823,1.4994052712927193,0.0445468509984639,0.49561041600069683,1.0,7/27,10.14%,ACTN2;TPM1;TNNT1;CSRP2;CSRP3;SYNPO2L;TNNT3
prerank,membrane lipid biosynthetic process (GO:0046467),-0.41148340935338207,-1.4992048910476234,0.01984126984126984,0.5161521620853147,1.0,13/58,11.40%,SGMS1;CERT1;ACER3;SGMS2;ELOVL7;ACER2;DEGS2;SPNS2;ELOVL5;DEGS1;ST8SIA6;SPTLC2;SPTSSB
prerank,inositol lipid-mediated signaling (GO:0048017),0.5300863280986228,1.4990337803898819,0.03283173734610123,0.4949648568309,1.0,9/50,6.84%,IGF1;PIK3R1;FGFR1;OGT;PDGFRA;PDGFRB;PLCD1;ADAP2;PLCB4
prerank,cellular response to amyloid-beta (GO:1904646),0.5548437385703124,1.498610361527091,0.043859649122807015,0.4944340402682781,1.0,6/35,7.77%,IGF1;GJA1;LRP1;EPHA4;CACNB1;TLR6
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.49283778961266755,-1.4979151527060341,0.04154302670623145,0.5153642289498732,1.0,7/25,10.18%,AFAP1L2;CCDC88A;BCAR3;CBL;HIP1R;ARAP1;SHKBP1
prerank,carbohydrate derivative transport (GO:1901264),-0.5382761788771664,-1.49780415903986,0.049315068493150684,0.5104348242468215,1.0,8/18,14.56%,PLTP;SLC15A2;LBP;NPC2;MFSD2A;ABCG1;SCARB1;VLDLR
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5523867881374988,1.4962786379787365,0.036671368124118475,0.5008877190241297,1.0,11/40,8.76%,TCF7L2;COL1A1;SMAD3;OLFM1;TGFBR1;AXIN2;PDPN;CRB2;WWTR1;DAB2;BMP2
prerank,endothelial cell proliferation (GO:0001935),-0.5507994287138687,-1.495927078964131,0.029490616621983913,0.5115192824887985,1.0,9/17,18.89%,TEK;BMPER;CD34;ACVRL1;THAP1;PRKX;ERN1;BMPR2;ITGB1BP1
prerank,cellular response to interleukin-6 (GO:0071354),0.5847670007875378,1.4949787051137535,0.05714285714285714,0.5037333117580763,1.0,6/26,6.87%,PTGIS;PID1;IL6R;YAP1;SRC;CEBPA
prerank,sphingolipid metabolic process (GO:0006665),-0.3710043881759082,-1.4947983883831673,0.017543859649122806,0.510667174200643,1.0,22/108,13.60%,ST6GALNAC3;SGMS1;CERT1;ESYT2;ACER3;ENPP2;SGMS2;ELOVL7;ACER2;DEGS2;PPT1;SPNS2;ELOVL5;HEXB;DEGS1;UGCG;SPTLC2;TECR;SPTSSB;ORMDL3;HACD2;ARV1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.48524255142306966,1.494435173580448,0.018270401948842874,0.5036218684083561,1.0,23/95,11.94%,GPC6;FMOD;OGN;CEMIP;ANGPT1;LUM;UST;DCN;BGN;HSPG2;PXYLP1;ST3GAL3;DSE;HS6ST1;SDC1;B4GALT1;OMD;CSPG5;EXT1;ABCC5;NDST1;CHST15;GALNT5
prerank,Golgi ribbon formation (GO:0090161),0.6828383871262647,1.4943164596706064,0.06563039723661486,0.501959420554414,1.0,4/13,8.93%,OPTN;MYO18A;STX16;TRIP11
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.6981089852021861,1.4938250684342096,0.07871198568872988,0.5015634595180496,1.0,5/11,11.11%,GRK3;ADRB3;DRD3;ARRB1;ADM
prerank,positive regulation of endothelial cell migration (GO:0010595),0.48321651836629886,1.4938111648552952,0.03194103194103194,0.49956157272304136,1.0,18/84,10.17%,NRP1;PDPK1;RIN2;ROCK2;ANGPT1;SPARC;SASH1;PLPP3;FGFR1;SEMA5A;SMOC2;ATOH8;AKT3;AAMP;FOXC2;ANXA3;ITGB3;FGF2
prerank,endothelial cell development (GO:0001885),-0.49854732606039326,-1.493261581438465,0.050746268656716415,0.5107472895154014,1.0,12/25,10.46%,PDE4D;PECAM1;RAP1A;PPP1R16B;MET;RDX;PDE2A;COL15A1;RAP1B;ROBO4;SOX18;MSN
prerank,positive regulation of natural killer cell activation (GO:0032816),0.6766952671371933,1.4915517842522474,0.0690846286701209,0.50524971237712,1.0,6/13,17.97%,GAS6;AXL;IL12B;ZBTB1;IL23A;IL18
prerank,regulation of actomyosin structure organization (GO:0110020),0.670908881757795,1.4907651420620933,0.06467661691542288,0.5059447363377625,1.0,4/13,6.66%,ROCK2;ASAP3;CDC42;ALMS1
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.4535098929836321,-1.490316283518978,0.03773584905660377,0.5162685667171214,1.0,10/34,9.47%,GRID2;MEF2C;GABRG3;GRIN2A;GABRA2;GLRA1;GABRG2;GRIN2B;GSK3A;GABRA3
prerank,ribosomal large subunit assembly (GO:0000027),-0.4994736732356223,-1.4876622470352925,0.05128205128205128,0.5211630388067157,1.0,11/24,27.97%,RPL3;RPL11;RPL6;PPAN;RPL5;FASTKD2;RPLP0;RRS1;RPF2;DDX28;RPL10
prerank,cellular response to glucagon stimulus (GO:0071377),0.6291710503620851,1.48729114434669,0.059870550161812294,0.5164245856259131,1.0,5/17,3.53%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9
prerank,positive regulation of secretion (GO:0051047),-0.6234131745956297,-1.4870789261321284,0.09069767441860466,0.5182452565631711,1.0,6/11,30.75%,NPR1;GPLD1;ACSL3;XBP1;AQP1;SCIN
prerank,bone development (GO:0060348),0.5455860461976558,1.4869652637849435,0.054491899852724596,0.5154658641994468,1.0,8/39,5.82%,GJA1;CYP26B1;SULF2;FGFR2;GNAS;SULF1;SH3PXD2B;SKI
prerank,regulation of protein kinase B signaling (GO:0051896),0.4418329744554785,1.4863148617904203,0.007709251101321586,0.5157499604562784,1.0,41/193,13.86%,TCF7L2;PDPK1;IGF2;ANGPT1;PIK3R1;AREG;DAG1;TGFA;FGFR1;EPGN;KL;FGFR2;KIT;FGFR4;GAS6;PDGFRA;PDGFRB;TGFBR1;SEMA5A;CCL19;AXL;OSBPL8;FRS2;ENG;SRC;CD28;GRM2;NTRK3;DRD3;EGFR;SPRY2;FGF2;HBEGF;RCN3;PHLPP2;INSR;MUL1;EGF;TSC2;PTEN;FLT3LG
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.5160540669398913,1.4854534109251745,0.03342245989304813,0.5168213038159655,1.0,14/56,10.51%,BMP6;LDLRAD4;BMPR1A;INHBE;PMEPA1;TGFBR1;TWSG1;ACVR1;ENG;EMILIN1;DAB2;RBPMS;BMP2;BMP15
prerank,apical junction assembly (GO:0043297),-0.4213909483345877,-1.485213643846917,0.007692307692307693,0.5199620763345781,1.0,13/53,12.65%,MPP7;OCLN;PECAM1;CLDN5;ESAM;F11R;CLDN11;RAMP2;PDCD6IP;PATJ;WDR1;STRN;PAK2
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.4486914087461393,1.485128236434968,0.012290502793296089,0.5160160488034827,1.0,36/166,12.59%,IGF1;SAMD4A;IGF2;SMAD3;ZEB2;PLD1;GLI2;SLC6A9;NOS1AP;NNMT;FGFR4;PDGFRB;CCL19;APOA1;SLC45A3;SLC25A37;LDLR;STAR;SMOC2;CPEB3;CD28;NPM2;SREBF1;TLR6;NR1D1;LPGAT1;EGFR;METTL14;ARNT;FGF2;EIF6;DDX3X;RGCC;GLI1;INSR;NMD3
prerank,regulation of glucose metabolic process (GO:0010906),0.5573167770345966,1.484406128846976,0.040059347181008904,0.5166246653078849,1.0,5/34,5.45%,PDK1;RORA;OGT;SLC45A3;GNB3
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.522635858214345,1.4838914329849817,0.040502793296089384,0.5166423560525695,1.0,6/46,4.27%,TCF7L2;PIK3R1;SMAD3;ZIC1;GAS6;NEDD4
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.6496024623946285,1.4836636235115541,0.07179487179487179,0.5154053344034499,1.0,5/15,14.46%,SH3D19;APOE;SNX33;ADRA2A;SNX9
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.5948894543468685,1.4819532076377284,0.07532051282051282,0.5196561994584414,1.0,10/23,16.86%,GJA1;GDNF;SMO;LBX2;WNT5B;FGF2;EGF;MDK;BMP4;LIF
prerank,cardiac muscle contraction (GO:0060048),0.5528308798896406,1.4818057295009797,0.05397727272727273,0.5181743798434547,1.0,8/34,9.67%,SLC8A1;GSN;ATP1A2;TPM1;TNNC1;MYL4;GAA;CSRP3
prerank,regulation of chromatin organization (GO:1902275),0.6660843025705897,1.4816108587082006,0.0852575488454707,0.5169145416662513,1.0,7/14,15.19%,IGF2;HPF1;MLLT3;SETD1A;SETD5;TLK1;METTL4
prerank,regulation of actin filament-based process (GO:0032970),0.49641259576926255,1.4804991348215917,0.029754204398447608,0.5188731531908716,1.0,14/70,7.97%,EPHA3;RHOH;ROCK2;LRP1;DLC1;RHOD;ARHGAP18;RHOBTB1;PDGFRB;CNN2;IQGAP2;RHOBTB3;RHOBTB2;ARHGAP35
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5431928759584927,1.4803433280056537,0.04822695035460993,0.5174151596156551,1.0,10/36,13.50%,NRP1;AREG;TGFA;EPGN;ADRA2C;EPHB2;HBEGF;ADRA2A;EGF;NCOA3
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.48019978855573386,1.48029182116948,0.02444987775061125,0.5156559823342027,1.0,17/88,12.74%,NELL1;SAMD4A;DAPK1;DNAJC1;APOE;CDK5RAP3;IGF2BP2;IGFBP5;CST3;CPEB3;EIF2AK3;RNF139;DDX3X;F2;CLN3;LARP1;TM4SF20
prerank,maturation of LSU-rRNA (GO:0000470),-0.48306400039838626,-1.4797937767167402,0.037037037037037035,0.5340771243847239,1.0,11/26,21.67%,NSA2;RPL7;MAK16;NIFK;RPL7A;SNU13;RPL7L1;RRP15;RPF1;RPF2;ZNHIT3
prerank,sensory perception of mechanical stimulus (GO:0050954),0.4846959385857597,1.4787977514958848,0.02334152334152334,0.5191487049076995,1.0,17/85,11.09%,ATP6V0A4;COL1A1;CEMIP;COL4A3;ADGRV1;EYA1;GRXCR1;COL11A1;EML2;RIPOR2;ROR1;USH2A;ALDH7A1;TIMM9;LRTOMT;COL11A2;GSDME
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.5221013167702069,-1.4784726769162861,0.0547945205479452,0.5339400520442765,1.0,9/20,14.43%,RPS6KA5;DIP2B;NOS1;PPARGC1A;BRD7;RPS6KA4;TADA2A;MAPK3;DIP2A
prerank,embryonic digit morphogenesis (GO:0042733),0.6201913604421811,1.477997225828918,0.07131537242472266,0.5199597517966442,1.0,6/18,7.90%,SALL1;GLI3;WDPCP;TBX3;MAP3K20;OSR1
prerank,response to glucose (GO:0009749),0.5318182333251906,1.4769708441588614,0.04299583911234397,0.5215079858327456,1.0,7/46,5.20%,TCF7L2;ZBTB20;NKX6-1;SLC30A8;GAS6;NEUROD1;PRKAA2
prerank,positive regulation of insulin secretion (GO:0032024),0.5476143804621374,1.4758614356027069,0.05146036161335188,0.5233332282856329,1.0,5/36,5.32%,TCF7L2;RBP4;SLC30A8;MCU;BAIAP3
prerank,autonomic nervous system development (GO:0048483),0.6352732348842547,1.4748654870281401,0.05592105263157895,0.5250881004231652,1.0,3/17,3.21%,NRP1;GDNF;ASCL1
prerank,cyclooxygenase pathway (GO:0019371),0.7095841531830962,1.4736653943306042,0.09259259259259259,0.5273425376518366,1.0,2/10,1.91%,PTGIS;PTGES
prerank,positive regulation of proteolysis (GO:0045862),0.5138197652043721,1.4731451104951767,0.0427807486631016,0.5272820627822898,1.0,8/55,6.72%,CCBE1;SH3D19;OGT;FGFR4;ASPH;APOE;CTSH;SNX33
prerank,glucose homeostasis (GO:0042593),0.47915432259564494,1.4729681778471946,0.03209876543209877,0.5259798919855061,1.0,20/83,15.81%,TCF7L2;RBP4;PIK3R1;LEPR;SLC30A8;FGFR4;APPL2;MCU;NEUROD1;PRKAA2;CEBPA;NR1D1;STK11;ADRA2A;INSR;CYB5R4;SLC2A4;FOXK2;PIK3R2;LRRC8A
prerank,regulation of cell migration (GO:0030334),0.42262308233111306,1.4719604714250618,0.0,0.527632129329725,1.0,83/382,11.33%,IGF1;ROBO1;PLXNA2;LDB2;PHACTR1;COL1A1;CEMIP;ROCK2;AMOTL2;PDGFD;SYNE2;SASH1;LDLRAD4;DAG1;MITF;SEMA3D;SERPINE1;DLC1;RHOD;PODN;NEDD9;TPM1;EPHA4;DOCK10;NKD1;KANK1;RECK;PPP3CA;CCN1;NKX2-1;MACF1;KIT;MYLK;PDGFRA;PDGFRB;TGFBR1;SMO;DPYSL3;SEMA5A;SULF1;CSF1;RFFL;APPL2;ACVR1;NTF3;SFRP1;CTSH;IGFBP5;TBCCD1;PDPN;CXCL16;CYP1B1;CDH5;ENG;SRC;BEX4;WNT5B;VCL;DPEP1;AFDN;CARMIL1;MYO1C;PARD6B;NTRK3;DAB2;EGFR;EPHB2;BMP2;MAP4K4;SPRY2;ACTN4;CAMK2B;MYADM;LMO4;MIA3;FAM89B;FGF2;NEXN;DNAI3;TRIP6;AMOTL1;HBEGF;ADRA2A
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.47517946775297504,-1.4714698238146349,0.04201680672268908,0.5539440951543019,1.0,8/27,14.09%,PDE4D;CAV1;PDE4B;CTNNA3;CAMK2D;JUP;RYR2;DSG2
prerank,regulation of chondrocyte differentiation (GO:0032330),0.5879986724457705,1.470455245372058,0.05511811023622047,0.5312258173294245,1.0,5/24,4.35%,ADAMTS12;TRPS1;SOX5;TGFBR1;CHADL
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.6565243603444082,1.4703839892420711,0.10677966101694915,0.5295312652307083,1.0,5/13,10.86%,PGM3;SLC35A3;GFPT1;UAP1;RENBP
prerank,negative regulation of cartilage development (GO:0061037),0.6765816547853787,1.4703083370801306,0.07205623901581722,0.5278564110913082,1.0,3/13,4.35%,ADAMTS12;TGFBR1;CHADL
prerank,myotube cell development (GO:0014904),0.70633545865361,1.469718092681442,0.08495575221238938,0.5282252018041194,1.0,2/10,5.82%,IGF1;SKI
prerank,regulation of developmental growth (GO:0048638),0.5719001659070033,1.4696711787121677,0.06932153392330384,0.5264866277764342,1.0,5/29,5.36%,IGF1;GHR;OLFM1;APOE;MUSK
prerank,regulation of transforming growth factor beta production (GO:0071634),0.622522528902732,1.4695980504184953,0.06721311475409836,0.5248663298277663,1.0,6/18,9.63%,LTBP1;SMAD3;ITGB8;ITGB6;CD200;ITGAV
prerank,regulation of fibroblast proliferation (GO:0048145),0.5299459661607282,1.4689803310024654,0.058029689608636977,0.525205531064062,1.0,7/45,5.82%,IGF1;DDR2;GAS6;PDGFRA;LIG4;SFRP1;SKI
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.5544035389813503,1.4674436353810212,0.0549777117384844,0.5288556463492785,1.0,8/35,6.49%,IRAG1;ADCY1;ADCY2;KSR1;APOE;RAPGEF2;PDE3A;PDE7B
prerank,cation transport (GO:0006812),-0.3331334379155995,-1.4674049874440749,0.0,0.5638718376856539,1.0,29/167,7.91%,TRPM3;PIEZO2;SLC6A6;SLC12A2;SLC47A1;KCNB2;KCNJ2;PIEZO1;ANO1;KCNK5;KCNAB1;NEDD4L;SLC9B2;SLC7A1;KCNJ3;SCN1A;KCNMA1;KCND3;SLC5A6;ABCC9;SLC38A5;KCNN2;SCN3A;SLC1A1;ATP1B1;KCNMB2;NDFIP2;SCN2A;TRPM7
prerank,pancreas development (GO:0031016),0.6694175206620394,1.466974518476224,0.06884681583476764,0.5285720510495641,1.0,3/12,7.54%,TCF7L2;NKX6-1;DNAAF1
prerank,cellular response to growth factor stimulus (GO:0071363),0.4493781736271294,1.4665484943786626,0.010180995475113122,0.5283048488698091,1.0,27/151,9.37%,NRP1;BMP6;ADAMTS12;PDPK1;CILP;CLEC3B;SMAD3;SOX5;BMPR1A;WNT4;RUNX2;TGFBR1;PDCD5;RAPGEF2;APPL2;ACVR1;SFRP1;PDE3A;ZFP36L1;ACAP2;SIRT2;NTRK3;EGFR;BMP2;STAT5B;SPRY2;RAPGEF1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.7027134805495987,1.4651311770216975,0.08041958041958042,0.5316222817135512,1.0,6/11,8.35%,NKD1;LBX2;MLLT3;SFRP1;WNT5B;DAB2
prerank,activation of protein kinase A activity (GO:0034199),0.6348181171949199,1.4645725539075043,0.06743421052631579,0.5315140171645644,1.0,5/16,3.53%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9
prerank,keratan sulfate biosynthetic process (GO:0018146),0.5839392022002792,1.4644887990596678,0.07253086419753087,0.5299514520907226,1.0,6/26,7.98%,FMOD;OGN;LUM;ST3GAL3;B4GALT1;OMD
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.6761821308577699,1.4640386393113856,0.07692307692307693,0.529803699547771,1.0,4/12,9.04%,ROCK2;APOE;RANBP9;PICALM
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.5340562461343096,1.4631252731476805,0.044382801664355064,0.5311831518195761,1.0,13/41,14.00%,AREG;TGFA;NEDD9;EPHA4;IL34;EPGN;GAS6;SRC;HBEGF;ADRA2A;NOX4;EGF;DLG4
prerank,diacylglycerol metabolic process (GO:0046339),-0.4935468560351147,-1.4630332158742299,0.040214477211796246,0.5742861419290893,1.0,10/23,17.45%,PLCE1;DGKB;DGKH;LIPE;DGKK;PGS1;DGKG;DGKQ;PNPLA2;DGKZ
prerank,response to prostaglandin E (GO:0034695),0.6890688087800715,1.4628613247326396,0.0985663082437276,0.5301590531417255,1.0,3/10,5.06%,TGFBR3;CCL19;SFRP1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.705211856483146,1.4626768922953444,0.09090909090909091,0.5288859310518456,1.0,3/10,4.43%,ENPP1;PID1;APPL2
prerank,cellular zinc ion homeostasis (GO:0006882),-0.4879316814522106,-1.4626039073478159,0.04395604395604396,0.5709792234570771,1.0,10/26,4.62%,SLC39A10;SLC39A8;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H
prerank,integrin-mediated signaling pathway (GO:0007229),0.4858913928204349,1.460026178785366,0.03018867924528302,0.536505602486117,1.0,16/73,9.63%,ITGBL1;NRP1;FYB1;PLPP3;ITGA11;NEDD9;FBLN1;APOA1;ITGB8;ITGB5;CDC42;SRC;DAB2;ITGB6;ITGB3;ITGAV
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.4856902744392249,1.4586029945672239,0.03109452736318408,0.5397454641660144,1.0,13/72,6.32%,IGF1;PIK3R1;PDGFD;DCN;LYN;FGFR1;KIT;PDGFRA;PDGFRB;NEDD4;NTF3;ROR1;SRC
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.5722813433823202,-1.4576576994388446,0.06935123042505593,0.5843198730297244,1.0,9/14,30.25%,ENTPD1;ENTPD2;ENTPD6;ENTPD3;ADPRM;NUDT16;NUDT9;ENTPD5;NUDT1
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.5420097468204961,-1.4558614805449597,0.06976744186046512,0.5857759872970814,1.0,7/18,14.50%,PLCG2;DYSF;LBP;FCER1G;IFI35;SBNO2;KARS1
prerank,ganglion development (GO:0061548),0.688333405290389,1.4555109892490732,0.08376068376068375,0.5490258049389554,1.0,2/11,3.21%,NRP1;ASCL1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.505808410559402,1.4552498311545765,0.049136786188579015,0.5480101929501124,1.0,9/48,6.95%,ADCY1;AMPD3;ADCY2;ADCY7;ADCY5;NUDT2;ADCY9;GUCY2C;GUCY2D
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.7002366651079615,1.4541488083110874,0.0975609756097561,0.550108767076392,1.0,3/10,8.78%,IGF2;DNMT3A;PCGF3
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.5315752016889048,-1.4540419181555257,0.06201550387596899,0.5880628225247254,1.0,8/19,12.63%,CSGALNACT1;EXTL3;NDST3;XYLT1;HS6ST3;HS3ST5;HS6ST2;UGDH
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.6752277434642909,1.4539133074074906,0.09878682842287695,0.5491616726830701,1.0,8/12,28.51%,INSIG2;KDELR3;INSIG1;RER1;HSPA5;OS9;KDELR2;TAPT1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.6501409532536583,1.4537393368016667,0.08803986710963455,0.5478647363601149,1.0,7/15,6.62%,DAAM2;DACT1;LBX2;RNF213;SFRP1;ZNRF3;WNT5B
prerank,renal water homeostasis (GO:0003091),0.5876563811902709,1.4533985469089714,0.06531881804043546,0.5471739596379059,1.0,5/23,3.53%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.5434650279746112,-1.4533815244937969,0.04834605597964377,0.5856490313874132,1.0,8/17,18.69%,NLGN1;RAB27A;SLC4A8;CACNA1H;RAB15;RAB3A;STX1A;SYT4
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.42407710684101885,-1.4533288294558626,0.04332129963898917,0.5809807972171133,1.0,16/42,22.19%,WARS1;WARS2;LARS1;TARS3;YARS1;YARS2;QARS1;TARS2;KARS1;FARS2;AIMP1;NARS2;MARS2;AIMP2;AARS2;TARS1
prerank,response to ATP (GO:0033198),-0.5217888929045844,-1.4524156390228067,0.07692307692307693,0.5794194819376962,1.0,5/18,12.50%,TRPC3;ABCC9;P2RX7;TAF1;DGKQ
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.6056083084429149,-1.4523060241443198,0.08037825059101655,0.5749280863550343,1.0,5/11,10.72%,NOS3;GCH1;DHFR;CALM1;SPR
prerank,substrate-dependent cell migration (GO:0006929),0.6422339259629574,1.4521550024826777,0.09090909090909091,0.5499480669927388,1.0,3/14,2.61%,NRP1;ITGA11;EPHA8
prerank,retinoic acid metabolic process (GO:0042573),0.6509152948467609,1.4509179308224684,0.0867430441898527,0.5526629261121296,1.0,3/14,7.29%,CYP26B1;ALDH1A2;ADH1A
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.6635526300141313,1.4507315426400755,0.10431654676258993,0.5514223072940814,1.0,2/11,7.38%,NRP1;SIRT2
prerank,blood vessel morphogenesis (GO:0048514),0.4989105387758346,1.4506518499599161,0.04986522911051213,0.5498901356431004,1.0,10/54,5.70%,NRP1;CCBE1;LAMA1;TGFBR3;LOX;EFNB2;TGFBR1;ITGB8;CYP1B1;ENG
prerank,artery morphogenesis (GO:0048844),0.5514227941854379,1.4503351868733678,0.06772334293948126,0.5492410197642962,1.0,7/30,6.17%,NRP1;LRP1;BMPR1A;PDGFRB;TGFBR1;ENG;ADAMTS9
prerank,keratan sulfate metabolic process (GO:0042339),0.5573799771817783,1.4502458866720065,0.07451564828614009,0.5477261604262913,1.0,7/31,7.98%,FMOD;OGN;LUM;ST3GAL3;GALNS;B4GALT1;OMD
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.6779102193692241,1.4498694992501915,0.10154905335628227,0.5471984967781286,1.0,7/10,22.42%,CPEB1;CPEB3;PAF1;CDC73;HSF1;LEO1;NCBP2
prerank,Golgi organization (GO:0007030),0.448593636903462,1.4498476116857053,0.02176541717049577,0.5454708897268751,1.0,40/112,19.67%,OBSL1;USP6NL;LMAN2L;OPTN;RAB30;MYO18A;GORASP2;ARHGAP21;TMED1;GOLGB1;LMAN1;CDC42;STX16;ZW10;LRRK2;UBXN2B;GOSR2;TRIP11;ARL1;TMED4;PLEKHM2;TJAP1;GOLPH3L;GORASP1;GOLGA8B;GOLGA5;TANGO2;ATP8B2;TBC1D20;BAG5;HACE1;HUWE1;CUL7;GOLPH3;ARFGEF1;TMED10;CSNK1A1;SEC16B;HTT;NSFL1C
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5856488903702669,1.4489563193053958,0.07067669172932331,0.5469885065514962,1.0,3/25,2.56%,ERRFI1;CBLB;SLC6A9
prerank,positive regulation of transferase activity (GO:0051347),0.4448959896542064,1.44876062403931,0.011574074074074073,0.5459564893599763,1.0,25/142,10.32%,EPHA3;EPHA7;IGF2;DDR2;ARRDC4;FGFR1;EPHA4;EPHA8;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;CHTF8;AXL;MUSK;ROR1;PARM1;NTRK3;EGFR;EPHB2;CD200;LMO4;RYK;PARN
prerank,response to interleukin-6 (GO:0070741),0.6880173577992708,1.4485185862379835,0.0846286701208981,0.5449772607291221,1.0,2/10,0.91%,PTGIS;PID1
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.5013903377991151,-1.4481306712499105,0.0431266846361186,0.5853518417897969,1.0,12/20,31.68%,DENND1B;B2M;CD55;PRKCZ;CD81;FZD5;TRAF2;MAP3K7;MALT1;TRAF6;NLRP3;IL1R1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5301008123793003,-1.448111142628592,0.07088607594936709,0.580648195595296,1.0,7/18,9.66%,GRID2;UNC13B;GRIK1;GRIK2;CDH8;GRIA2;GRID1
prerank,sensory organ development (GO:0007423),0.5094381509602641,1.4478333077770797,0.05459387483355526,0.545677825897555,1.0,7/51,6.98%,RBP4;PBX1;SHROOM2;ASCL1;SH3PXD2B;CPAMD8;SMOC1
prerank,protein localization to membrane (GO:0072657),-0.326476399817827,-1.4477625300433263,0.0,0.5773215180465459,1.0,41/187,10.09%,DLG2;CAV1;DPP10;SHANK3;KCNB2;KCNIP4;RAP1A;SMURF1;NLGN1;F11R;CDH1;ANK3;BSG;EFR3B;LIN7A;ZDHHC2;RAMP2;SPTBN1;NRXN1;RDX;LRRC7;LRP6;EMP2;TTC7A;RAB3C;ITGA4;LIN7C;ATP1B1;EHD4;RAB12;NUP54;GAK;RAB8B;INPP5K;RAB11A;MAP7;PTN;ARL3;JUP;ZDHHC15;SCRIB
prerank,peptidyl-tyrosine modification (GO:0018212),0.500860536687441,1.4461954352786108,0.03983516483516483,0.5498048366305377,1.0,11/56,3.57%,EPHA3;DDR2;LYN;FGFR1;EPHA4;FGFR2;KIT;FGFR4;TPST1;PDGFRA;PDGFRB
prerank,negative regulation of multicellular organismal process (GO:0051241),0.4356448120144591,1.44612115573829,0.012141280353200883,0.5483271318193425,1.0,45/199,15.88%,ALDH1A1;ROBO1;GJA1;ROCK2;ADAMTS5;MCC;LDLRAD4;LGR4;WWC2;IL17D;TNNT1;NKX2-1;NFIB;ACOT11;GAS6;NPR3;TWSG1;APOA1;SFRP1;NR1D1;RBPJ;FOXC2;EGFR;BMP2;SPRY2;USF3;STK11;FOXA1;SPRED3;ADM;RGCC;VASN;MAP2K6;SYT11;PTEN;PTPN23;MDK;HPN;NR1H3;BMP4;ASB1;SPRED1;BMP5;CHSY1;SDHAF2
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.5812937079412692,1.4459355831193474,0.07339449541284404,0.5473106126342232,1.0,2/25,0.72%,PDPK1;CEMIP
prerank,regulation of transmembrane transport (GO:0034762),-0.46041842623362284,-1.4455967302880361,0.05214723926380368,0.5802838326102205,1.0,7/31,3.19%,OCLN;SLC2A1;KCNJ2;ACTB;CTTNBP2NL;NEDD4L;KCNJ3
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.5202492496207777,1.4450104916736197,0.06657608695652174,0.5488693952479899,1.0,15/43,14.25%,ERRFI1;CBLB;AREG;TGFA;EPGN;CDC42;EPS15;EGFR;SPRY2;HBEGF;EPS15L1;PTPN3;EGF;MVP;GPRC5A
prerank,phospholipid transport (GO:0015914),-0.3996554227742505,-1.4449543170568553,0.03787878787878788,0.5779384784294086,1.0,21/52,17.76%,PITPNC1;ATP8A1;ATP8B1;ATP11C;PLTP;ABCC1;PITPNA;ATP11B;TNFAIP8L3;NPC2;ATP11A;MFSD2A;ABCG1;OSBPL2;SCARB1;PCTP;SCARB2;PITPNB;ATP10A;PRELID2;ABCB4
prerank,hippo signaling (GO:0035329),0.5653025622162645,1.4445275883499078,0.07680491551459294,0.5487875861247852,1.0,9/26,12.75%,AMOTL2;TEAD1;YAP1;WWTR1;DCHS1;STK4;AMOTL1;YWHAE;TEAD3
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.652188943235166,1.4443025915945582,0.09523809523809523,0.5478855062234452,1.0,3/14,4.35%,ADAMTS12;TGFBR1;CHADL
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.6866164146009741,1.444298856273412,0.09380530973451327,0.5461677343257016,1.0,6/11,10.56%,ACTN2;LEPROT;SNX33;PICALM;COMMD1;TAX1BP3
prerank,C-terminal protein amino acid modification (GO:0018410),-0.6090654306641871,-1.444103799794152,0.08158508158508158,0.576448911047488,1.0,7/11,30.01%,AGBL4;GPLD1;ATG7;TTL;AGTPBP1;LCMT1;AGBL1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.4908735092283353,1.44364760032809,0.05006765899864682,0.5466805433587303,1.0,10/57,8.21%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9;INSL3;HTR1A;MTNR1A;LPAR1;DRD3
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.5881117555185418,1.4435788732279322,0.07776049766718507,0.5451814230783664,1.0,2/25,4.82%,IGF1;NEUROD1
prerank,regulation of receptor binding (GO:1900120),0.6834178584574199,1.443392883044994,0.11703958691910499,0.5440826478430101,1.0,1/10,0.07%,GREM2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5460177434606266,1.4426553552381551,0.0641399416909621,0.5450597649580636,1.0,8/31,8.14%,TGFBR3;TPM1;BMPR1A;FGFR2;TGFBR1;ENG;TNNC1;RBPJ
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.4305564531337222,1.4422079758929005,0.013392857142857142,0.5448873733520295,1.0,46/182,14.20%,IGF1;ROBO1;CILP;SLC24A3;ROCK2;RBMS3;RUNX1;BMPR1A;OLFM1;OPTN;WNT4;YAP1;APOE;SMO;NOTCH2;SLC2A10;ITGB8;LDLR;SFRP1;PRKAA2;ENG;TNRC6B;ATOH8;EMILIN1;CD28;MAP2K1;TET1;TNRC6A;BMP2;PICALM;SNX12;PRKN;MYADM;PARP14;FGF2;TTBK1;RBL2;TCEAL1;REST;TERF2;LRP3;CCDC3;MYCN;DLG4;ZNF148;SETDB1
prerank,anion transport (GO:0006820),-0.44198975796635936,-1.4412189061960208,0.04391891891891892,0.5826515840765103,1.0,6/33,3.99%,ABCG2;SLC26A7;LRRC8C;LRRC8D;SLCO2B1;SLC22A6
prerank,amino acid import across plasma membrane (GO:0089718),0.5735737160364096,1.4402850091325745,0.0856269113149847,0.5499084426867825,1.0,6/24,4.20%,SLC1A3;SLC7A2;SLC1A5;SLC6A9;SLC6A13;SLC22A2
prerank,replicative senescence (GO:0090399),0.6690510443573116,1.4395279165840171,0.08813559322033898,0.5508239182025508,1.0,2/12,2.11%,SERPINE1;PLA2R1
prerank,actin filament depolymerization (GO:0030042),0.6861188694102758,1.4381785587942426,0.09682804674457429,0.5539493397137817,1.0,2/11,1.20%,MICAL3;GSN
prerank,regulation of execution phase of apoptosis (GO:1900117),0.6772462645537797,1.4380895942386713,0.0840630472854641,0.5525786929819856,1.0,3/11,7.38%,PTGIS;DLC1;SIRT2
prerank,positive regulation of response to stimulus (GO:0048584),-0.4203468077125288,-1.4375516911950368,0.056666666666666664,0.5912820401983004,1.0,20/40,35.07%,IFIH1;B2M;IL15;TGFB2;HOMER1;CGAS;SIRT1;CD80;ABI3;DHX9;HMGA2;NSMCE1;FMR1;ACOX2;IER5;FCGR2B;ARG2;ANKLE1;GATA3;HMGA1
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.5644972689742885,-1.4373985981111637,0.07801418439716312,0.5871523851116179,1.0,8/13,21.72%,NOTCH1;HEY2;GSK3A;TGFBR2;RYR2;CPE;FOXF1;NPY5R
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.7033780126662798,1.4367317729542852,0.10714285714285714,0.5560527784781026,1.0,3/10,3.05%,LYN;PIGR;KIT
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.656875592159495,1.4365760605197377,0.09515570934256055,0.5549011288906783,1.0,2/13,3.12%,ENPP1;TPST1
prerank,cellular response to nitrogen compound (GO:1901699),0.5919638908621507,1.4365640417852363,0.09936908517350158,0.5532402692692827,1.0,8/20,19.35%,ROCK2;RIOK3;DDI1;RTF2;TIMELESS;EPG5;ATRX;HSF1
prerank,regulation of endothelial cell migration (GO:0010594),0.46873486299845785,1.4364407209358676,0.04039167686658507,0.5519870602615137,1.0,20/85,10.33%,NRP1;RIN2;ROCK2;ANGPT1;SPARC;GLUL;SASH1;DCN;NR2F2;SP100;APOE;SMOC2;ATOH8;ADAMTS9;AAMP;FOXC2;ANXA3;ITGB3;FGF2;PTPRM
prerank,manganese ion transport (GO:0006828),-0.5557717038405627,-1.4360944121835542,0.08088235294117647,0.58710695709003,1.0,6/14,6.02%,TRPC3;TRPC4;SLC39A8;TRPC5;ATP2C1;TRPC1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.6613725410330383,1.436079893544429,0.10570469798657718,0.5516355371762811,1.0,5/13,8.74%,BMP6;BMPR1A;TGFBR1;DAB2;RBPMS
prerank,visual system development (GO:0150063),0.5313999681897811,1.4356235536654443,0.07943262411347518,0.5516292158571723,1.0,5/37,6.98%,RBP4;PBX1;SH3PXD2B;CPAMD8;SMOC1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.5616285312381848,1.4355359348811816,0.07317073170731707,0.5502455931436369,1.0,6/29,9.63%,IGF1;LYN;NOTCH2;SRC;RAPGEF1;ITGAV
prerank,BMP signaling pathway (GO:0030509),0.49250773548755383,1.435427179147909,0.04915912031047866,0.5490955954336045,1.0,17/62,15.58%,BMP6;TGFBR3;SMAD3;BMPR1A;RUNX2;ACVR1;ENG;RGMA;BMP2;SMAD1;BMP15;USP9Y;PDCD4;USP9X;HIVEP1;BMP4;BMP5
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.6515360430926933,1.434936203455576,0.09375,0.5491971129673117,1.0,4/12,8.91%,ADAMTS12;DCN;IL12B;SPRY2
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.45791271121720045,1.434641840372297,0.02832512315270936,0.5485746625263629,1.0,17/102,8.84%,PDPK1;ADCY1;ENPP1;TBC1D4;ADCY2;PIK3R1;ADCY7;ADCY5;ADCY9;INSIG2;CPEB1;ZFP36L1;LHCGR;SRC;TRARG1;SLC30A10;KAT2B
prerank,cell chemotaxis (GO:0060326),0.4905179922925916,1.4343076833834816,0.05181347150259067,0.5480826568109738,1.0,12/60,7.52%,NRP1;DOCK4;PARVA;XCR1;KIT;PDGFRA;PDGFRB;SEMA5A;ACKR2;CCR9;AGTR1;LPAR1
prerank,positive chemotaxis (GO:0050918),0.6081382794713207,1.4325660659904154,0.08517887563884156,0.5524465342649906,1.0,3/17,3.78%,NRP1;ANGPT1;SEMA5A
prerank,positive regulation of cell migration (GO:0030335),0.4195048393345625,1.4325611341944715,0.008620689655172414,0.5508180765737173,1.0,51/253,9.78%,IGF1;NRP1;COL1A1;DDR2;CEMIP;ROCK2;PDGFD;SYNE2;SEMA3D;RHOD;NEDD9;PPP3CA;CCN1;KIT;MYLK;PDGFRA;PDGFRB;TGFBR1;SMO;VTN;SEMA5A;CSF1;INSL3;RAPGEF2;SMURF2;ACVR1;NTF3;CTSH;PDPN;CXCL16;CDH5;SRC;WNT5B;DOCK5;RAB25;CARMIL1;MYO1C;NTRK3;DAB2;EGFR;EPHB2;BMP2;MAP4K4;SPRY2;CCN4;SYDE1;ACTN4;MYADM;S100A11;MIA3;FAM89B
prerank,regulation of steroid biosynthetic process (GO:0050810),0.660621184491036,1.431040554908095,0.11071428571428571,0.5543585400342373,1.0,5/11,8.76%,FGFR4;WNT4;STAR;NR5A1;BMP2
prerank,positive regulation of DNA binding (GO:0043388),0.558587289152955,1.4309977243696852,0.07993966817496229,0.5529070003236584,1.0,7/31,13.25%,IGF1;NEUROD1;SKI;SIRT2;PRKN;NIBAN2;EGF
prerank,ribosome biogenesis (GO:0042254),-0.32697157550167544,-1.430673927896303,0.0,0.6023182364656937,1.0,69/187,21.54%,RPL41;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;RPL21;RPL7;RPL18;RIOK1;RPL27;RPL35A;RPL38;RPS15;RPL39;RPS7;PAK1IP1;RPL11;WDR36;RPL30;RPL36;RPLP1;RPL37;RPS9;UTP4;RPL4;METTL17;RPL18A;RPL26;RPL6;RPL36A;RPL29;MALSU1;RPL13A;RPL7A;NVL;RPL19;RRP1;SNU13;POP4;RPL14;RPL13;RPL32;RPL5;NOL9;RPLP0;MPHOSPH10;KRR1;RPS6;RPL22;UTP15;RRP36;IMP4;FCF1;EXOSC5;NPM1;RRP12;RPL37A;NOP16;RPLP2;URB2;RPL17;RPL23;RPF1;WDR46;RRS1;RPF2
prerank,C21-steroid hormone metabolic process (GO:0008207),0.5995871322697652,1.4304234839503525,0.07894736842105263,0.553256912858584,1.0,4/20,10.91%,AKR1B1;STAR;HSD3B2;TSPO
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.5135823571375082,-1.430044218598449,0.08571428571428572,0.6000037256001701,1.0,5/20,6.07%,ZBTB16;CDK6;PTK2B;HOXA5;MEIS2
prerank,glycerophospholipid catabolic process (GO:0046475),-0.47615153848382513,-1.4299010307754176,0.058823529411764705,0.5960337992797358,1.0,13/27,27.23%,GPCPD1;ENPP2;PLA2G7;INPP5F;PNPLA8;PLA2G4C;PNPLA6;PLA2G4F;PLA2G4E;GDPD1;LIPC;PLA2G4B;PLA2G5
prerank,adrenergic receptor signaling pathway (GO:0071875),0.5924371234882446,1.429781269939201,0.10107197549770292,0.553747083304855,1.0,7/20,11.33%,ADRA1B;ADCY9;RAPGEF2;ADRA2C;ADRB3;DRD3;ADRA2A
prerank,protein localization to cell periphery (GO:1990778),-0.33563438643230337,-1.4297184629871609,0.0,0.5923458656834686,1.0,30/133,8.93%,CAV1;DPP10;KCNB2;KCNIP4;RAP1A;SMURF1;F11R;CDH1;ANK3;BSG;EFR3B;LIN7A;ZDHHC2;RAMP2;SPTBN1;RDX;LRP6;EMP2;TTC7A;RAB3C;LIN7C;ATP1B1;EHD4;RAB12;GAK;RAB8B;INPP5K;RAB11A;MAP7;ARL3
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.5876605319890302,-1.4289973566287357,0.08924485125858124,0.5904701774626554,1.0,3/12,3.55%,PODXL;PROM1;IQGAP1
prerank,muscle contraction (GO:0006936),0.44211593161338636,1.4270021776505721,0.02211874272409779,0.5618845938396807,1.0,23/126,7.33%,ROCK2;ACTN2;CALD1;SLC8A1;SNTB1;TPM1;TMOD4;TNNT1;MYL10;MYH13;ASPH;MYLK;LTB4R;MYL12A;TLN1;ITGB5;DES;SMTN;BDKRB2;TNNC1;VCL;MYL4;DTNA
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.47582531660966204,1.4247845851916414,0.05897771952817824,0.5680766457496097,1.0,15/67,8.62%,EPHA3;DDR2;GHR;LYN;FGFR1;EPHA4;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;PIBF1;SRC;EGFR;EPHB2
prerank,negative regulation of cell differentiation (GO:0045596),0.4306139166470815,1.4240290000851508,0.023411371237458192,0.5691485207162582,1.0,50/181,16.02%,ADAMTS12;IGF2;RORA;ENPP1;RUNX1T1;ADGRV1;SMAD3;COL5A1;LDLRAD4;ABCA1;NKX2-1;ASCL1;YAP1;TGFBR1;CHADL;SFRP1;TBX3;SKI;WWTR1;USH2A;SIRT2;OSR1;EGFR;SPRY2;METTL14;TRPM4;ITGB3;ITGAV;USF3;ANKRD26;FOXA1;SPRED3;REST;TMEM64;LRP3;VASN;PDCD4;PAF1;COL5A2;PTEN;HPN;TWIST2;NR1H3;BMP4;SUFU;SPRED1;BMP5;RIOX1;SDHAF2;TRIO
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.5106708938421046,1.4237985122270258,0.06179775280898876,0.5682859987518946,1.0,16/47,15.65%,NRP1;NEDD9;KANK1;FBLN1;APOA1;PDPN;CDC42;DOCK5;CARMIL1;CSPG5;ACTN4;MYADM;P4HB;MDK;FLNA;MELTF
prerank,digestive tract development (GO:0048565),0.5458537841173653,1.4237333825525358,0.08172362555720654,0.5669287943217733,1.0,14/32,15.66%,GLI2;SALL1;GLI3;FGFR2;KIT;SMO;RARB;CLMP;DNAAF1;EPHB3;CCDC40;GLI1;GATA6;NPY
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.577844208726035,-1.4234116045945755,0.07711442786069651,0.6064993135357998,1.0,7/12,23.45%,UBASH3B;PTK2B;DIAPH1;CASQ2;RYR2;MTLN;CASQ1
prerank,ceramide catabolic process (GO:0046514),-0.5513084692741268,-1.4232567482169924,0.09534883720930233,0.6025692168033135,1.0,7/14,25.08%,ACER3;ACER2;HEXB;HEXA;NEU1;GLA;NEU2
prerank,ncRNA processing (GO:0034470),-0.3227355729398499,-1.422736845000273,0.0,0.5999332783961835,1.0,72/200,21.19%,RPL41;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;INTS6;RPL34;RPL21;RPL7;RPL18;RPL27;RPL35A;RPL38;RPS15;RPL39;RPS7;LIN28B;RPL11;WDR36;RPL30;RPL36;RPLP1;RPL37;RPS9;UTP4;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;ADAR;RPL7A;NVL;RPL19;RRP1;SNU13;POP4;RPL14;RPL13;HNRNPA2B1;RPL32;RPL5;KARS1;NOL9;RPP21;MRPL44;FARS2;RPLP0;INTS8;MPHOSPH10;SRRT;KRR1;RPS6;RPL22;AGO1;UTP15;RRP36;IMP4;FCF1;EXOSC5;RRP12;RPL37A;RPLP2;RPL17;RPL23;RPF1;INTS1;WDR46
prerank,maintenance of blood-brain barrier (GO:0035633),-0.4500045606922638,-1.4210883703304114,0.05014749262536873,0.6015975094743026,1.0,12/30,5.15%,SLC12A2;OCLN;PECAM1;CLDN5;JAM2;ESAM;F11R;ACTB;TJP2;LSR;TJP1;SLC1A1
prerank,cortical cytoskeleton organization (GO:0030865),0.504135394232111,1.4209976117568424,0.08062234794908062,0.5751271112274279,1.0,13/41,16.63%,RHOH;ROCK2;RHOD;RHOBTB1;RHOBTB3;RHOBTB2;FMNL1;RHOQ;LLGL1;RND3;ARF6;EPB41L3;RHOG
prerank,regulation of glycolytic process (GO:0006110),0.476323328647282,1.4204724580515329,0.06060606060606061,0.5752600745458846,1.0,17/68,14.44%,IGF1;ZBTB20;OGT;PRKAG2;PFKFB4;NUP107;NUPR1;PRKAA2;NUP42;NCOR1;ARNT;EIF6;NUP98;RAE1;INSR;HDAC4;NUP214
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.5967576649541371,1.4192937208309993,0.10223642172523961,0.5762458916298403,1.0,5/19,18.80%,POLR2D;POLR2C;TERF2;ATRX;POLR2L
prerank,regulation of DNA recombination at telomere (GO:0072695),0.5967576649541371,1.4192937208309993,0.10223642172523961,0.5762458916298403,1.0,5/19,18.80%,POLR2D;POLR2C;TERF2;ATRX;POLR2L
prerank,platelet degranulation (GO:0002576),0.44582600243848447,1.419013378184646,0.028537455410225922,0.5756774752360186,1.0,21/118,9.59%,IGF1;IGF2;CLEC3B;ACTN2;TIMP3;SPARC;AHSG;SERPINE1;LYN;SERPING1;GAS6;APOA1;APLP2;PHACTR2;TLN1;VCL;NHLRC2;CD63;ACTN4;ISLR;ITGB3
prerank,fatty acid elongation (GO:0030497),-0.5522442476668229,-1.4189363675106434,0.08971553610503283,0.6051612726370975,1.0,4/13,13.49%,ELOVL7;ELOVL5;TECR;HACD2
prerank,positive regulation of endopeptidase activity (GO:0010950),0.5490320253139441,1.418112189606481,0.07298136645962733,0.577177453677124,1.0,6/26,10.93%,ROCK2;LYN;EPHA4;PICALM;TTBK1;APH1B
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.5198826946990671,-1.4177671483433325,0.07969151670951156,0.6053963616950766,1.0,5/17,10.26%,PODXL;PIEZO1;TGFB2;RET;SKAP1
prerank,regulation of focal adhesion assembly (GO:0051893),0.49619483001161896,1.4177521621872868,0.07258064516129033,0.5768244301329835,1.0,10/54,6.80%,EPHA3;NRP1;PHLDB2;ROCK2;ARHGAP6;DLC1;MACF1;SFRP1;SRC;VCL
prerank,regulation of pH (GO:0006885),0.6628054045534257,1.4176394240666375,0.10507880910683012,0.5756679738182302,1.0,1/11,0.20%,ATP6V0A4
prerank,regulation of cellular catabolic process (GO:0031329),0.4911576931682954,1.4176165120151623,0.06578947368421052,0.5741021944297835,1.0,19/62,21.00%,DAPK2;ITPR1;DAPK1;NUPR1;LRRK2;MTMR3;WDR91;PRKN;LONP2;RRAGD;USP10;PIK3R2;TPCN2;PIP4K2C;ATM;WDR41;PSAP;GPR137B;DDIT3
prerank,regulation of tissue remodeling (GO:0034103),0.6022847959997589,1.4169862053810467,0.09836065573770492,0.5747207069633569,1.0,5/18,6.81%,DDR2;RUNX1;LEPR;CST3;IL12B
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.667613314223462,1.4168942612354576,0.1076158940397351,0.5734693632662841,1.0,5/12,8.05%,UST;DCN;BGN;DSE;CSPG5
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.4626183255960058,1.4167571958068492,0.053217821782178217,0.572357732106361,1.0,9/84,7.87%,IGF1;SAMD4A;DAPK1;APOE;IGF2BP2;IGFBP5;CPEB3;EIF2AK3;RNF139
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.43566236970446237,-1.414849031475754,0.045454545454545456,0.6117994422732296,1.0,11/34,15.07%,PTPRB;PTPRJ;UBASH3B;PTPN12;DUSP22;PTPN2;PTPRT;DUSP7;PTPN22;DUSP8;PTPN6
prerank,gland development (GO:0048732),0.4853689809678313,1.4145430260020213,0.06300268096514745,0.5785496648506281,1.0,18/59,11.65%,TGFBR3;PRKCSH;GLI2;SALL1;ARID5B;NKX2-1;FGFR2;WNT4;TGFBR1;CDK5RAP3;TBX3;DKK3;CEBPA;ARHGAP35;ZBTB1;PHF2;EPHB3;NKX2-8
prerank,protein autophosphorylation (GO:0046777),0.42731028695314466,1.4145080797153906,0.037162162162162164,0.5770509537024816,1.0,35/157,13.78%,STK17B;DAPK2;PDPK1;DDR2;DAPK1;LYN;GRK5;FGFR1;EPHA4;EPHA8;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;MUSK;SRC;ULK2;LRRK2;SIK1;EIF2AK3;OXSR1;STK4;EGFR;CAMK2B;STK11;NEK6;TAOK3;EPHB3;MAP3K13;INSR;ACVR1B;STK16;MARK2;CDK12
prerank,central nervous system neuron differentiation (GO:0021953),-0.44464139609718445,-1.4142610497495074,0.0486322188449848,0.6098253710222331,1.0,8/33,11.80%,GRID2;MDGA2;MAP2;SPOCK1;LRP6;OPHN1;ZC4H2;ATP7A
prerank,ribosome assembly (GO:0042255),-0.40088875572372745,-1.414206783234614,0.046762589928057555,0.6058475746067602,1.0,17/47,21.54%,RPL3;RPS14;RPS19;RPS15;RPL11;RPS5;RPL6;PPAN;RPL5;RPSA;RPLP0;MTERF3;NPM1;C1QBP;MRPS7;RRS1;RPF2
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.5385191457232561,-1.4140448228102682,0.0728643216080402,0.6022238294083083,1.0,2/16,3.00%,CLDN5;CLDN11
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.44306053324869477,1.4139083263430567,0.033373063170441,0.5775239371805966,1.0,28/122,14.47%,IGF1;SAMD4A;IGF2;AR;PLD1;GLI2;SLC6A9;FGFR4;PDGFRB;CCL19;SLC25A37;SMOC2;CPEB3;CD28;NPM2;EGFR;METTL14;FGF2;EIF6;DDX3X;RGCC;GLI1;INSR;NMD3;EGF;MTPN;PLXNB2;NSUN5
prerank,regulation of stem cell proliferation (GO:0072091),0.6278261946978893,1.4138021202859754,0.09636650868878358,0.5762709345828045,1.0,4/17,5.78%,GJA1;YAP1;FBLN1;ZFP36L1
prerank,histone H3-K4 methylation (GO:0051568),0.562890066099502,1.4134865625740884,0.09411764705882353,0.5757880400822463,1.0,10/26,20.55%,OGT;SETD1A;WDR82;SETD4;KMT2A;WDR5;SETD1B;TET3;CXXC1;RBBP5
prerank,Ras protein signal transduction (GO:0007265),0.4331045590865094,1.4134456568148617,0.031914893617021274,0.574352209240026,1.0,32/137,15.57%,IGF1;COL1A2;RHOH;ROCK2;KSR1;PLD1;ARHGAP6;RHOD;CTNNAL1;CCNA2;RRAS2;ARHGAP29;CDC42EP4;RAPGEF2;MRAS;PDPN;AGTR1;NTN1;ARHGEF11;RAPGEF1;FGF2;TAX1BP3;ADRA2A;ARHGAP5;RAP2A;WASF1;SETDB1;EPS8L1;PLK2;RAPGEF6;HACE1;RASSF1
prerank,apoptotic cell clearance (GO:0043277),0.5407080029388015,1.4134351702821975,0.09487951807228916,0.5727995625039705,1.0,8/30,9.63%,RHOH;LRP1;RHOBTB1;GAS6;TXNDC5;RHOBTB2;ITGB3;ITGAV
prerank,branched-chain amino acid metabolic process (GO:0009081),0.5894895349181957,1.4128434134517267,0.09647779479326186,0.5716620070265767,1.0,13/20,26.46%,IVD;BCKDHB;DBT;ECHS1;ALDH6A1;ACADSB;MCCC2;BCKDK;DLD;HIBADH;HIBCH;ACAD8;BCAT2
prerank,branched-chain amino acid catabolic process (GO:0009083),0.5894895349181957,1.4128434134517267,0.09647779479326186,0.5716620070265767,1.0,13/20,26.46%,IVD;BCKDHB;DBT;ECHS1;ALDH6A1;ACADSB;MCCC2;BCKDK;DLD;HIBADH;HIBCH;ACAD8;BCAT2
prerank,protein localization to synapse (GO:0035418),-0.5756075112939614,-1.4122942356989676,0.10900473933649289,0.6042824894953543,1.0,5/12,10.52%,NLGN1;NRXN1;SHANK1;ZDHHC15;PCLO
prerank,purine ribonucleotide transport (GO:0015868),-0.5320234112828643,-1.4118851211662662,0.07772020725388601,0.6017033311776819,1.0,5/16,12.86%,LRRC8C;ABCC4;LRRC8D;ABCC6;SLC25A4
prerank,B cell homeostasis (GO:0001782),0.679082856114006,1.411589780758015,0.1070811744386874,0.5743992671684357,1.0,4/10,2.93%,LYN;DOCK10;DOCK11;GAPT
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.40320260576225303,1.4114847543954494,0.0030959752321981426,0.5732332214202179,1.0,82/348,14.99%,IGF1;ROBO1;BMP6;SLC24A3;GJA1;ROCK2;ANGPT1;PID1;GSN;SMAD3;RBMS3;AR;MITF;OLFM1;NOS1AP;NKX2-1;EPHX2;FGFR4;DTNBP1;YAP1;GAS6;TGFBR1;SMO;WNT6;RESF1;SLC2A10;TLE1;PDCD5;CSF1;SLC22A2;MT3;NTF3;ITGB8;CTSH;MUSK;CDH5;CUX2;TNRC6B;NR5A1;EMILIN1;NFE2L2;CD28;AFDN;EIF2AK3;MAP2K1;CD63;TLR6;OSR1;RBPJ;NTRK3;TNRC6A;ARRB1;EPHB2;BMP2;SPRY2;SMAD1;PRKN;ITCH;FGF2;PPHLN1;TTBK1;BRAF;DDX3X;RGCC;DNAJA4;C1QTNF1;TERF2;LRP3;HMGN5;INSR;TMEM119;MYCN;EGF;MTPN;PDCL3;ETS1;SETDB1;HPN;TADA3;BMP4;SFRP4;FUBP3
prerank,thyroid hormone generation (GO:0006590),0.6848285610886199,1.4113298684324052,0.09090909090909091,0.572251102131489,1.0,4/10,15.57%,CPQ;SLC5A5;DIO2;TG
prerank,adenine nucleotide transport (GO:0051503),-0.5217000941549179,-1.411188442347252,0.08051948051948052,0.6000263349680168,1.0,5/17,12.86%,LRRC8C;ABCC4;LRRC8D;ABCC6;SLC25A4
prerank,regulation of phospholipase C activity (GO:1900274),0.6160387573254588,1.4105504305285368,0.0958904109589041,0.5732966465002511,1.0,7/15,10.17%,FGFR1;KIT;PDGFRA;PDGFRB;NTF3;NTRK3;FGF2
prerank,glycoprotein biosynthetic process (GO:0009101),0.4670455249813492,1.4086565258555799,0.05105853051058531,0.5782427487291698,1.0,11/79,8.30%,IGF1;GAL3ST3;GAL3ST2;GALNTL5;B3GALT1;ST3GAL5;ST3GAL3;LARGE1;FUT10;B3GALNT1;ALG5
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.6026359675039348,1.4083666269961772,0.1085899513776337,0.5776726083064299,1.0,6/17,11.97%,NRP1;ROBO1;EFNB2;MIA3;FGF2;NR4A1
prerank,cellular response to glucose starvation (GO:0042149),0.5079781390277355,1.4082436980544555,0.0764872521246459,0.5766269396635703,1.0,24/41,26.65%,PRKAG2;PRKAA2;NUAK1;SIK1;EIF2AK3;BRSK1;MTMR3;HNRNPA1;IMPACT;PIK3R4;ITFG2;SESN2;TBL2;FOXO3;BECN1;PRKAG1;SZT2;CPEB4;HSPA5;PMAIP1;PRKAG3;SH3GLB1;RRP8;SESN3
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.5680246319194232,-1.4069541247215671,0.09808612440191387,0.6112397679404474,1.0,5/12,17.62%,ACTB;LAMA5;SCRIB;FUZ;ACTG1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.6766503258726364,1.406449495555541,0.1413427561837456,0.5811040533292248,1.0,2/10,1.78%,ADGRV1;GRXCR1
prerank,actin filament bundle assembly (GO:0051017),0.5433601881848465,1.4061398343301919,0.07604017216642754,0.5805496862163501,1.0,8/33,5.80%,CALD1;RHOD;NEDD9;SHROOM2;DPYSL3;MYO1B;FSCN3;LIMA1
prerank,toxin transport (GO:1901998),0.661197900203975,1.4058420514533803,0.11713286713286714,0.5801082274204719,1.0,3/10,4.20%,ANTXR1;ANTXR2;SLC22A2
prerank,response to retinoic acid (GO:0032526),0.4910411563289523,1.4056920424961294,0.05997392438070404,0.5791046218323865,1.0,10/59,6.62%,EPHA3;RBP4;LYN;WNT8B;ASCL1;WNT6;RARG;CTSH;PTK7;WNT5B
prerank,protein trimerization (GO:0070206),0.6280544692275672,1.4055453300973768,0.11260504201680673,0.5766262158170937,1.0,4/14,9.21%,SLC1A5;SCARA5;MLKL;CLYBL
prerank,protein homotrimerization (GO:0070207),0.6280544692275672,1.4055453300973768,0.11260504201680673,0.5766262158170937,1.0,4/14,9.21%,SLC1A5;SCARA5;MLKL;CLYBL
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.6500168757956808,1.4052074008862434,0.11498257839721254,0.5764093349606361,1.0,3/13,6.76%,PTGIS;NNMT;PARP16
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.647338413536773,1.4048868130301462,0.12074829931972789,0.5760400430281735,1.0,3/13,8.00%,GAL3ST3;B3GALT1;B3GALNT1
prerank,establishment of vesicle localization (GO:0051650),-0.5123742621835305,-1.4045080597112225,0.10204081632653061,0.6155528105994876,1.0,8/18,23.33%,LIMK2;RAB27A;CDK5;RAB11A;TESK1;SYNJ1;KIF5A;TMEM230
prerank,dermatan sulfate metabolic process (GO:0030205),0.6512152108078633,1.4043675052117346,0.10491803278688525,0.5762509242055064,1.0,5/13,8.05%,UST;DCN;BGN;DSE;CSPG5
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.6480332730017835,1.4043560311911647,0.11090909090909092,0.5747778705212468,1.0,5/11,14.18%,GAS6;CCL19;AXL;SELENOS;MERTK
prerank,regulation of cellular component movement (GO:0051270),0.49810609872832057,1.403129224564732,0.08064516129032258,0.5774784410772222,1.0,16/49,14.04%,MYCBP2;ROCK2;TGFBR3;LYN;ARHGAP18;SP100;TGFBR1;PDPN;MEMO1;EGFR;ZSWIM6;ACTN4;HBEGF;EGF;IGBP1;ETS1
prerank,regulation of insulin secretion (GO:0050796),0.4493131740476176,1.4030147521821699,0.05155875299760192,0.576366140220581,1.0,13/101,7.79%,TCF7L2;RBP4;ITPR1;RAPGEF4;ADCY5;SLC30A8;MCU;CDK16;NEUROD1;SFRP1;ADRA2C;CACNA1C;NR1D1
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.47326732573897123,-1.4026970611161007,0.05325443786982249,0.6179803800264239,1.0,9/24,17.83%,DACH1;ACVRL1;RPS3;MSH3;SUB1;ZRANB3;DFFA;BMPR2;CDKN1A
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.4169382719536776,1.4024604381451482,0.017448200654307525,0.5768013543459357,1.0,38/214,10.64%,NRP1;EPHA7;CCN2;ANGPT1;TIMP3;TGFBR3;PDGFD;LYN;CCN1;FGFR2;FGFR4;GAS6;PDGFRA;APOE;PDGFRB;CCL19;NOTCH2;FBLN1;RAPGEF2;MT3;ROR1;CCL4;RANBP9;EMILIN1;MAP2K1;TRAF7;MTURN;NTRK3;SLC30A10;ARRB1;EGFR;EPHB2;BMP2;SPRY2;FGF2;SPRED3;CARD9;BRAF
prerank,regulation of sodium ion transport (GO:0002028),-0.42999564629484244,-1.4024279469260037,0.0572289156626506,0.6149132011275845,1.0,11/34,9.72%,NKAIN2;ATP1A1;ANK3;YWHAH;NKAIN1;P2RX7;NKAIN3;FGF12;NOS1;ATP2B4;WNK2
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.4191362005405641,1.4022463916235657,0.02768549280177187,0.5760692382280787,1.0,44/173,15.19%,SEC24D;AREG;TGFA;DYNLL1;LMAN2L;ANK1;SEC31A;GAS6;TMED1;GOLGB1;YIF1B;DYNC1H1;LMAN1;ZW10;ARFGAP3;DCTN6;MIA2;TRAPPC4;COPB1;SPTAN1;COG8;CAPZB;COPZ2;GOSR2;TRIP11;BCAP31;MIA3;TMED4;KDELR3;ERGIC2;TRAPPC6B;ERGIC3;GORASP1;F2;COPA;DYNC1I2;CTSZ;KLHL12;USO1;SEC23A;ARF4;BET1L;TBC1D20;ERGIC1
prerank,positive regulation of cell junction assembly (GO:1901890),-0.3846653432674791,-1.4020762130927231,0.04580152671755725,0.6122266548236973,1.0,17/56,10.84%,TEK;CNTNAP2;GRID2;CAV1;PTPRJ;CLDN5;NLGN1;IL1RAPL1;KDR;PTPRD;EPHB1;NRXN1;MYOC;CLSTN2;VEGFA;ACE2;CLSTN3
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.5415477361344622,1.4013903981633313,0.10091743119266056,0.5774727026851283,1.0,5/28,4.43%,ENPP1;PID1;AHSG;KANK1;APPL2
prerank,regulation of cellular respiration (GO:0043457),-0.5242316559943495,-1.401201159955669,0.10148514851485149,0.6113618312941144,1.0,9/17,28.95%,CBFA2T3;PRDM16;NOA1;PNPT1;IL10RB;IFNAR1;VCP;IFNLR1;NOS2
prerank,cell projection organization (GO:0030030),0.5428363587340425,1.400917854417983,0.09895052473763119,0.5776242816270544,1.0,7/30,8.05%,RHOH;GSN;PARVA;CDC42;NPHP1;ATP1B2;CSPG5
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.5140474195665018,1.4007942759111334,0.0957004160887656,0.576598218903927,1.0,5/40,9.33%,IGF1;MOAP1;PDCD5;BCL2L11;PRKN
prerank,endocrine system development (GO:0035270),0.5864753382106327,1.400725113394348,0.1140495867768595,0.5753193836482737,1.0,6/21,5.73%,GLI2;SALL1;NKX2-1;WNT4;TGFBR1;DKK3
prerank,positive regulation of integrin activation (GO:0033625),-0.5727377602167207,-1.3998797447772393,0.09251101321585903,0.6121092522837865,1.0,5/11,10.69%,PIEZO1;RASIP1;RAP1B;SKAP1;PLEK
prerank,zinc ion homeostasis (GO:0055069),-0.459208562159725,-1.3998653096309284,0.053824362606232294,0.6082847532413914,1.0,10/28,4.62%,SLC39A10;SLC39A8;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.5096911363919511,1.398766800267538,0.09388335704125178,0.5805860345559085,1.0,11/45,10.51%,BMP6;BMPR1A;INHBE;TGFBR1;TWSG1;ACVR1;ENG;DAB2;RBPMS;BMP2;BMP15
prerank,lipid homeostasis (GO:0055088),0.47958269729528646,1.3986426235246188,0.07898259705488621,0.5795371646922114,1.0,14/57,16.31%,ZBTB20;ABCA1;RBP1;APOE;APOA1;PRKAA2;CEBPA;TLCD1;NR1D2;DDX3X;RCN3;DGAT2;NR1H3;THADA
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.44748742484984305,-1.398002786581975,0.057926829268292686,0.6109060383286866,1.0,14/30,25.99%,ACKR3;RPS3;KDM1A;PTTG1IP;TPT1;SIRT1;BCL2L1;CD44;CLU;SNAI2;TWIST1;CCAR2;MIF;SNAI1
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.5092094197469066,-1.397283815250498,0.11335012594458438,0.6093071980794442,1.0,8/17,18.91%,ATP5F1A;ATP5F1E;ATP5ME;ATP5MG;ATP5F1C;ATP5MF;ATP5PD;VPS9D1
prerank,arachidonic acid metabolic process (GO:0019369),0.5222903814711737,1.3966708624329698,0.08555399719495091,0.5848177733354183,1.0,7/35,7.08%,PTGIS;PTGES;DAGLA;EPHX2;PLA2G4A;CYP1B1;ALOXE3
prerank,glycoprotein catabolic process (GO:0006516),0.595604694731476,1.3964963693763286,0.1184,0.5839499663542906,1.0,5/17,16.23%,ADAMTS12;ADAMTS9;NGLY1;CTSL;NEU4
prerank,cellular response to cadmium ion (GO:0071276),-0.478000425031935,-1.3964061549251023,0.08443271767810026,0.6087792194555066,1.0,11/24,13.80%,MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;MAPK8;JUN;MAPK3
prerank,muscle filament sliding (GO:0030049),0.509822031272094,1.3961963466571223,0.08057553956834532,0.5819529583386506,1.0,8/38,13.03%,ACTN2;TPM1;TNNT1;DES;TNNC1;MYL4;TNNT3;TPM2
prerank,actin-myosin filament sliding (GO:0033275),0.509822031272094,1.3961963466571223,0.08057553956834532,0.5819529583386506,1.0,8/38,13.03%,ACTN2;TPM1;TNNT1;DES;TNNC1;MYL4;TNNT3;TPM2
prerank,cGMP-mediated signaling (GO:0019934),0.6325566896805668,1.3960031159443447,0.13458262350936967,0.5812103528511752,1.0,3/13,5.63%,IRAG1;APOE;PDE3A
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5971032388823302,1.3958860474534542,0.10606060606060606,0.5801781483695087,1.0,6/19,3.58%,RBP4;TGFBR3;RUNX1;BMPR1A;FGFR2;TGFBR1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.60893612787718,-1.3955690826093021,0.1016548463356974,0.6080223683080138,1.0,4/11,3.18%,SEMA6A;THBS1;EPN2;KLF2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.5509813675406107,-1.3954155513218693,0.10747663551401869,0.6048090930080151,1.0,4/13,14.06%,TMSB4X;HEY2;TAF1;HEY1
prerank,neuromuscular junction development (GO:0007528),0.560986913052934,1.394524974056527,0.10381679389312977,0.5834413114218315,1.0,7/24,6.60%,PDZRN3;PPFIBP2;UNC13C;NEDD4;MUSK;CACNB1;LRRK2
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.4629862738111308,1.3941097608141895,0.06719367588932806,0.5834955727643387,1.0,20/75,14.90%,NRP1;PDPK1;IGF2;FGFR1;VASH2;TGFBR1;SEMA5A;VIP;AKT3;AGTR1;BMP2;ITGB3;ARNT;FGF2;FGFBP1;NR4A1;EGF;PDCL3;MDK;BMP4
prerank,UV protection (GO:0009650),0.6651410443237401,1.3940228330841788,0.11191335740072202,0.5823649888302965,1.0,1/10,0.34%,MFAP4
prerank,regulation of neuroblast proliferation (GO:1902692),-0.5312562592565606,-1.3936127700668055,0.09359605911330049,0.6073832189045221,1.0,7/15,11.43%,KDM1A;TAFA1;PTN;DISC1;VEGFA;CX3CR1;NF1
prerank,axon extension (GO:0048675),0.5633284660211931,1.3929931870564018,0.096875,0.5845070549058387,1.0,7/23,10.13%,NRP1;AUTS2;SEMA5A;ALCAM;ULK2;SLIT3;SLIT1
prerank,synaptic vesicle localization (GO:0097479),-0.5517066375726482,-1.392919173294735,0.10301507537688442,0.6061272128874553,1.0,6/13,23.33%,NLGN1;RAB27A;CDK5;SYNJ1;KIF5A;TMEM230
prerank,actin filament bundle organization (GO:0061572),0.5365853927275132,1.392220125453683,0.07913669064748201,0.5857869782869545,1.0,8/33,5.80%,CALD1;RHOD;NEDD9;SHROOM2;DPYSL3;MYO1B;FSCN3;LIMA1
prerank,proteoglycan biosynthetic process (GO:0030166),0.5400099559218239,1.3922036999093774,0.09643916913946587,0.5844049957802733,1.0,3/31,2.15%,IGF1;GAL3ST3;PXYLP1
prerank,positive regulation of wound healing (GO:0090303),0.5193668577658063,1.3919469137293479,0.096045197740113,0.5838001660438696,1.0,11/36,11.77%,PLPP3;SERPINE1;KANK1;MYLK;VTN;INSL3;SMOC2;FOXC2;HBEGF;ADRA2A;F2
prerank,regulation of dendritic spine development (GO:0060998),-0.4930354498363829,-1.391807522974987,0.08974358974358974,0.6064473752243114,1.0,8/19,10.77%,MEF2C;SHANK3;PPFIA2;NLGN1;GRIN3A;TANC2;SHANK1;KIF1A
prerank,negative regulation of fat cell differentiation (GO:0045599),0.5256075697039859,1.3918003912354324,0.10147058823529412,0.5828363576585869,1.0,7/34,7.38%,RORA;ENPP1;RUNX1T1;SMAD3;YAP1;WWTR1;SIRT2
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.532769505353891,1.3912485167836746,0.09969325153374232,0.5832497485960275,1.0,6/29,8.76%,TGFBR3;TPM1;FGFR2;ENG;TNNC1;BMP2
prerank,aorta morphogenesis (GO:0035909),0.5966442792406669,1.3908299019749697,0.10869565217391304,0.5831455349127906,1.0,7/17,8.14%,LRP1;BMPR1A;MYLK;PDGFRB;ENG;ADAMTS9;RBPJ
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.5022821307030902,1.3902625560282826,0.0807799442896936,0.5835094103454556,1.0,9/46,9.87%,ALDH1A1;ADAMTS5;LGR4;ACOT11;NPR3;NR1D1;RBPJ;FOXC2;STK11
prerank,regulation of interleukin-2 production (GO:0032663),-0.4094808481878551,-1.3898161111033736,0.0625,0.609328113592732,1.0,20/43,27.14%,PDE4D;PDE4B;CD34;PLCG2;NAV3;SPTBN1;RPS3;TNFAIP3;CD80;PTPRC;HOMER3;PNP;CD86;ANXA1;TRAF2;MAP3K7;MALT1;CARD11;TRAF6;PRNP
prerank,cellular amide metabolic process (GO:0043603),0.4502419521018332,1.3893036402359473,0.039850560398505604,0.5852168667309767,1.0,21/102,14.88%,CPXM2;PCCA;PLPP3;AEBP1;NNMT;ACOT11;ACOT6;ACOT2;CPXM1;PCCB;SMPD2;MTHFR;ALDH1L1;ABCB9;NSMAF;NAPEPLD;FOLR2;ACSF2;CERK;THOP1;VNN1
prerank,inner dynein arm assembly (GO:0036159),0.6650132357893151,1.3892864264893952,0.11623616236162361,0.5838694244618121,1.0,5/10,15.91%,CFAP73;DNAAF1;DNAI3;CCDC40;DNAAF5
prerank,T cell differentiation in thymus (GO:0033077),0.619561487491826,1.3891854005916984,0.13278688524590163,0.5827825660107114,1.0,3/14,5.78%,GLI3;LIG4;ZFP36L1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.5291477913103652,1.3886184860537372,0.09388971684053651,0.583299802440583,1.0,9/32,10.43%,ZBTB20;PRKAG2;APOE;APOA1;PRKAA2;STAR;NR5A1;CREBL2;EIF6
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.4614676891515397,-1.3881987588088214,0.1043956043956044,0.61121408317152,1.0,11/24,13.50%,PDE4D;PDE3B;PDE2A;PRKAR1A;PRKAR2B;PRKAR1B;PRKAR2A;CGAS;PEX5L;UBE2B;APLNR
prerank,calcium-mediated signaling (GO:0019722),0.44319423780311307,1.388120595201893,0.05616605616605617,0.5835714124829517,1.0,19/93,9.41%,RCAN2;PDPK1;SLC8A1;DMPK;PPP3CA;XCR1;ADGRL1;MCTP2;MCU;ACKR2;CCR9;LRRK2;CACNA1C;AGTR1;EIF2AK3;RCAN1;EGFR;BCAP31;TRPM4
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.5864719501058202,-1.3879908204545914,0.09777777777777778,0.6082874800093955,1.0,7/11,25.88%,UQCRH;CYCS;UQCR10;UQCR11;UQCRQ;UQCRC1;UQCRFS1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.4216795273540938,1.3873923294272066,0.040183696900114814,0.5846397583483197,1.0,32/138,15.03%,POLR2D;RORA;CCN2;TBL1XR1;TEAD1;AR;THRB;YAP1;MAML3;RARB;NOTCH2;RARG;GTF2E1;GTF2H5;NR5A1;WWTR1;DR1;NR1D1;RBPJ;NCOR1;KAT2B;POLR2C;NR1D2;NCOR2;NR4A1;MNAT1;TEAD3;GTF2E2;TAF9;NRBF2;NR1H3;RXRA
prerank,prostanoid biosynthetic process (GO:0046457),0.6258894264717574,1.3872720730319885,0.11359724612736662,0.5836533914427916,1.0,3/15,5.18%,PTGIS;PTGES;PLA2G4A
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.42322208189209765,-1.3869228870395998,0.07467532467532467,0.6083917499956714,1.0,14/36,11.16%,CAV1;NOSTRIN;NOS3;DDAH1;GCH1;NOSIP;DDAH2;ATP2B4;CYGB;DHFR;CALM1;S100A1;SPR;SCARB1
prerank,negative regulation of bone mineralization (GO:0030502),0.6319841297645991,1.386889911856985,0.13344594594594594,0.5836349429644534,1.0,4/13,9.41%,ENPP1;AHSG;BCOR;TRPM4
prerank,regulation of establishment of cell polarity (GO:2000114),0.5924536868387476,1.386657485546867,0.11461794019933555,0.5829687347267225,1.0,5/16,5.69%,ROCK2;GSN;KANK1;RIPOR2;CDH5
prerank,phospholipid homeostasis (GO:0055091),0.6461129900603881,1.3862838790464347,0.13537906137184116,0.5828558901853065,1.0,4/11,12.19%,ABCA1;APOA1;TLCD1;RCN3
prerank,response to cadmium ion (GO:0046686),-0.46556304689542627,-1.3857245009040975,0.07458563535911603,0.6088892738062832,1.0,11/26,13.80%,MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;MAPK8;JUN;MAPK3
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.5614579353312984,1.3856791058464246,0.09774436090225563,0.5835801208905266,1.0,6/22,9.04%,ROCK2;LYN;EPHA4;RANBP9;SLC2A13;PICALM
prerank,B cell receptor signaling pathway (GO:0050853),-0.4355837661656667,-1.3850476325856778,0.08074534161490683,0.6076815595773452,1.0,12/32,16.26%,MEF2C;TEC;VAV3;PLCG2;CD38;BMX;NFATC2;PLEKHA1;BCAR1;BLNK;PTPRC;BTK
prerank,response to purine-containing compound (GO:0014074),-0.5003723987774111,-1.3849469745540344,0.09903381642512077,0.604476263859071,1.0,6/17,15.47%,TRPC3;ABCC9;P2RX7;DGKQ;RYR2;P2RY6
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.56426526943298,1.3843223517377508,0.11388455538221529,0.5866922498171611,1.0,7/24,6.96%,PDPK1;ANGPT1;SERPINE1;GAS6;SEMA5A;CDH5;NFE2L2
prerank,lung epithelium development (GO:0060428),0.6493043720457046,1.3841697981004342,0.12937062937062938,0.5857603067676396,1.0,4/10,14.90%,ERRFI1;ASCL1;RCN3;BMP4
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.6641675607451416,1.3838183748031518,0.13479052823315119,0.5855205843470052,1.0,9/11,26.98%,ZFP36L1;PAF1;ZC3H3;CDC73;LEO1;PAPOLA;NCBP2;AHCYL1;NCBP1
prerank,regulation of cell size (GO:0008361),-0.4774060854842849,-1.3835675746847071,0.07012987012987013,0.6057406007373984,1.0,9/23,12.78%,VAV3;RDX;RAP1GAP2;LARS1;EDN1;MSN;PLEK;MTOR;DEPTOR
prerank,transferrin transport (GO:0033572),0.5214886931788607,1.382106695723441,0.10304789550072568,0.589883792105222,1.0,2/33,0.82%,ATP6V0A4;STEAP3
prerank,smooth muscle contraction (GO:0006939),0.6233054312797831,1.3815954515726026,0.12709030100334448,0.5902538556114717,1.0,5/14,6.32%,ROCK2;SLC8A1;MYLK;SMTN;BDKRB2
prerank,entry into host (GO:0044409),-0.5436795365189107,-1.3815577163973596,0.10473815461346633,0.6089733218819026,1.0,4/13,5.14%,CDH1;MET;CBL;PPIA
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.5457569052041069,1.3814595230670774,0.11267605633802817,0.589338844001472,1.0,6/27,2.15%,PHLDB2;PIK3R1;CGNL1;ARHGAP6;DLC1;ARHGAP28
prerank,response to glucagon (GO:0033762),0.569726646195267,1.3809194684646597,0.10845295055821372,0.5896990218143777,1.0,5/19,3.53%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9
prerank,hepaticobiliary system development (GO:0061008),0.5634618319458322,1.3803936396660967,0.12116316639741519,0.5901610372279679,1.0,8/20,11.65%,TGFBR3;PRKCSH;ARID5B;WNT4;CDK5RAP3;CEBPA;PHF2;NKX2-8
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.6123660623895233,1.3799706065994084,0.1342512908777969,0.5902148773522329,1.0,7/14,17.54%,SEC24D;SEC31A;MIA3;SEC23B;SEC23A;TBC1D20;SEC24A
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.5376848872919742,1.3795481845349142,0.1111111111111111,0.5901935372592191,1.0,4/27,2.39%,ENPP1;PID1;AHSG;KANK1
prerank,macrophage activation involved in immune response (GO:0002281),-0.556915614231787,-1.379062819104091,0.10613207547169812,0.6136686136940389,1.0,6/13,13.00%,PLCG2;DYSF;LBP;IFI35;CX3CR1;SBNO2
prerank,cholesterol homeostasis (GO:0042632),0.4687995374291143,1.3790368973068827,0.06860158311345646,0.5904666585968609,1.0,10/64,7.79%,RORA;CYP7B1;ABCA1;EPHX2;FGFR4;APOE;APOA1;LDLR;LIMA1;NR1D1
prerank,response to muramyl dipeptide (GO:0032495),-0.5585000335585479,-1.37847234377678,0.13023255813953488,0.6122526880884913,1.0,7/12,16.10%,NOD1;ARHGEF2;VIM;PTPN22;NOD2;ERBIN;IRF5
prerank,cell projection assembly (GO:0030031),0.563236664669805,1.3784194927766875,0.11956521739130435,0.5910788274843627,1.0,4/22,6.16%,RHOH;GSN;PARVA;CDC42
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.5503159506742603,-1.377995630875714,0.12128712871287128,0.6103146427828552,1.0,9/13,29.37%,KDM1A;PTTG1IP;SIRT1;CD44;SNAI2;TWIST1;MIF;SNAI1;PSMD10
prerank,sterol homeostasis (GO:0055092),0.4658114061402927,1.377651834886376,0.07077326343381389,0.5922602608668607,1.0,10/65,7.79%,RORA;CYP7B1;ABCA1;EPHX2;FGFR4;APOE;APOA1;LDLR;LIMA1;NR1D1
prerank,epithelial cell migration (GO:0010631),0.502241864029182,1.3775869667028726,0.0953058321479374,0.5911369919191768,1.0,7/37,6.39%,NRP1;ZEB2;KANK1;KIT;FSTL1;CYP1B1;ADGRA2
prerank,negative regulation of cell motility (GO:2000146),0.4422217073296827,1.3763652907045032,0.0407673860911271,0.593954147538362,1.0,22/108,7.44%,ROBO1;LDLRAD4;DAG1;MITF;SERPINE1;DLC1;PODN;TPM1;EPHA4;KANK1;RECK;NKX2-1;DPYSL3;SULF1;FBLN1;SFRP1;IGFBP5;CYP1B1;ENG;VCL;DPEP1;AFDN
prerank,dendritic cell differentiation (GO:0097028),0.5524445063225891,1.376351419017672,0.12044374009508717,0.5926473689474905,1.0,5/22,6.85%,LYN;GAS6;CCL19;AXL;BATF
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.480369246309601,-1.3761059070516644,0.09042553191489362,0.612881164960707,1.0,10/21,27.25%,PDE4D;CAV1;INPP5K;DDIT4;NLRP2B;RACK1;NCK2;RASSF2;DMTN;MLXIPL
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.5942230819153348,1.3756803493501106,0.11912751677852348,0.5935541047601772,1.0,5/19,9.17%,RHOH;GAS6;AXL;ZMIZ1;ZBTB1
prerank,NAD biosynthetic process (GO:0009435),0.5802730593170392,1.3754536850552872,0.115625,0.5929347028652645,1.0,4/20,6.78%,PTGIS;NNMT;PARP16;KYNU
prerank,cellular potassium ion homeostasis (GO:0030007),-0.5403399139390264,-1.3752797094299687,0.1,0.6123675438382458,1.0,5/13,6.82%,SLC12A2;KCNJ2;ATP1A1;KCNMA1;ATP1B1
prerank,positive regulation of cell motility (GO:2000147),0.4073340214343986,1.3742515714538557,0.026373626373626374,0.5954401431853104,1.0,44/205,11.55%,IGF1;COL1A1;CEMIP;ROCK2;PDGFD;SYNE2;SEMA3D;RHOD;NEDD9;PPP3CA;CCN1;KIT;MYLK;PDGFRA;PDGFRB;TGFBR1;SMO;SEMA5A;CCL19;CSF1;ACVR1;NTF3;CTSH;PDPN;CXCL16;CDH5;WNT5B;CARMIL1;MYO1C;NTRK3;DAB2;EGFR;EPHB2;NTN1;BMP2;MAP4K4;SPRY2;ACTN4;MYADM;FAM89B;TRIP6;HBEGF;ADRA2A;CCDC25
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.45163688527428014,1.373766029137744,0.07329192546583851,0.5957508024855033,1.0,19/87,9.24%,FMOD;COL1A2;TGFBR3;SMAD3;BMPR1A;TGFBR1;TWSG1;APOA1;APPL2;ACVR1;ITGB5;CDH5;ENG;SKI;SRC;LTBP2;ARHGEF18;ZMIZ1;SMAD1
prerank,negative regulation of cell junction assembly (GO:1901889),0.5522794096122169,1.373683121432658,0.11729323308270677,0.5947127398715035,1.0,4/25,1.84%,PHLDB2;ROCK2;ARHGAP6;DLC1
prerank,negative regulation of cellular component organization (GO:0051129),0.44912974150807156,1.373299948341696,0.07360406091370558,0.594597564448663,1.0,17/74,14.38%,EPHA3;BMP6;AR;APOA1;CDC42;SRC;SNX33;CARMIL1;IRAK3;SPRY2;DDX3X;DNAJA4;IMPACT;TERF2;SYT11;RIOK3;RTEL1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.3150315441987176,-1.3730211059376836,0.0,0.6166975744108847,1.0,37/159,10.61%,ADGRL3;HMCN1;GRID2;PECAM1;CLDN5;CDH2;CADM1;NLGN1;CDH1;IL1RAPL1;TENM2;BSG;KIRREL3;TENM3;CLDN11;LRFN5;TENM4;PTPRD;TGFB2;NECTIN1;CDH12;ATP2C1;CNTN4;CDH6;NTNG1;CDH8;PTPRT;CDH9;CDH13;CNTN6;LRRC4C;ROBO4;TGFBR2;CDH10;FAT2;EMB;UNC5D
prerank,negative regulation of transposition (GO:0010529),0.6038829213823849,1.3729760893862415,0.12091503267973856,0.5944942722934955,1.0,7/16,17.51%,UBR2;TUT7;PIWIL4;SPOCD1;TUT4;MYBL1;DDX4
prerank,positive regulation of epithelial cell migration (GO:0010634),0.44338577384132505,1.3727201005327125,0.06535141800246609,0.5939831534470486,1.0,21/92,10.76%,NRP1;RIN2;ROCK2;ANGPT1;SPARC;SASH1;INSL3;CTSH;SMOC2;ATOH8;SRC;DOCK5;RAB25;AAMP;FOXC2;ANXA3;MAP4K4;MAPRE2;ITGB3;FGF2;CAPN7
prerank,sodium ion transport (GO:0006814),0.4468778930401113,1.3721796605679428,0.0705596107055961,0.5945493403118867,1.0,9/85,4.53%,SLC24A3;SCN7A;NALCN;SLC8A1;SLC8A3;ATP1A2;SLC6A9;SLC6A13;SLC24A1
prerank,negative regulation of gene expression (GO:0010629),0.3984587867847092,1.3719953328966101,0.014721345951629864,0.5938258495845532,1.0,68/302,15.17%,IGF1;ROBO1;SAMD4A;CILP;SLC24A3;ROCK2;DAPK1;RBMS3;LGR4;RUNX1;BMPR1A;OLFM1;WNT4;YAP1;DNMT3A;APOE;SMO;NOTCH2;SLC2A10;TWSG1;IGF2BP2;ITGB8;SFRP1;IGFBP5;PRKAA2;ENG;TNRC6B;ATOH8;EMILIN1;CPEB3;CD28;EIF2AK3;MAP2K1;DXO;RNF139;NCOR1;TNRC6A;BMP2;KAT2B;PICALM;SNX12;PRKN;MYADM;PARP14;RBBP7;FGF2;PHF1;PPHLN1;TTBK1;RBL2;NCOR2;TCEAL1;DDX3X;RGCC;REST;TERF2;LRP3;LARP1;CCDC3;MYCN;SYT11;ENC1;ZNF148;SETDB1;NUDT16L1;BMP4;ASB1;TMBIM6
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.6538874540020357,1.3712376096805357,0.14183123877917414,0.5949982200118383,1.0,5/10,13.64%,ENPP1;ERRFI1;ENG;IMPACT;MVP
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.6316807160222282,1.3710873202928575,0.13893653516295026,0.5941960088381464,1.0,4/11,10.86%,PGM3;GFPT1;UAP1;RENBP
prerank,ion homeostasis (GO:0050801),-0.4302176405908836,-1.3710553483433,0.07142857142857142,0.6199326755423828,1.0,8/30,9.72%,SLC4A10;FHL1;NEDD4L;CAMK2D;UNC80;KLHL3;SLC4A8;WNK2
prerank,acylglycerol homeostasis (GO:0055090),0.5709550104972838,1.3702329529992285,0.11513157894736842,0.5958334406247738,1.0,3/20,4.31%,RORA;APOE;APOA1
prerank,histone H3-K4 trimethylation (GO:0080182),0.6543557803158424,1.3701514172606917,0.1384083044982699,0.594791198838603,1.0,6/11,19.26%,OGT;SETD1A;WDR82;KMT2A;SETD1B;TET3
prerank,negative regulation of metabolic process (GO:0009892),0.47929897141375233,1.369543789113269,0.08981233243967829,0.5954932875941752,1.0,9/54,9.87%,ALDH1A1;ADAMTS5;LGR4;ACOT11;NPR3;NR1D1;RBPJ;FOXC2;STK11
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.3577963498978463,-1.3689295499893401,0.05627705627705628,0.6238211063496255,1.0,24/75,16.30%,PLCE1;RGS5;MGLL;RGS3;KCTD8;GIT2;NMT2;RGS6;CRY1;FNTA;RGS12;SYP;FNTB;CALM1;EDN1;RGS16;PLEK;RGS4;GIT1;DGKQ;RGS11;PDE6A;METAP2;GPER1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.4223090478122025,1.3689212121338656,0.04756380510440835,0.5961432656722275,1.0,20/132,11.49%,IGF1;ZBTB20;SH3D19;DAPK1;DCN;DACT1;OPTN;PFKFB4;APOE;APOA1;PRKAA2;LRRK2;SNX33;DXO;ARNT;STK11;ITCH;RNF152;ADRA2A;UFL1
prerank,cartilage development (GO:0051216),0.47619424188271514,1.3685671564682043,0.09379310344827586,0.5959476853826942,1.0,14/49,10.73%,SOX5;SULF2;RUNX1;NFIB;RUNX2;SULF1;ITGB8;CREB3L2;WNT5B;OSR1;BMP2;TRIP11;FGF2;COL11A2
prerank,actin filament network formation (GO:0051639),-0.5588619739053041,-1.368473390023405,0.11036036036036036,0.6220267844564766,1.0,5/11,10.45%,COBL;PLS3;SPIRE1;FHOD3;PLS1
prerank,embryonic skeletal system development (GO:0048706),0.5179435365441967,1.3676671595599106,0.10267229254571027,0.5976743010421594,1.0,6/35,4.16%,RBP4;COL1A1;SULF2;PDGFRA;SLC2A10;SULF1
prerank,cellular response to fatty acid (GO:0071398),0.6221512736557959,1.3673238116064428,0.1431095406360424,0.5974806595295339,1.0,1/12,0.91%,PID1
prerank,glycerolipid metabolic process (GO:0046486),-0.5652274746823862,-1.3671706601942741,0.11389521640091116,0.6230303568149762,1.0,5/11,17.45%,DGKB;PNPLA3;DGKG;DGKQ;DGKZ
prerank,liver development (GO:0001889),0.5146725386267439,1.3669306776316907,0.10979228486646884,0.5974424896825631,1.0,11/32,12.43%,TGFBR3;PRKCSH;ARID5B;WNT4;CDK5RAP3;CEBPA;DNAAF1;PHF2;CEBPB;NKX2-8;CCDC40
prerank,regulation of signal transduction (GO:0009966),0.40915927975371297,1.3656958228914426,0.029315960912052116,0.5999965874292164,1.0,30/190,8.36%,IGFBP2;RORA;GDNF;SLC8A3;GRK3;IGFBP4;GRK5;DHRS3;RUNX1;ZIC1;OGT;ITGA3;FGFR2;SP100;DTNBP1;SEMA5A;IRAK2;FBXL17;SULF1;NCAM1;TSPYL2;ACVR1;IGFBP5;USP20;SRC;LRRK2;WWTR1;CD63;TULP3;TCF7L1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.5684910500393096,-1.365664524153772,0.10888888888888888,0.6246535069116413,1.0,6/11,23.78%,NOTCH1;GSK3A;ATP2B4;FOXO1;MLIP;RGS2
prerank,triglyceride biosynthetic process (GO:0019432),0.5816074641887993,1.3650207865469677,0.13754045307443366,0.6010616165728496,1.0,7/18,21.75%,AGMO;LPGAT1;MOGAT3;DGAT2;GK;LPIN3;LPIN2
prerank,negative regulation of inflammatory response (GO:0050728),0.41088114398785486,1.3650009655347173,0.04318936877076412,0.5998308454413788,1.0,21/182,7.79%,IGF1;PTGIS;RORA;ADCY1;ADCY2;LYN;ADCY7;ADCY5;APOE;ADCY9;INSL3;APOA1;MVK;VIP;CDH5;LHCGR;ADRB3;SRC;CD247;DPEP1;NR1D1
prerank,cellular response to sterol (GO:0036315),0.6165148416417328,1.3646643557168192,0.1371527777777778,0.5996214980093582,1.0,3/13,3.87%,RORA;SMO;INSIG2
prerank,calcium ion import across plasma membrane (GO:0098703),0.5987634760473077,1.364631733614073,0.14123376623376624,0.5984231724623844,1.0,3/14,4.53%,SLC8A1;SLC8A3;SLC24A1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.5132366042974128,-1.3640786867547336,0.09268292682926829,0.6270534516306633,1.0,9/16,26.93%,ACKR3;RPS3;TPT1;BCL2L1;CLU;SNAI2;CCAR2;SNAI1;NACC2
prerank,presynapse assembly (GO:0099054),-0.5068554635308388,-1.3639511683269743,0.08333333333333333,0.6240796327680336,1.0,7/16,18.25%,NLGN1;IL1RAPL1;PTPRD;LRRTM3;PCLO;NLGN3;DVL1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.43140870983505125,1.363427485334763,0.07287933094384708,0.6011570226606221,1.0,19/101,11.52%,ROBO1;CEMIP;PDGFD;FGFR1;IL34;EPGN;KIT;PDGFRB;RAPGEF2;SRC;LRRK2;PARP16;MAP2K1;EGFR;TELO2;FGF2;DDX3X;ADRA2A;RGCC
prerank,organophosphate catabolic process (GO:0046434),-0.5644167365681997,-1.3633716131804507,0.1359447004608295,0.6227814232530687,1.0,1/11,0.91%,ENPP2
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.5689192130233802,-1.363097725914009,0.1367713004484305,0.620391341147006,1.0,8/10,38.46%,GALNT13;GALNT2;GALNT3;POGLUT3;GALNT4;MGAT5B;GALNT16;POGLUT1
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3876904391249004,1.362612984141013,0.0010131712259371835,0.6025453814215953,1.0,90/509,11.80%,IGF1;TCF7L2;PDPK1;WLS;IGF2;ADRA1B;GJA1;ROCK2;ANGPT1;PIK3R1;PDGFD;ADGRV1;KSR1;SASH1;AREG;TGFA;DCN;LYN;BCL2;FGFR1;PELI2;EPHA8;NOS1AP;EPGN;KL;FGFR2;KIT;FGFR4;GAS6;PDGFRA;CFLAR;PDGFRB;TGFBR1;NUPR1;SEMA5A;CCL19;NEDD4;CDK5RAP3;RAPGEF2;EDAR;AXL;NTF3;OSBPL8;FRS2;ROR1;ENG;ADRA2C;ADRB3;CCL4;SRC;RNF31;IL12B;CD28;DDX60;SPHK2;LPAR1;TRAF7;NMI;TLR6;NTRK3;BCL2L11;EGFR;BMP2;RUNDC3A;SPRY2;BCAP31;ACTN4;PRKN;GPR89A;LTBR;ITGAV;SLC38A9;SLC20A1;TMED4;FGF2;RYK;CXXC5;CARD9;NEK6;TRIP6;DDX3X;GSDME;HBEGF;LAMTOR2;ADRA2A;P2RX5;TNIP2;IKBKE;RRAGD;TBK1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.49518762725731613,-1.3623136428958025,0.11021505376344086,0.6197911991186295,1.0,11/18,34.43%,CHRM3;AGRN;GNB1;CHRM2;RGS10;GNA11;CDK5R1;CHRM1;GNAQ;HRH3;CHRM5
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.497727380575578,-1.3621559029561343,0.12433862433862433,0.6170499831372704,1.0,5/18,16.80%,CD34;NAV3;TNFAIP3;PTPRC;HOMER3
prerank,regulation of blood circulation (GO:1903522),0.515332937419986,1.3613342280382472,0.09954751131221719,0.6054193600382138,1.0,6/34,6.91%,CELF2;TPM1;DMPK;DES;BDKRB2;AGTR1
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.4683528037416035,-1.3608933575310715,0.07476635514018691,0.6180325987973267,1.0,5/24,10.46%,PECAM1;F11R;NT5E;ITGA4;MSN
prerank,COPII-coated vesicle budding (GO:0090114),0.4575483825387815,1.360786803752663,0.08903225806451613,0.6058805858050231,1.0,23/68,19.99%,SEC24D;AREG;TGFA;SEC31A;LMAN1;TRAPPC4;GOSR2;MIA3;SEC23B;TRAPPC9;TRAPPC10;TRAPPC6B;GORASP1;CTSZ;KLHL12;USO1;SEC23A;TBC1D20;SEC24A;TMED10;SEC16B;TRAPPC1;TRAPPC3
prerank,prostaglandin biosynthetic process (GO:0001516),0.5932698457626742,1.3604988593409397,0.12776831345826234,0.6056221036879221,1.0,3/18,5.18%,PTGIS;PTGES;PLA2G4A
prerank,purine-containing compound salvage (GO:0043101),0.6239905079663151,1.3595642245214912,0.1522491349480969,0.6074400160683686,1.0,2/12,2.80%,AMPD3;ADK
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.48324494016777614,1.3593343034344862,0.09563994374120956,0.606897318169348,1.0,13/48,14.43%,NRP1;NEDD9;OBSL1;APOA1;CUX2;CDC42;DOCK5;CARMIL1;CSPG5;MYADM;P4HB;MDK;FLNA
prerank,androgen receptor signaling pathway (GO:0030521),0.643445640779011,1.358921122641357,0.14685314685314685,0.6069562480765393,1.0,4/11,8.79%,AR;PMEPA1;DDX17;ZMIZ1
prerank,multivesicular body organization (GO:0036257),-0.4264857209704283,-1.3587463734892908,0.0736196319018405,0.6222329768963104,1.0,17/31,31.51%,RAB27A;RAB11A;PDCD6IP;VPS37B;VPS37A;VPS28;VPS36;VPS4A;CHMP2B;VPS37C;SNF8;CHMP4B;CHMP4A;HGS;MVB12A;CHMP4C;STAM2
prerank,regulation of cation channel activity (GO:2001257),-0.3395800999167724,-1.3586100730162798,0.037037037037037035,0.6194764758283305,1.0,29/89,20.30%,DLG2;PDE4D;MEF2C;GRIA4;NLGN1;PTK2B;ANK3;KCNAB1;GRIN2A;CAMK2D;FGF12;LRRC7;NOS1;GRIN2B;STAC;GRIA2;SHANK1;CALM1;HOMER1;APP;GSG1L;CACNG3;CACNG4;HPCA;AHNAK;CTSS;GRIN1;CACNB3;FKBP1A
prerank,cardiac muscle cell development (GO:0055013),0.5611072872286412,1.3583458050041803,0.1281198003327787,0.6074800874887359,1.0,5/20,3.57%,PDLIM5;SLC8A1;OBSL1;PDGFRA;PDGFRB
prerank,gene expression (GO:0010467),-0.28361548898121947,-1.3579164289400691,0.0,0.6186222856208939,1.0,121/348,20.78%,BICD1;NUP93;RPL41;RPS12;TAF1B;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;NUP35;RPL34;WARS1;RPS13;RPL21;RPL7;NUP153;RPL18;RPL27;NUP160;EIF4E;RPL35A;RPL38;RPS15;RPS3;SORL1;RPL39;APOBEC1;RPS7;GALNT2;RPS4X;RNGTT;RPL11;ELAVL4;MRRF;HNRNPK;RPL30;RPS23;NUP54;BAZ2A;PWP1;RPL36;RPLP1;RPS29;RPL37;RPS9;RBM8A;ALYREF;HHEX;HNRNPD;CHTOP;RPS5;YARS2;PTMA;RPL4;RPL18A;RPL26;SNRNP40;RPL6;RPL36A;RPL29;MRPS18A;RPL13A;PAX8;ADAR;MRPS5;RPL7A;RPL19;THAP1;RPS20;RPL14;EEF1A1;RPL13;DEDD2;HNRNPA2B1;DUSP11;RPL32;MRPS12;CLP1;RPL5;YTHDC1;TSPAN17;RPSA;SRSF7;NOL9;FASTKD2;SEC13;ADARB2;MRPL44;MRPS33;SMG7;RPLP0;NUP155;MPHOSPH10;MRPL55;DDX19B;RPS6;RPS6KB2;RPL22;RANBP2;GLE1;DHX38;NUP88;MRPS18B;POLR2E;MRPL42;RPS21;MCM3AP;TASP1;RPL37A;RPLP2;MRPS21;THOC6;SRSF4;MRPS7;RPL17;RPL23;NUP62;MRPL34;SLBP
prerank,skin development (GO:0043588),0.45732951963037266,1.3579076037876068,0.09149484536082474,0.6076637441722906,1.0,7/65,4.04%,COL1A2;COL1A1;ERRFI1;TXNIP;COL5A1;ITGA3;SLC2A10
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.5892274616681074,1.3575914703631204,0.13667820069204153,0.6074880210221785,1.0,6/15,14.16%,DACT1;ACVR1;SKI;LEMD3;ACVR1B;FSTL3
prerank,regulation of cellular protein catabolic process (GO:1903362),0.5820929298700771,1.3568448669621285,0.15181518151815182,0.6084845793117927,1.0,3/18,4.30%,NELL1;DACT1;CDK5RAP3
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.5341792129488061,1.3567080445517183,0.1293233082706767,0.6076723138897329,1.0,7/25,13.66%,NRP1;AR;SRC;DSCAM;EGFR;EGF;GLMN
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.44064538504624307,1.3564585511444105,0.07407407407407407,0.6071922277845644,1.0,15/87,7.97%,EPHA3;RHOH;ROCK2;LRP1;DLC1;RHOD;ARHGAP18;RHOBTB1;PDGFRA;PDGFRB;NOTCH2;IQGAP2;RHOBTB3;RHOBTB2;ARHGAP35
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.5921743093255288,1.3561900822017394,0.1500815660685155,0.6068051659308026,1.0,6/17,18.15%,NKX6-1;ATOH8;FGF2;BMP4;SFRP4;AHI1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.41252410409556667,1.3558806601521127,0.03567447045707915,0.6065760290863055,1.0,15/170,5.78%,IGF1;NELL1;ROCK2;SLC8A1;GDNF;C1D;AFF1;PRDM5;ASCL1;ZNF462;APOE;IGF2BP2;LDLR;GNB3;ZFP36L1
prerank,positive regulation of developmental process (GO:0051094),0.409718076448362,1.3553708321613063,0.04858757062146893,0.6068263465088433,1.0,40/164,14.21%,PHLDB2;GJA1;CCN2;GDNF;AR;DAG1;SOX5;DCN;FGFR1;BMPR1A;APOE;ADGRL1;SMURF2;NEUROD4;ACVR1;MCU;NEUROD1;SRC;CPEB3;PPP1R13L;KMT5B;BMP2;SYDE1;CAMK2B;PRKN;TRPM4;KRT10;CEBPB;RBM19;REST;NIBAN2;MAP3K13;INSR;ACVR1B;MUL1;TMEM119;NCOA3;DLG4;HMCES;MDK
prerank,neuron projection extension (GO:1990138),0.5067216103111465,1.3552667463522174,0.11465892597968069,0.6059186656868695,1.0,5/32,6.44%,NRP1;AUTS2;SEMA5A;ALCAM;ULK2
prerank,positive regulation of T cell differentiation (GO:0045582),0.5086868583894945,1.3549804568533468,0.11257309941520467,0.6055731326193119,1.0,11/36,16.72%,RHOH;GLI2;GLI3;BCL6;IL12B;ZMIZ1;ZBTB1;MDK;VNN1;IL23A;SHH
prerank,sodium ion transmembrane transport (GO:0035725),0.4416242451949614,1.3547919373006956,0.08848484848484849,0.6049545993428291,1.0,10/84,4.53%,SLC24A3;SCN7A;NALCN;SLC8A1;SLC8A3;ATP1A2;SLC6A9;SLC6A13;SLC9A9;SLC24A1
prerank,glycerolipid catabolic process (GO:0046503),-0.4852626422291087,-1.3545275470068554,0.11052631578947368,0.6267322547292403,1.0,10/19,24.06%,GPCPD1;MGLL;ABHD2;PLA2G4C;ABHD6;PNPLA6;LYPLA2;PLA2G4F;PLA2G4E;GDPD1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.4047789574027397,-1.3544208008329974,0.09003215434083602,0.62385675257449,1.0,6/39,5.85%,UTRN;FHL1;NEDD4L;YWHAH;FGF12;CHRM3
prerank,positive regulation of gene expression (GO:0010628),0.3853493066862788,1.3543681389248168,0.00819672131147541,0.6050222269447728,1.0,97/442,14.99%,IGF1;ROBO1;BMP6;SAMD4A;SLC24A3;GJA1;ROCK2;ANGPT1;PID1;PIK3R1;GSN;SMAD3;RBMS3;AR;MITF;PLD1;PLA2R1;OLFM1;NOS1AP;NKX2-1;EPHX2;FGFR4;DTNBP1;HNRNPLL;YAP1;GAS6;TGFBR1;SMO;WNT6;SLC2A10;TLE1;PDCD5;POLR1G;CSF1;SLC22A2;MT3;ITGB8;CTSH;MUSK;CDH5;CUX2;TNRC6B;NR5A1;EMILIN1;CPEB3;BATF;NFE2L2;CD28;SPHK2;AFDN;EIF2AK3;MAP2K1;MYO1C;TLR6;OSR1;RBPJ;NTRK3;TNRC6A;EGFR;EPHB2;RBM22;BMP2;KAT2B;SPRY2;METTL14;SMAD1;PRKN;NFAM1;FGF2;BAZ1B;PHF2;EIF6;TTBK1;CARD9;BRAF;TENT4A;DDX3X;ADRA2A;RGCC;DNAJA4;C1QTNF1;TERF2;LRP3;HMGN5;TMEM119;MYCN;EGF;GLMN;PDCL3;ETS1;PLXNB2;HPN;NSUN5;TADA3;BMP4;SFRP4;FUBP3
prerank,positive regulation of binding (GO:0051099),0.4430643354637645,1.3542444334696997,0.06327543424317618,0.6041507639222627,1.0,14/84,9.33%,IGF1;TCF7L2;LRP1;DACT1;APOE;VTN;RAPGEF2;SKI;DERL1;LRRK2;SIRT2;STK4;BMP2;PRKN
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5617592138078269,1.3538022245485657,0.15806451612903225,0.6044675182999439,1.0,12/21,24.16%,LRRK2;EIF2AK3;BCL2L11;PRKN;CREB3;SELENOS;TMBIM6;CREB3L1;DDIT3;OPA1;TXNDC12;PMAIP1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.48098275882552927,1.3533636285638035,0.11246612466124661,0.6046832449327373,1.0,10/46,9.63%,NRP1;ATRNL1;ANTXR1;PIK3R1;PARVA;LAMC1;USH2A;ATRN;ITGB3;ITGAV
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.3954585495242673,-1.3530646295436013,0.0738255033557047,0.6250795493802327,1.0,15/41,13.63%,KCNJ2;ANK3;KCNJ3;KCNMA1;KCNN2;KCNQ1;NOS1;AKAP6;STAC;KCNMB2;ACE2;KCNJ15;GNB1;KCNJ10;GNG2
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.6443487507337267,1.3525620469173634,0.16163410301953818,0.6048451273974316,1.0,1/10,2.64%,TULP1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.6443487507337267,1.3525620469173634,0.16163410301953818,0.6048451273974316,1.0,1/10,2.64%,TULP1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.5046924986334967,-1.3521116369942325,0.11442786069651742,0.6252058170793163,1.0,7/16,17.21%,ATP5F1A;ATP5F1E;ATP5ME;ATP5MG;ATP5F1C;ATP5MF;ATP5PD
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.46244188796522245,1.3518485596836614,0.10477453580901856,0.6034206485006871,1.0,21/61,19.99%,SEC24D;AREG;TGFA;SEC31A;LMAN1;TRAPPC4;GOSR2;TRAPPC9;TRAPPC10;TRAPPC6B;GORASP1;CTSZ;KLHL12;USO1;SEC23A;TBC1D20;SEC24A;TMED10;SEC16B;TRAPPC1;TRAPPC3
prerank,COPII vesicle coating (GO:0048208),0.46244188796522245,1.3518485596836614,0.10477453580901856,0.6034206485006871,1.0,21/61,19.99%,SEC24D;AREG;TGFA;SEC31A;LMAN1;TRAPPC4;GOSR2;TRAPPC9;TRAPPC10;TRAPPC6B;GORASP1;CTSZ;KLHL12;USO1;SEC23A;TBC1D20;SEC24A;TMED10;SEC16B;TRAPPC1;TRAPPC3
prerank,vesicle coating (GO:0006901),0.46244188796522245,1.3518485596836614,0.10477453580901856,0.6034206485006871,1.0,21/61,19.99%,SEC24D;AREG;TGFA;SEC31A;LMAN1;TRAPPC4;GOSR2;TRAPPC9;TRAPPC10;TRAPPC6B;GORASP1;CTSZ;KLHL12;USO1;SEC23A;TBC1D20;SEC24A;TMED10;SEC16B;TRAPPC1;TRAPPC3
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.51817686708279,-1.351401138313556,0.1134020618556701,0.6245581548023197,1.0,7/16,6.66%,GUCY1B1;NOS3;GUCY1A1;DDAH1;KCNC2;NOS1;DDAH2
prerank,negative regulation of signal transduction (GO:0009968),0.3981945921799554,1.3510567765892292,0.0288153681963714,0.604779096692515,1.0,62/249,16.40%,ADAMTS12;CILP;TRABD2B;ENPP1;PID1;CYP26B1;LRP1;AHSG;DCN;LYN;LGR4;BCL2;DACT1;SULF2;NKD1;LEPROT;KANK1;GLI3;MDFI;MGRN1;SLC2A10;TLE1;SULF1;NEDD4;ACVR1;SFRP1;IGFBP5;DKK3;LRRK2;EMILIN1;IL12B;CBLN1;TULP3;IRAK3;ARRB1;EGFR;NTN1;BMP2;CBY1;SPRY2;GLIS2;FGF2;TAX1BP3;IGFBP3;PTCH2;NIBAN2;BTRC;NDRG4;EGF;TSC2;PTEN;FSTL3;CXXC4;SFRP4;SUFU;TMBIM6;GRB10;BMP5;CD47;PIP4K2C;AKT1;KANK2
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.45239222456829103,1.35078314911996,0.08333333333333333,0.604397131034528,1.0,12/72,10.91%,POLR2D;FGFR1;KL;FGFR2;FGFR4;RBFOX2;FRS2;FLRT2;HNRNPA1;POLR2C;FGF2;FGFBP1
prerank,high-density lipoprotein particle assembly (GO:0034380),0.6524928185195976,1.3502707160921106,0.17753623188405798,0.6048629994421338,1.0,3/10,4.31%,ABCA1;APOE;APOA1
prerank,response to interleukin-1 (GO:0070555),0.44482292888726405,1.3491173302023605,0.08312020460358056,0.6073385071418379,1.0,17/73,18.50%,ADAMTS12;PTGIS;CCL19;IRAK2;SFRP1;CCL4;SRC;NR1D1;IRAK3;USP10;IGBP1;HDAC4;TAF9;CD47;CX3CL1;RC3H1;PRKCA
prerank,connective tissue development (GO:0061448),0.5051262556366783,1.348619092801341,0.10714285714285714,0.6077721664719138,1.0,11/35,10.82%,SOX5;SULF2;ARID5B;SULF1;SH3PXD2B;ITGB8;CREB3L2;TRIP11;PGRMC2;COL11A2;SLC39A13
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.500851054685407,-1.3479932011593643,0.11320754716981132,0.6329639065846911,1.0,8/17,21.88%,CAV1;KLF7;APOLD1;MAFG;PRKX;CEACAM1;DLL1;DSPP
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5470490194156807,1.3479418895409276,0.14444444444444443,0.6087608278531665,1.0,8/22,15.85%,AREG;FGFR2;NOTCH2;ZFP36L1;CASK;KLF9;MDK;EPPK1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.4381020201257859,-1.347339371659572,0.10344827586206896,0.6320773589972941,1.0,8/26,10.72%,ACER3;ACER2;NOS3;GCH1;NOS1;DDAH2;SPTLC2;SPR
prerank,modified amino acid transport (GO:0072337),0.6048841206434444,1.3472335271993654,0.14332784184514002,0.6097435067542797,1.0,5/15,12.65%,SLC16A12;SLC6A13;PDPN;MGST1;FOLR2
prerank,regulation of cardiac conduction (GO:1903779),0.4713997383454215,1.3472189848668732,0.09478021978021978,0.6085750247355586,1.0,7/54,4.13%,ITPR1;SLC8A1;SLC8A3;ATP1A2;DMPK;ASPH;STIM1
prerank,RNA stabilization (GO:0043489),0.5223062423979487,1.3470240069432993,0.12073863636363637,0.6079787493450962,1.0,9/33,12.42%,GDNF;TENT5A;PHAX;AXIN2;VIP;TENT5D;NSUN2;PARN;LARP1
prerank,regulation of embryonic development (GO:0045995),0.5138411484921065,1.3469906788894406,0.12518628912071536,0.6068567209054707,1.0,8/34,12.56%,PHLDB2;DAG1;WDPCP;CRB2;TRIP12;RBM19;NIBAN2;INSR
prerank,sodium-independent organic anion transport (GO:0043252),-0.5605909100638017,-1.3462230479751374,0.15064935064935064,0.6328225852739817,1.0,3/10,2.67%,SLCO2A1;SLCO1C1;SLCO2B1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.5451411524347632,1.3461877777390423,0.14677419354838708,0.6083181965230381,1.0,6/20,12.17%,ACTN2;HECW2;NEDD4;OSR1;ADRA2A;YWHAE
prerank,sterol metabolic process (GO:0016125),0.4619025785629741,1.3457397407435019,0.09689922480620156,0.6085551755925652,1.0,9/60,7.23%,CYP26B1;CYP7B1;ABCA1;PRKAG2;APOE;INSIG2;APOA1;CYP1B1;CYP27A1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.5908565867613683,1.345575457732973,0.1426086956521739,0.6078674711901562,1.0,4/16,3.03%,IGF1;TGFBR3;BMPR1A;FGFR2
prerank,gonad development (GO:0008406),0.5010610211133024,1.3451004480471564,0.1,0.6081803982377324,1.0,8/41,6.59%,AR;NR2F2;SALL1;KIT;WNT4;NUP107;LHCGR;NR5A1
prerank,regulation of programmed necrotic cell death (GO:0062098),0.5501316362139824,1.344701056428988,0.13679245283018868,0.6082386139622359,1.0,4/20,3.59%,OGT;MLKL;CFLAR;NUPR1
prerank,regulation of actin filament-based movement (GO:1903115),-0.568746621625682,-1.3441287821167134,0.13646532438478748,0.6368478431611745,1.0,2/10,1.19%,PDE4D;PDE4B
prerank,regulation of trophoblast cell migration (GO:1901163),0.59471652896326,1.3440676448902864,0.14918032786885246,0.6091909995089873,1.0,4/14,12.88%,GJA1;SMURF2;SYDE1;ACVR1B
prerank,response to sterol (GO:0036314),0.6382793454266675,1.3440612588830883,0.1703958691910499,0.608006447718845,1.0,2/11,3.58%,RORA;TGFBR1
prerank,amino sugar biosynthetic process (GO:0046349),0.6066743374437882,1.343902040191391,0.17200674536256325,0.6073384512493705,1.0,4/12,10.86%,PGM3;GFPT1;UAP1;RENBP
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.42705544554850744,1.3437994343053163,0.07473309608540925,0.606510678947359,1.0,14/100,6.32%,IGF1;PIK3R1;PDGFD;PTPN13;DCN;LYN;FGFR1;KIT;PDGFRA;PDGFRB;NEDD4;NTF3;ROR1;SRC
prerank,regulation of protein secretion (GO:0050708),0.4202404877743793,1.3431600983163956,0.0765661252900232,0.6073305377257947,1.0,12/119,6.81%,IGF1;BMP6;ITPR1;DNAJC1;RAPGEF4;APOE;MYO18A;MYH10;NEUROD1;ADRA2C;CACNA1C;IL12B
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4222199069312626,1.343016046779562,0.0738569753810082,0.6065553167677713,1.0,34/128,15.58%,BMP6;COL1A2;TGFBR3;SMAD3;BMPR1A;RUNX2;TGFBR1;TWSG1;APOA1;SMURF2;APPL2;ACVR1;ITGB5;CDH5;ENG;SKI;SRC;LTBP2;ARHGEF18;RGMA;BMP2;ZMIZ1;SMAD1;BMP15;USP9Y;PDCD4;ACVR1B;USP9X;HIVEP1;COL3A1;BMP4;PARD3;TGFBRAP1;BMP5
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.4932094172512501,1.3426978510972756,0.12889518413597734,0.6063776753606559,1.0,10/37,15.56%,DYNLL1;WDR35;IFT43;IFT27;TRIP11;IFT81;DYNC2I1;DYNLRB2;IFT22;IFT74
prerank,negative regulation of cellular catabolic process (GO:0031330),0.4552601475891634,1.342191672851589,0.09932885906040269,0.606794139204734,1.0,10/63,7.38%,NELL1;TIMP3;BCL2;LEPR;NUPR1;CDK5RAP3;MT3;CST3;TIMP2;SIRT2
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.496936732608609,-1.34168905403985,0.12631578947368421,0.6418578899826376,1.0,8/18,24.57%,JAM2;SLC39A8;ITGA4;CX3CR1;ROCK1;VCAM1;SELP;ITGB7
prerank,calcium ion import into cytosol (GO:1902656),0.5847040162083403,1.3416570303873199,0.15384615384615385,0.6073227389794402,1.0,3/15,4.53%,SLC8A1;SLC8A3;SLC24A1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.538955193819239,1.341358645500882,0.14173228346456693,0.6071054974871201,1.0,4/22,8.76%,SASH1;GADD45B;RELL1;BMP2
prerank,protein autoubiquitination (GO:0051865),0.45366618264050323,1.3399156345667296,0.0946822308690013,0.6106067899423099,1.0,15/61,15.29%,RNF220;SH3RF3;SH3RF1;RNF213;BFAR;RNF10;RNF185;PRKN;ITCH;RNF181;ERCC8;RAD18;RNFT1;AMFR;RNF13
prerank,positive regulation of MAP kinase activity (GO:0043406),0.45141911515070315,1.3398443728242082,0.09806451612903226,0.6096801759193936,1.0,16/66,13.25%,ROBO1;PDGFD;SASH1;FGFR1;IL34;EPGN;KIT;PDGFRB;LRRK2;TLR6;EGFR;FGF2;TAOK3;ADRA2A;DUSP19;EGF
prerank,negative regulation of receptor internalization (GO:0002091),-0.5513863477784126,-1.3390757709679098,0.12971698113207547,0.6478572561626739,1.0,4/12,6.57%,ANKRD13A;SDCBP;MTMR2;RIN3
prerank,action potential (GO:0001508),-0.39611872737339815,-1.339064457457637,0.06774193548387097,0.6447650726470014,1.0,11/44,7.82%,KCNJ2;ANK3;KCND2;SCN1A;YWHAH;SCN3A;KCNQ1;GNA14;AKAP6;KCNMB2;SCN2A
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.4727782620031932,-1.338046877439082,0.10335195530726257,0.6450996289609611,1.0,12/23,27.54%,MBOAT1;PLAAT3;PNPLA8;PLA2G4C;LPCAT3;PLA2G4F;PLA2G4E;ABHD4;PLA2G4B;PLA2G5;MBOAT2;LPCAT4
prerank,striated muscle contraction (GO:0006941),0.46386606240074885,1.3378322483185738,0.09212283044058744,0.6148620298830703,1.0,11/53,10.14%,SLC8A1;ATP1A2;TPM1;TNNT1;TNNC1;MYL4;DTNA;GAA;ARHGEF11;CSRP3;TNNT3
prerank,protein prenylation (GO:0018342),-0.5705818378193804,-1.337423846247163,0.16122004357298475,0.6440777522541014,1.0,6/10,22.82%,FNTA;FNTB;PTAR1;CHML;PGGT1B;RCE1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.5709725535434049,-1.3374145915486562,0.12826603325415678,0.6410477404263129,1.0,6/10,26.24%,ATP5F1A;ATP5MG;ATP5F1C;ATP5PD;VPS9D1;ATP5MC2
prerank,transition metal ion homeostasis (GO:0055076),0.5161846385130925,1.3373110714673988,0.13567073170731708,0.6153196090839422,1.0,8/28,9.33%,CP;MT3;HEPH;NEO1;CYBRD1;PICALM;COMMD1;PRKN
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4967113560316668,1.3372330371520762,0.10841654778887304,0.6144009310586758,1.0,10/40,10.17%,ARHGAP6;FGFR1;KIT;PDGFRA;PDGFRB;NTF3;LPAR1;NTRK3;EGFR;FGF2
prerank,positive regulation of cellular senescence (GO:2000774),-0.5678537199318808,-1.3368374391076676,0.14692982456140352,0.6399764475894013,1.0,5/10,20.17%,B2M;CGAS;SIRT1;ABI3;HMGA2
prerank,tRNA modification (GO:0006400),0.45775152590128937,1.3364024702791202,0.10704960835509138,0.6158483415606073,1.0,21/62,19.91%,TRMT44;PUS3;ADAT2;TRMO;NSUN2;BCDIN3D;TRMT9B;TRMT13;URM1;TRMT112;THUMPD3;THUMPD2;OSGEP;ELP5;THADA;DTWD1;ALKBH1;PUSL1;ANKRD16;TRUB1;METTL1
prerank,reverse cholesterol transport (GO:0043691),0.602933488385399,1.336160737100166,0.16554054054054054,0.6154091801038638,1.0,3/13,4.31%,ABCA1;APOE;APOA1
prerank,regulation of immunoglobulin production (GO:0002637),0.5445700147062291,1.335959522558497,0.14961832061068703,0.6148926568853609,1.0,1/23,0.15%,RBP4
prerank,negative regulation of protein phosphorylation (GO:0001933),0.4070446800458801,1.3352127000652958,0.06544202066590127,0.6160269119947226,1.0,35/150,13.80%,PDPK1;ENPP1;ERRFI1;PID1;PPM1E;LDLRAD4;PTPN13;PLPP3;LYN;DTNBP1;PMEPA1;PRKAG2;FBLN1;CDK5RAP3;NTF3;SFRP1;ENG;LRRK2;EMILIN1;WWTR1;SIRT2;NTRK3;DNAJC3;EPHB2;SPRY2;PRKN;MYADM;SPRED3;IGFBP3;IMPACT;DUSP19;TSC2;MVP;CNKSR3;PTEN
prerank,sphingoid biosynthetic process (GO:0046520),-0.5609238613256391,-1.335119689146066,0.14672686230248308,0.6396892195585214,1.0,3/11,10.37%,ACER3;ACER2;SPTLC2
prerank,sphingosine biosynthetic process (GO:0046512),-0.5609238613256391,-1.335119689146066,0.14672686230248308,0.6396892195585214,1.0,3/11,10.37%,ACER3;ACER2;SPTLC2
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.5658836398959834,-1.3346348699705424,0.14014251781472684,0.6381397139114416,1.0,5/10,19.80%,SEC14L1;RNF125;TKFC;UFD1;C1QBP
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.642214457290011,1.3342858524083478,0.14528301886792452,0.6165863062444328,1.0,2/10,6.16%,CDC42EP4;CDC42
prerank,regulation of pseudopodium assembly (GO:0031272),0.642214457290011,1.3342858524083478,0.14528301886792452,0.6165863062444328,1.0,2/10,6.16%,CDC42EP4;CDC42
prerank,peptide metabolic process (GO:0006518),0.44474898366733345,1.3341535797469966,0.08673469387755102,0.6158591116025794,1.0,12/75,9.75%,CPXM2;CPQ;AEBP1;CPXM1;GSTM4;GSTM2;DPEP1;NAALADL1;SEC11C;APEH;GSTT1;ABCB9
prerank,negative regulation of vascular permeability (GO:0043116),-0.5432504417938168,-1.3319645172082486,0.14832535885167464,0.6444024932133634,1.0,8/12,9.51%,SLIT2;PTPRJ;CLDN5;RAMP2;SH3GL2;PDE2A;DDAH1;VEGFA
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.4964018551641767,1.331833928532344,0.1148936170212766,0.6219895770783442,1.0,10/36,11.72%,VAMP5;MACF1;OPTN;GORASP2;GOLGA4;TRARG1;AFDN;GGA2;GOLPH3L;GORASP1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.5692613115184668,1.3312381929548849,0.1476725521669342,0.6226519548137341,1.0,5/17,6.94%,GJA1;SLC8A1;ATP1A2;CACNA1C;ATP1B2
prerank,positive regulation of histone modification (GO:0031058),-0.41778365508485393,-1.3308552691604614,0.10784313725490197,0.645063805408552,1.0,11/33,13.80%,RPS6KA5;KDM1A;NOS1;CTBP1;PPARGC1A;BRD7;RPS6KA4;CHTOP;TADA2A;APLNR;MAPK3
prerank,growth hormone receptor signaling pathway (GO:0060396),0.5981302671529936,1.3296142816201901,0.15502555366269166,0.6266180164601924,1.0,3/14,1.77%,GHR;PIK3R1;LYN
prerank,positive regulation by host of viral transcription (GO:0043923),-0.5032176180702981,-1.3289906080439782,0.13647642679900746,0.6484869464559965,1.0,6/15,16.95%,LEF1;CHD1;SNW1;JUN;EP300;TFAP4
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.4195831435719198,1.3289490216307005,0.07294117647058823,0.6276072183263782,1.0,11/108,4.20%,ROBO1;COL4A3;UACA;GSN;DAPK1;SMAD3;DLC1;CASP12;CFLAR;PDCD5;SLC22A2
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.6168571218677971,1.3287722920042513,0.16666666666666666,0.627023519381034,1.0,2/13,2.48%,RUNX1;GLI3
prerank,regulation of ion transmembrane transport (GO:0034765),-0.4131283433215664,-1.32839464729356,0.08940397350993377,0.6475764267920757,1.0,16/33,26.26%,KCNJ2;NEDD4L;KCNJ3;P2RX7;KCNQ1;CHRM3;AKAP6;KCNJ15;KCNJ10;CASQ2;ANO6;KCNJ8;KCNJ6;KCNJ13;KCNJ16;WWP2
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.47277836917062765,-1.3282891094275915,0.1297709923664122,0.6449700539557318,1.0,11/18,31.56%,TMEM14A;HIP1R;GSK3A;BAK1;ZNF205;ACAA2;GSK3B;FZD9;CHCHD10;BID;BAX
prerank,regulation of lipid kinase activity (GO:0043550),0.6214286929465012,1.327946074735319,0.18729096989966554,0.628439566843132,1.0,6/11,15.74%,PIK3R1;WDR81;WDR91;RBL2;F2;PIK3R2
prerank,positive regulation of lipid localization (GO:1905954),0.618206910737823,1.327858620833817,0.1813380281690141,0.6275185193900951,1.0,2/11,11.61%,LRP1;IKBKE
prerank,acylglycerol catabolic process (GO:0046464),-0.42344949199192955,-1.3277031627929083,0.10416666666666667,0.6441191397474774,1.0,13/30,27.50%,MGLL;ABHD2;LIPE;PNPLA3;PNPLA2;ABHD6;FABP7;LYPLA2;FABP3;LIPH;LIPC;FAAH;LPL
prerank,Wnt signaling pathway (GO:0016055),0.43024752978242675,1.327509553389398,0.09168704156479218,0.6275545058634427,1.0,14/92,6.62%,TCF7L2;WLS;PLPP3;WNT8B;FZD2;WNT4;WNT6;FZD1;RARG;SFRP1;BCL9;TCF7;LRRK2;WNT5B
prerank,positive regulation of cell projection organization (GO:0031346),0.4184425622584633,1.3274971154156496,0.07425149700598803,0.6264221906284899,1.0,29/115,14.30%,EPHA3;ROBO1;PLXNA2;CAMK1D;LYN;OBSL1;TIAM2;APOE;DPYSL3;RAPGEF2;FZD1;PTK7;ROR1;CUX2;ATP1B2;CARMIL1;ARHGAP35;NTRK3;CAMK2B;RAPGEF1;PLXNC1;MAP3K13;NDRG4;MARK2;PLXNA1;DLG4;MDK;CHODL;PLXNB2
prerank,alpha-amino acid metabolic process (GO:1901605),0.47087725912646217,1.3270054996782572,0.11452513966480447,0.626775514997096,1.0,9/45,8.64%,ASPG;GLUL;PYCR1;MTHFR;ASPA;PYCR3;DPEP1;MMUT;ALDH18A1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.5677440858334668,-1.3266612357134053,0.13501144164759726,0.6448239433619875,1.0,4/10,15.58%,FN1;HSP90AB1;TSKU;CDH3
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.5123989670079327,1.3263405641114066,0.12713178294573643,0.6276129390585876,1.0,6/29,8.36%,TCF7L2;TLE1;AXIN2;BCL9;TCF7;TCF7L1
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6274572616935885,1.3253188827628388,0.17584369449378331,0.6297661137723235,1.0,4/10,6.60%,DCN;BCL2;SRC;LRRK2
prerank,synaptic vesicle exocytosis (GO:0016079),-0.3897356559653594,-1.3250490330497104,0.09937888198757763,0.6470152839544703,1.0,15/40,25.18%,UNC13B;RIMS1;STX3;CDK5;RIMS2;SYT1;PCLO;CPLX1;RAB3A;STX1A;RIMS3;OTOF;SNPH;SYT5;SNAP29
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.5166380110355387,1.3249570055805953,0.12631578947368421,0.6297490811356554,1.0,8/29,8.72%,ZBTB20;APOE;APOA1;SLC45A3;LDLR;SREBF1;LPGAT1;CREBL2
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.6077691926737819,1.3247489411005675,0.18038528896672504,0.6291934675494771,1.0,6/12,18.69%,DPYSL3;DPYD;CTPS2;CDA;ALDH6A1;DPYSL2
prerank,vasodilation (GO:0042311),-0.5357431926101698,-1.3242980273758096,0.14321608040201006,0.64654582067302,1.0,6/13,16.30%,NOS3;KLF2;KCNMA1;NOS1;ADRB2;GPER1
prerank,acute-phase response (GO:0006953),0.5986552900061435,1.3241707580288093,0.17513134851138354,0.6298286877000526,1.0,2/12,2.21%,AHSG;IL6R
prerank,dopamine metabolic process (GO:0042417),0.5592076238041633,1.323895570959307,0.16422764227642275,0.6295720821537542,1.0,6/18,10.21%,MOXD1;COMT;SNCAIP;DRD3;PRKN;LRTOMT
prerank,blood vessel endothelial cell migration (GO:0043534),0.5375401989058409,1.3238680910748435,0.12708018154311648,0.6285341970963336,1.0,7/22,11.97%,NRP1;ROBO1;EFNB2;CDH5;MIA3;FGF2;NR4A1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.3631336154776623,-1.3234488856168742,0.088,0.646497081264717,1.0,21/59,15.19%,HMCN1;PECAM1;CDH2;CADM1;CDH1;BSG;KIRREL3;TENM3;NECTIN1;CNTN4;PTPRT;CDH13;CNTN6;ROBO4;FAT2;EMB;PVR;IGSF11;DSG2;CEACAM1;PLXNB3
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.4504436363580898,-1.3223115483067824,0.125,0.6474293228350445,1.0,6/22,16.30%,PDE3B;APOD;PPP2R5A;ALK;CEACAM1;GPER1
prerank,regulation of fat cell differentiation (GO:0045598),0.4436907642337557,1.3221147658816916,0.10709677419354839,0.6329027250086245,1.0,19/74,12.29%,RORA;ENPP1;RUNX1T1;SMAD3;MEDAG;YAP1;SFRP1;GNB3;ZFP36L1;WWTR1;SIRT2;NR1D1;CREBL2;BMP2;TRPM4;ANKRD26;CEBPB;TMEM64;LRP3
prerank,regulation of hemopoiesis (GO:1903706),0.6446789786116603,1.3219455115742509,0.1724137931034483,0.6323408867815284,1.0,2/10,2.77%,RUNX1;IL17D
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.5296658128101818,1.3218159574753254,0.1484375,0.6316631084976825,1.0,6/24,9.90%,PID1;LEPR;MT3;ADRB3;GFPT1;COQ10B
prerank,response to insulin (GO:0032868),0.4320656399142083,1.3217119566139375,0.09554140127388536,0.6308700214096644,1.0,14/80,12.56%,PDPK1;ENPP1;TBC1D4;PIK3R1;OGT;INSIG2;CPEB1;ZFP36L1;TRARG1;KAT2B;EIF6;RHOQ;SELENOS;INSR
prerank,dicarboxylic acid transport (GO:0006835),0.5147907942172588,1.3210092428456723,0.13914373088685014,0.632010291684215,1.0,4/28,5.40%,SLC1A3;GJA1;SLC13A3;PDPN
prerank,regulation of heart contraction (GO:0008016),0.42367701261662005,1.3207582427058895,0.10506798516687268,0.6317291539676547,1.0,11/90,6.94%,CELF2;ITPR1;SLC8A1;SLC8A3;ATP1A2;TPM1;DMPK;ASPH;STIM1;DES;ATP1B2
prerank,negative regulation of transmembrane transport (GO:0034763),-0.5608041721858291,-1.3202322900914036,0.1480637813211845,0.6513894535858712,1.0,3/10,7.80%,THBS1;CTTNBP2NL;INPP5K
prerank,cardiocyte differentiation (GO:0035051),0.63690576931862,1.3195355615055486,0.18312387791741472,0.6344761417054101,1.0,6/10,14.71%,SIK1;BMP2;EEF1AKMT4-ECE2;CBY1;AKAP13;GATA6
prerank,receptor signaling pathway via STAT (GO:0097696),0.518661364973379,1.3188888426995453,0.15409309791332262,0.6353991405033195,1.0,7/25,13.58%,GHR;IL31RA;NMI;STAT5B;STAT2;STAT6;STAT4
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.43022061720910976,-1.3186631305171472,0.11515151515151516,0.6535507007020948,1.0,14/29,27.54%,LPCAT1;PLAAT3;PNPLA8;PLA2G4C;MBOAT7;LPCAT3;LPCAT2;PLA2G4F;PLA2G4E;DBI;PLA2G4B;PLA2G5;MBOAT2;LPCAT4
prerank,positive regulation of cell population proliferation (GO:0008284),0.3770803834837605,1.3182293100727662,0.017364657814096015,0.6362787001315234,1.0,54/423,8.96%,IGF1;TCF7L2;BMP6;IGF2;ESM1;GJA1;DDR2;PID1;TGFBR3;GDNF;PDGFD;AR;AREG;TGFA;IL31RA;LYN;BCL2;GRK5;FGFR1;IL6R;BMPR1A;IL34;OSMR;CCN1;LAMC1;EPGN;FGFR2;FGFR4;YAP1;GAS6;PDGFRA;EFNB2;PDGFRB;TGFBR1;CSF1;NTF3;HTR1A;PHIP;LIG4;SFRP1;CTSH;TBX3;VIP;TSLP;WWTR1;RAB25;IL13RA1;OSR1;TET1;RBPJ;NTRK3;EGFR;BMP2;CCN4
prerank,ceramide metabolic process (GO:0006672),-0.37325644153267445,-1.3176448526209457,0.07196969696969698,0.6541711853296848,1.0,6/49,2.87%,ST6GALNAC3;SGMS1;ACER3;SGMS2;ACER2;DEGS2
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.41496765459078966,1.3172592906666993,0.08200734394124846,0.6381835814102885,1.0,27/118,10.42%,PHLDB2;PDLIM5;SH3D19;HECW2;PID1;GDNF;SPARC;DAG1;KIF13B;EPHA4;FGFR2;SP100;VASH2;NEDD4;PHIP;SFRP1;BCL6;ADGRA2;CRB2;LRRK2;BRSK1;ARHGAP35;WTIP;CAPZB;STAT2;FGF2;PDZD8
prerank,protein ADP-ribosylation (GO:0006471),0.5029015750811752,1.3172162259969038,0.1411229135053111,0.6371906988925372,1.0,10/28,19.04%,ART4;PARP11;HPF1;PARP16;SIRT2;PARP14;TNKS2;ARF4;PARP12;SIRT5
prerank,kidney development (GO:0001822),0.44712148641921456,1.3171875536079352,0.13324873096446702,0.6361360717271528,1.0,12/65,7.90%,GDNF;GLI2;SULF2;SALL1;WNT4;TGFBR1;SULF1;GREB1L;CTSH;AGTR1;IFT27;OSR1
prerank,axonogenesis (GO:0007409),0.38667085292799436,1.3171448878309164,0.035830618892508145,0.6351395280859639,1.0,39/237,10.38%,EPHA3;NRP1;ROBO1;EPHA7;LAMA1;AUTS2;GDNF;PIK3R1;DAG1;SEMA3D;LAMA2;GLI2;EPHA4;GFRA2;EPHA8;FGFR2;EFNB2;PALLD;SEMA5A;NOTCH2;NCAM1;LRTM1;FRS2;SRC;ULK2;RANBP9;EFNA2;BRSK1;ARHGAP35;SPTAN1;PARD6B;DSCAM;EPHB2;EFNB1;GFRA4;SLIT3;SLIT1;RYK;NEXN
prerank,excitatory postsynaptic potential (GO:0060079),-0.4593122070875695,-1.3167950662618575,0.13784461152882205,0.6540944557071338,1.0,5/19,7.65%,GRID2;MEF2C;GRIN2A;GRIN2B;GSK3A
prerank,filopodium assembly (GO:0046847),-0.4924950915368828,-1.3162514653679833,0.13881748071979436,0.6531309985335357,1.0,3/16,3.37%,DNM3;FGD5;SPATA13
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5792073010344084,1.3158320660694787,0.18165784832451498,0.6381244908273558,1.0,2/14,6.94%,ACTN2;ATP1B2
prerank,activin receptor signaling pathway (GO:0032924),0.5854562493993583,1.3155742561902737,0.18013468013468015,0.6378261512183794,1.0,3/15,4.67%,SMAD3;TGFBR1;ACVR1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.43564838206713485,1.3155075109933616,0.12276214833759591,0.63688774432312,1.0,8/68,6.60%,ENPP1;AMPD3;TPST1;ACOT11;ACOT6;ACOT2;RAB23;LRRK2
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.6288163458975101,1.3154961045033833,0.19494584837545126,0.6357962629740596,1.0,4/11,8.76%,TGFBR3;TGFBR1;ACVR1;BMP2
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.6337649298820751,1.3152894356620428,0.18650088809946713,0.635363653801741,1.0,4/10,12.59%,GHR;LYN;STAT5B;STAT6
prerank,monocarboxylic acid transport (GO:0015718),-0.3779941205799678,-1.3150495439623087,0.05952380952380952,0.6542795811456698,1.0,11/51,7.50%,ABCG2;ATP8B1;ABCC4;SLCO2A1;SLCO1C1;SLC16A6;SLCO2B1;SLC5A6;SLC16A9;SLC16A1;SLC16A4
prerank,visual perception (GO:0007601),0.4279442467856361,1.3147954217715032,0.09445843828715365,0.6357978066042734,1.0,8/84,4.53%,COL1A1;ADGRV1;COL11A1;EML2;DHRS3;TULP1;ZIC2;SLC24A1
prerank,sulfur compound biosynthetic process (GO:0044272),0.4268908989194321,1.314373031924059,0.10361445783132531,0.6359925955488258,1.0,20/104,11.74%,FMOD;OGN;ANGPT1;LUM;UST;DCN;BGN;ST3GAL3;DSE;CHAC2;GSTM4;GSTM2;B4GALT1;OMD;CSPG5;MGST1;GSTT1;CDO1;LIAS;CHST15
prerank,actomyosin structure organization (GO:0031032),0.4318275454450197,1.3135189377603858,0.0951188986232791,0.6375683394545638,1.0,16/75,10.14%,PHACTR1;ROCK2;ACTN2;TPM1;TMOD4;TNNT1;MYO18A;MYH10;FRMD6;CSRP2;ITGB5;SRC;ARRB1;CSRP3;SYNPO2L;TNNT3
prerank,MAPK cascade (GO:0000165),0.3834603358209704,1.3128254313651992,0.024261603375527425,0.6386574240267697,1.0,52/295,11.60%,IGF1;NRK;ANGPT1;ACTN2;GDNF;PIK3R1;KSR1;AREG;TGFA;IL31RA;FGFR1;GFRA2;EPGN;KL;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;ABHD17C;APOA1;RAPGEF2;NCAM1;MT3;RASA3;PSME4;FRS2;CTSH;MRAS;MAP3K20;ZFP36L1;RANBP9;LRRK2;MAP2K1;ARAF;SPTAN1;RGL1;EGFR;MAP3K8;ARL2;MAP4K4;CAMK2B;ITGAV;GFRA4;FGF2;FGF13;BRAF;TAOK3;HBEGF;LAMTOR2;KBTBD7;TNIP2
prerank,regulation of MAP kinase activity (GO:0043405),0.4234410934146393,1.3126729968951574,0.08198757763975155,0.6380332582455542,1.0,20/92,13.78%,ROBO1;PDGFD;KSR1;LYN;FGFR1;IL34;EPGN;KIT;APOE;PDGFRB;CDK5RAP3;LRRK2;IRAK3;EGFR;SPRY2;FGF2;ADRA2A;DUSP19;EGF;CDK12
prerank,canonical Wnt signaling pathway (GO:0060070),0.4447816115752915,1.3122970983130802,0.11847133757961784,0.6381020209478735,1.0,14/68,8.36%,TCF7L2;PLPP3;WNT8B;FZD2;WNT4;WNT6;FZD1;RARG;SFRP1;BCL9;TCF7;LRRK2;WNT5B;TCF7L1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.524456522477885,1.3121939349014462,0.1385083713850837,0.6373019776956877,1.0,10/26,19.26%,OGT;KMT5B;SETD1A;WDR82;SETD5;SETD4;KMT2A;EEF2KMT;SETD1B;TET3
prerank,sensory perception (GO:0007600),0.47499652576339096,1.3121541239061933,0.13049645390070921,0.6363454728882634,1.0,6/45,7.26%,ADGRV1;TRPA1;PTGES;GNAS;ALOXE3;USH2A
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.5891886699141162,1.3116186941140633,0.1423728813559322,0.636948504940312,1.0,2/14,2.79%,ENPP1;AK1
prerank,neuromuscular process controlling balance (GO:0050885),-0.5218250385575716,-1.3103820635766967,0.15347721822541965,0.667395359386427,1.0,4/12,9.86%,PCDH15;NRXN1;PAFAH1B1;SHANK1
prerank,regulation of GTPase activity (GO:0043087),-0.3051187474968524,-1.3103509878556237,0.01904761904761905,0.6646352836543301,1.0,45/177,11.96%,PKP4;DOCK9;CHN2;EFNA5;FGD5;LRCH1;PLXNA4;RAP1A;ITGA6;ARHGAP44;F11R;VAV3;CAV2;SH3BP4;RABGAP1;RAP1GDS1;SIPA1L1;BCAR3;NET1;SNX13;RGS6;RASIP1;PRKG1;RDX;TBC1D15;TGM2;ARHGAP27;ERBB2;EZH2;CCL14;EPHA5;NGEF;CHN1;TBC1D30;ARAP1;RASGRF1;RGS7;LARS1;PLXND1;RGS16;ADAP1;AGRN;NF1;EVI5;CD40
prerank,alcohol catabolic process (GO:0046164),0.638435171407681,1.30954355894157,0.18838028169014084,0.6425414393103329,1.0,3/10,7.23%,APOE;MT3;CYP27A1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6405163189352788,1.3095262819863338,0.1813186813186813,0.6414840049905938,1.0,8/10,26.51%,VTN;MT3;ITGB3;ARNT;GRB10;PRKCB;PRKD2;ITGA5
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.3429309073623565,-1.3090194745929307,0.04225352112676056,0.666318074807387,1.0,21/75,14.78%,SLC12A2;SLC12A7;SLC9A2;KCNJ2;SLC24A2;SLC39A10;ATP1A1;KCNJ3;SLC9A6;ABCC9;SLC39A8;SLC12A6;ATP1B1;ATP2B4;SLC9A7;KCNJ15;ATP1A3;KCNJ10;TRPV4;SLC12A5;CACNA2D1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.4133044370096738,1.3088114681774108,0.07885304659498207,0.6426619083639186,1.0,14/117,7.29%,IGF1;PCCA;CYP26B1;ABAT;ACOT11;ACOT6;PDHA1;CPT1C;ACOT2;PCCB;ALDH1A2;HOGA1;KYNU;ADH1A
prerank,cristae formation (GO:0042407),-0.4319338229920707,-1.3086420391173232,0.13505747126436782,0.6648268075933214,1.0,8/27,17.21%,LETM1;ATP5F1A;ATP5F1E;ATP5ME;ATP5MG;ATP5F1C;ATP5MF;ATP5PD
prerank,positive regulation of cellular component movement (GO:0051272),0.5265047317719284,1.3081922411548244,0.1618320610687023,0.6435533126140247,1.0,10/24,14.04%,LYN;TGFBR1;CCL19;PDPN;NTN1;ACTN4;STK11;CCDC25;TUBB2B;ETS1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5414802811389869,1.3076088380561366,0.16393442622950818,0.6443225593764005,1.0,10/21,23.00%,MT3;SIRT2;SLC30A10;PRKN;SLC18A2;ABCD2;SIRT5;AATF;HDAC6;BRCA1
prerank,contractile actin filament bundle assembly (GO:0030038),0.5752656813355891,1.3075566805366075,0.17168141592920355,0.6422581524991006,1.0,5/15,13.29%,PHACTR1;ITGB5;SRC;ARRB1;TNFAIP1
prerank,stress fiber assembly (GO:0043149),0.5752656813355891,1.3075566805366075,0.17168141592920355,0.6422581524991006,1.0,5/15,13.29%,PHACTR1;ITGB5;SRC;ARRB1;TNFAIP1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.41266596449971277,1.3072086385615667,0.09165687426556991,0.6422434448780648,1.0,17/110,8.21%,ADRA1B;ADCY1;ADCY2;ABCA1;ADCY7;LGR4;ADCY5;GNAS;ADCY9;ADGRL1;RAPGEF2;VIP;ADRA2C;LHCGR;ADRB3;LPAR1;DRD3
prerank,negative regulation of protein binding (GO:0032091),-0.34945645651921176,-1.3071485757839132,0.0867579908675799,0.6670875552094633,1.0,26/71,21.95%,CAV1;MAP2;ACTB;B2M;ADAM15;KDM1A;SORL1;CTNNBIP1;ITGA4;ATP2A3;DISC1;GTF2F1;MAPK8;ADRB2;RALB;CARD16;PPP1CA;ZFPM1;RACK1;CDKN1A;DVL1;EFHB;ITGB1BP1;ROCK1;STYX;GSK3B
prerank,nucleic acid metabolic process (GO:0090304),0.4366664445018002,1.3070259302201748,0.1285892634207241,0.6417192203517221,1.0,23/69,20.83%,POLR2D;ENPP1;RBFOX2;POLG;DXO;RECQL5;HNRNPR;METTL14;HNRNPA1;POLR2C;DNASE1L1;DNASE2;WTAP;LSM8;HNRNPC;KPNA2;METTL3;DDX1;POLR2L;HNRNPU;HNRNPH1;EXD2;DDX24
prerank,regulation of keratinocyte differentiation (GO:0045616),0.51796121889301,1.3069996862252833,0.14953271028037382,0.6407141386980268,1.0,4/24,5.78%,ERRFI1;ROCK2;RUNX1;ZFP36L1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.4906188107895676,-1.3066850797879652,0.16625916870415647,0.6657532574549307,1.0,5/15,4.18%,TMSB4X;THBS1;NOTCH1;MET;FGF1
prerank,regulation of neutrophil migration (GO:1902622),0.6193240414522813,1.306337282914523,0.198943661971831,0.6416380695087875,1.0,1/10,0.70%,RHOH
prerank,tRNA wobble base modification (GO:0002097),0.576966073847276,1.304399180745996,0.17314487632508835,0.6467425535403774,1.0,6/14,19.91%,ADAT2;TRMT9B;URM1;ALKBH1;DPH3;ELP4
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.39817982728527057,1.3043623073339756,0.08179723502304148,0.6457271418058358,1.0,27/151,10.64%,NRP1;CCN2;ANGPT1;PDGFD;FGFR2;FGFR4;GAS6;PDGFRA;APOE;PDGFRB;CCL19;NOTCH2;RAPGEF2;MT3;ROR1;CCL4;MAP2K1;MTURN;NTRK3;SLC30A10;ARRB1;EGFR;BMP2;SPRY2;FGF2;CARD9;BRAF
prerank,alanine transport (GO:0032328),-0.5592769697357144,-1.3039628784436406,0.17105263157894737,0.6719971745867275,1.0,3/10,13.96%,SLC6A6;SLC36A4;SLC1A4
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.4501016978336404,1.3038242147909658,0.13438735177865613,0.6463343477158768,1.0,12/52,18.32%,POLR2D;SAMD4A;TUT7;EXOSC1;PARN;EXOSC7;TUT4;RC3H2;CNOT3;DCP1A;PATL1;RC3H1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.37749658693132865,1.3038087307173964,0.04206098843322818,0.6452817628300935,1.0,69/308,15.29%,ADRA1B;COL1A1;GJA1;GHR;GDNF;SMAD3;LRP1;SOX5;NKX6-1;ABCA1;SERPINE1;PLA2R1;LEPR;OGT;ACSL1;BMPR1A;OLFM1;GNAS;GAS6;APOE;TGFBR1;SMO;SMURF2;APPL2;ACVR1;AXIN2;PDPN;VIP;EPAS1;DYNC1H1;ADRB3;CRB2;ALMS1;IL12B;BATF;CD28;WWTR1;DAB2;KMT5B;BMP2;SYDE1;TRPM4;NFAM1;FGF2;CARD9;MFAP2;CEBPB;ADRA2A;RBM19;RGCC;REST;NIBAN2;MAP3K13;STAT6;ACVR1B;DECR1;TMEM119;EGF;NCOA3;GLMN;DIO2;G0S2;HMCES;MDK;BMP4;CNOT3;GLIPR2;IL4R;GRB10
prerank,organophosphate ester transport (GO:0015748),-0.44275416553421965,-1.3037795432199701,0.14076246334310852,0.6697954553744276,1.0,10/24,17.09%,PITPNC1;PLTP;PITPNA;TNFAIP8L3;NPC2;OSBPL2;SCARB1;PCTP;PITPNB;PRELID2
prerank,regulation of synapse organization (GO:0050807),0.513317533960487,1.303110665387283,0.166412213740458,0.6463224467840328,1.0,9/26,12.63%,PDLIM5;EPHA4;ABHD17C;NEDD4;CAMK2B;SETD5;MDGA1;CLN3;SLITRK2
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.41378374369748505,1.3031015634150152,0.09541062801932366,0.6452631505054572,1.0,20/104,10.37%,PDPK1;CILP;SMAD3;LDLRAD4;ADAMTSL2;BMPR1A;NKX2-1;PMEPA1;TGFBR1;SLC2A10;SMURF2;ACVR1;SKI;EMILIN1;BMP2;SPRY2;LEMD3;SMAD1;FAM89B;SPRED3
prerank,cellular response to decreased oxygen levels (GO:0036294),0.44172723380516726,1.3024313094184081,0.11630847029077118,0.6462866484897318,1.0,10/65,7.38%,PTGIS;RORA;SLC8A3;MT3;SFRP1;CPEB1;EPAS1;ZFP36L1;NDRG1;SIRT2
prerank,negative chemotaxis (GO:0050919),0.4966676712756943,1.3023977566380265,0.15214180206794684,0.6452686010671626,1.0,10/33,10.13%,ROBO1;EPHA7;SEMA3D;APOA1;LRTM1;NTN1;ITGB3;ITGAV;SLIT3;SLIT1
prerank,neutrophil migration (GO:1990266),-0.3562118793937776,-1.3012719175151901,0.06666666666666667,0.6756100812839786,1.0,10/58,12.13%,PECAM1;PDE4B;BSG;TGFB2;PPIA;CCL14;FCER1G;EDN1;CKLF;CXADR
prerank,myotube differentiation (GO:0014902),0.5653098774057475,1.3010287876351356,0.16243654822335024,0.6484086526694911,1.0,2/17,0.94%,IGF1;ADAMTS5
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.5257153457634514,1.3003123787547242,0.18473282442748093,0.6495000904857294,1.0,2/23,3.56%,IGF1;EFNB2
prerank,regulation of cell morphogenesis (GO:0022604),0.49254299086208675,1.3002315767102905,0.16005873715124816,0.6486467925247019,1.0,8/30,10.42%,SH3D19;SPARC;MACF1;PHIP;PDPN;WTIP;CAPZB;PDZD8
prerank,positive regulation of protein polymerization (GO:0032273),-0.3525415903078522,-1.300206548188862,0.058577405857740586,0.6763273679432563,1.0,17/65,19.34%,OCLN;BAIAP2L1;PTK2B;NAV3;MET;RPS3;PAK1;FES;DCTN1;TPPP3;CDK5RAP2;CTTN;CDK5R1;PRKCE;NCK2;CLASP1;LMOD1
prerank,plasma membrane tubulation (GO:0097320),-0.5132041411734134,-1.3000070774123478,0.1782178217821782,0.6741912755243976,1.0,8/13,23.57%,FNBP1L;CAVIN2;BIN3;PACSIN2;PACSIN1;EHD2;CHMP4A;BIN2
prerank,T cell proliferation (GO:0042098),-0.5175516358064445,-1.299939076043364,0.16326530612244897,0.6716168070144852,1.0,8/13,37.51%,CADM1;MSN;PIK3CG;DOCK8;LILRB1;TNFRSF4;CRTAM;LMBR1L
prerank,female gonad development (GO:0008585),0.5553191261726472,1.2998825708558093,0.1870967741935484,0.6487287495010685,1.0,7/19,11.10%,NR2F2;KIT;NUP107;LHCGR;NR5A1;EIF2B4;CEBPB
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.5961416713694718,1.299772517381404,0.1913477537437604,0.648015236358586,1.0,2/12,2.08%,LYN;RUNX1
prerank,T cell activation (GO:0042110),0.42683579360534973,1.2992583274746272,0.12185430463576159,0.6486108570850734,1.0,14/69,14.21%,RHOH;KIF13B;LEPR;PPP3CA;KIT;CCL19;CD7;CD28;NHEJ1;GPR89A;GPR89B;IFNK;DDOST;MDK
prerank,establishment of protein localization to extracellular region (GO:0035592),0.4783005651689401,1.2990979435342707,0.14184397163120568,0.6480317280570402,1.0,13/39,17.59%,STEAP3;ABCA1;TVP23B;ARFGAP3;LTBP2;MIA2;MIA3;RCN3;MTTP;TVP23A;TANGO2;GOLPH3;COPG1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.43775131373700177,1.2985164858046854,0.12757731958762886,0.6487940442869844,1.0,10/69,7.38%,IGF1;PIK3R1;FGFR1;OGT;PDGFRA;PDGFRB;PLCD1;ZFP36L1;PLCB4;SIRT2
prerank,vascular transport (GO:0010232),0.4236525209179901,1.298305613705455,0.1251564455569462,0.6483698015476846,1.0,23/81,12.56%,SLC1A3;SLC24A3;SLC7A2;SLC1A5;LRP1;SLC16A12;ATP1A2;SLC13A3;LEPR;SLC6A9;SLC6A13;SLC44A1;SLC2A10;SLC22A2;SLCO3A1;ATP1B2;SLC2A13;SLC5A3;SLC29A1;ABCC5;SLC5A5;LRP3;INSR
prerank,ureteric bud morphogenesis (GO:0060675),0.5582926027682515,1.2981365769701538,0.1857379767827529,0.6478191753425883,1.0,6/16,16.72%,GDNF;SALL1;BMP2;FGF2;BMP4;SHH
prerank,regulation of actin filament depolymerization (GO:0030834),0.5970661132000094,1.2974390617681528,0.20379965457685664,0.6488483231793177,1.0,3/12,5.80%,PLEKHH2;SEMA5A;LIMA1
prerank,regulation of secretion by cell (GO:1903530),-0.35954592122378876,-1.2970535509874423,0.1037037037037037,0.678531582626989,1.0,20/54,19.34%,MEF2C;MCTP1;RIMS1;STXBP5L;RAB21;RAB3C;RIMS2;VAMP8;SYT1;RAB12;RAB8B;LGI3;NSF;CPLX1;RAB15;RAB3A;RIC1;ARFIP1;SYN1;ANXA1
prerank,lipid transport (GO:0006869),-0.3224044471156858,-1.2967419573245587,0.08139534883720931,0.6768133139891772,1.0,29/97,17.09%,PITPNC1;CERT1;ATP8A1;ATP8B1;PLTP;ABCC4;SLCO2A1;SLCO1C1;SLCO2B1;PPARD;PITPNA;TNFAIP8L3;SPNS2;LBP;PLEKHA3;NPC2;MFSD2A;ABCG1;OSBPL2;UGCG;SCARB1;PCTP;CEACAM1;ABCD3;ABCC3;MFSD2B;PITPNB;OSBP;PRELID2
prerank,protein kinase A signaling (GO:0010737),-0.5185501651488983,-1.2966809112240831,0.16009280742459397,0.6742595827437565,1.0,3/12,7.60%,RDX;PRKACB;MYOM1
prerank,oligosaccharide biosynthetic process (GO:0009312),0.539641321103373,1.2964903132951286,0.1648177496038035,0.6507757011245574,1.0,5/20,10.19%,ST6GALNAC5;B3GALT1;ST3GAL3;B4GALT1;ST6GALNAC6
prerank,regulation of cytoskeleton organization (GO:0051493),0.4062969008811552,1.2962854788567881,0.09692671394799054,0.6503911437474599,1.0,13/108,5.51%,EPHA3;PHLDB2;RHOH;ROCK2;LRP1;DLC1;RHOD;ARHGAP18;RHOBTB1;PDGFRB;IQGAP2;PRKAA2;RHOBTB3
prerank,macrophage activation (GO:0042116),-0.3997341723607206,-1.2958708503573222,0.13372093023255813,0.674421903404513,1.0,16/34,25.49%,CD93;PLCG2;DYSF;LBP;JAK2;FOXP1;IFI35;SBNO2;APP;TLR4;CLU;AGER;AIF1;TREM2;IFNGR1;TMEM106A
prerank,positive regulation of histone methylation (GO:0031062),0.5276902760277363,1.2953984468923745,0.17355371900826447,0.6522795627339025,1.0,11/24,23.00%,AUTS2;OGT;TET1;PHF1;PAF1;KMT2A;WDR5;DNMT3B;JARID2;DNMT1;BRCA1
prerank,negative regulation of immune system process (GO:0002683),0.5769242029580254,1.2951115040826284,0.17733990147783252,0.652098915031051,1.0,4/16,14.05%,LYN;IL17D;CD200;COL3A1
prerank,positive regulation of hydrolase activity (GO:0051345),-0.30365417957789675,-1.295020389435351,0.05,0.6743987226810748,1.0,32/137,11.96%,PKP4;DOCK9;RAP1A;ITGA6;F11R;CAV2;RAP1GDS1;BCAR3;NET1;SNX13;RGS6;TGM2;ARHGAP27;RPS3;ERBB2;EZH2;FNTA;CCL14;TBC1D30;ARAP1;RASGRF1;RGS7;LARS1;MAPK8;CALM1;MTMR9;RGS16;CALM3;AGRN;NF1;EVI5;CD40
prerank,positive regulation of phagocytosis (GO:0050766),0.457854785258361,1.2946864981892174,0.13991769547325103,0.6522934605786855,1.0,8/47,4.50%,CAMK1D;AHSG;TULP1;GAS6;MYO18A;APOA1;APPL2;C4B
prerank,epithelial to mesenchymal transition (GO:0001837),0.46551951108370676,1.294372143222331,0.15247252747252749,0.652211449791721,1.0,11/47,8.76%,ROCK2;TGFBR3;FGFR1;OLFM1;WNT4;TGFBR1;TBX3;ENG;DDX17;RBPJ;BMP2
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.5068594027918149,-1.294134785253095,0.15454545454545454,0.6746372457104554,1.0,8/13,16.78%,PTPRT;JAK2;MGAT5;HES1;CRLF2;PTPRC;PIGU;JAK3
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.591196582681464,1.2936288282292059,0.19529837251356238,0.6534622370723961,1.0,4/12,16.20%,IL12B;ZBTB1;CARD9;IL23A
prerank,negative regulation of biomineral tissue development (GO:0070168),0.5405385472722178,1.2934984687509732,0.16951788491446346,0.6527921029493198,1.0,5/21,5.95%,ENPP1;ROCK2;AHSG;GAS6;BCOR
prerank,membrane assembly (GO:0071709),-0.4009365996508007,-1.2930175451522476,0.1125,0.6756436121290335,1.0,9/34,10.27%,NLGN1;IL1RAPL1;ANK3;PTPRD;SPTBN1;NRXN1;EMP2;GAK;UGCG
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.46785587927900185,1.2924748880667993,0.16946778711484595,0.6549872724594658,1.0,5/41,4.53%,ITPR1;SLC8A1;SLC8A3;CCL19;SLC24A1
prerank,bile acid and bile salt transport (GO:0015721),-0.4301643065895018,-1.2910281390659095,0.13972602739726028,0.6793408451935299,1.0,4/24,2.67%,ATP8B1;ABCC4;SLCO1C1;SLCO2B1
prerank,positive regulation of filopodium assembly (GO:0051491),0.5133201434023512,1.2909586729435227,0.17377567140600317,0.6587209375080534,1.0,6/24,6.16%,NRP1;PIK3R1;DOCK11;RIPOR2;DPYSL3;CDC42
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.5411283808667333,1.2908399100058645,0.1834710743801653,0.658043872953475,1.0,4/21,6.80%,EPHA3;ROCK2;MACF1;VCL
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.49055630987332943,1.2907860134131166,0.1546242774566474,0.6571599685142916,1.0,4/33,7.38%,IGF1;PIK3R1;ZFP36L1;SIRT2
prerank,positive regulation of translational initiation (GO:0045948),0.5432959824582624,1.2893873519955517,0.17197452229299362,0.6604463430056854,1.0,4/18,12.42%,POLR2D;CDC123;DDX3X;LARP1
prerank,lipid translocation (GO:0034204),-0.4453460849892986,-1.2888037018409233,0.15384615384615385,0.6840500657302315,1.0,6/21,7.23%,ATP8A1;ATP8B1;ATP11C;ABCC1;ATP11B;ATP11A
prerank,positive regulation of cell aging (GO:0090343),-0.5318015412065926,-1.2886444671114596,0.16554809843400448,0.6819417485756006,1.0,5/11,20.17%,B2M;CGAS;SIRT1;ABI3;HMGA2
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.6167443555419767,1.2885389246218142,0.21762589928057555,0.6620190946589725,1.0,3/10,7.55%,ACTN2;SEMA5A;CARMIL1
prerank,positive regulation of axonogenesis (GO:0050772),0.4628762788047779,1.2878813558368125,0.1673469387755102,0.6630200193467845,1.0,11/43,14.30%,ROBO1;PLXNA2;MACF1;TIAM2;GOLGA4;NTN1;PLXNC1;MAP3K13;PLXNA1;CHODL;PLXNB2
prerank,regulation of nervous system process (GO:0031644),0.5433124899361595,1.2872825686796259,0.18829113924050633,0.6638263792372925,1.0,2/18,1.31%,ROCK2;SLC8A3
prerank,histone deacetylation (GO:0016575),0.465944310054547,1.287247632731244,0.14654002713704206,0.6628635422739053,1.0,18/43,23.33%,TBL1XR1;PRDM5;MIDEAS;SIRT2;MTA2;MTA3;BRMS1L;HDAC8;REST;HDAC4;SUDS3;ELK4;MIER3;BRMS1;SMARCAD1;HDAC6;HDAC5;SFPQ
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.46320843830268366,1.2872099047840202,0.15460992907801419,0.6619168419863785,1.0,6/43,13.47%,IGF1;GAS6;IRAK3;CD33;SELENOS;SYT11
prerank,positive regulation of nervous system process (GO:0031646),-0.46853195853186685,-1.2871917211639994,0.14646464646464646,0.6840016889547087,1.0,5/18,11.80%,UNC13B;RIMS1;TENM4;RIMS2;ATPSCKMT
prerank,catecholamine biosynthetic process (GO:0042423),0.6078680656362745,1.2871518293648088,0.2222222222222222,0.6610171227066717,1.0,1/11,0.53%,MOXD1
prerank,mononuclear cell differentiation (GO:1903131),0.5179473257086836,1.2869801466444366,0.16869300911854104,0.6605216294100738,1.0,4/24,4.71%,IL31RA;LYN;GAS6;AXL
prerank,synaptic vesicle transport (GO:0048489),-0.5306142475415304,-1.2864180866307804,0.18072289156626506,0.6840368619305712,1.0,5/11,23.33%,RAB27A;CDK5;SYNJ1;KIF5A;TMEM230
prerank,protein O-linked glycosylation (GO:0006493),0.41582588234737283,1.2862573494723888,0.11970979443772672,0.6617392141067309,1.0,11/96,5.90%,TMTC1;GXYLT2;GALNT18;GALNT15;GALNT14;TMTC4;OGT;PGM3;ST3GAL3;LARGE1;LARGE2
prerank,negative regulation of response to wounding (GO:1903035),0.5405381435363963,1.2858688148479358,0.1721311475409836,0.6618984995439005,1.0,8/19,15.85%,SERPINE1;EPHA4;PTPRS;CASK;FGF2;MDK;CERS2;EPPK1
prerank,ceramide transport (GO:0035627),-0.5220530502197385,-1.2857709778163955,0.16467780429594273,0.6835288580746661,1.0,3/12,6.74%,CERT1;PLTP;PLEKHA3
prerank,cellular response to peptide (GO:1901653),0.44284236581407216,1.2838586987011156,0.13630041724617525,0.6670993728491023,1.0,8/56,7.77%,IGF1;GJA1;LRP1;EPHA4;CACNB1;ZFP36L1;SRC;TLR6
prerank,transport across blood-brain barrier (GO:0150104),0.4202893097807295,1.283516357312291,0.12814070351758794,0.6671059236207216,1.0,23/83,12.56%,SLC1A3;SLC24A3;SLC7A2;SLC1A5;LRP1;SLC16A12;ATP1A2;SLC13A3;LEPR;SLC6A9;SLC6A13;SLC44A1;SLC2A10;SLC22A2;SLCO3A1;ATP1B2;SLC2A13;SLC5A3;SLC29A1;ABCC5;SLC5A5;LRP3;INSR
prerank,regulation of neurotransmitter transport (GO:0051588),-0.4801364300387104,-1.2832189252304476,0.16985645933014354,0.6892987230747928,1.0,3/16,1.86%,MEF2C;MCTP1;RIMS1
prerank,water-soluble vitamin metabolic process (GO:0006767),0.42958275025859977,1.2830546232111906,0.15186615186615188,0.6674896501449047,1.0,11/68,8.25%,ENPP1;MMAB;PCCA;NNMT;MTR;PCCB;MTHFR;PDXK;MMUT;CYB5A;ALDH1L1
prerank,GPI anchor biosynthetic process (GO:0006506),-0.3925031253508511,-1.2829399543590774,0.1375,0.6874444805661777,1.0,10/30,18.79%,DPM1;PIGP;PGAP2;PIGB;PIGL;DPM3;PIGU;DPM2;PIGO;PIGV
prerank,negative regulation of mitochondrion organization (GO:0010823),0.488949929440814,1.2827051159000995,0.1582089552238806,0.6675261390911263,1.0,1/33,0.01%,IGF1
prerank,peptidyl-amino acid modification (GO:0018193),0.6061909068337678,1.2822647361007689,0.21972318339100347,0.6678565644705361,1.0,3/10,6.63%,FKBP7;APOA1;TTLL4
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3838235607427448,1.2803611583562695,0.08249721293199554,0.6727581978800375,1.0,36/166,15.03%,POLR2D;RORA;CCN2;TBL1XR1;TEAD1;AR;THRB;YAP1;MAML3;RARB;NOTCH2;POLR1G;RARG;GTF2E1;BRF1;GTF3C1;GTF2H5;NR5A1;WWTR1;NR1D1;RBPJ;NCOR1;KAT2B;POLR2C;TFAM;NR1D2;NCOR2;POLRMT;NR4A1;MNAT1;TEAD3;GTF2E2;TAF9;NRBF2;NR1H3;RXRA
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.47804836370805365,-1.2801511691073282,0.14507772020725387,0.6937850995597291,1.0,4/16,7.65%,PRCP;KLK2;DDAH1;GSK3A
prerank,protein polyglutamylation (GO:0018095),-0.5321348939013388,-1.2800630200043612,0.17164179104477612,0.6914194822257972,1.0,2/11,1.61%,TTLL7;TTLL5
prerank,nucleosome assembly (GO:0006334),-0.4026421999723291,-1.2793491360061635,0.13190184049079753,0.6910828375084065,1.0,17/31,31.98%,NAP1L4;HIRA;NAP1L2;H3-3A;CHAF1A;NAA60;RSF1;HMGB2;NPM1;CABIN1;NASP;ASF1A;HAT1;ASF1B;GRWD1;NAP1L3;NAP1L1
prerank,miRNA metabolic process (GO:0010586),0.5403910673080274,1.278938507633799,0.18166939443535188,0.6763757463382076,1.0,10/20,22.17%,SND1;DDX17;TUT7;PARN;BCDIN3D;TUT4;PRKRA;TENT4B;DICER1;DROSHA
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.530300127143542,1.2788500714368676,0.1996779388083736,0.6755999690568016,1.0,8/20,9.92%,RUNX2;CHD6;MT3;NFE2L2;RBPJ;BMP2;SMAD1;CREB3
prerank,ribosomal small subunit assembly (GO:0000028),-0.4830541941264337,-1.2788302907858273,0.17632241813602015,0.6902331317248447,1.0,7/16,20.17%,RPS14;RPS19;RPS15;RPS5;RPSA;PRKDC;MRPS7
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.4668288590073562,1.2786805789277753,0.16326530612244897,0.6750725300744278,1.0,6/41,13.47%,IGF1;GAS6;IRAK3;CD33;SELENOS;SYT11
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3676947245965462,1.2783257259141843,0.049586776859504134,0.6751206651621628,1.0,46/348,8.91%,IGF1;NRP1;BMP6;IGF2;DDR2;CEMIP;ROCK2;ANGPT1;GHR;PDGFD;LYN;IL6R;LEPR;BMPR1A;IL34;PELI2;CCN1;INHBE;PRKAG2;GAS6;TGFBR1;VTN;CCL19;TWSG1;CSF1;RAPGEF2;MT3;ACVR1;NTF3;AXIN2;MUSK;SLCO3A1;ENG;SRC;LRRK2;ARAF;ALS2;NTRK3;STK4;DAB2;ARRB1;EGFR;CREBL2;RBPMS;BMP2;SPRY2
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.27899947500994465,-1.278160702719898,0.0,0.6898961669421729,1.0,143/306,31.20%,RAD17;RPL41;RPS12;TAF1B;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;WARS1;RPS13;RPL21;RPL7;RPL18;RPL27;B4GALT5;EEF2;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;MRRF;RPL30;RPS23;BAZ2A;PWP1;RPL36;RPLP1;RPS29;RPL37;DBF4;GTPBP1;RPS9;RPS5;ALAS1;RMI1;TOPBP1;ORC4;YARS2;PTMA;RPL4;RPL18A;RAD1;RPL26;RPL6;RPL36A;RPL29;MRPS18A;RPL13A;PAX8;MRPS5;RPL7A;RPL19;FAM111A;TYMS;THAP1;RPS20;INHA;RPL14;EEF1A1;RPL13;EEF1B2;RPL32;MRPS12;RPL5;RPSA;MCM8;HUS1;MRPS33;RPLP0;MRPL55;INHBA;RPS6;RPS6KB2;RPL22;NBN;MRPS18B;POLR2E;MRPL42;MCM3;RPS21;RPL37A;RPLP2;MRPS21;ALAS2;MRPS7;RPL17;RPL23;MRPL34;HELB;DTX1;EIF4EBP2;RPL28;PABPC4;MCM5;RPL31;EEF1A2;ST3GAL4;EXO1;RPS10;HOXD3;E2F1;RPS11;POLR2B;ORC5;RPS27;EEF2K;RHNO1;POLR2J;RPS16;NFKBIB;TOPORS;RPL10;RPL15;SET;RPL12;RPL9;RPS8;DONSON;MRPL28;GRWD1;MEF2A;CDK1;CDC6;PIF1;FEN1;MRPL43;TICRR;MRPS14;POLA1;RPS27A;POLD2;RNPS1;RPL10A;XAB2;TERT;RPS17
prerank,negative regulation of blood pressure (GO:0045776),-0.5047819910962374,-1.2780227246507578,0.17016317016317017,0.6877431078592072,1.0,3/13,6.37%,NOS3;PRCP;NOS1
prerank,prostaglandin metabolic process (GO:0006693),0.5182369294971387,1.2778360312469916,0.17711598746081506,0.6756652616779969,1.0,3/26,5.18%,PTGIS;PTGES;PLA2G4A
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.4174531062471628,-1.2777825194122503,0.13821138211382114,0.6858703639986283,1.0,6/25,7.65%,GRID2;MEF2C;GRIN2A;GLRA1;GRIN2B;GSK3A
prerank,protein localization to plasma membrane (GO:0072659),-0.30257502675993153,-1.277772723071498,0.0189873417721519,0.6833174805244463,1.0,27/129,8.24%,DPP10;KCNB2;KCNIP4;RAP1A;SMURF1;F11R;CDH1;ANK3;BSG;EFR3B;ZDHHC2;CCDC88A;RAMP2;SPTBN1;RDX;LRP6;EMP2;TTC7A;RAB3C;ATP1B1;EHD4;RAB12;GAK;RAB8B;INPP5K;RAB11A;MAP7
prerank,protein O-linked mannosylation (GO:0035269),0.5445317752292278,1.277452954940061,0.18351477449455678,0.6758330969437493,1.0,4/18,5.90%,TMTC1;TMTC4;LARGE1;LARGE2
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.53499756751392,1.277013005626602,0.18858954041204437,0.6761257581824974,1.0,6/19,17.31%,AMPD3;ADK;POLL;CDA;AMPD2;DCK
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5852507327149297,1.2769324234765866,0.20454545454545456,0.67430088080176,1.0,2/12,7.80%,FHL2;RCAN1
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.5852507327149297,1.2769324234765866,0.20454545454545456,0.67430088080176,1.0,2/12,7.80%,FHL2;RCAN1
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.5038068490720853,-1.276898204511019,0.17882352941176471,0.6835392807246082,1.0,5/13,21.43%,PRR5L;GTPBP1;PNPT1;CNOT7;CNOT8
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.4776656915927269,-1.2766447200537876,0.18059299191374664,0.6816850537146069,1.0,8/17,26.80%,COX4I1;COX6A1;COX5B;CYCS;COX5A;COX6C;COX8A;AFG1L
prerank,sulfur compound transport (GO:0072348),-0.41456681209761903,-1.2761297490317063,0.141643059490085,0.6808345865460699,1.0,7/27,9.96%,SLC6A6;ABCG2;SLC26A7;LRRC8D;SLC5A6;SLC25A30;SLC26A6
prerank,negative regulation of cell projection organization (GO:0031345),0.4549716006346642,1.2755306316122286,0.15106951871657753,0.677571561287654,1.0,16/48,15.94%,EPHA4;KANK1;APOE;EFNB2;DPYSL3;RAPGEF2;MT3;PTPRS;DENND5A;LPAR1;PTPN9;SPRY2;GORASP1;PTEN;BAG5;STX1B
prerank,sulfur amino acid metabolic process (GO:0000096),0.5127543280633171,1.2753330574166868,0.2009273570324575,0.6771248841523804,1.0,7/24,13.13%,MTR;MTHFR;DPEP1;MMUT;CDO1;SMS;NOX4
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.4733825900851268,1.2749451621608836,0.17956204379562044,0.6772684219661703,1.0,2/37,0.40%,EPHA3;PHLDB2
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.5816983585790355,1.2749270712719927,0.1950354609929078,0.6762891318217702,1.0,7/14,23.00%,AUTS2;KMT2E;KMT2A;WDR5;DNMT3B;DNMT1;BRCA1
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.46870104687300357,1.2747057834042892,0.1618075801749271,0.6759956197098158,1.0,4/38,7.68%,BMP6;SASH1;DDX60;NMI
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5338321059495664,-1.2744104570635972,0.17016317016317017,0.6838600550370675,1.0,4/12,6.92%,UNC13B;RIMS1;RIMS2;SYT1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6019629435944962,1.2741737632222643,0.21746880570409982,0.6765899966552805,1.0,4/10,7.90%,HECW2;ATP1A2;NEDD4;OSR1
prerank,small GTPase mediated signal transduction (GO:0007264),0.4004455034032466,1.273844946716649,0.11956521739130435,0.6765879579670089,1.0,17/103,9.06%,IGF1;RIN2;KSR1;PLD1;CCNA2;ARHGAP18;TIAM2;RRAS2;RAPGEF2;MRAS;ARHGAP32;ARHGEF18;PLD2;RGL1;NTN1;RUNDC3A;ARFIP2
prerank,secretory granule organization (GO:0033363),0.6174594063340114,1.273432006095276,0.22782608695652173,0.6768421388716063,1.0,3/10,9.56%,ABCA1;DTNBP1;BLOC1S1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.445556153192757,1.273234514632503,0.17832647462277093,0.6764419509861058,1.0,12/48,14.80%,ROBO1;DCST1;GAS6;RFFL;APOA1;IRAK3;STAT2;PARP14;SLIT3;MUL1;CCDC3;NR1H3
prerank,regulation of leukocyte activation (GO:0002694),0.5817467103951035,1.273129759754674,0.18556701030927836,0.6757003476907236,1.0,7/14,22.38%,LYN;MYO18A;CD200;CD33;PJA2;GPR137B;LCK
prerank,membrane repolarization (GO:0086009),-0.48937291363788205,-1.2729081306437544,0.16824644549763032,0.6861495060413773,1.0,5/15,6.82%,KCNJ2;ATP1A1;KCND3;KCNQ1;ATP1B1
prerank,presynaptic endocytosis (GO:0140238),-0.42759443995659185,-1.2717360349299718,0.14634146341463414,0.6877039110125118,1.0,11/24,24.83%,NLGN1;AMPH;OPHN1;CDK5;SYT1;PACSIN1;NLGN3;STX1A;SYNJ1;SYT5;SNCG
prerank,positive regulation of receptor internalization (GO:0002092),0.5146715597006646,1.2716305131496646,0.18789808917197454,0.6793012695659513,1.0,8/22,18.15%,ANGPT1;NTF3;CD63;ARRB1;INSR;EGF;SFRP4;AHI1
prerank,protein localization to cell-cell junction (GO:0150105),-0.47888274053307844,-1.2710576485192928,0.1675531914893617,0.6874277149573658,1.0,6/15,2.91%,MPP7;F11R;ACTB;TJP2;LSR;TJP1
prerank,limb development (GO:0060173),0.49706493147254477,1.270800671029374,0.18931297709923664,0.6808912766853746,1.0,6/28,8.84%,SALL1;GLI3;MAP3K20;ZNRF3;SMOC1;KAT2B
prerank,negative regulation of response to external stimulus (GO:0032102),0.39849559946401736,1.2697116811521014,0.11743341404358354,0.6831260106205713,1.0,25/105,15.05%,PTGIS;RORA;SERPINE1;EPHA4;APOE;APOA1;MVK;PTPRS;CDH5;CASK;MAPKBP1;SIRT2;NMI;NR1D1;DRD3;IRAK3;ITCH;FGF2;TNFAIP6;SELENOS;MUL1;PTEN;NR1H3;CERS2;TNFRSF1A
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.5381115064862503,1.269316279810905,0.20230263157894737,0.6833229903954093,1.0,4/18,8.69%,ADCY1;CAMK1D;CRTC3;CD200
prerank,positive regulation of lipid metabolic process (GO:0045834),0.5115947086919247,1.2692034457323724,0.19334389857369255,0.6826321919782742,1.0,5/22,11.77%,ZBTB20;APOE;APOA1;CREBL2;F2
prerank,anion transmembrane transport (GO:0098656),0.4287585817770658,1.2688280932689917,0.14208389715832206,0.682739815064025,1.0,9/67,6.09%,SLC1A3;SLC7A2;SLC16A12;SLC13A3;SLC13A4;SLC6A9;SLC6A13;SFXN2;SLC35A3
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.585104228486373,1.2679592124258245,0.23426573426573427,0.6843880187897735,1.0,3/11,11.60%,COLEC12;RFTN1;TNIP2
prerank,protein depolymerization (GO:0051261),0.505771803583231,1.2675808784056273,0.18513119533527697,0.6845911193181399,1.0,3/27,2.82%,MICAL3;GSN;NCKAP5
prerank,peptide catabolic process (GO:0043171),0.5273797327232712,1.2675372286531286,0.2208,0.6837044114041948,1.0,5/23,7.93%,CPQ;CHAC2;CTSH;DPEP1;NAALADL1
prerank,protein K48-linked deubiquitination (GO:0071108),-0.4347932658277229,-1.2675095740976905,0.1568627450980392,0.6968194137823847,1.0,7/23,11.50%,OTUD7B;MINDY2;MINDY1;OTUD7A;OTUD4;YOD1;TNFAIP3
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.5137664206414365,-1.266909233768092,0.18,0.696183397341694,1.0,4/13,10.72%,NOS3;GCH1;CALM1;SPR
prerank,neuron projection fasciculation (GO:0106030),0.589202069586889,1.2653650555322056,0.209009009009009,0.6894330906726334,1.0,5/10,11.56%,EPHA4;SEMA5A;ARHGAP35;EPHB2;EPHB3
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.5010142099479582,-1.2652926258104868,0.1986455981941309,0.6989888837268714,1.0,4/12,26.01%,JAM2;APP;AIF1;DOCK8
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.4224586971580876,1.2650791856791228,0.14634146341463414,0.6892769141060792,1.0,12/78,9.04%,EPHA3;PDPK1;PID1;PIK3R1;AR;LRP1;ITGA3;PTPN9;DAB2;EGFR;EPHB2;PICALM
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.5039838300276736,-1.2650742548341476,0.18048780487804877,0.6972373710834856,1.0,8/14,11.74%,PRKAR1A;ATP2B4;PKIB;PRKAR2B;PRKAR1B;PRKAR2A;ADRB2;SIRT1
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.4481851130222776,-1.2650477892701537,0.16954022988505746,0.6947992444646468,1.0,9/20,26.46%,CHRM3;AGRN;GNB1;CHRM2;RGS10;GNA11;CDK5R1;CHRM1;LY6G6D
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.419223780592485,-1.2647012122168677,0.16216216216216217,0.6934132077858612,1.0,7/24,13.91%,PDE4D;CAMK2D;NOS1;AKAP6;CALM1;CALM3;CASQ2
prerank,inhibitory synapse assembly (GO:1904862),-0.5353393215628466,-1.2643599207190974,0.21153846153846154,0.6920336002670943,1.0,4/11,8.12%,GABRA2;GABRB3;GABRG2;GABRB2
prerank,cGMP metabolic process (GO:0046068),-0.5204242388295008,-1.2642597585491042,0.17073170731707318,0.6898994284243993,1.0,5/12,8.35%,GUCY1B1;GUCY1A1;PDE2A;NPR1;PDE9A
prerank,cAMP-mediated signaling (GO:0019933),0.5082057388634532,1.264178874203945,0.1867283950617284,0.6910374053210746,1.0,6/24,6.49%,ADCY1;ADCY2;KSR1;RAPGEF2;PDE3A;PDE7B
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3569308128425766,1.2641261278492943,0.009027081243731194,0.6901997751953949,1.0,157/834,15.86%,IGF1;TCF7L2;TCF4;BMP6;LDB2;AUTS2;NFIA;IGF2;RORA;TBL1XR1;PID1;TEAD1;CDK8;GDNF;PIK3R1;PBX1;SMAD3;ARNT2;AR;ZEB2;MITF;DCN;GLIS3;NKX6-1;SERPINE1;NR2F2;GLI2;RUNX1;SALL1;SP7;OGT;BMPR1A;GLI3;PPP3CA;CCN1;NKX2-1;FGFR2;THRB;NFIB;ASCL1;SSBP3;ZNF462;YAP1;MAML3;RUNX2;MLXIP;RARB;NFIX;MEOX2;CRTC3;RLF;IRF1;RFX5;ACVR1;NEUROD1;NCOA2;KLF15;PHIP;RARG;BRD8;TBX3;EPAS1;HLF;ENG;SKI;BCL9;ATOH8;INO80;SMARCA1;MED14;NR5A1;CEBPA;ATAD2B;NFE2L2;WWTR1;RNF10;SREBF1;SIRT2;DDX17;DR1;ZBTB38;MED16;NR1D1;OSR1;TET1;RBPJ;DAB2;FOXC2;ARRB1;EGFR;RGMA;BMP2;ZMIZ1;KAT2B;STAT5B;MZF1;CCNK;SMAD1;PRKN;GLIS2;CSRP3;ARNT;CREB3L4;CREB3;RNASEL;FOXA1;FGF2;ZSCAN21;NR1D2;DDX3X;CEBPB;RGCC;TNIP2;NKX2-8;TBK1;HDAC8;REST;NR4A1;RHOQ;GLI1;STAT6;ZNF513;RIPK2;MYCN;SMARCD2;NPAS2;HELZ2;NCOA3;KMT2A;CDK12;HDAC4;TAF9;MED19;ARF4;HIVEP1;ETS1;FSTL3;TCF12;TCERG1;AKAP8L;GATA6;NR1H3;BMP4;FUBP3;HOXC4;RXRA;TNFRSF1A;FOXK2;SS18;SMARCB1;BMP5;CAMTA2;MTF1;TFCP2;PIK3R2;POGZ;ZBTB17
prerank,transcription preinitiation complex assembly (GO:0070897),-0.5232331424580215,-1.2636764855511828,0.2075,0.6893209710021639,1.0,7/12,22.93%,TAF1B;TAF1;TBP;GTF2A2;BDP1;POLR1E;GTF2B
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.33993222522171695,-1.2631148438607152,0.0851063829787234,0.6886641782781228,1.0,23/57,21.54%,RPS24;RPS19;RPL7;RIOK1;RPL35A;RPL38;RPS15;RPS7;PAK1IP1;RPL11;METTL17;RPL26;MALSU1;NVL;RPL14;RPL5;RPS6;RRP36;NPM1;NOP16;URB2;RRS1;RPF2
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.4132347914227738,1.262948836953996,0.12296110414052698,0.6929385321803002,1.0,19/87,15.82%,POLR2D;FGFR1;KL;FGFR2;FGFR4;RBFOX2;FRS2;SFRP1;ZFP36L1;FLRT2;HNRNPA1;POLR2C;FGF2;FGFBP1;NR4A1;TIAL1;DSTYK;SPRED1;FIBP
prerank,positive regulation of chemotaxis (GO:0050921),0.4479151904781672,1.2624734685025778,0.16944444444444445,0.6934646318454973,1.0,9/43,10.17%,NRP1;IL6R;PDGFRB;SEMA5A;CCL19;SMOC2;NTRK3;DSCAM;FGF2
prerank,ephrin receptor signaling pathway (GO:0048013),0.41283749367885003,1.2619959790767854,0.1421383647798742,0.693879705655439,1.0,13/82,9.03%,EPHA3;EPHA7;ROCK2;LYN;EPHA4;EPHA8;MMP2;EFNB2;CDC42;SRC;EFNA2;EPHB2;EFNB1
prerank,apical protein localization (GO:0045176),-0.5367283585726097,-1.261645940368298,0.1806930693069307,0.6910338251214798,1.0,3/10,2.24%,ATP8B1;ACTB;MAL
prerank,cellular iron ion homeostasis (GO:0006879),0.43930284995109786,1.261352820955929,0.15696887686062247,0.694877905237367,1.0,7/55,6.50%,BMP6;CP;SCARA5;HEPH;CYBRD1;SLC11A2;ACO1
prerank,positive regulation of protein kinase activity (GO:0045860),0.3888054283569339,1.2611873308395813,0.11199095022624435,0.6944166564912387,1.0,35/148,14.46%,DDR2;NRK;NEDD9;EPHA4;IL6R;IL34;CCN1;PRKAG2;GAS6;CCL19;CSF1;RAPGEF2;NAB2;SRC;PARP16;IL12B;MAP2K1;ALS2;STK4;MAP4K4;ITGB3;TELO2;STK11;TTBK1;MRNIP;TAOK3;DDX3X;ADRA2A;STRADA;DUSP19;INSR;NOX4;MARK2;DLG4;SNX9
prerank,focal adhesion assembly (GO:0048041),0.5151722815357551,1.2609328855990831,0.21779141104294478,0.6941625946873249,1.0,4/21,6.32%,ACTN2;DLC1;RHOD;SRC
prerank,ventricular septum development (GO:0003281),0.4676557854143103,1.260707914853586,0.18838526912181303,0.6937959610884202,1.0,6/37,4.67%,ROBO1;TGFBR3;SALL1;BMPR1A;TGFBR1;ACVR1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.5791454926736646,1.2604898777922586,0.20748299319727892,0.6934937884926462,1.0,6/13,18.64%,APOE;DKK3;BMP2;REST;BMP5;ERLIN1
prerank,acidic amino acid transport (GO:0015800),0.5467267982514875,1.2604818327392453,0.19249592169657423,0.6924904552430752,1.0,3/17,3.80%,SLC1A3;GJA1;SLC6A13
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.3388408824605636,-1.260451140619525,0.07563025210084033,0.6924285751336549,1.0,21/57,22.69%,DLG2;MEF2C;GRIA4;NLGN1;PTK2B;GRIN2A;DLGAP2;LRRC7;GRIN2B;GRIA2;SHANK1;LYNX1;APP;GSG1L;CACNG3;CACNG4;GRIN1;SHISA9;BEGAIN;MINK1;RELN
prerank,negative regulation of T cell differentiation (GO:0045581),0.6084571167197981,1.2604467880070722,0.21042830540037244,0.6915577940192119,1.0,4/10,14.90%,GLI3;IRF1;MDK;BMP4
prerank,regulation of angiogenesis (GO:0045765),0.37843307336368104,1.2599912865942369,0.09748083242059145,0.6919512460844899,1.0,28/192,6.64%,PDPK1;PTGIS;COL4A3;ROCK2;SPARC;GLUL;SASH1;DCN;SERPINE1;HSPG2;RUNX1;SP100;VASH2;ISM1;THBS2;SEMA5A;STIM1;SULF1;ITGB8;SFRP1;CTSH;SMOC2;CYP1B1;CDH5;SERPINF1;ADGRA2;PML;EMILIN1
prerank,inorganic anion transport (GO:0015698),-0.3560221097173784,-1.2594801163605065,0.10431654676258993,0.6932460586134497,1.0,10/53,9.96%,SLC4A10;SLC26A7;CLIC4;ANO1;ANO4;CLIC5;GLRA1;CLIC1;SLC25A30;SLC26A6
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.46870389636141135,1.2593064823850795,0.17478510028653296,0.6929839818569904,1.0,4/35,3.78%,NRP1;PLXNA2;SEMA3D;SEMA5A
prerank,response to hexose (GO:0009746),0.49994733263880076,1.259113855675588,0.18931297709923664,0.6925549437316391,1.0,7/25,16.08%,TCF7L2;SLC30A8;NEUROD1;EIF2B4;SELENOS;EIF2B3;MAFA
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.39795298549255104,-1.2590656373595865,0.1415929203539823,0.6921512790900661,1.0,11/31,15.03%,PPP1R13B;YWHAH;YWHAQ;HIP1R;GSK3A;MAPK8;CASP8;YWHAG;BBC3;BAK1;ZNF205
prerank,negative regulation of RNA splicing (GO:0033119),-0.4480240696503145,-1.2590279275822762,0.17105263157894737,0.6898627152417627,1.0,11/19,30.81%,RPS13;PTBP2;PTBP3;SRSF12;SRSF7;RBMX;C1QBP;SRSF4;PCBP4;U2AF2;RNPS1
prerank,regulation of microtubule-based process (GO:0032886),0.47328115818582484,1.2588120763768713,0.18424962852897475,0.6924292527631069,1.0,5/36,7.73%,EPHA3;PHLDB2;MACF1;PRKAA2;MEMO1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.44594980986756544,1.258675398568793,0.17458100558659218,0.6918813420360678,1.0,8/52,8.62%,EPHA3;PDPK1;PIK3R1;LRP1;ITGA3;PTPN9;EGFR;EPHB2
prerank,negative regulation of macrophage activation (GO:0043031),0.553627578516179,1.2586492815819652,0.20382165605095542,0.6909428953820241,1.0,7/16,17.52%,IL31RA;LDLR;NR1D1;CD200;SYT11;NR1H3;CX3CL1
prerank,regulation of chemotaxis (GO:0050920),0.47660008272467014,1.2583853969132845,0.18545994065281898,0.6907546152207379,1.0,7/30,9.25%,MYCBP2;PDGFRA;EFNB2;PDGFRB;CCL19;ADGRA2;ZSWIM6
prerank,regulation of DNA binding (GO:0051101),0.45501363251552024,1.2575994612028942,0.17379310344827587,0.6922037243785849,1.0,7/44,9.33%,IGF1;SP100;MDFI;SMO;SKI;SIRT2;PRKN
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.4369324963043208,1.2575356558861923,0.16469038208168643,0.6913639360924565,1.0,14/55,15.39%,PID1;PDGFRB;MT3;CYP1B1;AGTR1;SPHK2;SIRT2;PRKN;DCXR;EIF6;F2;NOXO1;ARF4;PIKFYVE
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.4445617525129922,1.2570246748531928,0.16279069767441862,0.6919896682140293,1.0,9/51,9.24%,GREM2;FBN1;BMPR1A;FSTL1;SMURF2;SKI;BMP2;LEMD3;SMAD1
prerank,regulation of Rho protein signal transduction (GO:0035023),0.41567572990183893,1.2569060719899205,0.15584415584415584,0.6913139830216696,1.0,13/72,8.60%,NRP1;ROBO1;ABCA1;DLC1;KANK1;ITGA3;RIPOR2;APOE;APOA1;ARHGEF18;LPAR1;ARHGAP35;ARRB1
prerank,regulation of lymphocyte migration (GO:2000401),-0.5274566398634541,-1.2568001297997058,0.18636363636363637,0.6945884033832911,1.0,3/10,10.46%,JAM2;STK10;MSN
prerank,positive regulation of protein localization to membrane (GO:1905477),0.40606198796923737,1.2558550015815901,0.1251564455569462,0.6936184650954529,1.0,14/98,9.33%,EPHA3;PDPK1;CEMIP;PIK3R1;LRP1;BCL2;ITGA3;PDCD5;MYO1C;PTPN9;EGFR;EPHB2;SLC5A3;PRKN
prerank,regulation of histone methylation (GO:0031060),0.5722940900027893,1.2557554452305268,0.23344947735191637,0.6929217140096452,1.0,5/13,12.73%,NNMT;MTHFR;TET1;NSD1;PAF1
prerank,transcription by RNA polymerase II (GO:0006366),0.3632190923098372,1.2554358753172714,0.05296610169491525,0.6929093193416382,1.0,92/305,21.90%,POLR2D;RORA;CCN2;TBL1XR1;TEAD1;AR;SOX5;GLIS3;PRRX1;MAF;THRB;YAP1;MAML3;HSF2BP;RARB;NOTCH2;NFIX;PHAX;RARG;MLLT3;GTF2E1;GTF2H5;NR5A1;WWTR1;PMF1;SNAPC1;MED16;NR1D1;RBPJ;NCOR1;KAT2B;TRIP11;ZBTB1;CCNK;POLR2C;RPAP2;WDR33;NR1D2;MBD1;NCOR2;INTS4;NKX2-8;TTF2;NR4A1;MNAT1;PAF1;TEAD3;TAF5L;GTF2E2;CDK12;TAF9;NELFE;ELL2;ADRM1;NRBF2;SNAPC5;AFF4;SNAPC4;PCF11;NR1H3;RXRA;TFCP2;COPS2;TFDP1;SP1;GTF2I;TSC22D1;ELOF1;CCNT2;LSM10;CPSF2;CDC73;POLR2L;FIP1L1;TAF2;PAX1;MAML2;GTF2A1;ELP4;DEAF1;NFE2L3;LEO1;TAF8;MLLT1;IRF9;SCAF8;NOCT;ERCC3;MED23;CCNT1;PAPOLA;RPAP1
prerank,regulation of cholesterol esterification (GO:0010872),0.6028777160952666,1.2551082125831827,0.2205128205128205,0.6929263922142435,1.0,3/10,6.91%,APOE;APOA1;AGTR1
prerank,SNARE complex assembly (GO:0035493),-0.5391241507036763,-1.2550084700981377,0.21495327102803738,0.6980113166365095,1.0,2/10,6.64%,STXBP6;VAMP8
prerank,L-glutamate transmembrane transport (GO:0015813),0.6004088512726865,1.254627245402052,0.23893805309734514,0.693456252035398,1.0,1/10,0.18%,SLC1A3
prerank,multivesicular body assembly (GO:0036258),-0.3940853380214235,-1.253871183025126,0.1253731343283582,0.6991896765777174,1.0,16/30,31.51%,RAB11A;PDCD6IP;VPS37B;VPS37A;VPS28;VPS36;VPS4A;CHMP2B;VPS37C;SNF8;CHMP4B;CHMP4A;HGS;MVB12A;CHMP4C;STAM2
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.44463568934109743,1.253624463986619,0.18144611186903137,0.6956382465680917,1.0,5/52,2.75%,EPHA3;PDPK1;PIK3R1;LRP1;ITGA3
prerank,cholesterol efflux (GO:0033344),0.5214667392444801,1.2535626449847967,0.20125786163522014,0.6947941608126492,1.0,3/20,4.31%,ABCA1;APOE;APOA1
prerank,regulation of gene expression (GO:0010468),0.35274882920845757,1.2535598844053664,0.01,0.6938018134249702,1.0,175/903,15.64%,IGF1;NELL1;ROBO1;BMP6;CILP;NFIA;IGF2;RORA;SLC24A3;GJA1;RHOH;ROCK2;ANGPT1;PID1;SLC8A1;GDNF;ATXN1;GSN;SMAD3;ARNT2;RBMS3;AR;C1D;MITF;LYN;RUNX1;WWC2;AFF1;BMPR1A;OLFM1;NOS1AP;SON;NKX2-1;EPHX2;FGFR4;PRDM5;DTNBP1;WNT4;ASCL1;HNRNPLL;ZNF462;YAP1;NUP107;GAS6;APOE;TGFBR1;SMO;WNT6;NOTCH2;SLC2A10;TLE1;PDCD5;OGG1;CSF1;SLC22A2;ZC3H7B;MSC;MT3;IGF2BP2;ITGB8;NCOA2;SFRP1;CTSH;PRKAA2;DENND4A;MUSK;GNB3;SNRNP70;BCL6;CDH5;ENG;CUX2;ZFP36L1;TNRC6B;TCF7;ATOH8;APBB2;NAB2;PML;NR5A1;EMILIN1;IL12B;CEBPA;NFE2L2;CD28;WWTR1;SAP30;REXO4;AFDN;ZBTB38;EIF2AK3;MAP2K1;TLR6;OSR1;WTIP;RBPJ;NTRK3;AFF3;TULP3;TCF7L1;TNRC6A;EPHB2;CREBL2;BMP2;ZBTB4;SPRY2;CCN4;PICALM;NONO;SNX12;MZF1;SMAD1;PRKN;GTF2IRD1;MYADM;NSD1;PARP14;FGF2;ACTR8;ZSCAN21;PHF1;RNF6;TTBK1;NR1D2;RBL2;BRAF;TCEAL1;DDX3X;CEBPB;IFNK;RGCC;DNAJA4;REST;C1QTNF1;TERF2;LRP3;LARP1;HMGN5;INSR;ZNF513;ACVR1B;TRIP4;CCDC3;TMEM119;MYCN;EGF;TAF5L;GLMN;HDAC4;PDCL3;ETS1;ZNF148;SETDB1;ZNF219;HPN;YAF2;TADA3;CLK4;AFF4;BMP4;SFRP4;ERMAP;FUBP3;SUFU;MYCBP;FOXK2;METTL4;CLK3;SAP30L;GPBP1;FADS1;TGFBRAP1;PSPC1;SLC38A2;MYT1
prerank,RNA modification (GO:0009451),0.4347403846336485,1.2532731007541713,0.15670650730411687,0.6936275504065177,1.0,17/54,19.91%,PUS3;ADAT2;NSUN2;FTSJ3;PARN;BCDIN3D;TRMT9B;URM1;NSUN5;NSUN4;ELP5;DTWD1;ALKBH1;METTL3;ANKRD16;TRUB1;METTL1
prerank,iron ion homeostasis (GO:0055072),0.43125634845308963,1.2528274076458517,0.1626984126984127,0.6939658535764044,1.0,8/58,6.50%,BMP6;CP;SCARA5;HEPH;NEO1;CYBRD1;SLC11A2;ACO1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.48820851153599404,-1.2525021863955228,0.21728971962616822,0.7012053928627789,1.0,8/15,19.53%,GRM7;GRM3;GRM5;GRM8;HOMER1;HOMER3;GRM1;DAGLB
prerank,regulation of cation transmembrane transport (GO:1904062),-0.39772844556215897,-1.2515308953252526,0.1834319526627219,0.701917000412618,1.0,8/29,11.81%,DPP10;KCNIP4;KCNAB1;KCNN2;FGF12;ATP2B4;HOMER1;DPP6
prerank,pinocytosis (GO:0006907),0.5927603130255,1.250367566578547,0.2476894639556377,0.7007421422231336,1.0,3/10,7.55%,AHSG;SNX33;CARMIL1
prerank,purine-containing compound catabolic process (GO:0072523),-0.49137205518731464,-1.2500828584556503,0.1925925925925926,0.7046039481248253,1.0,7/13,18.50%,NT5E;NT5C2;NT5C1A;GDA;NT5C;PNP;GPX1
prerank,proteolysis (GO:0006508),0.3675916706039718,1.250036098755597,0.08055853920515575,0.7008176062361802,1.0,49/252,18.27%,CPXM2;ADAMTS12;TRABD2B;ADAM33;ADGRV1;CPQ;OGT;AEBP1;MMP2;MMP19;VASH2;ENDOU;CPXM1;CTSH;CTSF;MMEL1;ADAMTS9;SPRTN;PRSS48;CLPX;ECE2;EEF1AKMT4-ECE2;APEH;ATG4A;HTRA1;LONP2;CAPN7;CLPP;APH1B;CASP7;RSPRY1;CPA2;CLN3;CTSZ;CTSL;SENP6;HPN;THOP1;SUFU;DPP3;CUL7;LONP1;PSEN2;UBE3A;PSMB5;MMP14;ST14;YME1L1;CASP1
prerank,skeletal system morphogenesis (GO:0048705),0.4614333213329766,1.2492839704856926,0.17705382436260622,0.7021856712169373,1.0,14/42,18.21%,CYP26B1;FBN2;FGFR1;FGFR2;PDGFRA;TGFBR1;SKI;DYNC2I1;SFRP4;HOXC4;SPEF2;ANKRD11;HHIP;SOX11
prerank,triglyceride homeostasis (GO:0070328),0.48846343349355303,1.2490894727399007,0.20124804992199688,0.7017540713101601,1.0,3/26,4.31%,RORA;APOE;APOA1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.40737729320998056,1.248891834255134,0.1504315659679408,0.7013222560926773,1.0,19/86,10.51%,BMP6;ZEB2;BMPR1A;CCN1;INHBE;TGFBR1;SLC2A10;TWSG1;SULF1;ACVR1;CDH5;ENG;CRB2;RBPJ;DAB2;RBPMS;BMP2;STK11;BMP15
prerank,smoothened signaling pathway (GO:0007224),0.47409232974486826,1.2488539277382777,0.2054794520547945,0.7004317217977578,1.0,8/32,12.49%,GLI2;GLI3;SMO;B9D1;IFT27;EVC2;PTCH2;GLI1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5308050241818881,1.2483408806085037,0.21731748726655348,0.7010357140655455,1.0,5/17,11.34%,SLC8A1;ATP1A2;CACNA1C;TRPM4;CACNA1G
prerank,positive regulation of RNA metabolic process (GO:0051254),0.44445444359363195,1.2479435691821799,0.1771978021978022,0.7012442477139509,1.0,15/45,15.61%,PIK3R1;HNRNPLL;BUD23;MAP2K1;DXO;EGFR;RBM22;DIMT1;WDR43;NMD3;MYCN;TRMT112;BMP4;DYRK1A;SLC38A2
prerank,carbohydrate biosynthetic process (GO:0016051),0.5142605140635209,1.2469434104403563,0.2078740157480315,0.7031818972980929,1.0,5/21,10.19%,ST6GALNAC5;B3GALT1;ST3GAL3;B4GALT1;ST6GALNAC6
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.49069637723083454,-1.2468504849747546,0.21016166281755197,0.7126494750300888,1.0,7/13,13.91%,PDE4D;CAV1;ANK3;CAMK2D;CALM1;CALM3;CASQ2
prerank,regulation of endocytic recycling (GO:2001135),0.5796032955192921,1.2468080421505934,0.22563176895306858,0.7026360648685765,1.0,2/11,3.63%,ACTN2;ATP9A
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.4832959502645967,-1.2466628065095098,0.18581907090464547,0.7109215547439363,1.0,6/14,16.55%,THBS1;ECSCR;ITGA4;CD40;GPER1;ANO6
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.5397422343375906,-1.2466302390124353,0.20594965675057209,0.7086162347983758,1.0,4/10,11.16%,KDM1A;DISC1;VEGFA;CX3CR1
prerank,extracellular matrix assembly (GO:0085029),0.5091120846631301,1.246427758325041,0.21077654516640254,0.7027667661490963,1.0,5/23,6.88%,MFAP4;FBLN5;GAS6;EMILIN1;LTBP3
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.42428638620208864,1.2459853036061088,0.17639257294429708,0.7031538037739494,1.0,9/59,8.47%,TCF7L2;CDK8;MITF;RUNX2;TNRC6B;MED14;MED8;MED16;TNRC6A
prerank,negative regulation of wound healing (GO:0061045),0.5003508490129757,1.2458777019511535,0.19753086419753085,0.7025129419855588,1.0,6/28,5.86%,PHLDB2;SERPINE1;APOE;VTN;TFPI;CASK
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.4968837816961528,1.2458675105939292,0.22312703583061888,0.7015564131751068,1.0,5/21,14.97%,SAMD4A;TUT7;PARN;TUT4;CNOT3
prerank,homeostasis of number of cells (GO:0048872),-0.5122744661741561,-1.2458409401682582,0.2099056603773585,0.708756158179543,1.0,5/12,14.21%,NOTCH1;NOS3;CCN3;CX3CR1;LPCAT3
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.487104600258094,-1.2454426197102129,0.1925,0.707698950477052,1.0,5/14,11.74%,SEMA7A;PLCG2;CAMK4;GPRC5B;SIRT1
prerank,cellular response to metal ion (GO:0071248),-0.3002897386003942,-1.245191304798394,0.06962025316455696,0.7060818441703947,1.0,22/123,4.62%,DLG2;SLC12A2;MEF2C;CPNE8;CLIC4;NLGN1;CDH1;ANK3;PLCG2;B2M;IQGAP1;CAMK2D;CPNE3;GLRA1;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.4982104070334855,-1.24508261601382,0.23655913978494625,0.7041138423645817,1.0,3/13,6.96%,SLC4A10;GRIK2;SYP
prerank,fat cell differentiation (GO:0045444),0.43317024218568606,1.2448178878953304,0.17857142857142858,0.7037871359884261,1.0,8/57,8.90%,TCF7L2;PID1;OSBPL8;FAM120B;WNT5B;CEBPA;ALOXE3;CBY1
prerank,sensory perception of light stimulus (GO:0050953),0.40590998201920686,1.244812025339115,0.1450189155107188,0.7028129671479082,1.0,8/87,4.53%,COL1A1;ADGRV1;COL11A1;EML2;DHRS3;TULP1;ZIC2;SLC24A1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.3728336726429451,-1.2448013769234743,0.13513513513513514,0.7027510298873691,1.0,13/39,16.19%,EFNA5;ACER2;THBS1;NOTCH1;SPOCK1;ADAM15;FZD4;MYOC;NEXMIF;SPRY4;HOXA7;CORO1C;RASA1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.42010993775716404,1.2444014075405683,0.17815344603381014,0.7031231717824494,1.0,25/62,23.90%,POLR2D;MLLT3;GTF2H5;CCNK;POLR2C;MNAT1;PAF1;CDK12;NELFE;ADRM1;AFF4;ELOF1;CCNT2;CDC73;POLR2L;ELP4;LEO1;MLLT1;ERCC3;CCNT1;NCBP2;CDK7;ERCC2;ELOC;CDK13
prerank,respiratory electron transport chain (GO:0022904),-0.4717266782710765,-1.2440510425776827,0.18993135011441648,0.7027668661784486,1.0,9/14,26.93%,SLC25A13;SLC25A12;PPARGC1A;NDUFA5;SDHB;SLC25A22;ETFRF1;UQCRFS1;GPD2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.4408103838030862,-1.2436868691172904,0.21024258760107817,0.7016764128916241,1.0,7/19,21.81%,HIPK2;SNW1;DDIT4;SIRT1;DYRK2;EP300;MSH2
prerank,regulation of membrane depolarization (GO:0003254),-0.4472071299784882,-1.2435568839969184,0.1642156862745098,0.6997900905929656,1.0,3/18,4.03%,FHL1;NEDD4L;CAMK2D
prerank,regulation of melanin biosynthetic process (GO:0048021),0.5923968525557699,1.2435404437332787,0.2482394366197183,0.7048872571969188,1.0,2/10,4.33%,ZEB2;RAPGEF2
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.5110295376421761,-1.24327545915844,0.19419642857142858,0.6983925229591581,1.0,5/11,10.23%,TBX1;LRP5;CTNNBIP1;TGFBR2;PDGFA
prerank,aortic valve morphogenesis (GO:0003180),0.4821006946949299,1.2427040266571627,0.2073529411764706,0.7064262930967397,1.0,3/30,0.85%,ROBO1;ROCK2;ELN
prerank,regulation of cell adhesion (GO:0030155),0.38105780079734725,1.2424899052378184,0.13411764705882354,0.7061388089802426,1.0,30/129,14.30%,PLXNA2;EPHA7;ROCK2;ANGPT1;LYN;RHOD;TPM1;EPHA4;EPHA8;PPP3CA;RIPOR2;SEMA5A;FBLN1;NUAK1;SRC;IL12B;DSCAM;EPHB2;RSU1;MYADM;ITGAV;MIA3;EPHB3;PLXNC1;SIPA1;DACT2;P4HB;PLXNA1;MDK;PLXNB2
prerank,engulfment of apoptotic cell (GO:0043652),0.5481841369611067,1.2423801046778127,0.21403508771929824,0.7054726169445825,1.0,3/15,6.76%,RHOH;RHOBTB1;RHOBTB2
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.35339667130732294,1.2421824793261478,0.03632694248234107,0.7051080746344687,1.0,109/572,15.03%,TCF7L2;BMP6;LDB2;IGF2;FHL2;TBL1XR1;TRPS1;ATXN1;SMAD3;AR;ZEB2;MITF;GLIS3;NKX6-1;NR2F2;DACT1;GLI2;RUNX1;WWC2;SALL1;KCNIP3;CBX7;GLI3;AEBP1;ARID5B;ZEB1;NKX2-1;FGFR2;THRB;PRDM5;SP100;MDFI;FOXP2;NFIB;ASCL1;YAP1;DNMT3A;JDP2;RARB;NFIX;MXI1;NEDD4;SMURF2;ZHX2;RARG;ETV6;TBX3;BCL6;CUX2;SKI;BCOR;CPEB3;MBD2;SAP30;SIRT2;DR1;NR1D1;OSR1;MTA2;RBPJ;DAB2;FOXC2;NCOR1;MTA3;BMP2;JAZF1;ZBTB4;BRMS1L;ZBTB1;MZF1;PRKN;GTF2IRD1;HEXIM2;GLIS2;NSD1;IFI27;ZKSCAN3;CXXC5;NR1D2;NCOR2;ZNF177;CEBPB;BHLHE41;SPDEF;HDAC8;REST;PER3;IMPACT;TCF25;PHF21A;PEX2;PAF1;USP9X;IGBP1;HDAC4;HIVEP1;FRK;ZNF148;ZNF219;TCERG1;HSBP1;GATA6;NR1H3;BMP4;SUDS3;UBE2D1;ZNF25;SUFU;RXRA
prerank,positive regulation of vasculature development (GO:1904018),0.39461481986633906,1.2415377213761363,0.16992665036674817,0.7061581010001458,1.0,13/94,5.69%,PDPK1;PTGIS;SASH1;SERPINE1;RUNX1;VASH2;SEMA5A;STIM1;ITGB8;CTSH;SMOC2;CYP1B1;CDH5
prerank,phasic smooth muscle contraction (GO:0014821),0.5874501924188937,1.2414908225915482,0.23992994746059546,0.7053240303690821,1.0,1/10,1.17%,GDNF
prerank,DNA biosynthetic process (GO:0071897),-0.4539632932712749,-1.2414648181548449,0.21553884711779447,0.7020123965795131,1.0,9/16,31.18%,PPIA;POLH;SIRT1;TYMS;POLD4;WRNIP1;POLA1;POLD2;TERT
prerank,meiosis I (GO:0007127),0.4975521063561284,1.2414139615976685,0.2222222222222222,0.7045683203989294,1.0,8/23,17.51%,HSF2BP;BCL2L11;ZSCAN21;SYCP3;SGO1;MYBL1;FOXJ3;DDX4
prerank,phospholipid catabolic process (GO:0009395),-0.41924486636570996,-1.2403829741172918,0.1710914454277286,0.7031758375989766,1.0,9/24,26.89%,GPCPD1;ENPP2;PLA2G4C;SMPDL3A;PNPLA6;PLA2G4F;PLA2G4E;GDPD1;PLA2G4B
prerank,microtubule-based transport (GO:0099111),0.5612656676101523,1.2395759210029194,0.25945017182130586,0.7093764861157014,1.0,6/12,19.56%,CCDC40;DYNC1I2;CABYR;SPEF2;HTT;ROPN1L
prerank,neuron development (GO:0048666),-0.29265638249053855,-1.239497615546327,0.035398230088495575,0.7036271931888051,1.0,33/141,9.28%,FRY;CNTNAP2;MEF2C;GPM6A;MAP2;PBX3;NLGN1;PPP1R9A;TENM2;ETV1;TENM3;GPM6B;PPT1;TENM4;STX3;TGFB2;SH3GL2;MYT1L;CNTN4;B4GALT5;MYOC;OPHN1;VSX1;CDK5;EPHA5;TMEM108;RP1;RAB11A;RASGRF1;ULK1;ALK;ARL3;BTG2
prerank,cellular amino acid catabolic process (GO:0009063),0.4064248229179739,1.2393221936530283,0.1564039408866995,0.7091944312390249,1.0,14/87,8.30%,GLUL;IVD;ABAT;HMGCLL1;BCKDHB;PHYKPL;TDO2;DDO;HOGA1;ASPA;HNMT;KYNU;DBT;ALDH7A1
prerank,regulation of postsynapse organization (GO:0099175),-0.39431529435255896,-1.2392221050362304,0.17543859649122806,0.7022478216909609,1.0,13/28,12.38%,SHANK3;PPFIA2;ARHGAP44;IL1RAPL1;SIPA1L1;SRCIN1;CDK5;TANC2;ABHD17B;ZDHHC15;KIF1A;HOMER1;ABI3
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.41005969589612173,-1.2391120805269553,0.17534246575342466,0.7003273017615683,1.0,15/25,27.10%,PDE4D;PDE4B;PLCG2;SPTBN1;RPS3;CD80;PTPRC;PNP;CD86;ANXA1;TRAF2;MAP3K7;MALT1;CARD11;TRAF6
prerank,protein deacetylation (GO:0006476),0.45363816114106037,1.2390089567943818,0.19400855920114124,0.7092428695133154,1.0,10/41,14.91%,TBL1XR1;PRDM5;MIDEAS;SIRT2;MTA2;MTA3;BRMS1L;HDAC4;FLNA;SUDS3
prerank,negative regulation of ossification (GO:0030279),0.5017436109767252,1.2389699268746086,0.21461897356143078,0.7083878912962372,1.0,6/23,9.41%,ENPP1;AHSG;SFRP1;BCOR;RBPJ;TRPM4
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.4320435097438776,-1.238134660004417,0.1702127659574468,0.7011666035725587,1.0,6/21,15.93%,PRKCH;SLC39A10;RPS3;FOXP1;CD81;PTPRC
prerank,cellular response to insulin stimulus (GO:0032869),0.38589069444266516,1.2377761928959352,0.1417142857142857,0.7110483202961895,1.0,14/124,8.84%,ATP6V0A4;PDPK1;IGF2;ENPP1;TBC1D4;PIK3R1;INSIG2;PHIP;CPEB1;ZFP36L1;TRARG1;FOXC2;ZNF106;KAT2B
prerank,positive regulation of monooxygenase activity (GO:0032770),0.4948745758854389,1.2376527178705468,0.2089783281733746,0.7104278360367918,1.0,4/26,3.68%,GDNF;NOS1AP;APOE;NPR3
prerank,second-messenger-mediated signaling (GO:0019932),0.4027692031753473,1.237400196846213,0.14705882352941177,0.7102651123386083,1.0,14/82,7.80%,RCAN2;PDPK1;XCR1;APOE;MCTP2;INPP5A;MCU;NEUROD1;ACKR2;CCR9;LRRK2;AGTR1;EIF2AK3;RCAN1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5550770775487819,1.2373152824276836,0.25925925925925924,0.7095652366717196,1.0,5/15,8.05%,UST;DCN;BGN;DSE;CSPG5
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.38180454325370206,-1.2373152109350436,0.153125,0.7015968743438599,1.0,13/31,12.38%,SHANK3;PPFIA2;NLGN1;ARHGAP44;SIPA1L1;SRCIN1;CDK5;NGEF;TANC2;LRP8;ZDHHC15;KIF1A;ABI3
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.45163256863801526,-1.2373084384403106,0.21065989847715735,0.6993841561448864,1.0,6/18,8.29%,RAP1A;NLGN1;RIMS1;RIMS2;RAP1B;SLC4A8
prerank,positive regulation of DNA metabolic process (GO:0051054),0.42200315859531917,1.237299588344348,0.18823529411764706,0.7086405753124375,1.0,14/61,14.38%,EYA2;EYA1;FGFR4;PDGFRB;SMOC2;PML;EGFR;FGF2;PPP1R10;RGCC;ERCC8;USP9X;NPAS2;RTEL1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.4571857441979506,1.2368072595416584,0.22065063649222066,0.7091962664705189,1.0,13/39,13.64%,ERRFI1;AREG;TGFA;EPGN;CDC42;EPS15;EGFR;SPRY2;HBEGF;EPS15L1;PTPN3;EGF;MVP
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.4446966480416562,1.2366455919367776,0.20081411126187246,0.7087420680735851,1.0,12/45,11.27%,PDPK1;PIK3R1;AREG;TGFA;EPGN;PIGR;SRC;SLC30A10;AAMP;EGFR;BRAF;HBEGF
prerank,response to UV-B (GO:0010224),0.5789696514119814,1.23660367287332,0.24046434494195687,0.7078901923710424,1.0,3/12,9.87%,MFAP4;IL12B;STK11
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4059281569186726,1.2362701147756114,0.1707920792079208,0.7079369826528504,1.0,15/80,12.17%,EPHA7;UACA;DAPK1;SH3RF1;GAS6;PDCD5;MT3;USP47;SRC;DPEP1;BCAP31;CARD9;DDX3X;REST;YWHAE
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3530886532179789,1.2361443365221205,0.047474747474747475,0.7073620340125275,1.0,102/476,16.78%,IGF1;TCF4;COL1A1;RORA;TBL1XR1;TEAD1;SMAD3;ARNT2;AR;MITF;IL31RA;NR2F2;GLI2;RUNX1;SALL1;ZIC1;GLI3;NKX2-1;FZD2;SP100;WNT4;NFIB;YAP1;APOE;RUNX2;TGFBR1;LBH;RLF;IRF1;ZIC2;MT3;ACVR1;NEUROD1;CREB3L2;FZD1;PHIP;MLLT3;SFRP1;ARID1B;ATXN7L3;ATOH8;SMARCA1;PML;MED14;ING5;RNF10;SMARCC2;MAP2K1;MED16;NR1D1;RAI1;FOXC2;EGFR;ARHGEF11;CREBL2;BMP2;ZMIZ1;PICALM;BICRAL;GLIS2;NSD1;ZKSCAN3;FGF2;TFAM;RNF6;NR1D2;CEBPB;NFE2;REST;NIBAN2;GLI1;HMGN5;BTRC;ZNF318;TRIP4;MYCN;NPAS2;EGF;KMT2E;KMT2A;HDAC4;ETS1;YAF2;TADA3;GATA6;NR1H3;PHF8;BMP4;FUBP3;RXRA;FOXK2;CDKN1C;DYRK1A;DYRK1B;AKT1;CREB5;ZNF423;PCBD2;RHOG;ATF5;SHH;SP1
prerank,ventricular septum morphogenesis (GO:0060412),0.48052062553204145,1.2355877756847713,0.22529069767441862,0.7081364011633653,1.0,5/27,4.67%,ROBO1;TGFBR3;BMPR1A;TGFBR1;ACVR1
prerank,negative regulation of hemostasis (GO:1900047),0.5782716894336453,1.2351457582999348,0.22996515679442509,0.7085036481747397,1.0,4/12,5.44%,SERPINE1;APOE;VTN;TFPI
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.5661172733558258,1.2349304941879393,0.23792486583184258,0.7082246784817156,1.0,1/12,0.46%,IGF2
prerank,negative regulation of cell activation (GO:0050866),0.5620538118532399,1.2345686669140519,0.22532894736842105,0.7083380182357966,1.0,8/14,12.07%,PDGFRA;APOE;LDLR;EMILIN1;NR1D1;CD200;F2;C1QTNF1
prerank,cellular response to mechanical stimulus (GO:0071260),-0.36251052619273144,-1.234476625483086,0.14122137404580154,0.7064139900613678,1.0,11/46,14.60%,PIEZO2;F11R;PIEZO1;CRADD;MAP3K1;PDE2A;MAPK8;CASP8;CD40;MAPK3;BAK1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.5706683119236544,1.2341918582476332,0.233387358184765,0.7084922116295401,1.0,2/12,2.59%,CCDC68;NINL
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.434601653937031,1.233476561605053,0.1906779661016949,0.7096914192377091,1.0,5/47,6.83%,PTGIS;ROCK2;WNT4;RAPGEF2;SIK1
prerank,protein mono-ADP-ribosylation (GO:0140289),0.5801636558899288,1.2332718620270444,0.24817518248175183,0.709393196191658,1.0,7/11,29.34%,PARP11;PARP16;PARP14;PARP12;PARP10;PARP9;PARP6
prerank,leukocyte tethering or rolling (GO:0050901),-0.4599076979453644,-1.23230831499471,0.2248062015503876,0.7110956620363431,1.0,7/17,24.57%,JAM2;ITGA4;CX3CR1;ROCK1;VCAM1;SELP;ITGB7
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.3796699328010537,-1.2319399817166685,0.1705685618729097,0.7101033687470929,1.0,10/33,11.48%,MEF2C;THBS1;NOTCH1;ACVRL1;MECP2;ATP2B4;JUP;VASH1;KLF4;TGFB1
prerank,heart trabecula morphogenesis (GO:0061384),0.536996463422977,1.231448701996791,0.23657718120805368,0.7139221326812414,1.0,6/18,8.14%,RBP4;TGFBR3;BMPR1A;TGFBR1;ENG;RBPJ
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.4945418615444564,1.2312919305229417,0.234472049689441,0.7134266059909381,1.0,2/24,3.59%,EPHA7;NUPR1
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.5428457602718743,1.2312097426701207,0.22705314009661837,0.7117454523867395,1.0,4/16,6.32%,PHLDB2;ARHGAP6;DLC1;SRC
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.5428457602718743,1.2312097426701207,0.22705314009661837,0.7117454523867395,1.0,4/16,6.32%,PHLDB2;ARHGAP6;DLC1;SRC
prerank,RNA metabolic process (GO:0016070),0.3855357147195088,1.2311567143502224,0.13748531139835488,0.710959903182607,1.0,41/127,22.42%,POLR2D;CELF2;RBMS1;ATXN1;RBFOX2;SND1;DDX17;RBMS2;HNRNPR;RBPMS;METTL14;HNRNPA1;POLR2C;RNASEL;PARN;DDX3X;WTAP;EXOSC7;MTREX;RBM39;RBM5;RBM6;RNASEH2C;LSM8;SYNCRIP;HNRNPC;PAPOLG;ALKBH1;METTL3;POLR2L;DICER1;FTO;HNRNPU;AGO4;HNRNPH1;DDX24;PAPOLA;RBM4;SIDT2;DROSHA;NCBP2
prerank,response to axon injury (GO:0048678),0.5191947062086033,1.2311212102251736,0.21690590111642744,0.7100990900051047,1.0,3/18,4.35%,NREP;DPYSL3;MTR
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.5144034992745262,1.2309857423738624,0.21474358974358973,0.7095618330150127,1.0,9/20,14.90%,TGFBR3;OLFM1;TGFBR1;TBX3;ENG;RBPJ;BMP2;PDCD4;BMP4
prerank,negative regulation of cellular component movement (GO:0051271),0.5372167032707458,1.2308038473865557,0.2435064935064935,0.7091315988072288,1.0,3/15,4.30%,TGFBR3;SP100;FBLN1
prerank,cellular response to lipid (GO:0071396),0.3690852967547052,1.2298947708131218,0.1277533039647577,0.7110250584692314,1.0,20/191,7.79%,EPHA3;RORA;ADCY1;ROCK2;PID1;ADCY2;AR;SERPINE1;LYN;ATP1A2;ADCY5;WNT8B;WNT6;AXL;SFRP1;PTK7;TFPI;WNT5B;SPHK2;NR1D1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.47475455071941863,1.2294649972732403,0.2147239263803681,0.711359522472093,1.0,4/27,4.20%,SLC1A3;SLC7A2;SLC6A9;SLC22A2
prerank,T cell migration (GO:0072678),-0.4838168412029373,-1.2290641151730342,0.2025,0.7170454005247617,1.0,4/13,14.25%,SLC12A2;S1PR1;MSN;GPR183
prerank,T cell mediated immunity (GO:0002456),-0.4941629135529352,-1.2288548234798908,0.22195704057279236,0.7154526573843939,1.0,3/13,6.57%,CADM1;EMP2;CD55
prerank,regulation of potassium ion transport (GO:0043266),-0.3880681585100827,-1.2287595093122607,0.1880597014925373,0.7135843707514113,1.0,8/31,6.37%,DPP10;FHL1;KCNIP4;PTK2B;ANK3;KCNAB1;KCNN2;NOS1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.5664341901759741,1.228478669021485,0.23938879456706283,0.7134445312278324,1.0,3/12,10.91%,AKR1B1;STAR;TSPO
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.3837952088481741,-1.2282051967473009,0.20134228187919462,0.7131992122483054,1.0,10/32,21.81%,PPP1R13B;HIPK2;SNW1;DDIT4;SIRT1;DYRK2;EP300;FHIT;DDX5;MSH2
prerank,regulation of cellular pH (GO:0030641),-0.4001865505523448,-1.2281773021330857,0.20382165605095542,0.7110658033000575,1.0,6/29,9.96%,SLC4A10;SLC9A2;SLC9A6;SLC4A8;SLC9A7;SLC26A6
prerank,regulation of cellular response to heat (GO:1900034),-0.31697636434742815,-1.227900866890003,0.10714285714285714,0.7096918375062068,1.0,30/77,25.01%,CD34;NUP93;HSPA8;NUP35;CAMK2D;NUP153;NUP160;HSP90AB1;NUP54;BAG4;CAMK2G;SIRT1;MTOR;DNAJB6;MAPK3;SEC13;NUP155;EP300;HIKESHI;RANBP2;NUP88;HSPH1;NUP62;AKT1S1;GSK3B;NUP85;MAPK1;DNAJB1;CCAR2;NUP43
prerank,muscle organ development (GO:0007517),0.43245174493653965,1.2277547001103915,0.18723994452149792,0.7146864767928071,1.0,13/54,14.37%,IGF1;LAMA2;ITGA11;VAMP5;LARGE1;MRAS;SMTN;CHD2;HBEGF;SGCE;COL6A3;CHODL;TCF12
prerank,histone H3-K36 demethylation (GO:0070544),0.5858872383295284,1.227500390193783,0.2690166975881262,0.7144983823655207,1.0,5/10,21.13%,KDM7A;PHF8;RIOX1;KDM4A;KDM4C
prerank,regulation of cell-cell adhesion (GO:0022407),-0.3573533989519847,-1.227230675727144,0.1793103448275862,0.7095892341571455,1.0,6/39,2.61%,PTPRG;EFNA5;PODXL;CDH1;ZDHHC2;TENM3
prerank,positive regulation of B cell proliferation (GO:0030890),-0.39381922055420127,-1.2272288676257985,0.18911174785100288,0.7074118636431378,1.0,10/29,17.03%,MEF2C;VAV3;CD38;TFRC;NFATC2;CD40;CD81;GPR183;PTPRC;CD320
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3245569255504723,-1.2265962298721074,0.11320754716981132,0.7070694344373867,1.0,24/75,18.55%,MEF2C;MAP2;ACTB;ANK3;NRCAM;KLF7;CNTN4;NTNG1;BTBD3;OPHN1;CDK5;DCDC2;MFSD2A;NEFH;DCC;APBB1;LMTK2;APP;MAP1B;RAB3A;SHTN1;UNK;DVL1;BRSK2
prerank,regulation of filopodium assembly (GO:0051489),0.4426786983306313,1.2256205720400308,0.2094017094017094,0.7193535140014514,1.0,8/38,8.38%,NRP1;PIK3R1;MYO10;DOCK11;RIPOR2;DPYSL3;CDC42;CAPZB
prerank,regulation of response to interferon-gamma (GO:0060330),-0.4744886640528474,-1.225398830466365,0.2293144208037825,0.7086699445070864,1.0,4/14,14.62%,PTPN2;HSP90AB1;JAK2;CDC37
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.46926596426534484,1.225371293331088,0.21601208459214502,0.7191570615279104,1.0,3/32,5.73%,PDPK1;CEMIP;GSTM2
prerank,cellular modified amino acid catabolic process (GO:0042219),0.5529293038731478,1.2247770370257791,0.2469352014010508,0.7200487117736117,1.0,5/15,11.59%,GGACT;CHAC2;HOGA1;DPEP1;SARDH
prerank,positive regulation of cellular process (GO:0048522),0.34651065647522117,1.2241386205617384,0.055499495459132187,0.7210784596667724,1.0,70/565,8.17%,IGF1;BMP6;IGF2;ESM1;CCN2;CAMK1D;GDNF;COLEC12;PDGFD;AR;AREG;LRP1;AHSG;TGFA;IL31RA;LYN;BCL2;GRK5;RHOD;TPM1;FGFR1;EPHA4;IL6R;IL34;OSMR;TULP1;PPP3CA;EPGN;FGFR2;FGFR4;GAS6;PDGFRA;EFNB2;PDGFRB;TGFBR1;NUPR1;CSF1;APOA1;MT3;NEUROD4;NTF3;NEUROD1;HTR1A;AXIN2;PHIP;SFRP1;CTSH;SLC30A2;PRKAA2;PDPN;CXCL16;TBX3;VIP;DYNC1H1;USP47;ZFP36L1;CDC42;INO80;SMC5;IL12B;TSLP;WWTR1;RNF10;RAB25;IL13RA1;SIRT2;IL15RA;PPP1R13L;TET1;NTRK3
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.5469566921855367,1.2226867126926884,0.2411467116357504,0.7246770235292967,1.0,5/14,5.13%,LRP1;SERPINE1;TPM1;BMPR1A;IGFBP5
prerank,regulation of lipid metabolic process (GO:0019216),0.40185304217244755,1.2223086771609646,0.18214716525934863,0.7248948424401802,1.0,27/88,20.06%,RORA;TBL1XR1;FGFR4;PRKAG2;C1QTNF2;CHD9;NCOA2;MVK;GNB3;SREBF1;NR1D1;NCOR1;IDI1;NR1D2;NCOR2;CCDC3;HELZ2;FASN;CERS2;RXRA;HMGCS1;SP1;CARM1;NCOA6;SCD;ABCA7;PSAP
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5140490168167424,1.2221704225569427,0.24058919803600654,0.7243872912420131,1.0,6/20,15.27%,TGFBR1;EPAS1;ZMIZ1;PRKN;ITCH;DCUN1D2
prerank,smooth muscle tissue development (GO:0048745),0.5878680276063253,1.2217787166392717,0.26545454545454544,0.7246634650820123,1.0,6/10,18.99%,MYLK;SMO;ENG;BMP4;SHH;EFEMP2
prerank,protein destabilization (GO:0031648),0.4629392787116307,1.2204665400280548,0.21609538002980627,0.727621875744736,1.0,10/32,13.03%,GSN;CTSH;DERL1;FBXL3;NR1D1;RNF139;PRKN;BTRC;PEX2;MUL1
prerank,positive regulation of synaptic transmission (GO:0050806),-0.3171761117702348,-1.22031498813157,0.13023255813953488,0.7227236446709693,1.0,25/72,17.32%,SHANK3;SLC24A2;NLGN1;PTK2B;RIMS1;ZDHHC2;GRIK2;TSHZ3;GRIN2A;NRXN1;RIMS2;GRIN2B;SYT1;CLSTN2;CLSTN3;ADCY8;PRKCZ;LGMN;APP;NLGN3;GPER1;LGI1;CACNG3;CACNG4;MPP2
prerank,positive regulation of vascular permeability (GO:0043117),0.5595858673565465,1.2200621114895356,0.2470389170896785,0.7279966079849786,1.0,4/12,7.31%,BMP6;ANGPT1;PDE3A;TJP3
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.526844805646222,-1.2200073250316947,0.23094170403587444,0.7215165495960578,1.0,3/10,10.26%,PODXL;PIEZO1;SKAP1
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.5139521901209748,1.2199394338011411,0.22402597402597402,0.7274359661518618,1.0,3/18,2.21%,CAMK1D;LYN;IL6R
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.49731506408546744,-1.2199129495759216,0.23821339950372208,0.7196187631976659,1.0,5/11,10.46%,RDX;MTMR2;SORL1;RAB21;MSN
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.47782970158707583,-1.2194993444598687,0.2222222222222222,0.7186632444242899,1.0,4/13,4.38%,NR3C2;ESR1;ABHD2;MED1
prerank,steroid catabolic process (GO:0006706),-0.5215369653412436,-1.2191487658321603,0.25,0.7176490782093351,1.0,5/10,28.48%,YWHAH;SPP1;HSD11B1;HSD17B11;HSD17B14
prerank,negative regulation of cell division (GO:0051782),0.5823626057338744,1.2190310089905383,0.2598684210526316,0.7292937763902565,1.0,1/11,1.01%,TXNIP
prerank,regulation of ossification (GO:0030278),0.4515640944993877,1.2185613678865062,0.23597122302158274,0.7297878022578939,1.0,8/36,8.76%,DDR2;ENPP1;AHSG;ANKH;ACVR1;SFRP1;RBPJ;BMP2
prerank,positive regulation of stem cell proliferation (GO:2000648),0.5256646359969235,1.2180511891647625,0.24675324675324675,0.7303914388053192,1.0,2/17,6.88%,GJA1;LTBP3
prerank,ncRNA transcription (GO:0098781),0.5469693189672274,1.2178826737086244,0.26621160409556316,0.7299584923107189,1.0,5/13,9.77%,POLR1G;BRF1;GTF3C1;USPL1;RPAP2
prerank,cellular response to hexose stimulus (GO:0071331),0.49357992749999835,1.2174083206153166,0.24508320726172467,0.7303917920029742,1.0,3/23,5.20%,ZBTB20;GAS6;PRKAA2
prerank,negative regulation of defense response (GO:0031348),0.3988159084943369,1.217133658314481,0.1625,0.7302440227822601,1.0,17/77,15.05%,PTGIS;RORA;APOE;APOA1;MVK;CDH5;MAPKBP1;SIRT2;NMI;NR1D1;IRAK3;ITCH;TNFAIP6;SELENOS;MUL1;NR1H3;TNFRSF1A
prerank,purine nucleotide metabolic process (GO:0006163),-0.4076540971886241,-1.2170339604392706,0.19825072886297376,0.7221280543690941,1.0,9/24,19.04%,NT5E;NT5C2;PRPS2;NT5C1A;GDA;NT5C;PNP;GPX1;FHIT
prerank,epithelial cell-cell adhesion (GO:0090136),0.5723140649458967,1.216787687011105,0.2597173144876325,0.7303356687019193,1.0,4/11,6.80%,PLEKHA7;KIT;ITGB5;VCL
prerank,post-translational protein modification (GO:0043687),0.35038416121836424,1.2167486466723112,0.09841269841269841,0.7294905484517926,1.0,83/332,20.65%,LTBP1;CP;FBN1;SPSB1;MATN3;AHSG;PRKCSH;IGFBP4;OBSL1;CCN1;LAMC1;GAS6;APOE;FSTL1;FBXL19;CSF1;APOA1;APLP2;PSME4;SERPIND1;IGFBP5;EPAS1;CST3;TNC;CUL4B;STT3A;CUL5;FBXL3;RCN1;DNAJC3;COMMD1;FN3KRP;MIA3;RBBP7;ASB12;BMP15;IGFBP3;PDIA6;FBXO9;FBXO11;KBTBD7;DCAF8;ERCC8;FBXO4;FBXL12;FEM1C;ITIH2;GPS1;BTRC;COPS3;P4HB;FSTL3;ASB6;WDR5;BMP4;ASB1;SENP8;MELTF;CUL7;KTN1;COPS2;HRC;KCTD7;PSMB5;LAMB2;PSMC2;CALU;CKAP4;FN3K;PSMD1;RABGGTA;ASB13;PSMD4;MXRA8;PRSS23;PSME3;FBXL18;FEM1B;HIF3A;DCAF11;DCAF6;RBBP5;PSMA3
prerank,regulation of T cell differentiation (GO:0045580),0.45773485349737597,1.2165047447842567,0.22832369942196531,0.7292803278139676,1.0,5/33,9.17%,RHOH;RUNX1;TCF7;ZMIZ1;ZBTB1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.5211834791981733,1.2163721647957497,0.23509933774834438,0.7287553541054571,1.0,5/17,5.86%,ITGA3;FSTL1;TWSG1;SULF1;CASK
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3429942643705405,1.2162184560305556,0.013013013013013013,0.7282683180670767,1.0,235/1082,18.30%,IGF1;TCF7L2;TCF4;BMP6;LDB2;AUTS2;NFIA;IGF2;COL1A1;RORA;TBL1XR1;PID1;TEAD1;CDK8;GDNF;PIK3R1;PBX1;SMAD3;ARNT2;AR;ZEB2;MITF;DCN;GLIS3;NKX6-1;IL31RA;SERPINE1;NR2F2;GLI2;RUNX1;SALL1;ZIC1;SP7;OGT;BMPR1A;GLI3;PPP3CA;CCN1;NKX2-1;FZD2;FGFR2;THRB;SP100;WNT4;NFIB;ASCL1;SSBP3;ZNF462;YAP1;MAML3;APOE;RUNX2;TGFBR1;MLXIP;RARB;LBH;NFIX;MEOX2;CRTC3;RLF;IRF1;ZIC2;MT3;RFX5;ACVR1;NEUROD1;CREB3L2;NCOA2;FZD1;KLF15;PHIP;RARG;MLLT3;SFRP1;ARID1B;BRD8;ATXN7L3;TBX3;EPAS1;HLF;ENG;SKI;BCL9;ATOH8;INO80;SMARCA1;PML;MED14;NR5A1;CEBPA;ING5;ATAD2B;NFE2L2;WWTR1;RNF10;SREBF1;SIRT2;DDX17;DR1;ZBTB38;EIF2AK3;SMARCC2;MAP2K1;MED16;NR1D1;RAI1;OSR1;TET1;RBPJ;DAB2;FOXC2;ARRB1;EGFR;RGMA;ARHGEF11;CREBL2;BMP2;ZMIZ1;KAT2B;STAT5B;PICALM;BICRAL;MZF1;CCNK;SMAD1;PRKN;GLIS2;CSRP3;NSD1;ARNT;CREB3L4;CREB3;RNASEL;FOXA1;ZKSCAN3;FGF2;ZSCAN21;TFAM;RNF6;NR1D2;DDX3X;CEBPB;NFE2;RGCC;TNIP2;NKX2-8;TBK1;HDAC8;REST;NR4A1;RHOQ;WDR43;NIBAN2;GLI1;HMGN5;STAT6;ZNF513;BTRC;RIPK2;ZNF318;TRIP4;MYCN;SMARCD2;NPAS2;EGF;KMT2E;HELZ2;NCOA3;KMT2A;HDAC4;TAF9;MED19;ARF4;HIVEP1;ETS1;FSTL3;TCF12;YAF2;TCERG1;TADA3;AKAP8L;GATA6;NR1H3;PHF8;BMP4;FUBP3;HOXC4;RXRA;TNFRSF1A;FOXK2;SS18;CDKN1C;DYRK1A;SMARCB1;BMP5;CAMTA2;MTF1;TFCP2;DYRK1B;PIK3R2;POGZ;ZBTB17;NCOA7;AKT1;CREB5;PLAG1;ZNF423;PCBD2;RHOG;ATF5;SHH;TFDP1;SP1;LIF;MYBL1;PRPF6;EFCAB7;IRF2;ABHD14B;FOXJ3;ATM;CX3CL1;TNIP1;ELOF1;ELF1;CCNT2;KAT5;FOXO3;IL18;AHI1;NFIL3;RFXANK;SOX11;WAC;TRIM45
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.5542034515055652,1.2161196965137893,0.2594594594594595,0.7276220313765474,1.0,1/13,0.46%,IGF2
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.5073750045319773,1.2160263939826894,0.25980392156862747,0.726937005787374,1.0,4/18,6.87%,IL6R;YAP1;SRC;CEBPA
prerank,in utero embryonic development (GO:0001701),0.48981153302454533,1.2152469475717667,0.2171875,0.7283557626146985,1.0,5/25,5.01%,IGF2;ARNT2;FGFR2;TGFBR1;LIG4
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.45724126358696726,-1.2149080927190923,0.22084367245657568,0.7269875971306627,1.0,4/14,10.00%,YBX3;ANGEL2;ELAVL4;ELAVL1
prerank,response to muscle stretch (GO:0035994),0.53290252596886,1.2145577504390144,0.23255813953488372,0.729401711712632,1.0,2/15,1.20%,SLC8A1;GSN
prerank,relaxation of muscle (GO:0090075),0.553943580134421,1.214008109936659,0.25,0.7301567753554896,1.0,4/13,5.73%,SLC8A1;GSN;ATP1A2;GSTM2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.36027133692458857,1.2138886603058316,0.12095032397408208,0.7295887036231371,1.0,38/208,15.05%,PDPK1;WLS;RORA;GJA1;RHOH;PELI2;OPTN;CFLAR;CCL19;TLE1;EDAR;ROR1;RNF31;MAPKBP1;SPHK2;LPAR1;TLR6;NR1D1;PRKN;GPR89A;LTBR;SLC20A1;TMED4;CXXC5;CARD9;NEK6;UFL1;TNIP2;IKBKE;TBK1;RIPK2;USP10;MUL1;RIOK3;FLNA;AKAP13;PLK2;TNFRSF1A
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.42683930610953014,-1.2137195331693038,0.20202020202020202,0.7286935142314402,1.0,6/19,14.93%,SLCO1C1;KLF2;MAPK8;KLF4;PAX8;APP
prerank,epithelial tube morphogenesis (GO:0060562),-0.38117141360502527,-1.2137037100074046,0.1926605504587156,0.726571064893957,1.0,13/32,13.99%,SLIT2;PODXL;MEF2C;ACVRL1;MET;SOX17;RASIP1;PAK1;RHOB;SCRIB;HES1;PRKX;RYR2
prerank,L-amino acid transport (GO:0015807),0.47085653079814715,1.2132662831736472,0.2374429223744292,0.7305811588147206,1.0,2/28,0.60%,SLC1A3;SLC7A2
prerank,amino sugar metabolic process (GO:0006040),-0.5165567316640323,-1.2131119031061666,0.23349056603773585,0.7262435247078232,1.0,2/10,0.97%,CSGALNACT1;ST6GAL1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.46784105302976,1.2131027838327673,0.23503649635036497,0.7301821189828187,1.0,7/31,12.81%,PYCR1;STAR;HSD3B2;PYCR3;SRD5A1;LIAS;MOCS1
prerank,blood circulation (GO:0008015),0.43606752692949213,1.2129973284484201,0.20275862068965517,0.7295864788090675,1.0,7/49,6.91%,COL4A3;ROCK2;ELN;SERPING1;MEOX2;BDKRB2;AGTR1
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.5050344219346197,-1.2127362577679797,0.22524752475247525,0.7252766930222997,1.0,7/11,27.59%,HIRA;H3-3A;CABIN1;NASP;ASF1A;HAT1;ASF1B
prerank,response to progesterone (GO:0032570),-0.4443067029001651,-1.212507805464665,0.2225201072386059,0.7239141871953225,1.0,4/18,3.96%,CAV1;THBS1;ABHD2;TGFB2
prerank,positive regulation of lipid transport (GO:0032370),0.5580699785298777,1.2122530185460183,0.2533557046979866,0.7308395929157069,1.0,2/12,3.47%,LRP1;APOE
prerank,protein neddylation (GO:0045116),-0.4791203406639579,-1.2118615696158044,0.23059360730593606,0.723783157462593,1.0,3/13,10.96%,RBX1;UBA3;DCUN1D4
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.5256909164447039,1.2117330158857724,0.27419354838709675,0.7314917364266715,1.0,9/18,24.16%,PIK3R1;RNF185;BCL2L11;TMEM259;RNFT1;DDIT3;BAG6;ATXN3;PMAIP1
prerank,positive regulation of biosynthetic process (GO:0009891),0.44739931875563715,1.2116727771960925,0.22191011235955055,0.7307474451049911,1.0,13/40,16.33%,ZBTB20;RUNX1;WNT4;APOE;APOA1;TLR6;CREBL2;SLC5A3;RGCC;F2;MTPN;BMP4;AKT1
prerank,positive regulation of potassium ion transport (GO:0043268),-0.36502304164812815,-1.2108545654878002,0.15806451612903225,0.7247673133703919,1.0,12/38,13.63%,FHL1;KCNJ2;KCNJ3;KCNMA1;KCNN2;KCNQ1;AKAP6;KCNMB2;KCNJ15;GNB1;KCNJ10;GNG2
prerank,intestinal lipid absorption (GO:0098856),0.5781963778217144,1.2107523728070935,0.25906735751295334,0.7325546119839532,1.0,2/11,5.80%,LDLR;LIMA1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.4032606396292938,1.2105011374020436,0.1997471554993679,0.7323999583219337,1.0,14/70,13.27%,NRP1;ATRNL1;ANTXR1;PIK3R1;PARVA;LAMC1;USH2A;RAB25;ATRN;ITGB3;ITGAV;EPHB3;DACT2;NTNG2
prerank,cellular response to increased oxygen levels (GO:0036295),-0.5065076952655532,-1.210092213125187,0.2408256880733945,0.7251745045681594,1.0,4/11,21.83%,CAV1;FOXO1;ATP6V0A2;ATG7
prerank,cellular copper ion homeostasis (GO:0006878),-0.47401704409756557,-1.2100078575356092,0.23076923076923078,0.7233663168686891,1.0,8/14,27.14%,ATOX1;ARF1;ATP7A;SLC31A1;APP;MT2A;SLC31A2;PRNP
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.5317723133916812,-1.2095138131514012,0.257847533632287,0.7229106667789514,1.0,3/10,9.89%,PRKCH;MED1;TRIM16
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.48574543489321204,-1.2086558669789371,0.24355971896955503,0.7235253489834349,1.0,2/12,2.63%,SLIT2;CCN3
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.4554079622220448,-1.2083100728286307,0.24345549738219896,0.7224876043537651,1.0,9/16,29.91%,PPT1;ACSS1;HSD17B8;DIP2A;PPT2;ACACA;SCD5;CBR4;MLYCD
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.41991847250750447,-1.208197727438919,0.19420289855072465,0.7207584195504158,1.0,6/20,6.82%,SLC12A2;KCNJ2;ATP1A1;NEDD4L;KCNMA1;ATP1B1
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.3419356973245712,-1.2081731519174297,0.17216117216117216,0.7187515100020042,1.0,11/48,19.91%,PDE4D;PDE4B;SLC7A5;CYRIB;SCRIB;PTPN22;ZFPM1;TLR4;TXK;CD276;FZD5
prerank,regulation of histone acetylation (GO:0035065),-0.37290676917242493,-1.2078976813165563,0.190625,0.7174718048004164,1.0,8/33,13.80%,RPS6KA5;NOS1;CTBP1;PPARGC1A;BRD7;RPS6KA4;TADA2A;MAPK3
prerank,lipoprotein localization (GO:0044872),0.5706921483993944,1.207167965370776,0.27378964941569284,0.7420310872530582,1.0,2/11,9.70%,LRP1;MIA3
prerank,protein auto-ADP-ribosylation (GO:0070213),0.5450114934187299,1.2069863799633382,0.2546689303904924,0.7416536261116853,1.0,6/12,23.92%,PARP11;PARP16;TNKS2;PARP12;PARP10;TNKS
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.4420738776757396,1.2069186909720506,0.23580786026200873,0.7409408492962463,1.0,4/38,2.69%,PTGIS;ROCK2;SMAD3;NOS1AP
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.5812674991367269,1.2067310186566513,0.27419354838709675,0.739676269970251,1.0,4/10,15.05%,SMPD2;SPHK2;NSMAF;TNFRSF1A
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.5812674991367269,1.2067310186566513,0.27419354838709675,0.739676269970251,1.0,4/10,15.05%,SMPD2;SPHK2;NSMAF;TNFRSF1A
prerank,transport along microtubule (GO:0010970),0.5431056556154232,1.206564971443304,0.26,0.7392450707204775,1.0,5/13,17.59%,ARHGAP21;CDC42;APBA1;DYNC1I2;COPG1
prerank,response to peptide hormone (GO:0043434),0.43334448319927116,1.2063082701547263,0.2189265536723164,0.7391037354948624,1.0,14/43,16.33%,ROCK2;TGFBR3;OGT;IGFBP5;ZFP36L1;SRC;STAT5B;STAT2;EIF6;EIF2B4;STAT6;STAT4;EIF2B3;AKT1
prerank,secretion (GO:0046903),0.5341673949040289,1.2062175601581255,0.25618374558303886,0.7384685015698932,1.0,5/14,8.21%,FBLN5;SLC22A2;VIP;SLC22A4;DRD3
prerank,response to cytokine (GO:0034097),0.3683682469207964,1.205951466783827,0.17033603707995365,0.7384059000055379,1.0,28/141,14.08%,PID1;TIMP3;SMAD3;PTPN13;BCL2;IL6R;OSMR;PTPN20;SP100;DPYSL3;IRAK2;CXCL16;ALDH1A2;SRC;PML;KYNU;TIMP2;PTPN9;AFF3;IRAK3;IKBKE;TBK1;DDOST;IGBP1;HDAC4;TAF9;COL3A1;PTPN23
prerank,regulation of dopamine secretion (GO:0014059),0.4869715192639927,1.2057750158246634,0.2527131782945736,0.7379366206255433,1.0,7/25,13.47%,GDNF;DTNBP1;SYT9;DRD3;PRKN;SYT11;SYT12
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.40271589051523,1.2055932995638579,0.195822454308094,0.7375356011407375,1.0,7/73,4.20%,ROBO1;COL4A3;SMAD3;DLC1;CASP12;CFLAR;SLC22A2
prerank,modulation by symbiont of host process (GO:0044003),-0.5148605973732621,-1.204032775434794,0.26180257510729615,0.7274263444199929,1.0,6/10,33.34%,B2M;HGS;UBC;RPS27A;TLR2;PGK1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.5004741618245816,1.203909912688497,0.2669902912621359,0.7418372755521683,1.0,3/19,4.19%,CAMK1D;IL34;CSF1
prerank,positive regulation of calcium ion import (GO:0090280),0.5566887630373238,1.2036849833979304,0.26654740608228983,0.7416104325609753,1.0,2/12,7.21%,PDGFRB;SPHK2
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.36755569935573096,-1.2033393777205619,0.1607717041800643,0.7274915497133438,1.0,8/35,7.10%,SGIP1;BICD1;B2M;PPT1;CBL;RAB21;HIP1R;HNRNPK
prerank,cellular response to cytokine stimulus (GO:0071345),0.3425453751276896,1.2031345604391432,0.09683995922528033,0.7423261889659614,1.0,48/416,8.88%,GREM2;ADAMTS12;PTGIS;COL1A2;RORA;PID1;GHR;PIK3R1;DAPK1;SMAD3;PTPN13;IL31RA;BCL2;IL6R;LEPR;IL34;OSMR;ZEB1;MMP2;PTPN20;KIT;RIPOR2;GAS6;NUMBL;DPYSL3;CCL19;IRAK2;CSF1;IRF1;AXL;SFRP1;BCL6;ZFP36L1;TCF7;CCL4;SDC1;IL12B;BATF;CEBPA;NFE2L2;IL13RA1;NR1D1;OXSR1;PTPN9;IRAK3;BCL2L11;STAT5B;CNTFR
prerank,cellular response to acid chemical (GO:0071229),-0.38627578172165744,-1.2028285450631648,0.2057142857142857,0.7270704302459167,1.0,9/27,12.39%,SH3BP4;KLF2;GLRA1;GLRA2;SPAAR;LARS1;VEGFA;IPO5;MTOR
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.5225979748244564,1.202797803857532,0.26557377049180325,0.742386473823999,1.0,4/16,6.67%,SLC8A1;ATP1A2;GSTM2;CACNA1C
prerank,aerobic electron transport chain (GO:0019646),-0.31672509483471845,-1.2026268081941014,0.16143497757847533,0.7256054495576841,1.0,31/68,28.83%,COX4I1;NDUFC1;UQCRH;SDHD;COX6A1;COX5B;NDUFA6;NDUFA5;CYCS;NDUFA7;NDUFA8;NDUFB7;NDUFA3;NDUFA10;COX5A;COX6C;NDUFS7;NDUFS1;NDUFS5;UQCR10;NDUFB3;COX8A;UQCR11;UQCRQ;UQCRC1;NDUFAB1;UQCRFS1;AFG1L;NDUFB4;NDUFV2;NDUFV3
prerank,receptor clustering (GO:0043113),-0.39631741646957996,-1.202440998869143,0.1927710843373494,0.724091090004417,1.0,11/27,18.89%,DLG2;NLGN1;NRXN1;LRRC7;ITGA4;PTN;SCRIB;AGRN;SYNJ2BP;DVL1;ITGB1BP1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.4763586613120294,1.201846463857645,0.24169184290030213,0.7444027398769747,1.0,13/25,23.18%,FBXL17;DERL1;RNF185;NGLY1;UGGT2;CLPP;AUP1;LONP1;YME1L1;ZER1;BAG6;HDAC6;ATXN3
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.4040083024433476,1.2018089822228275,0.20969855832241152,0.743599666028543,1.0,25/64,23.90%,POLR2D;MLLT3;GTF2H5;CCNK;POLR2C;MNAT1;PAF1;CDK12;NELFE;ADRM1;AFF4;ELOF1;CCNT2;CDC73;POLR2L;ELP4;LEO1;MLLT1;ERCC3;CCNT1;NCBP2;CDK7;ERCC2;ELOC;CDK13
prerank,negative regulation of cell population proliferation (GO:0008285),0.34717029886706635,1.2015127493738322,0.11770726714431934,0.7435828600820336,1.0,81/351,16.99%,NELL1;RBP4;MTSS1;OGN;COL4A3;MN1;TGFBR3;AR;MCC;LYN;DLC1;PODN;PDS5B;NUPR1;PDCD5;FBLN1;RAPGEF2;APPL2;IRF1;AXIN2;RARG;SFRP1;IGFBP5;PDPN;TBX3;CYP1B1;VIP;SKI;ALDH1A2;PML;IL12B;CEBPA;ING5;P3H3;SIRT2;MAP2K1;NMI;RNF139;CD200;BMP2;KAT2B;S100A11;STK11;INCA1;FGFBP1;IGFBP3;GSDME;IFNK;CGRRF1;RGCC;REST;CD33;NIBAN2;PEX2;NDRG4;NOX4;TSC2;GLMN;PTEN;CLMN;ETS1;FRK;HPN;GATA6;BMP4;SFRP4;RBM5;CDKN1C;PRKRA;BMP5;EPPK1;ZBTB17;SST;SPEG;KANK2;ADAMTS1;SLC16A2;ATF5;TFDP1;TNS2;CDKN2C
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.4955432371436581,-1.2008667381036664,0.24875621890547264,0.7269656949661035,1.0,5/12,14.09%,CAV1;CTNNA3;JUP;RYR2;DSG2
prerank,lipid biosynthetic process (GO:0008610),0.39796963798082385,1.2002865299983827,0.20363164721141375,0.746417346454409,1.0,10/77,7.90%,PAM;ACSL1;MVK;PRKAA2;STAR;HSD3B2;AGPAT3;SREBF1;SRD5A1;DOLPP1
prerank,regulation of axonogenesis (GO:0050770),0.42391993320727267,1.2000300527863397,0.21727395411605938,0.7462994669048114,1.0,14/51,14.30%,ROBO1;PLXNA2;KIF13B;EPHA4;TIAM2;BRSK1;ARHGAP35;EPHB3;PLXNC1;MARK2;PLXNA1;PTEN;CHODL;PLXNB2
prerank,glycogen catabolic process (GO:0005980),0.5248200357750611,1.200011381509371,0.27348993288590606,0.7454355048973184,1.0,7/15,16.46%,PHKB;GAA;AGL;PYGM;PYGB;PHKA1;PHKA2
prerank,response to molecule of bacterial origin (GO:0002237),-0.3158503166728207,-1.1999087816743441,0.1645021645021645,0.7279376650413514,1.0,19/69,19.91%,NOS3;TNFRSF11A;CYRIB;GGT5;LBP;GCH1;NOS1;JAK2;FOXP1;TNFAIP3;PTPN22;ERBIN;IRF5;TRIM6;TLR4;HMGB2;IFNAR1;GGT1;FZD5
prerank,protein phosphorylation (GO:0006468),0.34164932331469383,1.1993823285510656,0.07991803278688525,0.7464529141601293,1.0,77/478,12.88%,EPHA3;STK17B;DAPK2;PDK1;PDPK1;DDR2;NRK;ROCK2;CDK14;CAMK1D;TGFBR3;CDK8;DAPK1;GRK3;LYN;GRK5;FGFR1;EPHA4;BMPR1A;DMPK;MARK1;EPHA8;CCNA2;FGFR2;KIT;FGFR4;PRKAG2;GAS6;PDGFRA;PDGFRB;TGFBR1;ACVR1;CDK16;PRKAA2;MUSK;MAP3K20;NUAK1;SRC;ULK2;GTF2H5;LRRK2;AKT3;SIK1;EIF2AK3;BRSK1;MAP2K1;OXSR1;MAST2;STK4;IRAK3;EGFR;EPHB2;BMP2;MAP4K4;CAMK2B;VRK3;STK11;RNASEL;RYK;BAZ1B;TTBK1;NEK6;BRAF;TAOK3;IGFBP3;EPHB3;IKBKE;TBK1;TLK1;STRADA;WNK1;MAP3K13;INSR;MAP4K5;GRK4;MAP2K6;ACVR1B
prerank,ncRNA metabolic process (GO:0034660),0.43953182780262967,1.1993162485387756,0.2264957264957265,0.745700636285233,1.0,11/37,18.90%,TDRD1;DDX17;TUT7;PIWIL4;PARN;BCDIN3D;TUT4;PRKRA;TENT4B;DDX4;DICER1
prerank,regulation of transposition (GO:0010528),0.5453904889583984,1.198505472332025,0.29187396351575456,0.7472321434996554,1.0,5/13,17.51%,UBR2;PIWIL4;SPOCD1;MYBL1;DDX4
prerank,dicarboxylic acid catabolic process (GO:0043649),0.5430430680246923,1.198494078420997,0.259581881533101,0.7463389315798259,1.0,3/13,6.15%,GLUL;DDO;ASPA
prerank,cellular metal ion homeostasis (GO:0006875),0.37821946681126467,1.1981645588700998,0.2134969325153374,0.7464146094748386,1.0,16/102,8.21%,SLC24A3;SLC8A1;SLC8A3;ATP1A2;SLC41A1;DMPK;CCL19;STIM1;ATP13A3;SLC24A1;MT3;CDH5;SLC24A5;ATP1B2;TMEM203;DRD3
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.44735280291642643,-1.1979277881322343,0.25252525252525254,0.7322582272630979,1.0,8/16,19.53%,THBS1;PPP1R16B;JCAD;GATA2;VEGFA;APLNR;DLL4;PDCD10
prerank,regulated exocytosis (GO:0045055),0.3613045492431562,1.1971768719593074,0.15736607142857142,0.7483702547685717,1.0,22/173,9.59%,IGF1;IGF2;CLEC3B;ACTN2;TIMP3;SPARC;AHSG;SERPINE1;LYN;SERPING1;GAS6;APOA1;APLP2;PHACTR2;TLN1;VCL;NHLRC2;CD63;SYT9;ACTN4;ISLR;ITGB3
prerank,positive regulation of stem cell differentiation (GO:2000738),0.5319690160922406,1.1970845108484711,0.25838926174496646,0.7477404634799507,1.0,3/16,6.88%,SOX5;SP7;LTBP3
prerank,positive regulation of synapse assembly (GO:0051965),-0.39025169338969795,-1.1966739200863912,0.2138728323699422,0.7341791774521126,1.0,12/27,17.59%,GRID2;NLGN1;IL1RAPL1;PTPRD;EPHB1;NRXN1;CLSTN2;CLSTN3;AGRN;NLGN3;LRRC4B;VSTM5
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.578593994668037,1.1963995036500124,0.28804347826086957,0.7489345377089225,1.0,5/10,14.80%,APOA1;SLC45A3;LPGAT1;ABCD2;NR1H3
prerank,regulation of actin filament bundle assembly (GO:0032231),0.4752365436339508,1.1961143668405312,0.2364963503649635,0.7488644853502187,1.0,7/26,9.90%,ROCK2;ASAP3;SYNPO2;CDC42;ALMS1;PRKN;SYNPO2L
prerank,lipoprotein transport (GO:0042953),0.5835306950372993,1.1953932234439673,0.27854671280276816,0.7502469382997861,1.0,2/10,9.70%,LRP1;MIA3
prerank,metal ion export (GO:0070839),-0.37724927355242577,-1.1944768452909857,0.21921921921921922,0.7390403460858178,1.0,9/31,11.87%,KCNK5;ATP1A1;KCND3;KCNQ1;ATP1B1;ATP2B4;SLC40A1;ATP7A;ATP1A3
prerank,glucan catabolic process (GO:0009251),0.5284369635579946,1.1943104323253388,0.2808798646362098,0.752691750917966,1.0,7/15,16.46%,PHKB;GAA;AGL;PYGM;PYGB;PHKA1;PHKA2
prerank,negative regulation of GTPase activity (GO:0034260),-0.41074948984007287,-1.1940937556705005,0.23545706371191136,0.7382023419259717,1.0,4/22,4.83%,LRCH1;F11R;SH3BP4;RDX
prerank,aortic valve development (GO:0003176),0.45123339771142157,1.1940788652418044,0.24320457796852646,0.7524720153291368,1.0,3/34,0.85%,ROBO1;ROCK2;ELN
prerank,positive regulation of protein transport (GO:0051222),0.40365019980586675,1.1939480088254346,0.20774193548387096,0.7520325567708571,1.0,4/67,3.86%,IGF1;BMP6;MYO18A;MYH10
prerank,protein stabilization (GO:0050821),0.36018073277139323,1.1937362588111327,0.14872364039955605,0.751713375662182,1.0,29/168,15.67%,IGF1;PIK3R1;PLPP3;A1CF;EPHA4;PARVA;ZSWIM7;APOA1;MT3;ATP1B2;STK4;CREBL2;WDR81;PRKN;TELO2;PEX6;TNIP2;PER3;SUGT1;MUL1;USP9X;HYPK;PTEN;TAF9;PDCL3;FLNA;BAG5;PRKRA;LAMP2
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.484254941635372,1.1935762774815677,0.2579034941763727,0.7512758996181681,1.0,10/21,23.50%,SMO;SFRP1;TEDC1;TTC23;GLI1;SHH;EVC;PDCL;TXNDC15;STK36
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.35473262683410356,-1.1932824834380276,0.17647058823529413,0.738545501327568,1.0,7/39,5.00%,UTRN;ANK3;NEDD4L;HECW1;YWHAH;CAMK2D;FGF12
prerank,spliceosomal snRNP assembly (GO:0000387),-0.3575683469384429,-1.19318146564275,0.20327868852459016,0.7368113910337453,1.0,14/38,23.23%,SNRPB;PRMT7;SNRPD1;SRSF12;LSM2;SNUPN;PRPF31;USP4;SNRPD3;COIL;GEMIN8;STRAP;CD2BP2;GEMIN7
prerank,limb morphogenesis (GO:0035108),0.49915761901890665,1.1931671321739663,0.27759197324414714,0.7515873528480779,1.0,4/20,5.82%,CYP26B1;GLI3;TBX3;SKI
prerank,heart morphogenesis (GO:0003007),0.41844830486889467,1.1930275034886715,0.21808510638297873,0.7511241458791145,1.0,11/50,9.90%,TGFBR3;DLC1;BMPR1A;OLFM1;TGFBR1;ACVR1;TBX3;ENG;FLRT2;BMP2;SYNPO2L
prerank,regulation of monooxygenase activity (GO:0032768),-0.4108737067415672,-1.1923100083956515,0.23323615160349853,0.7377401721887671,1.0,9/23,10.72%,CAV1;NOSTRIN;NOS3;DDAH1;NOSIP;DDAH2;CYGB;CALM1;SPR
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3738259624227755,1.192304449703634,0.20119760479041915,0.7523841258614206,1.0,25/107,16.00%,ITPR1;PIK3R1;BCL2;GORASP2;CDK5RAP3;CREB3L2;ERLEC1;DERL1;ATG10;EIF2AK3;RNF185;RNF139;BCL2L11;AIFM1;BCAP31;PRKN;TMEM259;CEBPB;UFL1;RCN3;SELENOS;P4HB;UFC1;PIK3R2;ERP44
prerank,amino acid transport (GO:0006865),0.42408678956956586,1.1916406063188545,0.229901269393512,0.7534651612025043,1.0,8/49,9.73%,SLC7A11;SLC7A2;SLC1A5;SLC7A13;PDPN;SLC38A6;SLC38A9;SLC43A1
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.5026257342821163,1.1913662006176047,0.2737169517884914,0.7534479296210507,1.0,4/18,9.04%,ROCK2;EPHA4;SLC2A13;PICALM
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.4452475686616146,1.191339877785619,0.23478260869565218,0.7526349606135182,1.0,9/34,10.17%,PIK3R1;EPHA8;KIT;PDGFRA;PDGFRB;CCL19;WDR81;WDR91;FGF2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.5575227772693417,1.191175082942111,0.30341113105924594,0.7521976201190147,1.0,4/12,6.86%,DOCK4;TPM1;IGFBP5;DOCK5
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.5523958895123753,1.1903406447261757,0.2695035460992908,0.7537259451515732,1.0,5/12,17.97%,IL17D;IL12B;CARD9;IL23A;IL18
prerank,response to calcium ion (GO:0051592),-0.2967575766000424,-1.1895467888775348,0.10919540229885058,0.7445300124842372,1.0,27/102,13.99%,CAV1;MEF2C;CPNE8;CLIC4;NLGN1;TRPC3;THBS1;PLCG2;IQGAP1;KCNMA1;CAMK2D;SLC25A13;CPNE3;SLC25A12;TRPC1;SYT1;KCNMB2;ITPR3;CALM1;GPLD1;CALM3;ADCY8;LGMN;HOMER1;SYT6;CASQ2;RYR2
prerank,regulation of phosphorylation (GO:0042325),0.3741875428839842,1.1894708176331872,0.19136522753792298,0.7554922496980069,1.0,36/120,19.56%,NRP1;LDB2;SRPX2;AR;LYN;DYNLL1;OGT;PRKAG2;NUP107;PHIP;CDH5;PML;NUP42;SIRT2;DSCAM;EGFR;STAT2;EIF6;NUP98;RAE1;EGF;GLMN;PLXNB2;NUP214;BMP4;SESN2;CDKN1C;FNIP1;CDKN2C;KCTD20;GCK;SEH1L;TPR;CDKN1B;PRKAG1;ROPN1L
prerank,response to fatty acid (GO:0070542),0.5076391547994976,1.1894169961032601,0.2944078947368421,0.7547595584188561,1.0,1/17,0.91%,PID1
prerank,ion transport (GO:0006811),-0.2946876854374192,-1.1891656463864477,0.13725490196078433,0.7436724710725745,1.0,17/111,5.15%,TRPM3;PIEZO2;SLC12A2;SLC26A7;SLC12A7;SLC9A2;SLC24A2;SLC26A2;PIEZO1;ANO1;SLC9A6;ATP11B;GLRA1;GABRB1;KCNN2;SLC15A2;SLC1A1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.3831373806368223,-1.188709033221727,0.207492795389049,0.7430851644643397,1.0,7/30,5.44%,KCNJ2;ATP1A1;NEDD4L;GJC1;SCN1A;FGF12;KCNQ1
prerank,positive regulation of vasoconstriction (GO:0045907),0.5450335545357039,1.1883292147395987,0.27504244482173174,0.7571478975445204,1.0,2/13,9.41%,ADRA1B;TRPM4
prerank,monosaccharide transmembrane transport (GO:0015749),0.5101544882081946,1.1881961855601448,0.27101200686106347,0.7566956818620321,1.0,3/16,9.30%,SLC2A10;SLC45A3;SLC5A3
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.36104395326079697,1.1881521063523939,0.17772778402699663,0.7559484658113419,1.0,17/152,7.52%,ADRA1B;ADCY1;ADCY2;ABCA1;ADCY7;LGR4;GRK5;ADCY5;GNAS;ADCY9;ADGRL1;INSL3;VIP;LHCGR;ADRB3;MTNR1A;LPAR1
prerank,regulation of mitochondrial fusion (GO:0010635),0.5656968722948529,1.1881045811781652,0.3067375886524823,0.7552066499797273,1.0,4/11,15.21%,PID1;PRKN;MUL1;HUWE1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5353322812062332,1.1876395287103323,0.2659758203799655,0.755699936451348,1.0,5/14,17.97%,IL17D;IL12B;CARD9;IL23A;IL18
prerank,"phagocytosis, engulfment (GO:0006911)",0.445448214185693,1.186793343021158,0.25768667642752563,0.7573203653742605,1.0,6/36,7.40%,RHOH;GSN;RHOBTB1;CDC42;RHOBTB2;GULP1
prerank,steroid biosynthetic process (GO:0006694),0.41365748494702914,1.186330466884296,0.2261904761904762,0.7577799054389773,1.0,8/56,7.56%,CYP7B1;SLC27A5;PRKAG2;INSIG2;STAR;HSD3B2;CYP27A1;SRD5A1
prerank,regulation of cytoplasmic transport (GO:1903649),0.5500782567771179,1.1861411687741916,0.29381443298969073,0.7574250603174798,1.0,4/11,7.60%,ATP9A;SRC;LRRK2;MAP2K1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.2828478143192638,-1.1856985827549644,0.10714285714285714,0.750538503822014,1.0,40/119,19.28%,PIP5K1B;EFR3B;PLCG2;INPP5D;BMX;PIK3R6;DPM1;MTMR2;SOCS2;TTC7A;INPP4B;PLEKHA3;PIGP;INPP5K;PLEKHA1;INPP5F;PGAP2;MTMR9;IP6K1;PIK3R3;ARF1;PIGB;SACM1L;PIK3R5;MTMR6;ARF3;MBOAT7;PIK3C2B;PIGL;PIK3CA;RAB4A;DPM3;PIGU;DPM2;PITPNM3;INPP5E;PIGO;SYNJ1;PIGV;RUFY1
prerank,mesenchymal cell differentiation (GO:0048762),0.4198280466405122,1.1846365038959494,0.2551440329218107,0.7610655292861739,1.0,11/51,8.76%,ROCK2;TGFBR3;FGFR1;FGFR2;WNT4;TGFBR1;FBXL17;ENG;DDX17;RBPJ;BMP2
prerank,histone modification (GO:0016570),0.3779436943965977,1.184258569888051,0.19320843091334894,0.7612865070084316,1.0,16/109,10.21%,TBL1XR1;EYA2;EYA1;CCNA2;PRDM5;MIDEAS;MT3;BRD8;ATXN7L3;SIRT2;UBE2U;MTA2;MTA3;BRMS1L;NSD1;BAZ1B
prerank,oxoacid metabolic process (GO:0043436),0.4612142657704123,1.1839397397336027,0.2721804511278195,0.7613681029560847,1.0,3/27,5.85%,ENPP1;TPST1;DDO
prerank,stem cell differentiation (GO:0048863),0.430413306377161,1.183490033403717,0.25034770514603616,0.7618010296778511,1.0,10/39,11.49%,SP7;FGFR2;KIT;FBXL17;MLLT3;SFRP1;BATF;OSR1;EEF1AKMT4-ECE2;UFL1
prerank,positive regulation of viral transcription (GO:0050434),0.4748249285005306,1.1832689629512458,0.2652439024390244,0.7615593801749351,1.0,1/25,0.14%,POLR2D
prerank,phagosome acidification (GO:0090383),0.46132062118272893,1.1830977501814823,0.2692307692307692,0.7611572653338093,1.0,1/26,0.20%,ATP6V0A4
prerank,fibrinolysis (GO:0042730),0.5473416288966723,1.183042793950552,0.2607204116638079,0.7604213002768596,1.0,2/13,11.77%,SERPINE1;F2
prerank,relaxation of cardiac muscle (GO:0055119),0.5440649503879335,1.1829422507081773,0.3027681660899654,0.7598489087925687,1.0,4/13,5.73%,SLC8A1;GSN;ATP1A2;GSTM2
prerank,negative regulation of translation (GO:0017148),0.3881378397523341,1.1827272334566015,0.22715736040609136,0.759604737756664,1.0,10/87,8.96%,SAMD4A;ROCK2;DAPK1;IGF2BP2;IGFBP5;CPEB1;CPEB3;EIF2AK3;RNF139;METTL14
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.4941845593124695,-1.1825307753972125,0.26126126126126126,0.7584188027857865,1.0,3/10,12.70%,CD55;TGFBR2;CD81
prerank,regulation of cilium assembly (GO:1902017),-0.3246064566067008,-1.1824899007091907,0.21238938053097345,0.7564424842323546,1.0,17/62,14.22%,LIMK2;RABGAP1;CCDC88A;TBC1D1;TBC1D8;TBC1D14;TBC1D15;DCDC2;KCTD17;TBC1D30;CEP97;TESK1;EVI5;DYNLT2B;ATG3;TBC1D5;SDCCAG8
prerank,positive regulation of secretion by cell (GO:1903532),0.3954677450711222,1.181152367000168,0.22981366459627328,0.7634084969814429,1.0,6/70,5.32%,IGF1;BMP6;DTNBP1;MYO18A;MYH10;BAIAP3
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.3819316244153286,-1.1806562955761701,0.2012012012012012,0.7604028638711569,1.0,14/27,23.95%,IL1RAPL1;CCDC88A;MBOAT1;NTNG1;GSK3A;EFHC2;DISC1;CAMK2G;HOMER1;BRSK2;FBXO7;GSK3B;TREM2;CTNNA2
prerank,regulation of mRNA stability (GO:0043488),0.3636659875116739,1.1804124182041766,0.19473081328751432,0.7647747004591111,1.0,36/145,20.65%,SAMD4A;ROCK2;GDNF;TENT5A;CSDC2;IGF2BP2;PSME4;AXIN2;VIP;ZFP36L1;TENT5D;EXOSC1;METTL14;PARN;SERBP1;EXOSC7;LARP1;RC3H2;NUP214;MAPKAPK2;AKT1;DCP1A;PSMB5;PSMC2;RC3H1;METTL3;PSMD1;PRKCA;PSMD4;FASTKD3;PSME3;YTHDF2;FTO;HNRNPU;ZFP36L2;PSMA3
prerank,actin nucleation (GO:0045010),-0.4029628462136419,-1.179946508427656,0.21067415730337077,0.7605354702328986,1.0,6/21,19.34%,ARPC1B;SPIRE1;ARPC3;ARPC5L;ARPC4;LMOD1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.5081940283093412,1.1798044974403847,0.2842465753424658,0.765701822189071,1.0,4/15,20.48%,HECW2;NEK6;TPR;CDC23
prerank,bone morphogenesis (GO:0060349),0.5325643344322064,1.1796661418792889,0.296551724137931,0.7652271721360857,1.0,3/14,5.82%,CYP26B1;FGFR2;SKI
prerank,establishment of spindle orientation (GO:0051294),0.46631458457899155,1.179266026320685,0.2790346907993967,0.7655843789212483,1.0,13/28,23.46%,GJA1;SPDL1;ZW10;UBXN2B;LLGL1;CENPA;HTT;NUMA1;NSFL1C;NDE1;LLGL2;FBXW11;ITGB1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.43501990583634587,1.1790656718811225,0.27323943661971833,0.7652974653966981,1.0,10/39,12.63%,PDPK1;ANGPT1;SERPINE1;GAS6;SEMA5A;CDH5;NFE2L2;RGCC;TNIP2;PDCD4
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.49494089813408015,1.1789937062842033,0.268370607028754,0.7646150839788914,1.0,3/19,6.87%,AR;NAB2;CEBPA
prerank,positive regulation of GTPase activity (GO:0043547),-0.2660338162137304,-1.1789196592854272,0.0945945945945946,0.7616967506722966,1.0,44/188,11.96%,PKP4;DOCK9;RAP1A;ITGA6;F11R;CAV2;RABGAP1;RAP1GDS1;SIPA1L1;BCAR3;NET1;SNX13;TBC1D1;RGS6;ARHGEF15;SIPA1L2;TBC1D8;TBC1D14;TBC1D15;TGM2;ARHGAP27;RAP1GAP2;ERBB2;EZH2;TBC1D9;CCL14;NGEF;TBC1D30;ARAP1;RASGRF1;RGS7;CCDC125;LARS1;BCR;RUNDC1;RALGAPA2;SCRIB;RGS16;ARHGAP25;AGRN;RANGAP1;NF1;EVI5;CD40
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.41278892106226434,-1.1785901885981205,0.25396825396825395,0.7607412255131611,1.0,13/21,33.67%,KDM1A;DISC1;VEGFA;CX3CR1;DLL4;TOX;LRP2;FZD3;FZD9;DISP3;CTNNB1;NAP1L1;RASSF10
prerank,positive regulation of protein modification process (GO:0031401),0.3506338805817343,1.1783463234735492,0.15748898678414097,0.7657536863039407,1.0,37/203,13.69%,IGF2;TRABD2B;ROCK2;ANGPT1;LYN;DLC1;LEPR;IL34;PELI2;CCN1;NOS1AP;NNMT;GAS6;MT3;AXIN2;MUSK;SLCO3A1;CDH5;ENG;LRRK2;ATG10;NTRK3;STK4;DAB2;ARRB1;EGFR;BMP2;ITGB3;FGF2;DDX3X;F2;CAMTA1;INSR;RAP2A;TMEM119;RAB3GAP1;ALG10B
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.4122331147030579,-1.1782099593413105,0.2594752186588921,0.759824593031829,1.0,6/22,6.50%,SLIT2;TMSB4X;KANK3;CYRIB;TMSB10;HIP1R
prerank,negative regulation of protein processing (GO:0010955),0.5385843557833856,1.177285263806408,0.31343283582089554,0.7680976434665037,1.0,5/12,15.11%,SERPINE1;LRRK2;SNX12;CTSZ;GAS1
prerank,endomembrane system organization (GO:0010256),0.350295320348266,1.177041020897126,0.17601760176017603,0.7679571818194406,1.0,48/178,16.39%,OBSL1;USP6NL;DMPK;LMAN2L;OPTN;SEC31A;RAB30;MYO18A;GORASP2;ARHGAP21;TMED1;GOLGB1;LMAN1;CDC42;ARFGEF2;ZW10;LRRK2;SNX33;UBXN2B;EIF2AK3;RAB22A;ALS2;TLCD1;TRIP11;LEMD3;MIA3;ARL1;TMED4;PLEKHM2;TJAP1;GOLPH3L;GORASP1;GOLGA8B;GOLGA5;TANGO2;HOOK2;ATP8B2;TOR1B;FER1L5;TBC1D20;BAG5;HACE1;HUWE1;LAPTM4B;CUL7;GOLPH3;TOR1AIP2;ARFGEF1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.5595023835591179,1.1770014242775027,0.3041044776119403,0.7672021232444541,1.0,7/10,30.77%,SPHK2;KMT2A;SMARCB1;BRCA1;HDAC5;RAPGEF3;SMAD4
prerank,regulation of cellular biosynthetic process (GO:0031326),0.4569558516061605,1.1769748127967954,0.26356589147286824,0.766396063326487,1.0,5/28,5.20%,MITF;NOS1AP;FGFR4;PRKAG2;PRKAA2
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.3841875168000649,-1.176910489307093,0.23404255319148937,0.7619581627209802,1.0,8/25,15.19%,SLIT2;ARHGAP44;LIMK2;TBC1D30;CEP97;TESK1;ABI3;PLXNB3
prerank,pseudouridine synthesis (GO:0001522),0.5450026925853128,1.1768148113911834,0.2936378466557912,0.7659782306963282,1.0,5/13,18.90%,PUS3;RPUSD2;TRUB2;PUSL1;TRUB1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.39135025656204936,-1.1764872568213414,0.23795180722891565,0.7612990708631423,1.0,14/26,19.52%,SHANK3;NLGN1;PTK2B;RIMS1;NRXN1;MTMR2;RIMS2;TMEM108;SHANK1;PRKCZ;APP;NLGN3;TMEM25;GRIN1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3293199242104359,1.1762392377758417,0.014,0.7668840152977784,1.0,334/1668,17.26%,IGF1;TCF7L2;TCF4;BMP6;ZBTB20;LDB2;AUTS2;NFIA;IGF2;FHL2;RORA;TBL1XR1;ZFHX4;PID1;TRPS1;TEAD1;CDK8;GDNF;ATXN1;PIK3R1;PBX1;SMAD3;ARNT2;PKNOX2;AR;ZKSCAN2;ZEB2;SOX5;TGFA;MITF;DCN;GLIS3;NKX6-1;SERPINE1;NR2F2;DACT1;GLI2;RUNX1;PRRX1;WWC2;SALL1;KCNIP3;ZIC1;SP7;OGT;IKZF2;BMPR1A;VGLL3;CBX7;MAF;GLI3;AEBP1;PPP3CA;CCN1;ARID5B;ZEB1;NKX2-1;FGFR2;KIT;ARID4A;THRB;PRDM5;SP100;MDFI;FOXP2;NFIB;ASCL1;SSBP3;ZNF462;YAP1;DNMT3A;JDP2;MAML3;APOE;RUNX2;SIX5;MLXIP;RARB;MIDEAS;ZIC4;NFIX;MXI1;LBX2;FBXL19;MEOX2;CRTC3;IKZF4;RLF;MSC;SMURF2;BRWD1;IRF1;ZIC2;NEUROD4;RFX5;ACVR1;ZHX2;ZNF83;NEUROD1;CREB3L2;NCOA2;KLF15;PHIP;RARG;ETV6;ARID1B;BRD8;ATXN7L3;TBX3;SP4;EPAS1;HLF;BCL6;ENG;CUX2;ZBTB8B;SKI;BCL9;TNRC6B;BCOR;TCF7;ATOH8;HES7;INO80;SMARCA1;ZNF483;ZNF23;MED14;GTF2H5;NR5A1;CPEB3;BATF;CEBPA;ATAD2B;NFE2L2;ZNF697;MBD2;WWTR1;SAP30;RNF10;SREBF1;SIRT2;DDX17;DR1;ZBTB38;TSHZ2;ZBTB24;SMARCC2;MED8;MED16;PPP1R13L;NR1D1;RAI1;OSR1;BBX;TET1;MTA2;RBPJ;LIN9;DAB2;TCF7L1;FOXC2;SAFB2;NCOR1;CHD2;MTA3;TNRC6A;KDM5B;HIVEP2;ARRB1;EGFR;RGMA;BMP2;PCGF3;ZMIZ1;JAZF1;KAT2B;STAT5B;ZBTB4;BRMS1L;HOXC5;ZBTB1;MZF1;CCNK;SMAD1;GMEB1;PRKN;GTF2IRD1;HEXIM2;STAT2;GLIS2;CSRP3;NSD1;ARNT;RPAP2;CREB3L4;CREB3;RNASEL;FOXA1;IFI27;ZKSCAN3;FGF2;SP140;BAZ1B;ZSCAN21;PHF2;CXXC5;NR1D2;MED13L;NCOR2;SP5;ZBTB8A;DDX3X;ZNF177;CEBPB;KLF9;CCNL2;MED29;BHLHE41;NFE2;RGCC;TNIP2;SPDEF;NKX2-8;ZBTB37;TBK1;HDAC8;ZFP30;REST;NR4A1;PER3;RHOQ;IMPACT;CCNL1;MNAT1;TCF25;GLI1;CAMTA1;PHF21A;STAT6;ZNF513;RIPK2;PEX2;PAF1;TEAD3;MYCN;SMARCD2;USP9X;NPAS2;HELZ2;IGBP1;NCOA3;KMT2A;HOXC8;EBF1;STAT4;TIAL1;ZNF182;CDK12;HDAC4;PTEN;TAF9;MED19;ARF4;HIVEP1;ETS1;FRK;ZNF148;ZNF383;FSTL3;ZNF219;TWIST2;TCF12;HOXD1;TCERG1;HSBP1;TADA3;AKAP8L;KDM7A;GATA6;NR1H3;PHF8;BMP4;SUDS3;UBE2D1;ZNF25;FUBP3;HOXC4;SUFU;RXRA;TNFRSF1A;FOXK2;SS18;SMARCB1;TSHZ1;HDGFL3;BMP5;CAMTA2;MYT1;MTF1;TFCP2;RNF2;PIK3R2;POGZ;ZBTB17;ZNF585B;ZNF585A;CBX5;MAFA;ZNF276;MXD4;NCOA7;EBF4;KANK2;CREB5;FNIP1;PLAG1;CCNQ;ATF5;SHH;TFDP1;FOXO6;SP1;LIF;MYBL1;BAZ2B;PRPF6;EFCAB7;IRF2;ZSCAN20;CBX6;ABHD14B;KDM3B;FOXJ3
prerank,regulation of amyloid-beta clearance (GO:1900221),0.5065768337429049,1.1756576070123006,0.2944078947368421,0.7677608463655071,1.0,2/16,3.47%,LRP1;APOE
prerank,establishment of skin barrier (GO:0061436),-0.45438949343499463,-1.1749934882828454,0.2536945812807882,0.761647193123226,1.0,4/15,11.25%,LSR;MET;UGCG;HRNR
prerank,regulation of water loss via skin (GO:0033561),-0.45438949343499463,-1.1749934882828454,0.2536945812807882,0.761647193123226,1.0,4/15,11.25%,LSR;MET;UGCG;HRNR
prerank,regulation of integrin activation (GO:0033623),-0.4465127298275789,-1.1747668053602445,0.2815533980582524,0.7603273941982899,1.0,5/15,10.69%,PIEZO1;RASIP1;RAP1B;SKAP1;PLEK
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.49768147670785234,-1.174289387041924,0.27107061503416857,0.7557326830574701,1.0,3/10,23.31%,NBN;SLX4;EXO1
prerank,t-circle formation (GO:0090656),-0.49768147670785234,-1.174289387041924,0.27107061503416857,0.7557326830574701,1.0,3/10,23.31%,NBN;SLX4;EXO1
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.49768147670785234,-1.174289387041924,0.27107061503416857,0.7557326830574701,1.0,3/10,23.31%,NBN;SLX4;EXO1
prerank,positive regulation of protein binding (GO:0032092),0.4112286114306165,1.17389610510198,0.24370860927152319,0.7722047883433221,1.0,11/56,9.33%,TCF7L2;LRP1;DACT1;APOE;VTN;RAPGEF2;DERL1;LRRK2;STK4;BMP2;PRKN
prerank,negative regulation of hormone secretion (GO:0046888),0.5774154728205713,1.1735429803448603,0.2943327239488117,0.7723882196272946,1.0,1/10,0.60%,GJA1
prerank,proton transmembrane transport (GO:1902600),0.442024631670371,1.1730187150258584,0.2703862660944206,0.7730752781575232,1.0,2/36,1.81%,ATP6V0A4;ATP1A2
prerank,negative regulation of blood coagulation (GO:0030195),0.43802311987665987,1.1728999739576749,0.26705370101596515,0.7725201074630507,1.0,6/38,5.44%,SERPINE1;SERPING1;PDGFRA;APOE;VTN;TFPI
prerank,regulation of cell death (GO:0010941),0.3814234252479833,1.1728983529796289,0.21170610211706103,0.7716375275399713,1.0,19/94,13.23%,CCN2;LRP1;CCN1;RRAS2;MT3;SLC25A24;AXIN2;CCN5;LRRK2;PARP16;CCN4;PRKN;FGF2;TBK1;RAD18;IMPACT;RIPK2;CTSZ;NPAS2
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.44545686482492014,1.1724471334033066,0.2412831241283124,0.7721711150739085,1.0,9/33,13.80%,OGN;TPM1;IGFBP5;VIP;IL12B;IGFBP3;PDCD4;NDRG4;PTEN
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.5031932306008532,1.1724127284027483,0.2964824120603015,0.7713987162500442,1.0,4/17,6.32%,AR;ATP1A2;TFPI;SRC
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.469089312654849,1.172333490209724,0.2643171806167401,0.7707519269576042,1.0,5/29,7.56%,GDNF;TENT5A;AXIN2;VIP;TENT5D
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.5050045498774897,1.172258155979275,0.27495908346972175,0.7700881147480241,1.0,6/16,14.42%,ADCY7;APPL2;F2;PDCD4;ABCD2;CHID1
prerank,"wound healing, spreading of cells (GO:0044319)",0.4732623074503206,1.1710015670199008,0.2735562310030395,0.7730357297901619,1.0,4/24,7.97%,COL5A1;CCN1;PDPN;ARHGAP35
prerank,striated muscle tissue development (GO:0014706),0.4581156248739547,1.170734316647541,0.2727272727272727,0.7729521885071583,1.0,4/29,4.39%,RBP4;SVIL;CFLAR;MSC
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.4178960632834053,-1.170499083912376,0.2578125,0.7659349925899602,1.0,5/19,2.91%,PRKCH;OCLN;CLDN5;F11R;TJP1
prerank,positive regulation of heart rate (GO:0010460),0.5128197292831489,1.1701445091447813,0.30247933884297523,0.7738401237839408,1.0,4/17,11.11%,ADRA1B;TPM1;TRPM4;ADM
prerank,cellular protein metabolic process (GO:0044267),0.3355632399612987,1.1700352378495837,0.13580246913580246,0.7732563811129787,1.0,36/396,8.44%,LTBP1;IGF1;IGFBP2;PAPPA;CP;FBN1;IGF2;MATN3;LOX;AHSG;PRKCSH;IGFBP4;MSRB3;RRBP1;CCN1;LAMC1;MMP2;GAS6;APOE;FSTL1;CSF1;TGM5;APOA1;APLP2;SERPIND1;CTSH;IGFBP5;CST3;LMCD1;TNC;ADPRH;ARAF;RCN1;UBA7;SEC11C;DNAJC3
prerank,membrane organization (GO:0061024),-0.2606443996470474,-1.170020698787857,0.08860759493670886,0.7654159501248794,1.0,36/227,8.99%,DNM3;CERT1;SGCZ;FNBP1L;SGIP1;ACTB;ANK3;RIMS1;EPN2;NUP93;REEP1;REPS2;CCDC88A;TFRC;PPT1;HSPA8;CBL;DYSF;FZD4;SH3GL2;TMEM33;SPTBN1;AMPH;ATP2C1;HIP1R;VAMP8;SUN2;PLEKHA3;SYT1;SYP;ARPC3;GAK;SH3KBP1;PACSIN2;RTP4;OSBPL2
prerank,cellular response to pH (GO:0071467),-0.4307941840805936,-1.1699537505961637,0.24691358024691357,0.763675251652157,1.0,7/17,26.49%,HYAL1;GPLD1;GPR68;RAB11FIP5;HVCN1;PKD2L1;KCNK4
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.3624516256584387,-1.1698379212987564,0.2507462686567164,0.7620795388239175,1.0,9/33,4.18%,BMPER;SEMA6A;THBS1;PPP1R16B;EPN2;CEMIP2;TJP1;KLF2;FGF1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.49970969884211036,1.1690585863903264,0.2934609250398724,0.7753455537566244,1.0,4/17,8.17%,NRP1;NTF3;CDC42;NTRK3
prerank,regulation of T cell cytokine production (GO:0002724),-0.45005914989927487,-1.169003721789214,0.27543424317617865,0.7628552920767727,1.0,7/15,27.10%,B2M;CD55;FZD5;TRAF2;MAP3K7;MALT1;TRAF6
prerank,cellular response to purine-containing compound (GO:0071415),0.5682366147048249,1.1686695636847524,0.32098765432098764,0.7756651123044691,1.0,2/10,5.73%,SLC8A1;GSTM2
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.44403313664047955,1.1682775479316334,0.2884012539184953,0.7759919766261321,1.0,7/29,13.58%,GHR;IL31RA;NMI;STAT5B;STAT2;STAT6;STAT4
prerank,membrane depolarization during action potential (GO:0086010),0.4600757803098071,1.1682665641349679,0.2754777070063694,0.7751495196121126,1.0,3/26,1.81%,SCN7A;SLC8A1;ATP1A2
prerank,calcium ion transport (GO:0006816),0.36480976476343147,1.1682580034776842,0.2135102533172497,0.7742952317926081,1.0,15/113,9.63%,ITPR1;SLC24A3;NALCN;SLC8A1;SLC8A3;TRPA1;GAS6;STIM1;SLC24A1;SLC24A5;CACNA1C;PANX1;ORAI2;TRPM4;ITGAV
prerank,positive regulation of cellular component organization (GO:0051130),0.3714216843853377,1.1681133671852388,0.2243436754176611,0.7738372348937961,1.0,16/107,10.14%,ASAP1;TRABD2B;FRMPD4;AR;LRP1;RUNX1;APOE;TGFBR1;ADGRL1;CCL19;CDH5;LMAN1;DAB2;BCL2L11;CAMK2B;PLEKHM2
prerank,cellular response to retinoic acid (GO:0071300),0.43046364189789665,1.1680952830067672,0.27461858529819694,0.7730171775108392,1.0,6/42,6.62%,EPHA3;LYN;WNT8B;WNT6;PTK7;WNT5B
prerank,regulation of wound healing (GO:0061041),0.4266450162055933,1.167873602042422,0.26556016597510373,0.7728273884643083,1.0,11/42,11.77%,SERPINE1;KANK1;MYLK;VTN;INSL3;CASK;EPHB2;FGF2;HBEGF;ADRA2A;F2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5215685919512384,1.1678349168500048,0.2849740932642487,0.772066130979388,1.0,8/14,23.53%,LRRK2;PRKN;CREB3;SELENOS;TMBIM6;CREB3L1;OPA1;TXNDC12
prerank,establishment of mitotic spindle orientation (GO:0000132),0.48061796803717216,1.1674748629226215,0.2859399684044234,0.7722180836831425,1.0,11/23,23.46%,GJA1;SPDL1;ZW10;UBXN2B;CENPA;HTT;NUMA1;NSFL1C;NDE1;FBXW11;ITGB1
prerank,response to interleukin-4 (GO:0070670),-0.49522230056524835,-1.1673635067934873,0.29411764705882354,0.7660217491170149,1.0,1/10,0.16%,LEF1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5731443778048846,1.1673194547606438,0.298932384341637,0.7718411401388058,1.0,6/10,24.20%,IVD;ETFDH;ETFA;ETFB;ACADM;ACADVL
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.5023258781461611,1.1667376447783948,0.29193548387096774,0.7727877884758594,1.0,10/16,25.65%,LRRK2;BCAP31;MIA3;UBAC2;SEC16B;SEC16A;HSPA5;PPP1R15A;ANK2;VAPA
prerank,sensory perception of pain (GO:0019233),0.48529245890529504,1.1667144042073911,0.29307568438003223,0.7720004938320337,1.0,4/21,11.72%,TRPA1;PTGES;ALOXE3;NIPSNAP1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.46129531878576413,1.166209787387704,0.2744807121661721,0.7725777993110658,1.0,8/26,17.56%,GAL3ST2;LARGE1;GBGT1;ALG11;ALG6;GOLPH3;GK;TNIP1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.5228541222507573,1.1654367189868853,0.29965156794425085,0.7739629131201808,1.0,2/13,5.70%,NRP1;ENG
prerank,regulation of interleukin-4 production (GO:0032673),-0.4124543504481856,-1.1652967870135542,0.2514450867052023,0.7705086127418522,1.0,6/21,18.96%,LEF1;SLC7A5;FCER1G;PRKCZ;ZFPM1;CD86
prerank,positive regulation of type 2 immune response (GO:0002830),-0.4522058658763435,-1.1651804483592108,0.2639225181598063,0.7688967923210726,1.0,7/14,30.03%,DENND1B;PRKCZ;CD81;NOD2;CD86;RARA;NLRP3
prerank,response to chemokine (GO:1990868),-0.465552867210588,-1.1651084814612505,0.2749391727493917,0.7671142461332213,1.0,2/13,0.68%,SLC12A2;LRCH1
prerank,regulation of cartilage development (GO:0061035),0.49422883702310755,1.1646979565457827,0.29983525535420097,0.7752465987984681,1.0,5/18,14.90%,TRPS1;SOX5;BMP2;MDK;BMP4
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.37640203925104565,-1.1646493163600178,0.24149659863945577,0.7666821275453124,1.0,5/29,6.96%,SLC4A10;MCTP1;ZDHHC2;GRIK2;SYP
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.3901964940158367,-1.164594133337455,0.2188449848024316,0.7648920306708978,1.0,9/24,27.96%,TTLL7;TTLL5;AGBL4;TTLL3;TTLL8;PARP1;TTLL6;TTLL2;AGTPBP1
prerank,synaptic vesicle recycling (GO:0036465),-0.36563807629493755,-1.164444922870491,0.25386996904024767,0.7634292342964765,1.0,10/31,18.60%,NLGN1;AMPH;OPHN1;CDK5;SYT1;PACSIN1;NLGN3;RAB3A;STX1A;SYNJ1
prerank,establishment of melanosome localization (GO:0032401),-0.4128089807394292,-1.1643276919953198,0.2559366754617414,0.761882804950696,1.0,8/19,19.54%,RAB27A;RAB11A;RAB27B;ARL6;MLPH;BLOC1S5;BBS7;MREG
prerank,regulation of endothelial cell proliferation (GO:0001936),0.3845395600983876,1.1641109539058765,0.2427307206068268,0.7760848246150468,1.0,19/88,11.97%,NRP1;ANGPT1;SPARC;NR2F2;VASH2;APOE;TGFBR1;SEMA5A;SULF1;VIP;ATOH8;AKT3;BMP2;ITGB3;ARNT;FGF2;PTPRM;RGCC;NR4A1
prerank,cellular response to alcohol (GO:0097306),0.42354807745350176,1.1633418174668795,0.27450980392156865,0.7775561527590685,1.0,7/42,7.21%,ADCY1;ADCY2;ADCY7;ADCY5;SMO;SFRP1;SPHK2
prerank,tRNA methylation (GO:0030488),0.4371193044568233,1.1632695142129876,0.2888243831640058,0.776905124112756,1.0,10/34,16.31%,TRMT44;TRMO;NSUN2;BCDIN3D;TRMT13;TRMT112;PRORP;THUMPD3;THUMPD2;THADA
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.4027994261410799,-1.162803826192811,0.2617801047120419,0.7647030484523923,1.0,6/19,11.62%,PLCE1;NFATC2;NFATC3;NFATC1;EDN1;HRH1
prerank,positive regulation of protein import (GO:1904591),0.4409276156069901,1.1625904014534967,0.275811209439528,0.7779885402061988,1.0,10/30,18.64%,PIK3R1;SMAD3;ZIC1;PDCD5;RBM22;FLNA;PIK3R2;UBR5;EFCAB7;TPR
prerank,phospholipid biosynthetic process (GO:0008654),-0.3520375567748943,-1.1625764817279987,0.22910216718266255,0.7634500807028556,1.0,5/36,4.46%,SGMS1;SGMS2;CPNE3;LPCAT1;MBOAT1
prerank,positive regulation of exocytosis (GO:0045921),-0.3564715811319132,-1.1625524112291854,0.22295081967213115,0.7616124498021609,1.0,14/35,26.47%,RAB27A;SDCBP;CADPS;RAB27B;PDCD6IP;CFTR;RAB15;RAB3A;CLASP1;VPS4A;SNF8;EXPH5;STXBP5;HGS
prerank,regulation of primary metabolic process (GO:0080090),0.36182634934820074,1.1623997090219913,0.22753128555176336,0.7776936839977457,1.0,41/126,23.89%,ROCK2;TBL1XR1;FGFR4;C1QTNF2;CHD9;APOE;PSME4;NCOA2;LDLR;MVK;SREBF1;NR1D1;NCOR1;IDI1;NR1D2;NCOR2;HELZ2;FASN;CERS2;RXRA;HMGCS1;SP1;PSMB5;PSMC2;OAZ3;PSMD1;CARM1;NCOA6;SCD;PSMD4;ABCA7;PSME3;PSAP;PSMA3;RUBCNL;NFYC;CYP51A1;PSMA2;PSMC5;SREBF2;PRKAB2
prerank,myelination (GO:0042552),-0.33105761549180146,-1.1623349973922055,0.2,0.7603905594812344,1.0,15/46,14.74%,ADGRG6;ACER3;MAL;CMTM8;B4GALT5;MYOC;SCN2A;EIF2B5;DEGS1;TNFRSF21;NF1;MAL2;MALL;PLP1;NFASC
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.3968837260577758,-1.1620559475403285,0.24538258575197888,0.7593570114654711,1.0,4/21,4.35%,MTUS1;PTK2B;THBS1;CMKLR1
prerank,retrograde axonal transport (GO:0008090),-0.43278428487715714,-1.1618147378310688,0.2422062350119904,0.7581250264862098,1.0,8/16,27.71%,DLG2;TMEM108;PAFAH1B1;KIF1A;KIF5A;HAP1;SOD1;ACTR10
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.43361995415831606,1.1614802471939527,0.2934306569343066,0.7796305480572908,1.0,7/34,9.49%,LYN;LGR4;PTPRS;TLR6;NR1D1;IRAK3;RAB7B
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.37763592800878243,1.1609226550422762,0.24269377382465057,0.7804606041066752,1.0,12/80,9.60%,NRP1;AUTS2;PIK3R1;DOCK11;RIPOR2;DPYSL3;CCL19;CDC42EP4;CDC42;ARHGAP35;CROCC;PLEKHM1
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5052149785251349,1.160754251719442,0.3042071197411003,0.7801158186833175,1.0,6/18,17.47%,SETD7;ASH1L;SETD1A;SETD4;KMT2A;SETD1B
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.44221386831801784,1.1605502236858545,0.2861271676300578,0.7798098442525587,1.0,7/32,8.82%,PHLDB2;SERPINE1;ARHGAP6;DLC1;CASK;SRC;MAP4K4
prerank,neutrophil chemotaxis (GO:0030593),-0.32102093216108485,-1.16032640484755,0.1927710843373494,0.7608279056051281,1.0,9/53,12.13%,PDE4B;BSG;TGFB2;PPIA;CCL14;FCER1G;EDN1;CKLF;CXADR
prerank,negative regulation of nuclear division (GO:0051784),0.5423127853893912,1.1600713525774156,0.3104693140794224,0.780329540077193,1.0,3/11,14.90%,TOM1L2;NME6;BMP4
prerank,regulation of lamellipodium organization (GO:1902743),0.5188600915320343,1.1600694979378248,0.3181076672104405,0.7794768462046894,1.0,4/14,8.38%,PDPN;CDC42;CARMIL1;CAPZB
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.3044947520367271,-1.1596472742424262,0.20179372197309417,0.7611973311618541,1.0,31/69,28.83%,COX4I1;NDUFC1;UQCRH;SDHD;COX6A1;COX5B;NDUFA6;NDUFA5;CYCS;NDUFA7;NDUFA8;NDUFB7;NDUFA3;NDUFA10;COX5A;COX6C;NDUFS7;NDUFS1;NDUFS5;UQCR10;NDUFB3;COX8A;UQCR11;UQCRQ;UQCRC1;NDUFAB1;UQCRFS1;AFG1L;NDUFB4;NDUFV2;NDUFV3
prerank,cellular response to glucose stimulus (GO:0071333),0.44494294983712646,1.159099849426,0.29455081001472755,0.7815696233571401,1.0,3/30,5.20%,ZBTB20;GAS6;PRKAA2
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.4851103306503727,1.15897623387924,0.2861788617886179,0.7810739831580404,1.0,2/19,3.12%,ENPP1;TPST1
prerank,protein heterooligomerization (GO:0051291),-0.42205108808841657,-1.1589436774986765,0.2755905511811024,0.7614590764527006,1.0,10/17,27.86%,KCNC2;GRIN2B;CPSF7;MAT2A;HSD17B8;TMEM120A;GRIN1;CBR4;CPSF6;PKD1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.42204836608142227,1.1588135782165276,0.26906474820143883,0.7807029709518141,1.0,6/39,5.70%,NRP1;GDNF;GLI2;SALL1;NKX2-1;ENG
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.5625158377197216,1.1580476642114415,0.3409090909090909,0.7821137981652051,1.0,4/10,13.10%,ATP1A2;ADRA2A;YWHAE;VDAC1
prerank,peptide hormone secretion (GO:0030072),0.4575294470041636,1.157979102149451,0.28414442700156983,0.7814559420861688,1.0,5/26,5.61%,SLC30A8;CDK16;NEUROD1;VIP;FAM3B
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.5531636121204035,1.157466646695738,0.34615384615384615,0.7821562223079789,1.0,2/10,9.33%,MT3;PRKN
prerank,male meiosis I (GO:0007141),0.504521602888512,1.1573117825577615,0.30337078651685395,0.781750189834913,1.0,6/16,17.51%,HSF2BP;ZSCAN21;SYCP3;MYBL1;FOXJ3;DDX4
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.4244593527763322,-1.156808042005736,0.26616915422885573,0.7663438940638603,1.0,3/17,2.87%,CAV1;ADIPOR2;PPARD
prerank,negative regulation of locomotion (GO:0040013),-0.46812621026972945,-1.1563561914684073,0.28743961352657005,0.765887877857505,1.0,3/12,8.56%,FRMD5;PTPN2;CCDC125
prerank,positive regulation of B cell activation (GO:0050871),-0.3314736633600667,-1.1555805623904474,0.23214285714285715,0.7665015303373829,1.0,15/50,17.03%,MEF2C;VAV3;CD38;TFRC;NFATC2;SH3KBP1;SHLD1;CD40;CD81;GPR183;NOD2;PTPRC;BTK;CD27;CD320
prerank,cellular polysaccharide catabolic process (GO:0044247),0.5010460691555714,1.154444268912582,0.31385642737896496,0.7892947754468944,1.0,7/16,16.46%,PHKB;GAA;AGL;PYGM;PYGB;PHKA1;PHKA2
prerank,lamellipodium organization (GO:0097581),-0.364690980333877,-1.1543261512356622,0.22792022792022792,0.7684485489763008,1.0,9/29,9.32%,PARVB;CCDC88A;ABLIM1;S1PR1;SPATA13;CDH13;SNX1;ABLIM3;ABLIM2
prerank,AMP metabolic process (GO:0046033),0.5288574690740471,1.154106475376943,0.32367972742759793,0.7894380056972461,1.0,2/13,3.29%,AMPD3;NUDT2
prerank,cell junction organization (GO:0034330),-0.309727540715967,-1.1539276829775753,0.20192307692307693,0.7678267667640699,1.0,27/71,20.01%,CTNND2;OCLN;PPFIA2;LIMS2;ACTB;TJP2;TJP1;MYO9A;TGFB2;PPFIA1;GRM5;OPHN1;RAB8B;AGRN;TGFB1;CXADR;APP;NLGN3;LIMS1;ELFN1;CBLN2;MARVELD2;ACTG1;DVL1;PPFIA4;SH3BP1;TGFB3
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.39081622409151323,1.1536889403241122,0.2766497461928934,0.7898106567966346,1.0,12/75,6.64%,COL4A3;ROCK2;SPARC;DCN;HSPG2;WNT4;ISM1;THBS2;SULF1;SERPINF1;PML;EMILIN1
prerank,protein glycosylation (GO:0006486),0.36082031300875367,1.153573132585293,0.22606689734717417,0.7893086965689581,1.0,26/125,13.99%,GALNT18;GALNTL5;B3GALT1;OGT;ST3GAL5;PGM3;MAN1C1;ST3GAL3;LARGE1;MOGS;LARGE2;FUT10;B4GALT1;STT3A;DOLPP1;TET1;B3GALNT1;GFPT1;ALG5;ALG11;MGAT3;POMT1;DDOST;GALNT6;ALG10B;ALG6
prerank,regulation of protein localization to membrane (GO:1905475),0.45532545212317893,1.1535081434360692,0.2997076023391813,0.7886491274588964,1.0,3/28,1.39%,GPC6;GSN;AR
prerank,negative regulation of coagulation (GO:0050819),0.5172536891388069,1.1534991708220736,0.2959866220735786,0.7878159495392375,1.0,4/14,5.44%,SERPINE1;APOE;VTN;TFPI
prerank,gliogenesis (GO:0042063),-0.42911183642701356,-1.1533431415048914,0.2736318407960199,0.7677532346285628,1.0,3/15,3.96%,CDH2;CDK6;TGFB2
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.4685564585799646,1.1532121966413733,0.2727272727272727,0.7878126480710199,1.0,4/24,10.49%,ITPR1;CCL19;FGF2;ANXA6
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.4563390661270592,1.1531038852516897,0.3099688473520249,0.7872601027775491,1.0,10/26,22.09%,LGR4;APPL2;IRF1;IRAK3;GPR108;APPL1;TLR5;SMPDL3B;BIRC2;BIRC3
prerank,sulfate transport (GO:0008272),-0.44400016197394476,-1.1530334916025267,0.28110599078341014,0.7668405772575316,1.0,5/14,13.83%,SLC26A7;SLC26A2;SLC25A30;SLC26A6;SLC25A11
prerank,heart contraction (GO:0060047),0.41922365400100764,1.1528257185000148,0.27298050139275765,0.7872190040625164,1.0,7/41,9.67%,SLC8A1;ATP1A2;TPM1;TNNC1;MYL4;GAA;CSRP3
prerank,regulation of NMDA receptor activity (GO:2000310),-0.36671406371309667,-1.1527658860995071,0.2251655629139073,0.7658238362004218,1.0,9/32,8.47%,DLG2;MEF2C;GRIA4;NLGN1;PTK2B;GRIN2A;LRRC7;GRIN2B;GRIA2
prerank,barbed-end actin filament capping (GO:0051016),0.4963667581738897,1.152374284449373,0.31437598736176936,0.7868655270429071,1.0,2/18,1.20%,SVIL;GSN
prerank,actin filament capping (GO:0051693),0.4963667581738897,1.152374284449373,0.31437598736176936,0.7868655270429071,1.0,2/18,1.20%,SVIL;GSN
prerank,endothelial cell differentiation (GO:0045446),-0.4557643330505411,-1.1519725525117421,0.3109048723897912,0.7663675431704152,1.0,6/12,19.43%,TIE1;KDR;ACVRL1;SOX18;BMPR2;ACVR2B
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.4974894468584498,-1.1519479697354942,0.3063063063063063,0.7645727563638576,1.0,3/10,8.02%,HK2;PFKL;PFKP
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.4763684132124991,1.1518703185118193,0.3167202572347267,0.787464837709368,1.0,2/21,4.57%,EPHA7;MT3
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.5404224532323514,1.1514182273172378,0.31802120141342755,0.787992931426476,1.0,4/10,9.07%,HECW2;NEDD4;OSR1;COMMD1
prerank,cellular response to organic substance (GO:0071310),0.35936230646992623,1.1513291352386994,0.25504151838671413,0.7873891903558694,1.0,17/116,8.86%,CLEC3B;PID1;GHR;SMAD3;PTPN13;BMPR1A;PTPN20;TGFBR1;DPYSL3;ACVR1;NCOA2;SFRP1;IGFBP5;CYP1B1;LRRK2;PTPN9;STAT5B
prerank,regulation of mast cell activation (GO:0033003),0.5401292278276908,1.1510010920221216,0.30244755244755245,0.7875564526197661,1.0,2/10,7.08%,LYN;TSLP
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.312690092227558,-1.1504716743279357,0.21634615384615385,0.7672972115943345,1.0,17/67,14.82%,ATP8B1;PODXL;CAV1;PPP1R16B;RABGAP1;TBC1D1;TBC1D8;TBC1D14;RDX;TBC1D15;DCDC2;EVI5;DYNLT2B;ATG3;TBC1D5;SDCCAG8;GAP43
prerank,stress granule assembly (GO:0034063),-0.4075005158403809,-1.1504434716003293,0.2631578947368421,0.7655368546142597,1.0,6/20,12.90%,BICD1;CSDE1;RPS23;LSM14A;YTHDF3;G3BP1
prerank,cardiac muscle cell contraction (GO:0086003),-0.40291026505825966,-1.150110312347676,0.2896039603960396,0.7648407549199364,1.0,8/19,15.08%,KCNJ2;ATP1A1;SCN1A;CAMK2D;FGF12;PIK3CA;CACNA2D1;CACNA1D
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.3569163088363508,-1.1498803748267028,0.2610062893081761,0.7636969086711627,1.0,16/34,27.82%,PDE4D;PDE4B;KCNQ1;NOS1;ATP1B1;CALM1;CALM3;RYR2;CHGA;GJA5;PIK3CG;RGS2;PLN;CALM2;HCN4;SRI
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.5036463498329349,1.1496750829216567,0.3243697478991597,0.7906899621667245,1.0,7/16,23.00%,AUTS2;BCOR;KMT2A;WDR5;DNMT3B;DNMT1;BRCA1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.4540430344258342,-1.14937035823695,0.30170316301703165,0.7634399668194696,1.0,6/14,21.67%,RPL7;NIFK;NOL9;RPL7L1;RPF2;ZNHIT3
prerank,aspartate family amino acid metabolic process (GO:0009066),0.49192992075908004,1.1492900518108862,0.2977346278317152,0.7910295627433276,1.0,3/18,6.15%,ASPG;MTHFR;ASPA
prerank,organelle organization (GO:0006996),0.32690012757686837,1.149040746973323,0.16188524590163936,0.7909609123109413,1.0,109/388,19.67%,SH3D19;MICAL3;NEDD9;OBSL1;TPM1;PYROXD2;USP6NL;LMAN2L;MARK1;ANK1;OPTN;SEC31A;APOE;RAB30;MYO18A;PALLD;CNN2;WDPCP;FGD1;GORASP2;BRWD1;ARHGAP21;TMED1;GOLGB1;PHIP;LIG4;FGD4;FAF2;DES;LMAN1;ARHGAP10;CDC42;ZW10;RANBP9;LRRK2;UBXN2B;EPS15;EIF2AK3;CSPG5;WTIP;PLD2;MAST2;CAPZB;TRIP11;WDR81;PRKN;MIA3;RHOT1;ARL1;TMED4;PLEKHM2;LONP2;TJAP1;TFAM;PDZD8;POLRMT;PEX6;GOLPH3L;CFAP410;GORASP1;FGD3;SLC25A36;PEX2;SIPA1;GOLGA8B;GOLGA5;CHMP5;RAB3GAP1;ABCA3;TANGO2;CECR2;MDK;ABCD2;ATP8B2;TOR1B;PEX11B;TBC1D20;BAG5;HACE1;HUWE1;PIKFYVE;AUP1;CUL7;GOLPH3;VPS13D;TOR1AIP2;ARFGEF1;LONP1;RHOU;VPS13C;CAMSAP1;RAB32;TMED10;DYRK3;PRKCI;YME1L1;CSNK1A1;PHB2;ODF2;SEC16B;DPYSL2;CDCA8;SIRT5;HTT;NUMA1;SMPD4;ZFYVE16;PEX7;NSFL1C
prerank,regulation of protein ubiquitination (GO:0031396),0.3644004803458312,1.1488730383856978,0.25483091787439616,0.790594964189762,1.0,22/108,15.21%,MYCBP2;ANGPT1;SASH1;OGT;TGFBR1;CDK5RAP3;PRICKLE1;DERL1;LRRK2;SPRTN;ARRB1;SPRY2;COMMD1;PRKN;UFL1;FBXO4;HDAC8;RIPK2;FANCI;UBE2D1;BAG5;HUWE1
prerank,vacuolar acidification (GO:0007035),0.468790494304924,1.148800776240993,0.2859375,0.7899424319079524,1.0,1/21,0.20%,ATP6V0A4
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.37708987713729963,1.1487828914889877,0.26485148514851486,0.7891504720776552,1.0,14/80,11.00%,SAMD4A;ROCK2;PLD1;EPHA4;SMPD2;CPEB3;CD28;SPHK2;SLC2A13;METTL14;PICALM;EIF6;NSMAF;DDX3X
prerank,homocysteine metabolic process (GO:0050667),0.5296511088551503,1.148404623760098,0.3137614678899083,0.7894671796166415,1.0,4/11,13.13%,MTHFR;DPEP1;MMUT;NOX4
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.5379029097466007,1.1483439402579079,0.3201320132013201,0.7888060463657895,1.0,4/12,14.80%,ABCA1;ITGB3;ITGAV;NR1H3
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.4919185000262416,-1.1477919377403112,0.30855855855855857,0.7665697299576298,1.0,7/10,31.21%,NOTCH1;LRP6;LIN7C;DLL4;ARHGAP12;TBX20;PHACTR4
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5549966040044421,1.1477114425377926,0.30742049469964666,0.7898815343921652,1.0,1/10,0.24%,BMP6
prerank,nuclear pore organization (GO:0006999),-0.4299581388543452,-1.1475817857653101,0.2857142857142857,0.7654091506607275,1.0,4/14,7.43%,NUP93;NUP35;NUP153;NUP54
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3586693460006461,1.1474113193705884,0.24352941176470588,0.7899332663908213,1.0,13/116,6.97%,ADCY1;ADCY2;LYN;ADCY7;ADCY5;ADCY9;INSL3;VIP;LHCGR;ADRB3;SRC;CD247;DPEP1
prerank,"phototransduction, visible light (GO:0007603)",-0.43972459498909094,-1.1473533817443773,0.29081632653061223,0.7642609810421443,1.0,7/14,33.84%,RP1;GNB1;PDE6A;GNA11;GNAQ;PDE6B;SAG
prerank,positive regulation of nervous system development (GO:0051962),-0.3406160054643277,-1.1471977653014576,0.23452768729641693,0.7629252370047499,1.0,17/42,16.30%,GRID2;NLGN1;IL1RAPL1;PTPRD;EPHB1;NRXN1;TGM2;SNW1;CLSTN2;CLSTN3;CX3CR1;FAIM;MME;NUMB;NLGN3;LRRC4B;GPER1
prerank,negative regulation of chemokine production (GO:0032682),-0.43514659905960007,-1.146780037185683,0.2892768079800499,0.7623957844127147,1.0,4/14,14.23%,APOD;SIRPA;KLF4;SIGIRR
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.31256997058768915,-1.1467422307838793,0.18532818532818532,0.76070024625586,1.0,23/63,24.61%,MEF2C;VAV3;CD38;SLC7A1;IL15;TFRC;NFATC2;CD40;CD80;CD81;GPR183;PTPRC;JAK3;CD320;NCK2;PNP;CD86;ANXA1;CD276;AIF1;VCAM1;IRS2;MIF
prerank,icosanoid metabolic process (GO:0006690),0.4258111867657839,1.1458851866989348,0.2905027932960894,0.793569694901015,1.0,7/40,7.17%,PTGIS;DAGLA;PLA2G4A;CYP1B1;DPEP1;ALOXE3;DPEP2
prerank,neural crest cell differentiation (GO:0014033),-0.42199128408000186,-1.145528600789361,0.28296703296703296,0.7627542881509025,1.0,3/18,5.51%,MEF2C;CDH2;LRP6
prerank,protein mannosylation (GO:0035268),0.4793480851979988,1.1453748388147411,0.2936630602782071,0.7941588035250011,1.0,4/22,5.90%,TMTC1;TMTC4;LARGE1;LARGE2
prerank,regulation of DNA repair (GO:0006282),0.4085297601206834,1.1450954755199365,0.29219858156028367,0.7941230444337418,1.0,11/44,16.60%,EYA2;EYA1;AXIN2;PML;TRIP12;UBE2V2;EGFR;ERCC8;NPAS2;UBR5;SMCHD1
prerank,myoblast fusion (GO:0007520),-0.4666969973399556,-1.1450847260342851,0.2777777777777778,0.7623837327208984,1.0,6/12,13.74%,ADGRB3;JAM2;ADAM12;NOS1;CD81;CACNA1H
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.4203599531220259,-1.1440135149761705,0.3033419023136247,0.7638202062861031,1.0,4/15,15.96%,ARPC1B;ARPC3;ARPC5L;ARPC4
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.2761863581911888,-1.1427914062715445,0.17763157894736842,0.7657008217039422,1.0,33/114,23.95%,TMSB4X;PTK2B;TNFRSF11A;ST18;NFKBIA;TNFRSF11B;AIM2;JAK2;BAG4;TRAF5;EIF5A;CARD14;CD40;PSMF1;TRAF1;TXNDC17;PSMB8;PSMA4;PSMB10;PSMB2;LIMS1;CD27;PSMC4;PSMA6;PSMD9;PSMD11;PSMD5;TRAF2;COMMD7;CHUK;TNFRSF12A;PSMA8;PSMB1
prerank,negative regulation of secretion by cell (GO:1903531),-0.3446271582747356,-1.1425293946461819,0.25,0.7647609360289579,1.0,4/38,2.20%,GRM7;STXBP6;IL1RAPL1;NOTCH1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.40766209317347435,-1.142397225582312,0.28695652173913044,0.7633541150498352,1.0,11/20,27.21%,GATM;GCLM;PTDSS1;OPLAH;GAMT;GCLC;GGT1;GGCT;PLSCR1;GSS;PLOD2
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.3522735873923994,-1.1423753642005108,0.2585669781931464,0.7616545852848342,1.0,16/36,24.79%,SDCBP;RYBP;OPHN1;RPL11;HSP90AB1;AQP11;PSMF1;GIPC1;N4BP1;FHIT;DDRGK1;UBXN1;CAMLG;CCAR2;USP7;PRKCG
prerank,negative regulation of protein depolymerization (GO:1901880),0.45731045819434385,1.1422798072182785,0.2857142857142857,0.8015091498674374,1.0,8/24,21.34%,PLEKHH2;LIMA1;KATNB1;FGF13;HDGFL3;CAMSAP1;ATXN7;TAOK1
prerank,regulation of cell motility (GO:2000145),0.3569770015592686,1.1419796444966472,0.27423167848699764,0.801579418719472,1.0,27/121,14.43%,PLXNA2;LDB2;ROCK2;AMOTL2;DOCK10;ARHGAP18;MACF1;CCL19;FBLN1;TBCCD1;BEX4;MEMO1;PARD6B;EGFR;NTN1;LMO4;FGF2;NEXN;AMOTL1;HBEGF;CCDC25;MGAT3;PLXNC1;EGF;PLXNA1;PLXNB2;FLNA
prerank,pyruvate metabolic process (GO:0006090),-0.32172260726651547,-1.1418439721750038,0.24705882352941178,0.7615386094765405,1.0,13/52,12.09%,BSG;GPI;HK2;DLAT;SLC16A1;ME1;PDHX;PFKL;TPI1;PFKFB1;ALDOA;LDHB;ME2
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.479826784560976,1.1418351353552616,0.3011093502377179,0.8011382931811459,1.0,8/20,21.45%,SLC8A3;MCU;PMPCB;MICU2;YME1L1;PHB2;AFG3L2;STOML2
prerank,B cell activation involved in immune response (GO:0002312),0.5297625191518197,1.1417796538253613,0.3239929947460595,0.8004475642649642,1.0,3/13,6.85%,GAPT;LIG4;BATF
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.476518214729738,1.1414516048263261,0.330188679245283,0.8005443993558401,1.0,4/20,6.67%,SLC8A1;ATP1A2;GSTM2;CACNA1C
prerank,polyamine metabolic process (GO:0006595),0.5319850976599443,1.1410383539727302,0.3356643356643357,0.8009124054961049,1.0,5/13,22.75%,SMOX;SMS;SAT2;SAT1;HDAC6
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3566840213065682,1.1407560177247233,0.2505854800936768,0.8008676662754278,1.0,13/117,6.97%,ADCY1;ADCY2;LYN;ADCY7;ADCY5;ADCY9;INSL3;VIP;LHCGR;ADRB3;SRC;CD247;DPEP1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.4836084601533247,1.140631766935428,0.3311897106109325,0.800386962070271,1.0,6/20,14.19%,SULF2;SULF1;SMOC2;SPRY2;FGF2;DSTYK
prerank,positive regulation of tissue remodeling (GO:0034105),0.5425965739462116,1.1404577563256695,0.3333333333333333,0.8000521130775111,1.0,2/10,6.81%,ROCK2;IL12B
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.43395343783996265,1.1404341970275218,0.30612244897959184,0.7992753754154468,1.0,4/35,3.16%,PAM;SLC27A5;ACSS3;HMGCLL1
prerank,negative regulation of neurogenesis (GO:0050768),-0.3537747256723299,-1.1401928645004267,0.2534722222222222,0.7649748892341135,1.0,12/34,18.53%,NOTCH1;B2M;YWHAH;SORL1;GDI1;ARHGDIA;PTN;NF1;LINGO1;MAG;MCF2;RTN4R
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.3855232111811069,-1.1397672220756618,0.2506393861892583,0.7645099700675744,1.0,11/23,22.34%,PDE4B;TGM2;KCNQ1;ATP2B4;GNB1;GNG2;MAPK3;RYR2;GABPA;ATF4;MAPK1
prerank,regulation of transport (GO:0051049),0.4196985085890368,1.139247424899517,0.3001464128843338,0.8019278167799385,1.0,6/36,9.33%,NRP1;LEPR;SLC30A8;LRRK2;RAB25;PRKN
prerank,negative regulation of endocytosis (GO:0045806),0.45415376309573685,1.1388406821457853,0.30109204368174725,0.8022485328009733,1.0,6/24,15.37%,EPHA3;SNX33;PICALM;SYT11;NR1H3;ARF6
prerank,protein lipidation (GO:0006497),-0.3031531470052066,-1.1382610628483614,0.22477064220183487,0.7673753016050205,1.0,19/59,18.79%,ZDHHC2;DPM1;PIGP;ZDHHC16;PGAP2;ZDHHC15;GPLD1;UGCG;ZDHHC14;PIGB;WDR45B;ZDHHC5;PIGL;DPM3;WIPI2;PIGU;DPM2;PIGO;PIGV
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.3927130226617109,-1.1381350986202554,0.276536312849162,0.7659862618098872,1.0,11/22,31.32%,PTPRJ;PTPN2;PTPN22;CEACAM1;DGKZ;CD300A;DUSP3;PRNP;GPS2;FCGR2B;PHPT1
prerank,regulation of cellular localization (GO:0060341),0.41043130128229327,1.1379770225004573,0.2793914246196404,0.8039568809592472,1.0,11/46,9.33%,GSN;LYN;ADCY5;CDK16;DYNC1H1;LRRK2;BRSK1;NR1D1;PARD6G;PARD6B;PRKN
prerank,regulation of JNK cascade (GO:0046328),0.3619406203034432,1.1376946999584607,0.26951219512195124,0.8039431909056703,1.0,19/101,12.76%,CCN2;TGFBR3;SH3RF3;DACT1;SH3RF1;GADD45B;CCL19;EDAR;MTURN;NCOR1;EGFR;MAP4K4;PRKN;LTBR;ITCH;CARD9;TAOK3;DUSP19;RAP2A
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.3780444200492851,-1.1373061501334953,0.28493150684931506,0.7667138044641617,1.0,9/25,14.09%,CAV1;CTNNA3;CAMK2D;CALM1;JUP;CALM3;CXADR;RYR2;DSG2
prerank,circulatory system development (GO:0072359),0.35692049960936767,1.1372993022710605,0.2520808561236623,0.8042480984404042,1.0,21/118,8.84%,RBP4;FBN1;PDLIM5;HSPG2;GLI2;SALL1;PDLIM2;TGFBR1;SH3PXD2B;ACVR1;CDH5;ADAP2;BCOR;CRB2;CACNA1C;OSR1;NTRK3;FOXC2;BMP2;EEF1AKMT4-ECE2;KAT2B
prerank,regulation of protein phosphorylation (GO:0001932),0.3311945581480673,1.1372755320271732,0.21528525296017223,0.803478188666195,1.0,55/256,14.90%,EPHA7;IGF2;ROCK2;ANGPT1;PID1;PTPN13;PLPP3;LYN;LEPR;IL34;PELI2;CCN1;GAS6;FBLN1;CDK5RAP3;TSPYL2;MT3;AXIN2;PHIP;MUSK;SLCO3A1;CDH5;ENG;PML;LRRK2;WWTR1;EIF2AK3;NTRK3;STK4;DAB2;ARRB1;EGFR;EPHB2;BMP2;PRKN;MYADM;ITGB3;STAT2;NSD1;FGF2;IGFBP3;CEBPB;F2;IMPACT;PPP2R5D;INSR;RAP2A;TMEM119;PTEN;PDCL3;PLXNB2;IBTK;AKAP8L;RSPO1;BMP4
prerank,vasculature development (GO:0001944),0.49412350283809614,1.1371106512222897,0.330550918196995,0.8031397415624187,1.0,5/16,9.87%,ERRFI1;PDGFRA;PDGFRB;CDH5;STK11
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.46211076280723656,1.1363508139547207,0.3393124065769806,0.8045607919044906,1.0,8/23,15.03%,ENPP1;GLI3;MGRN1;TULP3;GLIS2;PTCH2;BTRC;SUFU
prerank,inorganic cation transmembrane transport (GO:0098662),0.33146481924341936,1.1360595721088715,0.2113127001067236,0.8045939738032535,1.0,30/268,9.63%,SLC1A3;ATP6V0A4;KCNK2;SLC24A3;SCN7A;NALCN;SLC8A1;SLC8A3;TRPA1;ATP1A2;SLC41A1;SCARA5;SLC6A9;SLC30A8;GAS6;SLC6A13;SLC9A9;SLC24A1;SLC30A2;KCNK7;SLC11A2;SLC24A5;CACNA1C;SLC30A10;NNT;KCNQ4;SLC9A5;KCNJ14;TRPM4;ITGAV
prerank,calcium ion homeostasis (GO:0055074),0.35777694234001434,1.1353960954660587,0.2631578947368421,0.8056704845573922,1.0,13/95,9.67%,SLC24A3;SLC8A1;SLC8A3;DMPK;CCL19;STIM1;ATP13A3;SLC24A1;CDH5;SLC24A5;TMEM203;DRD3;CSRP3
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.5249444432873598,1.1352945008694928,0.31393298059964725,0.8051271220333976,1.0,3/12,3.82%,DOCK10;DOCK11;NOTCH2
prerank,negative regulation of cellular process (GO:0048523),0.3244320650732459,1.1352858975373217,0.17522658610271905,0.8043243141548333,1.0,127/521,17.58%,PLXNA2;GJA1;ENPP1;COL4A3;CCN2;ANGPT1;TGFBR3;TXNIP;SMAD3;AR;LYN;DLC1;BCL2;PODN;CCN1;SP100;RIPOR2;PDS5B;NUPR1;SEMA5A;UBR2;PDCD5;FBLN1;APOA1;RAPGEF2;TSPYL2;APPL2;IRF1;MT3;AXIN2;RARG;SFRP1;CCN5;PDPN;CYP1B1;BCL6;SKI;CASK;ALDH1A2;APBB2;PML;EMILIN1;PARP16;CEBPA;ING5;P3H3;SPHK2;SIRT2;EIF2AK3;MAP2K1;NMI;RNF139;PIWIL4;DSCAM;EPHB2;CD200;BMP2;KAT2B;CCN4;PRKN;S100A11;MIA3;STK11;INCA1;RBBP7;SLIT3;FGF2;ANXA6;FGFBP1;DDX3X;IGFBP3;GSDME;IFNK;JADE1;CGRRF1;RGCC;ST7L;SPOCD1;NME6;RAD18;REST;NR4A1;IMPACT;CD33;PLXNC1;NIBAN2;CDA;PDCD4;SIPA1;ACVR1B;DACT2;MUL1;NOX4;NPAS2;SYT11;TSC2;GLMN;PLXNA1;PTEN;CLMN;ETS1;FRK;MDK;PLXNB2;NR1H3;FER1L5;BMP4;SFRP4;RBM5;TMBIM6;SESN2;PRKRA;BMP5;ZBTB17;SST;SPEG;KANK2;ADAMTS1;ATF5;SHH;TNS2;CDKN2C;MYBL1;VPS13C;DDX4;DCBLD2;CDK10
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.3893024034792845,1.1349678314329203,0.2634338138925295,0.8044195300818411,1.0,18/59,18.50%,PDPK1;ROCK2;TGFBR1;ACVR1;LRRK2;MAP2K1;OXSR1;TTBK1;TBK1;WNK1;ACVR1B;MARK2;DYRK1A;DYRK1B;AKT1;CDK10;DYRK3;PRKCA
prerank,regulation of hydrolase activity (GO:0051336),-0.29928740494288397,-1.1344084601421212,0.2264957264957265,0.7740598514342943,1.0,18/71,7.22%,CHN2;EFNA5;FGD5;CAV1;PLXNA4;ARHGAP44;VAV3;RABGAP1;SIPA1L1;RASIP1;PRKG1;RDX;TBC1D15;ARHGAP27;EPHA5;NOS1;NGEF;CHN1
prerank,regulation of cell population proliferation (GO:0042127),0.32145043090946457,1.1343493581505981,0.1354062186559679,0.8052705308554903,1.0,118/691,14.09%,IGF1;TCF7L2;BMP6;IGF2;ESM1;COL4A3;ELN;GDNF;PDGFD;KSR1;AR;AREG;TGFA;IL31RA;LYN;DLC1;BCL2;GRK5;PODN;RUNX1;FGFR1;IL6R;BMPR1A;IL34;OSMR;EPGN;FGFR2;KIT;FGFR4;RBFOX2;YAP1;PDGFRA;PDS5B;EFNB2;PDGFRB;TGFBR1;NUPR1;NPR3;PDCD5;CSF1;RAPGEF2;IRF1;NTF3;HTR1A;AXIN2;PHIP;RARG;SFRP1;CTSH;PDPN;TBX3;CYP1B1;VIP;BCL6;ENG;ZFP36L1;SKI;ALDH1A2;NUAK1;PML;BEX4;CEBPA;AGTR1;ING5;P3H3;TSLP;WWTR1;RAB25;IL13RA1;SIRT2;MAP2K1;NMI;RNF139;TET1;NTRK3;EGFR;CD200;BMP2;KAT2B;STAT5B;TRPM4;S100A11;ITGAV;STAT2;STK11;INCA1;FGF2;CDC123;TSPO;FGFBP1;SETD4;IGFBP3;GSDME;IFNK;HBEGF;ADRA2A;CGRRF1;UFL1;RGCC;REST;CD33;NIBAN2;GLI1;HMGN5;INSR;STAT6;FOLR2;NOX4;EGF;STAT4;TSC2;GLMN;HDAC4;PTEN;FLT3LG;CLMN;ETS1;FRK
prerank,Golgi localization (GO:0051645),0.539218186640526,1.134313406306072,0.3427065026362039,0.8045590948632205,1.0,5/11,17.59%,ARHGAP21;TBCCD1;CDC42;UVRAG;COPG1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.4351368771527566,1.1342055614360267,0.3064275037369208,0.8040573517668592,1.0,3/31,8.62%,RBP4;KMT5B;EPHB2
prerank,regulation of transferase activity (GO:0051338),0.48398339003024143,1.134036184773599,0.32172470978441126,0.8037061175995033,1.0,1/17,0.36%,LDB2
prerank,regulation of sensory perception of pain (GO:0051930),-0.47184809238273345,-1.1339321855414188,0.3443396226415094,0.7737209363154386,1.0,5/11,19.08%,MGLL;CCN3;ATPSCKMT;ZFHX2;ACP3
prerank,negative regulation of phosphorylation (GO:0042326),0.3703207100725689,1.1337837483342301,0.2747524752475248,0.803666778206511,1.0,23/85,15.47%,PID1;PTPN13;PLPP3;LYN;DYNLL1;NUPR1;FBLN1;CDK5RAP3;LRRK2;WWTR1;NTRK3;NCOR1;EPHB2;PRKN;MYADM;IGFBP3;IMPACT;HDAC4;PTEN;IBTK;BMP4;CDKN1C;NPRL2
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.41903739718132066,1.1337371996425063,0.30945558739255014,0.8029828686312973,1.0,5/38,7.79%,RORA;RHOH;TLE1;MAPKBP1;NR1D1
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.48589858312358675,-1.1332697546291064,0.3273542600896861,0.7740337011357443,1.0,3/10,10.51%,ENPP2;PLA2G7;PNPLA8
prerank,carboxylic acid transmembrane transport (GO:1905039),0.41963822279451063,1.1332571329745542,0.31532846715328466,0.8035529122138565,1.0,10/40,15.61%,SLC7A11;SLC13A3;SLC7A13;SLC38A6;SLC38A9;ABCC5;SLC38A3;SLC7A6;SLC38A10;SLC38A2
prerank,neuron migration (GO:0001764),0.4057718990419025,1.1325668656758279,0.2862957937584803,0.8047432520441438,1.0,7/48,5.49%,NRP1;AUTS2;FGFR1;MARK1;SH3RF1;RAPGEF2;LRP12
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.3343112150142647,-1.1323883247765418,0.2517985611510791,0.7749211594199994,1.0,12/42,10.26%,UTRN;TEK;PTPRJ;CDK6;PTK2B;KDR;MYOC;EMP2;CDH13;VEGFA;JUP;SKAP1
prerank,positive regulation of catalytic activity (GO:0043085),0.41337338736433826,1.1323373666629895,0.31353591160220995,0.8046156574401925,1.0,6/37,9.30%,IGF2;FGFR4;APOA1;MT3;NHEJ1;SLC5A3
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.4105931650087486,1.132284243842105,0.30307262569832405,0.8039294231619438,1.0,13/46,17.56%,TIMP3;LYN;FBLN1;RANBP9;EMILIN1;EPHB2;SPRY2;SPRED3;CNKSR3;PTEN;SPRED1;DUSP4;TNIP1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.44771545279577224,1.1318661840359263,0.3188622754491018,0.804322853725897,1.0,2/28,1.86%,ITPR1;BCL2
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.4323001268122387,1.1311166449753813,0.29651162790697677,0.8056744505967164,1.0,2/32,0.72%,PDPK1;CEMIP
prerank,aspartate family amino acid catabolic process (GO:0009068),0.48487291183045167,1.1309597981520836,0.3099688473520249,0.8053092585632389,1.0,4/19,8.30%,PHYKPL;DDO;ASPA;ALDH7A1
prerank,regulation of cell junction assembly (GO:1901888),-0.36838770608843313,-1.1308254514140765,0.2891566265060241,0.7780358323343549,1.0,7/27,2.91%,PRKCH;MEF2C;OCLN;CLDN5;RAP1A;F11R;TJP1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.5099153501369805,1.1304936602959246,0.3242784380305603,0.8057849147313803,1.0,4/13,14.79%,OGG1;NEIL1;MBD4;UPP2
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.4354055026224423,-1.1304085562268973,0.3185378590078329,0.7776012672806578,1.0,6/14,19.53%,THBS1;NOTCH1;KLF4;DLL4;ITGB1BP1;PDCD10
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5130430945702327,1.1302612841571016,0.35181975736568455,0.8056218978200779,1.0,4/13,11.82%,PGM3;LARGE1;RENBP;MGAT3
prerank,mesenchymal cell development (GO:0014031),-0.41668481656859097,-1.1299587992094853,0.3074792243767313,0.7772778585364508,1.0,8/18,28.16%,CDH2;NOTCH1;HEY2;SOX8;HEYL;SNAI2;NOLC1;TBX20
prerank,cell differentiation in hindbrain (GO:0021533),-0.46171744007102655,-1.1298952020076258,0.3384279475982533,0.7757115956086503,1.0,3/11,11.80%,GRID2;OPHN1;ATP7A
prerank,regulation of cell communication (GO:0010646),0.4224236086052612,1.1297931481705765,0.31654676258992803,0.8061447944789011,1.0,4/35,4.40%,SLC8A1;GRK3;GRK5;TSPYL2
prerank,regulation of protein localization to cell surface (GO:2000008),0.42254433347369846,1.1297200735693251,0.3206997084548105,0.8055021179604627,1.0,10/33,19.68%,ACTN2;LEPROT;SNX33;PICALM;COMMD1;TAX1BP3;EGF;BDNF;TM9SF4;ABCA7
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.509709018886061,1.129710512322698,0.32081911262798635,0.8047123695525803,1.0,3/14,4.31%,GAS6;RFFL;APOA1
prerank,macrophage chemotaxis (GO:0048246),-0.4838917964817867,-1.1294125033220177,0.33111111111111113,0.7754808330193717,1.0,7/10,47.64%,CKLF;EDNRB;CCL2;CXCL17;CCL3;CCL5;LGALS3
prerank,positive regulation of protein ubiquitination (GO:0031398),0.37036248121406795,1.1293724650716614,0.2884130982367758,0.804876380541712,1.0,15/80,15.27%,MYCBP2;ANGPT1;ARRDC4;CDK5RAP3;PRICKLE1;DERL1;LRRK2;SPRTN;COMMD1;FBXO4;RIPK2;FANCI;UBE2D1;HUWE1;DCUN1D2
prerank,cortical actin cytoskeleton organization (GO:0030866),0.46694409577356333,1.1293434618402056,0.32741935483870965,0.8041443976194567,1.0,9/20,23.18%,ROCK2;FMNL1;RHOQ;LLGL1;ARF6;FHOD1;LLGL2;NCKAP1L;DLG1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.3688960444882254,1.129150527066529,0.289873417721519,0.8038915793514405,1.0,18/76,17.56%,MYCBP2;ANGPT1;CDK5RAP3;PRICKLE1;DERL1;LRRK2;SPRTN;COMMD1;FBXO4;RIPK2;MUL1;HDAC4;FANCI;UBE2D1;HUWE1;DCUN1D2;UBE3A;TNIP1
prerank,somite development (GO:0061053),0.5268576816961857,1.1288567241132264,0.3493150684931507,0.8039071194374111,1.0,5/11,21.15%,SMO;MEOX2;SHH;SOX11;PPP2R3A
prerank,blood vessel diameter maintenance (GO:0097746),-0.3416286384667574,-1.1288424539958002,0.28213166144200624,0.7754246557188512,1.0,14/34,20.25%,EDNRA;NOS3;KLF2;NOS1;NPR1;KCNMB2;GCLM;ACE2;EDN1;EDNRB;GPER1;GCLC;ITGB1BP1;ROCK1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.4647999581649101,1.128249103756043,0.3234375,0.8049375705992617,1.0,7/20,19.02%,NR2F2;CEBPA;HEXIM2;INCA1;PTEN;CDKN1C;CDKN1B
prerank,synaptic vesicle endocytosis (GO:0048488),-0.3512469391438885,-1.1274360655266484,0.24600638977635783,0.7780550059640374,1.0,13/33,18.60%,DNM3;NLGN1;AMPH;OPHN1;CDK5;SYT1;GAK;ITSN2;PACSIN1;NLGN3;DNM1;STX1A;SYNJ1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.47708115506958637,1.127210975290577,0.3184818481848185,0.8071795683336528,1.0,4/18,8.21%,DAAM2;IL34;SLC45A3;DRD3
prerank,positive regulation of actin nucleation (GO:0051127),0.5290676318000052,1.1270856304606396,0.3607142857142857,0.8067344064563552,1.0,3/11,16.32%,GSN;WASF1;FCHSD2
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.32831549962947276,1.1270733112229245,0.2203742203742204,0.8059467184787602,1.0,79/327,18.97%,NFIA;IGF2;RORA;RHOH;ATXN1;ARNT2;MITF;WWC2;NUP107;TGFBR1;OGG1;MSC;NCOA2;DENND4A;ENG;TCF7;APBB2;NAB2;PML;CEBPA;WWTR1;SAP30;REXO4;ZBTB38;WTIP;TULP3;TCF7L1;CREBL2;BMP2;ZMIZ1;ZBTB4;NONO;MZF1;ACTN4;GTF2IRD1;NSD1;ACTR8;ZSCAN21;PHF1;RNF6;NR1D2;CEBPB;IFNK;REST;HMGN5;INSR;ACVR1B;TRIP4;TAF5L;ZNF219;YAF2;SUFU;MYCBP;FOXK2;SAP30L;GPBP1;FADS1;TGFBRAP1;PSPC1;MYT1;MAFA;PLAG1;COPS2;ZNF423;ATF5;SP1;ZFAT;MYBL1;SPIN4;IRF2;SRSF10;PPIE;NFIL3;SOX11;GON4L;CARM1;ATRX;CREM;CHD7
prerank,negative regulation of mRNA processing (GO:0050686),-0.4365717703320402,-1.1266607130411668,0.3146341463414634,0.7785592247132116,1.0,9/15,32.67%,SRSF12;SRSF7;RBMX;C1QBP;SRSF4;PCBP4;U2AF2;RNPS1;BARD1
prerank,protein localization to cell junction (GO:1902414),-0.3837114522145877,-1.126437968390681,0.2969187675070028,0.7775333068746058,1.0,8/22,12.65%,NLGN1;TJP2;TJP1;NECTIN1;HEG1;SHANK1;PCLO;PAK2
prerank,RNA methylation (GO:0001510),0.38065664500806784,1.1264000954973576,0.2821522309711286,0.8070465235953447,1.0,18/60,19.91%,TRMT44;BUD23;TRMO;NSUN2;METTL14;DIMT1;FTSJ3;WTAP;BCDIN3D;TRMT13;TRMT112;NSUN5;THUMPD3;THUMPD2;NSUN4;THADA;METTL3;METTL1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.4525475909166668,1.1263539798083793,0.33183183183183185,0.8063590501425217,1.0,10/23,26.88%,EPHX2;GSTM4;GSTM2;ALOXE3;FADS1;CYP1A1;ALOX12;HPGD;LTA4H;ACOT7
prerank,positive regulation of protein metabolic process (GO:0051247),0.3549271335798804,1.1261194588912644,0.27383863080684595,0.8062374913983866,1.0,15/110,6.91%,ROCK2;HECW2;DACT1;NKD1;SLC6A9;IL17D;APOE;CSF1;NEDD4;SLC25A37;SMURF2;VIP;RANBP9;IL12B;AGTR1
prerank,potassium ion export across plasma membrane (GO:0097623),-0.4540071802366671,-1.125999969736644,0.32142857142857145,0.7771376483820186,1.0,3/13,5.44%,KCNK5;KCND3;KCNQ1
prerank,positive regulation of apoptotic process (GO:0043065),0.33107470676328193,1.1259415114021685,0.24066390041493776,0.8059309027020042,1.0,59/293,16.02%,STK17B;EPHA7;DAPK2;PTGIS;DAPK1;DLC1;OLFM1;PLEKHG2;GADD45B;TIAM2;PHLDA1;TGFBR1;NUPR1;MOAP1;SOS2;FGD1;PDCD5;NEUROD1;ING3;RARG;SFRP1;FGD4;MAP3K20;CYP1B1;BCL6;ARHGEF17;SIK1;ING5;SPHK2;SIRT2;ARHGEF18;TRAF7;STK4;BCL2L11;ARHGEF11;BMP2;AIFM1;FOXA1;APH1B;DDX3X;IGFBP3;SPDEF;ADAMTSL4;FGD3;REST;PLEKHN1;PAWR;IFIT2;AKAP13;MTCH2;MTCH1;BMP4;SUDS3;SFRP4;RBM5;NLRC4;ARHGEF19;CASP9;TRIO
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.37787396928278844,1.1257906393128454,0.28754813863928114,0.8055171303976175,1.0,17/66,17.14%,PIK3R1;SMAD3;ZIC1;YAP1;CDK5RAP3;WWTR1;EIF2AK3;RBM22;F2;NMD3;FLNA;SESN2;PIK3R2;UBR5;AKT1;LIF;EFCAB7
prerank,heart process (GO:0003015),-0.4377161868284705,-1.1257160885881106,0.31971153846153844,0.7762781646380698,1.0,1/14,0.35%,SGCZ
prerank,cellular component disassembly (GO:0022411),0.38950438115992997,1.125550179590401,0.3077922077922078,0.8054120199055733,1.0,10/53,9.84%,ADAMTS5;GSN;LAMC1;MMP2;MMP19;SH3PXD2B;MMP11;TIMP2;SCUBE1;HTRA1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.441420803571587,-1.125407361376042,0.28361858190709044,0.7754952532691574,1.0,8/14,30.81%,SRSF12;SRSF7;RBMX;C1QBP;SRSF4;PCBP4;U2AF2;RNPS1
prerank,synaptic membrane adhesion (GO:0099560),0.5066586554173991,1.1253367073006364,0.34982935153583616,0.8052533284362494,1.0,2/14,5.19%,GPC6;PTPRS
prerank,positive regulation of metabolic process (GO:0009893),0.35834335901289877,1.1248415996132233,0.28263473053892213,0.8058685732553266,1.0,22/103,15.29%,GJA1;CAMK1D;LEPR;OGT;ACSL1;GNAS;APPL2;EPAS1;DYNC1H1;ADRB3;ALMS1;MFAP2;CEBPB;INSR;STAT6;DECR1;DIO2;G0S2;FASN;CNOT3;IL4R;GRB10
prerank,stabilization of membrane potential (GO:0030322),0.4843540031671661,1.1230122829534812,0.32405891980360063,0.8104035417576024,1.0,2/16,6.18%,KCNK2;KCNK7
prerank,muscle cell development (GO:0055001),0.4319560762281952,1.1228155472893169,0.29797191887675506,0.8101310593535168,1.0,4/30,6.56%,IGF1;SLC8A1;ENG;SDC1
prerank,regulation of coagulation (GO:0050818),-0.45948351842612795,-1.1225829460166425,0.30120481927710846,0.7822112274668531,1.0,2/11,5.27%,CAV1;HS3ST5
prerank,generation of neurons (GO:0048699),0.3417594895070745,1.1224401449538814,0.25877192982456143,0.8103190728015001,1.0,25/190,7.60%,NRP1;AUTS2;RUNX1;FGFR1;MARK1;SH3RF1;WNT8B;FZD2;WNT4;ASCL1;YAP1;RUNX2;WNT6;RAPGEF2;NEUROD4;NEUROD1;FZD1;LRP12;THOC2;ATOH8;HES7;SMARCA1;WNT5B;BRSK1;MAP2K1
prerank,melanosome localization (GO:0032400),-0.38672019236343663,-1.1223467422561588,0.2991913746630728,0.781197075463003,1.0,8/21,19.54%,RAB27A;RAB11A;RAB27B;ARL6;MLPH;BLOC1S5;BBS7;MREG
prerank,regulation of protein kinase activity (GO:0045859),0.35700226544567487,1.122265547258917,0.2950236966824645,0.8100098518450185,1.0,11/106,4.40%,PDPK1;DDR2;PPM1E;CCN1;DTNBP1;PRKAG2;GAS6;CCL19;CSF1;RAPGEF2;TSPYL2
prerank,spliceosomal complex assembly (GO:0000245),0.39411977494873635,1.122155744142628,0.31444759206798867,0.8095166225051329,1.0,12/46,18.52%,CELF2;SF1;DDX23;NOL3;SNRPD2;SRSF5;RBM5;PRPF6;SF3B1;SRSF10;KHDC4;DDX1
prerank,phosphorylation (GO:0016310),0.32023221264314805,1.1215672056283825,0.21836734693877552,0.8103839904875275,1.0,66/384,14.18%,STK17B;EPHA7;DAPK2;PDK1;PDPK1;NRK;ROCK2;CDK14;CDK8;DAPK1;GRK3;LYN;GRK5;FGFR1;BMPR1A;DMPK;MARK1;PRKAG2;GAS6;TGFBR1;ACVR1;CDK16;PRKAA2;MAP3K20;NUAK1;LRRK2;AKT3;SIK1;SPHK2;EIF2AK3;BRSK1;MAP2K1;OXSR1;MAST2;STK4;IRAK3;EPHB2;BMP2;MAP4K4;CAMK2B;XYLB;STK11;RNASEL;RYK;TTBK1;NEK6;BRAF;TAOK3;PI4KA;IGFBP3;IKBKE;TBK1;TLK1;STRADA;WNK1;MAP3K13;INSR;MAP4K5;GRK4;ACVR1B;MARK2;PIK3R4;CDK12;CERK;FRK;MERTK
prerank,neuron projection regeneration (GO:0031102),0.5482371373064305,1.1214116154795175,0.36493738819320215,0.8100695850636574,1.0,2/10,4.35%,NREP;MTR
prerank,regulation of defense response (GO:0031347),0.36392788502485185,1.121362568220752,0.29419191919191917,0.8093916783953516,1.0,9/76,6.91%,ADAMTS12;AHSG;PTGES;CASP12;APOE;APPL2;IRF1;BCL6;AGTR1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.4794158112160533,1.1211854843158757,0.35379644588045234,0.8090859137485784,1.0,4/17,12.18%,OGG1;NEIL1;MBD4;TERF2
prerank,positive regulation of innate immune response (GO:0045089),-0.35275010779796506,-1.121110491757486,0.30606060606060603,0.7833178855882852,1.0,13/30,27.23%,RPS19;GBP5;LBP;NLRC5;IFI35;UBE2K;TRIM6;TRIM62;DHX9;PLSCR1;POLR3C;SLC15A4;PLA2G5
prerank,granulocyte chemotaxis (GO:0071621),-0.30759070911060515,-1.1208626941575854,0.23293172690763053,0.7823587976885708,1.0,9/55,12.13%,PDE4B;BSG;TGFB2;PPIA;CCL14;FCER1G;EDN1;CKLF;CXADR
prerank,response to metal ion (GO:0010038),0.37284980675804597,1.1205802334102624,0.2804718217562254,0.8100165290370209,1.0,10/67,6.48%,PAM;BCL2;PPP3CA;SLC30A8;SEC31A;NEDD4;MT3;SLC30A2;NDRG1;SLC11A2
prerank,positive regulation of cell development (GO:0010720),0.4258471554473966,1.1200668362989177,0.31791044776119404,0.8106965877252804,1.0,5/31,5.79%,NKX6-1;NUMBL;LIG4;PDE3A;SERPINF1
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.37715354611068636,-1.1197135418263093,0.2693409742120344,0.7823525790976817,1.0,12/22,37.36%,ZDHHC2;ZDHHC15;ZDHHC14;ZDHHC18;ZDHHC8;ZDHHC24;CLIP3;ZDHHC22;ZDHHC6;ZDHHC12;ZDHHC19;ZDHHC21
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.37715354611068636,-1.1197135418263093,0.2693409742120344,0.7823525790976817,1.0,12/22,37.36%,ZDHHC2;ZDHHC15;ZDHHC14;ZDHHC18;ZDHHC8;ZDHHC24;CLIP3;ZDHHC22;ZDHHC6;ZDHHC12;ZDHHC19;ZDHHC21
prerank,regulation of inflammatory response (GO:0050727),0.3326614514574865,1.1196539206342462,0.2600652883569097,0.8110707264740216,1.0,40/190,18.27%,ADAMTS12;PTGIS;RORA;AHSG;SERPINE1;PTGES;DAGLA;CASP12;APOE;APOA1;MVK;BCL6;CDH5;IL12B;CEBPA;AGTR1;TSLP;NMI;NR1D1;CD200;CCN4;NR1D2;SETD4;TNFAIP6;UFL1;NAPEPLD;SELENOS;PDCD4;ETS1;MDK;NR1H3;TNFRSF1A;CD47;IL23A;FNDC4;LACC1;CX3CL1;TNIP1;IL18;CASP1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.49590135344058284,1.1194701035099661,0.355,0.8108045479109603,1.0,3/15,3.05%,ADGRV1;COL11A1;KIT
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.44081340548110376,-1.119464413379712,0.3407960199004975,0.7813491199536763,1.0,6/12,30.28%,RAD17;TOPBP1;HUS1;HUS1B;CDC6;TICRR
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.34969008489820225,1.1193529864330598,0.2924187725631769,0.810359908952555,1.0,16/107,8.28%,SLC24A3;SLC8A1;SLC8A3;SLC41A1;DMPK;SLC30A8;CCL19;STIM1;ATP13A3;SLC24A1;MT3;CDH5;SLC24A5;TMEM203;DRD3;SLC30A10
prerank,cellular protein modification process (GO:0006464),0.31343175588438316,1.1192240911525697,0.13713713713713713,0.8099581013289507,1.0,157/982,14.18%,LTBP1;STK17B;DAPK2;PDK1;PDPK1;CP;FBN1;SPSB1;NRK;PPM1H;ROCK2;CDK14;LOXL1;PPM1E;MATN3;CDK8;DAPK1;UST;LOX;PTPN13;AHSG;GRK3;PRKCSH;GALNTL5;IGFBP4;LYN;GRK5;OBSL1;ART4;FGFR1;B3GALT1;BMPR1A;DMPK;ST3GAL5;MARK1;PPP3CA;CCN1;LAMC1;PRKAG2;GAS6;APOE;PTPN21;TGFBR1;ST3GAL3;FSTL1;FBXL19;CSF1;LARGE1;TGM5;APOA1;APLP2;MT3;ACVR1;PSME4;CDK16;SERPIND1;IGFBP5;PTPRS;PRKAA2;MAP3K20;EPAS1;CST3;NUAK1;FUT10;TNC;CD247;CUL4B;LRRK2;ADPRH;AKT3;PARP16;ATG10;SIK1;STT3A;CUL5;SIRT2;EIF2AK3;BRSK1;MAP2K1;FBXL3;ARAF;RCN1;OXSR1;PTPN9;B3GALNT1;UBA7;MAST2;ALG5;STK4;IRAK3;DNAJC3;MTMR3;BMP2;MAP4K4;COMMD1;MTMR7;FN3KRP;CAMK2B;KRT10;MIA3;NGLY1;STK11;CTDSP2;RNASEL;PARP14;RBBP7;RYK;ASB12;PTPRM;TTBK1;BMP15;NEK6;BRAF;TAOK3;IGFBP3;PDIA6;FBXO9;FBXO11;UFL1;KBTBD7;DCAF8;IKBKE;ERCC8;FBXO4;TBK1;FBXL12;TLK1;STRADA;WNK1;PPP2R5D;FEM1C;MAP3K13;INSR;ITIH2;GPS1;BTRC;WIPI1;MAP4K5;GRK4;ACVR1B;PTPN3;COPS3;DDOST;TNKS2;P4HB;ENGASE;MARK2;ALG10B;PIK3R4;CDK12;PTEN;JMJD7;ARF4;COL3A1;FRK;FSTL3;MERTK
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.31377610261921557,1.1189650764678896,0.068,0.8099133528529348,1.0,325/1646,17.26%,IGF1;TCF7L2;TCF4;ZBTB20;NFIA;IGF2;COL1A1;RORA;RHOH;CDK14;TBL1XR1;ZFHX4;TRPS1;RUNX1T1;TEAD1;ATXN1;PBX1;SMAD3;ARNT2;PKNOX2;AR;ZKSCAN2;ZEB2;SOX5;TGFA;MITF;GLIS3;NKX6-1;IL31RA;NR2F2;GLI2;RUNX1;PRRX1;WWC2;SALL1;ZIC1;SP7;OGT;IKZF2;VGLL3;MAF;GLI3;ARID5B;ZEB1;NKX2-1;FZD2;KIT;ARID4A;PRDM5;SP100;WNT4;FOXP2;NFIB;ASCL1;RBFOX2;YAP1;NUP107;GAS6;JDP2;APOE;RUNX2;SIX5;TGFBR1;MLXIP;LBH;MIDEAS;ZIC4;NFIX;MXI1;LBX2;TLE1;FBXL19;OGG1;MEOX2;IKZF4;RLF;MSC;SMURF2;BRWD1;IRF1;ZIC2;PRICKLE1;MT3;NEUROD4;RFX5;ACVR1;ZHX2;ZNF83;CDK16;NEUROD1;CREB3L2;NCOA2;FZD1;KLF15;PHIP;MLLT3;SFRP1;ETV6;DENND4A;ARID1B;ATXN7L3;TBX3;SP4;EPAS1;HLF;BCL6;ENG;CUX2;ZBTB8B;DKK3;USP47;BCOR;TCF7;CBX3;ATOH8;HES7;APBB2;NAB2;SMARCA1;ZNF483;PML;ZNF23;MED14;NR5A1;BATF;CEBPA;ING5;NFE2L2;ZNF697;MBD2;WWTR1;SAP30;RNF10;SREBF1;SIRT2;DDX17;REXO4;ZBTB38;TSHZ2;ZBTB24;SMARCC2;MAP2K1;MED8;MED16;PPP1R13L;NR1D1;RAI1;OSR1;BBX;WTIP;RBPJ;LIN9;TULP3;TCF7L1;FOXC2;SAFB2;NCOR1;ZMYND15;CHD2;MTA3;KDM5B;HIVEP2;ARRB1;EGFR;ARHGEF11;CREBL2;SCML2;BMP2;PCGF3;ZMIZ1;STAT5B;ZBTB4;CBY1;HOXC5;PICALM;NONO;ZBTB1;BICRAL;MZF1;CCNK;SMAD1;GMEB1;GTF2IRD1;HEXIM2;STAT2;GLIS2;NSD1;ARNT;CREB3L4;CREB3;FOXA1;PBXIP1;ZKSCAN3;FGF2;SP140;BAZ1B;ACTR8;ZSCAN21;PHF1;PHF2;TFAM;RNF6;NR1D2;MBD1;KDM5C;MED13L;NCOR2;SETD5;SP5;ZBTB8A;ZNF177;CEBPB;KLF9;IFNK;CCNL2;MED29;L3MBTL1;BHLHE41;NFE2;SPDEF;NKX2-8;ZBTB37;ZFP30;REST;NR4A1;CCNL1;MNAT1;NIBAN2;GLI1;CAMTA1;HMGN5;INSR;STAT6;PDCD4;BTRC;TEAD3;ZNF318;ACVR1B;TRIP4;L3MBTL2;MYCN;SMARCD2;NPAS2;EGF;KMT2E;KMT2A;HOXC8;EBF1;TAF5L;STAT4;TIAL1;ZNF182;HDAC4;HIVEP1;ETS1;ZNF148;ZNF383;FSTL3;ZNF219;TWIST2;TCF12;HOXD1;YAF2;TADA3;KDM7A;GATA6;NR1H3;PHF8;BMP4;SUDS3;ZNF25;FUBP3;HOXC4;SUFU;RXRA;MYCBP;FOXK2;METTL4;CDKN1C;DYRK1A;SAP30L;SMARCB1;GPBP1;TSHZ1;FADS1;TGFBRAP1;HDGFL3;PSPC1;CAMTA2;MYT1;MTF1;TFCP2;DYRK1B;RIOX1;ZBTB17;ZNF585B;ZNF585A;CBX5;MAFA;ZNF276;SCMH1;MXD4;NCOA7;EBF4;AKT1;CREB5;PLAG1;ZNF423;CCNQ;PCBD2;RHOG;ATF5;SHH;TFDP1;FOXO6;SP1;ZFAT;MYBL1;BAZ2B;SPIN4;TIMELESS;IRF2;ZSCAN20;KDM3B;FOXJ3
prerank,defense response to Gram-negative bacterium (GO:0050829),0.4065230325319986,1.1189524925580472,0.3290960451977401,0.8091608445035423,1.0,9/42,16.20%,SERPINE1;IL6R;OPTN;IL12B;CAMP;RNASE7;F2;GSDMD;IL23A
prerank,regulation of synapse assembly (GO:0051963),0.4020216879467002,1.1188048097437506,0.30097087378640774,0.8088341060849988,1.0,11/46,12.63%,GPC6;PDLIM5;SRPX2;MUSK;CUX2;EPHB2;SLIT1;SETD5;MDGA1;EPHB3;SLITRK2
prerank,protein transport (GO:0015031),0.32380851147621903,1.1185471417731288,0.22543950361944157,0.8087975574733823,1.0,59/332,16.18%,ATP6V0A4;WLS;RABGAP1L;TBC1D4;STEAP3;TXNIP;LRP1;ARRDC4;ABCA1;VAMP5;USP6NL;LMAN2L;MACF1;OPTN;SEC31A;APOE;TMED1;VPS26C;GOLGA4;RAB23;STXBP3;TVP23B;TOM1;STX16;ARFGAP3;ADPRH;SNX33;LTBP2;MIA2;IFT27;RAB22A;COPZ2;ARFIP2;MIA3;TBC1D2B;ARL1;GGA2;ATP6V1E1;TMED4;ARRDC2;GOLPH3L;STXBP1;RCN3;TLK1;MTTP;COPA;USO1;TVP23A;ARF4;TANGO2;SNX9;IFT22;ARF6;LAMP2;STX1B;ARL5A;SNX31;GOLPH3;RAB19
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3155300331194038,1.118285246907867,0.1593186372745491,0.8087431878673462,1.0,148/807,15.07%,TCF7L2;BMP6;LDB2;IGF2;FHL2;TBL1XR1;TRPS1;RUNX1T1;ATXN1;SMAD3;AR;ZEB2;MITF;GLIS3;NKX6-1;NR2F2;DACT1;GLI2;RUNX1;WWC2;SALL1;KCNIP3;CBX7;GLI3;AEBP1;ARID5B;ZEB1;NKX2-1;FGFR2;ARID4A;THRB;PRDM5;SP100;MDFI;WNT4;FOXP2;ASCL1;RBFOX2;YAP1;DNMT3A;GAS6;JDP2;RUNX2;RARB;LBH;MIDEAS;NFIX;MXI1;TLE1;IKZF4;SMURF2;IRF1;ZIC2;PRICKLE1;MT3;ZHX2;RARG;SFRP1;ETV6;TBX3;BCL6;CUX2;DKK3;USP47;SKI;BCOR;CBX3;ATOH8;NAB2;PML;CPEB3;CEBPA;MBD2;SAP30;SIRT2;DR1;ZBTB38;SMARCC2;NR1D1;OSR1;MTA2;RBPJ;DAB2;FOXC2;NCOR1;ZMYND15;MTA3;SCML2;BMP2;JAZF1;ZBTB4;BRMS1L;CBY1;NONO;ZBTB1;MZF1;PRKN;GTF2IRD1;HEXIM2;GLIS2;NSD1;PBXIP1;IFI27;ZKSCAN3;CXXC5;NR1D2;MBD1;KDM5C;NCOR2;ZNF177;CEBPB;L3MBTL1;BHLHE41;SPDEF;HDAC8;REST;PER3;IMPACT;NIBAN2;TCF25;PHF21A;PDCD4;BTRC;PEX2;PAF1;ZNF318;L3MBTL2;USP9X;IGBP1;HDAC4;HIVEP1;FRK;ZNF148;ZNF219;TWIST2;FLNA;YAF2;TCERG1;HSBP1;GATA6;NR1H3;BMP4;SUDS3;UBE2D1;ZNF25;SUFU;RXRA;FOXK2
prerank,regulation of protein import into nucleus (GO:0042306),0.4110576175884543,1.1179905078728518,0.33715925394548063,0.8087663836767662,1.0,12/36,18.64%,PIK3R1;SMAD3;ZIC1;RAB23;RBM22;FLNA;BMP4;SUFU;PIK3R2;UBR5;EFCAB7;TPR
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.4833962045289789,1.1179818768522032,0.3394648829431438,0.8079889164151473,1.0,6/16,24.20%,APPL2;NCOR1;ERLIN1;BRCA1;ERLIN2;ACADVL
prerank,positive regulation of protein import into nucleus (GO:0042307),0.4277062916444369,1.1179787429542656,0.31845238095238093,0.8072109868855991,1.0,9/28,18.64%,PIK3R1;SMAD3;ZIC1;RBM22;FLNA;PIK3R2;UBR5;EFCAB7;TPR
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.47146243682028494,1.1179520190860672,0.3495798319327731,0.8064949761205079,1.0,5/18,7.97%,DLC1;KANK1;ITGA3;RIPOR2;ARHGAP35
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.4092683057787339,1.117572737056241,0.32217573221757323,0.8067507555017402,1.0,8/39,8.84%,ROBO1;YAP1;MAML3;ENHO;SRC;RBPJ;ZMIZ1;KAT2B
prerank,regulation of microglial cell activation (GO:1903978),0.4938023547291416,1.1175287659068147,0.35960591133004927,0.8060939060005252,1.0,5/15,17.52%,LDLR;NR1D1;TTBK1;SYT11;CX3CL1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.42149650296807745,1.1173296973472788,0.3146853146853147,0.805868781567451,1.0,3/34,8.62%,RBP4;SPHK2;EPHB2
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.4900374415536498,1.1173214787886467,0.3555926544240401,0.8051105063421808,1.0,5/16,20.49%,ZFP36L1;CPEB3;PLEKHN1;RC3H1;ZFP36L2
prerank,extracellular matrix disassembly (GO:0022617),0.39037200774056885,1.1172376154192818,0.3187830687830688,0.8045409199787528,1.0,13/53,14.34%,ADAMTS5;GSN;LAMC1;MMP2;MMP19;SH3PXD2B;MMP11;TIMP2;SCUBE1;HTRA1;NOXO1;CTSL;HPN
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.38535243352379756,-1.117135160892333,0.3104325699745547,0.7848235030342212,1.0,7/23,11.57%,PPP1R13B;YWHAH;YWHAQ;MAPK8;CASP8;YWHAG;BBC3
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.38535243352379756,-1.117135160892333,0.3104325699745547,0.7848235030342212,1.0,7/23,11.57%,PPP1R13B;YWHAH;YWHAQ;MAPK8;CASP8;YWHAG;BBC3
prerank,neuron apoptotic process (GO:0051402),-0.39641580717646274,-1.1166297240871177,0.32642487046632124,0.7846360177702709,1.0,8/19,14.93%,TRPC5;SIAH1;CIT;CDK5;SCN2A;TNFRSF21;ERBB3;APP
prerank,covalent chromatin modification (GO:0016569),0.4969857952696425,1.1158970082084247,0.3612040133779264,0.8075004780833387,1.0,4/14,11.49%,MT3;MBD2;SETD5;UFL1
prerank,T-helper cell differentiation (GO:0042093),-0.43150761577912483,-1.1156698455750125,0.3397129186602871,0.7858685343935226,1.0,5/14,17.09%,LEF1;FOXP1;ATP7A;GPR183;ZFPM1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.4931082412112055,1.115600871017096,0.35472370766488415,0.8075266211151684,1.0,1/14,0.14%,NRP1
prerank,sphingoid metabolic process (GO:0046519),0.5157269579650221,1.115411961197403,0.34375,0.8072707422930679,1.0,3/12,10.90%,PLPP3;SPHK2;KDSR
prerank,positive regulation of neuron projection development (GO:0010976),0.36424105038065224,1.1146474329172187,0.29197994987468673,0.8086083770695891,1.0,15/85,9.37%,EPHA3;CAMK1D;LYN;APOE;DPYSL3;RAPGEF2;FZD1;PTK7;ROR1;CUX2;ATP1B2;ARHGAP35;NTRK3;CAMK2B;RAPGEF1
prerank,long-chain fatty acid import into cell (GO:0044539),0.5262580696621082,1.1146377721642222,0.37568058076225047,0.8078547941148906,1.0,2/10,2.35%,SLC27A5;ACSL1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.5121499772919331,1.1143798313226387,0.33962264150943394,0.8077884085331511,1.0,2/12,3.64%,GDNF;SMO
prerank,phospholipid translocation (GO:0045332),-0.35764803606277895,-1.1142899942475646,0.2697947214076246,0.7883575738513304,1.0,8/28,7.78%,ATP8A1;ATP8B1;ATP11C;ABCC1;ATP11B;P2RX7;ATP11A;MFSD2A
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.4261531395573168,1.1142221941793022,0.31059506531204645,0.8074784586286783,1.0,11/29,22.17%,SMAD3;ZC3H7B;TUT7;SMAD1;TUT4;PRKRA;METTL3;DICER1;AGO4;SMAD2;DROSHA
prerank,B cell differentiation (GO:0030183),-0.32579034766326936,-1.1140261132234097,0.2746478873239437,0.7873936907728593,1.0,28/46,36.43%,PTPRJ;TPD52;PLCG2;TCF3;PTPN2;ITGA4;HHEX;BLNK;PTPRC;JAK3;ADGRG3;MSH2;KLF6;VCAM1;DCAF1;CEBPG;IRF2BP2;GPS2;FLT3;CR2;LYL1;IL11;MS4A1;ZBTB7A;CLCF1;SYVN1;IL4;CD79A
prerank,apoptotic process (GO:0006915),-0.24143848324910047,-1.1140008593514008,0.1375,0.7857942947286705,1.0,50/203,15.77%,EFNA5;ZBTB16;SEMA6A;ELMO1;PTK2B;MAL;FAP;EGLN3;PLAGL1;PPARD;TNFRSF19;PAK5;TBX1;ADAM15;TRPC5;SIAH1;BCL2L13;CIT;PPIA;NFKBIA;DPF2;PRUNE2;HK2;MAGI3;CDK5;RHOB;SCN2A;JAK2;RFK;TGFBR2;YARS1;DDIT4;CASP8;DCC;CYFIP2;TNFRSF21;BBC3;MTOR;ERBB3;BCL2L1;PAEP;BNIP1;PIK3CA;BAK1;APP;ARHGEF6;FASTKD2;FOXO1;DAP;IAPP
prerank,regulation of phosphate metabolic process (GO:0019220),0.4887819005835264,1.1139139101240452,0.33610648918469216,0.8076090899084768,1.0,3/16,7.38%,SRPX2;GNB3;SIRT2
prerank,epithelial cell development (GO:0002064),0.46735849026325155,1.113579388593404,0.33746130030959753,0.8077804950460274,1.0,5/20,13.00%,BFSP1;WNT5B;RAB25;LRTOMT;DACT2
prerank,nucleic acid-templated transcription (GO:0097659),0.4041394287501751,1.1135775704702067,0.3342618384401114,0.8070108423447879,1.0,6/42,11.65%,POLR2D;THRB;CREBL2;POLR3A;POLR2C;NKX2-8
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.4546194202122913,-1.1130691916362923,0.3378684807256236,0.7869122871248118,1.0,5/11,33.80%,ITM2A;BACE2;NECAB2;ITM2C;NECAB3
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.49661630949695196,1.1127379572433944,0.34925864909390447,0.80859417796142,1.0,3/13,9.88%,MOAP1;BCL2L11;RHOT1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.4774141356045233,1.1125317189263486,0.3685092127303183,0.8084242224421887,1.0,1/18,0.43%,FBN1
prerank,gastrulation (GO:0007369),-0.4102583804578239,-1.1122413245058234,0.34366925064599485,0.7877112027449018,1.0,4/15,12.63%,GPC3;LRP5;TASOR;UGDH
prerank,lymphocyte chemotaxis (GO:0048247),0.4147783408640616,1.1118806168312958,0.3103953147877013,0.8094777160268944,1.0,5/34,6.12%,CYP7B1;GAS6;CCL19;CXCL16;CCL4
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.4135561337403533,1.1116897881540055,0.328125,0.8092518286634229,1.0,8/35,8.79%,AR;PMEPA1;RBFOX2;YAP1;NEDD4;SRC;DDX17;ZMIZ1
prerank,positive regulation of neurogenesis (GO:0050769),0.37774089656318965,1.1112931849996421,0.318122555410691,0.8096236529079116,1.0,8/68,5.79%,ROBO1;PLXNA2;OBSL1;TIAM2;NUMBL;LIG4;CUX2;SERPINF1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.49597103833054657,1.1112085357255068,0.3623693379790941,0.809075933287814,1.0,5/12,16.83%,MYCBP2;ARHGAP35;EPHB2;PTEN;B4GALT6
prerank,glycolipid biosynthetic process (GO:0009247),0.41688183247665,1.1110524639930281,0.3361462728551336,0.8087696543287566,1.0,4/38,4.34%,ST6GALNAC5;ST3GAL5;LARGE1;GBGT1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3412447846229634,1.1110386145015376,0.27855477855477856,0.8080243057425822,1.0,26/136,16.11%,TCF7L2;PTGIS;SP100;MDFI;GAS6;NUPR1;IRAK2;CDK5RAP3;CYP1B1;SIK1;MTURN;IRAK3;ARRB1;CD200;COMMD1;GLIS2;ITCH;UFL1;BTRC;HDAC4;FLNA;SFRP4;SUFU;EGLN1;RNF2;NWD1
prerank,establishment of mitotic spindle localization (GO:0040001),0.43649388310393505,1.1108295215802284,0.33883058470764615,0.8078540942369377,1.0,12/28,23.46%,GJA1;SPDL1;ZW10;UBXN2B;CENPA;KPNB1;HTT;NUMA1;NSFL1C;NDE1;FBXW11;ITGB1
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.4488269837293392,-1.1108013045875649,0.3228915662650602,0.7902772090372744,1.0,3/11,2.91%,F11R;TJP2;TJP1
prerank,regulation of endocytosis (GO:0030100),0.37592380449703755,1.1102598859307617,0.32073011734028684,0.8087222884615515,1.0,10/61,9.18%,EPHA3;LRP1;APOE;CCL19;SRC;SNX33;STON1;DAB2;PICALM;SNX12
prerank,lamellipodium assembly (GO:0030032),-0.3664382325890947,-1.1100893759356956,0.32947976878612717,0.7908185149551817,1.0,8/26,9.32%,PARVB;CCDC88A;ABLIM1;S1PR1;SPATA13;CDH13;ABLIM3;ABLIM2
prerank,epithelium development (GO:0060429),0.34899852521553754,1.1099954967462282,0.2888086642599278,0.8086869253971574,1.0,24/107,18.31%,ERRFI1;DAG1;DACT1;SALL1;FGFR2;WNT4;SMO;CNN3;MEOX2;ALDH1A2;VCL;OSR1;BMP2;RCN3;NDRG4;VDAC1;GSTK1;GATA6;KANK2;SHH;TIMELESS;AHI1;SOX11;FN3K
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.450855561938943,1.1098844205826213,0.33588957055214724,0.8082290836891245,1.0,3/24,6.16%,AUTS2;PIK3R1;CDC42
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.3447861030871079,-1.1097215871782171,0.32,0.7903116516025532,1.0,11/32,12.39%,PPP1R16B;ITGA1;PPIA;HSP90AB1;PPP1R15B;PPP2R5A;SPPL3;CALM1;CALM3;TGFB1;MTOR
prerank,chromosome organization (GO:0051276),0.3580167438274686,1.1096367091773898,0.3031400966183575,0.8081248631007536,1.0,17/99,12.96%,TCF7L2;SETD7;BRWD1;AXIN2;LIG4;MTHFR;CUL4B;TOP2B;TCF7L1;POLE3;PHF1;CENPH;L3MBTL1;RAE1;HDAC8;GPS1;COPS3
prerank,microglial cell activation (GO:0001774),-0.3879773476225711,-1.1082298692448318,0.31466666666666665,0.7929933106486605,1.0,8/21,24.16%,JAK2;CX3CR1;APP;CLU;AGER;AIF1;TREM2;IFNGR1
prerank,vesicle organization (GO:0016050),-0.3197312559503548,-1.1082260021819408,0.28888888888888886,0.7913258971705629,1.0,11/46,16.17%,CAV1;FNBP1L;CD34;CAV2;DNAJC13;ALS2CL;WASHC5;EXOC8;AKTIP;SRGN;DNM1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.465920870508013,1.1080977547844724,0.3504,0.8116923188028612,1.0,4/20,7.38%,EPHX2;APOE;GNB3;SREBF1
prerank,import into cell (GO:0098657),0.40092426978040646,1.1076234048836788,0.31741573033707865,0.8122699334411065,1.0,9/41,9.99%,SLC1A3;GLUL;ATP1A2;SLC6A13;SLC22A2;SLC11A2;SLC22A4;SLC5A3;SLC29A1
prerank,mesonephros development (GO:0001823),-0.46000398977557,-1.1075237529516269,0.3246445497630332,0.7918114473803601,1.0,3/11,11.75%,ZBTB16;FGF1;PAX8
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.39991960310757313,-1.10739952774519,0.33,0.7905100730781104,1.0,5/17,17.45%,PTPRJ;PTPN2;PTPN22;CEACAM1;DGKZ
prerank,heterocycle biosynthetic process (GO:0018130),0.4807313827168864,1.106755069173863,0.3557377049180328,0.8139007348630684,1.0,4/14,12.81%,PYCR1;PYCR3;LIAS;MOCS1
prerank,positive regulation of angiogenesis (GO:0045766),0.34552195359586896,1.106381442038023,0.3221556886227545,0.8142140037125639,1.0,13/108,5.69%,PDPK1;PTGIS;SASH1;SERPINE1;RUNX1;VASH2;SEMA5A;STIM1;ITGB8;CTSH;SMOC2;CYP1B1;CDH5
prerank,regulation of myoblast fusion (GO:1901739),0.5321131943939374,1.1061697766425824,0.3605072463768116,0.8139923828006032,1.0,3/11,11.18%,RIPOR2;CFLAR;CD53
prerank,regulation of vacuole organization (GO:0044088),0.45771431928703293,1.105908422645631,0.34094616639477976,0.8140098059825356,1.0,8/20,18.11%,NPRL3;ADPRH;ENO2;MTMR3;PIKFYVE;NPRL2;LAPTM4B;ENO3
prerank,cardiac ventricle morphogenesis (GO:0003208),0.39954035907756885,1.1053826296805518,0.3490701001430615,0.8147261194269401,1.0,7/41,8.14%,TGFBR3;TPM1;BMPR1A;FGFR2;ENG;TNNC1;RBPJ
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.4089553089397328,-1.10532638827,0.3364485981308411,0.7949967964147407,1.0,4/17,21.48%,NEDD4L;KCNQ1;RYR2;KCNJ8
prerank,neuropeptide signaling pathway (GO:0007218),-0.3067731597084136,-1.105246805038541,0.27530364372469635,0.7935379700061069,1.0,17/58,24.42%,SORCS2;GLRA1;SORL1;GLRA2;HCRTR2;CYSLTR1;CYSLTR2;SORCS1;GPR37;NXPH2;PPY;CPE;SORCS3;PNOC;NMUR2;GLRA3;NXPH4
prerank,RNA destabilization (GO:0050779),0.46611527340917613,1.1050022493649254,0.3448275862068966,0.815046992722767,1.0,10/18,27.72%,ROCK2;DXO;METTL14;METTL3;YTHDF2;FTO;METTL16;GIGYF2;ZC3H18;PUM1
prerank,neuron projection organization (GO:0106027),-0.41540071868272754,-1.1048421971134952,0.3271461716937355,0.7931543214483872,1.0,9/15,27.14%,PLS1;ARF1;LGMN;ATP1A3;DCTN1;APP;GSK3B;PICK1;PRNP
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.37117117983861014,1.104684573066929,0.3252858958068615,0.8151532013405312,1.0,10/67,9.63%,NRP1;ROCK2;PIK3R1;SULF1;AXL;CDC42;SRC;AAMP;ITGB3;ITGAV
prerank,aminoglycan catabolic process (GO:0006026),0.4333635667750662,1.1046718015156891,0.32272727272727275,0.8144161883014471,1.0,3/28,6.56%,GPC6;HSPG2;SDC1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.44825442310211433,1.1045936645584131,0.34408602150537637,0.8138656042216221,1.0,2/23,1.03%,ERRFI1;CBLB
prerank,protein localization to condensed chromosome (GO:1903083),0.5102476371023581,1.1036567934070467,0.3634782608695652,0.8157822373968974,1.0,4/12,9.46%,SPDL1;ZW10;CHAMP1;MTBP
prerank,tRNA aminoacylation (GO:0043039),-0.3379170941764632,-1.102834326439691,0.32014388489208634,0.7975489662685992,1.0,12/37,22.19%,WARS1;WARS2;LARS1;YARS1;YARS2;QARS1;KARS1;FARS2;AIMP1;MARS2;AIMP2;TARS1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.34770333863494673,-1.1027638714660675,0.2808641975308642,0.7961302200743089,1.0,10/29,22.16%,CAV1;THBS1;TNFSF10;RET;PAK2;DEDD2;GPER1;INHBA;TRAF2;TNFRSF12A
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.4539455170256085,1.1027050053942489,0.34894991922455576,0.8175857872325584,1.0,9/20,24.20%,WNT4;SIK1;BMP2;BMP5;ERLIN1;SLC27A1;BRCA1;ERLIN2;ACADVL
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.49084353788627433,1.1026601050279154,0.36683417085427134,0.8169462742231253,1.0,3/15,3.58%,FGFR2;PDGFRA;TGFBR1
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.3034309266328311,-1.1023898585449405,0.24782608695652175,0.7956852326917194,1.0,17/64,11.43%,UTRN;EFNA5;CDK6;ACER2;PTK2B;THBS1;LIMCH1;GPM6B;ADAM15;MYOC;EMP2;CDH13;NEXMIF;JUP;SKAP1;PEAK1;NF1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.5082410371587894,1.1019304469052629,0.37261698440207974,0.8182160629747581,1.0,2/12,2.01%,CYP26B1;DHRS3
prerank,regulation of protein kinase C signaling (GO:0090036),0.48426954631967783,1.1016900080140812,0.3680555555555556,0.8181448751526249,1.0,3/14,9.41%,ADGRV1;SPHK2;MYADM
prerank,positive regulation of neuron death (GO:1901216),0.39792862111943916,1.1013690530283213,0.31763122476446837,0.8182568757457874,1.0,5/46,9.04%,EPHA7;EFNB2;NUPR1;TLR6;PICALM
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.37841146156323674,1.1011156806603715,0.34547908232118757,0.8181829400834216,1.0,8/60,8.47%,TCF7L2;CDK8;RUNX2;TNRC6B;MED14;MED8;MED16;TNRC6A
prerank,regulation of ion transport (GO:0043269),-0.2884335343285016,-1.100898314340251,0.2512315270935961,0.798545368332521,1.0,14/76,6.92%,NKAIN2;KCNJ2;ATP1A1;ANK3;NEDD4L;B2M;KCNJ3;PXK;YWHAH;NKAIN1;P2RX7;NKAIN3;NOS1;SYT1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.4232260326077457,1.1004817831999567,0.34820143884892085,0.8191268466028128,1.0,7/35,6.81%,COL4A3;SPARC;NR2F2;APOE;SULF1;ATOH8;IL12B
prerank,regulation of Rac protein signal transduction (GO:0035020),0.4920825998504973,1.100303331217134,0.3657331136738056,0.8188460489324979,1.0,4/16,11.52%,AUTS2;OGT;ALS2;KBTBD7
prerank,regulation of collagen biosynthetic process (GO:0032965),0.47049291019481565,1.1000173809176084,0.3504,0.8188757139575529,1.0,8/19,20.90%,RUNX1;WNT4;EMILIN1;RGCC;F2;BMP4;LARP6;CREB3L1
prerank,membrane lipid metabolic process (GO:0006643),0.4479713987391899,1.09996478525022,0.3551829268292683,0.8182473159535282,1.0,4/22,7.21%,AGMO;CYP1B1;ALOXE3;SPHK2
prerank,negative regulation of epithelial cell migration (GO:0010633),0.4196912078627275,1.0997702255248176,0.34691011235955055,0.8180237676272043,1.0,11/33,15.85%,MCC;DCN;NR2F2;SP100;APOE;ADAMTS9;PTPRM;DNAJA4;PTEN;PTPN23;EPPK1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.5015423363456732,1.0994607517693231,0.3595890410958904,0.8181097099825198,1.0,5/15,16.72%,GLI3;IL12B;EBI3;IL23A;SHH
prerank,actin polymerization or depolymerization (GO:0008154),0.39055302777319567,1.099428509691153,0.3592896174863388,0.8174479993882537,1.0,4/50,1.79%,MICAL3;SVIL;GSN;ARHGAP6
prerank,sulfation (GO:0051923),0.5130924189003082,1.0994213999364937,0.39201451905626133,0.8167122721303566,1.0,1/11,1.33%,UST
prerank,cell part morphogenesis (GO:0032990),0.49387832025077694,1.0991501566940822,0.37067545304777594,0.8167042830865937,1.0,4/13,13.22%,PID1;CSPG5;NUBPL;WASF1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.42656954938844605,1.0989642677677798,0.36570561456752654,0.8164559728830356,1.0,11/30,16.72%,SP7;KIT;MLLT3;SFRP1;BATF;UFL1;FSTL3;BMP4;PRRC2C;PLD4;SHH
prerank,intraciliary retrograde transport (GO:0035721),0.5016120545492337,1.0988927245310705,0.3732394366197183,0.8158976626717941,1.0,3/12,10.61%,WDR35;IFT43;DYNC2I1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5291860507244537,1.0988857074581797,0.36568457538994803,0.8151623398284245,1.0,3/10,15.29%,LYN;MAP2K1;RNF13
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.4408998537638001,1.0983048166258718,0.33647798742138363,0.8160180624453183,1.0,8/24,15.29%,VTN;NEDD4;MT3;EMILIN1;ITGB3;ARNT;NIBAN2;GRB10
prerank,calcium ion transmembrane transport (GO:0070588),0.35684514711377674,1.0981632049616494,0.33889602053915274,0.8156487709633473,1.0,14/86,9.92%,SLC24A3;NALCN;SLC8A1;SLC8A3;TRPA1;GAS6;SLC24A1;MCU;SLC24A5;CACNA1C;PMPCB;TRPM4;ITGAV;MICU2
prerank,mitochondrion morphogenesis (GO:0070584),0.5076953398197266,1.098094120990872,0.3645655877342419,0.8150727043115569,1.0,3/11,13.22%,PID1;NUBPL;WASF1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.49265767928094006,1.0979140575198094,0.34328358208955223,0.8148226002345732,1.0,4/14,10.17%,SULF2;SULF1;SPRY2;FGF2
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.4149833878310457,-1.0975532426033652,0.3432098765432099,0.8069766729536616,1.0,5/14,11.19%,MYO9A;OPHN1;SCRIB;MSN;PATJ
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.4585056094900861,-1.0974786682834174,0.3387096774193548,0.8055522049211912,1.0,4/12,9.72%,ANK3;NOS1;ATP1B1;WNK2
prerank,steroid hormone biosynthetic process (GO:0120178),0.4302897021321557,1.0972533198812655,0.32585949177877427,0.8159777028484204,1.0,5/29,10.91%,AKR1B1;STAR;HSD3B2;SRD5A1;TSPO
prerank,negative regulation of neuron differentiation (GO:0045665),-0.3707056349175392,-1.097163214687986,0.2997275204359673,0.8048021481845935,1.0,10/22,24.22%,B2M;MED1;CNTN4;HES1;HEY1;DLL1;DTX1;GSK3B;NEPRO;EIF2AK4
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.4371238254251635,1.097063266914426,0.37003058103975534,0.8157346819957709,1.0,5/24,9.52%,NRP1;PIK3R1;SFRP1;MAP4K4;MAPRE2
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.47479367326907845,-1.0970519442308646,0.3622222222222222,0.8035074710823953,1.0,5/10,13.50%,PDE4D;PDE3B;PDE2A;UBE2B;APLNR
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.3376221646150998,-1.0968379320541808,0.3098159509202454,0.8025261583560926,1.0,17/33,34.42%,PTPRJ;RPS3;PTPN2;CD81;PTPN22;CEACAM1;DGKZ;CD300A;NECTIN2;CARD11;DUSP3;RAB29;PRNP;IKBKG;PHPT1;TRAT1;CD226
prerank,positive regulation of acute inflammatory response (GO:0002675),0.48879260526131,1.0967576382819033,0.3515358361774744,0.8158421835942202,1.0,1/14,2.52%,OSMR
prerank,positive regulation of signaling (GO:0023056),-0.33091339070216574,-1.096713714040466,0.3037974683544304,0.8012691793432113,1.0,12/37,12.19%,RIMS1;GRIK2;RIMS2;SYT1;CLSTN2;INPP5F;EDN1;SCRIB;CLSTN3;NSF;HOMER1;CD80
prerank,negative regulation of angiogenesis (GO:0016525),0.36522455471531634,1.096661019992891,0.3379571248423707,0.8153476489532073,1.0,13/84,6.64%,COL4A3;ROCK2;SPARC;DCN;SERPINE1;HSPG2;ISM1;THBS2;SULF1;SERPINF1;ADAMTS9;PML;EMILIN1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.32572822138479207,1.0966330442153587,0.29347826086956524,0.8146941732420094,1.0,22/190,8.21%,ITPR1;RORA;RHOH;UACA;CGNL1;DAG1;LYN;BCL2;WWC2;MGRN1;NPRL3;TLE1;UBR2;RFFL;PRKAA2;PDE3A;SRC;MAPKBP1;NMI;NR1D1;WTIP;DRD3
prerank,cellular response to chemokine (GO:1990869),-0.319587537506679,-1.0965763966470838,0.2978723404255319,0.8000529504565365,1.0,5/46,6.29%,SLC12A2;LRCH1;PTK2B;ACKR3;CCL14
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.44511801461024797,1.0963453910817063,0.346031746031746,0.8147141252614896,1.0,3/22,5.68%,RUNX1;IRF1;BCL6
prerank,B cell activation (GO:0042113),-0.2933797373613089,-1.0963308410047705,0.25327510917030566,0.7991616842593905,1.0,23/68,23.49%,MEF2C;PTPRJ;TPD52;PLCG2;TCF3;PTPN2;ITGA4;HHEX;CASP8;CD40;BLNK;GPR183;PTPRC;BTK;JAK3;ADGRG3;CD86;MSH2;KLF6;VCAM1;DCAF1;MALT1;CEBPG
prerank,iron ion transmembrane transport (GO:0034755),0.5201813776252527,1.0957948193226754,0.3832752613240418,0.8154492559999831,1.0,4/10,10.71%,SCARA5;SLC25A37;SLC11A2;ABCC5
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.4797031464019574,1.095776848730847,0.36577181208053694,0.8147613342605425,1.0,8/16,22.94%,AMPD3;NUDT2;GART;AMPD2;PPAT;PFAS;ADSS1;ADSL
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.43140611919496524,1.0957466418275088,0.3616692426584235,0.8140867063735894,1.0,11/24,24.02%,SEC24D;SEC31A;BCAP31;ABCB9;SEC23A;TAPBP;SEC24A;IDE;TAP1;PDIA3;CANX
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.46346060155064106,-1.095540109393045,0.350109409190372,0.7999300239777372,1.0,4/10,5.72%,PTPRJ;APOD;PTPN12;PTPN2
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.27976414763430874,-1.0953102457914636,0.22660098522167488,0.7989737550671134,1.0,24/86,19.39%,OCLN;BAIAP2L1;PTK2B;NAV3;MET;RPS3;PAK1;CFL2;EDN1;PLEK;WDR1;FES;DCTN1;TRPV4;CDK5RAP2;APP;CTTN;CDK5R1;PRKCE;NCK2;GPX1;CLASP1;LMOD1;CLU
prerank,cellular response to drug (GO:0035690),-0.36127530147484194,-1.0951525051309625,0.32386363636363635,0.7978485661266267,1.0,7/25,10.27%,MEF2C;PDE4B;ACER2;TFRC;KCNQ1;AIM2;GPLD1
prerank,cell differentiation in spinal cord (GO:0021515),-0.4664517356233783,-1.0950594121727502,0.34065934065934067,0.7965339244264662,1.0,2/10,9.30%,MDGA2;ZC4H2
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.36717661716473177,-1.0950299641723822,0.32967032967032966,0.7950290179942513,1.0,6/25,9.82%,GPI;HK2;PFKL;TPI1;PFKP;ALDOA
prerank,regulation of adenylate cyclase activity (GO:0045761),0.4400338968047449,1.095027776980391,0.38184663536776214,0.815312554296527,1.0,5/22,8.21%,ADGRV1;STIM1;CACNA1C;GRM2;DRD3
prerank,motor neuron axon guidance (GO:0008045),0.4715807767824534,1.0939028526532337,0.36363636363636365,0.8176970425495564,1.0,4/15,10.13%,RHOH;EPHA4;NTN1;SLIT1
prerank,mRNA splice site selection (GO:0006376),0.42337037661784754,1.0937041574664939,0.35958395245170877,0.8175322365626972,1.0,6/30,18.00%,CELF2;SF1;NOL3;SRSF5;SRSF10;KHDC4
prerank,JNK cascade (GO:0007254),-0.3274750996853001,-1.0935083144040438,0.31545741324921134,0.7980891480902882,1.0,20/40,30.87%,NOD1;TNFRSF19;MAPK10;MAPK8;MAP4K3;ARHGEF6;NOD2;TAB1;MAP3K11;UBE2V1;MINK1;MAP3K7;MAP2K4;TRAF6;GPS2;PTGER4;UBC;RPS27A;MAP3K10;IKBKG
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.4523087195547425,1.0930959500807957,0.3502377179080824,0.8184729833930421,1.0,6/21,10.49%,SLC8A3;MCU;BCAP31;MICU2;PDZD8;ANXA6
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.36960994417421433,-1.0930078907416796,0.3190348525469169,0.7979369214495643,1.0,3/25,1.79%,TMTC2;CAV1;ANK3
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3186380490740369,1.0929760000766702,0.29014989293361887,0.8180810228730346,1.0,33/259,9.23%,NRP1;ASAP1;MTSS1;ACTN2;GSN;DYNLL1;RHOD;PARVA;KIT;MYLK;WDPCP;FGD1;RAPGEF2;DZIP1L;RAB23;FGD4;CYS1;CPLANE1;PIBF1;TTC39C;B9D1;WDR35;VCL;PMP22;IFT43;DNAAF1;CARMIL1;FBF1;EMP3;NTN1;MAP4K4;ARFIP2;IFT81
prerank,cellular response to oxidative stress (GO:0034599),0.33793518030298886,1.0927757390865367,0.31652989449003516,0.8179236844393957,1.0,21/118,13.13%,DAPK1;TPM1;PLA2R1;PYCR1;NUDT2;PDGFRA;MT3;SLC25A24;PRKAA2;GPX8;LRRK2;NFE2L2;ERCC6L2;SIRT2;EGFR;ARNT;MGAT3;FANCC;SELENOS;GPX3;NOX4
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.3963544844302189,1.0926668011926064,0.34507042253521125,0.817486930230304,1.0,4/40,6.60%,PID1;BCL2;PYCR1;LRRK2
prerank,epithelial cell morphogenesis (GO:0003382),0.46831879785978403,1.0924822562784884,0.3584905660377358,0.8172467652278043,1.0,3/17,13.00%,COL22A1;RAB25;DACT2
prerank,histone lysine demethylation (GO:0070076),0.43792545567897195,1.092318710479309,0.3570300157977883,0.8169849936262374,1.0,11/25,23.23%,KDM5B;PHF2;KDM5C;KDM7A;PHF8;RIOX1;KDM3B;KDM4A;KDM5A;KDM4C;KDM3A
prerank,intracellular pH reduction (GO:0051452),0.4111012779492287,1.0919325122524774,0.34758620689655173,0.8173742545260932,1.0,4/33,10.05%,ATP6V0A4;GPR89A;GPR89B;ATP6V1E1
prerank,heart development (GO:0007507),0.3326173866668973,1.0916145013961305,0.3231292517006803,0.8174813715424609,1.0,24/150,9.90%,RBP4;FBN1;PDLIM5;TGFBR3;DLC1;GLI2;SALL1;PDLIM2;TGFBR1;SH3PXD2B;ACVR1;ADAP2;BCOR;CACNA1C;SCUBE1;FLRT2;OSR1;NTRK3;FOXC2;BMP2;EEF1AKMT4-ECE2;KAT2B;CSRP3;SYNPO2L
prerank,cellular response to hormone stimulus (GO:0032870),0.3667611383168407,1.0915340586162727,0.3177083333333333,0.8169792119162083,1.0,19/69,13.50%,GHR;AR;ATP1A2;THRB;NCOA2;SFRP1;CTSH;BRD8;TFPI;ZFP36L1;LHCGR;SRC;STAT5B;SLIT3;KLF9;ADRA2A;SLC5A5;CTSL;NCOA3
prerank,cellular glucose homeostasis (GO:0001678),0.3975558964836986,1.0907157641033978,0.3425034387895461,0.8185048782420317,1.0,5/41,7.79%,ZBTB20;PIK3R1;GAS6;PRKAA2;NR1D1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.5152702283099759,1.09066158484716,0.3806921675774135,0.8171835524322484,1.0,3/10,12.38%,APOA1;MYADM;WNK1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.5152702283099759,1.09066158484716,0.3806921675774135,0.8171835524322484,1.0,3/10,12.38%,APOA1;MYADM;WNK1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.417107341639778,-1.0905695668177584,0.3309178743961353,0.8033815531596258,1.0,9/15,35.38%,RAD17;MDC1;HUS1;FANCD2;ATF2;HUS1B;NEK11;RAD9A;EME1
prerank,protein localization to cell surface (GO:0034394),0.42754887983799517,1.0904751794015233,0.34728682170542635,0.81697550621369,1.0,6/26,15.37%,FBLN5;ANGPT1;VCL;GGA2;FLNA;ARF6
prerank,snRNA transcription (GO:0009301),0.37036875653213247,1.0903371218853362,0.33989501312335957,0.8165991518931426,1.0,25/70,24.69%,POLR2D;PHAX;GTF2E1;SNAPC1;CCNK;USPL1;POLR2C;RPAP2;INTS4;GTF2E2;TAF9;ELL2;SNAPC5;SNAPC4;SP1;CCNT2;POLR2L;GTF2A1;TAF8;CCNT1;NCBP2;CDK7;INTS7;NABP2;ICE1
prerank,canonical glycolysis (GO:0061621),-0.3729525739283149,-1.0902478658458221,0.35195530726256985,0.8011624187566452,1.0,6/24,9.82%,GPI;HK2;PFKL;TPI1;PFKP;ALDOA
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.3729525739283149,-1.0902478658458221,0.35195530726256985,0.8011624187566452,1.0,6/24,9.82%,GPI;HK2;PFKL;TPI1;PFKP;ALDOA
prerank,nervous system development (GO:0007399),0.3142051771299208,1.0895727008509728,0.2665985699693565,0.8179898581004268,1.0,65/429,10.51%,NELL1;ROBO1;LDB2;TEAD1;FARP1;GDNF;ATXN1;GSN;ADGRV1;ARNT2;ZEB2;DACT1;RBFOX1;OBSL1;ZIC1;DAGLA;GFRA2;WNT8B;ASCL1;RBFOX2;YAP1;TGFBR1;NUMBL;SMO;SEMA5A;NOTCH2;ZIC4;FBXL17;WDPCP;MTR;ZIC2;IGF2BP2;AXL;NTF3;NEUROD1;LIG4;NAV2;TBX3;ALDH1A2;FUT10;ATXN10;NAB2;ADGRA2;PMP22;FGF11;WWTR1;DCHS1;LPAR1;APBA1;CSPG5;CBLN1;SH3GL1;DSCAM;NHEJ1;EPHB2;CNTFR;PRKN;MARCKSL1;GLIS2;GFRA4;FGF2;FGF13;RYK;NRSN1;PCDHB3
prerank,response to organic cyclic compound (GO:0014070),0.3862343001057698,1.089568366634721,0.3401639344262295,0.8172628576339617,1.0,11/52,10.01%,WNT8B;FGFR4;SFRP1;IGFBP5;CYP1B1;STRN3;LRRK2;KYNU;DRD3;STAT5B;FOXA1
prerank,embryonic heart tube development (GO:0035050),-0.4270148722333147,-1.088883428994114,0.35904255319148937,0.803640845995151,1.0,6/14,16.88%,SOX17;TBX2;SOX18;HES1;RYR2;CITED2
prerank,brain development (GO:0007420),0.3368515290768133,1.088780032197453,0.3127853881278539,0.8187168560791624,1.0,14/136,4.48%,EPHA7;ATXN1;PBX1;ARNT2;HSPG2;ZIC1;PCDH18;SHROOM2;NKX2-1;NFIB;CDK5RAP3;SYNJ2;RAPGEF2;ZIC2
prerank,regulation of cell growth (GO:0001558),-0.24968981901509674,-1.0886676725761089,0.1927710843373494,0.8026537633522614,1.0,49/204,14.57%,PLCE1;SLIT2;PTPRJ;FHL1;ADAM10;NRG3;SPOCK1;SH3BP4;CCN3;ACVRL1;NET1;PAK5;TFRC;PPT1;ADAM15;OSGIN2;SDCBP;SOX17;TGFB2;CAMK2D;ERBB2;SOCS2;NPR1;AKAP6;NDRG3;MFSD2A;EGLN2;SERTAD3;HYAL1;WFDC1;SGK1;RPS6KA1;CCDC85B;LTBP4;OGFR;MINAR1;BCAR1;TGFB1;SLC25A33;SIRT1;MTOR;ATAD3A;FAM107A;SERTAD2;SUPV3L1;APBB1;CEACAM1;H3-3A;DERL2
prerank,embryonic hemopoiesis (GO:0035162),-0.43977997944318087,-1.0883444890476104,0.3864734299516908,0.8021036185104736,1.0,4/12,9.68%,KITLG;KDR;TAL1;TGFBR2
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.5234046182313286,1.088055426215976,0.3708838821490468,0.8200773959870696,1.0,3/10,8.91%,DCN;IL12B;SPRY2
prerank,protein-containing complex assembly (GO:0065003),0.32093803479786853,1.0870889082074948,0.30257510729613735,0.8220255143819266,1.0,79/259,22.81%,TCF7L2;TEAD1;SEC24D;AREG;TGFA;MITF;PLEKHA7;LAMC1;SEC31A;YAP1;TLE1;SH3PXD2B;MCU;AXIN2;LMAN1;BCL9;TCF7;PML;CD247;ZW10;RANBP9;LRRK2;TRAPPC4;AFDN;PARD6B;TCF7L1;GOSR2;PICALM;TSPAN4;CDC123;TRAPPC9;TRAPPC10;TRAPPC6B;GORASP1;FANCC;MNAT1;CTSZ;KLHL12;NOL3;USO1;WASF1;KMT2A;SEC23A;LLGL1;DLG4;SNX9;COL16A1;TBC1D20;TNFRSF1A;PARD3;GSDMD;TAPBP;CX3CL1;SEC24A;KAT5;DARS1;TMED10;CDC73;CSNK1A1;SEC16B;HSF1;MDM4;TRAPPC1;TRAPPC3;AFG3L2;RBBP5;HGSNAT;LEO1;TLE3;CAPZA1;OPA1;STOML2;TLE4;IL1RAP;SEC16A;SLC9A1;FANCA;NAPA;NCKAP1L
prerank,regulation of Golgi organization (GO:1903358),0.4543307400307641,1.0864608387592394,0.3696369636963696,0.8229906927690348,1.0,3/17,7.60%,USP6NL;RBSN;MAP2K1
prerank,regulation of viral life cycle (GO:1903900),-0.37931377257577814,-1.0862631077732698,0.33518005540166207,0.8068416013873635,1.0,10/21,21.76%,TRIM14;PPIA;HS3ST5;TRIM25;TRIM68;TYRO3;TRIM6;TRIM62;VPS4A;NECTIN2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.4588619908450087,1.0861967953060816,0.35960591133004927,0.8229565384375545,1.0,8/18,26.76%,DNAAF1;CCDC40;CABYR;CFAP53;SPEF2;ROPN1L;ODAD4;NPHP3
prerank,basement membrane organization (GO:0071711),0.48759837849369503,1.0860519513583091,0.37435897435897436,0.8226055959374237,1.0,8/14,23.25%,NID1;NID2;FLRT2;NTNG2;HPN;LAMB2;COL4A1;PXDN
prerank,secondary alcohol metabolic process (GO:1902652),0.3947141182132058,1.0858656167260468,0.3518776077885953,0.8224018046315669,1.0,8/42,15.42%,ABCA1;APOE;APOA1;CYP27A1;IDH2;LCAT;RXRA;OSBPL5
prerank,chromatin remodeling (GO:0006338),0.3455923990459272,1.0856175789137446,0.33616504854368934,0.8223917618875389,1.0,36/100,23.33%,ARID1B;NPM3;CBX3;INO80;SMARCA1;NPM2;MBD2;DR1;SMARCC2;MTA2;KDM5B;KAT2B;ZBTB1;POLE3;FOXA1;BAZ1B;ACTR8;KDM5C;SMARCD2;HDAC4;CECR2;SMARCB1;HNRNPC;BAZ2B;ATRX;KDM4A;SRCAP;KDM5A;TAF6L;KDM4C;JARID2;NUDT5;SMARCAD1;PBRM1;HDAC5;SMARCE1
prerank,vasculogenesis (GO:0001570),-0.3409150015940989,-1.0852475423168642,0.3215434083601286,0.8083058629869704,1.0,12/32,13.50%,CAV1;KDR;NOTCH1;SOX17;RASIP1;RAMP2;HEY2;SOX18;VEGFA;TGFBR2;TGFB1;APLNR
prerank,aminoglycan biosynthetic process (GO:0006023),0.3887836236087135,1.0852059935062481,0.3491847826086957,0.8227735804051777,1.0,10/49,11.94%,GPC6;HSPG2;PXYLP1;B3GALT1;HS6ST1;SDC1;B3GALNT1;EXT1;NDST1;GALNT5
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.3539795154283539,-1.0849122170788692,0.321875,0.8077191427644856,1.0,16/30,25.67%,SDCBP;RYBP;RPL11;HSP90AB1;USP14;GIPC1;N4BP1;SVIP;FHIT;DDRGK1;STYX;UBXN1;CAMLG;CCAR2;USP7;SGTA
prerank,response to organonitrogen compound (GO:0010243),0.3903508011437191,1.0845261863093967,0.3616398243045388,0.8238908018460491,1.0,9/38,12.19%,ERLEC1;DERL1;KYNU;RNF185;RNF139;DRD3;IRAK3;PRKN;RCN3
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.25620905076481276,-1.0837086945626082,0.21621621621621623,0.809729666477245,1.0,42/149,21.78%,PRKCH;CAV1;NOD1;RPS6KA5;TNFRSF11A;TFRC;TRIM14;PPIA;NFKBIA;RPS3;ARHGEF2;RBCK1;AIM2;TRIM25;ALK;RPS6KA4;TRAF5;CX3CR1;PRKCZ;RTKN2;CARD14;CD40;TRAF1;TRIM68;APP;NOD2;CARD16;TAB1;TRIM6;BTK;EP300;TLR4;TRIM62;NPM1;CLU;DHX9;PSMA6;AGER;TRAF2;UBE2V1;DDRGK1;CHUK
prerank,organelle fission (GO:0048285),-0.36194437937284824,-1.0835684236826648,0.36890243902439024,0.808584084355009,1.0,6/24,16.18%,DNM3;WASHC5;MTFR1;CORO1C;DNM1;MTFR2
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.47451635875132514,1.082822320406479,0.3639398998330551,0.8279144025826926,1.0,2/15,3.64%,GDNF;SMO
prerank,regulation of ruffle assembly (GO:1900027),-0.3702725641955299,-1.082145419515717,0.34782608695652173,0.8114694642082964,1.0,4/23,7.19%,CAV1;NLGN1;RDX;EPS8L2
prerank,protein localization to vacuole (GO:0072665),-0.4313940555035763,-1.0818316403166683,0.3743961352657005,0.8108545732044371,1.0,4/13,19.76%,SH3BP4;KPTN;CD81;LMBRD1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.36845563233186546,-1.0817563193264277,0.3307291666666667,0.8095373036441391,1.0,11/22,25.45%,AKAP6;STAC;ATP1B1;CALM1;CALM3;RYR2;P2RY6;HAP1;CASQ1;VMP1;CALM2
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3843258156155088,1.0812631174691423,0.37166900420757365,0.8314220970315099,1.0,9/49,11.09%,DAPK2;BCL2;NUPR1;SRC;EIF2AK3;BCL2L11;BCAP31;DDX3X;GSDME
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.43818915612486076,1.0804558467356502,0.3701399688958009,0.8328336554610437,1.0,3/24,3.78%,NRP1;SEMA3D;SEMA5A
prerank,regulation of adaptive immune response (GO:0002819),0.45857877409769465,1.0800412474652514,0.37080536912751677,0.8331910415799493,1.0,2/18,4.44%,ADCY7;IRF1
prerank,regulation of protein modification process (GO:0031399),0.37984408722258056,1.0799754386773612,0.35325365205843295,0.8326326646267855,1.0,11/50,10.37%,IGF2;LYN;MT3;HPF1;PHIP;CDH5;PML;ATG10;KAT2B;STAT2;SPRED3
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.3762311515582664,-1.0799315201702513,0.35405405405405405,0.8135612023207087,1.0,8/21,12.63%,EXTL3;NDST3;HS3ST4;XYLT1;HS6ST3;HS3ST5;HS6ST2;UGDH
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.34595491049467253,-1.0796564138152178,0.34324324324324323,0.812806178699428,1.0,9/27,23.10%,RIMS1;ARHGAP17;RIMS2;SYT1;SYT6;SYT4;RIMS3;SYT15;SYT5
prerank,proteasomal protein catabolic process (GO:0010498),0.3197770482547117,1.0794394454877545,0.33111849390919157,0.8333278675982972,1.0,65/201,23.52%,SPSB1;TBL1XR1;HECW2;FBXL17;FBXL19;NEDD4;RFFL;SMURF2;PSME4;ERLEC1;BFAR;DERL1;PML;CUL4B;NFE2L2;UBE4B;SIRT2;UBXN2B;UBE2U;RNF185;NR1D1;RNF139;ARRB1;UBXN11;PRKN;ITCH;IFI27;KBTBD7;ERCC8;RCN3;FEM1C;BTRC;TNFAIP1;ENC1;APPBP2;HACE1;HUWE1;DDI1;NHLRC3;SPOP;PSMB5;PSMC2;KAT5;RNF34;PSMD1;PSMD4;NSFL1C;PSME3;CCDC47;FEM1B;KCTD13;DCAF11;PSMA3;ZSWIM8;DDIT3;UCHL1;BIRC2;RNF216;BAG6;KLHL20;PSMA2;FBXW11;ATXN3;PSMC5;ARMC8
prerank,rRNA pseudouridine synthesis (GO:0031118),0.5143117739908379,1.0791865367724343,0.40034965034965037,0.8332777639641556,1.0,3/10,17.56%,RPUSD4;RPUSD2;NAF1
prerank,cellular glucan metabolic process (GO:0006073),0.5104075484954282,1.0786794910357687,0.3872113676731794,0.8339254887660983,1.0,5/11,16.25%,PHKB;PRKAG2;PYGM;PPP1R3C;PHKA1
prerank,rRNA 3'-end processing (GO:0031125),0.5245311489511923,1.0786343037926118,0.39963503649635035,0.8333031074856567,1.0,7/10,27.35%,ERI3;ERI1;EXOSC7;EXOSC2;ERI2;EXOSC8;EXOSC9
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.4028282592824834,-1.0785714950405776,0.34772182254196643,0.8145290579560207,1.0,3/17,6.48%,ANK3;KCNAB1;AKAP6
prerank,chromatin assembly or disassembly (GO:0006333),0.5076328905947495,1.0780537558640348,0.4050632911392405,0.8340802071850765,1.0,3/11,11.81%,CHAF1B;MTA2;HDAC8
prerank,regulation of epithelial cell migration (GO:0010632),0.380556070818819,1.0779350524315259,0.36363636363636365,0.8336562098421266,1.0,9/51,7.29%,GLUL;SASH1;MCC;MACF1;INSL3;CTSH;SRC;DOCK5;RAB25
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.41588076819457426,-1.077777514420172,0.36049382716049383,0.8153598391726661,1.0,6/15,14.14%,MVB12B;PTPN12;ERBB2;CDH13;LGMN;CEACAM1
prerank,ERBB signaling pathway (GO:0038127),0.36847951318206945,1.0777446084753173,0.3528645833333333,0.8334391340596256,1.0,13/64,11.27%,PDPK1;PIK3R1;AREG;TGFA;EPGN;PIGR;SRC;CUL5;SLC30A10;AAMP;EGFR;BRAF;HBEGF
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.29943890340777485,-1.0776058822449714,0.31906614785992216,0.8143467905587067,1.0,25/54,30.50%,CAV1;IVNS1ABP;NXN;RPS3;CRY1;RPL11;MINAR1;COPS9;TNFAIP3;RPL5;USP4;N4BP1;VPS28;PRMT3;PRR7;ADGRB1;UBXN1;CAMLG;PRKCG;CAPN3;ISG15;BAG2;U2AF2;CTNNB1;SQSTM1
prerank,negative regulation of immune response (GO:0050777),0.32691045794564116,1.0774972227519295,0.3536036036036036,0.8334471605752795,1.0,17/154,8.40%,ADCY1;ADCY2;LYN;ADCY7;ADCY5;ADCY9;INSL3;VIP;LHCGR;ADRB3;SRC;CD247;MAPKBP1;DPEP1;SIRT2;NMI;IRAK3
prerank,regulation of proteolysis (GO:0030162),0.38490735527469777,1.0768751194318156,0.3474114441416894,0.8343889035100974,1.0,14/48,16.72%,DNAJC1;OGT;FGFR4;ASPH;CST3;RNF139;ITCH;F2;CLN3;BTRC;TM4SF20;SPOP;AKT1;SHH
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.4568244294657886,-1.0767560019889777,0.4,0.8152964441469597,1.0,4/11,16.30%,MEF2C;TGFB2;TGFB1;GPER1
prerank,positive regulation of response to external stimulus (GO:0032103),0.3367816100570177,1.0766271174809603,0.3466981132075472,0.8343506827868105,1.0,29/128,18.50%,BMP6;SASH1;SERPINE1;OPTN;PDGFRB;CCL19;IL12B;CEBPA;AGTR1;TSLP;DDX60;NMI;CCN4;SETD4;IFNK;F2;NAPEPLD;PDCD4;ETS1;MDK;RIOK3;TNFRSF1A;CD47;IL23A;CX3CL1;TNIP1;IL18;DHX58;PRKCA
prerank,long-chain fatty acid metabolic process (GO:0001676),0.36600700142799125,1.0762180850363008,0.35271317829457366,0.8347456674758892,1.0,9/64,7.08%,DAGLA;ACSL1;EPHX2;ACOT2;GSTM4;PLA2G4A;CYP1B1;GSTM2;ALOXE3
prerank,mitotic sister chromatid cohesion (GO:0007064),0.4651045419128643,1.075937655899772,0.38898163606010017,0.8347702932086043,1.0,6/16,19.21%,PDS5B;POGZ;SGO1;NIPBL;BOD1;NAA50
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.4350833565776063,-1.0759330014338935,0.37320574162679426,0.8161359090916387,1.0,6/12,20.96%,PLCG2;RAB27A;ZNF205;TLR4;GRIN1;ADGRB1
prerank,response to laminar fluid shear stress (GO:0034616),0.512429602487188,1.0756857443313763,0.40176991150442476,0.8347469322635095,1.0,2/10,6.96%,ABCA1;NFE2L2
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.4175566547393602,1.0754342165307176,0.37317784256559766,0.834728934595522,1.0,8/30,10.78%,AR;NCOA2;SFRP1;DAB2;SAFB2;NCOR1;RNF6;NCOR2
prerank,regulation of intracellular protein transport (GO:0033157),-0.34513379481599804,-1.0750463445716762,0.3516819571865443,0.8171848148138118,1.0,12/32,27.49%,PRR5L;PTPN14;KIF20B;TGFB1;UHMK1;PDCD10;PLK3;TENM1;CEP131;GCC2;RAB29;LCP1
prerank,cobalamin metabolic process (GO:0009235),0.45982384628403894,1.0750040502350755,0.39434276206322794,0.8351842479742383,1.0,3/17,8.03%,MMAB;MTR;MMUT
prerank,sphingolipid biosynthetic process (GO:0030148),-0.286690551305811,-1.074835074687049,0.29130434782608694,0.8162486467599196,1.0,9/71,5.34%,SGMS1;CERT1;ACER3;SGMS2;ELOVL7;ACER2;DEGS2;SPNS2;ELOVL5
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.3577643221485214,-1.0747618919896793,0.3508771929824561,0.8149090836068897,1.0,10/25,23.25%,SLC7A5;PLCG2;B2M;CD55;NOD2;TRIM6;FZD5;TRAF2;MAP3K7;MALT1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.4361319088649451,1.0743882908830864,0.37715179968701096,0.8361567936656246,1.0,2/23,3.25%,CEMIP;PRKAG2
prerank,positive regulation of lamellipodium organization (GO:1902745),0.4148947166436433,1.0743318386604797,0.3558823529411765,0.8355740305585955,1.0,5/32,7.55%,AUTS2;PIK3R1;CDC42;SRC;CARMIL1
prerank,cell-cell junction assembly (GO:0007043),0.3667551441541249,1.0740536958307,0.36304909560723514,0.8355757059424341,1.0,12/63,8.02%,GJA1;CDH11;GJB6;GJB2;TLN2;ARVCF;TLN1;CDH5;VCL;DCHS1;FBF1;PARD6B
prerank,"transcription, DNA-templated (GO:0006351)",0.3208866065621491,1.0739303067687045,0.3252747252747253,0.8352046666447014,1.0,66/207,23.83%,POLR2D;SOX5;GLIS3;MAF;THRB;HSF2BP;NFIX;MLLT3;GTF2E1;BRF1;GTF3C1;GTF2H5;PMF1;MED16;CREBL2;POLR3A;TRIP11;CCNK;POLR2C;TFAM;MBD1;POLRMT;NKX2-8;TTF2;MNAT1;PAF1;TEFM;TAF5L;GTF2E2;TAF9;NELFE;AFF4;FUBP3;TTF1;COPS2;TFDP1;TSC22D1;CCNT2;FOXO3;CDC73;NCOA6;POLR2L;TAF2;PAX1;HSF1;GTF2A1;DEAF1;BRF2;NFE2L3;LEO1;MLLT1;IRF9;GTF3C3;NOCT;ERCC3;CCNT1;RPAP1;NCBP2;POLR1C;CDK7;ERCC2;KLF13;TAF4B;NAT14;ELOC;SETX
prerank,negative regulation of programmed cell death (GO:0043069),0.3117367148053652,1.073885784794353,0.3305785123966942,0.8345898388217085,1.0,71/355,17.07%,IGF1;FHL2;ANGPT1;GDNF;PIK3R1;IL31RA;BCL2;GRK5;SON;SH3RF1;ASCL1;GAS6;CFLAR;NUPR1;MYO18A;NOTCH2;TXNDC5;FSTL1;MT3;AXL;PHIP;SFRP1;CTSH;PRKAA2;PDPN;TBX3;VIP;USP47;BFAR;ARHGAP10;SRC;DPEP1;TSLP;CD28;ARAF;OSR1;DAB2;DNAJC3;EGFR;MAP4K4;SPRY2;ITCH;BRAF;DDX3X;CLN3;ANXA5;NIBAN2;HMGN5;RIPK2;NOL3;VDAC1;HYPK;TAF9;HSPA9;ARF4;TM7SF3;DSTYK;HPN;FLNA;PLK2;GATA6;BMP4;TMBIM6;GOLPH3;AKT1;KANK2;ATF5;SHH;PIM1;PSEN2;GLO1
prerank,positive regulation of cell communication (GO:0010647),-0.3459090251838504,-1.07361594480804,0.37026239067055394,0.8168001084286302,1.0,10/28,12.19%,ANK3;RIMS1;GRIK2;RIMS2;SYT1;CLSTN2;EDN1;CLSTN3;HOMER1;CD80
prerank,regulation of leukocyte migration (GO:0002685),0.4634483024004178,1.0735709718112552,0.38079470198675497,0.8347052190585198,1.0,1/16,0.70%,RHOH
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.41483415094051723,1.0735665425497054,0.3799392097264438,0.8332666396918275,1.0,6/29,17.19%,ACOT11;ACOT6;ACOT2;ACSF2;ACOT9;OXSM
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.41483415094051723,1.0735665425497054,0.3799392097264438,0.8332666396918275,1.0,6/29,17.19%,ACOT11;ACOT6;ACOT2;ACSF2;ACOT9;OXSM
prerank,positive regulation of neuron differentiation (GO:0045666),0.3996812653220419,1.072931947717687,0.3727144866385373,0.8342763105120093,1.0,9/40,12.09%,TCF4;FGFR1;ZEB1;ASCL1;NEUROD1;ADRA2C;BMP2;REST;IMPACT
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.41744525631160667,1.0727550196077191,0.37631184407796103,0.8340102452514191,1.0,3/28,3.47%,ADCY1;EPHA4;APOE
prerank,cellular response to interleukin-4 (GO:0071353),-0.4538079843957285,-1.0727035371185951,0.36818181818181817,0.8179878576973926,1.0,1/10,0.16%,LEF1
prerank,positive regulation of histone acetylation (GO:0035066),-0.35795268965684585,-1.0726760199431615,0.37534246575342467,0.8165158957718351,1.0,7/23,13.80%,RPS6KA5;NOS1;PPARGC1A;BRD7;RPS6KA4;TADA2A;MAPK3
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.32685068340988194,-1.0719280989361835,0.3486238532110092,0.8171261216143162,1.0,18/37,25.67%,SDCBP;HIPK2;RYBP;RPS7;RPL11;HSP90AB1;TAF1;RPL5;GIPC1;N4BP1;FHIT;RPL23;DDRGK1;UBXN1;CAMLG;CCAR2;USP7;SGTA
prerank,negative regulation of type I interferon production (GO:0032480),-0.32372220395701345,-1.0715972881294369,0.3201320132013201,0.8166001426842401,1.0,12/40,19.26%,IFIH1;RNF125;SIRPA;TRIM25;NLRC5;YY1;REL;TNFAIP3;RELB;PCBP2;UFD1;TAX1BP1
prerank,positive regulation of response to wounding (GO:1903036),0.4263871451621923,1.071260013012412,0.3924242424242424,0.8373359270338115,1.0,8/24,16.39%,KANK1;MYLK;VTN;INSL3;HBEGF;ADRA2A;MDK;ARFGEF1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.42901168731756845,1.0711461247831466,0.3639240506329114,0.8369299720645317,1.0,2/26,3.81%,ITPR1;CCL19
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.3786707492607624,-1.0711190328913096,0.37150127226463103,0.8164105329684952,1.0,9/20,30.27%,ADAM10;TGFB1;MBTPS2;ADAM9;RHBDD1;APH1A;MBTPS1;TRAF6;NCSTN
prerank,macromolecule catabolic process (GO:0009057),-0.36695587914547895,-1.0708197526061864,0.3343558282208589,0.8157833630177098,1.0,8/26,12.39%,SMURF1;PPT1;SIAH1;TRIM24;KIF16B;TGFB1;LGMN;MTOR
prerank,histone ubiquitination (GO:0016574),0.43601765596653463,1.0706688560651239,0.3864353312302839,0.8374921904895359,1.0,12/21,27.36%,UBR2;ATXN7L3;UBE2U;PAF1;HUWE1;WAC;CDC73;LEO1;RNF20;UBE2E1;RNF40;UBE2N
prerank,regulation of cellular component organization (GO:0051128),-0.25354322202207796,-1.0702989501007996,0.2814814814814815,0.8157918516337833,1.0,31/135,14.29%,PLCE1;RAP1A;NRG3;RIT2;SPOCK1;TJP1;NET1;PAK5;TFRC;HSPA8;CAMK2D;SOCS2;OPHN1;HIP1R;RAP1B;RAB5B;CDH13;EGLN2;PACSIN2;WFDC1;SGK1;LTBP4;SSRP1;OGFR;BCAR1;MTOR;ATAD3A;FAM107A;PACSIN1;CEACAM1;RAB4A
prerank,phosphatidylserine metabolic process (GO:0006658),-0.34097005661414037,-1.0701294557591088,0.3323615160349854,0.8147480163713516,1.0,13/32,27.54%,SERINC5;MBOAT1;PLA1A;PLAAT3;PTDSS1;LPCAT3;PLA2G4F;PLA2G4E;PLSCR1;PLA2G4B;PLA2G5;MBOAT2;LPCAT4
prerank,cellular response to interferon-beta (GO:0035458),-0.41001701013959346,-1.0700863389863084,0.37115839243498816,0.8133598155123587,1.0,5/14,16.14%,AIM2;PNPT1;UBE2K;UBE2G2;TRIM6
prerank,glycine metabolic process (GO:0006544),-0.4374662999224424,-1.0698455825016115,0.3938679245283019,0.8125373903758951,1.0,6/12,33.59%,GCSH;GCAT;SHMT1;AMT;GLYAT;GLDC
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.3095200580196349,-1.0694060132742926,0.33559322033898303,0.8122485019638213,1.0,13/44,13.63%,KCNJ2;KCNJ3;KCNMA1;KCNN2;KCNQ1;AKAP6;ATP1B1;KCNMB2;WNK2;KCNJ15;GNB1;KCNJ10;GNG2
prerank,renal filtration (GO:0097205),0.5188746972107143,1.0690413663441254,0.4036697247706422,0.8411162036503356,1.0,3/10,4.16%,SULF2;ITGA3;SULF1
prerank,skeletal muscle organ development (GO:0060538),0.4222050256901171,1.0689413213170378,0.38753799392097266,0.840670420505109,1.0,4/26,4.39%,SVIL;CFLAR;LARGE1;MSC
prerank,telomere maintenance via recombination (GO:0000722),0.501043821338388,1.0683878172578605,0.4074074074074074,0.8414438548535488,1.0,5/11,20.25%,SMC5;SMC6;TEP1;RAD51D;NSMCE2
prerank,regulation of vasoconstriction (GO:0019229),0.42146918099678665,1.0680120578171461,0.39092240117130306,0.8416937151981502,1.0,5/27,11.11%,ADRA1B;BDKRB2;AGTR1;TRPM4;ADM
prerank,negative regulation of autophagosome assembly (GO:1902902),0.48513670273777404,1.0679752300523853,0.4143835616438356,0.8410609850794474,1.0,2/13,6.60%,NUPR1;LRRK2
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.37197426734339245,1.0673225035244174,0.3789764868603043,0.8420744522256576,1.0,5/51,4.19%,SERPINE1;IL6R;IL34;GAS6;CSF1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.4390874564424027,-1.0673040082650638,0.39853300733496333,0.8171810734378209,1.0,8/12,29.93%,SGTB;CHMP4B;CHMP4A;SGTA;SEC61G;GET3;SEC61A2;SEC63
prerank,positive regulation of cation channel activity (GO:2001259),-0.32261936624516546,-1.0670988573251858,0.3581081081081081,0.8162710622967486,1.0,17/40,23.45%,SHANK3;TMSB4X;ANK3;AKAP6;STAC;CALM1;CALM3;ADRB2;ATPSCKMT;P2RY6;NLGN3;CTSS;KCNIP2;HAP1;RELN;CCL2;CASQ1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.3839300655670346,1.0666923232066325,0.3988995873452545,0.8430800805785315,1.0,5/44,7.23%,CYP7B1;SLC27A5;PRKAG2;INSIG2;CYP27A1
prerank,regulation of acrosome reaction (GO:0060046),-0.45519092223624913,-1.0666473455596512,0.38944723618090454,0.8160039426980578,1.0,2/10,13.74%,GLRA1;CACNA1H
prerank,primary miRNA processing (GO:0031053),0.5085583309237496,1.0657691004852288,0.395910780669145,0.844781975389552,1.0,5/10,22.17%,SMAD3;SMAD1;METTL3;SMAD2;DROSHA
prerank,negative regulation of cellular metabolic process (GO:0031324),0.4001295377922555,1.0655444687080406,0.35235378031383735,0.8446818129978236,1.0,8/37,9.63%,OPTN;APOE;MT3;SIRT2;NCOR1;PRKN;ITGB3;ITGAV
prerank,cardiac muscle cell differentiation (GO:0055007),0.4297741159711438,1.0649134207424875,0.38175675675675674,0.8457017360678609,1.0,5/21,8.90%,SLC8A1;ACVR1;SIK1;BMP2;CBY1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.3418440820785797,1.0645185907339076,0.35591133004926107,0.8460436784627962,1.0,13/93,10.84%,CCN2;SH3RF3;SASH1;SH3RF1;GADD45B;CCL19;EDAR;RELL1;MTURN;BMP2;LTBR;CARD9;TAOK3
prerank,ether lipid metabolic process (GO:0046485),0.4682273338715408,1.0637575878738343,0.4092465753424658,0.8473599229694544,1.0,1/14,0.62%,AGMO
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.4831399649132274,1.063595773684849,0.40672268907563025,0.8470672485216434,1.0,3/13,8.21%,ADGRV1;GRM2;DRD3
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3073891571744369,1.0635691362241932,0.3548717948717949,0.8464148778732027,1.0,81/366,18.97%,NFIA;IGF2;RORA;RHOH;ATXN1;ARNT2;MITF;WWC2;CCNA2;NUP107;TGFBR1;OGG1;MSC;NCOA2;DENND4A;ENG;TCF7;APBB2;NAB2;PML;CEBPA;WWTR1;SAP30;REXO4;ZBTB38;WTIP;TULP3;TCF7L1;CREBL2;BMP2;ZBTB4;NONO;MZF1;GTF2IRD1;NSD1;ACTR8;ZSCAN21;PHF1;RNF6;NR1D2;EIF2B4;CEBPB;IFNK;REST;HMGN5;INSR;ACVR1B;TRIP4;MTPN;TAF5L;ZNF219;YAF2;SUFU;MYCBP;FOXK2;SAP30L;GPBP1;RBM4B;FADS1;TGFBRAP1;PSPC1;MYT1;MAFA;PLAG1;ZNF423;ATF5;SP1;ZFAT;MYBL1;SPIN4;IRF2;FOXO3;SRSF10;PPIE;NFIL3;SOX11;GON4L;CARM1;ATRX;CREM;CHD7
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.34867963903892735,1.0632250208174743,0.3553421368547419,0.8466443097504605,1.0,13/94,11.61%,ITPR1;PDK1;BCL2;MOAP1;CYP1B1;PML;CUL5;BCL2L11;AIFM1;STK11;DDX3X;CEBPB;IKBKE
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.509354459175201,1.0631721528649034,0.39892665474060823,0.8460573760677551,1.0,3/10,6.96%,PYCR1;LRRK2;NFE2L2
prerank,mitotic cytokinesis (GO:0000281),0.3776733274328235,1.0623907595781095,0.3770718232044199,0.8473835486761111,1.0,8/47,9.03%,ROCK2;SON;KIF20A;MYH10;EFHC1;SNX33;SNX18;KLHDC8B
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.3779548643793849,1.0623083415957888,0.3748290013679891,0.8469022597082392,1.0,4/48,2.08%,PDPK1;ANGPT1;SRPX2;FGFR1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.4851457420005993,1.0620789181380514,0.4079173838209983,0.8468252869629417,1.0,5/12,22.38%,MIA3;WNK1;MDK;AKT1;LCK
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3610627006553867,1.062018293876578,0.36876640419947504,0.846259145921085,1.0,24/69,24.69%,POLR2D;PHAX;GTF2E1;SNAPC1;CCNK;POLR2C;RPAP2;INTS4;GTF2E2;TAF9;ELL2;SNAPC5;SNAPC4;SP1;CCNT2;POLR2L;GTF2A1;TAF8;CCNT1;NCBP2;CDK7;INTS7;NABP2;ICE1
prerank,neuromuscular synaptic transmission (GO:0007274),0.45171463862332695,1.0618302655475282,0.3953488372093023,0.846055464600065,1.0,6/18,24.26%,ERC2;DTNA;FCHSD2;STAC3;CHRNB2;RIMBP2
prerank,synaptic vesicle cycle (GO:0099504),-0.34352146512372184,-1.0615496643692122,0.3776435045317221,0.8293481403388129,1.0,7/30,16.85%,NLGN1;RIMS1;CDK5;PCLO;CPLX1;RAB3A;STX1A
prerank,regulation of cholesterol transport (GO:0032374),0.4386221639888006,1.0614879320177029,0.41321044546851,0.8462227804987941,1.0,5/20,18.09%,LRP1;APOA1;TSPO;NR1H3;YJEFN3
prerank,glycolipid metabolic process (GO:0006664),-0.298329377500083,-1.0612526184992008,0.32525951557093424,0.8286870281463788,1.0,3/47,0.81%,ST6GALNAC3;ST3GAL6;ESYT2
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.40526950666085804,1.0611681927002852,0.38565022421524664,0.8463734870241026,1.0,6/30,11.53%,VAMP5;MACF1;OPTN;GOLGA4;GGA2;GOLPH3L
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.4438360062388198,-1.0609272795291156,0.40093240093240096,0.8281235746926834,1.0,5/11,16.32%,NOVA2;PCBP3;PCBP1;RASA1;PCBP2
prerank,translational elongation (GO:0006414),-0.26740762891230596,-1.0605164497115132,0.358974358974359,0.827858076622824,1.0,40/101,32.16%,EEF2;GTPBP1;GFM2;MRPL46;MRPS18A;MRPS5;MRPL39;MRPS26;EEF1A1;EEF1B2;MRPS12;MRPL48;MRPL4;MRPL21;MRPL44;MRPS33;MRPL55;MRPL57;RACK1;MRPS18B;MRPL42;MRPS10;MRPS21;MRPS7;MRPL34;MRPL15;MRPL19;EEF1A2;LTN1;MRPS22;MRPL38;MRPS31;EEF2K;MRPL12;MRPL28;MRPL43;MRPS14;MRPL54;MRPL2;AURKAIP1
prerank,negative regulation of histone acetylation (GO:0035067),-0.4404399928159859,-1.0602527828381145,0.4004524886877828,0.8271371353030561,1.0,4/11,28.28%,CTBP1;SIRT1;THAP7;SET
prerank,mesenchymal to epithelial transition (GO:0060231),0.5107768670625268,1.0601864535892365,0.41397849462365593,0.8482598746521124,1.0,1/10,2.13%,SALL1
prerank,negative regulation of histone methylation (GO:0031061),0.5250127750691359,1.0598932859796877,0.4270650263620387,0.8483211073427784,1.0,7/10,23.00%,BCOR;PHF1;WDR5;DNMT3B;JARID2;DNMT1;BRCA1
prerank,lipid modification (GO:0030258),-0.3191274976261756,-1.0595792453399413,0.3522012578616352,0.8276783951083262,1.0,15/37,20.81%,DGKB;DGKH;PLA2G7;MBOAT1;PLPPR5;DGKK;PLPPR1;DGKG;DGKQ;PLPP4;MBOAT7;LPCAT3;DGKZ;PLPP6;DGKI
prerank,negative regulation of viral transcription (GO:0032897),-0.4238459902417949,-1.059367893651444,0.375,0.8267268144193858,1.0,7/13,27.84%,TRIM14;TRIM11;TRIM62;IFITM3;TRIM13;MID2;UBP1
prerank,natural killer cell activation (GO:0030101),0.42265980933895986,1.0592557935145859,0.3990895295902883,0.8492273104473133,1.0,4/23,11.12%,PBX1;AXL;IL12B;IFNK
prerank,regulation of neuron projection development (GO:0010975),0.32177355830622956,1.0586575658267219,0.3781038374717833,0.8501893581915266,1.0,27/163,9.37%,EPHA3;PDLIM5;CAMK1D;LYN;KIF13B;EPHA4;KANK1;MARK1;APOE;EFNB2;DPYSL3;RAPGEF2;MT3;FZD1;PTK7;PTPRS;ROR1;LRRK2;ATP1B2;DENND5A;LPAR1;BRSK1;PTPN9;ARHGAP35;NTRK3;CAMK2B;RAPGEF1
prerank,negative regulation of cyclase activity (GO:0031280),0.476508479153763,1.0582239407530787,0.4006734006734007,0.8505970475593704,1.0,3/14,8.21%,ADGRV1;GRM2;DRD3
prerank,muscle tissue development (GO:0060537),0.479946213403787,1.057487972157056,0.4226618705035971,0.8518675034547246,1.0,6/13,16.72%,SMO;CSRP2;ENG;CSRP3;BMP4;SHH
prerank,regulation of immune response (GO:0050776),0.32188362035541346,1.0574124734626948,0.3873563218390805,0.8513403223730658,1.0,10/135,6.92%,COL1A2;COL1A1;COLEC12;LYN;ADCY7;APPL2;IRF1;BCL6;CD247;KLRD1
prerank,nuclear migration (GO:0007097),0.47756815456841056,1.0572342856445267,0.4137353433835846,0.8511289576622432,1.0,6/13,23.45%,SYNE2;DYNC1H1;CLMN;CEP120;FBXW11;TMEM201
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.3526884451407778,1.057133603769749,0.38402061855670105,0.8506817373040718,1.0,14/67,9.41%,NRP1;NEDD9;CSF1;APOA1;SFRP1;ECM2;CDC42;PLEKHA2;DOCK5;CARMIL1;CSPG5;ARL2;RSU1;MYADM
prerank,electron transport chain (GO:0022900),-0.39692667932271625,-1.0569729084134656,0.3735224586288416,0.832348892389727,1.0,7/15,25.88%,PDIA5;PPARGC1A;CYB561;NDUFA5;SDHB;ETFRF1;UQCRFS1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.36178301330860474,-1.0569182739462741,0.3791208791208791,0.8309978034109927,1.0,9/20,18.58%,ENTPD1;NT5E;P2RX7;HSP90AB1;APP;TXN;ANO6;C3AR1;PSTPIP1
prerank,regulation of autophagosome assembly (GO:2000785),0.40527489829778224,1.056680018636378,0.37702503681885124,0.8512048802538099,1.0,9/33,16.30%,NUPR1;NPRL3;LRRK2;ADPRH;MTMR3;RAB3GAP1;PIKFYVE;NPRL2;PIP4K2C
prerank,axonal transport of mitochondrion (GO:0019896),-0.44306260674327325,-1.0562507052175654,0.39712918660287083,0.8314642193928828,1.0,7/11,39.31%,SYBU;HIF1A;TRAK2;HAP1;ACTR10;MAPT;NEFL
prerank,protein ubiquitination (GO:0016567),0.29978680826438925,1.0560107701965953,0.34959349593495936,0.8522438934971045,1.0,120/471,20.86%,MYCBP2;RNF220;SPSB1;PDZRN3;HECW2;SH3RF3;SASH1;ARRDC4;BCL2;PELI2;SH3RF1;MGRN1;FBXL17;UBR2;FBXL19;NEDD4;SMURF2;PSME4;RNF213;EPAS1;BFAR;DERL1;ZNRF3;CUL4B;RNF31;NFE2L2;UBE4B;RNF10;TRIP12;CUL5;UBE2U;DTX4;FBXL3;TRAF7;RNF185;RNF139;UBE2V2;ARRB1;UBOX5;COMMD1;FBXO28;PRKN;ITCH;RNF181;ASB12;RNF6;RNF38;RNF152;MIB1;FBXO9;FBXO11;ERCC8;FBXO4;FBXL12;RAD18;SELENOS;BTRC;PEX2;PAF1;RNFT1;RNF217;KLHL12;MUL1;USP9X;TNFAIP1;TNKS2;RNF19A;ENC1;RC3H2;UBE2E2;AMFR;UBA6;THOP1;UBE2D1;ASB1;HACE1;HUWE1;RNF13;HLTF;DZIP3;CUL7;NHLRC3;SPOP;UBR5;UBE2R2;MSL2;UBR3;UBE3B;RNF138;UBE3A;PSMB5;RNF135;PJA2;PSMC2;DTX3;HERC6;UNKL;KLHL18;WAC;RC3H1;CDC73;RNF34;PSMD1;TRIM47;TRIM41;TRIM32;PSMD4;TRIM26;PSME3;TRIM21;FBXL18;HIF3A;RNF11;KCTD13;ARIH2;CDC23;UBE2T;PSMA3;LEO1;ZSWIM8
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5014050989914051,1.05562064949082,0.41986062717770034,0.8525845205817101,1.0,1/11,1.20%,GSN
prerank,granulocyte differentiation (GO:0030851),-0.37282601026119777,-1.0555264331103056,0.375,0.8320563996439948,1.0,3/18,8.30%,LEF1;CBFA2T3;TAL1
prerank,Golgi to plasma membrane transport (GO:0006893),-0.3033358794764044,-1.0554139122103428,0.3611111111111111,0.8308863884794582,1.0,13/47,14.63%,STXBP6;EXOC4;EXOC6;ANK3;EXOC5;SPTBN1;KIF13A;STEAP2;ARL3;NSF;EXOC8;EXOC2;CCDC93
prerank,cellular response to radiation (GO:0071478),-0.30729976014884425,-1.0548402351431965,0.3490909090909091,0.8310312014105625,1.0,22/40,35.90%,NET1;RHOB;RAD1;SIRT1;KDM4D;HUS1;RAD51;ECT2;CDKN1A;TANK;RAD51AP1;RHNO1;RRH;OPN1MW3;OPN1MW;FIGNL1;OPN3;GRB2;RAD9A;MAPK14;NSMCE3;EEF1D
prerank,macrophage differentiation (GO:0030225),0.47759642254772194,1.0547801595689754,0.42203389830508475,0.8540940235763426,1.0,3/13,6.16%,IL31RA;CSF1;CDC42
prerank,ceramide biosynthetic process (GO:0046513),-0.3133885910509921,-1.0546576357917974,0.3576388888888889,0.830085613943579,1.0,9/40,11.40%,ST6GALNAC3;SGMS1;ST8SIA4;SGMS2;DEGS2;DEGS1;ST8SIA6;SPTLC2;SPTSSB
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.36272812730384185,-1.0545093805804615,0.38858695652173914,0.82904854024352,1.0,7/21,11.07%,PDE4D;NT5E;NT5C2;PDE2A;NUDT4;PDE9A;NT5C1A
prerank,steroid metabolic process (GO:0008202),0.353688355785745,1.0539915937423567,0.3940149625935162,0.8554489954118508,1.0,7/72,7.56%,CYP26B1;CYP7B1;STAR;HSD3B2;CYP1B1;CYP27A1;SRD5A1
prerank,phagosome maturation (GO:0090382),0.387361426732342,1.053768702923904,0.4046639231824417,0.8553601551563492,1.0,1/35,0.20%,ATP6V0A4
prerank,negative regulation of protein modification process (GO:0031400),0.34899595313608595,1.0533513029772184,0.40339425587467365,0.8557987682834943,1.0,14/79,9.41%,PID1;PTPN13;PLPP3;LYN;FBLN1;CDK5RAP3;PRKAA2;LRRK2;BEX4;WWTR1;NTRK3;EPHB2;PRKN;MYADM
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.41029472011366075,-1.053301937746806,0.41044776119402987,0.831151983942264,1.0,3/14,9.98%,NOS3;ACE2;EDN1
prerank,long-chain fatty acid transport (GO:0015909),0.4113121011545665,1.053068624169988,0.3964757709251101,0.8558376886136568,1.0,4/30,5.20%,ACSL1;PRKAG2;APOE;PRKAA2
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.4953748764956039,1.0529835705343793,0.422680412371134,0.8553729706813005,1.0,2/12,8.00%,B3GALT1;B3GALNT1
prerank,icosanoid biosynthetic process (GO:0046456),0.5037214747576656,1.051545087784178,0.4199288256227758,0.8585858523218898,1.0,6/10,27.00%,PLA2G4A;FADS1;ALOX5AP;LTA4H;MGST3;MGST2
prerank,negative regulation of TORC1 signaling (GO:1904262),0.47310369492989096,1.0514288567334076,0.41796200345423146,0.8581821436836133,1.0,7/13,20.42%,STK11;RNF152;CASTOR2;ITFG2;SESN2;ATM;SZT2
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.4896553869945086,1.0511909392935126,0.43010752688172044,0.8581218637248007,1.0,2/11,7.77%,LYN;TLR6
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.4312520533318118,1.0511611624389827,0.4176,0.85749736569722,1.0,4/22,7.08%,GHR;KIT;CYP1B1;TSLP
prerank,histone H2A acetylation (GO:0043968),0.4617075084062502,1.0505664211594279,0.3990066225165563,0.8583522192515529,1.0,3/16,7.21%,ING3;BRD8;SPHK2
prerank,negative regulation of viral entry into host cell (GO:0046597),0.46908847919766083,1.050537475540878,0.4023372287145242,0.8577319357669602,1.0,1/12,1.20%,GSN
prerank,regulation of interleukin-1 beta production (GO:0032651),0.3563474563349734,1.0504691856459007,0.4049479166666667,0.8571926171878959,1.0,5/66,7.77%,IGF1;CCL19;APOA1;PANX1;TLR6
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.4112779021209134,1.0499593413543473,0.3987635239567233,0.8578127154302277,1.0,4/28,7.97%,ARHGAP28;PLEKHG2;ARHGAP18;ARHGAP35
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.2777430923880858,-1.0498726429171217,0.3651452282157676,0.8398112949683493,1.0,28/70,27.54%,ENPP2;PLA2G7;LPCAT1;MBOAT1;SLC44A5;MFSD2A;PLAAT3;GPLD1;PNPLA8;PLA2G4C;PCTP;MBOAT7;LPCAT3;STARD7;LPCAT2;PCYT1B;PLA2G4F;PLA2G4E;CHKA;DBI;ABHD4;PLAAT1;CHPT1;LIPC;PLA2G4B;PLA2G5;MBOAT2;LPCAT4
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.3617921060300613,1.049498065737573,0.3768506056527591,0.8582536996165281,1.0,13/53,21.27%,EYA2;EYA1;PLA2R1;EGFR;SPRED3;ERCC8;NPAS2;SPRED1;SMCHD1;ATM;UIMC1;BRCC3;NSMCE4A
prerank,pentose-phosphate shunt (GO:0006098),0.4960338278981473,1.049477906683429,0.4099264705882353,0.8575994601794188,1.0,6/11,31.06%,H6PD;PGD;TALDO1;PGLS;TKT;DERA
prerank,xenobiotic transport (GO:0042908),-0.379405018479838,-1.0492056769329117,0.376657824933687,0.8402446601036091,1.0,5/17,5.07%,SLC47A1;ABCG2;SLC7A5;ABCC1;SLC15A2
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.3631493905152537,1.0488389951781403,0.39335180055401664,0.8586160378123581,1.0,25/52,27.13%,SEC31A;TSPYL2;TLN1;PARP16;GFPT1;DNAJC3;GOSR2;CTDSP2;KDELR3;PDIA6;WIPI1;ZBTB17;CUL7;YIF1A;SRPRB;CXXC1;WFS1;ATP6V0D1;HSPA5;EXTL2;ACADVL;SSR1;LMNA;FKBP14;DNAJB9
prerank,cellular response to alkaloid (GO:0071312),0.4489281534974055,1.0484940922836956,0.4165341812400636,0.8588156115649179,1.0,3/17,10.97%,SLC8A1;GSTM2;CASP7
prerank,neuron projection morphogenesis (GO:0048812),-0.25235989873160425,-1.0483644738381463,0.4016393442622951,0.8412016836661149,1.0,33/137,15.06%,CNTNAP2;SHANK3;CTNND2;GPM6A;MAP2;NLGN1;ACTB;ANK3;NGF;NRCAM;IQGAP1;SLC9A6;KLF7;EPHB1;CNTN4;NTNG1;BTBD3;CDK5;DCDC2;PAK1;SGK1;SHANK1;NEFH;DCC;KIF20B;ATP7A;PACSIN1;NYAP2;APBB1;DIP2A;LMTK2;APP;MAP1B
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.4395321275147409,-1.0482137922282528,0.39864864864864863,0.8401888169012243,1.0,4/11,14.21%,ATL2;BNIP1;ARL6IP1;LPCAT3
prerank,acute inflammatory response (GO:0002526),0.4233806808993693,1.047875682889851,0.3915756630265211,0.8597909922508822,1.0,2/23,2.21%,AHSG;IL6R
prerank,7-methylguanosine mRNA capping (GO:0006370),0.39499743056362724,1.0478268407330416,0.39285714285714285,0.8584928951284095,1.0,10/31,23.02%,POLR2D;GTF2H5;POLR2C;MNAT1;CMTR2;POLR2L;ERCC3;NCBP2;CDK7;ERCC2
prerank,7-methylguanosine RNA capping (GO:0009452),0.39499743056362724,1.0478268407330416,0.39285714285714285,0.8584928951284095,1.0,10/31,23.02%,POLR2D;GTF2H5;POLR2C;MNAT1;CMTR2;POLR2L;ERCC3;NCBP2;CDK7;ERCC2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.27528982623910314,-1.0476560498547873,0.34285714285714286,0.840311438868151,1.0,22/71,19.02%,ELMO1;YES1;ACTB;VAV3;PLCG2;ARPC1B;DOCK1;PAK1;HSP90AB1;ARPC3;WIPF3;WASF2;FCER1G;CYFIP2;PLPP4;MAPK3;PIK3CA;ARPC4;PRKCE;ACTG1;FCGR1A;FGR
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.3994439885546206,1.0474389804929953,0.39280575539568346,0.8588915224922676,1.0,7/30,14.66%,ROBO1;APOA1;LPAR1;ARRB1;SYNPO2L;COL3A1;AKAP13
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.32265296941131605,1.0472670799733736,0.38111490329920367,0.8586719637967658,1.0,29/140,9.88%,RHOH;CGNL1;ARHGAP6;SYDE2;DLC1;RHOD;ARHGAP28;PLEKHG2;ARHGAP18;TIAM2;SOS2;ARHGAP29;FGD1;ARHGAP21;FGD4;ARHGAP19;ARHGAP32;ARHGAP10;CDC42;SRC;FAM13A;ARHGEF17;ARHGEF18;ARHGAP35;ARHGAP9;ARHGEF11;SYDE1;ITGAV;RHOT1
prerank,histone H4-K16 acetylation (GO:0043984),0.44782379948239187,1.046889183406438,0.4177215189873418,0.8589430485996828,1.0,9/19,24.63%,OGT;JADE1;KMT2A;WDR5;MSL2;KANSL1;MEAF6;KANSL3;JADE2
prerank,regulation of fibrinolysis (GO:0051917),-0.4197196961146661,-1.0465139187825274,0.41732283464566927,0.8421726449877287,1.0,3/13,2.59%,THBS1;FAP;THBD
prerank,inner mitochondrial membrane organization (GO:0007007),-0.2995754940549475,-1.046509805873582,0.39649122807017545,0.8406870380928679,1.0,13/47,21.51%,TOMM70;LETM1;ATP5F1A;ATP5F1E;ATP5ME;ATP5MG;ATP5F1C;ATP5MF;MTX3;MTX2;ATP5PD;MTX1;TIMM10
prerank,neural crest cell migration (GO:0001755),0.3887724569074772,1.0464777403452437,0.42574257425742573,0.8593128301897501,1.0,4/36,3.78%,NRP1;GDNF;SEMA3D;SEMA5A
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.28754947463624414,-1.0460049369847921,0.3389121338912134,0.8406663102584031,1.0,7/62,2.31%,MEF2C;ZBTB16;CDK6;PTK2B;TNRC6C;THBS1;HOXA5
prerank,alpha-amino acid catabolic process (GO:1901606),0.40632910674655226,1.0460033877949233,0.41517857142857145,0.8598718019135465,1.0,10/29,22.55%,TDO2;DDO;HOGA1;KYNU;SARDH;ACADSB;PRODH;CBS;KYAT1;FAH
prerank,inositol phosphate metabolic process (GO:0043647),-0.3036896906330023,-1.0459058349172692,0.36013986013986016,0.8395045698175253,1.0,20/46,25.99%,PLCE1;PLCG2;INPP5D;INPP4B;NUDT4;MINPP1;CALM1;IP6K1;ISYNA1;IPMK;PLCD4;INPP5B;SYNJ1;PLCH1;PPIP5K1;NUDT11;ITPKB;IMPA2;NUDT10;ITPKC
prerank,hexose biosynthetic process (GO:0019319),0.3855915275490282,1.0458213056281862,0.3940256045519203,0.8596313654679859,1.0,4/42,8.03%,RBP4;AKR1B1;MDH2;ENO2
prerank,negative regulation of developmental growth (GO:0048640),0.4040973877037053,1.0456985031158867,0.4101040118870728,0.8592292626273182,1.0,7/30,10.41%,WWC2;NKD1;MT3;PTPRS;ULK2;FGF13;RNF6
prerank,cell-substrate junction assembly (GO:0007044),0.3981176227742838,1.0456528941129006,0.4195906432748538,0.8586376570367015,1.0,5/33,6.32%,ACTN2;DLC1;RHOD;LAMC1;SRC
prerank,response to gamma radiation (GO:0010332),0.42554002253269546,1.0454865270787856,0.4211332312404288,0.8583822264078903,1.0,3/24,5.52%,YAP1;LIG4;MAP3K20
prerank,glycolytic process (GO:0006096),-0.33572716072155045,-1.0453959662063685,0.3839779005524862,0.8395721741666774,1.0,10/28,23.32%,GPI;HK2;PFKL;TPI1;PFKFB1;ALDOA;PKM;PGAM1;PGAM4;ALDOC
prerank,amino acid import (GO:0043090),0.4301691788548774,1.0452151568467163,0.42990654205607476,0.8583900195302389,1.0,5/21,7.63%,SLC1A3;SLC6A13;SLC22A2;SFXN2;SLC22A4
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.41848587699136397,1.0450197927022626,0.4185692541856925,0.858194850784507,1.0,13/26,25.71%,PRKAG2;APOA1;SLC45A3;PRKAA2;LPGAT1;EIF6;NR1H3;ERLIN1;BRCA1;ERLIN2;PRKAB2;ACADVL;PDK4
prerank,glutathione derivative metabolic process (GO:1901685),0.43900909541148125,1.0449150174561095,0.42879019908116384,0.857055368117482,1.0,10/20,27.27%,GSTM4;GSTM2;MGST1;GSTT1;GSTK1;AKR1A1;MGST3;ESD;MGST2;GSTZ1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.43900909541148125,1.0449150174561095,0.42879019908116384,0.857055368117482,1.0,10/20,27.27%,GSTM4;GSTM2;MGST1;GSTT1;GSTK1;AKR1A1;MGST3;ESD;MGST2;GSTZ1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.3458981297847694,1.0448871639596193,0.4099616858237548,0.8564163678550593,1.0,14/71,13.36%,ADAMTS12;FBXL17;CTSH;CTSF;CUL4B;NR1D1;CLPX;PRKN;NGLY1;CLPP;RSPRY1;CTSZ;USP9X;CTSL
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.3885880602202074,1.044559168858997,0.40564635958395245,0.8565916888859637,1.0,9/37,15.35%,CEMIP;PRKAG2;SIRT2;SPRY2;SPRED3;RIPK2;EGF;PARD3;SPRED1
prerank,glutamine family amino acid metabolic process (GO:0009064),0.3892951311286419,1.0443210071127969,0.41124260355029585,0.8565142765254177,1.0,5/33,8.64%,GLUL;ART4;PYCR1;PYCR3;ALDH18A1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.4309172938006775,1.0442783450896076,0.4254658385093168,0.8559399232611522,1.0,9/22,25.91%,ROCK2;PPP4R4;BOD1L1;PTPA;BOD1;NCKAP1L;PPP1R15A;MASTL;STYXL1
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.38344526051250494,-1.0440271919958597,0.3894736842105263,0.8422146668239983,1.0,3/18,7.80%,OCLN;SLC2A1;INPP5K
prerank,histone H2B ubiquitination (GO:0033523),0.49812804212301337,1.0435605754913895,0.45863309352517984,0.8571439471338977,1.0,7/10,27.03%,PAF1;WAC;CDC73;LEO1;RNF20;UBE2E1;RNF40
prerank,regulation of macrophage migration (GO:1905521),-0.44734624373368087,-1.0413674795164194,0.42572062084257206,0.8487062646610615,1.0,4/10,12.70%,MTUS1;PTK2B;CX3CR1;CD81
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.4508473766065405,-1.0413077661210983,0.4238875878220141,0.8473739841608164,1.0,6/10,19.88%,PDE4B;NIPSNAP2;CALM1;CALM3;CACNA2D1;CACNB3
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.434323916364427,-1.0412670927161192,0.43243243243243246,0.846024150403213,1.0,5/11,35.95%,JAK2;SIRT1;TMEM106A;XBP1;IL4
prerank,ncRNA 3'-end processing (GO:0043628),-0.4017517548633279,-1.0412344012355357,0.41975308641975306,0.8446483154392361,1.0,4/14,17.97%,INTS6;PTCD1;INTS8;ELAC2
prerank,negative regulation of hydrolase activity (GO:0051346),-0.29530451233186816,-1.0412124981912882,0.3715277777777778,0.843248321220064,1.0,6/49,6.37%,LRCH1;MAP2;F11R;SH3BP4;RDX;NOS1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.46031577807809215,1.04116669799742,0.42789223454833597,0.862721003764605,1.0,7/16,20.90%,RUNX1;WNT4;RGCC;F2;BMP4;LARP6;CREB3L1
prerank,actin filament organization (GO:0007015),0.3192510943378944,1.0409860134373754,0.40346820809248557,0.8625229247327172,1.0,23/151,10.61%,RHOH;SVIL;GSN;CGNL1;RHOD;NEDD9;TPM1;TMOD4;SHROOM2;RHOBTB1;DPYSL3;MYO1B;MCU;RHOBTB3;CDC42;RHOBTB2;CARMIL1;MYO1C;FAT1;MARCKSL1;MPRIP;SHROOM3;EFS
prerank,organic acid transport (GO:0015849),0.334029418399713,1.0408585047236973,0.40441176470588236,0.862192059278044,1.0,9/94,5.40%,SLC7A11;SLC7A2;SLC1A5;SLC13A3;SLC27A5;ACSL1;SLC6A13;NCOA2;PDPN
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.30261651485724506,-1.0407251397387234,0.3763837638376384,0.8431723709877244,1.0,12/43,14.28%,MEF2C;NOTCH1;SOX17;TBX2;ZIC3;SOX18;TGFBR2;HES1;STIL;APLNR;RYR2;MICAL2
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.37621900760431665,-1.0406329183969747,0.3702770780856423,0.8419667576665318,1.0,7/18,24.85%,SEC14L1;RNF125;USP15;UFD1;C1QBP;OASL;PUM2
prerank,lipid catabolic process (GO:0016042),-0.3790104645648609,-1.040276255044515,0.41247002398081534,0.841599870757871,1.0,9/18,28.48%,PPT1;LIPE;PLA1A;PLAAT3;HSD11B1;LIPH;LIPC;LPL;HSD17B14
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.4440397422216005,1.0398442714121519,0.41243862520458263,0.8641941499374765,1.0,8/17,23.12%,SPDL1;ZW10;CHAMP1;MTBP;CENPA;BOD1;IK;CTCF
prerank,aminoglycan metabolic process (GO:0006022),0.489209894534498,1.039675186756565,0.4380610412926391,0.8639420389201105,1.0,1/10,1.37%,GAL3ST3
prerank,regulation of Ras protein signal transduction (GO:0046578),0.34075010590300386,1.039590204877095,0.42379182156133827,0.863483781629986,1.0,11/85,9.37%,IGF1;LYN;DLC1;OGT;KANK1;NOTCH2;DENND4A;ARHGEF18;EPHB2;SPRY2;RAPGEF1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.34273676191106867,-1.039511755425893,0.39790575916230364,0.8422722063516244,1.0,8/26,13.10%,EFNA5;ANO1;LRP5;KLF7;EPHA5;GPLD1;ADCY8;CFTR
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.34405428747104433,1.0394618674730556,0.4,0.8631376481430695,1.0,12/75,9.97%,SLC8A1;SLC8A3;LYN;NR2F2;APOE;CDK5RAP3;PKIA;CEBPA;IRAK3;SPRY2;HEXIM2;INCA1
prerank,regulation of mitochondrial fission (GO:0090140),0.4107519884014298,1.03940736761957,0.4247226624405705,0.8625825795764981,1.0,6/24,13.03%,DCN;MCU;LRRK2;PRKN;STAT2;MUL1
prerank,metal ion transport (GO:0030001),0.3353012302740198,1.0391740138976915,0.40852130325814534,0.8625141053790103,1.0,9/86,7.01%,ITPR1;SLC8A1;SLC8A3;SLC41A1;SLC30A8;SLC24A1;MT3;CACNA1C;PANX1
prerank,regulation of microtubule-based movement (GO:0060632),-0.42914172254019356,-1.0389567742242862,0.41898148148148145,0.8423404652222276,1.0,5/11,25.37%,MAP2;NEFH;DYNLT2B;HAP1;CCDC65
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.400159349934101,-1.0389163200408067,0.40594059405940597,0.8409978698090194,1.0,3/15,9.89%,PRKCH;MED1;TRIM16
prerank,ruffle organization (GO:0031529),0.44856580616687236,1.038765120869573,0.42528735632183906,0.8629196110256989,1.0,4/16,9.06%,TPM1;LIMA1;CARMIL1;ARFIP2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.4460377588609085,-1.0387344372914709,0.4205607476635514,0.8400574504948969,1.0,3/10,5.23%,ZBTB16;ACVRL1;PKDCC
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.3755396061600664,1.037951980097721,0.4170096021947874,0.8643555245208693,1.0,17/45,21.06%,SMAD3;TOM1L2;BCL6;ZFP36L1;ZW10;ZWINT;RGCC;NME6;PTPN3;PLK2;BMP4;GAS1;CDKN1C;CDKN1B;FOXC1;ZFP36L2;PRCC
prerank,bile acid biosynthetic process (GO:0006699),0.41877172396112305,1.0377911913248705,0.43188854489164086,0.8640712596764231,1.0,3/24,7.23%,CYP7B1;SLC27A5;CYP27A1
prerank,central nervous system neuron development (GO:0021954),-0.3849390649765195,-1.0373099976001094,0.4128205128205128,0.8427758720654771,1.0,5/15,11.80%,MAP2;LHX6;B4GALT5;HSP90AB1;ATP7A
prerank,modulation by host of viral genome replication (GO:0044827),0.4737344186786759,1.0372148777920283,0.45532646048109965,0.8649268862510125,1.0,4/13,15.02%,CCNK;PRKN;IFI27;TBC1D20
prerank,positive regulation of phospholipid transport (GO:2001140),0.4932021700389622,1.0369835194838428,0.43275862068965515,0.864842959419058,1.0,5/10,22.48%,APOE;APOA1;ABCA3;ABCA7;PRELID1
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.4116466582315004,1.0366551737105623,0.43543543543543545,0.8650342106798224,1.0,7/25,8.14%,BMPR1A;CCN1;SULF1;CDH5;ENG;CRB2;RBPJ
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3346021154395408,1.0366362751003066,0.4058679706601467,0.8643901166502034,1.0,19/90,15.29%,GJA1;LEPR;OGT;ACSL1;GNAS;APPL2;EPAS1;DYNC1H1;ADRB3;ALMS1;MFAP2;CEBPB;STAT6;DECR1;DIO2;G0S2;CNOT3;IL4R;GRB10
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.4839611308527516,1.0366091283641425,0.43270868824531517,0.8637706154010093,1.0,1/12,1.39%,AR
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3478976516459007,1.036436539437114,0.4225721784776903,0.8635068554374712,1.0,17/72,23.02%,POLR2D;GTF2H5;CUL4B;POLR2C;ERCC8;MNAT1;GPS1;COPS3;COPS2;PPIE;XPA;POLR2L;RFC5;ERCC3;CDK7;LIG1;ERCC2
prerank,camera-type eye morphogenesis (GO:0048593),-0.44648112670435713,-1.0361439082013795,0.43155452436194897,0.8445096378294333,1.0,5/10,11.43%,TENM3;LRP6;TBX2;VEGFA;NF1
prerank,polyol metabolic process (GO:0019751),-0.3024903084835726,-1.035944122412782,0.3829787234042553,0.8436250019303118,1.0,20/46,25.99%,PLCE1;PLCG2;INPP5D;INPP4B;NUDT4;MINPP1;CALM1;IP6K1;ISYNA1;IPMK;PLCD4;INPP5B;SYNJ1;PLCH1;PPIP5K1;NUDT11;ITPKB;IMPA2;NUDT10;ITPKC
prerank,photoreceptor cell development (GO:0042461),-0.4089328074202545,-1.0355849672981399,0.4054726368159204,0.8432151465536529,1.0,5/14,9.51%,RORB;RP1;MFSD2A;ARL3;VEGFA
prerank,mitochondrial fission (GO:0000266),-0.38710541223618733,-1.0347564679478354,0.42216358839050133,0.8443597493632569,1.0,4/16,16.18%,DNM3;MTFR1;DNM1;MTFR2
prerank,epiboly involved in wound healing (GO:0090505),0.45373974625170854,1.0345427468211619,0.4307178631051753,0.8677331433265554,1.0,4/16,14.43%,CCN1;PDPN;ARHGAP35;FLNA
prerank,negative regulation of neuron projection development (GO:0010977),0.3637912624057825,1.034529146415056,0.4093333333333333,0.8670848989027996,1.0,10/56,7.93%,EPHA4;KANK1;APOE;EFNB2;DPYSL3;MT3;PTPRS;DENND5A;LPAR1;PTPN9
prerank,regulation of humoral immune response (GO:0002920),0.3733481377299872,1.0343737934920438,0.4102920723226704,0.8668361303608605,1.0,12/44,20.23%,SERPING1;VTN;CFH;C4B;C8G;F2;CFHR2;CXCL13;GATA6;PROS1;PHB2;SUSD4
prerank,regulation of mRNA polyadenylation (GO:1900363),0.44614207270749373,1.0342837954470168,0.4276315789473684,0.8663765598395767,1.0,10/17,27.03%,CPEB1;CPEB3;NELFE;ZC3H3;HSF1;CCNT1;RNF20;NCBP2;NCBP1;RNF40
prerank,negative regulation of interferon-beta production (GO:0032688),-0.4321640987084156,-1.0342023244819885,0.43555555555555553,0.8445985344500121,1.0,4/10,14.18%,SIRPA;YY1;REL;RELB
prerank,regulation of phagocytosis (GO:0050764),0.3591710305383782,1.034147941744849,0.42698191933240615,0.8660729632130635,1.0,11/53,16.04%,CAMK1D;AHSG;TULP1;GAS6;APOA1;IL15RA;ITGAV;SYT11;MERTK;FER1L5;CD47
prerank,tetrapyrrole metabolic process (GO:0033013),0.43767025891048555,1.0338784177269895,0.4380165289256198,0.8660752374514177,1.0,3/18,8.03%,MMAB;MTR;MMUT
prerank,negative regulation of protein polymerization (GO:0032272),-0.33399138819622165,-1.033516924810269,0.3805309734513274,0.8451094350032157,1.0,5/27,6.50%,SLIT2;MAP2;KANK3;CYRIB;HIP1R
prerank,triglyceride metabolic process (GO:0006641),0.36863930469056116,1.0332232712865594,0.4025069637883008,0.8670550987205455,1.0,3/48,3.47%,AGMO;SLC27A5;APOE
prerank,regulation of blood coagulation (GO:0030193),-0.34147263360228935,-1.0329416559180273,0.41033434650455924,0.8453245242489561,1.0,5/27,2.59%,CAV1;CD34;THBS1;FAP;THBD
prerank,regulation of microtubule polymerization (GO:0031113),-0.3060992474969723,-1.0327380885983923,0.38271604938271603,0.84441770161781,1.0,11/40,18.87%,OCLN;MAP2;NAV3;MET;RPS3;PAK1;FES;DCTN1;CDK5RAP2;CDK5R1;CLASP1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.2697307817002046,-1.0325662454784925,0.38207547169811323,0.8434510512528893,1.0,22/73,19.02%,ELMO1;YES1;ACTB;VAV3;PLCG2;ARPC1B;DOCK1;PAK1;HSP90AB1;ARPC3;WIPF3;WASF2;FCER1G;CYFIP2;PLPP4;MAPK3;PIK3CA;ARPC4;PRKCE;ACTG1;FCGR1A;FGR
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.4184978821867021,1.0324420102460474,0.4254992319508449,0.8684028314329515,1.0,6/22,15.25%,NR2F2;CEBPA;HEXIM2;INCA1;PTEN;CDKN1C
prerank,positive regulation of JNK cascade (GO:0046330),0.3425962872690964,1.032333901399537,0.4222503160556258,0.8679760811372844,1.0,11/70,12.37%,CCN2;SH3RF3;SH3RF1;GADD45B;CCL19;EDAR;MTURN;LTBR;CARD9;TAOK3;DUSP19
prerank,cholesterol transport (GO:0030301),0.3672363909767343,1.0320780878614992,0.4331983805668016,0.8679349590969598,1.0,6/45,5.80%,ABCA1;APOE;APOA1;LDLR;STAR;LIMA1
prerank,regulation of B cell apoptotic process (GO:0002902),0.47162471187722343,1.031717051161283,0.433389544688027,0.8682439452096127,1.0,2/12,5.68%,LYN;BCL6
prerank,protein localization to lysosome (GO:0061462),-0.3369850166365932,-1.0314637192031926,0.4024024024024024,0.8452215948441878,1.0,9/28,19.76%,SH3BP4;SORL1;KPTN;NCOA4;CD81;SCARB2;GGA3;VPS4A;LMBRD1
prerank,regulation of presynapse assembly (GO:1905606),0.4351393492113065,1.030921825721328,0.4318555008210181,0.8689271323476202,1.0,1/18,0.24%,GPC6
prerank,regulation of presynapse organization (GO:0099174),0.4351393492113065,1.030921825721328,0.4318555008210181,0.8689271323476202,1.0,1/18,0.24%,GPC6
prerank,lytic vacuole organization (GO:0080171),0.39157616109918336,1.030699531781945,0.4128843338213763,0.8687713920803087,1.0,10/32,19.33%,ABCA1;LRRK2;GAA;ZKSCAN3;CLN3;HOOK2;TPCN2;HPS4;TMEM106B;SNAPIN
prerank,positive regulation of cell growth (GO:0030307),0.3340689208572109,1.030442178017867,0.4175691937424789,0.8687731195920825,1.0,12/96,8.66%,IGF1;BCL2;MACF1;TGFBR1;GOLGA4;SFRP1;CXCL16;USP47;CDC42;INO80;EGFR;NTN1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.37799280064813295,1.0301871614609432,0.42419825072886297,0.8686962958381343,1.0,8/40,8.60%,ANGPT1;SERPINE1;VTN;CCL19;NTF3;CD63;DAB2;ARRB1
prerank,protein modification by small protein conjugation (GO:0032446),0.29565360330660867,1.030015863548549,0.42012448132780084,0.8684450010530004,1.0,95/361,20.86%,MYCBP2;RNF220;SPSB1;PDZRN3;HECW2;ARRDC4;EYA1;MGRN1;NUP107;FBXL17;UBR2;NEDD4;CDK5RAP3;SMURF2;RNF213;EPAS1;DERL1;ZNRF3;CUL4B;ATG10;NFE2L2;NUP42;CUL5;DTX4;FBXL3;TRAF7;RNF139;UBA7;UBE2V2;ARRB1;COMMD1;PRKN;TRPM4;ITCH;RNF181;ASB12;RNF6;RNF38;RNF152;MIB1;NUP98;FBXO9;FBXO11;UFL1;RAE1;FBXO4;RAD18;SELENOS;BTRC;PEX2;PAF1;URM1;MUL1;USP9X;TNFAIP1;ENC1;AMFR;NUP214;UBA6;UFC1;UBE2D1;ASB1;HACE1;HUWE1;DCUN1D2;HLTF;CUL7;UBE2R2;MSL2;UBR3;RNF138;RNF135;PJA2;DTX3;SEH1L;KLHL18;WAC;CDC73;RNF34;TRIM47;TRIM41;TPR;TRIM32;SUMO1;TRIM26;TRIM21;HIF3A;AAAS;NSMCE2;KCTD13;ARIH2;CDC23;UBE2T;LEO1;ZSWIM8
prerank,nucleus organization (GO:0006997),-0.2940535566544896,-1.0298625308030842,0.39763779527559057,0.8484976174622039,1.0,12/47,19.81%,SYNE1;NUP93;RPS19;NUP35;SUN2;NUP54;PDCD6IP;PITPNB;NUP155;IRAG2;VPS4A;CHMP2B
prerank,regulation of osteoclast differentiation (GO:0045670),0.39178193632440395,1.029861098701635,0.4487369985141159,0.8681716959324016,1.0,10/33,21.05%,FBN1;CSF1;IL12B;TCTA;CEBPB;FSTL3;IL23A;CARTPT;GPR137B;PRXL2A
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.42476659415719986,-1.0298557036146814,0.4305239179954442,0.8470858427492798,1.0,3/10,13.18%,LBP;IFI35;PTPN22
prerank,response to X-ray (GO:0010165),0.4673615060054741,1.0294699678602466,0.43327556325823224,0.8685225249678971,1.0,5/14,20.17%,LIG4;IKBIP;ATM;NIPBL;BRCC3
prerank,long-term synaptic potentiation (GO:0060291),-0.3573096741144198,-1.0294073114684763,0.4,0.8470059694765302,1.0,5/21,6.70%,SLC24A2;PTK2B;TSHZ3;GRIN2A;GRIN2B
prerank,protein localization to kinetochore (GO:0034501),0.4658482488063322,1.0293593922932445,0.44501718213058417,0.8681433239327647,1.0,4/14,9.46%,SPDL1;ZW10;CHAMP1;MTBP
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.29390998020598263,1.029197542886171,0.4200404858299595,0.8678980461987249,1.0,92/497,15.25%,TCF7L2;SAMD4A;ENPP1;RUNX1T1;ATXN1;DAPK1;NR2F2;SALL1;GLI3;ARID5B;ZEB1;NKX2-1;ARID4A;PRDM5;WNT4;FOXP2;ASCL1;RBFOX2;GAS6;RUNX2;LBH;MIDEAS;TLE1;IKZF4;SMURF2;TSPYL2;IRF1;ZIC2;PRICKLE1;MT3;IGF2BP2;ZHX2;SFRP1;IGFBP5;TBX3;BCL6;DKK3;USP47;BCOR;CBX3;ATOH8;PML;CPEB3;CEBPA;MBD2;SIRT2;ZBTB38;EIF2AK3;SMARCC2;NR1D1;RNF139;RBPJ;NCOR1;ZMYND15;MTA3;SCML2;BMP2;ZBTB4;CBY1;NONO;HEXIM2;S100A11;GLIS2;PBXIP1;ZKSCAN3;NR1D2;MBD1;KDM5C;NCOR2;DDX3X;L3MBTL1;BHLHE41;REST;NIBAN2;SELENOS;LARP1;PDCD4;BTRC;ZNF318;L3MBTL2;HDAC4;ENC1;ZNF148;ZNF219;TWIST2;YAF2;GATA6;BMP4;SUDS3;FOXK2;WAPL;CDKN1C
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.39723843121129115,-1.0287818685178394,0.4121951219512195,0.8474320211711083,1.0,6/15,16.68%,ENTPD1;AK5;ENTPD2;ENTPD6;AK7;ENTPD3
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.4388645739858877,-1.0287101710152131,0.43777777777777777,0.8461783317848123,1.0,6/10,28.85%,DGKH;GAP43;CHRM1;PICK1;PLPP1;F2R
prerank,axonemal dynein complex assembly (GO:0070286),0.3999032467382413,1.0280937195186428,0.42289348171701113,0.8700607094472734,1.0,9/27,18.77%,SPAG1;CFAP73;DNAAF1;DNAI3;CCDC40;DNAAF5;DNAL1;DNAH8;TTC12
prerank,response to nitric oxide (GO:0071731),0.47147928376449255,1.027771015686858,0.4343257443082312,0.8701698187328916,1.0,4/13,6.97%,CCL19;MTR;MT3;DPEP1
prerank,zinc ion transport (GO:0006829),0.4247557039921794,1.0277575557741674,0.44141252006420545,0.8695157300617501,1.0,5/21,10.82%,SLC30A8;MT3;SLC30A2;SLC30A10;SLC39A13
prerank,heart looping (GO:0001947),-0.3072896534497059,-1.0275418948454937,0.40625,0.8480998379425508,1.0,10/39,14.28%,MEF2C;NOTCH1;SOX17;TBX2;ZIC3;SOX18;TGFBR2;STIL;APLNR;MICAL2
prerank,nitrogen compound transport (GO:0071705),0.3159589454263054,1.0274643666437804,0.41839080459770117,0.8695996285208227,1.0,12/141,5.63%,SLC7A11;SLC7A2;TXNIP;SLC1A5;ARRDC4;LMAN2L;SLC6A13;SLC44A1;SLC22A2;SLC35F3;PDPN;TOM1
prerank,glycogen metabolic process (GO:0005977),0.41325096375021475,1.0274551077371663,0.41590214067278286,0.8689406512450507,1.0,10/27,16.46%,PHKB;PRKAG2;NR1D1;GAA;AGL;PYGM;PPP1R3C;PYGB;PHKA1;PHKA2
prerank,positive regulation of DNA replication (GO:0045740),0.4411972587346357,1.0273638116597186,0.426890756302521,0.8684551363597438,1.0,5/16,13.25%,GLI2;NPM2;EGFR;GLI1;EGF
prerank,negative regulation of axon extension (GO:0030517),-0.3285653735820693,-1.0273602553808423,0.391304347826087,0.8471988006439798,1.0,9/30,12.61%,SEMA6D;SEMA6A;MAP2;SEMA7A;DIP2B;SEMA5B;SEMA3G;SEMA3C;SEMA4B
prerank,regulation of translational initiation (GO:0006446),0.3489412494924325,1.0273409486118,0.39215686274509803,0.8678361986121335,1.0,19/63,22.42%,POLR2D;EIF2AK3;DNAJC3;EIF4A2;CDC123;DDX3X;CEBPB;EIF5B;IMPACT;LARP1;ALKBH1;DDX1;TPR;CTIF;YTHDF2;MIF4GD;EIF4G2;RBM4;NCBP2
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.34696629453303507,-1.0271769987793158,0.4289772727272727,0.8463676464414521,1.0,15/23,43.71%,CADM1;PIK3R6;PVR;RAET1E;NECTIN2;LILRB1;SLAMF6;CD226;CRTAM;ARRB2;NCR1;CD160;KLRK1;LAMP1;AP1G1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.3204907736912233,-1.0266075739358234,0.41569767441860467,0.8465583968656473,1.0,9/32,13.80%,TAF1B;RRN3;TAF1;TBP;CAVIN1;GTF2H1;TAF1C;UBTF;MAPK3
prerank,cellular protein-containing complex assembly (GO:0034622),0.31178631661944434,1.026582105923058,0.4379310344827586,0.8691453070420683,1.0,23/159,14.46%,TCF4;FMOD;ANGPT1;SMAD3;NUP107;COX7A2;SPAG1;SRC;EPS15;DNAAF1;ARL2;AIFM1;PICALM;SMAD1;CENPC;NUP98;STXBP1;UVRAG;CCDC40;RAB5IF;NSG2;ADRM1;SNX9
prerank,regulation of protein neddylation (GO:2000434),-0.44707908368478555,-1.026529636412397,0.44,0.8453540318404552,1.0,5/10,15.15%,RPL11;DCUN1D4;COPS9;RPL5;HIF1A
prerank,regulation of p38MAPK cascade (GO:1900744),0.37742954930432965,1.0264690768931237,0.43641618497109824,0.8687527290578596,1.0,4/35,8.76%,SASH1;GADD45B;RELL1;BMP2
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.37530772444090954,-1.025855073820684,0.4180929095354523,0.8459920393024448,1.0,5/16,18.99%,CELF4;SNW1;THRAP3;RBMX;SF3B4
prerank,anterograde axonal transport (GO:0008089),-0.30852312123619413,-1.0254774521716787,0.4006734006734007,0.8456398130447089,1.0,14/37,27.59%,DLG2;RAB21;AP3B1;RAB27B;KIF1A;TRAK2;AP3S1;BLOC1S5;KIF5A;KIF4A;HAP1;KIF1B;AP3B2;SOD1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.32960501333120484,-1.0251709701876988,0.4024024024024024,0.8451933469332773,1.0,12/29,30.46%,RPS14;RPS19;UTP4;RRP36;RPS21;HELB;WDR46;RRS1;RPS16;RPS8;TSR1;RPP40
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.3728226817978474,-1.0251530874494437,0.44086021505376344,0.8438523354492358,1.0,7/20,12.61%,SEMA6D;SEMA6A;SEMA7A;SEMA5B;SEMA3G;SEMA3C;SEMA4B
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.4587038927397121,1.0250974528813306,0.4388609715242881,0.8715807440502935,1.0,3/14,16.20%,CSF1;IL12B;IL23A
prerank,positive regulation of macrophage differentiation (GO:0045651),0.4714817126030827,1.0249461822400134,0.45454545454545453,0.8712913563888969,1.0,5/11,19.35%,IL34;CSF1;LIF;PRKCA;HSF1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.4105469365824503,-1.0247159524075022,0.43828715365239296,0.8437713551181302,1.0,2/14,1.66%,ADAM10;PTK2B
prerank,positive regulation of sodium ion transport (GO:0010765),-0.42126147817641374,-1.0246719846049523,0.4423076923076923,0.8425031122854596,1.0,2/12,6.37%,ANK3;NOS1
prerank,cell cycle G2/M phase transition (GO:0044839),0.31927232342106626,1.0245610551785558,0.43663594470046085,0.8716058670744468,1.0,23/129,14.92%,CDK14;DYNLL1;NINL;CCNA2;OPTN;CEP152;PHLDA1;FBXL17;DYNC1H1;ALMS1;BRSK1;FBXL3;FBXL12;YWHAE;MNAT1;DYNC1I2;BTRC;HAUS1;HAUS7;HAUS3;CEP164;AKAP8L;CEP192
prerank,negative regulation of complement activation (GO:0045916),0.4901262692878782,1.0244611421075631,0.45357142857142857,0.8711928384427103,1.0,1/10,2.27%,SERPING1
prerank,linoleic acid metabolic process (GO:0043651),0.4378386689472888,1.0244424620764196,0.4375,0.8705680359025647,1.0,3/17,7.08%,ACSL1;GSTM2;ALOXE3
prerank,regulation of cytokinesis (GO:0032465),-0.2642345602121933,-1.0240478505283472,0.39035087719298245,0.8429146002060595,1.0,24/78,21.14%,PKP4;CIT;KIF13A;RAB11A;RAB11FIP3;CALM1;CALM3;KIF20B;CDC14A;CSPP1;GIT1;BCL2L1;CETN2;GIPC1;PRPF40A;PRC1;KIF23;PRKCE;ECT2;CUL3;VPS4A;E2F7;FLCN;PLK3
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.48730356738850134,1.0238078937685986,0.4673721340388007,0.8714441721999591,1.0,4/11,14.90%,MAP2K1;EGFR;MYCN;BMP4
prerank,regulation of fatty acid oxidation (GO:0046320),0.4436417199888994,1.0237479026720535,0.44221105527638194,0.8709289488664457,1.0,3/16,10.20%,PRKAG2;APPL2;LONP2
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.40042913179214257,1.0231569811917913,0.42024539877300615,0.8718018675879476,1.0,5/27,3.81%,EPHA8;KIT;PDGFRA;PDGFRB;CCL19
prerank,cellular component assembly (GO:0022607),0.3022547440001332,1.0227465781040186,0.4272151898734177,0.8721830034523964,1.0,45/253,14.46%,RHOH;TEAD1;CALD1;GSN;MITF;RHOD;NEDD9;PARVA;LAMC1;SHROOM2;YAP1;GAS6;DPYSL3;MYO1B;GORASP2;FZD1;FSCN3;CHAF1B;LIMA1;CDC42;PML;CD247;ZW10;RANBP9;PARD6B;SYCE2;TLCD1;CFAP46;PICALM;TEX12;TSPAN4;FLNC;STAG3;FANCC;RHOQ;MNAT1;CCDC40;PAWR;WASF1;KMT2A;ABCA3;LLGL1;DLG4;FLNA;SNX9
prerank,Golgi inheritance (GO:0048313),-0.43312680227213696,-1.021897207717848,0.4406392694063927,0.8474834080941646,1.0,4/11,29.32%,VRK1;PDCD10;PLK3;CDK1
prerank,melanosome organization (GO:0032438),0.4032353742517433,1.0218920877896116,0.44879518072289154,0.8736608440274277,1.0,9/26,19.33%,SHROOM2;DTNBP1;BLOC1S1;AP1M1;PIKFYVE;ABCB6;RAB32;HPS4;SNAPIN
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.34465905118017753,-1.0218138075080305,0.4314868804664723,0.8463065844756684,1.0,6/23,17.75%,PTPN2;HSP90AB1;JAK2;NLRC5;CDC37;TXK
prerank,rRNA methylation (GO:0031167),0.41909416403986866,1.0217263193099089,0.4483870967741935,0.873415877884003,1.0,6/22,15.17%,BUD23;DIMT1;FTSJ3;TRMT112;NSUN5;NSUN4
prerank,prostanoid metabolic process (GO:0006692),0.4612506293953075,1.0216616008048685,0.44093178036605657,0.8729026934703953,1.0,1/13,1.91%,PTGES
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3436525355320763,1.0216225882573418,0.43781725888324874,0.8723408632196882,1.0,13/72,10.17%,PLEKHH2;EML2;KANK1;APOE;CHADL;LDLR;CDH5;LIMA1;EMILIN1;PRKN;MYADM;KATNB1;FGF13
prerank,ameboidal-type cell migration (GO:0001667),-0.28476252699675475,-1.0211519278861008,0.4153225806451613,0.8468712382315176,1.0,18/51,16.21%,GPC3;SEMA6D;SEMA6A;SEMA7A;CCN3;ERBB4;TBX1;ITGA4;PKN1;SEMA5B;SEMA3G;FAT2;PKN3;SEMA3C;SEMA4B;PDLIM1;CORO1C;SOX8
prerank,regulation of autophagy (GO:0010506),0.30449618280458496,1.0210304431567105,0.43603411513859275,0.8732760769618746,1.0,51/216,21.23%,DAPK2;ITPR1;DAPK1;DCN;BCL2;LEPR;OPTN;PRKAG2;NUPR1;NEDD4;MT3;PRKAA2;LRRK2;SREBF1;SIRT2;MTMR3;PRKN;SLC38A9;STK11;ATP6V1E1;ZKSCAN3;RNF152;LAMTOR2;UFL1;RRAGD;USP10;VDAC1;PLK2;FOXK2;NPRL2;PIK3R2;TPCN2;PIP4K2C;AKT1;ATM;KAT5;FOXO3;PRKACA;KDM4A;PRKAG1;RHEB;TRIM21;WDR41;PSAP;GPR137B;MLST8;ATP13A2;SNX6;DDIT3;UCHL1;EIF4G2
prerank,regulation of peptide hormone secretion (GO:0090276),0.344960150536886,1.0209339560605595,0.4222503160556258,0.87285664957796,1.0,5/67,6.67%,ITPR1;RAPGEF4;NEUROD1;ADRA2C;CACNA1C
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.28708607035206285,-1.0208252048574127,0.43373493975903615,0.8463743540789135,1.0,17/55,23.95%,FHL1;CUL1;RBX1;FBXL7;AVEN;PSMF1;PSMB8;PSMA4;PSMB10;PSMB2;PSMC4;PSMA6;PSMD9;PSMD11;PSMD5;PSMA8;PSMB1
prerank,negative regulation of potassium ion transport (GO:0043267),-0.4078184232867319,-1.0205488126832982,0.4419753086419753,0.8458074008827867,1.0,4/13,6.37%,CAV1;PTK2B;NEDD4L;NOS1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.43590932191959975,1.0203817420739008,0.460655737704918,0.8735637487906874,1.0,4/19,11.52%,BMP6;AFDN;FOXA1;RGCC
prerank,mesenchyme development (GO:0060485),0.4559633287725713,1.0202429979950907,0.4554794520547945,0.8732613158988449,1.0,4/15,14.90%,FGFR2;TGFBR1;BMP2;BMP4
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.41554392694436315,1.0201754729145975,0.4418960244648318,0.8727639142629476,1.0,5/23,13.94%,MOAP1;COX18;BCL2L11;TIMM9;TOMM22
prerank,negative regulation of transport (GO:0051051),0.35798977297114976,1.0197716817710938,0.42428571428571427,0.8731218441659159,1.0,11/51,14.84%,EPHA3;SNX33;SNX12;PRKN;ITGB3;ITGAV;EGF;SYT11;PTEN;NR1H3;FER1L5
prerank,cellular response to estrogen stimulus (GO:0071391),0.4530397259699728,1.0192315106369256,0.45051194539249145,0.8737859739472205,1.0,2/14,5.06%,AR;SFRP1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.4423701374254182,1.0191108242959253,0.4415156507413509,0.8734250255100372,1.0,3/16,3.68%,NOS1AP;APOE;NPR3
prerank,receptor metabolic process (GO:0043112),-0.2833163702259485,-1.0189807454961703,0.4624505928853755,0.8489279207179254,1.0,12/53,12.70%,DNM3;CAV1;SMURF1;ACKR3;TFRC;RAMP2;SNX1;FCER1G;KIF16B;TGFB1;LGMN;CD81
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.3665413280651734,-1.018936123055945,0.4228723404255319,0.8476678304621528,1.0,4/18,8.82%,CAV1;NEDD4L;CAMK2D;SLC43A2
prerank,positive regulation of intracellular protein transport (GO:0090316),0.31213321431686697,1.0189320042300702,0.4369266055045872,0.8731916638660608,1.0,8/144,3.44%,TCF7L2;CEMIP;PIK3R1;SMAD3;BCL2;ZIC1;LEPROT;GAS6
prerank,calcium ion import (GO:0070509),0.39666700935315335,1.0188479285052383,0.44242424242424244,0.8727265966657987,1.0,5/28,11.34%,SLC8A1;MCU;CACNA1C;MICU2;CACNA1G
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.38475660348756263,1.0180494219876586,0.4510948905109489,0.8740776455148904,1.0,7/35,8.17%,NRP1;PDGFRA;NOTCH2;NTF3;IQGAP2;CDC42;NTRK3
prerank,synaptonemal complex organization (GO:0070193),0.4411647495819822,1.0168494543204218,0.4552980132450331,0.8757798148382705,1.0,3/15,11.79%,SYCE2;TEX12;STAG3
prerank,synaptonemal complex assembly (GO:0007130),0.4411647495819822,1.0168494543204218,0.4552980132450331,0.8757798148382705,1.0,3/15,11.79%,SYCE2;TEX12;STAG3
prerank,cardiac muscle cell action potential (GO:0086001),-0.31495246536448296,-1.0167768440791625,0.4479768786127168,0.8525699147540114,1.0,7/30,6.82%,KCNJ2;ATP1A1;SCN1A;KCND3;FGF12;KCNQ1;ATP1B1
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.36827219423767166,1.0167303524457247,0.43948126801152737,0.8754228797519817,1.0,17/42,25.04%,ARID1B;INO80;SMARCA1;MBD2;SMARCC2;MTA2;ACTR8;SMARCD2;CECR2;SMARCB1;HNRNPC;SRCAP;SMARCAD1;PBRM1;SMARCE1;DMAP1;HDAC1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.39672666997388073,-1.0163118512808762,0.4373522458628842,0.8524856846764097,1.0,3/14,9.72%,ANK3;ATP1B1;WNK2
prerank,response to hydrogen peroxide (GO:0042542),-0.29206447520340945,-1.0161248596161274,0.4253731343283582,0.8516479067625504,1.0,14/45,19.53%,NET1;RPS3;SIRPA;RHOB;PLEKHA1;TNFAIP3;SIRT1;APTX;ADAM9;ECT2;GPX1;ANXA1;CAT;PDCD10
prerank,positive regulation of immune system process (GO:0002684),-0.37440419718987766,-1.016095628915633,0.44533333333333336,0.8503316279515676,1.0,3/16,9.51%,IL15;TGFB2;VEGFA
prerank,maturation of 5.8S rRNA (GO:0000460),0.43847242278187737,1.0157299797116914,0.46568627450980393,0.8772905925541195,1.0,5/17,12.91%,C1D;MPHOSPH6;FTSJ3;EIF6;MTREX
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.4240338523218612,-1.0154547837551169,0.4647887323943662,0.8508169378209931,1.0,2/11,1.68%,MECOM;CD34
prerank,regulation of neuron differentiation (GO:0045664),0.33766098975884806,1.0151587709237533,0.4485387547649301,0.8781043242444149,1.0,10/76,6.60%,TCF4;NREP;FGFR1;ZEB1;ASCL1;CDK5RAP3;NTF3;NEUROD1;ADRA2C;LRRK2
prerank,regulation of calcium-mediated signaling (GO:0050848),0.3985987380711199,1.015141283723119,0.46687211093990755,0.877469908498959,1.0,3/25,6.60%,ITPR1;CCL4;LRRK2
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.34712984923588824,1.0150707569541126,0.44150943396226416,0.8769734562610462,1.0,13/70,16.01%,PDPK1;SMAD3;BCL2;IL6R;MOAP1;ITGAV;IFI27;DDX3X;ACVR1B;G0S2;CASP8AP2;TNFRSF1A;CASP9
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.4320569300813114,1.0145349073464078,0.4467741935483871,0.8777252431696889,1.0,2/18,6.91%,GDNF;AGTR1
prerank,regulation of mast cell degranulation (GO:0043304),0.44610724562427784,1.0142790857074495,0.4666666666666667,0.8777224013066665,1.0,2/14,7.21%,LYN;SPHK2
prerank,response to lipopolysaccharide (GO:0032496),-0.23744659882119476,-1.0142468605868948,0.44525547445255476,0.8529441147089121,1.0,30/138,19.51%,MEF2C;PDE4B;NOS3;TNFRSF11A;GGT5;LBP;GCH1;VIM;NOS1;SIRPA;JAK2;FOXP1;MAPK8;SCARB1;CX3CR1;TNFAIP3;CD80;GIT1;SBNO2;PTPN22;NOD2;CARD16;ERBIN;TRIM6;ADAM9;TLR4;HMGB2;IFNAR1;CD86;GGT1
prerank,negative regulation of lyase activity (GO:0051350),0.44081152927397405,1.0139920614035407,0.4533551554828151,0.8777782520552814,1.0,3/16,8.21%,ADGRV1;GRM2;DRD3
prerank,positive regulation of telomere capping (GO:1904355),-0.3709535774169805,-1.0138681185089835,0.456,0.8525883285261129,1.0,6/17,22.34%,NEK7;PKIB;HNRNPD;MAPK3;PNKP;MAPK1
prerank,carbohydrate catabolic process (GO:0016052),-0.30347223768555914,-1.0133701267064625,0.43034055727554177,0.8526005071394542,1.0,13/38,25.08%,GPI;HK2;PFKL;TPI1;PFKFB1;ALDOA;MAN2B1;NEU1;PKM;PGAM1;PGAM4;ALDOC;NEU2
prerank,mitochondrial translational termination (GO:0070126),-0.2582668350944007,-1.0129930553260145,0.4329268292682927,0.8523058927842283,1.0,34/88,32.16%,MRRF;MTRF1L;GFM2;MRPL46;MRPS18A;MRPS5;MRPL39;MRPS26;MRPS12;MRPL48;MRPL4;MRPL21;MRPL44;MRPS33;MRPL55;MRPL57;MRPS18B;MRPL42;MRPS10;MRPS21;MRPS7;MRPL34;MRPL15;MRPL19;MRPS22;MRPL38;MRPS31;MRPL12;MRPL28;MRPL43;MRPS14;MRPL54;MRPL2;AURKAIP1
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.3574474092197029,1.012819843838728,0.4583883751651255,0.8800501292917503,1.0,8/52,11.95%,CELF2;RBFOX1;RBFOX2;DDX17;HNRNPA1;SMU1;WTAP;REST
prerank,protein processing (GO:0016485),0.3189754212247086,1.0126370472303101,0.4348355663824604,0.8798327189592635,1.0,13/102,11.91%,CPXM2;OGT;AEBP1;CPXM1;CTSH;MMEL1;SPRTN;SEC11C;ECE2;EEF1AKMT4-ECE2;LONP2;APH1B;CLN3
prerank,myeloid leukocyte differentiation (GO:0002573),0.34347367147699354,1.0126111900902608,0.4478203434610304,0.8792165439273004,1.0,10/65,6.87%,IL31RA;RUNX1;KIT;CCL19;CSF1;CDC42;PML;EFNA2;BATF;CEBPA
prerank,positive regulation of hormone secretion (GO:0046887),-0.3676569555782697,-1.012583920951729,0.42574257425742573,0.8521887943375585,1.0,10/17,45.89%,VAMP8;EDN1;SPP1;GRP;C1QTNF3;PLA2G3;RASL10B;TFR2;CYP19A1;HCAR2
prerank,tRNA wobble uridine modification (GO:0002098),0.4469497899608435,1.0121636598273733,0.45263157894736844,0.8796706524867495,1.0,5/14,20.95%,TRMT9B;URM1;DPH3;ELP4;TRMU
prerank,histone H3 acetylation (GO:0043966),-0.29923092389882533,-1.012135989873682,0.41009463722397477,0.852143833917052,1.0,13/40,18.28%,LEF1;JADE3;TRIM16;KAT2A;TAF10;TADA2A;LDB1;PER1;KAT6A;NAA60;BRCA2;SGF29;YEATS2
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.4430424323838389,1.0118653011488417,0.4567062818336163,0.8797486609983408,1.0,3/16,4.23%,ST6GALNAC5;ST3GAL5;LARGE1
prerank,postsynaptic membrane organization (GO:0001941),-0.3733543563190255,-1.0111215975697103,0.41581632653061223,0.8538216632076032,1.0,3/17,4.75%,SHANK3;NLGN1;NRXN1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.4083888105235193,1.0109313733137708,0.4666666666666667,0.8814323687047054,1.0,4/23,6.20%,GHR;KIT;CYP1B1;PIBF1
prerank,bile acid metabolic process (GO:0008206),0.3935886624828439,1.0108614893557795,0.46026986506746626,0.8809359074856303,1.0,3/27,7.23%,CYP7B1;SLC27A5;CYP27A1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.39617197341093124,-1.0106260969897283,0.4318766066838046,0.8538473215933844,1.0,3/14,5.21%,TMSB4X;FAF1;NFKBIA
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.43964350974854066,1.0105124654148032,0.4813008130081301,0.8811471001366934,1.0,5/16,14.62%,AR;RBFOX2;DDX17;TRIP4;TADA3
prerank,positive regulation of mitochondrial fission (GO:0090141),0.42453824245545746,1.010389797246813,0.45230263157894735,0.8807873571887201,1.0,4/18,13.03%,DCN;MCU;PRKN;MUL1
prerank,extracellular transport (GO:0006858),0.4623670632087045,1.0100145480657576,0.4504347826086956,0.8811355244149909,1.0,5/12,21.88%,CCDC40;CABYR;SPEF2;ROPN1L;TSG101
prerank,regulation of apoptotic process (GO:0042981),0.28805412191612895,1.0091948665859778,0.4678714859437751,0.8825874472475,1.0,114/676,15.17%,IGF1;STK17B;DAPK2;FHL2;ANGPT1;STEAP3;ACTN2;GDNF;PIK3R1;DAPK1;IL31RA;BCL2;GRK5;OLFM1;SON;SH3RF1;PLEKHG2;ASCL1;GADD45B;TIAM2;GAS6;PHLDA1;CFLAR;NUPR1;MYO18A;MOAP1;NOTCH2;SOS2;TXNDC5;FSTL1;FGD1;PDCD5;MT3;AXL;NTF3;NEUROD1;ING3;PHIP;RARG;SFRP1;CTSH;FGD4;PRKAA2;PDPN;TBX3;MAP3K20;CYP1B1;VIP;BCL6;USP47;BFAR;ARHGAP10;NDRG1;SRC;ARHGEF17;ING5;DPEP1;TSLP;CD28;SPHK2;ARHGEF18;ARAF;OSR1;STK4;DAB2;DNAJC3;BCL2L11;EGFR;ARHGEF11;BMP2;MAP4K4;SPRY2;AIFM1;ACTN4;PRKN;FOXA1;ITCH;BRAF;APH1B;DDX3X;IGFBP3;FBXO11;SPDEF;ADAMTSL4;FGD3;CLN3;ANXA5;REST;NIBAN2;HMGN5;RIPK2;PLEKHN1;NOL3;PAWR;IFIT2;VDAC1;HYPK;TAF9;HSPA9;ARF4;DSTYK;HPN;FLNA;AKAP13;PLK2;GATA6;MTCH2;MTCH1;BMP4;SUDS3;SFRP4;RBM5;GAS1;TMBIM6
prerank,carnitine shuttle (GO:0006853),0.4888875495406513,1.008719807392755,0.4608843537414966,0.883112026781761,1.0,2/11,5.20%,PRKAG2;PRKAA2
prerank,error-prone translesion synthesis (GO:0042276),-0.3494467502272469,-1.0085848609771262,0.4634760705289673,0.8583815600417013,1.0,2/21,8.38%,REV3L;POLH
prerank,mRNA modification (GO:0016556),0.4104937924844773,1.0083006744623506,0.4442748091603053,0.8834782985299208,1.0,8/22,18.90%,PUS3;NSUN2;METTL14;RPUSD2;WTAP;TRUB2;METTL3;TRUB1
prerank,cellular response to organic cyclic compound (GO:0071407),0.3139888780495273,1.0079817964228424,0.4605714285714286,0.8836461248175799,1.0,15/141,6.60%,RORA;ADCY1;ROCK2;ADCY2;AR;ATP1A2;ADCY5;RAPGEF2;SFRP1;IGFBP5;TFPI;CYP1B1;PDE3A;ZFP36L1;LRRK2
prerank,negative regulation of ATP metabolic process (GO:1903579),0.43787086540342335,1.0074736485662181,0.47163695299837927,0.8842519427331074,1.0,3/17,8.40%,PID1;NUPR1;NCOR1
prerank,regulation of vasculature development (GO:1901342),-0.3329165201861912,-1.0069457459549327,0.42201834862385323,0.8616287085405029,1.0,9/26,11.43%,BMPER;WARS1;ERBB2;EMP2;HTATIP2;TSPAN12;PLXND1;VASH1;NF1
prerank,presynapse organization (GO:0099172),-0.43438619579779714,-1.0067817387447164,0.44575471698113206,0.8607410949550468,1.0,4/10,18.25%,NLGN1;LRRTM3;NLGN3;DVL1
prerank,positive regulation of transport (GO:0051050),0.32992599441993226,1.0064341666992682,0.4719387755102041,0.8861942432700408,1.0,11/85,8.35%,CAMK1D;LRP1;AHSG;TULP1;GAS6;APOE;CCL19;APOA1;DYNC1H1;IL15RA;DAB2
prerank,purine-containing compound biosynthetic process (GO:0072522),0.4004195244133339,1.006182777306943,0.44290123456790126,0.8861568654769912,1.0,7/25,19.43%,AMPD3;ADK;GART;AMPD2;DCK;PRPSAP2;PPAT
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.36039416454831835,-1.0059925178458748,0.44072164948453607,0.8616425139827,1.0,5/18,11.48%,ESR1;RPS13;PTBP2;PTBP3;TGFB1
prerank,negative regulation of cell death (GO:0060548),0.3260834660972095,1.005562458426568,0.4666666666666667,0.887092325517898,1.0,21/88,18.21%,CCN2;CCN1;INPP5A;CSF1;MT3;CCN5;LRRK2;PARP16;CD200;CCN4;PRKN;FGF2;RAD18;IMPACT;NPAS2;TM7SF3;BMP4;AKT1;KANK2;BECN1;SOX11
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.4438108380263722,1.0055156805561387,0.45746388443017655,0.8865420425638366,1.0,2/13,4.87%,CBLB;KPNA6
prerank,DNA catabolic process (GO:0006308),0.45839368820676346,1.0054640697329589,0.4518900343642612,0.8860131222003266,1.0,2/11,10.46%,REXO4;DNASE1L1
prerank,positive regulation of ATPase activity (GO:0032781),0.3673764017096793,1.0048452370334946,0.43859649122807015,0.8869032629583534,1.0,6/41,11.53%,DYNLL1;TPM1;ATP1B2;MYL4;TNNT3;TOR1AIP1
prerank,urogenital system development (GO:0001655),0.4541573886429961,1.0047447225879313,0.4663299663299663,0.886504736961794,1.0,4/11,16.72%,OSR1;EPHB2;EPHB3;SHH
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.313829301479727,1.0044488807330778,0.48216340621403914,0.8865955521313185,1.0,22/128,14.92%,CDK14;DYNLL1;NINL;CCNA2;OPTN;CEP152;PHLDA1;FBXL17;DYNC1H1;ALMS1;BRSK1;FBXL3;FBXL12;YWHAE;MNAT1;DYNC1I2;BTRC;HAUS1;HAUS7;HAUS3;CEP164;CEP192
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.2660983694295952,-1.0039421973556923,0.4225352112676056,0.8662975750529383,1.0,21/70,19.02%,ELMO1;YES1;ACTB;VAV3;PLCG2;ARPC1B;DOCK1;PAK1;HSP90AB1;ARPC3;WIPF3;WASF2;CYFIP2;PLPP4;MAPK3;PIK3CA;ARPC4;PRKCE;ACTG1;FCGR1A;FGR
prerank,body fluid secretion (GO:0007589),0.44137000722158926,1.0033969284902347,0.4782608695652174,0.88860410495215,1.0,3/15,7.63%,SLC22A2;VIP;SLC22A4
prerank,response to ketone (GO:1901654),-0.342445869127987,-1.0031701791002654,0.46827794561933533,0.8670471668279547,1.0,5/24,3.96%,SLIT2;CAV1;THBS1;ABHD2;TGFB2
prerank,detection of calcium ion (GO:0005513),-0.3986721323520197,-1.0031018280480666,0.44660194174757284,0.8659074690820233,1.0,7/13,19.41%,SYT1;KCNMB2;CALM1;CALM3;CASQ2;RYR2;KCNIP2
prerank,positive regulation of collagen metabolic process (GO:0010714),0.43638400791380794,1.003050923065477,0.4694835680751174,0.8887955164132698,1.0,7/17,20.90%,RUNX1;WNT4;RGCC;F2;BMP4;LARP6;CREB3L1
prerank,protein complex oligomerization (GO:0051259),-0.2538893750928115,-1.0030041126548022,0.4632768361581921,0.8647990094868558,1.0,22/85,17.78%,LRRC8C;LRRC8D;LETM1;KCNC2;EHD4;CPSF7;ATL2;MAT2A;ELAVL1;PNPT1;AQP11;PDCD6IP;ADCY8;HOMER1;TMEM120A;UGDH;UPB1;CUTC;RBMX;MPP2;VSTM5;ECT2
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.39223002462387135,-1.002779204488925,0.46973365617433416,0.8640389668372105,1.0,6/14,35.14%,ECI2;AMACR;ACOX1;ACOX2;ACOXL;ACOT8
prerank,peptide cross-linking (GO:0018149),-0.3309091989086651,-1.002567091723002,0.4415954415954416,0.8633287655268106,1.0,3/25,4.94%,FN1;THBS1;TGM2
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.358472114800029,1.002331484160342,0.4643356643356643,0.8899460394542361,1.0,12/44,16.41%,SH3RF1;GAS6;CAST;MT3;USP47;SRC;DPEP1;DDX3X;YWHAE;IGBP1;AKT1;FNIP1
prerank,cellular calcium ion homeostasis (GO:0006874),0.3088804271485853,1.0022732019422222,0.46806039488966317,0.8894286916319674,1.0,22/133,12.17%,SLC24A3;SLC8A1;SLC8A3;BCL2;DMPK;CCL19;STIM1;ATP13A3;SLC24A1;MCU;CDH5;PML;SLC24A5;TMEM203;DRD3;CSRP3;MICU2;PDZD8;ANXA6;F2;CLN3;YWHAE
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.4256357104697053,1.0022298322822667,0.4901639344262295,0.8888841400477859,1.0,4/18,5.69%,ROCK2;KANK1;RIPOR2;CDH5
prerank,B cell proliferation (GO:0042100),0.43018123994375923,1.0020196260877774,0.46337308347529815,0.8887551843688732,1.0,2/17,2.93%,BCL2;GAPT
prerank,cGMP biosynthetic process (GO:0006182),-0.43974651862486647,-1.0018885982893906,0.47845804988662133,0.8639609922085489,1.0,3/10,6.46%,GUCY1B1;GUCY1A1;NPR1
prerank,regulation of striated muscle contraction (GO:0006942),0.3894830394086816,1.0015966843388726,0.4751552795031056,0.8891782997718569,1.0,2/27,1.81%,SLC8A3;ATP1A2
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.4814718121621982,1.0015294324411446,0.46466431095406363,0.8886834317846092,1.0,4/10,14.38%,DCLRE1C;DCLRE1A;TERF2;RTEL1
prerank,peptidyl-serine phosphorylation (GO:0018105),0.3042436041648363,1.0012116039690846,0.48031496062992124,0.888847403607948,1.0,43/153,21.36%,PDPK1;ROCK2;CAMK1D;DMPK;MARK1;GAS6;TGFBR1;ULK2;LRRK2;AKT3;EIF2AK3;BRSK1;MAST2;STK4;VRK3;TTBK1;NEK6;IKBKE;TBK1;TLK1;WNK1;MAP3K13;MARK2;PLK2;DYRK1A;PIKFYVE;DYRK1B;MAPKAPK2;AKT1;ATM;CDC7;DYRK3;PRKCI;CSNK1A1;PRKCA;PRKACA;RICTOR;CLSPN;SGK3;SGK2;PKN2;AURKA;PRKCB
prerank,negative regulation of axonogenesis (GO:0050771),-0.3286764880524815,-1.0010694948346113,0.45652173913043476,0.8649680963770348,1.0,11/27,18.53%,MAP2;DIP2B;GDI1;ULK1;ARHGDIA;SEMA3G;DCC;LINGO1;MAG;MCF2;RTN4R
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3739404198286228,-1.0010689875722192,0.46335078534031415,0.8636123470096726,1.0,7/17,15.93%,ITGA1;HSP90AB1;PPP1R15B;CALM1;CALM3;MTOR;PTPRC
prerank,protein targeting to lysosome (GO:0006622),-0.3533530113708888,-1.0010199983880972,0.47058823529411764,0.8623901245995584,1.0,10/20,26.51%,HSPA8;SORL1;NCOA4;SCARB2;GGA3;CLU;VPS4A;GNPTAB;HGS;GCC2
prerank,membrane fusion (GO:0061025),-0.31919694608171,-1.0009603997886722,0.4527027027027027,0.8612218356692045,1.0,5/33,11.54%,DNM3;RIMS1;DYSF;GCA;NSF
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.38017692129202585,-1.0009372278353714,0.4332552693208431,0.8599449903347779,1.0,5/14,16.67%,PPP2R2B;PPP1R15B;PPP2R2A;PPP2R2C;PPP1CA
prerank,insulin secretion (GO:0030073),0.41616245396513274,1.000603559487089,0.4662480376766091,0.8897568807734642,1.0,5/19,16.08%,SLC30A8;NEUROD1;FAM3B;CYB5R4;MAFA
prerank,integrated stress response signaling (GO:0140467),0.44310734468496843,1.0004107154813857,0.4691151919866444,0.889592377896501,1.0,5/14,23.11%,NFE2L2;EIF2AK3;IMPACT;DDIT3;HSPA5
prerank,response to ethanol (GO:0045471),-0.3786460771311748,-1.000395461421457,0.4142857142857143,0.8601557214363892,1.0,5/14,7.48%,GRIN2A;GLRA1;GLRA2;GRIN2B;GRIN3A
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.4292829400322019,0.9996598778315309,0.46416938110749184,0.8908294009462703,1.0,6/18,20.49%,ZFP36L1;BCL2L11;KLF9;REST;HNRNPU;ZFP36L2
prerank,polarized epithelial cell differentiation (GO:0030859),-0.3966303460687332,-0.9994397302595015,0.4812206572769953,0.8614359545486301,1.0,4/13,10.46%,MYO9A;OPHN1;SCRIB;MSN
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.41743369181950873,0.9989836394479217,0.4801980198019802,0.8918744335402622,1.0,4/19,10.86%,PGM3;GFPT1;UAP1;RENBP
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.31574118073259455,0.9989405167470291,0.46619217081850534,0.8913091691435848,1.0,30/104,22.91%,SLC8A1;KSR1;SLC8A3;CCNA2;CDK5RAP3;SRC;PARP16;MAP2K1;CCNK;TELO2;DDX3X;UVRAG;MNAT1;DUSP19;CNPPD1;CDK12;AKT1;CDKN2C;CCNT2;CDKN1B;HTT;ETAA1;SERTAD1;CCND2;TRIB1;CCNT1;TSG101;CCNG2;CDK7;SLC27A1
prerank,positive regulation of cellular metabolic process (GO:0031325),0.32096861049315195,0.9989096624574996,0.4864864864864865,0.890719975255903,1.0,19/98,14.95%,ANGPT1;PID1;APOE;PDGFRB;CSF1;APOA1;MT3;NTF3;AGTR1;CD63;ARRB1;DCXR;F2;INSR;EGF;HPN;FASN;NR1H3;SFRP4
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.37619003712777094,0.9987496655833189,0.4764621968616263,0.8904728751275349,1.0,5/36,7.66%,DAPK2;BCL2;TGFBR1;ING5;TRAF7
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.46741664443971287,0.9987032111230645,0.4735915492957746,0.8899248876693264,1.0,6/11,28.84%,SLC30A10;SLC18A2;ABCD2;ABCD1;FYN;PPARA
prerank,lipoprotein catabolic process (GO:0042159),0.465079515120402,0.9984424332056141,0.48494983277591974,0.8899662908894391,1.0,3/11,6.13%,APOE;ABHD17C;LYPLAL1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.4007641504629027,0.9975252481606512,0.465818759936407,0.8916119420065183,1.0,9/23,24.33%,FAF2;LMAN1;DERL1;SELENOS;AUP1;TECPR2;SEC16A;RANGRF;OS9
prerank,central nervous system myelination (GO:0022010),-0.4024188268832529,-0.9970574436394073,0.4666666666666667,0.8669318644404438,1.0,4/11,19.39%,TENM4;B4GALT5;PLP1;CLU
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.44692924330939154,0.9965104487874024,0.44858156028368795,0.8934645293653429,1.0,3/12,17.97%,IL12B;IL23A;IL18
prerank,defense response to protozoan (GO:0042832),-0.40359611887196245,-0.9963746462660124,0.44212962962962965,0.8675572173294881,1.0,5/12,21.28%,GBP4;GBP7;CD40;LYST;GBP6
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.26321740244121117,-0.9963323797676833,0.45188284518828453,0.8663391232002505,1.0,20/65,23.95%,FHL1;CUL1;RBX1;FBXL7;AVEN;PSMF1;PSMB8;PSMA4;PSMB10;PSMB2;CHFR;PSMC4;VPS4A;PSMA6;PSMD9;PSMD11;PSMD5;NABP1;PSMA8;PSMB1
prerank,receptor-mediated endocytosis (GO:0006898),0.307223762683938,0.996248520244583,0.46651532349602726,0.8934165602501556,1.0,26/132,13.36%,DNAJC6;COLEC12;SPARC;LRP1;GRK3;HSPG2;APOE;NEDD4;APOA1;LDLR;CXCL16;COLEC11;ADRB3;EPS15;DAB2;AP1G2;PICALM;IGF2R;MASP1;ADM;CLN3;LRP3;INSR;GRK4;WASF1;CTSL
prerank,O-glycan processing (GO:0016266),0.34877762820279157,0.9961244113238334,0.4823848238482385,0.8930782244970407,1.0,4/54,3.70%,GXYLT2;GALNT15;GALNT14;ST3GAL3
prerank,cellular response to light stimulus (GO:0071482),-0.2666971953994017,-0.9957688040092044,0.4585152838427948,0.8665939235878929,1.0,26/66,30.06%,PTPRK;KDM1A;TAF1;YY1;RPL26;COPS9;GNB1;BAK1;PDE6A;EP300;N4BP1;RHBDD1;NPM1;PARP1;POLK;TRIAP1;ATF4;SDE2;EIF2AK4;FMR1;RUVBL2;RHNO1;AQP1;RRH;OPN1MW3;OPN1MW
prerank,protein modification process (GO:0036211),-0.2577634176525763,-0.9955687557066408,0.4759825327510917,0.8658355328125922,1.0,17/76,19.36%,ST3GAL6;ST8SIA4;YES1;STK38;UBA3;CHRM3;B4GALT7;MMP15;MAN2B1;UBE2D3;ATG3;UBE2S;PRKDC;RPN1;QPCT;CPE;PARP1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.47076206259657627,0.9955206235905681,0.47128378378378377,0.8939654434827605,1.0,3/11,6.32%,KANK1;PDPN;SRC
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.3754399072643545,0.9953564494960658,0.47305389221556887,0.8936860983587264,1.0,7/35,8.91%,DLC1;KANK1;ITGA3;RIPOR2;ARHGAP35;EPHB2;SPRY2
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4157374969184987,-0.9952822217994445,0.4861751152073733,0.865293628484952,1.0,3/10,14.93%,SHANK3;SYP;APP
prerank,diol metabolic process (GO:0034311),-0.35200837662545414,-0.9949855114943125,0.4603174603174603,0.8648670300936669,1.0,6/19,10.72%,NOS3;DEGS2;GCH1;NAAA;CALM1;SPR
prerank,positive regulation of ion transport (GO:0043270),0.35516530555096953,0.9949434026415903,0.4797843665768194,0.894034436602059,1.0,4/48,6.12%,ACTN2;GDNF;MYLK;CCL4
prerank,I-kappaB phosphorylation (GO:0007252),-0.426980874254642,-0.9943990348074974,0.47544642857142855,0.8651031178551587,1.0,7/10,38.76%,TLR4;DAB2IP;CHUK;MAP3K7;ERC1;TLR2;TLR3
prerank,response to estrogen (GO:0043627),-0.3174745169381889,-0.9940947837757808,0.47477744807121663,0.8646378724953153,1.0,10/31,17.81%,CAV1;ESR1;TRIM24;TRIM25;NCOA4;ARID5A;EP300;SERPINB9;CITED2;KRT19
prerank,regulation of fibroblast migration (GO:0010762),0.4258712660982983,0.9938824520998856,0.4848966613672496,0.8960661700528831,1.0,5/20,11.91%,DDR2;RFFL;APPL2;FGF2;CLN3
prerank,endothelial cell migration (GO:0043542),0.3701751612346547,0.9937797950932027,0.47723935389133626,0.8956631572495377,1.0,5/37,6.39%,NRP1;FSTL1;CYP1B1;CDH5;ADGRA2
prerank,positive regulation of viral process (GO:0048524),0.3356455685419011,0.993758800510226,0.4789808917197452,0.8950630066323123,1.0,13/60,18.80%,POLR2D;AXL;KPNA6;CD28;POLR2C;DDX3X;LARP1;STAU1;NELFE;TBC1D20;KPNA2;PPIE;POLR2L
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.35813992434355846,-0.9929343068342894,0.46070460704607047,0.8666015909020011,1.0,10/19,27.14%,PTPRJ;KDR;GRM5;RYR2;PTPRC;FIS1;VCAM1;SELP;DMTN;PRNP
prerank,muscle tissue morphogenesis (GO:0060415),0.42703567029814665,0.9928564150755409,0.4856175972927242,0.8966921250430024,1.0,3/16,8.76%,TGFBR3;MYLK;BMP2
prerank,amyloid fibril formation (GO:1990000),0.34765648533900484,0.9927488584328742,0.4692737430167598,0.8962954771165813,1.0,9/51,13.18%,GSN;HSPG2;APOA1;CST3;SNCAIP;PRKN;GGA2;APH1B;USP9X
prerank,nucleoside phosphate catabolic process (GO:1901292),0.4476152024206468,0.9920337342496107,0.45293072824156305,0.8974584835250367,1.0,1/13,0.63%,ENPP1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3732118445257399,0.9920291058000344,0.47540983606557374,0.896809858298098,1.0,5/36,8.47%,TCF7L2;PPP3CA;FZD2;TNRC6B;TNRC6A
prerank,cellular response to hydroxyurea (GO:0072711),0.4801223542447036,0.9920286470776504,0.49125874125874125,0.8961555150249126,1.0,4/10,18.75%,DDI1;RTF2;TIMELESS;ATRX
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.36690207914678613,-0.9919716660764395,0.48175182481751827,0.8679187955122637,1.0,6/17,11.48%,NOTCH1;TENM4;PTN;ID2;HES1;TGFB1
prerank,retina homeostasis (GO:0001895),0.4056566548769858,0.991109223236878,0.49074074074074076,0.8977401459296774,1.0,4/23,6.94%,TULP1;PIGR;CRB2;ATP1B2
prerank,regulation of cellular metabolic process (GO:0031323),0.3577348380081339,0.9906448531836403,0.4793956043956044,0.8982175837499047,1.0,9/45,14.76%,PID1;GNB3;CYP1B1;PRKN;EIF6;NCOR2;ARF4;RSPO1;FASN
prerank,cognition (GO:0050890),-0.29203779528852963,-0.9905738881462793,0.4772727272727273,0.8706282620133763,1.0,15/42,23.26%,SHROOM4;GRM5;MFSD2A;DOP1B;GPR155;STRA6;NF1;FAM107A;SLC1A4;CBR3;APP;CHMP2B;JAKMIP1;PTCHD1;ST3GAL4
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.35609913950633126,0.9901956070052466,0.48409405255878285,0.8986610702913645,1.0,8/43,14.90%,TEAD1;SMAD3;NFIB;ATOH8;FGF2;REST;ETS1;BMP4
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.38855593899723445,-0.9901614810115381,0.46634615384615385,0.870483375980957,1.0,6/13,14.60%,GRIN2A;PERP;CASP8;CYFIP2;LGMN;BAK1
prerank,hemidesmosome assembly (GO:0031581),-0.40509364378620466,-0.9899888161132078,0.45348837209302323,0.8696761988383829,1.0,2/11,3.29%,ITGA6;ITGB4
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.4555336894011567,0.9888368366901822,0.48771929824561405,0.9013267011313391,1.0,4/12,10.78%,SFRP1;DAB2;NCOR1;NCOR2
prerank,indolalkylamine catabolic process (GO:0046218),0.4779953498533429,0.9888202724663594,0.48700173310225303,0.9007098240688609,1.0,2/10,6.78%,TDO2;KYNU
prerank,positive regulation of chromosome organization (GO:2001252),0.43711835638656704,0.9887856923370769,0.4797297297297297,0.9001262896359433,1.0,7/15,26.06%,LIG4;PML;PPP1R10;RTEL1;ATRX;MRE11;RAD50
prerank,protein localization to nucleus (GO:0034504),0.3150648233938549,0.988731510486431,0.4685230024213075,0.8996047626197198,1.0,29/102,20.16%,COL1A1;RANBP17;NUP107;APPL2;FAM53C;PRICKLE1;PML;ARL2;HEATR3;CSE1L;PPP1R10;TOR1AIP1;YWHAE;PAF1;BANP;TSC2;NUP214;TOR1B;BMP4;PIKFYVE;AKT1;TOR1AIP2;PHB2;XPA;TPR;APPL1;KPNB1;ABCA7;HNRNPU
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.25078687491402546,-0.9887055553048915,0.48,0.8720190999317751,1.0,38/100,24.70%,RNF144B;CBFA2T3;RNF144A;SDCBP;RBX1;RYBP;TRIB2;RPL11;HSP90AB1;TAF1;GSK3A;FOXF2;HSPBP1;ZYG11B;GIPC1;RAD23A;COP1;GNA12;N4BP1;RACK1;BBS7;DVL1;RNF14;FHIT;CLU;DDRGK1;GSK3B;GABARAP;UBXN1;RCHY1;CAMLG;USP5;NUB1;CSNK1D;VCP;CCAR2;USP7;DDA1
prerank,negative regulation of protein kinase activity (GO:0006469),0.31904825261428577,0.9882454544013483,0.4896719319562576,0.9001560799415111,1.0,7/88,4.30%,PDPK1;PPM1E;SLC8A1;SLC8A3;DTNBP1;PRKAG2;CDK5RAP3
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.3646253590006377,-0.9880299109197691,0.472,0.8726470451742322,1.0,5/18,6.64%,ACTB;ZDHHC2;SPTBN1;CDK5;VAMP8
prerank,regulation of axon extension (GO:0030516),0.36904506404539583,0.9878342021244454,0.47360912981455067,0.9004586361840571,1.0,9/37,12.46%,OLFM1;MACF1;APOE;MT3;GOLGA4;PTPRS;NTN1;RNF6;MAP3K13
prerank,cellular response to fluid shear stress (GO:0071498),0.44933975923477326,0.9877179155913369,0.475,0.9000909358787957,1.0,2/12,6.96%,MTSS1;NFE2L2
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.3347903948099263,-0.9871370623714114,0.4878048780487805,0.8739151362323315,1.0,8/23,14.78%,UBASH3B;PTK2B;DIAPH1;CAMK2D;NOS1;CASQ2;CBARP;CACNA2D1
prerank,mitochondrial protein processing (GO:0034982),0.4584724973081593,0.9870454769355526,0.5,0.9010999040642336,1.0,6/11,24.92%,PMPCB;IMMP1L;YME1L1;AFG3L2;STOML2;MIPEP
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.3689589647278789,0.9869169233476968,0.497841726618705,0.9007491583069792,1.0,6/36,9.95%,GAS6;CSF1;AXL;TSLP;PRKN;PARP14
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.30882467545945397,-0.9869143650662587,0.47416413373860183,0.8731738181414564,1.0,14/31,19.80%,DLG2;LIN7A;MYO9A;LRRC7;OPHN1;LIN7C;SCRIB;MSN;PDCD6IP;WDR1;ERBIN;SYNJ2BP;MTCL1;SH3BP1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.420180416168628,-0.9868286006656466,0.5032397408207343,0.8720970675266381,1.0,4/10,10.23%,TBX1;LRP5;TGFBR2;PDGFA
prerank,regulation of viral transcription (GO:0046782),0.36173064423640416,0.986639428446471,0.4860335195530726,0.9007606142313521,1.0,1/39,0.14%,POLR2D
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.44447483829548273,0.9865727759023224,0.4931506849315068,0.9002720596601208,1.0,2/13,6.67%,GJA1;CACNA1C
prerank,protein localization to mitochondrion (GO:0070585),0.46005600984477774,0.9862984860726858,0.47719298245614034,0.9002823785557246,1.0,4/11,16.33%,COX18;LRRK2;MTCH2;AKT1
prerank,cellular response to interleukin-12 (GO:0071349),-0.2804431850540266,-0.9861790929322225,0.45925925925925926,0.8726639355713505,1.0,14/48,15.70%,PITPNA;PPIA;RAP1B;SIRPA;JAK2;MSN;LMNB1;ARF1;PAK2;TYK2;BOLA2;HNRNPA2B1;SNRPA1;RPLP0
prerank,negative regulation of chemotaxis (GO:0050922),0.3804301211221481,0.9860509258955915,0.4985507246376812,0.9002326527892424,1.0,4/31,3.78%,ROBO1;SEMA3D;ANGPT2;SEMA5A
prerank,copper ion homeostasis (GO:0055070),-0.3682884135537473,-0.9858449097688781,0.4823848238482385,0.8722469416059844,1.0,9/17,27.14%,ATOX1;ARF1;ATP7A;SLC31A1;APP;CUTC;MT2A;SLC31A2;PRNP
prerank,methylguanosine-cap decapping (GO:0110156),-0.4213838639232036,-0.985773925322306,0.4965675057208238,0.8711355198466776,1.0,4/10,21.58%,EDC3;PNRC2;DCP2;DCPS
prerank,regulation of feeding behavior (GO:0060259),0.46537171211263334,0.9833175177674133,0.5,0.9063008850980849,1.0,2/11,5.45%,LEPR;GNB3
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.38646955949399153,0.983026831474856,0.4788732394366197,0.906387246619267,1.0,9/26,21.29%,MAPKBP1;SIRT2;NMI;IRAK3;ITCH;MUL1;DHX58;TRIM21;TRIB1
prerank,regulation of intracellular pH (GO:0051453),-0.3018961611068133,-0.9828918021631826,0.4984126984126984,0.8780580854851201,1.0,6/34,9.96%,SLC4A10;SLC9A2;SLC9A6;SLC4A8;SLC9A7;SLC26A6
prerank,nuclear export (GO:0051168),0.32611439205665776,0.9828482158991405,0.48911651728553135,0.9061776360709283,1.0,15/80,14.58%,ATXN1;RANBP17;PHAX;U2AF1L4;THOC2;NUP42;HNRNPA1;XPO7;DDX39A;CSE1L;RAE1;MAGOHB;STRADA;NUP214;SRSF5
prerank,sphingosine metabolic process (GO:0006670),-0.3623482027627072,-0.9825912796177075,0.45268542199488493,0.877572223100313,1.0,4/17,10.37%,ACER3;ACER2;NAAA;SPTLC2
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.42851015472816284,0.9824106907106349,0.49663299663299665,0.9065720059647966,1.0,3/15,8.76%,GLI2;WNT6;BMP2
prerank,potassium ion transport (GO:0006813),0.30567212705277175,0.9823828886095077,0.5109826589595375,0.9059825274629708,1.0,11/120,9.28%,SLC1A3;KCNK2;SLC24A3;NALCN;ATP1A2;SLC9A9;SLC24A1;KCNK7;KCNQ4;SLC9A5;KCNJ14
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.403335267596468,0.982244457216394,0.47634069400630913,0.9056745278398727,1.0,3/22,6.07%,RBP1;UBIAD1;ALDH1A2
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.29661020182291337,0.9819488707436683,0.5082690187431091,0.9057391774576307,1.0,27/158,15.05%,WLS;GJA1;PELI2;CFLAR;CCL19;EDAR;ROR1;RNF31;LPAR1;TLR6;PRKN;GPR89A;LTBR;SLC20A1;TMED4;CXXC5;CARD9;NEK6;TNIP2;IKBKE;TBK1;RIPK2;MUL1;FLNA;AKAP13;PLK2;TNFRSF1A
prerank,negative regulation of apoptotic process (GO:0043066),0.282270123110742,0.9819019115087387,0.5379098360655737,0.9051996054929864,1.0,73/444,14.90%,IGF1;FHL2;ANGPT1;GDNF;PIK3R1;IL31RA;BCL2;GRK5;SON;SH3RF1;ASCL1;YAP1;GAS6;APOE;CFLAR;NUPR1;MYO18A;NOTCH2;TXNDC5;TLE1;FSTL1;MT3;AXL;NTF3;RNF213;PHIP;LIG4;SFRP1;CTSH;PRKAA2;PDPN;TBX3;VIP;USP47;BFAR;ARHGAP10;SRC;DPEP1;TSLP;CD28;ARAF;OSR1;SLC30A10;DAB2;DNAJC3;EGFR;MAP4K4;SPRY2;PRKN;ITCH;BRAF;DDX3X;CLN3;ANXA5;YWHAE;NIBAN2;HMGN5;RIPK2;NOL3;VDAC1;IGBP1;HYPK;TAF9;HSPA9;ARF4;MERTK;DSTYK;MDK;HPN;FLNA;PLK2;GATA6;BMP4
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.32317026818258204,0.981774067941953,0.49812734082397003,0.9048513717481693,1.0,10/76,9.90%,NRP1;SEMA5A;CDC42EP4;SYNPO2;NTF3;DYNC1H1;CDC42;CARMIL1;NTRK3;SYNPO2L
prerank,brain morphogenesis (GO:0048854),-0.39684661896822404,-0.9817152243056091,0.49489795918367346,0.8787566463955562,1.0,2/12,8.62%,SHANK3;PAFAH1B1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.44330174041544484,0.9815675521849707,0.5025817555938038,0.9046737137147469,1.0,2/15,2.08%,RAI2;FGFR1
prerank,glycerophospholipid metabolic process (GO:0006650),-0.2617680471763281,-0.9815536324967697,0.5047619047619047,0.8779341478070456,1.0,20/75,18.84%,GPCPD1;SERINC5;DGKH;CPNE3;PLA2G7;PLA1A;PIGP;PAFAH1B1;GPLD1;PLEK;PNPLA3;PIGB;PLA2G4C;CRLS1;PIGL;ABHD6;DPM2;SYNJ1;PIGV;PNPLA6
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.45461221630026655,0.98143843819894,0.5035087719298246,0.9043031139279777,1.0,1/11,0.87%,ACTN2
prerank,peptidyl-threonine modification (GO:0018210),0.331182553376241,0.9811606475387622,0.517464424320828,0.9043213380202161,1.0,18/66,18.50%,PDPK1;ROCK2;TGFBR1;ACVR1;LRRK2;MAP2K1;OXSR1;TTBK1;TBK1;WNK1;ACVR1B;MARK2;DYRK1A;DYRK1B;AKT1;CDK10;DYRK3;PRKCA
prerank,intracellular cholesterol transport (GO:0032367),0.42660371905434413,0.9811242055292642,0.4925373134328358,0.903754974274214,1.0,3/15,5.22%,ABCA1;LDLR;STAR
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.3737315099136635,0.9809455750837479,0.5,0.9035590398021289,1.0,4/33,10.17%,TEAD1;SMAD3;ATOH8;FGF2
prerank,determination of heart left/right asymmetry (GO:0061371),-0.28802178972197956,-0.9808876927921972,0.4908424908424908,0.8785008873874738,1.0,10/42,14.28%,MEF2C;NOTCH1;SOX17;TBX2;ZIC3;SOX18;TGFBR2;STIL;APLNR;MICAL2
prerank,negative regulation of DNA binding (GO:0043392),-0.3158088189144612,-0.9807700114792376,0.49691358024691357,0.8775494127601027,1.0,9/28,17.16%,LEF1;NFKBIA;KDM1A;HEY2;JAK2;JUN;HEY1;TFAP4;RSF1
prerank,isotype switching (GO:0045190),0.4731681720519722,0.9807115862087546,0.48566308243727596,0.9034582589273289,1.0,2/10,6.85%,LIG4;BATF
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.4265228297934342,-0.9805765490268816,0.5054466230936819,0.8767743250010835,1.0,4/10,23.25%,ESR1;ATF7IP;PSMC4;THRA
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.33864337141925316,-0.9804306643331082,0.4973544973544973,0.8758513497028033,1.0,4/22,8.16%,ESR1;MED1;MED4;SUB1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.32902422518485513,-0.980418925820676,0.4781420765027322,0.8745850330069581,1.0,12/25,25.67%,HIPK2;RPS7;OPHN1;RPL11;HSP90AB1;TAF1;PSMF1;RPL5;RPL23;EFNA1;PRKCG;SGTA
prerank,chromatin disassembly (GO:0031498),0.426795610029202,0.9803800016536558,0.4938704028021016,0.902975083008974,1.0,6/14,23.33%,SMARCC2;NFE2;SMARCD2;SMARCB1;ARID2;SMARCE1
prerank,nucleosome disassembly (GO:0006337),0.426795610029202,0.9803800016536558,0.4938704028021016,0.902975083008974,1.0,6/14,23.33%,SMARCC2;NFE2;SMARCD2;SMARCB1;ARID2;SMARCE1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.4538929999097586,0.9802066646362697,0.5177065767284992,0.9027708682119844,1.0,2/13,5.02%,ABCA1;LDLR
prerank,positive regulation of cyclase activity (GO:0031281),-0.3788619223026371,-0.979883734485883,0.45823389021479716,0.8747551335599189,1.0,6/14,15.08%,NOS3;NOS1;MAPK8;NF1;MAPK3;CACNA1D
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.4075602564594424,0.9797756863876956,0.4936708860759494,0.9031453971420127,1.0,6/20,18.03%,GSN;PLA2R1;RGCC;PDCD4;SFRP4;PRKCI
prerank,positive regulation of endocytosis (GO:0045807),0.34940909202504034,0.979239306261679,0.49666221628838453,0.9037618671093287,1.0,9/45,8.35%,LRP1;SERPINE1;APOE;VTN;CCL19;APPL2;AXL;CDC42;DAB2
prerank,regulation of complement activation (GO:0030449),0.3612933464081046,0.9791970944220968,0.46637426900584794,0.9032301326841604,1.0,5/40,6.13%,SERPING1;VTN;CFH;C4B;C8G
prerank,protein localization to organelle (GO:0033365),0.303075027629711,0.9791651262264959,0.5164960182025028,0.9026624023003416,1.0,34/133,19.93%,COL1A1;OBSL1;TULP1;OPTN;TRAM2;LRRK2;WDR35;CYB5A;TULP3;CROCC;CSRP3;ARL1;DDX3X;TRAM1;TOR1AIP1;YWHAE;UBAC2;PAF1;BANP;TOR1B;MTCH2;BMP4;ARF6;PIKFYVE;LAMP2;AUP1;ZNF423;DCP1A;MICALL1;DDX1;XPA;ABCA7;CCDC47;EHD1
prerank,eye photoreceptor cell differentiation (GO:0001754),0.4566358702193376,0.9789274585665172,0.48514851485148514,0.9025981163350284,1.0,3/12,8.46%,NKD1;TULP1;DSCAM
prerank,peptidyl-lysine monomethylation (GO:0018026),0.47348389565107035,0.9787756680755064,0.49731663685152055,0.9023338726411873,1.0,2/10,11.02%,SETD7;SETD4
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.4072559298571213,-0.9787271186158357,0.4682352941176471,0.8767434650560316,1.0,5/12,23.35%,PRKDC;CCND1;FBXO31;PLK3;SDE2
prerank,organic hydroxy compound transport (GO:0015850),0.36673380888495205,0.9787096666892646,0.4943502824858757,0.9018607484870382,1.0,3/36,4.89%,RBP4;SLC27A5;NCOA2
prerank,regulation of interleukin-13 production (GO:0032656),-0.39204707468052513,-0.9785463363765459,0.46411483253588515,0.8758905911550813,1.0,3/13,11.31%,LEF1;TNFRSF21;PRKCZ
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.3395519385935342,0.9784949885721361,0.5026595744680851,0.9017073447671524,1.0,11/60,13.40%,FGFR4;PDGFRB;CHTF8;SMOC2;PARM1;HNRNPA1;FGF2;PARN;RGCC;FBXO4;TNKS2
prerank,positive regulation of vasculogenesis (GO:2001214),0.46973876396275005,0.9782220722242395,0.49914529914529915,0.9017250594088635,1.0,2/10,4.33%,RIN2;RAPGEF2
prerank,striated muscle cell differentiation (GO:0051146),0.42528626849010137,0.9781800647386938,0.47796610169491527,0.9011974006727799,1.0,5/16,8.90%,SKI;SDC1;SIK1;BMP2;CBY1
prerank,oligosaccharide metabolic process (GO:0009311),0.34673480055649414,0.978162847056399,0.4951048951048951,0.90059949971891,1.0,5/46,6.86%,ST6GALNAC5;GAL3ST3;B3GALT1;ST3GAL3;B4GALT1
prerank,regulation of protein localization to nucleus (GO:1900180),0.357326056501354,0.9781555720904506,0.510548523206751,0.8999809473747146,1.0,13/43,18.64%,GLUL;YAP1;CDK5RAP3;WWTR1;EIF2AK3;BYSL;F2;BMP4;SESN2;AKT1;SHH;LIF;TPR
prerank,mitochondrial translation (GO:0032543),-0.24212576959181215,-0.978009998121185,0.527027027027027,0.8761067522256992,1.0,39/104,32.16%,MRRF;NOA1;MTRF1L;GFM2;MRPL46;MRPS18A;MRPS5;MRPL39;MRPS26;MRPS12;NDUFA7;MRPL48;MRPL4;MRPL21;FASTKD2;MRPL44;MRPS33;MRPL55;MRPL57;MRPS18B;MRPL42;MRPS10;MRPS21;MRPS7;MRPL34;MRPL15;MRPL19;MRPS22;GATC;MRPL38;MRPS31;MRPL12;MRPL28;MRPL43;MTIF3;MRPS14;MRPL54;MRPL2;AURKAIP1
prerank,neuron differentiation (GO:0030182),0.2990127274053743,0.9778202308020985,0.5337837837837838,0.9001351633652274,1.0,21/165,7.60%,PBX1;GLI2;RUNX1;WNT8B;FZD2;WNT4;ASCL1;RUNX2;TGFBR1;WNT6;NEUROD4;HS6ST1;NEUROD1;FZD1;THOC2;ATOH8;SMARCA1;WNT5B;USH2A;BRSK1;MAP2K1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.3219115729706711,0.9777039371039435,0.49370277078085645,0.8997818452676319,1.0,26/73,23.94%,IGF2;DNMT3A;POLR1G;SPHK2;MYO1C;KAT2B;RBBP7;BAZ1B;PHF1;PHF2;PPHLN1;GLMN;HDAC4;SF3B1;DNMT3B;POLR2L;POLR1F;JARID2;DNMT1;POLR1H;POLR1C;HDAC6;CTCF;HDAC5;PPM1D;TDG
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.32271203855171404,0.9774357747043847,0.5018963337547409,0.8998144284851454,1.0,14/79,10.17%,ADAMTS12;SULF2;BMPR1A;SULF1;NEDD4;SMURF2;SKI;CASK;EMILIN1;BMP2;SPRY2;LEMD3;SMAD1;FGF2
prerank,protein heterotetramerization (GO:0051290),-0.38696087758298137,-0.9771815411135895,0.49019607843137253,0.8770995171575323,1.0,7/13,27.86%,GRIN2B;CPSF7;HSD17B8;GRIN1;CBR4;CPSF6;PKD1
prerank,neuron projection development (GO:0031175),0.29343839185882536,0.9768506820136424,0.5260821309655938,0.9006193721274265,1.0,33/168,14.00%,NRK;GDNF;ADGRV1;LYN;GRXCR1;EPHA4;DOCK10;EPHA8;DTNBP1;VASH2;APOE;NEDD4;RAPGEF2;NTF3;CDK16;LRP12;CDC42;ATXN10;LRRK2;ALS2;EPHB2;MAP4K4;BLOC1S1;RYK;PTPRM;MANF;TAOK3;EPHB3;NRTN;GAS7;MARK2;PTEN;DLG4
prerank,cholesterol metabolic process (GO:0008203),0.33016952636028946,0.9768301314572745,0.5122265122265123,0.9000272606830622,1.0,12/68,15.74%,ABCA1;APOE;INSIG2;APOA1;MT3;MVK;CYP27A1;IDI1;LCAT;RXRA;OSBPL5;HMGCS1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.3978569616151717,0.97668834455411,0.5062893081761006,0.8997513601273053,1.0,4/21,6.67%,SLC8A1;ATP1A2;GSTM2;CACNA1C
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.37961837788235353,-0.976428182657365,0.4742729306487696,0.8778249458951864,1.0,4/13,18.69%,SYT1;CACNA1H;STX1A;SYT4
prerank,regulation of monocyte differentiation (GO:0045655),0.4331420279844076,0.9759370512778551,0.47684391080617494,0.9009853152260101,1.0,3/14,5.78%,IL34;CSF1;ZFP36L1
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.4091149053114967,-0.9756991765622085,0.5113636363636364,0.8785910595066938,1.0,3/11,6.41%,ZFPM2;TGFB2;HEY2
prerank,negative regulation of ion transport (GO:0043271),0.389327315977198,0.9754236751585224,0.4856687898089172,0.9015691419622193,1.0,7/24,13.47%,ACTN2;NEDD4;VIP;ADRA2A;CD33;WNK1;SYT11
prerank,ureteric bud development (GO:0001657),-0.3555343041490024,-0.9751897893573268,0.5023809523809524,0.878742139533571,1.0,3/17,2.74%,SLIT2;GPC3;SIX1
prerank,regulation of BMP signaling pathway (GO:0030510),0.3242773733314203,0.9751275207933489,0.5050251256281407,0.9016402059193452,1.0,22/73,16.78%,BMPR1A;CCN1;ITGA3;FSTL1;TWSG1;SULF1;SMURF2;CDH5;ENG;SKI;CRB2;RBPJ;BMP2;LEMD3;SMAD1;FSTL3;BMP4;UBE2D1;SFRP4;SPART;ZNF423;DAND5
prerank,mesoderm development (GO:0007498),-0.35419635256952264,-0.9748675626640225,0.47572815533980584,0.8783577294056549,1.0,12/18,30.61%,TIE1;TBX1;BMX;JAK2;VEGFA;BTK;HCK;MEST;MESD;TCF15;IKZF1;IKZF3
prerank,positive regulation of translation (GO:0045727),0.31334648070437304,0.9745890956131118,0.5135135135135135,0.9022924827270972,1.0,10/94,11.00%,POLR2D;SAMD4A;PLD1;RPUSD4;CPEB3;CD28;METTL14;EIF6;CDC123;DDX3X
prerank,regulation of neuron migration (GO:2001222),0.38887199257777255,0.9745350977121037,0.5101088646967341,0.9017863009584932,1.0,9/26,17.76%,PHACTR1;RAPGEF2;CAMK2B;NTNG2;COL3A1;MDK;PLXNB2;CX3CL1;NIPBL
prerank,regulation of immune effector process (GO:0002697),0.3548569362087064,0.9745308306394438,0.48364153627311524,0.9011650132630838,1.0,5/41,6.13%,SERPING1;VTN;CFH;C4B;C8G
prerank,regulation of response to cytokine stimulus (GO:0060759),0.410861353370268,0.9744731000554571,0.5057096247960848,0.9006702703427313,1.0,3/19,4.31%,RUNX1;IRAK2;APOA1
prerank,protein import into nucleus (GO:0006606),0.330729343477596,0.9742339464317682,0.5,0.9006303185787863,1.0,19/66,18.84%,CBLB;RANBP17;NUP107;APPL2;FAM53C;PRICKLE1;KPNA6;HEATR3;CSE1L;PPP1R10;TSC2;NUP214;AKT1;KPNA2;KPNA1;PHB2;TPR;APPL1;KPNB1
prerank,histone monoubiquitination (GO:0010390),0.3857883329362285,0.9734495776761396,0.5083969465648855,0.9019801275321955,1.0,9/24,22.33%,ATXN7L3;BCOR;CUL4B;PAF1;RNF2;WAC;CDC73;LEO1;RNF20
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.4205620502604819,0.9732402671370669,0.4926829268292683,0.9018408295352841,1.0,5/17,8.76%,BMPR1A;NOTCH2;ACVR1;RBPJ;BMP2
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.2867946721630281,0.9726065262737529,0.534983853606028,0.902735468594684,1.0,35/234,13.80%,ADCY1;DDR2;CAMK1D;SMAD3;AR;PLPP3;NKX6-1;ARID5B;FZD2;KIT;CFLAR;SMO;IRAK2;CRTC3;ZIC2;NEUROD1;FZD1;SLCO3A1;ROR1;RNF31;TLR6;IRAK3;ANXA3;CD200;RAB7B;FOXA1;NFAM1;CARD9;RGCC;IKBKE;MAP3K13;RIPK2;MTPN;HDAC4;PTEN
prerank,transcription by RNA polymerase I (GO:0006360),-0.299987993958512,-0.9725299279362721,0.5107033639143731,0.8836254378929544,1.0,9/34,13.80%,TAF1B;RRN3;TAF1;TBP;CAVIN1;GTF2H1;TAF1C;UBTF;MAPK3
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.28763469579902184,-0.9722814412526201,0.46178343949044587,0.8829938176453349,1.0,11/39,21.94%,FNBP1L;PPFIA2;MYO1D;TANC2;PAFAH1B1;KIF1A;BICDL1;TRAK2;SYT4;MYO15A;HAP1
prerank,positive regulation of rRNA processing (GO:2000234),0.4733141891925152,0.9721548040687623,0.5027027027027027,0.9031880561812567,1.0,4/10,13.25%,BUD23;DIMT1;WDR43;TRMT112
prerank,PERK-mediated unfolded protein response (GO:0036499),0.47026882507145973,0.9719370984346632,0.5052816901408451,0.9030651765809402,1.0,4/10,23.11%,NFE2L2;EIF2AK3;DDIT3;HSPA5
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.2604652824913635,-0.9718120072995431,0.4669421487603306,0.8817516553386857,1.0,23/56,28.83%,NDUFC1;NDUFAF2;NDUFA6;DMAC2;NDUFA5;TMEM126B;NDUFA7;NDUFA8;NDUFB7;NDUFA3;NDUFA10;NDUFAF8;NDUFS7;NDUFS1;NDUFS5;NDUFB3;NDUFAF3;DMAC1;NDUFAB1;NDUFB4;NDUFV2;NDUFAF7;NDUFV3
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.2604652824913635,-0.9718120072995431,0.4669421487603306,0.8817516553386857,1.0,23/56,28.83%,NDUFC1;NDUFAF2;NDUFA6;DMAC2;NDUFA5;TMEM126B;NDUFA7;NDUFA8;NDUFB7;NDUFA3;NDUFA10;NDUFAF8;NDUFS7;NDUFS1;NDUFS5;NDUFB3;NDUFAF3;DMAC1;NDUFAB1;NDUFB4;NDUFV2;NDUFAF7;NDUFV3
prerank,transition metal ion transport (GO:0000041),0.3634167615630438,0.9715580283856783,0.5159420289855072,0.9033649926663099,1.0,6/35,8.28%,CP;SLC30A8;MT3;HEPH;SLC11A2;SLC30A10
prerank,response to cAMP (GO:0051591),-0.29244531930775514,-0.971541628637324,0.4725609756097561,0.8812399380504186,1.0,9/37,13.10%,RAP1A;PDE2A;KCNQ1;AKAP6;RAP1B;INPP5K;SLC26A6;DGKQ;CFTR
prerank,hyaluronan metabolic process (GO:0030212),0.39000090908885576,0.9707750733599773,0.5056179775280899,0.904557570424069,1.0,4/23,10.71%,CEMIP;LYVE1;FGF2;ABCC5
prerank,adipose tissue development (GO:0060612),0.45890310073735197,0.9707476070450917,0.4944237918215613,0.9039824236336984,1.0,5/11,15.72%,ARID5B;SH3PXD2B;PGRMC2;DGAT2;DYRK1B
prerank,negative regulation of hippo signaling (GO:0035331),0.45213533806608863,0.970429070230973,0.496415770609319,0.904096243175383,1.0,2/12,8.07%,WWC2;WTIP
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.3120129113018509,0.9702564881608472,0.54632972322503,0.9038914259818501,1.0,18/101,14.80%,SAMD4A;PLD1;DACT1;OGT;FGFR4;ASPH;CSF1;CPEB3;ATG10;AGTR1;CD28;METTL14;EIF6;DDX3X;BTRC;PLXNB2;NSUN5;NR1H3
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.3473878170855392,0.9701993624396019,0.5071022727272727,0.903393279703072,1.0,13/49,14.61%,RUNX1;TNRC6B;MTURN;TNRC6A;SETD1A;KAT2B;RAB7B;EIF6;L3MBTL1;NFE2;KMT2E;KMT2A;WDR5
prerank,regulation of Notch signaling pathway (GO:0008593),-0.2619458859730372,-0.9701986870752118,0.536036036036036,0.8836962136795569,1.0,23/76,19.59%,NOTCH3;EPN2;NOTCH1;NOS3;CCN3;BEND6;TGFB2;JAG2;GATA2;NOTCH4;SNW1;MFNG;LFNG;GALNT11;HEY1;NOD2;EP300;DLL4;SYNJ2BP;ITGB1BP1;PDCD10;DLL1;EGFL7
prerank,negative regulation of cytokine production (GO:0001818),-0.2284343705552657,-0.9698001413920754,0.5486725663716814,0.8834606483638138,1.0,41/163,19.80%,LEF1;FN1;TMSB4X;IFIH1;CD34;THBS1;RPS6KA5;NAV3;OTUD7B;APOD;RNF125;CMKLR1;TRIB2;SIRPA;TRIM25;NLRC5;RPS6KA4;TNFRSF21;KLF4;TNFAIP3;PTPN22;INHBB;INHA;CEACAM1;SIGIRR;CUEDC2;PTPN6;SRGN;PTPRC;PCBP2;JAK3;HOMER3;N4BP1;INHBA;ZFPM1;TLR4;UFD1;TAX1BP1;ANXA1;DLL1;C1QBP
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.39363854804204085,-0.9696267561152468,0.4897959183673469,0.8826547158387974,1.0,4/12,13.10%,ANO1;GPLD1;ADCY8;CFTR
prerank,regulation of DNA biosynthetic process (GO:2000278),0.3776266398741874,0.9695153846855963,0.5022156573116692,0.9043903150018385,1.0,7/27,12.33%,FGFR4;PDGFRB;SMOC2;FGF2;RGCC;TERF2;NIBAN2
prerank,cranial nerve development (GO:0021545),0.46175854096613134,0.9694539950382082,0.5128205128205128,0.903912904510473,1.0,4/11,21.17%,SALL1;CHD7;CHRNB2;TIFAB
prerank,male gonad development (GO:0008584),0.3699868778957348,0.9692483478496572,0.5094614264919942,0.903788883699802,1.0,5/34,6.59%,AR;KIT;WNT4;LHCGR;NR5A1
prerank,protein localization to chromatin (GO:0071168),-0.355570805386522,-0.9686002308191497,0.48525469168900803,0.8842443671840015,1.0,10/18,28.23%,ESR1;TASOR;MCM8;LRWD1;SGF29;MSH2;RAD21;RUVBL2;PIH1D1;PLK1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.3646107057873078,0.9683595126353332,0.5244956772334294,0.9052413811692473,1.0,5/33,6.81%,RUNX1;IL34;CSF1;ZFP36L1;IL12B
prerank,dendrite morphogenesis (GO:0048813),0.3607759737069357,0.9682046955223603,0.5035765379113019,0.9049882065161741,1.0,8/35,14.00%,PHACTR1;FARP1;DOCK10;CDC42;EPHB2;EPHB3;PTEN;DLG4
prerank,mRNA stabilization (GO:0048255),0.3615456287278876,0.9681571087920323,0.5315068493150685,0.9044717354881112,1.0,14/40,22.89%,GDNF;TENT5A;AXIN2;VIP;TENT5D;LARP1;MAPKAPK2;SYNCRIP;HNRNPC;HNRNPU;TIRAP;NOCT;MYD88;IGF2BP1
prerank,cellular sodium ion homeostasis (GO:0006883),0.4261799533486799,0.968129685623949,0.5066445182724253,0.9039153375341554,1.0,3/15,6.94%,SLC8A1;ATP1A2;ATP1B2
prerank,maturation of SSU-rRNA (GO:0030490),-0.2998507122295553,-0.9679349204264913,0.4759036144578313,0.88480002115534,1.0,9/34,21.19%,RPS14;RPS19;RIOK1;UTP4;LSM6;SNU13;RRP36;HELB;WDR46
prerank,regulation of metal ion transport (GO:0010959),0.4240561436114959,0.9677655842051522,0.5106732348111659,0.9041033408068919,1.0,4/16,9.32%,BCL2;STIM1;SLC30A10;CAMK2B
prerank,positive regulation of developmental growth (GO:0048639),-0.2703433035572788,-0.967520922164961,0.5095785440613027,0.8846440484062669,1.0,8/49,7.82%,SMURF1;SEMA7A;RIMS1;NGF;NEDD4L;RIMS2;SYT1;ITSN2
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.34194741878404755,-0.9674893622378905,0.4890710382513661,0.8834494913278832,1.0,8/20,26.09%,FAR2;PPT1;HSD17B8;PPT2;ACSL3;ACACA;SCD5;CBR4
prerank,regulation of dendrite morphogenesis (GO:0048814),0.3708067381942801,0.9674448521807286,0.5083969465648855,0.9042539985835403,1.0,5/32,5.70%,HECW2;OBSL1;NEDD4;RAPGEF2;CUX2
prerank,apoptotic mitochondrial changes (GO:0008637),-0.299313949186198,-0.9672271585264636,0.5360501567398119,0.8829077023399918,1.0,13/32,23.99%,ERBB4;HK2;BBC3;BCL2L1;ATG3;BAK1;BIK;CLU;NDUFS1;FIS1;GGCT;SOD2;CCAR2
prerank,cellular response to hypoxia (GO:0071456),0.30242111026924956,0.9671083392838506,0.5254437869822485,0.9044191328759815,1.0,11/126,7.38%,PTGIS;RORA;SLC8A3;MT3;PSME4;SFRP1;CPEB1;EPAS1;ZFP36L1;NDRG1;SIRT2
prerank,regulation of rRNA processing (GO:2000232),0.4207424034446762,0.9670897818926236,0.49658703071672355,0.9038419443228493,1.0,5/16,13.25%,BUD23;KAT2B;DIMT1;WDR43;TRMT112
prerank,nitric oxide metabolic process (GO:0046209),-0.36797728376734734,-0.9670114745468035,0.5150753768844221,0.8822308151309369,1.0,5/14,10.72%,NOS3;GCH1;NOS1;DDAH2;SPR
prerank,regulation of cell projection organization (GO:0031344),0.42843091900297287,0.9669878735742593,0.502495840266223,0.90343733017378,1.0,4/13,13.27%,MACF1;CCL19;SPRY2;NTNG2
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3005009289936199,-0.9668908608736511,0.5030864197530864,0.8812745987626424,1.0,19/34,22.00%,SEMA6A;KDR;NOTCH1;RAMP2;MT1G;FLT4;GAB1;VEGFA;PIK3CA;ERN1;DLL4;FLT1;VEGFC;ITGB1BP1;ANXA1;EGR3;DAB2IP;MAP2K3;VEGFD
prerank,acylglycerol biosynthetic process (GO:0046463),0.3887355391368431,0.9668900601452135,0.5046728971962616,0.903035366389625,1.0,7/23,19.50%,AGMO;PLA2G4A;LPGAT1;MOGAT3;DGAT2;GK;LPIN3
prerank,neuron maturation (GO:0042551),-0.35858186453058954,-0.9666354262274593,0.4934725848563969,0.8807215613583005,1.0,8/18,22.38%,ADGRB3;B4GALT5;SCARF1;APP;ANKS1A;SRRM4;LGI4;RND1
prerank,membrane depolarization (GO:0051899),-0.30174593588991033,-0.9662645844216912,0.5193548387096775,0.8804658419488892,1.0,6/32,7.82%,CAV1;SCN1A;YWHAH;P2RX7;SCN3A;SCN2A
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.4433620571308466,0.9660806493102677,0.5043630017452007,0.9042880214365981,1.0,4/12,18.53%,CHAMP1;CENPC;SEH1L;BOD1
prerank,nitric oxide biosynthetic process (GO:0006809),-0.37366943552840104,-0.9659298646309941,0.4975369458128079,0.8801068676142219,1.0,5/13,10.72%,NOS3;GCH1;NOS1;DDAH2;SPR
prerank,negative regulation of cell growth (GO:0030308),0.3057033430018641,0.9655662316842807,0.5456674473067916,0.9048943680166728,1.0,26/121,13.03%,GJA1;ENPP1;SMAD3;TSPYL2;MT3;SFRP1;PTPRS;BCL6;APBB2;PML;ULK2;SPHK2;STK11;RBBP7;SLIT3;FGF13;RNF6;DDX3X;JADE1;CGRRF1;ST7L;NME6;CDA;SIPA1;ACVR1B;MUL1
prerank,insulin receptor signaling pathway (GO:0008286),0.3269989123015476,0.9653825798821019,0.5150753768844221,0.904685126724021,1.0,9/69,12.56%,ATP6V0A4;IGF2;PIK3R1;PHIP;FOXC2;ZNF106;ATP6V1E1;RHOQ;INSR
prerank,copper ion transport (GO:0006825),0.46122152189884663,0.9651084847473298,0.5035335689045937,0.9047301739006528,1.0,2/11,6.48%,STEAP3;SLC11A2
prerank,response to tumor necrosis factor (GO:0034612),0.31316239023028336,0.9650309413146413,0.5341772151898734,0.9043168797879447,1.0,10/91,8.19%,ADAMTS12;PID1;CCL19;SFRP1;CXCL16;ZFP36L1;CCL4;NFE2L2;NR1D1;AFF3
prerank,histone H4 deacetylation (GO:0070933),0.461403210190105,0.9649882656091079,0.5166374781085814,0.9038068606342533,1.0,6/10,25.04%,SIRT2;HDAC8;REST;HDAC4;SMARCAD1;HDAC1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.31098025659666045,0.9646181194106028,0.5469336670838548,0.9040850622098592,1.0,13/91,9.63%,NRP1;PLD1;SLC30A8;ATP9A;SRC;LRRK2;RAB25;MAP2K1;STON1;RNF139;PICALM;SNX12;ITGAV
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.4336138371776575,0.9638217669414922,0.5104529616724739,0.9053552866097453,1.0,6/13,12.49%,TGFBR3;BMPR1A;FGFR2;RBPJ;FGF2;GLI1
prerank,regulation of gene silencing by RNA (GO:0060966),0.3366064197348292,0.9635965797647233,0.5054054054054054,0.9046651185301416,1.0,7/50,11.58%,POLR2D;NUP107;NUP42;TNRC6A;POLR2C;NUP98;RAE1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.3366064197348292,0.9635965797647233,0.5054054054054054,0.9046651185301416,1.0,7/50,11.58%,POLR2D;NUP107;NUP42;TNRC6A;POLR2C;NUP98;RAE1
prerank,negative regulation of DNA recombination (GO:0045910),0.34800873503618684,0.9634305583316312,0.5131761442441054,0.9044329373973755,1.0,8/43,18.80%,POLR2D;POLR2C;TERF2;RTEL1;SHLD3;SMCHD1;ATRX;POLR2L
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.42175609947179704,0.9633991307899448,0.5226130653266332,0.9038792496532618,1.0,3/17,6.80%,ROCK2;CDH5;VCL
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.44665828306335315,0.9627626754940011,0.5267702936096719,0.9047206264841718,1.0,4/13,17.39%,PLA2R1;SPRED3;SPRED1;ATM
prerank,positive regulation of programmed cell death (GO:0043068),0.284455195343325,0.9612995587268897,0.5840336134453782,0.9075244138920072,1.0,52/272,16.02%,STK17B;DAPK2;DAPK1;OLFM1;PLEKHG2;GADD45B;TIAM2;PHLDA1;MOAP1;SOS2;FGD1;PDCD5;NEUROD1;ING3;RARG;SFRP1;FGD4;MAP3K20;CYP1B1;BCL6;LRRK2;ARHGEF17;ING5;SPHK2;ARHGEF18;STK4;BCL2L11;ARHGEF11;BMP2;AIFM1;FOXA1;APH1B;DDX3X;IGFBP3;SPDEF;ADAMTSL4;FGD3;REST;PLEKHN1;PAWR;IFIT2;AKAP13;MTCH2;MTCH1;BMP4;SUDS3;SFRP4;RBM5;NLRC4;ARHGEF19;CASP9;TRIO
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.443226088026714,0.9612505778245747,0.5092436974789916,0.9070139552312751,1.0,5/13,21.73%,IRAK2;TNIP2;PIK3R4;EPG5;MYD88
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.38902716436477824,-0.9611628508298764,0.5061728395061729,0.8920029937712896,1.0,3/12,3.67%,PTPRJ;APOD;CBL
prerank,carnitine metabolic process (GO:0009437),0.4424824792781886,0.9609847578638109,0.5072463768115942,0.9070170169766956,1.0,7/12,30.21%,CPT1C;BBOX1;CPT1A;ACADM;CPT2;CPT1B;CRAT
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3763633585843176,0.9609262564065725,0.5107361963190185,0.9065324286134461,1.0,13/26,20.59%,EGFR;MTBP;DDX3X;RGCC;KMT2E;UBE2E2;AKT1;ADAMTS1;TFDP1;CDK10;LSM10;PLCB1;CCND2
prerank,positive regulation of protein catabolic process (GO:0045732),0.3138837434272612,0.9607047166530325,0.527180783817952,0.9064282873018912,1.0,16/84,15.21%,SH3D19;HECW2;DACT1;NKD1;APOE;NEDD4;SMURF2;VIP;SNX33;PRKN;ITCH;ADRA2A;SNX9;PLK2;HACE1;HUWE1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.27499605856074505,0.9604760916031334,0.5863125638406538,0.9063229098816467,1.0,85/417,16.68%,TCF7L2;RUNX1T1;ATXN1;NR2F2;SALL1;GLI3;ARID5B;ZEB1;NKX2-1;ARID4A;PRDM5;WNT4;FOXP2;ASCL1;RBFOX2;GAS6;RUNX2;LBH;MIDEAS;TLE1;IKZF4;SMURF2;IRF1;ZIC2;PRICKLE1;MT3;ZHX2;SFRP1;TBX3;BCL6;DKK3;USP47;BCOR;CBX3;ATOH8;PML;CEBPA;MBD2;SIRT2;ZBTB38;SMARCC2;NR1D1;RBPJ;NCOR1;ZMYND15;MTA3;SCML2;BMP2;ZBTB4;CBY1;NONO;EIF4A2;HEXIM2;GLIS2;PBXIP1;ZKSCAN3;NR1D2;MBD1;KDM5C;NCOR2;L3MBTL1;BHLHE41;REST;NIBAN2;PDCD4;BTRC;ZNF318;L3MBTL2;HDAC4;ZNF148;ZNF219;TWIST2;YAF2;GATA6;BMP4;SUDS3;FOXK2;CDKN1C;PSPC1;RIOX1;CBX5;SCMH1;COPS2;ZNF423;ATF5
prerank,protein tetramerization (GO:0051262),-0.2540388410521078,-0.9601214070957418,0.5889830508474576,0.8936111569342959,1.0,26/67,26.42%,KCNJ2;B2M;GBP5;GRIN2B;CPSF7;OSBPL2;ACOT13;ALDOA;HSD17B8;HOMER1;AQP4;APIP;ALDH9A1;UPB1;CUTC;ACACB;GRIN1;HCN1;KCNC1;SOD2;ALDH1A3;ACACA;SHMT1;PKD2L1;CBR4;CPSF6
prerank,cellular response to cAMP (GO:0071320),-0.3055902598128373,-0.959693007589383,0.5313432835820896,0.8935332392122965,1.0,8/30,13.10%,RAP1A;PDE2A;KCNQ1;AKAP6;RAP1B;INPP5K;SLC26A6;CFTR
prerank,transepithelial transport (GO:0070633),0.4292972485148124,0.9593533886314264,0.5249169435215947,0.9083928138231655,1.0,1/15,0.18%,SLC1A3
prerank,genitalia development (GO:0048806),0.4340155539103464,0.9589690782628794,0.5,0.9087120368381528,1.0,5/12,21.17%,TBX3;LHCGR;SHH;CHD7;TIFAB
prerank,plasma membrane organization (GO:0007009),-0.2648998173333565,-0.9587327539233113,0.5546558704453441,0.8949499380947682,1.0,15/61,13.60%,FNBP1L;CAVIN2;ANK3;AHNAK2;DYSF;SPTBN1;P2RX7;BIN3;PACSIN2;OSBPL2;DEGS1;UGCG;NSF;PACSIN1;ARV1
prerank,negative regulation of viral life cycle (GO:1903901),0.41084495038198543,0.9586865315841013,0.5081699346405228,0.9087586159889252,1.0,1/15,1.20%,GSN
prerank,neural tube development (GO:0021915),0.41630569484616964,0.9585572219259615,0.5067796610169492,0.9084348736038369,1.0,2/15,6.07%,DACT1;ALDH1A2
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.38675969027103907,-0.958497919733304,0.5142857142857142,0.8943830138950983,1.0,4/13,6.98%,TMSB4X;NOS3;NOS1;PPARGC1A
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.36314180546129654,0.9582502400298224,0.5140740740740741,0.9085522838227093,1.0,5/33,8.37%,SERPINE1;LYN;EPHA8;CYP1B1;FOXC2
prerank,positive regulation of macroautophagy (GO:0016239),0.34360077924487287,0.9577871376049881,0.5348189415041783,0.909000876205982,1.0,15/48,19.61%,DCN;OPTN;PRKAA2;TBK1;UVRAG;LARP1;VDAC1;RAB3GAP1;TSC2;SESN2;PIP4K2C;VPS13D;WAC;HTT;GPSM1
prerank,regulation of T cell migration (GO:2000404),-0.34030241990232896,-0.9577779034100301,0.5341772151898734,0.895049419131457,1.0,2/18,3.35%,LRCH1;APOD
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.23109156588105045,-0.9577429079818325,0.5508982035928144,0.8938895542032711,1.0,21/113,11.48%,MPP7;UNC13B;FNIP2;PIEZO1;ESR1;TFRC;WARS1;RASIP1;FAF1;RBX1;GBP5;RPS3;MMP1;RAP1B;TAL1;VEGFA;GTF2H1;DDB2;SKAP1;PLEK;TGFB1
prerank,plasma membrane repair (GO:0001778),-0.3816752576299099,-0.9576318075842178,0.5048543689320388,0.8929591457503858,1.0,2/13,4.08%,AHNAK2;DYSF
prerank,atrioventricular valve morphogenesis (GO:0003181),0.4086325548109262,0.9573435443283531,0.5319148936170213,0.9094214402748138,1.0,5/19,10.12%,BMPR1A;OLFM1;ACVR1;BMP2;SLIT3
prerank,nuclear body organization (GO:0030575),0.4427860910436422,0.9572825392337597,0.49382716049382713,0.9089487777358503,1.0,5/12,17.95%,PML;USPL1;SERBP1;ETS1;DYRK3
prerank,Rac protein signal transduction (GO:0016601),0.4009727484220913,0.9572088181521887,0.524451939291737,0.9085123535662704,1.0,1/18,0.70%,RHOH
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.4012116965974256,0.9570252990727132,0.5235109717868338,0.9083289714579114,1.0,6/18,14.90%,MAP2K1;NCOR1;EGFR;NCOR2;MYCN;BMP4
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.44774723346717604,0.9569353459389441,0.5121107266435986,0.9079503003504504,1.0,2/12,8.52%,PIK3R1;BCL2L11
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.3168575757693247,-0.9568705360069623,0.48563218390804597,0.8937082426404445,1.0,10/27,25.45%,PDE4D;CAMK2D;NOS1;CALM1;HPCA;AHNAK;CACNB3;FKBP1A;PLN;CALM2
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.4262176738383711,0.9568160007532336,0.5218855218855218,0.9076042515176914,1.0,4/13,13.84%,GAS6;AXL;TSLP;TAF9
prerank,ear morphogenesis (GO:0042471),0.39863634370382445,0.9564211683445334,0.5207296849087893,0.9079127648923728,1.0,4/20,8.62%,ZIC1;FGFR2;OSR1;EPHB2
prerank,positive regulation of lipid kinase activity (GO:0090218),0.36986060404017035,0.9561809417792323,0.515527950310559,0.9078926704261687,1.0,5/29,3.81%,EPHA8;KIT;PDGFRA;PDGFRB;CCL19
prerank,response to alcohol (GO:0097305),0.38155556468175916,0.9560072092875853,0.5248868778280543,0.9077185039206137,1.0,6/27,10.12%,TGFBR3;TGFBR1;CCL19;HSD3B2;DRD3;SLIT3
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.4023152843500061,-0.9558727281074492,0.537712895377129,0.8939320015519661,1.0,5/11,28.73%,PTK2B;STAT5A;JAK3;IL2RG;SHC1
prerank,cellular response to interleukin-2 (GO:0071352),-0.4023152843500061,-0.9558727281074492,0.537712895377129,0.8939320015519661,1.0,5/11,28.73%,PTK2B;STAT5A;JAK3;IL2RG;SHC1
prerank,regulation of necroptotic process (GO:0060544),0.381462471738634,0.9555226444395366,0.516566265060241,0.9082457280348252,1.0,3/23,3.51%,OGT;MLKL;CFLAR
prerank,regulation of stem cell differentiation (GO:2000736),0.3056600749683612,0.9551141829998557,0.5364647713226205,0.908575452787025,1.0,22/89,20.65%,GDNF;RUNX1;SP7;BMPR1A;YAP1;PDGFRA;PSME4;SETD1A;NSUN2;ITCH;KMT2A;TCF12;PSMB5;PSMC2;METTL3;PSMD1;PSMD4;PSME3;YTHDF2;HNRNPU;ZFP36L2;PSMA3
prerank,regulation of anoikis (GO:2000209),0.39430647727404927,0.9548820936451181,0.5293185419968305,0.9085025704398201,1.0,4/19,6.83%,BCL2;TLE1;SRC;SIK1
prerank,rRNA modification (GO:0000154),0.3950149227636516,0.9547320071185306,0.5296,0.9082556994501124,1.0,5/21,15.17%,BUD23;DIMT1;FTSJ3;TRMT112;NSUN4
prerank,positive regulation of leukocyte migration (GO:0002687),0.37625554520116133,0.9546330988646875,0.5229357798165137,0.9078786820924286,1.0,4/27,14.21%,IL6R;CSF1;MIA3;MDK
prerank,regulation of neuron death (GO:1901214),-0.2470652158356105,-0.9545218075945027,0.5577889447236181,0.8964963547826515,1.0,12/82,10.38%,GRID2;MEF2C;CD34;EGLN3;EPHB1;SORL1;CDK5;GRIN2B;PPARGC1A;EGLN2;DDIT4;DCC
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.39055215051451986,-0.954331536081369,0.5263157894736842,0.8957621035512139,1.0,3/12,11.48%,ESR1;ELAVL1;TGFB1
prerank,chondroitin sulfate catabolic process (GO:0030207),0.44046854125768625,0.9542308744715358,0.534923339011925,0.9082430832323798,1.0,3/13,8.05%,DCN;BGN;CSPG5
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.30601666326034593,-0.954163913764527,0.5263157894736842,0.8949687370996486,1.0,4/31,3.78%,CDK6;NOTCH1;RORB;LRP5
prerank,negative regulation of synaptic transmission (GO:0050805),0.38113107083112796,0.9541617712500485,0.5219435736677116,0.9077824252487449,1.0,8/23,14.70%,SLC24A1;LRRK2;CBLN1;DRD3;STXBP1;SYT11;PTEN;PLK2
prerank,regulation of interferon-gamma production (GO:0032649),-0.2512868405994057,-0.9540768346043699,0.5550660792951542,0.8939047465054689,1.0,15/71,19.91%,PDE4D;PDE4B;SLC7A5;CYRIB;SIRPA;SCRIB;PTPN22;INHA;INHBA;ZFPM1;TLR4;TXK;CD276;C1QBP;FZD5
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.2735211043505596,-0.9537983401252151,0.5652173913043478,0.893385932204335,1.0,20/50,28.68%,CAV1;IVNS1ABP;NXN;RPS3;CRY1;TAF1;MINAR1;TNFAIP3;USP4;N4BP1;VPS28;PRMT3;PRR7;ADGRB1;UBXN1;CAMLG;PRKCG;ISG15;BAG2;U2AF2
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.346664302936012,-0.9536511581252499,0.5222772277227723,0.8925301547980811,1.0,11/16,43.71%,CADM1;PVR;RAET1E;NECTIN2;SLAMF6;CD226;CRTAM;CD160;KLRK1;LAMP1;AP1G1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.33655702677131977,0.9535809563917144,0.5166444740346205,0.9085302676264819,1.0,13/50,16.41%,SH3RF1;GAS6;RFFL;MT3;USP47;SRC;DPEP1;DDX3X;YWHAE;NOL3;IGBP1;AKT1;FNIP1
prerank,Notch signaling pathway (GO:0007219),0.33200647158619556,0.9533897424392013,0.526867627785059,0.9084136538984415,1.0,13/59,10.93%,PBX1;GMDS;ASCL1;MAML3;NOTCH2;DTX4;TRAF7;RBPJ;BMP2;KAT2B;ITCH;MIB1;APH1B
prerank,lysosome organization (GO:0007040),0.3533608300766689,0.9531668672218827,0.5149359886201992,0.9083276744431361,1.0,10/36,19.33%,ABCA1;LRRK2;GAA;ZKSCAN3;CLN3;HOOK2;TPCN2;HPS4;TMEM106B;SNAPIN
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.24993251573648928,-0.9526908883458252,0.5804878048780487,0.8938841662941092,1.0,28/78,24.70%,CAV1;RNF144B;CBFA2T3;RNF144A;RBX1;TRIB2;TAF1;GSK3A;HSPBP1;ZYG11B;RAD23A;COP1;RACK1;BBS7;DVL1;RNF14;UBQLN2;CLU;PLK3;DDRGK1;GSK3B;GABARAP;RCHY1;USP5;NUB1;CSNK1D;VCP;DDA1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.36111587036158166,0.9516424507691176,0.5042492917847026,0.9112470119459605,1.0,10/36,11.89%,DCN;NR2F2;SP100;APOE;ANGPT2;ADAMTS9;FGF2;PTPRM;RGCC;DNAJA4
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3152729088437273,0.9515556175151452,0.5552763819095478,0.9108596137006172,1.0,11/76,11.49%,PTGIS;IRAK2;CDK5RAP3;CYP1B1;MTURN;IRAK3;ARRB1;CD200;COMMD1;ITCH;UFL1
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.285284785599086,-0.9513967407357027,0.5664335664335665,0.8961793277396202,1.0,12/40,27.07%,PGLYRP1;RPL39;LBP;GBP4;GBP7;HMGB2;FGR;CHGA;GBP6;PPP1R11;MPEG1;STAB2
prerank,negative regulation of autophagy (GO:0010507),0.32960660164941874,0.9511165442939996,0.5384615384615384,0.9113122555167041,1.0,8/54,10.16%,BCL2;LEPR;NUPR1;MT3;SNRNP70;LRRK2;SIRT2;ZKSCAN3
prerank,negative regulation of binding (GO:0051100),-0.24911760024499133,-0.950951875345971,0.574468085106383,0.8961158612424426,1.0,28/81,21.95%,LEF1;CAV1;ACTB;NFKBIA;KDM1A;SORL1;BTAF1;CTNNBIP1;JAK2;DISC1;GTF2F1;MAPK8;RALB;JUN;CARD16;PPP1CA;TFAP4;ZFPM1;RSF1;RACK1;CDKN1A;DVL1;EFHB;ITGB1BP1;HMGA2;ROCK1;STYX;GSK3B
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.29736005041702035,-0.9508039356694065,0.5015576323987538,0.8952300828443377,1.0,13/32,19.53%,KDR;THBS1;NOTCH1;JCAD;GATA2;VEGFA;KLF4;PTGS2;MAP3K3;DLL4;ITGB1BP1;ANXA1;PDCD10
prerank,neural crest cell development (GO:0014032),-0.27381852671247714,-0.9507384092870473,0.5331010452961672,0.8941733436627582,1.0,6/44,3.34%,SEMA6D;CDH2;SEMA6A;SEMA7A;ERBB4;TBX1
prerank,negative regulation of cilium assembly (GO:1902018),-0.402644485033399,-0.9505367356366601,0.5062034739454094,0.8934819757346149,1.0,4/12,10.94%,LIMK2;TBC1D30;CEP97;TESK1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.4460485365995692,0.9502581018938018,0.5303292894280762,0.9127275494291025,1.0,2/11,5.50%,NOS1AP;CACNB1
prerank,erythrocyte development (GO:0048821),-0.4104749411450468,-0.9500000707717099,0.5287610619469026,0.8937215255480024,1.0,4/10,24.34%,MED1;ALAS1;ALAS2;DMTN
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.44220627617033365,0.9497103975777409,0.5120689655172413,0.9133741078894992,1.0,2/11,4.33%,LYN;RAPGEF2
prerank,antibacterial humoral response (GO:0019731),0.41445807945256796,0.9496977885101722,0.5143824027072758,0.9127900180677199,1.0,3/16,11.57%,WFDC3;CAMP;RNASE7
prerank,regulation of cell cycle (GO:0051726),0.27848103377692607,0.9494717524152838,0.5938818565400844,0.9127129894676284,1.0,41/271,12.86%,TCF7L2;SMAD3;GRK5;SON;FGFR2;GADD45B;TGFBR1;NUPR1;SND1;NOTCH2;FBXL17;CDK5RAP3;TSPYL2;IRF1;LIN52;SFRP1;PCLAF;TBX3;MAP3K20;APBB2;PML;IL12B;SIK1;SIRT2;MAP2K1;FBXL3;CKS1B;LIN9;TTC28;BMP2;KAT2B;STK11;CDC123;NEK6;L3MBTL1;RGCC;FBXL12;NR4A1;PDCD4;MAP2K6;SIPA1
prerank,negative regulation of B cell proliferation (GO:0030889),0.4556141186563346,0.9494610858973836,0.536178107606679,0.9121321362239135,1.0,1/11,1.77%,LYN
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.3359164150314874,0.9491919952332922,0.5332409972299169,0.9121276847094291,1.0,6/46,8.12%,PLD1;PLA2G4A;GPD1;AGPAT3;DDHD2;PLD2
prerank,ERAD pathway (GO:0036503),0.30687711242198357,0.9490565424808944,0.5357590966122961,0.9118386425393673,1.0,33/83,27.22%,ERLEC1;FAF2;DERL1;UBXN4;DERL3;UBE4B;RNF185;RNF139;ECPAS;PRKN;UGGT2;FOXRED2;RCN3;SELENOS;AMFR;TMUB1;AUP1;TMEM67;ERLIN1;CCDC47;JKAMP;BAG6;WFS1;HSPA5;ATXN3;ERLIN2;OS9;UBE2J2;FBXO2;FBXO17;DNAJB12;DNAJB9;TMUB2
prerank,glycerol metabolic process (GO:0006071),-0.4012349572982674,-0.9488734232385391,0.5266821345707656,0.8956070373720221,1.0,6/10,37.71%,TPI1;TKFC;GOT1;COQ2;PDXP;PGP
prerank,regulation of TOR signaling (GO:0032006),0.3216451462447452,0.9488598376732499,0.5398936170212766,0.9116797489930767,1.0,21/67,20.59%,GAS6;NPRL3;UBR2;RFFL;PRKAA2;ARAF;SLC38A9;TELO2;FBXO9;LAMTOR2;RRAGD;TSC2;ITFG2;NPRL2;GOLPH3;FNIP1;SEH1L;DYRK3;RICTOR;RHEB;MLST8
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.3872683645100271,0.9487921499813923,0.5323854660347551,0.9112045948340355,1.0,4/22,9.49%,LYN;APPL2;NR1D1;RAB7B
prerank,intermediate filament organization (GO:0045109),0.400296155514614,0.9486906008666296,0.510569105691057,0.9108193753175025,1.0,4/17,15.85%,BFSP1;DES;KRT9;EPPK1
prerank,regulation of muscle contraction (GO:0006937),0.37033564313015405,0.9485895817991451,0.5315457413249212,0.9104346656878215,1.0,6/26,10.49%,ATP1A2;TPM1;TNNT1;TNNC1;TNNT3;ANXA6
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.4535835375205203,0.9484912633432135,0.5509838998211091,0.9100504649333119,1.0,2/10,4.45%,PXYLP1;DSE
prerank,pulmonary valve morphogenesis (GO:0003184),0.4069946650410826,0.9481595086149237,0.5201288244766505,0.9101968504257125,1.0,2/17,3.82%,ROBO1;NOTCH2
prerank,regulation of DNA replication (GO:0006275),0.3369999346130225,0.9480939474417052,0.5528571428571428,0.9097383085076326,1.0,10/49,15.20%,GLI2;CCNA2;TSPYL2;NPM2;ZBTB38;EGFR;S100A11;GLI1;EGF;WAPL
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.44402626321441263,0.9480120719281262,0.5401709401709401,0.9093352506179582,1.0,3/11,13.52%,PRKN;REST;P4HB
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.2167837040790428,-0.947697634439959,0.6086956521739131,0.89752479460982,1.0,48/172,18.60%,PIP5K1B;PLCG2;DGKB;INPP5D;BMX;DGKH;PIK3R6;CPNE3;LPCAT1;SLC44A5;MTMR2;INPP4B;PLEKHA3;MFSD2A;INPP5K;PLEKHA1;INPP5F;AGPAT1;PGS1;MTMR9;PIK3R3;PNPLA3;ARF1;PLA2G4C;ETNK1;SACM1L;DGKG;PCTP;DGKQ;CRLS1;PIK3R5;MTMR6;ARF3;MBOAT7;PIK3C2B;PTDSS1;LPCAT3;PIK3CA;RAB4A;AGPAT5;STARD7;PITPNM3;LPCAT2;DGKZ;PCYT1B;INPP5E;SELENOI;SYNJ1
prerank,negative regulation of developmental process (GO:0051093),0.3170449597827468,0.9469518503054503,0.5427841634738186,0.911101678179023,1.0,10/69,9.33%,ROCK2;KANK1;IL17D;NFIB;GAS6;SFRP1;PTPRS;CST3;BMP2;PRKN
prerank,negative regulation of microtubule polymerization (GO:0031115),0.4361347426518719,0.9469123402817493,0.5225694444444444,0.9105866351580304,1.0,2/12,5.69%,EML2;CDH5
prerank,sodium ion homeostasis (GO:0055078),0.3962226534437521,0.9468258851894327,0.5339805825242718,0.9102078604502273,1.0,3/21,6.94%,SLC8A1;ATP1A2;ATP1B2
prerank,protein polymerization (GO:0051258),-0.2650207772540384,-0.9462421005206081,0.6038461538461538,0.900303723737695,1.0,25/55,24.59%,COBL;DIAPH1;SPIRE1;DIAPH3;GPX4;JAK2;WASHC5;UBE2K;MSRB2;FAM107A;TPPP3;TTC17;TRPV4;CASQ2;ARL6;UBE2S;TRIM6;CORO7;PSTPIP1;PREX1;AIF1;CASQ1;CHMP4B;CHMP4A;MID1IP1
prerank,regulation of lipid catabolic process (GO:0050994),-0.3444253650474691,-0.9455115973711714,0.5440414507772021,0.9009725600737257,1.0,2/19,8.61%,PDE3B;ALK
prerank,negative regulation of protein secretion (GO:0050709),0.3502941723733105,0.9454436940841885,0.5586924219910847,0.9128319544702759,1.0,12/38,18.60%,APOE;SFRP1;IL12B;DRD3;CD200;PRKN;ADRA2A;REST;SERGEF;NR1H3;RHBDF2;DPH3
prerank,neurotransmitter transport (GO:0006836),0.3168326480797175,0.9450332601442315,0.5819567979669632,0.913169947691912,1.0,12/73,13.19%,SLC1A3;GLUL;ATP1A2;SLC22A2;STXBP3;CASK;BRSK1;APBA1;SLC29A1;PPFIA3;STXBP1;SLC18A2
prerank,membrane lipid catabolic process (GO:0046466),-0.39219651272663725,-0.9450120173835647,0.5246636771300448,0.9010723954289922,1.0,2/10,3.32%,ENPP2;PPT1
prerank,amino acid transmembrane transport (GO:0003333),0.3367039802394236,0.9447282648152876,0.5418439716312057,0.9132768486224465,1.0,13/45,16.48%,SLC7A11;SLC6A13;SLC22A2;SLC7A13;SFXN2;SLC38A6;SLC22A4;SLC38A9;SLC38A3;SLC7A6;SLC38A10;SLC38A2;SLC16A2
prerank,chromatin assembly (GO:0031497),-0.2855920161236518,-0.9446837631323676,0.5114754098360655,0.9007903738414071,1.0,16/38,29.47%,NAP1L4;SIRT1;NAP1L2;H3-3A;CHAF1A;NAA60;RSF1;HMGB2;NPM1;CDAN1;HMGA2;LIN54;ASF1A;GRWD1;H1-0;NAP1L3
prerank,inner ear morphogenesis (GO:0042472),0.39030980108244273,0.9442199172780403,0.5365079365079365,0.9138599237138556,1.0,4/22,8.62%,ZIC1;FGFR2;TTC39C;EPHB2
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.3967305961252574,0.9440185423903981,0.5308441558441559,0.9137192428329076,1.0,5/18,10.91%,SRPX2;AKT3;FOXC2;FGF2;FGFBP1
prerank,hyaluronan catabolic process (GO:0030214),0.39199829954192295,0.9439430270117158,0.5303776683087028,0.9132959940426183,1.0,3/18,10.17%,CEMIP;LYVE1;FGF2
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.3252316226412689,-0.9437840223055366,0.5414201183431953,0.9019271533153606,1.0,6/23,15.95%,NMT2;FNTA;FNTB;CALM1;PDE6A;METAP2
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.2399942481123937,-0.943253952604978,0.5970149253731343,0.9020862706543912,1.0,23/93,20.20%,PDE4D;CAV1;FNIP2;NGF;BCAR3;TFRC;NOS1;PAK1;HSP90AB1;INPP5K;ATP2B4;VEGFA;DDIT4;TGFB1;NLRP2B;APP;TRIM6;TXN;RACK1;NCK2;CD44;PDCD10;HCLS1
prerank,peptidyl-lysine modification (GO:0018205),0.30126977473840233,0.9423257582414086,0.5705521472392638,0.9163246083603444,1.0,24/99,20.25%,LOXL1;LOX;EYA1;NUP107;P3H3;NUP42;SIRT2;KAT2B;USPL1;TRPM4;BLOC1S1;NUP98;RAE1;HDAC4;SENP6;NUP214;SENP7;SEH1L;KAT5;TPR;SIRT5;SUMO1;AAAS;NSMCE2
prerank,nucleotide-excision repair (GO:0006289),0.3011685501123392,0.9422111868075631,0.5710843373493976,0.916010502037331,1.0,13/101,12.96%,POLR2D;OGG1;LIG4;GTF2H5;CUL4B;POLL;COMMD1;POLR2C;ERCC8;FANCC;MNAT1;GPS1;COPS3
prerank,early endosome to Golgi transport (GO:0034498),0.4372465977488128,0.9421601313180894,0.5444444444444444,0.9155288168891059,1.0,3/11,11.29%,LMAN1;RBSN;TRAPPC10
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.36228965866851376,0.9419246519814709,0.5580029368575624,0.9154631498067578,1.0,9/31,13.49%,STXBP3;SYT9;ADRA2A;CACNA1G;REST;STXBP1;SYT11;SYT12;RAB3GAP1
prerank,lipoprotein biosynthetic process (GO:0042158),0.4410033160058141,0.9418835189065694,0.5403624382207578,0.9149691902153549,1.0,3/11,12.70%,APOE;ATG10;WIPI1
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.34393886091292836,0.9418461381914892,0.532394366197183,0.9144626225017543,1.0,6/41,7.08%,DAGLA;ACSL1;PLA2G4A;CYP1B1;GSTM2;ALOXE3
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.29981941743985085,0.9414840851773822,0.5745992601726264,0.9146679818446242,1.0,15/88,10.09%,SH3D19;DNAJC6;DTNBP1;TXNDC5;MYO1B;GOLGB1;MON2;ARFGEF2;EPS15;ARRB1;AP1G2;COMMD1;BLOC1S1;AP1M1;VPS35L
prerank,protein N-linked glycosylation (GO:0006487),0.3196942376855225,0.9414579222966939,0.5369897959183674,0.9141285189359357,1.0,16/66,13.99%,PGM3;MAN1C1;MOGS;LMAN1;B4GALT1;STT3A;DERL3;DOLPP1;GFPT1;ALG5;UGGT2;ALG11;MGAT3;DDOST;ALG10B;ALG6
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.39480076655538604,0.9413370188373492,0.5258899676375405,0.9138219091914199,1.0,3/19,8.82%,NRP1;SFRP1;MAP4K4
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.39800195855332615,-0.9411705867877378,0.5233853006681515,0.9064199240026414,1.0,3/10,14.14%,PRKG1;RDX;CEACAM1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.3062760718447882,-0.9404135854077073,0.5476190476190477,0.9071820873787484,1.0,9/30,16.53%,ST6GAL1;FUT8;DPM1;UBE2J1;UGGT1;MGAT5;DPM3;RPN1;DPM2
prerank,regulation of response to oxidative stress (GO:1902882),-0.40079853361259676,-0.9399583822870741,0.5271867612293144,0.9071485423761969,1.0,1/11,0.90%,MCTP1
prerank,regulation of actin filament polymerization (GO:0030833),-0.2473984158100481,-0.9393188827889436,0.5911111111111111,0.9076755512742403,1.0,6/69,3.00%,SLIT2;BAIAP2L1;KANK3;ESAM;PTK2B;CYRIB
prerank,peptidyl-arginine modification (GO:0018195),0.40404258497773704,0.9391389782147728,0.5430016863406408,0.9182607528814052,1.0,1/15,2.07%,ART4
prerank,carboxylic acid transport (GO:0046942),0.32796957850754455,0.9388317195826182,0.5411436541143654,0.9183560964773486,1.0,16/55,20.06%,SLC1A5;SLC16A12;SLC13A3;SLC6A9;SLC6A13;SLC38A6;CLN3;SLC16A3;SLC38A3;SLC7A6;SLC38A2;SLC16A2;SLC38A1;SLC25A29;SLC6A12;PSAP
prerank,fatty acid transmembrane transport (GO:1902001),0.39544878270121164,0.9386014119429845,0.5275590551181102,0.9182981721680297,1.0,3/19,5.20%,SLC27A5;PRKAG2;PRKAA2
prerank,negative regulation of myotube differentiation (GO:0010832),-0.36966435751729537,-0.9385580142768272,0.5645161290322581,0.9085185167350364,1.0,2/12,2.63%,NOTCH1;CCN3
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.40201406891752134,0.9385369761416787,0.5287162162162162,0.917828027645023,1.0,6/16,16.72%,GDNF;SALL1;BMP2;FGF2;BMP4;SHH
prerank,potassium ion transmembrane transport (GO:0071805),0.2900327823788709,0.9384620265333766,0.5924657534246576,0.9173980491346845,1.0,13/135,9.28%,SLC1A3;KCNK2;SLC24A3;NALCN;ATP1A2;KCNT2;SLC9A9;SLC24A1;KCNK7;ATP1B2;KCNQ4;SLC9A5;KCNJ14
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.38860304666099243,0.9383384713059151,0.5384615384615384,0.9171069806903315,1.0,4/19,20.08%,APOE;COLQ;RAPSN;CHRNB2
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.26948884688735564,-0.9381991156975866,0.55893536121673,0.9082570907238969,1.0,13/46,15.70%,PITPNA;PPIA;RAP1B;JAK2;MSN;LMNB1;ARF1;PAK2;TYK2;BOLA2;HNRNPA2B1;SNRPA1;RPLP0
prerank,regulation of macrophage activation (GO:0043030),0.36540656342235994,0.9381707260818297,0.5443786982248521,0.9168979303518178,1.0,8/30,17.42%,IL31RA;MYO18A;CEBPA;TLR6;CD200;TNIP2;NR1H3;PJA2
prerank,aromatic amino acid family catabolic process (GO:0009074),0.41450750969120065,0.9379009248152257,0.541871921182266,0.9168937770822492,1.0,2/15,6.78%,TDO2;KYNU
prerank,dendrite self-avoidance (GO:0070593),-0.3505283793590769,-0.9372145311123323,0.5409429280397022,0.9096328551292509,1.0,5/16,10.50%,BSG;CNTN4;CNTN6;ROBO4;EMB
prerank,response to reactive oxygen species (GO:0000302),-0.26075490806129187,-0.9368761582872076,0.5735849056603773,0.9093535798636551,1.0,21/54,22.43%,APOD;PTPRK;PXN;RPS3;HYAL1;MAPK8;SIRT1;JUN;APTX;MAPK3;HIF1A;PTPRN;ADAM9;GPX1;CAT;PDCD10;PLK3;CHUK;PRDX5;MAPK1;SOD2
prerank,vesicle transport along microtubule (GO:0047496),-0.3209636432422802,-0.9366883555464536,0.5212765957446809,0.9086061311328342,1.0,8/23,21.94%,KIFAP3;KIF13A;PAFAH1B1;KIF1A;BICDL1;TRAK2;KIF5A;HAP1
prerank,negative regulation of kinase activity (GO:0033673),0.3175145497214364,0.936185465541552,0.5421052631578948,0.9201174632212579,1.0,4/62,3.25%,PDPK1;PPM1E;DTNBP1;PRKAG2
prerank,fatty acid transport (GO:0015908),0.39452168222814477,0.9361003853228983,0.5526315789473685,0.9197031648615029,1.0,2/17,3.47%,ACSL1;APOE
prerank,regulation of intracellular signal transduction (GO:1902531),0.2678838827483815,0.9360533152533319,0.665650406504065,0.9192092879300058,1.0,65/420,12.50%,DAPK2;PDPK1;NRK;RHOH;PTPN13;LYN;ARHGAP6;SYDE2;DLC1;RHOD;WWC2;ARHGAP28;PLEKHG2;ARHGAP18;OPTN;PRKAG2;TIAM2;LBH;AKAP7;SOS2;ARHGAP29;FGD1;RFFL;ARHGAP21;FGD4;ARHGAP19;PRKAA2;ARHGAP32;ARHGAP10;CDC42;NUAK1;PML;LRRK2;FAM13A;ARHGEF17;ING5;SPHK2;GRM2;ARHGEF18;PPP1R13L;ARAF;ARHGAP35;MTA2;NTRK3;STK4;ARHGAP9;EGFR;ARHGEF11;MAP4K4;SYDE1;ITGAV;TELO2;STK11;RHOT1;RBBP7;TAOK3;CASTOR2;L3MBTL1;FBXO9;UFL1;FGD3;RHOQ;RCN3;ARHGAP5;FAM13B
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.34722367555233064,0.9355525625537333,0.5611814345991561,0.919761467972215,1.0,10/37,16.57%,ADCY7;IL17D;APPL2;TLR6;CARD9;F2;PDCD4;ABCD2;CHID1;PLD4
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.38458281410337697,0.9350117333298062,0.5501618122977346,0.9203706469555345,1.0,6/22,16.49%,MAN1C1;RNF185;RNF139;UGGT2;AMFR;MAN1A2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.38991135209693584,0.9348634315066988,0.5568,0.9201007906772285,1.0,2/20,3.24%,GRK3;MGRN1
prerank,aggrephagy (GO:0035973),0.36373652532334255,0.9345926816668959,0.5450310559006211,0.920145021028605,1.0,5/27,12.47%,DYNLL1;DYNC1H1;WDR81;PRKN;DYNC1I2
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.33173351120244987,-0.934307933068635,0.5668449197860963,0.913756241948096,1.0,9/21,20.82%,SLIT2;CYRIB;TGFB2;ARHGAP25;SPRY4;CD2AP;SH3BP1;ARHGAP12;DAB2IP
prerank,cardiac myofibril assembly (GO:0055003),0.4008486772271226,0.9340655448965841,0.5264054514480409,0.9208195379559773,1.0,3/15,3.57%,OBSL1;PDGFRA;PDGFRB
prerank,peptidyl-serine modification (GO:0018209),0.2827619995243774,0.9340198606196245,0.6017997750281214,0.9203458226311936,1.0,43/166,21.36%,PDPK1;ROCK2;CAMK1D;DMPK;MARK1;GAS6;TGFBR1;HPF1;ULK2;LRRK2;AKT3;EIF2AK3;BRSK1;MAST2;STK4;VRK3;TTBK1;NEK6;IKBKE;TBK1;TLK1;WNK1;MAP3K13;MARK2;PLK2;DYRK1A;DYRK1B;MAPKAPK2;AKT1;ATM;CDC7;DYRK3;PRKCI;CSNK1A1;PRKCA;PRKACA;RICTOR;CLSPN;SGK3;SGK2;PKN2;AURKA;PRKCB
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.3576882425999415,-0.9339874890748092,0.5647921760391198,0.9134059278421912,1.0,6/15,28.81%,SCYL2;HIP1R;UBQLN2;SNAP91;UNC119;BMP2K
prerank,neutrophil activation (GO:0042119),-0.38575501879556295,-0.933942121305072,0.568019093078759,0.9123103371407002,1.0,3/12,19.48%,IL15;FCER1G;PREX1
prerank,regulation of T cell mediated immunity (GO:0002709),0.44774143205017725,0.9338820979878721,0.5738963531669866,0.9200779857494393,1.0,2/10,9.41%,ZBTB1;TRPM4
prerank,chromosome condensation (GO:0030261),-0.2797032926359707,-0.9336455405392138,0.5689655172413793,0.911886033662721,1.0,23/36,40.07%,MCPH1;NCAPD3;SMC4;TOP2A;GPER1;KMT5A;NCAPH;NCAPG;TTN;PLK1;SET;CDK1;H1-0;BANF2;NCAPG2;ERN2;NUSAP1;DFFB;SMC2;CSNK2A1;CSNK2A2;RB1;NCAPD2
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.2633781785765204,-0.9336085518819313,0.5302491103202847,0.9107485719675206,1.0,6/47,4.35%,ZBTB16;CREB1;SIX1;PPARD;LRP5;CMKLR1
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.38382165868639934,0.9334746700718319,0.5750798722044729,0.9204141406625946,1.0,6/20,20.33%,WNT4;SIK1;NCOR1;CDA;GCK;BCKDK
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.3900611849963166,-0.9333247005533306,0.5376106194690266,0.9103144974823305,1.0,4/10,23.23%,SORL1;DNAJB6;SACS;DNAJB1
prerank,pulmonary valve development (GO:0003177),0.3953560816578985,0.9331405568242527,0.5500794912559619,0.9205892550300838,1.0,2/18,3.82%,ROBO1;NOTCH2
prerank,regulation of cell development (GO:0060284),0.355797404168738,0.9330982838939142,0.5557142857142857,0.9200888516100696,1.0,11/36,19.98%,ASCL1;YAP1;NOTCH2;HES7;ADGRA2;BHLHE41;AKT1;CX3CL1;WNT3;RHEB;YTHDF2
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.33044092647113504,-0.932954886086313,0.5587467362924282,0.9100814137394988,1.0,8/20,23.37%,PPIA;FKBP5;PPIG;PPID;PPIL1;FKBP1A;PPIB;PPIL6
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.28744616545582735,0.9329494207846293,0.5864485981308412,0.919832301542119,1.0,21/124,10.76%,GDNF;LYN;TPM1;EPHA8;DTNBP1;APOE;WDPCP;NEDD4;RAPGEF2;CDK16;LRP12;LIMA1;ATXN10;ATP1B2;RAB25;CARMIL1;ARFIP2;BLOC1S1;RYK;PTPRM;MANF
prerank,negative regulation of interleukin-6 production (GO:0032715),0.37211492055257134,0.9326524830305892,0.5368916797488226,0.9199103611648984,1.0,7/27,17.52%,GAS6;IRAK3;ARRB1;CD200;SELENOS;SYT11;CX3CL1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.2712784667501362,0.9326283776387448,0.6252631578947369,0.9193631691921456,1.0,41/291,13.54%,EPHA3;RORA;ROCK2;PID1;DAPK1;SERPINE1;LYN;TPM1;WNT8B;PDGFRA;WNT6;RAPGEF2;MTR;MT3;AXL;SFRP1;PTK7;IGFBP5;CPEB1;PDE3A;ZFP36L1;WNT5B;CPEB3;DPEP1;ERCC6L2;NR1D1;EGFR;RAPGEF1;SLC38A9;LAMTOR2;TNIP2;RRAGD;SLC5A5;IMPACT;SELENOS;PDCD4;PAF1;CD14;CHMP5;NCOA3;CXCL13
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.40828150732940716,-0.9324208617476516,0.5829493087557603,0.9102973253654489,1.0,1/10,0.97%,ST6GAL1
prerank,synapse organization (GO:0050808),0.293571294250888,0.9323813101371448,0.5669383003492433,0.9193652883066782,1.0,17/125,8.46%,GPC6;PDZRN3;FARP1;PPFIBP2;SLC8A3;OBSL1;UNC13C;CAST;NEDD4;PTPRS;MUSK;CACNB1;CDC42;APBB2;LRRK2;CBLN1;DSCAM
prerank,regulation of oxidative phosphorylation (GO:0002082),0.40938369858045487,0.9319937013561199,0.5657237936772047,0.9196399071733118,1.0,2/16,5.33%,NUPR1;COX7A2
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.34892793727802157,-0.9316577135861256,0.5251989389920424,0.9110575002101368,1.0,5/16,18.79%,PIGP;PIGB;PIGL;DPM2;PIGV
prerank,regulation of actin nucleation (GO:0051125),0.4277402158040482,0.9314066558862651,0.575,0.9203710866997478,1.0,2/12,9.06%,GSN;ARFIP2
prerank,regulation of protein kinase A signaling (GO:0010738),0.377404740488952,0.9313709071198363,0.5276872964169381,0.9198685202887786,1.0,3/20,6.60%,ADGRV1;AKAP7;LRRK2
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.3795572540501487,-0.9313422580309481,0.5379310344827586,0.9107054545812517,1.0,2/11,5.91%,CAV1;PTPRT
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.42150719144130294,0.9308438799892004,0.5514834205933682,0.9204499699589165,1.0,7/12,21.84%,NEDD4;IFI27;NUP214;BMP4;TPR;AAAS;RBM4
prerank,digestive tract morphogenesis (GO:0048546),0.4205401889843493,0.9308333009000948,0.5380622837370242,0.9198824775092568,1.0,6/14,18.21%,FGFR2;PDGFRA;EPHB3;GLI1;NIPBL;SOX11
prerank,regulation of dendrite development (GO:0050773),0.3447826935153038,0.9308216932463289,0.547887323943662,0.9193131176143732,1.0,4/37,4.27%,CAMK1D;HECW2;MARK1;NEDD4
prerank,regulation of tube diameter (GO:0035296),0.42498743060624533,0.9306776562743327,0.5580204778156996,0.9184562806062909,1.0,2/13,6.91%,ROCK2;AGTR1
prerank,vascular process in circulatory system (GO:0003018),0.42498743060624533,0.9306776562743327,0.5580204778156996,0.9184562806062909,1.0,2/13,6.91%,ROCK2;AGTR1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.39812601012302745,-0.930151483490016,0.5754923413566739,0.9125653391533911,1.0,5/10,25.87%,CALM1;CALM3;CBARP;FMR1;CRHR1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.3427215986872415,-0.9296676024646704,0.535,0.9125551024465618,1.0,6/15,21.94%,NGF;DDIT4;BCAR1;ZFYVE27;NTRK2;HAP1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.32508056508862426,0.9294453368699385,0.5685752330226365,0.9206569733707404,1.0,11/54,15.96%,GPC6;HSPG2;PXYLP1;HS6ST1;SDC1;EXT1;NDST1;GALNT5;SDC4;GNS;EXT2
prerank,monocarboxylic acid catabolic process (GO:0072329),0.38974821209358756,0.92939647232943,0.5562805872756933,0.9201771604240819,1.0,7/21,23.13%,CYP26B1;HOGA1;NUDT19;LPIN3;LPIN2;FAH;LDHD
prerank,negative regulation of catalytic activity (GO:0043086),-0.3070396442588016,-0.929165989259109,0.5457317073170732,0.9126556003210736,1.0,5/24,11.74%,NOTCH1;NOSIP;NOS1;TMBIM1;SIRT1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.4036703708837923,0.9282160132354914,0.5432525951557093,0.9222059342814298,1.0,9/14,26.43%,CHKB;ETNK2;LPIN3;CEPT1;LPIN2;PCYT2;SLC27A1;PISD;LPIN1
prerank,phosphatidic acid metabolic process (GO:0046473),0.32681492984326166,0.9277441336367708,0.5649171270718232,0.9227002690301109,1.0,6/48,8.12%,PLD1;PLA2G4A;GPD1;AGPAT3;DDHD2;PLD2
prerank,homotypic cell-cell adhesion (GO:0034109),0.34538374350207984,0.9277408741865805,0.5590778097982709,0.9221193899111058,1.0,11/39,15.82%,PLPP3;GNAS;PDGFRA;MYL12A;TLN1;STXBP3;VCL;ITGB3;STXBP1;FLNA;FIBP
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.34277881302047514,0.9275906847894931,0.5585585585585585,0.921875932288693,1.0,11/33,19.70%,MN1;APPL2;INO80;GLI1;PAF1;PTEN;CDC73;PHB2;APPL1;CDKN1B;PSME3
prerank,activation of GTPase activity (GO:0090630),0.30057997172273937,0.9272921146153834,0.5864570737605804,0.9219686080625569,1.0,15/89,13.54%,RABGAP1L;TBC1D4;SYDE2;USP6NL;TIAM2;ARHGAP29;NTF3;ADPRH;NTRK3;SYDE1;TBC1D2B;TAX1BP3;ARHGEF10;SIPA1;CXCL13
prerank,cytosolic calcium ion transport (GO:0060401),0.3654326543262111,0.9266168140503899,0.5725308641975309,0.9228766802528638,1.0,4/28,9.92%,SLC8A1;MCU;CACNA1C;MICU2
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.32209838684015785,0.9263559235031277,0.575208913649025,0.9229377026106884,1.0,5/49,6.32%,LDLRAD4;DACT1;PMEPA1;CDC42;SRC
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.26505669376984625,0.9256206905398651,0.6556016597510373,0.9239951944255413,1.0,90/314,23.52%,SPSB1;TBL1XR1;HECW2;FBXO48;FBXL17;UBR2;FBXL19;NEDD4;RFFL;SMURF2;CDC20B;PSME4;FAF2;BFAR;DERL1;PML;CUL4B;UBXN4;NFE2L2;DERL3;UBE4B;CUL5;SIRT2;UBXN2B;UBE2U;FBXL3;RNF185;ARRB1;UBXN11;ECPAS;ANAPC5;PRKN;ITCH;IFI27;FOXRED2;FBXO9;KBTBD7;ERCC8;FBXO4;FBXL12;SELENOS;FEM1C;BTRC;TNFAIP1;APPBP2;AMFR;FBXO38;UBE2D1;HACE1;HUWE1;TMUB1;AUP1;NHLRC3;SPOP;UBR3;AMN1;PSMB5;PSMC2;KAT5;TMEM67;RNF34;PSMD1;ERLIN1;PSMD4;NSFL1C;PSME3;FBXL18;FEM1B;KCTD13;DCAF11;CDC23;PSMA3;ZSWIM8;DDIT3;UCHL1;AURKA;JKAMP;BIRC2;RNF216;BAG6;ANAPC4;KLHL20;WFS1;PSMA2;HSPA5;FBXW11;ATXN3;PSMC5;ERLIN2;ARMC8
prerank,vesicle transport along actin filament (GO:0030050),-0.3292753258537729,-0.9256046777266792,0.5405405405405406,0.9207946473779515,1.0,2/19,1.46%,FNBP1L;MYO1D
prerank,cellular senescence (GO:0090398),0.35863009960006076,0.9255091199935737,0.5725552050473186,0.9236490916742375,1.0,6/27,12.18%,TBX3;PML;SMC5;MAP2K1;SMC6;TERF2
prerank,peptidyl-asparagine modification (GO:0018196),-0.29963711384595865,-0.9252171631466308,0.559322033898305,0.9205848477182895,1.0,9/31,16.53%,ST6GAL1;FUT8;DPM1;UBE2J1;UGGT1;MGAT5;DPM3;RPN1;DPM2
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.3215782922452594,-0.925196304471755,0.536986301369863,0.9194126684762158,1.0,8/19,18.32%,DLG2;CLIC4;LRRC7;SCRIB;PATJ;ERBIN;SYNJ2BP;MTCL1
prerank,clathrin-dependent endocytosis (GO:0072583),-0.3008067253973649,-0.9246269667608603,0.6010498687664042,0.9196969590172254,1.0,11/26,23.11%,FNBP1L;SGIP1;GAK;ITSN2;INPP5F;AP2A1;CLTB;DLL1;LMBRD1;SNAP91;AP2M1
prerank,regulation of neuron apoptotic process (GO:0043523),0.2955295620463901,0.9245349229421089,0.594692400482509,0.9252066107668472,1.0,8/96,5.01%,EPHA7;GDNF;BCL2;APOE;NUPR1;MT3;NTF3;LIG4
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.3835020293190874,0.9239877095377802,0.5707547169811321,0.9258362110530621,1.0,1/23,0.20%,ATP6V0A4
prerank,protein import (GO:0017038),0.30534937995262035,0.9238401198115972,0.5871212121212122,0.925578157592918,1.0,23/84,18.84%,RANBP17;NUP107;APOE;APPL2;FAM53C;PRICKLE1;SNX33;PXMP2;HEATR3;CSE1L;PPP1R10;PEX2;TSC2;TOMM22;ABCD2;NUP214;PEX11B;LAMP2;AKT1;PHB2;TPR;APPL1;KPNB1
prerank,coenzyme A metabolic process (GO:0015936),0.4113244864901459,0.9235400787367261,0.564625850340136,0.9256648161510754,1.0,8/14,30.12%,NUDT7;PANK1;COASY;SLC25A16;DCAKD;ACOT7;PANK2;ACLY
prerank,negative regulation of lipid storage (GO:0010888),0.3852000767506375,0.9233817034360353,0.583596214511041,0.9254469335979315,1.0,4/19,9.63%,ABCA1;OSBPL8;ITGB3;ITGAV
prerank,microtubule anchoring (GO:0034453),0.4213218458533362,0.9229910486307511,0.5750853242320819,0.925760303864023,1.0,2/12,9.50%,DAG1;SAXO2
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.3813057556845235,0.9227050829234069,0.5495356037151703,0.9258165986372132,1.0,1/22,1.07%,PPM1E
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.3541106147920775,-0.9226874875044923,0.554726368159204,0.923589351339218,1.0,4/15,20.52%,RPS7;RPL11;RPL5;RPL23
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.30750264897432483,0.9226719688771318,0.6,0.9253086109784942,1.0,26/78,24.29%,NR2F2;CCNA2;CDK5RAP3;CEBPA;EGFR;CCNK;HEXIM2;INCA1;RGCC;MNAT1;CNPPD1;PTEN;CDKN1C;AKT1;CDKN2C;CCNT2;CDKN1B;SERTAD1;CCND2;CCNT1;CCNG2;CDK7;HEXIM1;CCNY;CCNE2;PKD2
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.442859466080486,0.9226099947453781,0.5483870967741935,0.9248575216163445,1.0,4/10,15.03%,RARB;RARG;ACTN4;RXRA
prerank,negative regulation of protein transport (GO:0051224),0.3615455158732044,0.9223326119408212,0.5793650793650794,0.9248797788112957,1.0,9/25,22.57%,APOE;IL12B;DRD3;SNX12;SERGEF;RHBDF2;DPH3;RSAD2;CYP51A1
prerank,cellular response to heat (GO:0034605),0.3437562457893174,0.922233791686532,0.5690440060698028,0.9245259391495817,1.0,1/35,0.14%,POLR2D
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.27288632605310786,-0.9221253158981607,0.6125461254612546,0.9238852863687785,1.0,14/42,24.34%,NOTCH1;SPOCK1;FZD4;VIT;EMP2;JAK2;NF1;CORO1C;LIMS1;NDNF;CORO2B;MINK1;TBCD;DMTN
prerank,piRNA metabolic process (GO:0034587),0.38551336543670717,0.9219961121756577,0.5622047244094488,0.9244628735936832,1.0,4/19,17.51%,TDRD1;PIWIL4;MYBL1;DDX4
prerank,response to zinc ion (GO:0010043),0.36419419284410254,0.9214729247938809,0.5721003134796239,0.9249948463892398,1.0,4/25,5.16%,PAM;SLC30A8;MT3;SLC30A2
prerank,glucan biosynthetic process (GO:0009250),-0.37071087028338623,-0.9212619667285941,0.5963302752293578,0.923710549951405,1.0,3/12,6.97%,GBE1;GYS1;UGP2
prerank,glycogen biosynthetic process (GO:0005978),-0.37071087028338623,-0.9212619667285941,0.5963302752293578,0.923710549951405,1.0,3/12,6.97%,GBE1;GYS1;UGP2
prerank,defense response to bacterium (GO:0042742),0.29147823852755184,0.920996265119208,0.5954106280193237,0.9254751678144792,1.0,16/105,16.20%,COLEC12;SERPINE1;IL6R;OPTN;OAS2;WFDC3;IL12B;TLR6;CAMP;ANXA3;CEBPB;RNASE7;CXCL13;NLRC4;GSDMD;IL23A
prerank,sensory perception of chemical stimulus (GO:0007606),0.40504071530175106,0.9208209094554117,0.5695142378559463,0.925302717904596,1.0,1/15,3.30%,GNAS
prerank,phosphate ion transmembrane transport (GO:0035435),-0.3666886037425447,-0.9205289049065897,0.531615925058548,0.9244338726490662,1.0,4/12,15.86%,SLC37A3;SLC25A30;SLC25A11;XPR1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.28721092116495733,0.9204249230482549,0.6039952996474736,0.9255830238674703,1.0,11/124,6.16%,TCF7L2;PPP3CA;FZD2;WNT4;SMURF2;PRICKLE1;PSME4;FZD1;SFRP1;TNRC6B;CDC42
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.28521467071017675,0.9202610980269,0.6288308740068105,0.9253223070429405,1.0,23/142,14.00%,ADRA1B;SLC8A1;SMAD3;ATP1A2;ADCY5;XCR1;PDGFRA;ACKR2;CCR9;BDKRB2;CACNA1C;AGTR1;LPAR1;DRD3;BCAP31;TRPM4;F2;CLN3;C1QTNF1;YWHAE;CXCR6;CXCL13;DLG4
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.38501697054975387,0.9202469940859617,0.5650741350906096,0.9247669593739383,1.0,4/20,12.04%,PID1;DAB2;PICALM;RHOQ
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3405315412756461,0.9202341723332645,0.5971631205673759,0.924216754635067,1.0,4/38,3.44%,NEDD9;EPHA4;IL34;GAS6
prerank,amyloid-beta metabolic process (GO:0050435),0.40066930942576595,0.9201287193468362,0.5628058727569332,0.9238697684500488,1.0,7/16,19.72%,APEH;APH1B;MGAT3;DYRK1A;PSEN2;ABCA7;IDE
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.31856755507616447,0.9201129760903013,0.5747422680412371,0.9233284276711831,1.0,5/54,3.73%,PDPK1;ANGPT1;FGFR1;APOE;ANGPT2
prerank,positive regulation of autophagy (GO:0010508),0.30266133289385566,0.9200104441185462,0.5977722772277227,0.9229779923793374,1.0,22/81,19.79%,DAPK1;DCN;OPTN;PRKAA2;LRRK2;PRKN;STK11;RNF152;UFL1;TBK1;LARP1;TSC2;PLK2;SESN2;NPRL2;KAT5;FOXO3;WAC;PHB2;HTT;GPSM1;TRIM21
prerank,positive regulation of growth (GO:0045927),0.31275950489490534,0.9200066422392041,0.5915492957746479,0.9224125377038073,1.0,23/64,23.39%,BCL2;TGFBR1;RFTN1;SFRP1;CXCL16;USP47;CDC42;INO80;EGFR;DDX3X;INSR;MTPN;HPN;AKT1;MMP14;TRIM32;PLCB1;DDX49;N6AMT1;EIF4G2;WFS1;EXOSC2;BRAT1
prerank,RNA processing (GO:0006396),0.2799920621384891,0.9198570677167172,0.6299212598425197,0.9221530412115784,1.0,37/176,18.90%,CELF2;RBMS1;ATXN1;SON;DDX17;TUT7;RBMS2;HNRNPR;RBPMS;NONO;RNASEL;TENT4A;SMU1;DDX23;PRMT9;MAGOHB;TUT4;NOL3;SNRPD2;CDK12;TCERG1;SRSF5;AKAP8L;RBM39;RBM5;RNPC3;RBM6;GEMIN2;TENT4B;SYNCRIP;HNRNPC;PRPF6;SF3B2;SF3B1;METTL3;PRKACA;DICER1
prerank,establishment of epithelial cell polarity (GO:0090162),-0.32415183844001383,-0.9197799453786878,0.5949367088607594,0.9251514929009074,1.0,7/19,19.80%,CYTH3;MYO9A;OPHN1;MSN;CYTH1;CLASP1;SH3BP1
prerank,response to interferon-alpha (GO:0035455),0.4002253949775949,0.9196510623012146,0.5628058727569332,0.9220096906995106,1.0,2/16,4.71%,GAS6;AXL
prerank,regulation of protein polymerization (GO:0032271),0.3430067281832188,0.91943597263461,0.5475841874084919,0.9218880244603511,1.0,5/35,10.44%,ARHGAP28;PLEKHG2;ARHGAP18;ARL2;TTBK1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.30718940774909653,-0.9193435231884669,0.5456989247311828,0.9250742331453077,1.0,12/24,25.99%,ACKR3;KDM1A;TPT1;SIRT1;BCL2L1;CD44;CLU;TRIAP1;SNAI2;CCAR2;MIF;SNAI1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.36250888822529537,0.9190708386302372,0.5781487101669196,0.9220819368177106,1.0,3/27,2.15%,DCN;BGN;PXYLP1
prerank,regulation of lamellipodium assembly (GO:0010591),0.3460571450756899,0.9190099095739123,0.5704125177809388,0.9216514640508846,1.0,4/34,8.38%,AUTS2;PIK3R1;CDC42;CAPZB
prerank,cellular transition metal ion homeostasis (GO:0046916),0.30096150342119854,0.9188010812933993,0.6007556675062973,0.9215460314095139,1.0,9/91,6.50%,BMP6;CP;SCARA5;SLC30A8;MT3;HEPH;CYBRD1;SLC11A2;ACO1
prerank,histone methylation (GO:0016571),-0.3045289433910492,-0.9187527972669202,0.5723076923076923,0.925351978492914,1.0,6/26,14.46%,EZH2;PRMT7;SMYD2;SUV39H1;SMYD1;PRMT6
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.2771004467723843,-0.9186350674214188,0.6212624584717608,0.9244457525031394,1.0,17/37,31.14%,ENTPD1;HNRNPD;PNPT1;ENTPD2;SUPV3L1;ENTPD6;ENTPD3;ADPRM;RNASEH1;DNASE1L2;NUDT16;PABPC4;NUDT9;ISG20;ENTPD5;NUDT1;RNASEH2B
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.36096271770434313,0.9185676298315048,0.575516693163752,0.9214766934487889,1.0,5/26,12.17%,ATP1A2;GSTM2;DRD3;ADRA2A;YWHAE
prerank,negative regulation of nervous system development (GO:0051961),-0.33696216948604696,-0.9183488506641344,0.5546666666666666,0.9239943453868471,1.0,3/17,5.59%,NOTCH1;B2M;SORL1
prerank,cellular protein localization (GO:0034613),0.2673951355226918,0.9177310578860811,0.6545643153526971,0.9227656369282534,1.0,52/285,16.18%,WLS;GJA1;FBLN5;RABGAP1L;TBC1D4;ANGPT1;USP6NL;SEC31A;SH3PXD2B;TMED1;VPS26C;AXIN2;RAB23;STXBP3;STX16;NPHP1;COX18;ARFGAP3;LRRK2;ADPRH;VCL;IFT27;CD63;RAB22A;CROCC;COPZ2;EGFR;ARFIP2;CSRP3;TBC1D2B;ARL1;GGA2;TMED4;LAMTOR2;TM9SF2;RRAGD;STXBP1;TLK1;COPA;WIPI1;RAP2A;USO1;ARF4;FLNA;SNX9;IFT22;ARF6;EPB41L3;STX1B;ARL5A;SNX31;RAB19
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.3741338015435557,0.9175366782430073,0.5623052959501558,0.9225840899600782,1.0,9/22,23.90%,CCNK;CDK12;TCERG1;CCNT2;CDC73;LEO1;SCAF8;CCNT1;CDK13
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3400596988896714,0.9175215151118563,0.5737463126843658,0.9220400254297524,1.0,4/35,5.54%,GHR;LEPROT;KIT;CYP1B1
prerank,DNA double-strand break processing (GO:0000729),0.38587004811289943,0.9174156019530091,0.5501567398119123,0.9216804127819774,1.0,12/18,30.65%,UBE2V2;RNF138;ATM;KAT5;EXD2;SMARCAD1;BRCA1;MRE11;RAD50;UBE2N;RBBP8;DNA2
prerank,macrophage migration (GO:1905517),-0.3652606985915684,-0.9169270996230452,0.562200956937799,0.9262818635487379,1.0,3/13,23.02%,CKLF;EDNRB;CCL2
prerank,negative regulation of catabolic process (GO:0009895),0.3252163519914711,0.9168820525945486,0.5917241379310345,0.9222754104198438,1.0,12/47,16.25%,NUPR1;CST3;SIRT2;NCOR1;IRAK3;EGFR;SNX12;ADRA2A;BANP;HDAC4;FLNA;AGAP2
prerank,regulation of receptor internalization (GO:0002090),0.34141896987803566,0.9162726568835498,0.5820029027576198,0.9230437900160763,1.0,9/35,14.95%,ANGPT1;NTF3;CD63;ARRB1;INSR;EGF;DLG4;RSPO1;SFRP4
prerank,response to hydroxyurea (GO:0072710),0.4309068755540841,0.9162393856954767,0.5808080808080808,0.9225435067341772,1.0,4/11,18.75%,DDI1;RTF2;TIMELESS;ATRX
prerank,negative regulation by host of viral process (GO:0044793),0.4431084023692068,0.9161567277124761,0.5662650602409639,0.9221424095722834,1.0,2/10,9.33%,CCNK;PRKN
prerank,Fc receptor signaling pathway (GO:0038093),0.2857170673412812,0.9157228073856388,0.6018845700824499,0.9225273437612875,1.0,7/110,4.77%,PDPK1;PIK3R1;LYN;PPP3CA;PIGR;KIT;PSME4
prerank,cellular response to DNA damage stimulus (GO:0006974),0.26497283689479617,0.9155631517318206,0.6935146443514645,0.9223104742607001,1.0,106/336,24.39%,LYN;BCL2;SETD7;YAP1;PDS5B;MOAP1;OGG1;PSME4;HPF1;PCLAF;BCL6;USP47;CBX3;INO80;PML;RAD51B;CUL4B;SPRTN;SMC5;BATF;TRIP12;REXO4;UBE2U;ZBTB38;BRSK1;UBA7;RECQL5;KMT5B;BCL2L11;ZBTB4;ZBTB1;CCNK;SMC6;POLE3;STK11;BAZ1B;PHF1;MRNIP;TAOK3;UFL1;IKBKE;ERCC8;RAD18;FANCC;MBD4;UVRAG;MNAT1;BOD1L1;MAP2K6;MTREX;USP10;TAF9;HMCES;RAD51D;UBE2E2;RTEL1;UBA6;MAPKAPK2;CASP9;CBX5;UBR5;XRCC2;TIMELESS;ATM;NIPBL;ALKBH1;ZBTB40;WAC;METTL3;XPA;ENDOV;RAD54L;NCOA6;SUMO1;RFC5;NRDE2;AATF;ETAA1;STK33;RBBP5;FAN1;USP3;UBE2T;MUTYH;DDIT3;RMI2;NSMCE4A;TAOK1;ERCC3;APLF;FANCA;XIAP;LIG1;BRCA1;MACROD1;BRAT1;VCPIP1;PPP1R15A;PSEN1;SETX;POLI;MSH6;NABP2;MAPK12;MASTL;MRE11
prerank,positive regulation of cell death (GO:0010942),0.3149269551279924,0.915482775461956,0.577120822622108,0.9219108914630006,1.0,8/59,9.04%,LRP1;EFNB2;SLC6A13;MT3;AXIN2;RARG;LRRK2;PICALM
prerank,Notch signaling involved in heart development (GO:0061314),-0.3855318652073729,-0.9153844294370553,0.5668202764976958,0.9289819609623076,1.0,8/11,25.99%,NOTCH1;HEY2;GALNT11;HEY1;DLL4;HEYL;SNAI2;SNAI1
prerank,DNA modification (GO:0006304),0.3770505542157717,0.915263690514959,0.586046511627907,0.9217904886327746,1.0,4/22,12.18%,OGG1;NEIL1;MBD4;TERF2
prerank,positive regulation of cytokine production (GO:0001819),0.2671843211552324,0.9152224406715379,0.6828752642706131,0.9213147375155856,1.0,37/292,12.98%,CCBE1;RORA;ROCK2;SERPINE1;SULF2;RUNX1;PLA2R1;IL6R;IL17D;RFTN1;CCL19;SULF1;IRF1;CYP1B1;PIBF1;IL12B;BATF;TSLP;CD28;SPHK2;EIF2AK3;TLR6;CD200;POLR3A;RAB7B;ARNT;NFAM1;CARD9;SETD4;CEBPB;ADRA2A;RGCC;TBK1;EBI3;STAT6;RIPK2;CD14
prerank,heterochromatin organization (GO:0070828),-0.3541990360592117,-0.915212415946639,0.6,0.9282280612112891,1.0,2/14,3.93%,MECOM;PRDM16
prerank,mitotic chromosome condensation (GO:0007076),-0.3012069158423974,-0.9149648479903776,0.6016042780748663,0.927683569882824,1.0,17/26,40.07%,MCPH1;NCAPD3;SMC4;KMT5A;NCAPH;NCAPG;TTN;PLK1;SET;CDK1;NCAPG2;NUSAP1;SMC2;CSNK2A1;CSNK2A2;RB1;NCAPD2
prerank,cellular response to gamma radiation (GO:0071480),0.3965674629869478,0.9148478108246524,0.5687203791469194,0.9215876579602427,1.0,2/17,5.52%,YAP1;MAP3K20
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.3560114080738764,0.9146224165127115,0.5811836115326252,0.9214908059206228,1.0,8/31,18.60%,LYN;CEBPB;GLMN;SDC4;ATM;SOX11;RC3H1;VTCN1
prerank,plasma membrane invagination (GO:0099024),0.3526396295959993,0.914181486627307,0.5595238095238095,0.9218557398293497,1.0,5/29,8.98%,GSN;CDC42;SNX33;GULP1;SNX18
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.3635998302734462,-0.9136904459262124,0.5531400966183575,0.9298578112286016,1.0,5/13,21.57%,SRSF12;LSM2;PRPF31;USP4;CD2BP2
prerank,neuromuscular process (GO:0050905),0.39566838292496115,0.9131595676068388,0.5579119086460033,0.9234801289463855,1.0,1/16,0.51%,MYCBP2
prerank,regulation of gene silencing by miRNA (GO:0060964),0.3087904714908926,0.9127713758341419,0.5974193548387097,0.9237023770075488,1.0,8/62,11.58%,POLR2D;NUP107;NUP42;WTIP;TNRC6A;POLR2C;NUP98;RAE1
prerank,protein homooligomerization (GO:0051260),0.28808228396711705,0.9127603230385862,0.624113475177305,0.9231498834993535,1.0,15/114,10.54%,SLC1A5;TRPA1;SCARA5;MLKL;IKZF4;TDO2;APPL2;RNF213;ALDH1A2;ALS2;CBY1;ZBTB1;CLYBL;TRPM4;CARD9
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.3721341783079393,0.9126778165707048,0.5723370429252782,0.9227619660445288,1.0,3/21,7.71%,MITF;MED14;MED16
prerank,histone H4-K8 acetylation (GO:0043982),0.4095731384762282,0.9126442801595659,0.5688524590163935,0.921693779100311,1.0,7/15,24.63%,OGT;JADE1;WDR5;KANSL1;MEAF6;KANSL3;JADE2
prerank,histone H4-K5 acetylation (GO:0043981),0.4095731384762282,0.9126442801595659,0.5688524590163935,0.921693779100311,1.0,7/15,24.63%,OGT;JADE1;WDR5;KANSL1;MEAF6;KANSL3;JADE2
prerank,positive regulation of cytokinesis (GO:0032467),-0.28098950325090916,-0.9126184191068073,0.588957055214724,0.9314081823821438,1.0,10/32,18.72%,PKP4;CIT;KIF20B;CDC14A;CSPP1;GIPC1;KIF23;PRKCE;ECT2;CUL3
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.3000144379655781,0.9121679397716814,0.6193390452876377,0.9221870266327696,1.0,11/84,11.95%,CELF2;RBFOX1;SON;RBFOX2;SF1;DDX17;HNRNPA1;NUP98;SMU1;WTAP;REST
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.27800376708058916,-0.9115002827187528,0.5753424657534246,0.9330760463027834,1.0,8/35,10.07%,NLGN1;CDH12;ATP2C1;CDH6;CDH8;CDH9;CDH13;CDH10
prerank,lymphocyte differentiation (GO:0030098),0.3096842472254584,0.9114140263925464,0.5897771952817824,0.9232882683704837,1.0,10/68,11.12%,RHOH;PBX1;LEPR;KIT;AXL;NHEJ1;GPR89A;GPR89B;NFAM1;IFNK
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.2541012195038574,-0.9112591330270874,0.6190476190476191,0.9312707821250759,1.0,22/51,33.49%,NUP93;NUP35;NUP160;VRK1;PPP2R2A;RANGAP1;EMD;SEC13;NUP155;VPS4A;CCNB2;CHMP2B;NUP85;CHMP4B;CHMP4A;NUP43;CHMP4C;CDK1;NUP37;LBR;LEMD2;CC2D1B
prerank,mitotic nuclear membrane organization (GO:0101024),-0.2541012195038574,-0.9112591330270874,0.6190476190476191,0.9312707821250759,1.0,22/51,33.49%,NUP93;NUP35;NUP160;VRK1;PPP2R2A;RANGAP1;EMD;SEC13;NUP155;VPS4A;CCNB2;CHMP2B;NUP85;CHMP4B;CHMP4A;NUP43;CHMP4C;CDK1;NUP37;LBR;LEMD2;CC2D1B
prerank,mammary gland development (GO:0030879),0.3800668177798184,0.9112580646063678,0.5796178343949044,0.9230598791728661,1.0,4/21,7.97%,GLI2;WNT4;TBX3;ARHGAP35
prerank,histone lysine methylation (GO:0034968),0.35342090201729365,0.9112168710862801,0.587183308494784,0.9225846545129667,1.0,11/33,20.89%,PRDM5;WDR82;SMYD3;TRMT112;KMT2A;SETDB1;WDR5;SETD1B;CXXC1;RBBP5;N6AMT1
prerank,fatty acid oxidation (GO:0019395),-0.25003449485444385,-0.9106495193523383,0.6138996138996139,0.9316061621142464,1.0,11/57,21.04%,ADIPOR2;PPARD;ECI2;ECHDC1;PPARGC1A;ACAD11;ABCD3;ACOX1;ABCD4;MTLN;ACAA2
prerank,regulation of response to external stimulus (GO:0032101),0.2823019441369392,0.910619179805481,0.6295427901524033,0.923266026176691,1.0,12/121,6.95%,ADAMTS12;AHSG;PTGES;CASP12;PDGFRA;EFNB2;APPL2;IRF1;BCL6;ADGRA2;AGTR1;GUCY2D
prerank,cellular response to ATP (GO:0071318),-0.35386343083548677,-0.9105962091004506,0.5829145728643216,0.9305563354859824,1.0,2/14,6.97%,P2RX7;TAF1
prerank,cellular response to inorganic substance (GO:0071241),0.3767582338330621,0.9101688045252809,0.5773353751914242,0.9236253355110552,1.0,7/21,18.75%,MTR;MT3;DPEP1;DDI1;RTF2;TIMELESS;ATRX
prerank,negative regulation of MAPK cascade (GO:0043409),0.29588617938570067,0.9099725808345017,0.5919117647058824,0.923480345707586,1.0,18/87,15.74%,TIMP3;DAG1;LYN;APOE;FBLN1;CDK5RAP3;RANBP9;EMILIN1;IRAK3;EPHB2;SPRY2;SPRED3;IGBP1;CNKSR3;PTEN;BMP4;SPRED1;PIK3R2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.29917398440914883,-0.9099511697229514,0.6083333333333333,0.9309539934703852,1.0,4/25,6.57%,ANKRD13A;SDCBP;MTMR2;RIN3
prerank,positive regulation of telomerase activity (GO:0051973),-0.284766136442538,-0.9094657999077066,0.6204620462046204,0.9309355225897734,1.0,7/33,16.68%,NEK7;HSP90AB1;PKIB;KLF4;NVL;MAPK3;PNKP
prerank,muscle cell migration (GO:0014812),-0.39094217026676725,-0.9091541386008948,0.5888888888888889,0.9305087235202087,1.0,5/10,21.46%,CCN3;SIX1;ITGB1BP1;ROCK1;MEGF10
prerank,positive regulation of protein deacetylation (GO:0090312),0.3952755567876365,0.9090041657554564,0.5516637478108581,0.924959534987392,1.0,6/14,20.82%,NNMT;AKAP8L;DYRK1A;SAP30BP;NIPBL;BRMS1
prerank,negative regulation of dephosphorylation (GO:0035305),-0.34168132854994027,-0.9084813941989669,0.5688775510204082,0.9310102933221616,1.0,6/18,27.26%,PPP1R16B;INPP5K;URI1;PPP1R35;MFHAS1;GPATCH2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.339903458115333,-0.9084739090542939,0.5894206549118388,0.9298441025495691,1.0,7/16,26.02%,SHLD1;CGAS;PARPBP;POLQ;HELB;SHLD2;KLHL15
prerank,negative regulation of innate immune response (GO:0045824),0.34124195795060425,0.9076786379827426,0.5881481481481482,0.9271580498376703,1.0,11/34,20.23%,SERPING1;DCST1;NMI;IRAK3;STAT2;MUL1;DHX58;METTL3;TRIM21;YTHDF2;SUSD4
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.3983232569103688,0.9075045942565863,0.5432525951557093,0.9269406473935987,1.0,3/15,10.17%,PDPK1;SMAD1;FGF2
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.3663559321686914,0.9067110765117055,0.6,0.9280459302697597,1.0,5/25,13.62%,ACTN2;SLC6A9;ATP1B2;WNK1;PIRT
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.3692996084192114,0.9053674091767225,0.5800933125972006,0.9302885922023397,1.0,2/24,7.68%,CEMIP;MYO1C
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.3598170775177808,0.9051604021866385,0.5997023809523809,0.9302036755808318,1.0,5/27,9.63%,ABCA1;CSF1;AGTR1;ITGB3;ITGAV
prerank,regulation of cellular senescence (GO:2000772),-0.292363125250695,-0.9049470151938335,0.636085626911315,0.9376580497812296,1.0,8/28,15.46%,CDK6;B2M;PNPT1;VASH1;CGAS;SIRT1;ABI3;MAP3K3
prerank,regulation of monocyte chemotaxis (GO:0090025),0.35955121892151776,0.9045318308556086,0.598159509202454,0.9309754157187651,1.0,2/24,1.77%,SERPINE1;LYN
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.29203022747882235,0.9044375197950458,0.6172370088719898,0.930625604015079,1.0,16/80,15.39%,DENND2A;BAIAP3;RHOBTB3;LMAN1;STX16;RBSN;DENND5A;GOSR2;HEATR5A;SNX12;RAB7B;ARL1;TRAPPC10;TMEM87B;BET1L;PIKFYVE
prerank,regulation of cellular component biogenesis (GO:0044087),0.33667950589669166,0.9043374003479631,0.5929078014184397,0.930285463060947,1.0,6/39,9.37%,ROCK2;APOE;CCL19;RAPGEF2;SNCAIP;RAPGEF1
prerank,central nervous system development (GO:0007417),0.2661014524361275,0.9037069712755081,0.6838235294117647,0.931076690550371,1.0,28/250,9.66%,EPHA7;ATXN1;GSN;PBX1;ARNT2;SLC8A3;HSPG2;ZIC1;PCDH18;SHROOM2;NKX2-1;NFIB;SMO;ZIC4;CDK5RAP3;SYNJ2;ZIC2;LIG4;TBX3;SMARCA1;ADGRA2;SH3GL1;NHEJ1;SETD1A;EEF1AKMT4-ECE2;PRKN;MARCKSL1;GLIS2
prerank,hemopoiesis (GO:0030097),0.29305412622161214,0.9035513324064076,0.59625,0.9308444213170338,1.0,12/87,6.87%,TGFBR3;RUNX1;PGM3;MFAP5;FGFR2;KIT;RUNX2;NOTCH2;SFRP1;ETV6;FUT10;CEBPA
prerank,regulation of hippo signaling (GO:0035330),-0.32802554023335184,-0.9032110480222793,0.5975609756097561,0.9409420885916535,1.0,3/17,5.06%,MOB3B;SCHIP1;CIT
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.42324415608739036,0.9025799934842618,0.6013628620102215,0.9323591034027884,1.0,4/11,15.93%,DERL1;RNF185;UGGT2;AUP1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.4252285495298255,0.9025636957471593,0.5721476510067114,0.9312682988578554,1.0,2/11,4.33%,INPP5A;SYNJ2
prerank,inositol phosphate dephosphorylation (GO:0046855),0.4252285495298255,0.9025636957471593,0.5721476510067114,0.9312682988578554,1.0,2/11,4.33%,INPP5A;SYNJ2
prerank,negative regulation of cholesterol transport (GO:0032375),0.42848176740099175,0.9025266366815816,0.563573883161512,0.9307822293237357,1.0,10/10,57.18%,SHH;SREBF2;NFKB1;APOC1;APOC3;ABCG8;PLA2G10;APOA2;ABCG5;ABCA2
prerank,skeletal muscle contraction (GO:0003009),0.36894795772016875,0.9023169974247818,0.5799676898222941,0.9306809566258335,1.0,3/19,10.14%,TNNT1;TNNC1;TNNT3
prerank,gluconeogenesis (GO:0006094),0.33619784281283427,0.9022805216496784,0.5830945558739254,0.9301909234757681,1.0,3/39,8.03%,RBP4;MDH2;ENO2
prerank,cytokine-mediated signaling pathway (GO:0019221),0.2569015899565911,0.9022189956081897,0.7669021190716448,0.9297701399053377,1.0,55/532,10.17%,GREM2;COL1A2;RORA;GHR;PIK3R1;IL31RA;BCL2;IL6R;LEPR;IL34;PELI2;OSMR;ZEB1;MMP2;KIT;SP100;YAP1;NUMBL;CCL19;IRAK2;CNN2;CSF1;NCAM1;APPL2;BRWD1;IRF1;EDAR;MT3;PSME4;OAS2;BCL6;CCL4;CDC42;SRC;PML;SDC1;IL12B;BATF;CEBPA;TSLP;IL13RA1;IL15RA;IRAK3;BCL2L11;MAP3K8;STAT5B;CNTFR;ACTN4;CAMK2B;RAPGEF1;LTBR;STAT2;RNASEL;IFI27;FGF2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.24002427425411493,-0.9021693067196265,0.6568627450980392,0.9423122101546846,1.0,26/76,24.70%,SMURF1;RNF144B;CBFA2T3;RNF144A;RBX1;TRIB2;TAF1;GSK3A;HSPBP1;ZYG11B;RAD23A;COP1;RACK1;BBS7;DVL1;RNF14;CLU;DDRGK1;GSK3B;GABARAP;RCHY1;USP5;NUB1;CSNK1D;VCP;DDA1
prerank,regulation of tumor necrosis factor production (GO:0032680),0.2832624159634832,0.9019042980519412,0.6346153846153846,0.9298718331403164,1.0,14/112,13.47%,IGF1;GAS6;CCL19;OAS2;ARFGEF2;IL12B;SPHK2;IRAK3;EPHB2;SETD4;CD33;SELENOS;CD14;SYT11
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.3140881138740349,0.9018085425905827,0.6314363143631436,0.9295099159960146,1.0,7/56,8.98%,ROCK2;SON;KIF20A;MYH10;EFHC1;SNX33;SNX18
prerank,response to thyroid hormone (GO:0097066),0.412609650319272,0.9014839126868066,0.5893155258764607,0.9296110316330044,1.0,6/13,14.34%,THRB;CTSH;BRD8;KLF9;CTSL;HPN
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.3504196435397025,0.9012407719234009,0.5903083700440529,0.929508997223375,1.0,7/27,15.43%,FBXL17;PML;SIK1;FBXL3;FBXL12;PER3;RBM4B
prerank,sodium ion export across plasma membrane (GO:0036376),0.4037561111071041,0.9010855284365855,0.5700164744645799,0.9292701855937253,1.0,2/13,6.94%,ATP1A2;ATP1B2
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.3337145907014966,-0.9003535407069124,0.5808080808080808,0.9456830351036326,1.0,9/15,45.62%,CCT8;RUVBL1;RUVBL2;SHQ1;NHP2;CCT6A;NOP10;CCT7;CCT2
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.3376532458033447,0.9003214221243848,0.5957120980091883,0.9303405922850286,1.0,5/31,15.27%,ARRDC4;GORASP1;BTRC;PTEN;DCUN1D2
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.28089940581242173,-0.9003033651178816,0.6122448979591837,0.944617606217549,1.0,4/32,7.24%,RPS19;PGLYRP1;RPL39;RPL30
prerank,regulation of establishment of protein localization (GO:0070201),-0.35174170426856344,-0.900080848154505,0.5724815724815725,0.9440242379190203,1.0,5/13,28.82%,GAPVD1;CEP135;CORO2B;TREM2;PTP4A3
prerank,endocardial cushion morphogenesis (GO:0003203),-0.3271621604286501,-0.9000394558370887,0.578005115089514,0.9429415051200771,1.0,6/18,9.68%,NOTCH1;NOS3;ACVRL1;TGFB2;TBX2;TGFBR2
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.23270051361566285,-0.8997475511392582,0.684931506849315,0.9425282347650891,1.0,26/73,30.04%,PTPRJ;IFIH1;THBS1;PLCG2;IL33;LBP;ARHGEF2;JAK2;APP;NOD2;PTPRC;TLR4;CD86;CLU;DHX9;FZD5;AGER;TWIST1;IFNGR1;MIF;TMEM106A;C1QTNF4;LPL;TLR1;IL1A;HSPB1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.3798883364442619,0.8993819301520154,0.5902439024390244,0.9317137021705812,1.0,8/19,23.43%,SREBF1;PRKN;VDAC1;HTT;ATP13A2;HAX1;HDAC6;SREBF2
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.3189088122055218,0.8992957557790615,0.5971428571428572,0.9313403922495027,1.0,6/44,8.96%,ROCK2;ZFP36L1;TNRC6B;CPEB3;TNRC6A;METTL14
prerank,determination of left/right symmetry (GO:0007368),-0.27567025733758843,-0.8990394218500258,0.6613418530351438,0.9430781214161824,1.0,10/36,19.58%,NOTCH1;TBX1;ZIC3;GALNT11;DNAH11;STIL;ARL6;CITED2;BBS7;DLL1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.35610738676658443,-0.8990121992832476,0.5740318906605922,0.9419578760582059,1.0,7/12,40.04%,FOXP1;KLF4;TLR4;LPL;OAS3;MBP;TNF
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.36262164009026665,0.8988756635864406,0.61875,0.9316759930505609,1.0,4/26,8.86%,PDPK1;ZFP36L1;EGFR;STAT5B
prerank,inflammatory response (GO:0006954),0.26661091720465224,0.8988087006194689,0.6800433839479393,0.931259283059072,1.0,34/195,16.07%,ADCY1;HSPG2;IL17D;XCR1;KIT;TPST1;CCL19;LTB4R;CCL4;BDKRB2;AGTR1;SCUBE1;TLR6;BMP2;ITCH;NFAM1;CDO1;LIAS;CEBPB;ADM;TNFAIP6;TBK1;FOLR2;RIPK2;CD14;NOX4;CXCL13;HDAC4;ADORA2A;VNN1;TNFRSF1A;NLRC4;MAPKAPK2;KLRG1
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.2792806578650586,-0.8984081814039654,0.6392405063291139,0.9422128388704765,1.0,12/35,17.76%,CDK6;HOXA5;MED1;TAL1;ACVR2A;LDB1;HIF1A;PRKDC;INHBA;ZFPM1;FAM210B;HMGB2
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.2741501189873329,-0.8982998907328515,0.6123188405797102,0.941306237231772,1.0,4/41,2.91%,PODXL;PIEZO1;ANK3;TJP1
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.4330784770285056,0.8982929048279882,0.6071428571428571,0.9317686918225765,1.0,1/11,2.90%,PIGR
prerank,positive regulation of inflammatory response (GO:0050729),0.29440094270846023,0.8977679845869239,0.6371463714637147,0.932307918742046,1.0,20/86,17.97%,SERPINE1;OSMR;NUPR1;IL12B;CEBPA;AGTR1;TSLP;NMI;CCN4;SETD4;NAPEPLD;PDCD4;ETS1;MDK;TNFRSF1A;CD47;IL23A;CX3CL1;TNIP1;IL18
prerank,regulation of B cell proliferation (GO:0030888),-0.2606599261507013,-0.8974629703569651,0.6508474576271186,0.9422239318305845,1.0,11/44,17.03%,MEF2C;VAV3;CD38;TFRC;NFATC2;TNFRSF21;CD40;CD81;GPR183;PTPRC;CD320
prerank,positive regulation of interleukin-13 production (GO:0032736),0.42830645539261963,0.8973868733770071,0.5979020979020979,0.9325575900677531,1.0,4/10,21.58%,TSLP;SPHK2;IL18;LGALS9
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.32268158973952776,-0.8972142055043577,0.6042780748663101,0.9416747762589548,1.0,8/18,31.61%,OTUD7B;APOD;CABP1;FLCN;GSK3B;MFHAS1;LATS1;MDFIC
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.29854149703627103,0.896922091422306,0.6214470284237726,0.9329777718375233,1.0,24/66,20.59%,DACT1;APPL2;INO80;EGFR;RBL2;DDX3X;JADE1;RGCC;KMT2E;PTEN;UBE2E2;AKT1;KANK2;ADAMTS1;CDK2AP2;TFDP1;CDKN2C;LSM10;MYO16;CDC73;APPL1;PSME3;PLCB1;CCND2
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.3468926381699279,-0.8967942415913855,0.5862068965517241,0.9415728566246282,1.0,8/14,34.42%,RPS3;CD81;NECTIN2;CARD11;RAB29;IKBKG;TRAT1;CD226
prerank,negative regulation of cell adhesion (GO:0007162),0.30197339242462046,0.8967206509393418,0.638676844783715,0.9328525226976596,1.0,16/72,14.30%,PLXNA2;ANGPT1;SERPINE1;RIPOR2;SEMA5A;FBLN1;CYP1B1;DSCAM;EPHB2;MIA3;PLXNC1;SIPA1;DACT2;PLXNA1;MDK;PLXNB2
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.3479423922673937,-0.8966131519875017,0.5825,0.9408475198159938,1.0,7/14,28.82%,CPSF7;ERN1;CSTF2;CPSF1;CPSF6;CPSF4L;TUT1
prerank,response to UV (GO:0009411),0.2918261586375489,0.8964951558695153,0.6383763837638377,0.9327547446818127,1.0,11/95,9.17%,MFAP4;NEDD4;PCLAF;USP47;INO80;SPRTN;IL12B;UBE4B;BRSK1;EGFR;ZBTB1
prerank,negative regulation of anoikis (GO:2000811),0.39099524965285615,0.8963373346432698,0.6056105610561056,0.9325163124114717,1.0,3/14,6.32%,BCL2;TLE1;SRC
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.37165218728889254,0.8959605517530073,0.6015748031496063,0.9327523778677104,1.0,3/21,4.92%,WNT8B;FZD2;FZD1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.221041863146094,-0.8959603419046812,0.7401129943502824,0.9413128226126423,1.0,28/96,22.14%,NUP93;NUP35;NUP153;NUP160;EIF4E;NUP54;RBM8A;ALYREF;HHEX;CHTOP;HNRNPA2B1;YTHDC1;SRSF7;SEC13;SMG7;NUP155;DDX19B;RANBP2;GLE1;DHX38;NUP88;MCM3AP;THOC6;SRSF4;NUP62;SLBP;DDX25;NUP85
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.34259683613683356,-0.8959246878756169,0.6066838046272494,0.9402410362953687,1.0,7/15,25.82%,FAM98B;CLP1;ERN1;CSTF2;TSEN54;TSEN34;CPSF1
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.27765234244687026,-0.8950975842564595,0.6175548589341693,0.9399538893893884,1.0,11/32,22.14%,NUP93;NUP35;NUP153;NUP160;NUP54;SEC13;NUP155;RANBP2;NUP88;NUP62;NUP85
prerank,tRNA export from nucleus (GO:0006409),-0.27765234244687026,-0.8950975842564595,0.6175548589341693,0.9399538893893884,1.0,11/32,22.14%,NUP93;NUP35;NUP153;NUP160;NUP54;SEC13;NUP155;RANBP2;NUP88;NUP62;NUP85
prerank,glycosphingolipid metabolic process (GO:0006687),0.32666011595523736,0.8950333322542979,0.6090014064697609,0.9341178334792847,1.0,6/42,10.19%,ST6GALNAC5;ST3GAL5;LARGE1;SMPD2;B3GALNT1;ST6GALNAC6
prerank,cellular response to interleukin-1 (GO:0071347),0.2712438882793957,0.8950062204823805,0.6540229885057471,0.9336070615058613,1.0,11/143,8.61%,ADAMTS12;PTGIS;PELI2;CCL19;IRAK2;PSME4;SFRP1;CCL4;NR1D1;IRAK3;MAP3K8
prerank,protein methylation (GO:0006479),-0.2701300621571173,-0.894978901327643,0.6468646864686468,0.9390517728677596,1.0,9/40,19.14%,RAB6A;EZH2;SNRPB;PRMT7;ATPSCKMT;FAM98B;PRMT6;SNRPD3;PRMT3
prerank,kinetochore organization (GO:0051383),0.405477913668832,0.8948949735333892,0.5810344827586207,0.9332912083381617,1.0,4/13,18.44%,CENPC;CENPH;POGZ;CENPA
prerank,inorganic ion transmembrane transport (GO:0098660),-0.35930277904368835,-0.8945927344975567,0.59375,0.9387938093714425,1.0,8/12,39.65%,ABCC9;CACNA1H;KCNJ8;ABCC8;PKD2L1;P2RX3;KCNJ11;RHAG
prerank,ganglioside biosynthetic process (GO:0001574),0.3914601544915245,0.8944419880845312,0.5989583333333334,0.9336617596649739,1.0,2/15,2.41%,ST6GALNAC5;ST3GAL5
prerank,cytoplasmic sequestering of protein (GO:0051220),0.4075062326511154,0.8939972387257838,0.5928449744463373,0.9340221954404626,1.0,3/13,15.03%,MDFI;FLNA;SUFU
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.3652072780514051,0.8937815901819681,0.5841750841750841,0.9338921617238393,1.0,5/20,10.43%,TNRC6B;WTIP;HELZ;TNRC6A;EIF6
prerank,negative regulation of calcium ion transport (GO:0051926),0.39536385471122926,0.8937513135029017,0.5877342419080068,0.9333951228521242,1.0,4/15,15.17%,ATP1A2;ADRA2A;CD33;TMBIM6
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.3987596112273752,0.8934662647739999,0.577391304347826,0.9334388280683665,1.0,3/13,6.96%,PYCR1;LRRK2;NFE2L2
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.3894507061781927,0.8934230290324168,0.610032362459547,0.9329872843139262,1.0,4/17,8.84%,PBX1;MAML3;RBPJ;KAT2B
prerank,histone H2A ubiquitination (GO:0033522),0.3740812551763475,0.8930248406632061,0.5924092409240924,0.9332620541893821,1.0,3/17,6.57%,UBR2;BCOR;CUL4B
prerank,negative regulation of protein metabolic process (GO:0051248),0.3196750318717728,0.8928101943556908,0.6446280991735537,0.9331316535536976,1.0,12/48,16.76%,APOE;LDLR;SIRT2;IRAK3;EGFR;SNX12;ITGB3;ITGAV;BANP;FLNA;AGAP2;VBP1
prerank,mRNA 3'-end processing (GO:0031124),0.295021838383733,0.8926782134901103,0.6353383458646616,0.932861121129814,1.0,28/78,27.30%,POLR2D;U2AF1L4;THOC2;DDX39A;WDR33;MAGOHB;PAF1;SRSF5;PCF11;TENT4B;PAPOLG;CPSF2;CDC73;FIP1L1;LEO1;SCAF8;SRSF3;PAPOLA;NCBP2;CASC3;PAPOLB;SLU7;GRSF1;SSU72;AHCYL1;CDC40;NCBP1;PABPN1
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.31734062303727306,-0.8923750195586998,0.5926892950391645,0.943114558594307,1.0,9/18,45.62%,CCT8;CEP135;CORO2B;TREM2;PTP4A3;CCT6A;TNF;CCT7;CCT2
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.34013997488373415,0.892317795819775,0.6119828815977175,0.9330361910039972,1.0,6/33,11.49%,AR;RUNX1;NCOA2;SAFB2;RNF6;UFL1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.31439632409111173,-0.8919490702147456,0.615979381443299,0.9429603341721239,1.0,10/21,27.54%,MBOAT1;PLA1A;PLAAT3;LPCAT3;PLA2G4F;PLA2G4E;PLA2G4B;PLA2G5;MBOAT2;LPCAT4
prerank,negative regulation of bone remodeling (GO:0046851),-0.3703070454021725,-0.891784338867704,0.5857142857142857,0.9422185458711885,1.0,3/11,11.50%,UBASH3B;P2RX7;TNFAIP3
prerank,mesenchyme morphogenesis (GO:0072132),-0.33818597303697606,-0.8912575991174492,0.613941018766756,0.9424217336581356,1.0,5/17,6.42%,NOTCH1;NOS3;ACVRL1;TGFB2;TBX2
prerank,oligodendrocyte differentiation (GO:0048709),0.38323320602629957,0.8912241181929388,0.6159754224270353,0.9347619978863372,1.0,5/19,16.72%,SLC8A3;EIF2B4;NSUN5;EIF2B3;SHH
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.3962260821264594,0.8909565731613573,0.5953177257525084,0.9347385995368712,1.0,5/15,20.49%,ZFP36L1;BCL2L11;REST;HNRNPU;ZFP36L2
prerank,sterol biosynthetic process (GO:0016126),0.34201798702583985,0.8908949707589218,0.6098265895953757,0.9343055774866511,1.0,5/33,9.34%,PRKAG2;INSIG2;APOA1;MVK;IDI1
prerank,negative regulation of TOR signaling (GO:0032007),0.33124139640964967,0.8907568911626277,0.6162790697674418,0.9340309487436647,1.0,12/36,17.39%,NPRL3;UBR2;PRKAA2;STK11;RNF152;CASTOR2;TSC2;ITFG2;SESN2;NPRL2;FNIP1;ATM
prerank,neuronal action potential (GO:0019228),-0.3110031341742784,-0.8906733800606851,0.5956284153005464,0.9426615258657082,1.0,10/22,20.84%,ANK3;SCN1A;SCN3A;KCNMB2;SCN2A;KCNA2;CACNA1H;GPER1;MYH14;SCN8A
prerank,glycoprotein metabolic process (GO:0009100),0.30718431923018974,0.8906240859322279,0.6158038147138964,0.9337548451518995,1.0,15/53,17.56%,GAL3ST2;PRKCSH;MAN1C1;LARGE1;ADAMTS9;NGLY1;ST6GALNAC6;GANAB;ENGASE;AGA;ERP44;GOLPH3;NEU4;MAN1A2;TNIP1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.31164072359434847,0.890502300991627,0.6103038309114928,0.9334628790171936,1.0,10/57,12.68%,UACA;DAPK1;ASPH;PDCD5;BCAP31;TTBK1;CARD9;DDX3X;REST;RIPK2
prerank,regulation of neuron projection arborization (GO:0150011),-0.33798967428965915,-0.8903334338430487,0.6342592592592593,0.9422934347657893,1.0,4/15,7.78%,MYO9A;FZD4;NTNG1;MFSD2A
prerank,anterior/posterior pattern specification (GO:0009952),0.3087653903355376,0.889889721394,0.6265389876880985,0.9341636025947462,1.0,9/53,15.01%,WLS;TGFBR1;SKI;HES7;BMP2;HOXC5;BHLHE41;ATP6AP2;HOXC4
prerank,skeletal muscle tissue development (GO:0007519),0.3397293291968735,0.8897760216438525,0.6109467455621301,0.9338471855239667,1.0,5/32,9.67%,SVIL;CFLAR;MSC;SKI;CSRP3
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.379260076740342,0.8897748953151619,0.6049766718506998,0.9332977136033043,1.0,7/18,16.33%,NFE2L2;NONO;PRKN;NOL3;VNN1;BAG5;AKT1
prerank,cellular protein catabolic process (GO:0044257),0.3067622459497211,0.8897081825109558,0.6018766756032171,0.9328810880948853,1.0,10/59,13.36%,ADAMTS12;CTSH;CTSF;CLPX;PRKN;CLPP;RSPRY1;CPA2;CTSZ;CTSL
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.39408243611578286,0.8892842886865223,0.606418918918919,0.9331996852407565,1.0,4/15,15.93%,FAF2;DERL1;SELENOS;AUP1
prerank,tryptophan catabolic process (GO:0006569),0.42030334032210726,0.8892695976047537,0.5862068965517241,0.9326784526806557,1.0,2/11,6.78%,TDO2;KYNU
prerank,vasoconstriction (GO:0042310),0.42172534158286074,0.8892019638042449,0.5975820379965457,0.9322838273154658,1.0,1/11,1.14%,SLC8A1
prerank,response to unfolded protein (GO:0006986),0.3170573336292085,0.889118016386716,0.6354883081155434,0.931886085850739,1.0,18/48,24.70%,OPTN;DERL1;SERPINH1;PRKN;HSPB7;HSPA9;TM7SF3;TOR1B;TMBIM6;ERP44;HSPB2;HSF1;DDIT3;HSPA14;HSPA5;DNAJA1;HSPA4;BAG3
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.2318206416500459,-0.8889341278821119,0.6936936936936937,0.9445160142213597,1.0,25/69,30.04%,PTPRJ;IFIH1;THBS1;PLCG2;IL33;LBP;ARHGEF2;JAK2;APP;NOD2;PTPRC;TLR4;CLU;DHX9;FZD5;AGER;TWIST1;IFNGR1;MIF;TMEM106A;C1QTNF4;LPL;TLR1;IL1A;HSPB1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.35988480077447743,0.8885760275923503,0.6356821589205397,0.9324842405441276,1.0,9/26,16.33%,PYCR1;LRRK2;NFE2L2;PRKN;REST;NOL3;VNN1;BAG5;AKT1
prerank,negative regulation of growth (GO:0045926),0.2805341751942835,0.8884792331292977,0.6728971962616822,0.9321351306911534,1.0,24/121,13.03%,GJA1;ENPP1;SMAD3;NOTCH2;TSPYL2;MT3;SFRP1;BCL6;APBB2;PML;ING5;SPHK2;STK11;RBBP7;SLIT3;DDX3X;JADE1;CGRRF1;ST7L;NME6;CDA;SIPA1;ACVR1B;MUL1
prerank,acyl-CoA metabolic process (GO:0006637),0.33566918460059375,0.8881909441059032,0.5965166908563135,0.9321748412283432,1.0,8/35,17.19%,ACOT11;ACOT6;ACOT2;SUCLG2;ACSF2;HMGCS1;ACOT9;OXSM
prerank,positive regulation of dephosphorylation (GO:0035306),-0.28726820369004774,-0.8879939450086024,0.6706948640483383,0.9455477688181438,1.0,8/27,11.48%,PPP1R16B;PPIA;PPP2R5A;SPPL3;CALM1;MTMR9;CALM3;TGFB1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.3140673793449211,0.8876611979492861,0.6308100929614874,0.9326949697607817,1.0,2/48,0.72%,PDPK1;CEMIP
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.2955478864029805,0.8873804883058672,0.6336760925449871,0.9327307350139411,1.0,18/72,24.39%,ENPP1;OGG1;GTF2H5;CUL4B;REXO4;DXO;DNASE1L1;DCP1A;DDX1;XPA;DICER1;RFC5;FAN1;EXD2;ERCC3;ERCC2;SPO11;MRE11
prerank,positive regulation of ruffle assembly (GO:1900029),-0.353489908285503,-0.8872548957679007,0.5957943925233645,0.9461803701586606,1.0,2/13,7.19%,NLGN1;EPS8L2
prerank,ganglioside metabolic process (GO:0001573),0.3649869266013578,0.8868790482735559,0.596244131455399,0.9331785666386229,1.0,2/20,2.41%,ST6GALNAC5;ST3GAL5
prerank,organelle disassembly (GO:1903008),-0.27606571201399505,-0.8868519028123599,0.621875,0.9459251660228557,1.0,6/33,11.06%,VRK1;MRRF;TEX264;ULK1;GFM2;UBA5
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.3683921658424961,-0.8862218666499646,0.6211764705882353,0.9451626732513922,1.0,8/11,31.94%,CALM1;CALM3;CASQ2;FKBP1A;CALM2;SRI;FKBP1B;GSTO1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.3683921658424961,-0.8862218666499646,0.6211764705882353,0.9451626732513922,1.0,8/11,31.94%,CALM1;CALM3;CASQ2;FKBP1A;CALM2;SRI;FKBP1B;GSTO1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.2603684027415917,-0.8848076422735117,0.6578073089700996,0.9474354208647279,1.0,16/38,28.83%,NDUFC1;NDUFA6;NDUFA5;NDUFA7;NDUFA8;NDUFB7;NDUFA3;NDUFA10;NDUFS7;NDUFS1;NDUFS5;NDUFB3;NDUFAB1;NDUFB4;NDUFV2;NDUFV3
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.3036597475987008,0.8847527751492502,0.6770833333333334,0.9370117389645837,1.0,14/65,14.14%,ERRFI1;AREG;TGFA;EPGN;CDC42;EPS15;EGFR;SPRY2;HBEGF;EPS15L1;PTPN3;EGF;MVP;PDE6G
prerank,organic substance transport (GO:0071702),0.2765392584516575,0.8847381192020702,0.6760895170789164,0.9364942965968753,1.0,20/121,14.23%,TXNIP;ARRDC4;ABCA1;ABCA9;LMAN2L;SLC22A2;APOA1;SLC35F3;TOM1;PLEKHA8;SLC22A4;MIA3;ABCB9;ARRDC2;SLC22A18;RCN3;SLC48A1;SLC18A2;ABCA3;ABCD2
prerank,protein maturation (GO:0051604),0.28557113342501694,0.8846111606738787,0.6469864698646987,0.9362107560947995,1.0,10/95,11.91%,CPXM2;OGT;AEBP1;CPXM1;MMEL1;ECE2;EEF1AKMT4-ECE2;LONP2;APH1B;CLN3
prerank,neuron remodeling (GO:0016322),-0.3850395438650669,-0.8845970548161156,0.6292906178489702,0.9467644138835821,1.0,5/10,22.38%,ADGRB3;SCARF1;APP;ANKS1A;RND1
prerank,regulation of platelet activation (GO:0010543),0.37206506858904964,0.884521971846639,0.6010016694490818,0.9358290627594845,1.0,6/21,12.07%,LYN;PDGFRA;APOE;PLA2G4A;F2;C1QTNF1
prerank,acetyl-CoA metabolic process (GO:0006084),0.39978501625223933,0.8844273265393341,0.6139767054908486,0.9354626392015687,1.0,3/15,5.15%,TDO2;MVK;NUDT7
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.3077516390354415,0.8841491232243855,0.6484375,0.9354806406946403,1.0,10/50,12.98%,SASH1;CCL19;IL12B;NMI;EGFR;ACTN4;TRIP6;DDX3X;PDCD4;CD14
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.30078560035444457,-0.8840927692127181,0.6266666666666667,0.9467654435972345,1.0,5/23,13.49%,ELOVL7;FAR2;ELOVL5;TECR;HACD2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.34728679847813215,0.8837521744582866,0.628125,0.9357722366929587,1.0,3/26,10.63%,HECW2;ANAPC5;NEK6
prerank,actin filament-based transport (GO:0099515),0.364399964626,0.8831483068720634,0.6134185303514377,0.9365316817269279,1.0,4/21,9.29%,SYNE2;MYO1B;MYO1C;ACTN4
prerank,metanephric mesenchyme development (GO:0072075),0.42160773844648647,0.8824427089516359,0.6090225563909775,0.9373718745428912,1.0,5/10,24.84%,WNT4;OSR1;SHH;PKD2;STAT1
prerank,renal absorption (GO:0070293),0.4205032906772939,0.8824107117240582,0.6143106457242583,0.9368932906453956,1.0,1/10,1.20%,GSN
prerank,protein-DNA complex disassembly (GO:0032986),0.3712171011315831,0.8823400670097518,0.5915254237288136,0.9364731689063558,1.0,6/16,23.33%,SMARCC2;NFE2;SMARCD2;SMARCB1;ARID2;SMARCE1
prerank,neutral amino acid transport (GO:0015804),-0.2949204717450066,-0.8822876691957001,0.6458333333333334,0.9498971264248072,1.0,8/28,13.96%,SLC6A6;SLC7A5;SLC38A5;SLC1A1;SLC43A2;SLC36A4;SLC3A2;SLC1A4
prerank,monocyte differentiation (GO:0030224),0.4328394671483485,0.8814160319040194,0.6149825783972126,0.9377802075924726,1.0,1/10,1.75%,IL31RA
prerank,photoperiodism (GO:0009648),0.34208642408291695,0.8813912586339804,0.625920471281296,0.9372886477465345,1.0,7/28,15.43%,FBXL17;PML;SIK1;FBXL3;FBXL12;PER3;RBM4B
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.3267488605085251,0.8813539381800826,0.628005657708628,0.9368171241954377,1.0,7/39,12.38%,BMP6;APOA1;BMP2;MYADM;MIA3;RGCC;WNK1
prerank,ovarian follicle development (GO:0001541),0.40484088481032665,0.8812787913759703,0.6179966044142614,0.9364239611860063,1.0,4/13,11.10%,KIT;LHCGR;EIF2B4;CEBPB
prerank,icosanoid secretion (GO:0032309),-0.35463962527388077,-0.8810813159680552,0.6524822695035462,0.9515503707446247,1.0,7/12,31.30%,ABCC4;PNPLA8;ANXA1;NMUR2;PLA2G5;NOS2;ACE
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.2921411082051534,0.8809924822527371,0.6472868217054264,0.9364737024321205,1.0,8/76,8.21%,ADRA1B;ACTN2;LTB4R;VIP;LHCGR;AGTR1;LPAR1;DRD3
prerank,positive regulation of defense response (GO:0031349),0.28576111379476915,0.8795316393728251,0.6609124537607891,0.9388414999827114,1.0,22/89,17.97%,SERPINE1;OPTN;IL12B;CEBPA;AGTR1;TSLP;NMI;CCN4;SETD4;IFNK;NAPEPLD;PDCD4;NPAS2;ETS1;MDK;RIOK3;TNFRSF1A;CD47;IL23A;CX3CL1;TNIP1;IL18
prerank,axonal transport (GO:0098930),-0.26620136573834324,-0.8794674625341352,0.6666666666666666,0.9544177325849909,1.0,15/36,27.59%,RAB21;AP3B1;TMEM108;SYBU;PAFAH1B1;KIF1A;DCTN1;HIF1A;AP3S1;BLOC1S5;KIF4A;HAP1;KIF1B;AP3B2;SOD1
prerank,positive regulation of lyase activity (GO:0051349),-0.3366365903609499,-0.8793829586537151,0.6447688564476886,0.9534917088986908,1.0,5/14,15.08%,NOS3;NOS1;NF1;ISCU;CACNA1D
prerank,DNA replication checkpoint signaling (GO:0000076),-0.3253630911380239,-0.878997322791415,0.6340852130325815,0.9532331003127319,1.0,9/16,40.75%,RAD17;TOPBP1;HUS1;HUS1B;CDC6;TICRR;RAD9A;RAD9B;CDT1
prerank,dendritic cell chemotaxis (GO:0002407),0.3933134597344242,0.8786542778022788,0.6153846153846154,0.9400472820426101,1.0,2/14,9.41%,CCL19;TRPM4
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.4180430067869381,0.8778901982149748,0.6073943661971831,0.9410458236026993,1.0,3/11,8.76%,EFNB2;FRS2;BMP2
prerank,intracellular protein transport (GO:0006886),0.25443648794036006,0.877840121235317,0.7526096033402923,0.9406019754117186,1.0,56/304,16.33%,WLS;RABGAP1L;TBC1D4;KIF13B;USP6NL;RANBP17;SEC31A;NUP107;APPL2;FAM53C;PRICKLE1;TMED1;VPS26C;RAB23;STXBP3;LMAN1;FUT10;STX16;COX18;ARFGAP3;ADPRH;TRARG1;LTBP2;NUP42;IFT27;MYO1C;RAB22A;COPZ2;ARFIP2;XPO7;KATNB1;HEATR3;TBC1D2B;ARL1;GGA2;TMED4;CSE1L;PPP1R10;STXBP1;TLK1;STRADA;COPA;USO1;TSC2;ARF4;NUP214;SNX9;IFT22;ARF6;LAMP2;STX1B;ARL5A;SNX31;RAB19;TECPR2;AKT1
prerank,inositol phosphate catabolic process (GO:0071545),0.40514035081399014,0.8774771181769678,0.6139767054908486,0.9407801505159263,1.0,2/12,4.33%,INPP5A;SYNJ2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.22948656766026662,-0.8774379468646647,0.7359307359307359,0.9557488119276055,1.0,24/74,23.95%,NOTCH1;EGLN3;RBX1;EGLN2;VEGFA;PSMF1;PSMB8;PSMA4;PSMB10;HIF1A;PSMB2;HIGD1A;CUL2;EP300;CITED2;PSMC4;PSMA6;PSMD9;PSMD11;PSMD5;BACH1;VHL;PSMA8;PSMB1
prerank,negative regulation of JNK cascade (GO:0046329),0.3347563847579423,0.8774371047503656,0.6237037037037036,0.9403087894927042,1.0,7/31,12.63%,DACT1;NCOR1;PRKN;ITCH;TAOK3;DUSP19;PDCD4
prerank,protein K63-linked deubiquitination (GO:0070536),-0.2759563084283897,-0.877206353545962,0.6686217008797654,0.9551152856028134,1.0,10/31,27.61%,OTUD7B;OTUD7A;OTUD4;YOD1;TNFAIP3;BABAM1;BABAM2;USP7;OTUB2;USP33
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.34328603911146005,-0.8772006118067586,0.6292682926829268,0.9539785959847712,1.0,3/14,9.59%,ADAM10;ABCG1;ADAM19
prerank,cardiac ventricle development (GO:0003231),-0.30994857650381025,-0.8765278286165676,0.6382428940568475,0.9544352505428816,1.0,9/20,21.70%,NOTCH1;PDE2A;HEY2;HES1;STRA6;HEY1;DLL4;HEYL;GJA5
prerank,regulation of TORC1 signaling (GO:1903432),0.32787321174507295,0.8764069130470833,0.6316568047337278,0.9418118269323122,1.0,12/33,20.42%,TELO2;STK11;RNF152;CASTOR2;RRAGD;ITFG2;SESN2;ATM;SEH1L;DYRK3;GPR137B;SZT2
prerank,regulation of defense response to virus by host (GO:0050691),-0.28044691775509184,-0.8760866235699254,0.6324786324786325,0.9543265864232469,1.0,12/30,27.98%,TOMM70;AIM2;TNFAIP3;CGAS;PTPN22;TRIM6;DHX9;EIF2AK4;TRIM44;IFNLR1;LILRB1;TRAF3IP2
prerank,mitotic recombination (GO:0006312),0.3858031985674485,0.8756716135770799,0.6186440677966102,0.9427108741177465,1.0,5/15,14.13%,DMC1;SMC5;SMC6;TEP1;RAD51D
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.3366361485433759,0.8755948700422528,0.6551724137931034,0.9423130604587937,1.0,8/33,16.33%,AREG;TGFA;EPGN;HBEGF;ADRA2A;EGF;PDE6G;AKT1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.34826618483747035,0.8752227655370151,0.6236722306525038,0.9424733316663104,1.0,6/27,14.90%,TNRC6B;MAP2K1;WTIP;EGFR;MYCN;BMP4
prerank,phagosome-lysosome fusion (GO:0090385),0.4117607586516401,0.8747361921361161,0.6035087719298246,0.9428933365585971,1.0,3/10,15.39%,RAB7B;CLN3;PIKFYVE
prerank,base conversion or substitution editing (GO:0016553),0.41143126819117926,0.8745489653407754,0.5978260869565217,0.9427219412834588,1.0,1/11,1.90%,A1CF
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.32119983973853933,0.8738269858508575,0.6154910096818811,0.9436547090225729,1.0,5/38,5.06%,SERPINE1;SP100;CFLAR;RFFL;SFRP1
prerank,glucose transmembrane transport (GO:1904659),-0.3192997942156801,-0.8736052718563978,0.645320197044335,0.9589587167529399,1.0,2/18,2.87%,SLC2A1;PPARD
prerank,mesonephric tubule development (GO:0072164),0.38045378457187096,0.8734608317220813,0.6196213425129088,0.9438208501288178,1.0,3/15,7.90%,SALL1;FGFR2;OSR1
prerank,mesoderm formation (GO:0001707),0.38171529906652113,0.8734276481178556,0.6348228043143297,0.9433408363824848,1.0,3/17,9.59%,ITGA3;CRB2;ITGB3
prerank,histone mRNA catabolic process (GO:0071044),0.3928209838885791,0.8733778457542324,0.6306156405990017,0.9428993169668752,1.0,5/15,17.39%,TUT7;ERI1;TUT4;TENT4B;ATM
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.3770585420863084,0.8726798824017421,0.6143572621035058,0.9431996360990661,1.0,3/15,6.71%,ZFP36L1;TNRC6B;CPEB3
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.3770585420863084,0.8726798824017421,0.6143572621035058,0.9431996360990661,1.0,3/15,6.71%,ZFP36L1;TNRC6B;CPEB3
prerank,mitochondrion localization (GO:0051646),0.35677624072876224,0.8725367238679335,0.6103059581320451,0.9429570808461053,1.0,4/19,13.60%,MARK1;LRRK2;MUL1;MARK2
prerank,cytoplasmic translational initiation (GO:0002183),0.37730362774108767,0.8724216877382985,0.6148867313915858,0.9426489956992801,1.0,8/17,23.86%,EIF4A2;EIF3A;EIF2S2;EIF2B3;EIF3I;RBM4;MCTS1;EIF2D
prerank,neuron fate commitment (GO:0048663),0.39810773803337185,0.8724148038454603,0.6359060402684564,0.9421218344017346,1.0,2/14,3.58%,ASCL1;TGFBR1
prerank,morphogenesis of an epithelium (GO:0002009),0.34734522299027404,0.8721200223837637,0.6243980738362761,0.9421700056470449,1.0,3/25,6.80%,DAG1;FGFR2;VCL
prerank,tRNA transport (GO:0051031),-0.26437647935685726,-0.8719763588759112,0.6721311475409836,0.961638252467748,1.0,11/35,22.14%,NUP93;NUP35;NUP153;NUP160;NUP54;SEC13;NUP155;RANBP2;NUP88;NUP62;NUP85
prerank,negative regulation of biosynthetic process (GO:0009890),0.37726460933359873,0.8719479814033296,0.615,0.9419745256915265,1.0,4/16,14.23%,EMILIN1;SLC30A10;SLC18A2;ABCD2
prerank,embryonic axis specification (GO:0000578),-0.3328719983925007,-0.8718541352848536,0.6253101736972705,0.9607566291523816,1.0,5/15,19.91%,COBL;TASOR;STIL;PTCH1;FZD5
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.3743443440783898,-0.8717694965321584,0.6283783783783784,0.9597980602210742,1.0,3/10,10.46%,MYO9A;OPHN1;MSN
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.2710906779935707,-0.8712732751439873,0.6656050955414012,0.9598415586749578,1.0,12/33,24.26%,NET1;RPS3;SIRPA;RHOB;PLEKHA1;TNFAIP3;SIRT1;SIGMAR1;ECT2;ANXA1;RNF112;MAPK7
prerank,protein polyubiquitination (GO:0000209),0.25209381750607013,0.8712186075157967,0.7681007345225603,0.9429192730808873,1.0,71/297,20.65%,SPSB1;HECW2;SASH1;BCL2;PELI2;FBXL17;UBR2;FBXL19;NEDD4;RFFL;SMURF2;PSME4;RNF213;BFAR;RNF31;UBE4B;TRIP12;UBE2U;FBXL3;UBE2V2;UBOX5;ANAPC5;FBXO28;PRKN;ITCH;IFI27;RNF6;RNF152;FBXO9;FBXO11;KBTBD7;ERCC8;FBXO4;FBXL12;BTRC;RNF217;MUL1;TNKS2;RNF19A;RC3H2;UBE2E2;AMFR;FBXO38;THOP1;UBE2D1;HACE1;HUWE1;DZIP3;NHLRC3;SPOP;UBR5;UBE2R2;UBE3B;UBE3A;PSMB5;RNF135;PSMC2;HERC6;UNKL;RC3H1;RNF34;PSMD1;TRIM32;PSMD4;PSME3;TRIM21;FBXL18;ARIH2;CDC23;UBE2T;PSMA3
prerank,positive regulation of RNA splicing (GO:0033120),0.3355580453151686,0.8711628740776032,0.6387195121951219,0.9424785288577864,1.0,6/29,15.61%,PIK3R1;HNRNPLL;RBM22;NUP98;DYRK1A;SLC38A2
prerank,tryptophan metabolic process (GO:0006568),0.41421792969809357,0.8707678966536209,0.6226086956521739,0.9427428659738362,1.0,2/11,6.78%,TDO2;KYNU
prerank,regulation of cellular component size (GO:0032535),-0.2776006934385638,-0.870679046124818,0.6555891238670695,0.960085597919584,1.0,7/30,12.39%,VAV3;RDX;RAP1GAP2;RIN3;LARS1;MSN;MTOR
prerank,response to interferon-gamma (GO:0034341),0.29430959622208197,0.8701029776319638,0.6461949265687583,0.9435243000943886,1.0,6/67,6.78%,DAPK1;SP100;CCL19;CXCL16;CCL4;KYNU
prerank,regulation of protein binding (GO:0043393),0.27458205008359327,0.8699324018050556,0.6956521739130435,0.9433135321201971,1.0,22/114,15.17%,TCF7L2;LRP1;DACT1;VTN;RAPGEF2;DERL1;LRRK2;STK4;DAB2;BMP2;PRKN;TTBK1;NMD3;RIPK2;CTSZ;IFIT2;CFHR2;MARK2;HDAC4;AMFR;BMP4;TMBIM6
prerank,regulation of muscle cell differentiation (GO:0051147),0.3401140267610225,0.8698680027615109,0.6234756097560976,0.9429002215622324,1.0,3/31,6.16%,IGF2;FGFR2;CDC42
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.3618191984237922,-0.8698659169394006,0.6533333333333333,0.9607495593644496,1.0,4/11,19.01%,EGLN3;EGLN2;P4HA3;P3H2
prerank,negative regulation of cell cycle (GO:0045786),0.29440472396323764,0.8697830375316006,0.6670886075949367,0.9425313909222974,1.0,17/73,15.86%,SMAD3;NR2F2;NUPR1;TSPYL2;CEBPA;BMP2;HEXIM2;INCA1;NR4A1;PDCD4;SIPA1;PTPN3;PTEN;BMP4;GAS1;CDKN1C;ZBTB17
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.3297735046032006,-0.8689974277301881,0.6631853785900783,0.9615773958094236,1.0,11/14,35.65%,PRKCZ;CD80;NFKBIZ;CD86;ANXA1;MALT1;RARA;NFKBID;NLRP3;SOCS5;MYB
prerank,regulation of type I interferon production (GO:0032479),-0.22145712388531094,-0.8684657653935395,0.7475728155339806,0.9616543970406172,1.0,20/84,19.40%,IFIH1;RNF125;LRRFIP1;POLR3H;TRIM25;NLRC5;TNFAIP3;CGAS;G3BP1;PTPN22;PRKDC;IRF5;PCBP2;EP300;DDX41;IRF8;POLR2E;UFD1;TAX1BP1;DHX9
prerank,positive regulation of cell adhesion (GO:0045785),0.28514866898438446,0.8684294702388948,0.6962025316455697,0.9446451110770241,1.0,11/74,9.63%,RHOD;TPM1;EPHA4;PPP3CA;ECM2;IL12B;AFDN;FOXC2;ARL2;RSU1;ITGAV
prerank,DNA metabolic process (GO:0006259),0.2520214728106405,0.8683343578667905,0.7557894736842106,0.9443069389119085,1.0,79/270,26.39%,TCF7L2;SP100;PDS5B;OGG1;PSME4;AXIN2;LIG4;NEIL1;INO80;RAD51B;DMC1;POLG;REXO4;UBE2U;TOP3B;TOP2B;POLL;RECQL5;KMT5B;UBE2V2;ZBTB1;POLE3;DNASE1L1;DNASE2;DDX23;RAD18;FANCC;MBD4;UVRAG;TERF2;MCM2;MNAT1;RAD51D;RTEL1;SMARCB1;XRCC2;LONP1;PRIMPOL;KPNA2;TIMELESS;ATM;CDC7;KAT5;ALKBH1;XPA;ENDOV;RAD54L;SUMO1;RFC5;FAN1;USP3;UBE2T;EXD2;MUTYH;CBS;RMI2;DNMT1;NSMCE4A;ERCC3;SMARCAD1;NOC3L;FANCA;LIG1;BRCA1;POLI;TDG;MSH6;NABP2;MRE11;POLE2;MCM6;HMGB3;MPG;ATRIP;RAD50;RPAIN;MMS19;UPF1;HMGB1
prerank,RNA transport (GO:0050658),0.29175849507181917,0.8682194136735273,0.6670870113493065,0.9439755110083156,1.0,12/71,14.58%,RBFOX1;RFTN1;U2AF1L4;SIDT1;ZFP36L1;THOC2;HNRNPA1;DDX39A;RAE1;MAGOHB;NUP214;SRSF5
prerank,modulation by host of symbiont process (GO:0051851),-0.2685568381072302,-0.8676762393609,0.6504854368932039,0.9622644953605359,1.0,8/31,16.95%,LEF1;CHD1;SNW1;INPP5K;CX3CR1;JUN;EP300;TFAP4
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.2473720335158388,-0.8667794456191226,0.6879699248120301,0.9631106470198817,1.0,11/52,12.06%,PPP1R13B;YWHAH;YWHAQ;SAE1;GSK3A;ABLIM3;MAPK8;CASP8;YWHAG;BBC3;UBE2D3
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.3038636190624535,-0.8667618424647584,0.6955380577427821,0.9620201888792204,1.0,11/22,28.24%,MVB12B;VPS37B;VPS37A;RNF126;VPS28;VPS36;VPS4A;VPS37C;SNF8;MVB12A;UBAP1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.35219638034816625,-0.866761270958126,0.6270022883295194,0.9608840038238657,1.0,3/12,11.48%,ESR1;LIN28B;TGFB1
prerank,positive regulation of neuron migration (GO:2001224),-0.3772248943520476,-0.8664070873684949,0.6490825688073395,0.9605386008453409,1.0,5/11,20.82%,SEMA6A;ARHGEF2;KIF20B;SHTN1;DAB2IP
prerank,regulation of ATP biosynthetic process (GO:2001169),0.3825628598539178,0.8663252589364843,0.6291946308724832,0.9471599518629378,1.0,2/16,7.21%,PID1;SPHK2
prerank,negative regulation of viral process (GO:0048525),-0.24432310286420944,-0.8657206097542091,0.728,0.9609031509852185,1.0,21/57,29.88%,IFIH1;TRIM14;PPIA;SRPK1;FAM111A;TRIM11;TRIM6;N4BP1;TRIM62;OASL;PLSCR1;IFITM3;TRIM28;TRIM13;MID2;UBP1;ISG15;ISG20;TRIM35;IFIT1;ZC3HAV1
prerank,positive regulation of isotype switching (GO:0045830),-0.33000169094454085,-0.8657001513724459,0.6609336609336609,0.9598215858128941,1.0,4/15,11.96%,TFRC;SHLD1;TGFB1;CD40
prerank,embryonic appendage morphogenesis (GO:0035113),0.4058961840068438,0.8656434842662313,0.6191369606003753,0.947956674355652,1.0,2/12,5.82%,CYP26B1;SKI
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.31591621636711037,0.8655633193619581,0.6457461645746164,0.9475666048668829,1.0,14/41,20.11%,OGT;PRKAG2;NUP107;NUP42;EIF6;NUP98;RAE1;NUP214;LACC1;GCK;SEH1L;TPR;PRKAG1;AAAS
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.3191129673419688,-0.8652707758182442,0.6474820143884892,0.9597030293634625,1.0,8/16,31.19%,TRIB2;TNFRSF21;JAK3;DLL1;AGER;VSIR;LILRB1;FCGR2B
prerank,regulation of protein localization (GO:0032880),0.30215665418623555,0.8647495696771216,0.654843110504775,0.9486136503675544,1.0,9/58,11.49%,RABGAP1L;WDPCP;DZIP1L;VIP;AFDN;PICALM;ITGB3;PLEKHM2;UFL1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.36295102740060575,-0.8646648450616382,0.6607929515418502,0.9599769455567864,1.0,5/11,30.83%,PWP1;MTOR;SMARCA4;PIH1D1;IPPK
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.26717193023203567,-0.8643875352316287,0.6824817518248175,0.9594781731323071,1.0,16/38,29.15%,HIRA;MIS18BP1;KNL1;H3-3A;RUVBL1;RSF1;NPM1;CENPI;CENPN;CABIN1;NASP;ASF1A;HAT1;ASF1B;HJURP;ITGB3BP
prerank,placenta development (GO:0001890),-0.3335893212841837,-0.86412122444027,0.6523929471032746,0.958960038255841,1.0,6/12,30.93%,ADAM19;E2F7;PLAC1;SOD1;E2F8;PTK2
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.3845159785283617,0.8633515767349875,0.622673434856176,0.9507794833821906,1.0,4/15,15.05%,SMPD2;SPHK2;NSMAF;TNFRSF1A
prerank,regulation of vasculogenesis (GO:2001212),0.38471775065059843,0.8632860697068643,0.6199677938808373,0.9503642791619065,1.0,2/14,4.33%,RIN2;RAPGEF2
prerank,response to acidic pH (GO:0010447),-0.34520218809627606,-0.8631013582769027,0.6752941176470588,0.9601362672463049,1.0,5/13,26.08%,LGMN;GPR4;CTSS;RAB11FIP5;PKD2L1
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.3474203621680202,-0.8629868706646587,0.627039627039627,0.9592782933985239,1.0,4/11,12.86%,YBX3;ARHGEF2;CASP8;SLC25A4
prerank,carboxylic acid metabolic process (GO:0019752),0.3289557284407806,0.8627475473086637,0.6478454680534919,0.9508546447403166,1.0,5/33,11.08%,PTGIS;PLA2G4A;DDO;CYB5A;LIAS
prerank,detection of visible light (GO:0009584),0.3808933523539102,0.8626412826209998,0.6363636363636364,0.9505353914394945,1.0,1/16,2.64%,TULP1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.2790170814850217,-0.8623214790146311,0.6430678466076696,0.9596102147377177,1.0,4/26,13.18%,CAV1;LBP;IFI35;PTPN22
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.36408393853797666,-0.8621017776763032,0.6606741573033708,0.9590103266661923,1.0,7/10,55.05%,CCT8;CCT6A;CCT7;CCT2;TCP1;WRAP53;DKC1
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.40314520256997854,0.86204792193134,0.6638370118845501,0.9511458765817711,1.0,2/12,5.02%,APOE;LDLR
prerank,positive regulation of glucose metabolic process (GO:0010907),0.38270420662204496,0.8618256585506344,0.6453287197231834,0.9510435133600922,1.0,2/14,4.38%,NNMT;SLC45A3
prerank,positive regulation of cartilage development (GO:0061036),-0.311337591065051,-0.8613760446768259,0.6592592592592592,0.9595549935501806,1.0,3/17,5.23%,ZBTB16;ACVRL1;PKDCC
prerank,mitochondrial gene expression (GO:0140053),-0.24740467890223994,-0.8612579152358683,0.7062937062937062,0.9587028298161989,1.0,12/42,20.17%,TFB2M;NOA1;GFM2;SLC25A33;MRPS18A;MRPS12;NDUFA7;FASTKD2;MRPL57;MRPS18B;MRPS21;MRPS7
prerank,positive regulation of ERAD pathway (GO:1904294),0.3897597844273441,0.860984036523314,0.6143344709897611,0.9521493500385125,1.0,5/13,12.77%,NFE2L2;RNF185;BCAP31;TMEM259;RNFT1
prerank,response to exogenous dsRNA (GO:0043330),0.36599215030603044,0.8609675852588878,0.654485049833887,0.9516389007266925,1.0,5/18,13.03%,COLEC12;RFTN1;IRAK3;IFNK;MUL1
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.3516417393515585,-0.8608502402572125,0.6658476658476659,0.9584591029989901,1.0,3/12,13.55%,MAOA;ATP7A;DDC
prerank,DNA strand elongation (GO:0022616),-0.3071535004167914,-0.8601534329208367,0.6551724137931034,0.9588657655669147,1.0,9/18,34.69%,DCLRE1B;GINS3;NBN;MCM3;GINS2;POLA1;POLD2;TERT;MCM7
prerank,platelet aggregation (GO:0070527),0.3308973641811437,0.85898496062347,0.64,0.9548805805906995,1.0,10/33,15.82%,GNAS;PDGFRA;MYL12A;TLN1;STXBP3;VCL;ITGB3;STXBP1;FLNA;FIBP
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.3338357448774375,-0.8589698942344622,0.6420323325635104,0.9604499649565349,1.0,5/13,29.56%,ANAPC15;CDK5RAP2;GEN1;LCMT1;DYNC1LI1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.4079885302641388,0.858911841855729,0.6201413427561837,0.9544741112196633,1.0,3/10,10.79%,KLF15;PRKAA2;SETD5
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.3303280444621808,0.8583518394910844,0.6449612403100775,0.9550487755125702,1.0,3/30,4.51%,SLC27A5;ACSL1;ACOT2
prerank,protein monoubiquitination (GO:0006513),0.32400961897177594,0.8577520873448955,0.657856093979442,0.955693821962267,1.0,14/36,22.33%,MGRN1;ATXN7L3;PRKN;RAD18;PAF1;KLHL12;HUWE1;UBE2R2;WAC;CDC73;TRIM21;UBE2T;LEO1;RNF20
prerank,regulation of regulated secretory pathway (GO:1903305),-0.26279738143825115,-0.8574736106797722,0.7284345047923323,0.9627115011986124,1.0,13/34,23.10%,RIMS1;RAB27A;RIMS2;SYT1;SYT6;RAB15;RAB3A;SYT4;SYN1;RIMS3;SYT15;GSK3B;SYT5
prerank,endodermal cell differentiation (GO:0035987),0.32510920112383357,0.8571420423804955,0.6443452380952381,0.956304361797605,1.0,9/31,18.32%,COL11A1;MMP2;VTN;ITGB5;ITGAV;PAF1;COL4A2;MMP14;CDC73
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.33214667039104456,0.8565239732814725,0.6474926253687315,0.9569685704052465,1.0,5/29,9.41%,PLEKHH2;KANK1;LIMA1;PRKN;MYADM
prerank,DNA repair (GO:0006281),0.24913294749847767,0.8564770179395307,0.781414994720169,0.9565260421321693,1.0,94/284,26.37%,EYA1;PDS5B;OGG1;PSME4;HPF1;LIG4;USP47;NEIL1;INO80;RAD51B;GTF2H5;CUL4B;SPRTN;ERCC6L2;REXO4;UBE2U;DCLRE1C;POLL;RECQL5;KMT5B;UBE2V2;MLH1;COMMD1;ZBTB1;ASCC3;WDR33;EXO5;BAZ1B;ACTR8;TENT4A;TDP2;ERCC8;DCLRE1A;RAD18;FANCC;MBD4;UVRAG;MNAT1;RAD51D;FANCE;FANCI;HUWE1;XRCC2;PRIMPOL;KPNA2;TIMELESS;ATM;KAT5;ALKBH1;DDX1;XPA;ENDOV;RAD54L;KDM4A;SUMO1;RFC5;UIMC1;FTO;BRCC3;FAN1;USP3;UBE2T;EXD2;MUTYH;RMI2;NSMCE4A;ERCC3;EME2;APLF;FANCA;CENPX;LIG1;BRCA1;ERCC2;ATXN3;VCPIP1;SETX;POLI;TDG;MSH6;NABP2;RAD51AP2;MRE11;POLE2;MPG;XRCC4;ATRIP;ABL1;RAD23B;RAD50;RPAIN;BAP1;MMS19;UPF1
prerank,positive regulation of transporter activity (GO:0032411),0.3913822407573012,0.8564502074043503,0.6354344122657581,0.9560388608654451,1.0,6/13,20.47%,SYNGR3;KMT2A;NR1H3;RXRA;KCTD7;SGK2
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.2768331509783707,-0.8563254153275953,0.6852941176470588,0.9640319261087583,1.0,13/27,25.99%,KDM1A;PTTG1IP;SMYD2;SIRT1;KMT5A;SPRED2;CD44;DDX5;MSX1;SNAI2;TWIST1;MIF;SNAI1
prerank,polyol biosynthetic process (GO:0046173),-0.3317368080345802,-0.8562628138425673,0.6799007444168734,0.9630578850803819,1.0,4/16,11.02%,ACER3;IP6K1;ISYNA1;IPMK
prerank,regulation of mitochondrion organization (GO:0010821),0.3030183476004888,0.856186898558072,0.6759002770083102,0.9560206297702765,1.0,8/47,13.10%,PID1;LRRK2;SREBF1;PRKN;STAT2;RHOT1;MUL1;VDAC1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.35145671479494456,-0.8561708810374536,0.6698113207547169,0.9621254219495635,1.0,2/11,11.53%,MSH3;ZRANB3
prerank,endocardial cushion development (GO:0003197),-0.29545379244460135,-0.8552255245980138,0.6861111111111111,0.9630222106079234,1.0,10/21,21.06%,NOTCH1;NOS3;ACVRL1;TGFB2;TBX2;HEY1;BMPR2;HEYL;CRELD1;FOXF1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.27359694399330337,-0.8551384537895931,0.72,0.9621009076491381,1.0,11/31,25.11%,EDC3;LSM2;LSM6;DIS3L2;EXOSC5;CNOT7;DCP2;CNOT8;DCPS;LSM7;EXOSC4
prerank,regulation of telomere capping (GO:1904353),-0.2914581336571773,-0.8548156517356017,0.6727272727272727,0.9617438220857202,1.0,8/23,24.24%,NEK7;PKIB;HNRNPD;MAPK3;PNKP;NBN;MAPK1;USP7
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.300890657772216,0.8537467802334187,0.6807639836289222,0.9601785482049602,1.0,15/51,18.90%,NRK;DTNBP1;NTF3;LRRK2;ALS2;MAP4K4;TAOK3;WASF1;GAS7;EPB41L3;TRIO;MYO16;BDNF;NYAP1;DICER1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.34963994827188816,0.8536908191620545,0.6485225505443235,0.9597380625440545,1.0,7/20,24.47%,ZC3H7B;PRKRA;TSNAX;DICER1;AGO4;DROSHA;AGO3
prerank,regulation of mitotic cell cycle (GO:0007346),-0.20056007243066815,-0.8536368303399993,0.8921568627450981,0.9632038753716515,1.0,34/171,15.71%,AFAP1L2;CAV2;NEK7;IQGAP1;SDCBP;CUL1;BRINP3;EIF4E;MEIS2;ANGEL2;BRINP1;ANAPC16;ANAPC15;ANAPC7;TAL1;BORA;BTG2;SCRIB;KIF20B;TGFB1;BRINP2;LGMN;SIRT1;DYNLT3;PSMF1;USP22;THAP1;PSMB8;PSMA4;APP;PSMB10;PSMB2;UBE2S;BUB1B
prerank,positive regulation of dendritic spine development (GO:0060999),-0.30093158805998105,-0.853099498019672,0.6222222222222222,0.9632429262903898,1.0,4/20,9.86%,SHANK3;NLGN1;LRP8;SHANK1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.27967843161631156,0.8530824087489177,0.6876574307304786,0.9599049805365493,1.0,11/78,13.74%,SEC24D;DYNLL1;SEC31A;CTSF;DYNC1H1;DCTN6;CAPZB;AP1M1;DYNC1I2;CTSL;SEC23A
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.27967843161631156,0.8530824087489177,0.6876574307304786,0.9599049805365493,1.0,11/78,13.74%,SEC24D;DYNLL1;SEC31A;CTSF;DYNC1H1;DCTN6;CAPZB;AP1M1;DYNC1I2;CTSL;SEC23A
prerank,immunoglobulin mediated immune response (GO:0016064),0.4219205627787699,0.8530253874728791,0.647887323943662,0.9594847579167105,1.0,2/10,10.54%,GAPT;CARD9
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.3829097207876987,0.8525771131434262,0.6446700507614214,0.9597914296985236,1.0,1/13,0.57%,ADCY1
prerank,toll-like receptor signaling pathway (GO:0002224),0.27795587435333563,0.852577028622015,0.6865482233502538,0.959252826202621,1.0,24/84,22.13%,COLEC12;RFTN1;IRAK2;NMI;TLR6;IRAK3;TNIP2;RIPK2;CD14;CTSL;PIK3R4;UBE2D1;MAPKAPK2;TNIP1;EPG5;TLR5;SFTPA1;SFTPA2;TIRAP;LGALS9;MYD88;BIRC2;BIRC3;CNPY3
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.3988662821290676,0.8524228557858078,0.6451612903225806,0.9590019991773707,1.0,5/12,13.36%,THRB;CTSH;BRD8;KLF9;CTSL
prerank,eye photoreceptor cell development (GO:0042462),0.3838224270610489,0.8520935948034687,0.6454388984509466,0.9591106437845521,1.0,2/15,6.58%,TULP1;CRB2
prerank,outer dynein arm assembly (GO:0036158),0.3814010554553636,0.8519714069600103,0.6319444444444444,0.9588243921352736,1.0,6/14,24.56%,DNAAF1;DNAAF5;DNAL1;DNAH8;ODAD4;ODAD1
prerank,positive regulation of leukocyte activation (GO:0002696),-0.31605461755424524,-0.8519454539133323,0.6848137535816619,0.9646409973180609,1.0,7/18,21.76%,THBS1;IL33;LBP;KARS1;CRLF2;TLR4;NECTIN2
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.3057365259789826,0.8519285371257855,0.6716417910447762,0.9583823427501571,1.0,7/47,11.77%,PID1;PDGFRB;AGTR1;TLR6;SLC5A3;DCXR;F2
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.30927352906007977,-0.8516431693482542,0.6781002638522428,0.964204616632995,1.0,6/18,13.80%,RDX;MTMR2;DNAJC13;RAB21;MSN;MAPK3
prerank,cellular response to starvation (GO:0009267),0.2592478369606111,0.8515269385777369,0.7366071428571429,0.9586176786176246,1.0,40/147,20.59%,PRKAG2;NPRL3;SFRP1;PRKAA2;NUAK1;LRRK2;SIK1;SREBF1;EIF2AK3;BRSK1;MTMR3;HNRNPA1;SLC38A9;ATP6V1E1;RNF152;CEBPB;CASTOR2;LAMTOR2;RRAGD;IMPACT;WIPI1;PIK3R4;ITFG2;SESN2;NPRL2;FADS1;LAMP2;TBL2;FNIP1;MAP1LC3A;SEH1L;FOXO3;BECN1;PRKAG1;RHEB;CARTPT;WDR45;SZT2;GCGR;MLST8
prerank,oogenesis (GO:0048477),-0.32996057937402234,-0.8515230907426583,0.6682692307692307,0.9633628821561484,1.0,7/15,34.14%,FMN2;PTN;MEI4;TRIP13;KMT2D;PIWIL2;IHO1
prerank,membrane raft organization (GO:0031579),0.36375045966312425,0.8514419159232381,0.640625,0.9582459886514593,1.0,6/15,19.68%,RFTN1;MYADM;CLN3;NPC1;YJEFN3;ABCA7
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.2989935902399531,-0.8513140968348527,0.6843434343434344,0.9627221260543797,1.0,6/18,24.52%,NUP93;HHEX;DDX19B;MCM3AP;DDX25;POLDIP3
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.37332701182648204,-0.8509110460372665,0.6526806526806527,0.9624449398957625,1.0,1/10,1.02%,ADAM10
prerank,cation transmembrane transport (GO:0098655),0.2999566570067261,0.8505855653208952,0.6789250353606789,0.959417410082933,1.0,4/44,5.38%,SLC7A2;ATP1A2;SLC6A9;SFXN2
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.34724369283258183,-0.8504761490350047,0.6457831325301204,0.96227267813924,1.0,3/12,20.57%,SKAP1;CD44;AGER
prerank,DNA methylation (GO:0006306),0.34775433319569593,0.850475576430949,0.681203007518797,0.9590893040727054,1.0,10/23,24.64%,DNMT3A;SPOCD1;KMT2E;METTL4;DNMT3B;ATRX;N6AMT1;DNMT1;PPM1D;DMAP1
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.36215401964153815,-0.8504557498196429,0.6535796766743649,0.9612153417991535,1.0,2/10,3.35%,LRCH1;APOD
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.36483593504874723,0.8503683570217727,0.6533333333333333,0.958785907529945,1.0,2/17,9.92%,SERPINE1;CREB3
prerank,protein localization to cilium (GO:0061512),0.3230784070419785,0.8501782709440638,0.6781437125748503,0.9585994048255705,1.0,11/32,25.67%,TULP1;WDR35;TULP3;INVS;ZNF423;EHD1;ODAD4;IFT140;TULP2;TTC21B;TCTN2
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.201343940411965,-0.8500554356909723,0.8897058823529411,0.9610005945978894,1.0,44/145,23.95%,FHL1;CUL1;RBX1;FBXL7;KCNH5;AVEN;MECP2;RAB11A;TUBB4B;PRKAR2B;PAFAH1B1;YWHAG;RAD51C;ACTR1A;PSMF1;CEP70;CEP135;DCTN1;PSMB8;SDCCAG8;CETN2;CDK5RAP2;PSMA4;PSMB10;CEP57;PSMB2;CCND1;CEP43;CEP63;PSMC4;CLASP1;PSMA6;HAUS2;PSMD9;PSMD11;PSMD5;CENPF;DTL;HMMR;KIF14;CEP131;PSMA8;CSNK1D;PSMB1
prerank,negative regulation of leukocyte activation (GO:0002695),0.38002676811141206,0.8497688214696767,0.6440972222222222,0.9588298737112023,1.0,3/15,14.80%,IL31RA;CD200;NR1H3
prerank,regulation of axon regeneration (GO:0048679),0.3855192913632792,0.8496829469577712,0.6284722222222222,0.9584649602878333,1.0,2/12,5.19%,EPHA4;PTPRS
prerank,fatty acid biosynthetic process (GO:0006633),-0.22895610853632606,-0.8494830808411913,0.7807017543859649,0.9611655904317178,1.0,22/63,28.26%,ELOVL7;ABHD2;ELOVL5;GPX4;DEGS1;TECR;HSD17B8;TECRL;HACD2;PTGS2;ABCD3;ACACA;LIPH;SCD5;NDUFAB1;HACD3;CBR4;LIPC;LPL;XBP1;ELOVL2;ALOX5
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.3085578787587177,-0.8489619159444739,0.6497326203208557,0.9612120360305856,1.0,8/17,30.72%,EMC3;EMC9;CAMLG;MMGT1;EMC4;SGTA;GET3;GET1
prerank,sterol transport (GO:0015918),-0.2995164394626487,-0.8483573443295171,0.6702412868632708,0.9613808300495548,1.0,6/19,18.10%,CAV1;NPC2;OSBPL2;ARV1;OSBP;MSR1
prerank,dephosphorylation (GO:0016311),0.2625469454832123,0.848042914029537,0.7323290845886443,0.9610461797805446,1.0,28/147,17.53%,PPM1H;PPM1E;PTPN13;PLPP3;PXYLP1;PPP3CA;EPHX2;PTPN21;PTPRS;PTPN9;MTMR3;MTMR7;STK11;CTDSP2;PTPRM;PLPP5;PPP2R5D;BTRC;PTPN3;PTEN;PSPH;SDHAF2;PTPRA;ACP6;PPM1G;UBLCP1;DUSP4;DUSP12
prerank,myeloid cell differentiation (GO:0030099),-0.24636314951100632,-0.848017213864787,0.7357142857142858,0.9610478599196114,1.0,16/47,20.20%,ZBTB16;RPS14;RPS19;HIPK2;PTPN2;TAL1;JAK2;UBA5;INHA;PRKX;KAT6A;JAK3;INHBA;ZFPM1;ALAS2;HCLS1
prerank,nuclear pore complex assembly (GO:0051292),-0.35248168919731226,-0.8478149649946675,0.6297968397291196,0.9603865379019195,1.0,2/10,4.51%,NUP93;NUP153
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.3339741456049389,-0.8478128812750654,0.6538461538461539,0.9593045255674255,1.0,6/13,28.46%,SORL1;CD81;BRSK2;TMEM30A;GCC2;TMEM30B
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.27272378195277613,-0.8475325061696874,0.6932515337423313,0.9587839431513459,1.0,12/29,28.15%,ELOVL7;PPT1;ELOVL5;TECR;HSD17B8;HACD2;PPT2;ACSL3;ACACA;SCD5;CBR4;ELOVL2
prerank,carbohydrate transport (GO:0008643),-0.3577685918813803,-0.8471296547602717,0.6526806526806527,0.9585837518792341,1.0,2/11,10.71%,SLC26A6;AQP11
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.2843258583520376,0.8467205979507436,0.7077922077922078,0.9631158725845846,1.0,10/72,11.37%,RUNX1;GAS6;CFLAR;IRAK2;AXL;RNF31;TSLP;IRAK3;RNASEL;ABCE1
prerank,regulation of astrocyte differentiation (GO:0048710),0.38483313632038707,0.8463343908072833,0.6702127659574468,0.9633450078077906,1.0,3/12,11.77%,EPHA4;BMP2;F2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.29873097743180005,0.8461798413257362,0.6807639836289222,0.9630985086814458,1.0,9/48,10.34%,POLR1G;ARID1B;ATAD2B;SPHK2;MYO1C;ZMIZ1;KAT2B;BAZ1B;PHF2
prerank,protein targeting to membrane (GO:0006612),-0.21575992952506803,-0.8461246806609636,0.7947368421052632,0.9596145117759977,1.0,34/83,31.63%,ZDHHC2;SDCBP;RAB8B;RTP4;ZDHHC15;AQP11;ZDHHC14;VPS37B;PEX26;VPS37A;ARL6IP1;ATG3;ABCD3;ARL6;SGTB;PEX12;FIS1;VPS37C;ZDHHC18;CHMP4B;CHMP4A;PEX16;SGTA;PEX5;PXMP4;ZDHHC24;NACAD;SRPRA;GET3;ZDHHC22;SEC63;NCF1;ZDHHC6;ZDHHC12
prerank,mitochondrial transport (GO:0006839),0.297797463387505,0.8461185523686523,0.6998654104979811,0.9626820762429559,1.0,8/53,10.91%,BCL2;SLC25A24;TIMM17B;COX18;BCAP31;TIMM44;TIMM9;TSPO
prerank,regulation of aerobic respiration (GO:1903715),-0.33088727238485377,-0.8459291145592217,0.6751269035532995,0.9589497716162039,1.0,3/15,11.80%,CBFA2T3;SLC25A33;ATP7A
prerank,RNA export from nucleus (GO:0006405),-0.20595124796195038,-0.8456022042193772,0.8662790697674418,0.9585456296647543,1.0,28/100,22.14%,NUP93;NUP35;NUP153;NUP160;EIF4E;NUP54;RBM8A;ALYREF;HHEX;CHTOP;HNRNPA2B1;YTHDC1;SRSF7;SEC13;SMG7;NUP155;DDX19B;RANBP2;GLE1;DHX38;NUP88;MCM3AP;THOC6;SRSF4;NUP62;SLBP;DDX25;NUP85
prerank,primary neural tube formation (GO:0014020),0.3355735485245586,0.8455630866866496,0.6618075801749271,0.9632298912364939,1.0,7/30,14.30%,DLC1;PRICKLE1;MTHFR;SKI;LMO4;TSC2;PLXNB2
prerank,response to amino acid (GO:0043200),-0.26361062224236376,-0.8453488688288352,0.7269938650306749,0.9579993396948215,1.0,7/31,12.39%,SH3BP4;GLRA1;GLRA2;SPAAR;LARS1;IPO5;MTOR
prerank,regulation of T cell chemotaxis (GO:0010819),-0.35731089057031107,-0.8452520637870393,0.6459770114942529,0.9571292156411069,1.0,1/11,1.02%,ADAM10
prerank,lymphocyte migration (GO:0072676),-0.26722627441125135,-0.844939475998846,0.696969696969697,0.956670725963824,1.0,5/32,10.46%,S1PR1;CCL14;RET;CKLF;MSN
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.3769108143824274,0.8447334368998948,0.645,0.9643113608078395,1.0,5/14,15.35%,ZEB1;OSR1;SPRY2;SPRED3;SPRED1
prerank,fatty acid catabolic process (GO:0009062),0.28778617670323525,0.8445212928650593,0.6970899470899471,0.9641554611986862,1.0,11/67,14.23%,PCCA;PCCB;NUDT7;ECHDC2;ECI1;MMUT;ABHD3;ECHS1;PEX2;DECR1;ABCD2
prerank,phospholipid dephosphorylation (GO:0046839),0.31449403219756317,0.8444548073905453,0.6509298998569385,0.9637511757600244,1.0,6/37,10.54%,PLPP3;EPHX2;SYNJ2;MTMR3;MTMR7;PLPP5
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.3482404121352589,-0.8443071493842662,0.6782407407407407,0.9569000204700402,1.0,4/12,11.84%,CAV1;IFIH1;CGAS;RALB
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.2705915864074092,-0.8440135682592281,0.6978193146417445,0.9564341156989176,1.0,4/30,10.70%,HSPA8;UGGT1;GAK;DNAJB14
prerank,regulation of microtubule nucleation (GO:0010968),0.4060063492045563,0.8436041730622104,0.6684782608695652,0.9648311199566858,1.0,1/10,1.79%,EML2
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.3619843185825888,-0.8433324014639904,0.6572104018912529,0.9568227940916618,1.0,6/10,38.16%,CRY1;WDR76;CCAR2;RPA2;THOC5;RFWD3
prerank,positive regulation of organelle assembly (GO:1902117),0.3067912955241891,0.8425889168048815,0.6829971181556196,0.9662109532327455,1.0,12/44,20.67%,ASAP1;DYNC1H1;SDC1;ARHGAP35;CROCC;RAB3GAP1;SDC4;PIP4K2C;HTT;NUMA1;FSCN1;CEP120
prerank,calcium import into the mitochondrion (GO:0036444),0.4105644996317998,0.8424986155443153,0.6835443037974683,0.965858412906963,1.0,2/10,9.92%,MCU;MICU2
prerank,sodium ion import across plasma membrane (GO:0098719),0.3558058178654594,0.8423829652834209,0.6546052631578947,0.9655449790420849,1.0,4/17,9.41%,SLC8A1;SLC9A9;SLC9A5;TRPM4
prerank,regulation of keratinocyte migration (GO:0051547),0.39551466576045513,0.8419092707962001,0.6519524617996605,0.9659401759442628,1.0,5/12,15.85%,MAP4K4;MAPRE2;PTEN;ARF6;EPPK1
prerank,development of primary male sexual characteristics (GO:0046546),0.3220936358196214,0.8416735398580134,0.6938775510204082,0.9658546003057265,1.0,5/34,6.59%,AR;KIT;WNT4;LHCGR;NR5A1
prerank,mitochondrial translational elongation (GO:0070125),-0.2138132204187336,-0.8413762955346441,0.8154761904761905,0.9598855228563037,1.0,32/88,32.16%,GFM2;MRPL46;MRPS18A;MRPS5;MRPL39;MRPS26;MRPS12;MRPL48;MRPL4;MRPL21;MRPL44;MRPS33;MRPL55;MRPL57;MRPS18B;MRPL42;MRPS10;MRPS21;MRPS7;MRPL34;MRPL15;MRPL19;MRPS22;MRPL38;MRPS31;MRPL12;MRPL28;MRPL43;MRPS14;MRPL54;MRPL2;AURKAIP1
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.3408253673053412,-0.8412399907946791,0.6568627450980392,0.95907004123639,1.0,2/11,8.30%,PLA2G7;ABCG1
prerank,cellular response to UV (GO:0034644),0.2818726274977536,0.841207851701011,0.7293233082706767,0.966194852459907,1.0,8/76,9.87%,MFAP4;MMP2;NEDD4;USP47;INO80;CUL4B;ZBTB1;STK11
prerank,regulation of DNA metabolic process (GO:0051052),-0.24579830903814012,-0.8403940466958139,0.7516778523489933,0.9596893456816246,1.0,12/44,20.87%,SUB1;POLH;ALYREF;HNRNPD;PDGFA;MPHOSPH8;NBN;YLPM1;PARG;WRNIP1;UBE2V1;HELB
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.20904381597844413,-0.8400078921687475,0.8385416666666666,0.9594099596849115,1.0,38/94,31.88%,NOD1;RPS6KA5;CUL1;RBX1;ST18;NFKBIA;RPS6KA4;PSMF1;PSMB8;MAPK3;PSMA4;NOD2;PSMB10;PSMB2;MAP3K3;TAB1;PSMC4;PSMA6;PSMD9;PSMD11;PSMD5;UBE2V1;CHUK;PELI1;MAP3K7;PSMA8;PSMB1;EGR1;TRAF6;PSMD10;IL1A;IL1R2;SQSTM1;UBC;RPS27A;IKBKG;IL1R1;PSMC3
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.3947673241799235,0.8400013937146066,0.6453287197231834,0.9678856854855303,1.0,4/11,20.23%,ARID1B;ZMIZ1;ELOF1;SERTAD1
prerank,positive regulation of macrophage activation (GO:0043032),-0.31486020509727775,-0.8397690598850935,0.6772486772486772,0.9588309827931434,1.0,3/17,5.63%,THBS1;IL33;LBP
prerank,cellular response to type I interferon (GO:0071357),0.30950288070891,0.839624452230409,0.6944444444444444,0.9675421948854033,1.0,11/41,21.73%,SP100;IRF1;OAS2;STAT2;RNASEL;IFI27;IFIT2;IRF2;RSAD2;IRF9;MYD88
prerank,type I interferon signaling pathway (GO:0060337),0.30950288070891,0.839624452230409,0.6944444444444444,0.9675421948854033,1.0,11/41,21.73%,SP100;IRF1;OAS2;STAT2;RNASEL;IFI27;IFIT2;IRF2;RSAD2;IRF9;MYD88
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.2700471109171344,0.839191221472835,0.7185185185185186,0.9678136936327087,1.0,26/94,23.16%,DYNLL1;NINL;CEP152;DYNC1H1;NPHP1;B9D1;ALMS1;FBF1;YWHAE;DYNC1I2;HAUS1;HAUS7;HAUS3;CEP164;CEP192;TMEM67;AHI1;ODF2;PRKACA;CEP250;KIF24;NDE1;HAUS5;HAUS6;TUBG1;SFI1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.2947459959372284,0.8388617825609476,0.7047872340425532,0.967918420834523,1.0,5/53,6.55%,XCR1;HTR1A;LHCGR;ADRB3;MTNR1A
prerank,response to steroid hormone (GO:0048545),0.3285245707804945,0.8383787343953222,0.6813353566009105,0.9683055448992695,1.0,4/31,5.44%,AR;ATP1A2;YAP1;TFPI
prerank,negative regulation of intracellular protein transport (GO:0090317),0.3392463374972477,0.838341001069919,0.632952691680261,0.9678301062298976,1.0,4/22,6.60%,SP100;RAB23;LMAN1;LRRK2
prerank,regulation of ATP metabolic process (GO:1903578),0.29328878799337227,0.8382611871314027,0.7142857142857143,0.9674555784475728,1.0,15/54,20.11%,OGT;PRKAG2;NUP107;COX7A2;NUP42;SPHK2;EIF6;NUP98;RAE1;NUP214;GCK;SEH1L;TPR;PRKAG1;AAAS
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.21572170833446094,-0.8380926668421531,0.8398058252427184,0.9611560723476124,1.0,30/85,25.42%,RNF144B;CBFA2T3;RNF144A;RBX1;TRIB2;ECSCR;TAF1;GSK3A;HSPBP1;TMTC3;ZYG11B;RAD23A;COP1;RACK1;BBS7;DVL1;RNF14;CLU;DAB2IP;DDRGK1;GSK3B;GABARAP;RCHY1;USP5;NUB1;CSNK1D;VCP;TREM2;DDA1;FMR1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3105731317136632,0.8377171187544966,0.692524682651622,0.9679420937537692,1.0,16/38,26.31%,LEPROT;LMAN1;LRRK2;RNF31;SREBF1;PRKN;HUWE1;RHOU;HPS4;ARIH2;HAX1;SREBF2;VPS11;UBE2J2;SH3GLB1;BAP1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.32936856914417545,0.836263531330795,0.6856702619414484,0.9701851596954496,1.0,3/26,6.94%,ACTN2;NEDD4;ATP1B2
prerank,cardiac cell development (GO:0055006),0.38472728929363226,0.8359019791278572,0.6579925650557621,0.9703077272467868,1.0,1/11,1.14%,SLC8A1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.2491894622541851,0.8355416898324458,0.7881165919282511,0.9705119636834527,1.0,49/184,23.34%,HECW2;DYNLL1;NINL;CEP152;APPL2;PSME4;DYNC1H1;ZFP36L1;INO80;ZW10;ALMS1;NPM2;SIRT2;ANAPC5;NEK6;RGCC;YWHAE;DYNC1I2;BTRC;HAUS1;HAUS7;HAUS3;CEP164;CEP192;UBE2D1;PSMB5;PSMC2;KLHL18;PSMD1;ODF2;PRKACA;APPL1;PSMD4;PSME3;CDC23;ZFP36L2;PSMA3;CEP250;AURKA;ERCC3;NDE1;ANAPC4;HAUS5;HAUS6;TUBG1;PSMA2;ERCC2;SFI1;PSMC5
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.22397578570764753,-0.835297642962901,0.7844036697247706,0.9657215247002109,1.0,10/73,9.51%,CAV1;FNIP2;NGF;BCAR3;TFRC;NOS1;PAK1;HSP90AB1;ATP2B4;VEGFA
prerank,production of siRNA involved in RNA interference (GO:0030422),0.3986051263183339,0.8351488324919994,0.6725978647686833,0.9707471221696715,1.0,4/10,22.17%,PRKRA;TSNAX;DICER1;DROSHA
prerank,positive regulation of TOR signaling (GO:0032008),0.306810662408833,0.8349248856829662,0.6962025316455697,0.9706423827437594,1.0,12/40,20.59%,GAS6;SLC38A9;TELO2;LAMTOR2;RRAGD;GOLPH3;FNIP1;SEH1L;RICTOR;RHEB;GPR137B;MLST8
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.2624897217676003,-0.8341073657421912,0.7492063492063492,0.9670673068338674,1.0,10/33,17.76%,HOXA5;MED1;TAL1;FES;ACVR2A;HIF1A;PRKDC;INHBA;FAM210B;HMGB2
prerank,tube closure (GO:0060606),0.33063139931755126,0.8337092382943148,0.6758321273516642,0.9724228109356485,1.0,7/31,14.30%,DLC1;PRICKLE1;MTHFR;SKI;LMO4;TSC2;PLXNB2
prerank,regulation of sister chromatid cohesion (GO:0007063),0.38485652623537225,0.8332427100373273,0.6526845637583892,0.9727570399092215,1.0,3/12,15.20%,AXIN2;HDAC8;WAPL
prerank,cellular response to leucine (GO:0071233),0.38997248028863374,0.8327143353619871,0.6618705035971223,0.9726789386469366,1.0,3/10,15.24%,UBR2;RRAGD;SESN2
prerank,response to leucine (GO:0043201),0.38997248028863374,0.8327143353619871,0.6618705035971223,0.9726789386469366,1.0,3/10,15.24%,UBR2;RRAGD;SESN2
prerank,lysine metabolic process (GO:0006553),0.3910044008675921,0.8324214932392715,0.649746192893401,0.972167184463035,1.0,2/12,8.30%,PHYKPL;ALDH7A1
prerank,lysine catabolic process (GO:0006554),0.3910044008675921,0.8324214932392715,0.649746192893401,0.972167184463035,1.0,2/12,8.30%,PHYKPL;ALDH7A1
prerank,protein dephosphorylation (GO:0006470),0.25791237522095317,0.8322150407451421,0.7505854800936768,0.9720188773493673,1.0,26/135,17.53%,PPM1H;EYA2;PPM1E;PTPN13;EYA1;PPP3CA;PTPN21;PTPRS;PTPN9;MTMR3;MTMR7;RPAP2;STK11;CTDSP2;PTPRM;PPP2R5D;BTRC;PTPN3;PTEN;SDHAF2;PTPRA;TNS2;PPM1G;UBLCP1;DUSP4;DUSP12
prerank,protein modification by small protein removal (GO:0070646),0.24337689364085632,0.8316715991415675,0.80927291886196,0.9724850597691708,1.0,70/252,23.50%,SMAD3;AR;OGT;CCNA2;TGFBR1;SMURF2;USP11;PSME4;USP47;USP20;INO80;USP35;USP24;USP48;KAT2B;SMAD1;PRKN;USPL1;RHOT1;ACTR8;OTULINL;TNIP2;USP30;USP9Y;GPS1;COPS3;USP32;USP10;USP9X;USP38;PTEN;SENP6;ADRM1;TADA3;SUDS3;UBE2D1;FOXK2;SENP8;SENP7;COPS2;PSMB5;PSMC2;TNIP1;BECN1;PSMD1;PSMD4;UIMC1;CLSPN;MDM4;PSME3;USP49;USP46;BRCC3;MBD6;USP37;USP3;PSMA3;ASXL2;UCHL1;STAMBPL1;ATXN7;SMAD2;BIRC2;BIRC3;ABRAXAS2;PSMA2;BRCA1;ATXN3;PSMC5;VCPIP1
prerank,intracellular sterol transport (GO:0032366),0.3789717958947898,0.8316572345652824,0.648936170212766,0.971978855351141,1.0,2/13,5.22%,ABCA1;STAR
prerank,cellular response to nutrient levels (GO:0031669),-0.22733958227048717,-0.8314562219917806,0.8160919540229885,0.9714182975572434,1.0,20/62,22.27%,HSPA8;MFSD2A;ULK1;CLEC16A;WDR45B;SIRT1;RALB;MTOR;FAM107A;ATG14;GAS2L1;INHBB;FOXO1;WIPI2;BMPR2;FLCN;VPS41;ATG7;NUPR2;ZFYVE1
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.3722070332223766,0.8311565302435632,0.6593220338983051,0.9723688114819914,1.0,4/13,16.72%,GLI2;VNN1;BMP4;SHH
prerank,negative regulation of immune effector process (GO:0002698),-0.3218711949297174,-0.8310169433769039,0.7113924050632912,0.9712330490215596,1.0,2/13,6.57%,RPS19;CD55
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.3996571194859575,0.8310012414577048,0.6466431095406361,0.9721074463592999,1.0,5/10,25.74%,TLR6;MIA3;AKT1;MYD88;TICAM1
prerank,histone acetylation (GO:0016573),-0.22548799063923486,-0.8309829767102809,0.8483412322274881,0.970236140135953,1.0,18/69,18.75%,LEF1;JADE3;PHF20L1;TRIM16;KAT2A;TAF10;TADA2A;APBB1;PER1;RUVBL1;KAT6A;NAA60;EP300;MRGBP;BRCA2;SGF29;YEATS2;ZZZ3
prerank,arachidonate transport (GO:1903963),0.39290310001458867,0.8307673000384137,0.6666666666666666,0.9715198886948471,1.0,2/10,8.21%,BDKRB2;DRD3
prerank,arachidonic acid secretion (GO:0050482),0.39290310001458867,0.8307673000384137,0.6666666666666666,0.9715198886948471,1.0,2/10,8.21%,BDKRB2;DRD3
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.27248489442687424,0.8302085950190456,0.7121212121212122,0.9719787527271397,1.0,11/79,13.74%,SEC24D;DYNLL1;SEC31A;CTSF;DYNC1H1;DCTN6;CAPZB;AP1M1;DYNC1I2;CTSL;SEC23A
prerank,positive regulation of cholesterol efflux (GO:0010875),0.3382824883866013,0.8298634144855862,0.693815987933635,0.9720704755210355,1.0,3/21,4.31%,LRP1;APOE;APOA1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.31592325153894896,-0.8289769630022459,0.678391959798995,0.9731419224831943,1.0,1/15,0.27%,PRKCH
prerank,selective autophagy (GO:0061912),0.28591796419131127,0.8281201932987456,0.7083333333333334,0.9748269377999679,1.0,14/56,18.45%,DYNLL1;DYNC1H1;ULK2;WDR81;PRKN;UFL1;USP30;DYNC1I2;UFC1;AUP1;ATM;BECN1;ATG2B;PHB2
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.2745684922572305,0.8272504378599623,0.7332474226804123,0.9758582331346014,1.0,26/69,27.22%,FAF2;DERL1;UBXN4;DERL3;UBE4B;RNF185;ECPAS;FOXRED2;SELENOS;AMFR;TMUB1;AUP1;TMEM67;ERLIN1;JKAMP;BAG6;WFS1;HSPA5;ERLIN2;OS9;UBE2J2;FBXO2;FBXO17;DNAJB12;DNAJB9;TMUB2
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.33124577032383024,0.8272167394252662,0.6961240310077519,0.9753890000567876,1.0,10/25,23.90%,RECQL5;WDR43;CDK12;NELFE;TCERG1;CDC73;HNRNPU;LEO1;HEXIM1;CDK13
prerank,positive regulation of catabolic process (GO:0009896),0.2808104536446329,0.8272015305249125,0.7304582210242587,0.9748878176273872,1.0,6/65,5.57%,HECW2;DACT1;NKD1;NEDD4;SMURF2;VIP
prerank,establishment of protein localization to membrane (GO:0090150),0.2798587152882345,0.826719931924773,0.7184713375796178,0.9752416405452685,1.0,17/66,18.03%,RFTN1;GORASP2;YIF1B;COX18;AFDN;MYO1C;EGFR;BRAF;VPS37D;GORASP1;RAB3GAP1;PARD3;PIKFYVE;NPC1;ZDHHC20;MICALL1;PRKCI
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.3324756691361354,0.826396519977689,0.6776212832550861,0.9752631525149446,1.0,7/23,18.90%,REXO4;DNASE1L1;DNASE2;CECR2;KPNA1;KPNB1;DICER1
prerank,negative regulation of leukocyte migration (GO:0002686),-0.357227730996891,-0.8261864236515462,0.6969026548672567,0.9776468802310702,1.0,1/10,0.43%,SLIT2
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.33629453156530936,0.8256132822305242,0.6784,0.9761552039798076,1.0,9/22,19.93%,RAPGEF2;NTF3;ACAP2;NTRK3;RAPGEF1;WASF1;AKT1;BDNF;EHD1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.37789756564233046,0.8255615259104061,0.6791171477079796,0.9757266050333793,1.0,5/12,23.04%,RECQL5;NELFE;TCERG1;HNRNPU;HEXIM1
prerank,negative regulation of B cell activation (GO:0050869),0.345105165044156,0.8252054065672616,0.7206349206349206,0.975850418429498,1.0,2/21,5.06%,LYN;SFRP1
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.34018097712316664,-0.82510075614048,0.6861313868613139,0.9787482651950743,1.0,7/12,37.23%,PPARGC1A;MTLN;TWIST1;IRS2;MLYCD;NR4A3;PLIN5
prerank,regulation of viral release from host cell (GO:1902186),-0.29177936635134205,-0.8246891624918296,0.7117346938775511,0.9784801493712877,1.0,10/21,29.20%,TRIM25;VPS37B;TRIM11;TRIM62;VPS4A;CHMP2B;TRIM28;TRIM13;MID2;TRIM35
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.32663771560924904,0.8244112831003038,0.6804915514592934,0.9767884122336933,1.0,3/25,7.77%,SMAD3;NOS1AP;TLR6
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.36124180511236526,0.8242060731201349,0.6890343698854338,0.9766577644691266,1.0,5/16,17.56%,TERF2;TNKS2;RTEL1;ATM;NAF1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.3574201495360001,0.823931138515098,0.6915422885572139,0.9766340724962674,1.0,3/16,7.38%,APOA1;LDLR;SREBF1
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.2891384390801431,-0.8238557315099835,0.7127371273712737,0.9790234350089784,1.0,7/21,19.78%,ADAM10;SPPL3;BACE2;ADAM19;RBMX;ADAM9;APH1A
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.2330107600240792,-0.823832829451822,0.7795275590551181,0.9779947033469041,1.0,12/48,16.61%,FNIP2;HIPK2;SNW1;CRIP1;DDIT4;SIRT1;BCL2L1;MCL1;BAK1;DYRK2;PRKDC;EP300
prerank,regulation of catecholamine secretion (GO:0050433),0.31977877925127574,0.8238146594826327,0.7132352941176471,0.9763301006760072,1.0,8/29,20.08%,DTNBP1;SYT9;DRD3;PRKN;SYT11;SYT12;SYT13;CHRNB2
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.21391964333696253,-0.8234578544614697,0.8737864077669902,0.977632486909329,1.0,27/86,24.26%,EGLN3;KLF2;RBX1;EGLN2;VEGFA;PSMF1;PSMB8;PSMA4;PSMB10;HIF1A;PSMB2;HIGD1A;CUL2;EP300;PSMC4;PSMA6;PSMD9;PSMD11;PSMD5;BACH1;ATF3;ATF4;VHL;DNAJB1;PSMA8;PSMB1;MAPK7
prerank,substantia nigra development (GO:0021762),0.2999578581579492,0.8228529807290919,0.7162576687116564,0.977533927088464,1.0,10/37,14.91%,DYNLL1;CDC42;SIRT2;CKB;TTBK1;YWHAE;SYNGR3;ZNF148;MAOB;SUDS3
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.3673290148476376,0.8224582586259194,0.69,0.9777471472108926,1.0,5/13,23.04%,RECQL5;NELFE;TCERG1;HNRNPU;HEXIM1
prerank,regulation of mononuclear cell migration (GO:0071675),0.3284272829301098,0.8224357253014846,0.7036474164133738,0.9772621469335073,1.0,3/23,4.19%,LYN;IL34;CSF1
prerank,amide biosynthetic process (GO:0043604),0.29482189925750063,0.8220005545368008,0.7373461012311902,0.9775178944750514,1.0,6/47,9.71%,PAM;SMPD2;ALOXE3;CERS6;CERS5;NMRAL1
prerank,phosphate ion transport (GO:0006817),-0.3060245232607094,-0.8219185025899688,0.7453580901856764,0.9795934353635793,1.0,4/16,15.86%,SLC37A3;SLC25A30;SLC25A11;XPR1
prerank,negative regulation of neuron death (GO:1901215),0.265634700300626,0.8217161007410255,0.7433090024330901,0.977523299732362,1.0,14/93,11.95%,GDNF;BCL2;APOE;INPP5A;CSF1;MT3;NTF3;LIG4;LRRK2;SLC30A10;CD200;PRKN;CLN3;REST
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.24517854734275776,-0.8214885986831587,0.7736486486486487,0.9794299560939754,1.0,14/40,26.22%,CRY1;POLH;SMYD2;MCL1;WDR76;KMT5A;PARG;HMGA2;WRNIP1;UBE2V1;IER3;NSMCE1;FMR1;USP1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3225887076242584,0.8211119296147301,0.6996951219512195,0.9781256989205985,1.0,5/29,11.49%,RUNX1;YAP1;STRN3;FOXA1;UFL1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.32582009626106556,0.820949167612864,0.7,0.9779082441045713,1.0,10/24,23.53%,LRRK2;PRKN;CREB3;SELENOS;NR1H3;TMBIM6;CREB3L1;OPA1;WFS1;TXNDC12
prerank,cell proliferation in forebrain (GO:0021846),0.39996468187766865,0.8207366353060118,0.6844919786096256,0.9777673394673899,1.0,3/10,20.67%,NUMBL;AKNA;CEP120
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.2838660670778234,0.8206167160901312,0.727027027027027,0.9774571460213458,1.0,5/59,7.23%,CYP7B1;SLC27A5;ALDH1A2;HOGA1;CYP27A1
prerank,non-motile cilium assembly (GO:1905515),-0.2624704235504536,-0.8205185779285304,0.7475409836065574,0.9802620851001459,1.0,9/30,26.41%,DISC1;TMEM216;DCTN1;FUZ;CCDC13;CSNK1D;VANGL2;GORAB;BBS10
prerank,positive regulation of DNA repair (GO:0045739),0.29230022353012464,0.8204579368364091,0.7227586206896551,0.9772093623282144,1.0,2/46,1.57%,EYA2;EYA1
prerank,regulation of protein catabolic process (GO:0042176),0.2604205305707565,0.8198622492237789,0.7736077481840193,0.977728677429156,1.0,24/99,19.72%,HECW2;DACT1;NKD1;NEDD4;SMURF2;VIP;SIRT2;IRAK3;EGFR;SNX12;WDR91;PRKN;ITCH;BANP;FLNA;PLK2;HACE1;HUWE1;AGAP2;OAZ3;TRIM32;CDKN1B;MDM4;IDE
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.2886556560530098,-0.8198575732586154,0.7191011235955056,0.9804946277578788,1.0,7/22,23.25%,B2M;CYRIB;CD55;FZD5;TRAF2;MAP3K7;MALT1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.36312985171255985,0.819525140006864,0.6837606837606838,0.9778601450231275,1.0,2/14,4.19%,IL34;CSF1
prerank,glycine transport (GO:0015816),0.4007039118409435,0.8194457146305982,0.6890909090909091,0.9774782609424235,1.0,3/10,19.00%,SLC6A9;SLC6A5;SLC25A38
prerank,mitotic cell cycle phase transition (GO:0044772),0.2464308567466568,0.8193598449568159,0.8221258134490239,0.9771120003626654,1.0,52/203,23.16%,CDK14;DYNLL1;NINL;CCNA2;OPTN;CEP152;PHLDA1;FBXL17;ACVR1;DYNC1H1;CUL4B;ALMS1;CUL5;BRSK1;FBXL3;FBXL12;YWHAE;MNAT1;DYNC1I2;BTRC;HAUS1;ACVR1B;HAUS7;HAUS3;CEP164;PLK2;PHF8;CEP192;CDKN2C;CDC7;ODF2;PRKACA;CDKN1B;CACUL1;TAF2;CDC23;PLCB1;GSPT1;USP37;CCND2;CEP250;AURKA;NES;NDE1;EPS8;CCNG2;HAUS5;HAUS6;TUBG1;CDK7;FBXW11;SFI1
prerank,protein sumoylation (GO:0016925),-0.23275281138321086,-0.819347381150352,0.7822878228782287,0.9804397496062518,1.0,13/49,17.88%,IFIH1;NUP93;NUP35;NUP153;NUP160;SAE1;NUP54;BCL11A;RANGAP1;NUP155;STX1A;RANBP2;NUP88
prerank,erythrocyte differentiation (GO:0030218),0.2969899932385047,0.8190607110013889,0.7453769559032717,0.9771295416790544,1.0,4/44,4.30%,TGFBR3;LYN;KIT;CDK5RAP3
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.20504467872079424,-0.8189278963693654,0.9226519337016574,0.9802168369567852,1.0,31/87,29.24%,SDHAF3;NDUFC1;COX17;SLC25A33;NDUFAF2;NDUFA6;DMAC2;NDUFA5;SURF1;TMEM126B;NDUFA7;NDUFA8;COA3;NDUFB7;NDUFA3;NDUFA10;NDUFAF8;NDUFS7;NDUFS1;NDUFS5;NDUFB3;NDUFAF3;DMAC1;NDUFAB1;UQCRFS1;SDHAF1;NDUFB4;NDUFV2;NDUFAF7;NDUFV3;COA5
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.24449742177461115,-0.8185579512232074,0.7857142857142857,0.9798718639086559,1.0,10/40,16.03%,SMURF1;PTK2B;HIPK2;RPS7;RPL11;TAF1;FOXF2;RPL5;RAD23A;GNA12
prerank,regulation of protein dephosphorylation (GO:0035304),-0.24838121273030314,-0.8183625036678539,0.7866666666666666,0.9791783438630027,1.0,7/37,11.48%,PPP1R16B;PPIA;PPP2R5A;SPPL3;CALM1;CALM3;TGFB1
prerank,positive regulation of locomotion (GO:0040017),-0.2612267089817858,-0.8183123463003995,0.7582089552238805,0.9782438781265244,1.0,5/27,11.48%,SPOCK2;THBS1;STX3;CAVIN1;TGFB1
prerank,protein localization to Golgi apparatus (GO:0034067),0.32004871805427987,0.8181926617313816,0.6987951807228916,0.9781338424076601,1.0,8/27,17.91%,OBSL1;OPTN;ARL1;ARL5A;GOLPH3;VPS13D;VPS13C;TMED10
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.3698960813294079,0.818132914512692,0.6820512820512821,0.9777227921348948,1.0,4/13,20.23%,ARID1B;ZMIZ1;ELOF1;SERTAD1
prerank,protein localization to microtubule organizing center (GO:1905508),-0.31704787888492747,-0.8176934786737095,0.6997455470737913,0.9783254653340883,1.0,6/15,24.39%,CEP83;STIL;SPAG5;CEP131;CSNK1D;CCDC14
prerank,protein autoprocessing (GO:0016540),0.3527938974708836,0.8176627311283894,0.6786324786324787,0.9780658419464495,1.0,4/17,20.02%,SPRTN;CTSL;CASP1;AFG3L2
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.38864218400022776,0.817588631382597,0.6720142602495544,0.9776688152085257,1.0,2/10,7.38%,CDC42;SIRT2
prerank,endoderm formation (GO:0001706),0.30493384933095175,0.817411730762096,0.6974063400576369,0.9774715297219688,1.0,4/35,5.48%,COL11A1;MMP2;VTN;ITGB5
prerank,megakaryocyte differentiation (GO:0030219),-0.3338195601374283,-0.8173167730108317,0.7398720682302772,0.9779703585766899,1.0,4/11,17.09%,MED1;TAL1;UBA5;ZFPM1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.3818026836762861,0.8171369485476198,0.6835664335664335,0.977449846893466,1.0,3/11,11.95%,NONO;PRKN;REST
prerank,neural tube closure (GO:0001843),0.3157543283546428,0.8170640548073493,0.693069306930693,0.9770716389102955,1.0,7/34,14.30%,DLC1;PRICKLE1;MTHFR;SKI;LMO4;TSC2;PLXNB2
prerank,neurogenesis (GO:0022008),0.2958356636694265,0.816580667464185,0.7349228611500701,0.9773714014881919,1.0,8/43,10.18%,DAGLA;ASCL1;NEUROD1;THOC2;DCHS1;LPAR1;METTL14;RYK
prerank,Rap protein signal transduction (GO:0032486),0.3862605463861725,0.8159077285633363,0.6865942028985508,0.9780389029579377,1.0,4/10,14.70%,RAPGEF2;RAPGEF1;RAP2A;PLK2
prerank,protein export from nucleus (GO:0006611),0.32060547763857844,0.81552532242015,0.7059748427672956,0.9781973840818657,1.0,8/27,20.52%,RANBP17;NUP42;XPO7;CSE1L;STRADA;NUP214;TPR;CCHCR1
prerank,stress-activated MAPK cascade (GO:0051403),-0.22443471076713678,-0.8154987486929562,0.8359375,0.980390949873535,1.0,26/61,30.87%,NOD1;TNFRSF19;CUL1;MAPK10;MAPK8;MAPK3;MAP4K3;ARHGEF6;NOD2;TAB1;MAP3K11;UBE2V1;MAP2K3;CHUK;MAPK1;MINK1;MAP3K7;MAPK11;MAP2K4;TRAF6;GPS2;PTGER4;UBC;RPS27A;MAP3K10;IKBKG
prerank,monocyte chemotaxis (GO:0002548),0.31217456713929614,0.8153079581124899,0.7212121212121212,0.9780430989208264,1.0,3/32,6.12%,IL6R;CCL19;CCL4
prerank,clathrin coat assembly (GO:0048268),-0.31058967523466313,-0.8152707671613995,0.7231503579952268,0.979766737336585,1.0,2/15,6.50%,SGIP1;HIP1R
prerank,mRNA transport (GO:0051028),-0.20022425415433642,-0.8151104227452903,0.9240506329113924,0.978981362555261,1.0,28/101,22.14%,NUP93;NUP35;NUP153;NUP160;EIF4E;NUP54;RBM8A;ALYREF;HHEX;CHTOP;HNRNPA2B1;YTHDC1;SRSF7;SEC13;SMG7;NUP155;DDX19B;RANBP2;GLE1;DHX38;NUP88;MCM3AP;THOC6;SRSF4;NUP62;SLBP;DDX25;NUP85
prerank,regulation of chemokine production (GO:0032642),-0.2437175810437961,-0.8150833713800254,0.7341389728096677,0.9779787915046796,1.0,13/36,27.50%,IL33;FOXP1;SIGIRR;APP;HIF1A;TLR4;ACKR1;AGER;AIF1;SNAI2;TREM2;EGR1;LPL
prerank,chromatin organization (GO:0006325),0.2539650093793644,0.8149235560981182,0.7990762124711316,0.9781911566349358,1.0,24/132,14.20%,SETD7;BRWD1;NPM3;CBX3;INO80;SMARCA1;NPM2;DR1;SMARCC2;MTA2;TCF7L1;KDM5B;KAT2B;ZBTB1;FOXA1;BAZ1B;PHF1;KDM5C;SETD5;L3MBTL1;HDAC8;SMARCD2;HDAC4;SETDB1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.3544930484463108,-0.8149147109064885,0.7225950782997763,0.9761964456364548,1.0,4/10,32.08%,VLDLR;AP2A1;AP2M1;MYLIP
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.3544930484463108,-0.8149147109064885,0.7225950782997763,0.9761964456364548,1.0,4/10,32.08%,VLDLR;AP2A1;AP2M1;MYLIP
prerank,nucleotide-sugar metabolic process (GO:0009225),0.3802167571714168,0.814880510064304,0.6794425087108014,0.9777463466702472,1.0,3/12,8.22%,GMDS;SLC35A3;GFPT1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.33831360859486503,0.8148661572766657,0.6957928802588996,0.9772481065562768,1.0,4/20,12.04%,PID1;DAB2;PICALM;RHOQ
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.34945597853825416,-0.8148629454375229,0.7352297592997812,0.9742110996136222,1.0,2/11,5.62%,TNRC6C;NOTCH4
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.34945597853825416,-0.8148629454375229,0.7352297592997812,0.9742110996136222,1.0,2/11,5.62%,TNRC6C;NOTCH4
prerank,negative regulation of cation channel activity (GO:2001258),0.31947828893500646,0.8148602610377078,0.7027863777089783,0.9767406985191908,1.0,4/26,8.62%,SLC6A9;GSTM2;DRD3;EPHB2
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.37443515886156015,0.8144231936689197,0.7001795332136446,0.9770183634150819,1.0,4/13,14.80%,NUPR1;EIF2AK3;MANF;NR1H3
prerank,protein-containing complex subunit organization (GO:0043933),0.25534422558264236,0.8139878572804308,0.789598108747045,0.9772957335499369,1.0,20/109,15.12%,TEAD1;MITF;LAMC1;YAP1;PML;CD247;ZW10;RANBP9;PARD6B;PICALM;TSPAN4;NUP98;FANCC;MNAT1;WASF1;KMT2A;LLGL1;DLG4;SNX9;PARD3
prerank,translational termination (GO:0006415),-0.2049412041709519,-0.8138090645555348,0.8716216216216216,0.9750524108462847,1.0,24/95,21.01%,MRRF;MTRF1L;GFM2;MRPL46;MRPS18A;MRPS5;MRPL39;MRPS26;MRPS12;MRPL48;MRPL4;MRPL21;MRPL44;MRPS33;MRPL55;MRPL57;MRPS18B;MRPL42;MRPS10;MRPS21;MRPS7;MRPL34;MRPL15;MRPL19
prerank,regulation of DNA recombination (GO:0000018),-0.2576773190304716,-0.8128774252324428,0.7727272727272727,0.9757243859982324,1.0,14/32,35.95%,KDM1A;MSH3;ALYREF;ZRANB3;RAD51;SHLD2;MSH2;RAD51AP1;H1-0;FIGNL1;IL7R;RPA2;SIRT6;IL4
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.3192688991567257,-0.8126771152653934,0.7115384615384616,0.9750332123225491,1.0,2/14,4.35%,THBS1;CMKLR1
prerank,protein K48-linked ubiquitination (GO:0070936),0.28527602630202104,0.8117604434940722,0.7479784366576819,0.9807823821104313,1.0,20/54,20.64%,RFFL;BFAR;PRKN;ITCH;IFI27;RNF6;RNF152;KBTBD7;UBE2E2;AMFR;FBXO38;UBE2D1;HACE1;UBR5;UBE2R2;UBE3A;RNF34;TRIM32;ARIH2;UBE2T
prerank,B cell mediated immunity (GO:0019724),-0.34783985131581874,-0.8117212319701481,0.7321016166281755,0.9757858028845957,1.0,5/10,32.15%,FCER1G;CD27;MSH2;FCGR2B;TLR8
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.33734213081228964,0.8116456084487846,0.7196110210696921,0.980473089004571,1.0,10/22,27.45%,ERI3;FTSJ3;ERI1;EXOSC7;EXOSC2;NOP14;ERI2;EXOSC8;EXOSC9;KRI1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.29794163057351863,0.8114615340877499,0.7122302158273381,0.9802855573707081,1.0,5/35,12.08%,OGG1;NEIL1;POLG;POLL;MBD4
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.2701141853221209,-0.811201446880739,0.7506925207756233,0.9757318766721282,1.0,8/25,17.76%,MED1;TAL1;ACVR2A;HIF1A;PRKDC;INHBA;FAM210B;HMGB2
prerank,regulation of ERAD pathway (GO:1904292),0.3844062029891618,0.8109747276939088,0.6771799628942486,0.9806411642225116,1.0,5/11,23.18%,RNF185;TMEM259;RNFT1;BAG6;ATXN3
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.37712497667969674,0.8109224119761803,0.6958105646630237,0.9802122054842385,1.0,3/11,16.20%,IL12B;CARD9;IL23A
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.3451740900214635,0.8107880713371914,0.6937086092715232,0.9799365929629253,1.0,4/17,15.93%,FAF2;DERL1;SELENOS;AUP1
prerank,atrial septum morphogenesis (GO:0060413),0.3958575186387019,0.8107553660757163,0.6839285714285714,0.9794795067546062,1.0,2/10,4.67%,NOTCH2;ACVR1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.3346126226971622,0.8107117644391684,0.7020933977455717,0.979040052431197,1.0,6/19,20.16%,SRC;HNRNPA1;TERF2;TENT4B;HNRNPC;HNRNPU
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.24950131281877186,-0.8106657133450689,0.7610062893081762,0.9757360898321071,1.0,6/33,15.44%,ANKRD28;HSP90AB1;DCLRE1B;CTC1;ZBTB48;RAD51
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.3760696168534883,0.8104966201455789,0.6809269162210339,0.9789127897514696,1.0,4/11,24.24%,NOS1AP;ALG10B;LRRC38;LRRC55
prerank,regulation of neurogenesis (GO:0050767),0.286372008086365,0.8099818654422924,0.7584345479082322,0.9793220633268972,1.0,7/55,6.12%,ASCL1;YAP1;NUMBL;APPL2;LIG4;SERPINF1;HES7
prerank,mammary gland epithelium development (GO:0061180),-0.31950395404258425,-0.8096610988776377,0.7086419753086419,0.9765786815874576,1.0,4/14,10.09%,ERBB4;JAK2;ID2;SCRIB
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.31553057657902567,0.8091545545476758,0.7211093990755008,0.9802659536622931,1.0,1/29,1.53%,ARRDC4
prerank,positive regulation of cell division (GO:0051781),0.29751255835769874,0.8091208955119111,0.7259887005649718,0.9798125729692051,1.0,5/38,8.21%,SVIL;FGFR2;CDC42;SIRT2;DRD3
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.2710272679226488,-0.8090335578821386,0.7787356321839081,0.9767039904686469,1.0,12/26,29.19%,EIF4E;MEIS2;TAL1;HES1;LGMN;USP22;APP;CUL3;RPS6KB1;DUSP3;TTL;USP2
prerank,regulation of myotube differentiation (GO:0010830),-0.26938500709433805,-0.8088954031066615,0.7710144927536232,0.975934587953379,1.0,5/24,11.40%,PIEZO1;NOTCH1;CCN3;ATP11A;SMYD1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.24995826967584028,0.8088312526883559,0.7885714285714286,0.979795809716357,1.0,19/140,14.00%,ADRA1B;SLC8A1;ADCY5;XCR1;PDGFRA;ACKR2;CCR9;BDKRB2;CACNA1C;AGTR1;LPAR1;DRD3;BCAP31;TRPM4;P2RX5;C1QTNF1;CXCR6;CXCL13;DLG4
prerank,regulation of histone deacetylation (GO:0031063),-0.32267059378910345,-0.8086649851443238,0.720763723150358,0.9753153909970959,1.0,4/13,14.46%,CAMK2D;CTBP1;APLNR;PRMT6
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.3759513827338794,0.8083675234583895,0.6684027777777778,0.9800819572326023,1.0,4/12,14.20%,RESF1;TET1;PPHLN1;SETDB1
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.26870963594797986,-0.8081984839201021,0.7506702412868632,0.9751695477108789,1.0,8/28,19.59%,NOTCH3;BEND6;GATA2;LFNG;HEY1;DLL4;DLL1;EGFL7
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.31762585975275986,0.8076067192788073,0.7145038167938931,0.9809001233166914,1.0,3/26,7.77%,SMAD3;NOS1AP;TLR6
prerank,female gamete generation (GO:0007292),0.3122028120199947,0.8074805693739421,0.7275494672754946,0.9805882444774153,1.0,11/29,24.42%,DMC1;DIAPH2;PARN;BMP15;USP9X;MDK;METTL3;GDF9;TOB2;SPO11;NANOS3
prerank,TOR signaling (GO:0031929),-0.2666416966936943,-0.8074503102078048,0.7777777777777778,0.9754461347138791,1.0,11/26,28.50%,PRR5L;CCDC88A;MTOR;RPS6;RPS6KB2;FLCN;EIF4EBP2;PRR5;RPS6KB1;CARD11;RHEBL1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.31880833893972654,0.8072433229168806,0.7216338880484114,0.9804879043079789,1.0,9/24,24.10%,SRC;HNRNPA1;TERF2;TNKS2;TENT4B;HNRNPC;HNRNPU;TNKS;XRN1
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.37385174658376974,0.8066963543515009,0.6897746967071057,0.9809260799959043,1.0,5/11,21.26%,RESF1;PPHLN1;SETDB1;TPR;DNMT1
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.246728464702377,0.8065317565716771,0.8178733031674208,0.9807105830773591,1.0,20/151,11.50%,PAM;GAL3ST2;PLPP3;APOE;SLC44A1;LARGE1;APOA1;GSTM4;PLA2G4A;GSTM2;SPHK2;CERS6;CERS5;MGST1;GSTT1;NMRAL1;CHKB;CDO1;KDSR;ABHD3
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.36340476392398957,0.806453490951007,0.6779964221824687,0.9803350241232796,1.0,3/12,17.97%,NUPR1;TTBK1;IL18
prerank,nucleoside catabolic process (GO:0009164),-0.3355386269719673,-0.8061489996595662,0.7317596566523605,0.9767495825314353,1.0,4/11,17.64%,NT5E;NT5C1A;UPB1;NT5C
prerank,endodermal cell fate commitment (GO:0001711),-0.34450948625940725,-0.8061171228942924,0.7116704805491991,0.9757828304857867,1.0,2/10,9.50%,SOX17;RTF1
prerank,positive regulation of embryonic development (GO:0040019),0.3346276309494303,0.8053975627211181,0.7161936560934892,0.9816247063529857,1.0,4/19,12.33%,WNT4;OSR1;RBM19;NIBAN2
prerank,cellular response to osmotic stress (GO:0071470),-0.28106422888145716,-0.8051243750286826,0.7549295774647887,0.9765946499376531,1.0,6/21,13.90%,LRRC8D;YBX3;ARHGEF2;SCN2A;RCSD1;TRPV4
prerank,positive regulation of interferon-beta production (GO:0032728),0.3028169113075569,0.8043421217215031,0.7247838616714697,0.983008788242111,1.0,9/33,18.23%,IRF1;OAS2;POLR3A;DDX3X;TBK1;RIPK2;RIOK3;RNF135;DHX58
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.2946381333134688,0.8042781876028225,0.7298444130127298,0.9825932704998606,1.0,13/41,20.11%,OGT;PRKAG2;NUP107;NUP42;EIF6;NUP98;RAE1;NUP214;GCK;SEH1L;TPR;PRKAG1;AAAS
prerank,serine family amino acid catabolic process (GO:0009071),-0.3397668261513729,-0.803979408484442,0.7152317880794702,0.9776190276685593,1.0,6/10,38.33%,GCSH;SHMT1;AMT;GLDC;DAO;THNSL2
prerank,negative regulation of DNA replication (GO:0008156),0.3711392992178577,0.802837465487839,0.72,0.9845912902460214,1.0,3/13,15.20%,TSPYL2;S100A11;WAPL
prerank,axon development (GO:0061564),0.2636028299056091,0.8026906769600582,0.785,0.9843357785594453,1.0,16/78,15.12%,NREP;FGFR2;VASH2;SEMA5A;MTR;BRSK1;ARHGAP35;PARD6B;EPHB2;RYK;EPHB3;SLITRK2;NTNG2;MARK2;LLGL1;PARD3
prerank,water transport (GO:0006833),0.37174948051887696,0.8025480630629979,0.7073578595317725,0.9840635473281256,1.0,2/12,8.39%,PDPN;AQP6
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.34573820892406343,-0.8024967366643175,0.7321814254859611,0.979258802766782,1.0,4/10,17.64%,NT5E;NT5C1A;UPB1;NT5C
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.3134485381473703,0.8022075787592154,0.7208201892744479,0.9841683049773077,1.0,5/26,10.78%,SFRP1;STRN3;DAB2;NCOR1;NCOR2
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.27065558529244804,-0.8018848224937127,0.7357512953367875,0.9793063109892787,1.0,9/24,27.98%,TOMM70;AIM2;CGAS;PTPN22;TRIM6;EIF2AK4;TRIM44;LILRB1;TRAF3IP2
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.3159241284494609,0.8018141573510763,0.7012383900928792,0.9843641631816965,1.0,1/26,0.43%,FBN1
prerank,negative regulation of interferon-gamma production (GO:0032689),0.32287584518140017,0.8017929337288486,0.7133956386292835,0.9838835184062049,1.0,2/23,4.71%,GAS6;AXL
prerank,pore complex assembly (GO:0046931),0.3375836094955549,0.8008217495412375,0.7067082683307332,0.9850789351419516,1.0,4/19,10.96%,PLEKHA7;NUP107;AFDN;NUP98
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.3850293882860122,0.800599769947674,0.7345454545454545,0.9849547461708449,1.0,1/11,1.77%,LYN
prerank,RNA polyadenylation (GO:0043631),0.3162544236975668,0.8005460785587877,0.7039274924471299,0.9840186471629262,1.0,15/26,26.20%,WDR33;PAF1;PCF11;TENT4B;PAPOLG;CPSF2;CDC73;FIP1L1;LEO1;SCAF8;PAPOLA;PAPOLB;GRSF1;SSU72;AHCYL1
prerank,mRNA polyadenylation (GO:0006378),0.3162544236975668,0.8005460785587877,0.7039274924471299,0.9840186471629262,1.0,15/26,26.20%,WDR33;PAF1;PCF11;TENT4B;PAPOLG;CPSF2;CDC73;FIP1L1;LEO1;SCAF8;PAPOLA;PAPOLB;GRSF1;SSU72;AHCYL1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.3694999908053349,0.8004834093222061,0.7064846416382252,0.9836271885255505,1.0,5/13,28.02%,ETS1;MDK;NFAT5;RELA;IL6
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.2605641832110714,0.8004495774390369,0.7950310559006211,0.9831759051587554,1.0,20/80,19.24%,PLPP3;ATP9A;ZW10;ARFGAP3;COPB1;COPZ2;KDELR3;ERGIC2;GOLPH3L;ERGIC3;UVRAG;COPA;ARF4;ERGIC1;GOLPH3;TAPBP;COPG1;TMED10;RER1;HTT
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.33460679493147916,0.7996088735717837,0.709480122324159,0.984103913800329,1.0,3/20,9.63%,BCL2;MOAP1;ITGAV
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.3542151657793098,0.7992976407152631,0.7096774193548387,0.9841579634395389,1.0,4/15,10.17%,FGFR1;SEMA5A;SMOC2;FGF2
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.3008451449536711,-0.7992283541841015,0.7641277641277642,0.9830727258420852,1.0,6/15,23.53%,KDR;CDH13;VEGFA;VEGFC;VEGFD;F3
prerank,endosome organization (GO:0007032),-0.23434626212498424,-0.799208523450257,0.8344594594594594,0.9820758183562541,1.0,9/41,16.17%,RAB27A;CLCN3;DNAJC13;ALS2CL;WASHC5;EXOC8;CORO1C;AKTIP;DNM1
prerank,stem cell development (GO:0048864),-0.29870251145482957,-0.7987850023800401,0.7386666666666667,0.9818509830340838,1.0,6/16,29.10%,CDH2;PTPRC;SOX8;SNAI2;NOLC1;WNT7A
prerank,negative regulation of MAP kinase activity (GO:0043407),0.2874953032893348,0.7987783086640634,0.7319148936170212,0.9845543253748739,1.0,8/44,14.90%,LYN;APOE;CDK5RAP3;IRAK3;SPRY2;DUSP19;PDCD4;BMP4
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.2965802402728002,0.7986399853661477,0.7438136826783115,0.9842806573028615,1.0,15/33,20.59%,EGFR;DDX3X;RGCC;GLI1;PAF1;KMT2E;UBE2E2;AKT1;ADAMTS1;TFDP1;LSM10;CDC73;PHB2;PLCB1;CCND2
prerank,mitochondrial transcription (GO:0006390),0.3832839917094357,0.7984431422622782,0.6750448833034112,0.9841031848057301,1.0,4/10,17.93%,TFAM;POLRMT;TEFM;FOXO3
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.2706712561127188,-0.7983627914217504,0.7436619718309859,0.9815440985273294,1.0,6/23,12.41%,CBFA2T3;CRY1;GSK3A;PFKFB1;PLEK;GIT1
prerank,positive regulation of intracellular transport (GO:0032388),0.29059079741693267,0.7974270212138278,0.7308823529411764,0.9853875177489749,1.0,4/38,9.87%,ACTN2;NEDD4;DYNC1H1;STK11
prerank,receptor catabolic process (GO:0032801),-0.2721896134707308,-0.7974164728345849,0.7900262467191601,0.9821863580412765,1.0,7/24,15.09%,SMURF1;KIF16B;RNF43;TGFB1;LGMN;VLDLR;AP2A1
prerank,long-term memory (GO:0007616),0.33456007124638626,0.7971630449708883,0.707667731629393,0.9853233652014399,1.0,3/19,6.71%,APOE;LDLR;CPEB3
prerank,carbohydrate derivative catabolic process (GO:1901136),0.33592430806433293,0.7968806858778649,0.734959349593496,0.9853061077994387,1.0,4/18,16.23%,ADAMTS9;NGLY1;BPGM;NEU4
prerank,protein targeting (GO:0006605),-0.1962924254294533,-0.7968310336705312,0.9391891891891891,0.9821695073539947,1.0,46/118,29.93%,NLGN1;RASSF9;ZDHHC2;SDCBP;TOMM70;SORL1;AP4E1;RPL11;AKAP6;RTP4;ZDHHC15;AQP11;ZDHHC14;VPS37B;VPS37A;ATG3;CDC37;GIPC1;ARL6;TOMM7;TRAK2;HOMER3;CACNG3;ZFAND2B;TOMM40;SPCS1;PEX12;FBXO7;FIS1;TIMM10;VPS37C;HAP1;GABARAP;ZDHHC18;PEX16;EDEM1;AIP;HACL1;ZDHHC24;NACAD;SRPRA;TIMM17A;TIMM22;SEC61G;ZDHHC22;SEC63
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.2981297236632071,-0.7965699275993985,0.7365728900255755,0.9815829523861764,1.0,5/16,27.62%,TUBB4B;LYST;RAET1E;CEBPG;CORO1A
prerank,regulation of macrophage differentiation (GO:0045649),0.3483731783465012,0.7965165924423097,0.7235494880546075,0.9854361177007807,1.0,2/15,4.19%,IL34;CSF1
prerank,regulation of exosomal secretion (GO:1903541),0.3360780805945136,0.7964789699673985,0.72,0.9849909666099101,1.0,4/19,13.91%,ATP9A;SDC1;PRKN;SDC4
prerank,atrioventricular valve development (GO:0003171),0.36027469388929256,0.7964183618780841,0.7142857142857143,0.9845793735980762,1.0,4/14,10.12%,BMPR1A;ACVR1;BMP2;SLIT3
prerank,response to interferon-beta (GO:0035456),-0.27081608086573,-0.7959239539910248,0.7958115183246073,0.9817006831560292,1.0,8/22,28.44%,AIM2;PNPT1;UBE2K;UBE2G2;TRIM6;PLSCR1;IFITM3;IFNAR2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.34216427395520854,0.7958535764609899,0.7182410423452769,0.9850303778957162,1.0,2/18,3.47%,DACT1;APOE
prerank,regulation of protein targeting to membrane (GO:0090313),0.311135168146983,0.7957999380989325,0.7182890855457227,0.984621289772064,1.0,1/28,0.72%,CEMIP
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.32628083181987827,-0.7957102762693871,0.7300771208226221,0.9810590865356603,1.0,6/12,26.31%,GCLM;OPLAH;GCLC;GGT1;GGCT;GSS
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.19941869428687545,-0.7945775299167873,0.9222797927461139,0.9819465453305853,1.0,26/83,24.43%,CDK6;CDK17;CUL1;USP29;EIF4E;CDK5;DBF4;DHFR;BCAT1;TYMS;NPAT;CCND1;CUL2;INHBA;E2F3;CDKN1A;CUL3;CDK18;HINFP;PLK3;BACH1;CDKN3;MAX;PIM2;NASP;RPS6KB1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.2503776155856593,-0.7944301114154871,0.7988165680473372,0.9812150065264057,1.0,7/30,15.93%,CAV1;SRCIN1;PTPN2;INPP5F;PRKCZ;PTPN6;PTPRC
prerank,glutathione biosynthetic process (GO:0006750),-0.33010535301973265,-0.7938144461162646,0.7,0.9812750431541574,1.0,6/11,26.31%,GCLM;OPLAH;GCLC;GGT1;GGCT;GSS
prerank,gas transport (GO:0015669),-0.3390252451927003,-0.793625693803879,0.727710843373494,0.9805860909770572,1.0,2/10,8.56%,IPCEF1;CYGB
prerank,protein targeting to mitochondrion (GO:0006626),0.2736615709468917,0.7933750789294863,0.76657824933687,0.9883391057522394,1.0,9/52,13.94%,TIMM17B;PMPCB;AIFM1;BCAP31;TIMM44;TIMM9;TSPO;IMMP1L;TOMM22
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.31718227558329126,0.7928776531331801,0.7252747252747253,0.9887046334833857,1.0,10/24,21.00%,CHD6;MT3;NFE2L2;RBPJ;CEBPB;SESN2;HSF1;MUC1;CREB3L1;DDIT3
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.3015911011570695,0.7928524220267616,0.7485380116959064,0.9882403099727217,1.0,2/32,4.80%,CDK14;CDK16
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.27958102256834655,0.7926770719057112,0.7789613848202397,0.9880194711095807,1.0,10/55,11.09%,BCL2;TGFBR1;NUPR1;PML;ING5;TRAF7;BCL2L11;BCAP31;LTBR;GSDME
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.36595594644647855,0.7923877298984355,0.7109243697478992,0.9880291770543557,1.0,4/11,14.77%,BMPR1A;CD200;GATA6;ATP6AP2
prerank,response to lipid (GO:0033993),0.25390545765922234,0.792098026580405,0.8009592326139089,0.988002773759661,1.0,16/105,15.92%,RBP4;WNT8B;FGFR4;ASCL1;RARG;CTSH;STRN3;IRAK3;STAT5B;FOXA1;LIAS;GPX3;PAQR7;GATA6;RXRA;MAPKAPK2
prerank,phosphate-containing compound metabolic process (GO:0006796),0.23842315291999347,0.7920728639062854,0.8593406593406593,0.9875366326367861,1.0,19/198,9.79%,EPHA7;ENPP1;PLPP3;PXYLP1;ACYP2;PPP3CA;EPHX2;PFKFB4;PLCD1;INPP5A;PLA2G4A;LRRK2;PLCB4;SPHK2;GFPT1;EPHB2;INPP4A;XYLB;SLC20A1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.3755234738576822,0.7918511513420828,0.7075812274368231,0.9874164356491506,1.0,2/10,12.34%,OGT;SELENOS
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.30208856912888216,0.7917190853890235,0.7496274217585693,0.9871349506378274,1.0,14/32,24.99%,CDK5RAP3;BRSK1;MRNIP;TAOK3;ATM;UIMC1;CLSPN;BRCC3;TAOK1;TRIM39;BRCA1;MRE11;RINT1;CDC14B
prerank,ncRNA catabolic process (GO:0034661),0.31061270858494305,0.7914939394136151,0.7303030303030303,0.9869968107924263,1.0,11/28,25.25%,SND1;PARN;EXOSC7;TUT4;MTREX;NUDT16L1;TENT4B;DIS3L;EXOSC2;XRN1;EXOSC8
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.2592831828842705,0.7906551402836812,0.7938144329896907,0.987945264932341,1.0,23/82,23.16%,DYNLL1;NINL;CEP152;DYNC1H1;ALMS1;YWHAE;DYNC1I2;HAUS1;HAUS7;HAUS3;CEP164;CEP192;ATF5;DYRK3;ODF2;PRKACA;CEP250;AURKA;NDE1;HAUS5;HAUS6;TUBG1;SFI1
prerank,cellular response to dsRNA (GO:0071359),-0.30186711724444476,-0.7893861916040043,0.7452380952380953,0.9867311659403969,1.0,6/15,19.40%,CAV1;IFIH1;CGAS;RALB;NPM1;DHX9
prerank,cellular respiration (GO:0045333),-0.23234224755808303,-0.7893858383698851,0.8421052631578947,0.9857086465974534,1.0,17/41,25.88%,SLC25A13;PPARGC1A;MTFR1;UQCRH;NDUFA5;CYCS;SURF1;SDHB;MTFR2;MTLN;NDUFS7;NDUFS1;UQCR10;COQ10A;UQCRC1;ETFRF1;UQCRFS1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.32868720107791516,-0.78922016040222,0.7407407407407407,0.9849830364103214,1.0,7/11,55.05%,CCT8;CCT6A;CCT7;CCT2;TCP1;WRAP53;DKC1
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.3820909974202447,0.7889418526480801,0.7419354838709677,0.9903698080156537,1.0,3/10,6.64%,CHADL;CST3;EMILIN1
prerank,regulation of cellular protein localization (GO:1903827),0.28505538972109523,0.7889019347822482,0.7906976744186046,0.9899236970573846,1.0,2/45,5.20%,GPC6;PRKAA2
prerank,positive regulation of T cell activation (GO:0050870),0.26356874429835697,0.7888299197252232,0.7774725274725275,0.9895379626213429,1.0,6/62,9.17%,RHOH;CCL19;IL12B;CD28;ZMIZ1;ZBTB1
prerank,regulation of chromatin binding (GO:0035561),-0.3392695461228836,-0.7887062796398302,0.7424593967517401,0.9848026731178906,1.0,3/10,24.44%,BTAF1;KDM4D;HMBOX1
prerank,regulation of programmed cell death (GO:0043067),0.24173311084305807,0.7886168947671294,0.8557046979865772,0.9894057131777078,1.0,13/161,9.33%,DAPK2;STEAP3;ACTN2;DAPK1;MOAP1;NTF3;RARG;BCL6;NDRG1;LRRK2;BCL2L11;ACTN4;PRKN
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.339051816994234,0.7884362634641925,0.6958041958041958,0.9891960462905924,1.0,3/16,9.95%,LEPROT;PIBF1;PARP14
prerank,regulation of cytokine production (GO:0001817),0.2472809238041032,0.7882186503830277,0.8323424494649228,0.9890459001355477,1.0,24/126,16.57%,LYN;LGR4;PLA2R1;TWSG1;IGF2BP2;BCL6;IL12B;BATF;CD28;DTX4;MAST2;CCN4;NFAM1;CARD9;ADRA2A;RGCC;TBK1;SYT11;GLMN;ERMAP;ASB1;MAPKAPK2;CD47;PLD4
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.30114211535972296,-0.7880873275640642,0.7378640776699029,0.9848084294626114,1.0,6/14,25.82%,FAM98B;CLP1;CSTF2;TSEN54;TSEN34;CPSF1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.3506857319163336,0.7873884427417011,0.7210884353741497,0.9899581813400433,1.0,3/15,7.38%,LDLR;SIK1;SREBF1
prerank,positive regulation of double-strand break repair (GO:2000781),-0.230622648079802,-0.7869738194691467,0.8248175182481752,0.9856968153360698,1.0,9/39,21.29%,SPIRE1;FMN2;SHLD1;KDM4D;PRKDC;SLF1;PNKP;PARP1;SHLD2
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.31784222563239856,0.7866885198682532,0.7378787878787879,0.9906813991782405,1.0,3/23,11.00%,UACA;NMI;DDX3X
prerank,cardiac atrium morphogenesis (GO:0003209),-0.30302790864444096,-0.7865085227804488,0.7868421052631579,0.9854591618616488,1.0,6/16,17.36%,NOTCH1;TGFB2;HEY2;ZFPM1;DLL4;BMPR2
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.2645791335037717,0.7860701937761319,0.7828863346104725,0.9912028585975866,1.0,9/69,9.33%,GDNF;BCL2;APOE;MT3;NTF3;LIG4;SLC30A10;NONO;PRKN
prerank,regulation of calcium ion import (GO:0090279),0.32300117874901324,0.7858682224628606,0.7299509001636661,0.9910270727812839,1.0,4/21,17.03%,PDGFRB;SPHK2;EGF;PSEN2
prerank,mucosal immune response (GO:0002385),0.34497306475027045,0.7856989090405303,0.7128205128205128,0.9907985397829387,1.0,2/15,7.87%,PIGR;CAMP
prerank,autophagosome organization (GO:1905037),0.2757429179705595,0.7856498877086968,0.7655172413793103,0.9903684943720414,1.0,15/50,22.94%,RAB23;ULK2;UBXN2B;EMC6;WIPI1;RAB19;MAP1LC3A;BECN1;ATG2B;NSFL1C;WDR45;ATP13A2;ATG9A;STX12;AMBRA1
prerank,glutamine family amino acid catabolic process (GO:0009065),0.35111681921056626,0.785185569757956,0.7305084745762712,0.9906376415076927,1.0,1/13,1.26%,GLUL
prerank,regulation of cholesterol efflux (GO:0010874),0.3011096521421769,0.7850197200231382,0.7367668097281831,0.9904200197900908,1.0,9/30,19.68%,LRP1;APOE;APOA1;ABCA3;NR1H3;RXRA;SHH;YJEFN3;ABCA7
prerank,T cell receptor signaling pathway (GO:0050852),0.239876943947283,0.7849719060454733,0.8469505178365938,0.9899985941012748,1.0,9/138,7.10%,PDPK1;THEMIS;PIK3R1;FYB1;RFTN1;PSME4;CD247;RNF31;CD28
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.35734077261543473,0.784840769467421,0.7179054054054054,0.9896971570542974,1.0,5/12,24.20%,PIBF1;ERLIN1;BRCA1;ERLIN2;ACADVL
prerank,ribonucleoprotein complex assembly (GO:0022618),0.24432018915194426,0.7847564591584648,0.8376777251184834,0.9893282606740742,1.0,23/132,18.90%,POLR2D;CELF2;SF1;TRAF7;ERAL1;EIF6;EIF3A;EIF2S2;DDX23;NOL3;SNRPD2;SRSF5;RBM5;RRP7A;GEMIN2;PRPF6;NAF1;SF3B1;SRSF10;KHDC4;CDC73;DDX1;DICER1
prerank,nerve growth factor signaling pathway (GO:0038180),0.37448803144448134,0.7843944381331497,0.7145390070921985,0.9894504123904239,1.0,3/10,9.37%,RAPGEF2;NTF3;RAPGEF1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.20502099491109985,-0.7842440060727779,0.8846153846153846,0.9882828592213413,1.0,20/70,24.94%,B2M;VAMP8;NCF2;FCER1G;MFSD6;PSMF1;PSMB8;PSMA4;PSMB10;PSMB2;PSMC4;FCGR1A;PSMA6;PSMD9;PSMD11;PSMD5;CHUK;PSMA8;PSMB1;LNPEP
prerank,DNA methylation or demethylation (GO:0044728),0.3340471095602808,0.784142025880547,0.759375,0.988850874828165,1.0,8/19,24.64%,DNMT3A;SPOCD1;KMT2E;DNMT3B;ATRX;DNMT1;PPM1D;DMAP1
prerank,DNA alkylation (GO:0006305),0.3340471095602808,0.784142025880547,0.759375,0.988850874828165,1.0,8/19,24.64%,DNMT3A;SPOCD1;KMT2E;DNMT3B;ATRX;DNMT1;PPM1D;DMAP1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.20286920749686166,-0.7840857557710514,0.91005291005291,0.9875050848229686,1.0,21/87,20.60%,FHL1;CDK6;CUL1;RBX1;FBXL7;AVEN;BRD7;KLF4;PSMF1;FAM107A;PSMB8;PSMA4;PSMB10;PSMB2;CDKN1A;PSMC4;PSMA6;E2F7;PSMD9;PSMD11;PSMD5
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.31395516501193943,0.7840806524707583,0.730593607305936,0.987951220442899,1.0,4/23,9.87%,ZEB2;SLC2A10;DAB2;STK11
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.31395516501193943,0.7840806524707583,0.730593607305936,0.987951220442899,1.0,4/23,9.87%,ZEB2;SLC2A10;DAB2;STK11
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.37662817155573636,0.783468745117639,0.724561403508772,0.9884688080387165,1.0,1/11,1.86%,BCL2
prerank,striated muscle cell development (GO:0055002),-0.3047344543840716,-0.7833525623383873,0.7441860465116279,0.9877607503869152,1.0,3/14,6.03%,TMOD2;PGM5;TMOD3
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.3021993650014419,-0.7829163018309651,0.7585365853658537,0.9874670719725246,1.0,11/13,52.49%,TGFB1;SOD1;MAPT;GSTP1;ITGB2;F2RL1;CD177;SYK;TYROBP;FPR2;CRP
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.2513112883904135,-0.7824351689588751,0.8178913738019169,0.9872308152446065,1.0,10/29,25.11%,EDC3;LSM2;LSM6;EXOSC5;CNOT7;DCP2;CNOT8;DCPS;LSM7;EXOSC4
prerank,regulation of cell division (GO:0051302),0.26036179697626277,0.7822413762609648,0.8141361256544503,0.9899245289550135,1.0,13/72,18.01%,TXNIP;FGFR2;KIF20A;EFHC1;MLLT3;SIRT2;UVRAG;NCOA3;PIK3R4;PLK2;CDK2AP2;SHH;BECN1
prerank,histone H3 deacetylation (GO:0070932),0.34173927127055925,0.7819187064031823,0.735632183908046,0.9899532068677008,1.0,7/15,25.04%,SIRT2;HDAC8;HDAC4;ELK4;SMARCAD1;SFPQ;HDAC1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.35922699613188414,0.7816491220360716,0.7239583333333334,0.9893655827674352,1.0,3/12,9.29%,KANK1;FBLN1;ACTN4
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.35922699613188414,0.7816491220360716,0.7239583333333334,0.9893655827674352,1.0,3/12,9.29%,KANK1;FBLN1;ACTN4
prerank,N-glycan processing (GO:0006491),0.3358567474243851,0.7814476942144726,0.7536945812807881,0.9892082814042271,1.0,2/18,2.63%,PRKCSH;MAN1C1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.29997737275428354,0.7812023753809467,0.7551319648093842,0.9891112959272663,1.0,4/30,9.34%,INSIG2;APOA1;MVK;IDI1
prerank,cilium assembly (GO:0060271),0.22574393494310468,0.7806826660013451,0.9051094890510949,0.9894614985031672,1.0,42/296,14.92%,ASAP1;GSN;DYNLL1;PARVA;NINL;CEP152;WDPCP;DZIP1L;RAB23;CYS1;CPLANE1;DYNC1H1;PIBF1;NPHP1;TTC39C;B9D1;ALMS1;WDR35;IFT43;IFT27;DNAAF1;FBF1;CFAP46;TRIP11;IFT81;DYNC2I1;CFAP44;CFAP410;YWHAE;CCDC40;DYNC1I2;HAUS1;DYNLRB2;PTPDC1;ARF4;PTPN23;HAUS7;FLNA;HAUS3;CEP164;IFT22;CEP192
prerank,negative regulation of protein localization to membrane (GO:1905476),0.3114075603728161,0.7805655420140376,0.7354330708661417,0.9891569741010339,1.0,4/24,12.04%,PID1;DAB2;PICALM;RHOQ
prerank,negative regulation of viral genome replication (GO:0045071),-0.2364014358189841,-0.7804630837495243,0.7877697841726619,0.9894845625066886,1.0,16/40,29.88%,IFIH1;INPP5K;SRPK1;TASOR;MPHOSPH8;FAM111A;TRIM6;N4BP1;HMGA2;OASL;PLSCR1;IFITM3;ISG15;ISG20;IFIT1;ZC3HAV1
prerank,heme biosynthetic process (GO:0006783),-0.26044680330620024,-0.7803768910779239,0.7871148459383753,0.9886210023432703,1.0,1/22,0.42%,ABCG2
prerank,negative regulation of defense response to virus (GO:0050687),0.37883530127801446,0.7799841692168067,0.7245080500894454,0.9895694307671442,1.0,2/10,13.03%,ITCH;MUL1
prerank,regulation of RNA metabolic process (GO:0051252),0.2707397184389486,0.7799790936457037,0.7960264900662252,0.9890758201454515,1.0,6/59,5.58%,MITF;SON;HNRNPLL;IGF2BP2;OAS2;SNRNP70
prerank,dendritic spine organization (GO:0097061),0.30972972266506255,0.7798267692580011,0.7441497659906396,0.9888232385770528,1.0,8/26,14.00%,DOCK10;ITGA3;CDC42;EPHB2;EPHB3;INSR;PTEN;DLG4
prerank,nuclear membrane reassembly (GO:0031468),-0.21699877698304498,-0.779508850304451,0.8979591836734694,0.9890063914165398,1.0,16/54,25.01%,NUP93;NUP35;NUP160;VRK1;PPP2R2A;RANGAP1;EMD;SEC13;NUP155;VPS4A;CCNB2;CHMP2B;NUP85;CHMP4B;CHMP4A;NUP43
prerank,phosphatidylinositol metabolic process (GO:0046488),0.24627474342437639,0.7788311347465137,0.8335329341317366,0.9899395469851966,1.0,20/109,16.30%,PIK3R1;PTPN13;PDGFRB;PLCD1;SYNJ2;PLA2G4A;PLEKHA8;PLEKHA2;LPGAT1;MTMR3;INPP4A;MTMR7;FGF2;PI4KA;PIK3R4;PTEN;PGAP3;PIKFYVE;PIK3R2;PIP4K2C
prerank,positive regulation of peptidase activity (GO:0010952),0.3229450204836826,0.7788306082538279,0.7596153846153846,0.9894413742324143,1.0,6/20,24.23%,CTSH;APH1B;RCN3;PSME3;PRELID1;MAPK12
prerank,regulation of centrosome cycle (GO:0046605),-0.26871373337695736,-0.7785420488263062,0.8252688172043011,0.9895984792735548,1.0,8/21,29.11%,PDCD6IP;SIRT1;NPM1;CHMP2B;CEP131;CHMP4B;GEN1;CHMP4C
prerank,response to glucocorticoid (GO:0051384),0.3044212131730777,0.7782948223188617,0.7439759036144579,0.9898639114527159,1.0,5/26,11.95%,HSD3B2;ZFP36L1;BCL2L11;SLIT3;REST
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.2590208206093903,0.7780799011542752,0.8341645885286783,0.9896974279875939,1.0,11/76,12.98%,UACA;SASH1;CCL19;IL12B;NMI;EGFR;ACTN4;TRIP6;DDX3X;PDCD4;CD14
prerank,DNA replication initiation (GO:0006270),-0.2362825729591613,-0.7779527568011586,0.84,0.9895516677684764,1.0,15/37,34.69%,DBF4;TOPBP1;ORC4;POLE4;MCM8;LRWD1;MCM3;MCM5;ORC5;PRIM1;CDC6;POLA1;RPA2;CDC34;MCM7
prerank,epithelial cell differentiation (GO:0030855),0.2528951834919283,0.7779370759373924,0.8268991282689913,0.9894538665474615,1.0,12/88,14.90%,MAF;FGFR2;ASCL1;CNN3;FSTL1;SCUBE1;DAB2;GLI1;VDAC1;GSTK1;GATA6;BMP4
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.3466444023705503,0.7777309567648644,0.7421487603305785,0.9892913369063366,1.0,3/16,17.69%,LEPROT;CHMP5;TMEM50B
prerank,nucleotide metabolic process (GO:0009117),0.31763852703556505,0.7777006333029673,0.748829953198128,0.9888412516277509,1.0,8/23,24.03%,AK1;REXO2;CTPS2;AK8;DCK;NMNAT2;NUDT5;NMNAT1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.2996131632847947,0.777341892848381,0.7561683599419449,0.9889294812585525,1.0,12/30,26.31%,LEPROT;PDCD5;RNF31;HUWE1;RHOU;HPS4;ARIH2;SREBF2;VPS11;UBE2J2;SH3GLB1;BAP1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.26469586744398654,0.7773289743029367,0.7758620689655172,0.9884514416280016,1.0,15/58,20.25%,LIG4;SMC5;DCLRE1C;POLL;UBE2V2;NHEJ1;ERCC8;DCLRE1A;UVRAG;ATM;KAT5;SUMO1;UIMC1;BRCC3;NSMCE2
prerank,dendritic cell migration (GO:0036336),0.3369546934001183,0.7771802434791673,0.7188552188552189,0.9881876885757171,1.0,2/16,9.41%,CCL19;TRPM4
prerank,negative regulation of heart contraction (GO:0045822),0.3658115512506898,0.776944096580837,0.7202680067001676,0.9880935270989483,1.0,1/11,1.81%,ATP1A2
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3265357959132095,0.7769145691461969,0.7580645161290323,0.9876380388007038,1.0,7/20,22.94%,AMPD3;GART;AMPD2;PPAT;PFAS;ADSS1;ADSL
prerank,endocytic recycling (GO:0032456),0.26933488538481404,0.7764732266878603,0.7840112201963534,0.9878367047144438,1.0,12/50,17.25%,VPS26C;ACAP2;TRARG1;EPS15;SNX12;VPS35L;DENND1A;PTPN23;ARF6;SNX31;ANKRD50;MICALL1
prerank,maintenance of protein location in nucleus (GO:0051457),-0.2748084148686199,-0.7763079013879086,0.7990074441687345,0.9912347705909719,1.0,4/20,12.59%,SYNE1;SUN2;RANGAP1;MORC3
prerank,pharyngeal system development (GO:0060037),0.350221428803813,0.7759050966118366,0.7302631578947368,0.9882704446935486,1.0,2/15,3.58%,BMPR1A;TGFBR1
prerank,regulation of urine volume (GO:0035809),0.3713508906779563,0.7757243254731673,0.7327433628318584,0.988066996905897,1.0,2/10,11.11%,NPR3;ADM
prerank,chemical homeostasis (GO:0048878),0.26418328818290665,0.7756110753698476,0.789544235924933,0.9877416558627642,1.0,10/61,16.58%,ZBTB20;RBP1;CEBPA;TLCD1;NR1D2;DDX3X;WNK1;NR1H3;THADA;TENT4B
prerank,cellular response to amino acid stimulus (GO:0071230),0.29076180257626605,0.7753664639820296,0.7838616714697406,0.9876317299164569,1.0,7/33,11.71%,UBR2;CPEB1;CPEB3;SLC38A9;CASTOR2;LAMTOR2;RRAGD
prerank,protein deubiquitination (GO:0016579),0.22768155837231505,0.7751778087321829,0.9017094017094017,0.9874543196844467,1.0,65/242,23.50%,SMAD3;AR;OGT;CCNA2;TGFBR1;SMURF2;USP11;PSME4;ATXN7L3;USP47;USP20;INO80;USP35;USP24;USP48;KAT2B;SMAD1;PRKN;RHOT1;ACTR8;OTULINL;TNIP2;USP30;USP9Y;USP32;USP10;USP9X;USP38;PTEN;ADRM1;TADA3;SUDS3;UBE2D1;FOXK2;SENP8;PSMB5;PSMC2;TNIP1;BECN1;PSMD1;PSMD4;UIMC1;CLSPN;MDM4;PSME3;USP49;USP46;BRCC3;MBD6;USP37;USP3;PSMA3;ASXL2;UCHL1;STAMBPL1;ATXN7;SMAD2;BIRC2;BIRC3;ABRAXAS2;PSMA2;BRCA1;ATXN3;PSMC5;VCPIP1
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.3294052683890461,-0.7747532831462833,0.7348314606741573,0.9927303569202132,1.0,2/10,6.87%,SORL1;HSP90AB1
prerank,regulation of viral entry into host cell (GO:0046596),-0.2516528559224833,-0.7747515281422719,0.7987220447284346,0.991721447003257,1.0,8/30,18.25%,LY6E;TRIM14;HS3ST5;TRIM25;TRIM68;TRIM11;TRIM6;TRIM62
prerank,regulation of establishment of planar polarity (GO:0090175),0.25116985949387755,0.7743175235668169,0.8209876543209876,0.9883097995857958,1.0,7/88,6.16%,DACT1;FZD2;SMURF2;PRICKLE1;PSME4;FZD1;CDC42
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.34290867063516645,0.7742885180641775,0.7281879194630873,0.987866689804002,1.0,4/15,16.33%,SLC45A3;PPM1K;ADM;AKT1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.2779356756868903,-0.7741159582739213,0.784503631961259,0.9916924225401874,1.0,8/18,32.98%,MECP2;RAB11A;RAD51C;CCND1;DTL;RCC2;CDK1;BRD4
prerank,tricarboxylic acid metabolic process (GO:0072350),0.35329105068475053,0.7738579165658465,0.7243150684931506,0.9880568338268901,1.0,2/12,9.52%,ACO1;IDH2
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.30462666788525966,-0.7737553482126003,0.7628361858190709,0.9912342385123156,1.0,7/13,34.41%,CPSF7;CSTF2;CPSF1;CPSF6;CPSF4L;TUT1;NUDT21
prerank,rRNA transcription (GO:0009303),0.3375273821137274,0.7737381913119176,0.7381756756756757,0.9877664576006289,1.0,3/17,5.98%,POLR1G;BRF1;GTF3C1
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.3458486185948255,0.7734524314739162,0.7425249169435216,0.9877369484985674,1.0,2/15,4.31%,APOE;APOA1
prerank,positive regulation of cholesterol transport (GO:0032376),0.3037239277982121,0.7731649677864946,0.7680945347119645,0.9877039219537539,1.0,3/27,4.31%,LRP1;APOE;APOA1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.26954104781794636,-0.7731612431476107,0.8055555555555556,0.9911515530827552,1.0,10/21,32.44%,RPS7;RPL11;RPL5;UBE2S;RPL23;FZR1;PLK1;BAG2;CDC20;UBE2C
prerank,regulation of secretion (GO:0051046),-0.31354553619600944,-0.7729288907295865,0.7373271889400922,0.9904949494007734,1.0,4/13,12.76%,KCNQ1;SGK1;GPLD1;ERBB3
prerank,regulation of amyloid fibril formation (GO:1905906),0.3432941471866889,0.772435963505817,0.7561779242174629,0.9883738840580952,1.0,2/15,5.02%,APOE;LDLR
prerank,negative regulation of JUN kinase activity (GO:0043508),0.3719183150389746,0.7723271610743621,0.75,0.988047989272601,1.0,5/10,26.75%,DUSP19;PDCD4;AIDA;DNAJA1;HIPK3
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.30931880395770417,0.7720739011624295,0.754601226993865,0.9879344114238959,1.0,3/25,8.52%,MOAP1;PDCD5;BCL2L11
prerank,glucose metabolic process (GO:0006006),0.2687048668130598,0.7718116437090874,0.803475935828877,0.9878406689520894,1.0,6/58,11.22%,RBP4;MDH2;ENO2;GAA;DCXR;GALM
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.33228549452442,-0.7716762267163293,0.7571743929359823,0.9915119871624124,1.0,2/10,10.09%,PRKAR1A;SCRIB
prerank,positive regulation of hemostasis (GO:1900048),0.37595464219260516,0.7716706563574158,0.718978102189781,0.9870962391479332,1.0,2/10,11.77%,SERPINE1;F2
prerank,positive regulation of coagulation (GO:0050820),0.37595464219260516,0.7716706563574158,0.718978102189781,0.9870962391479332,1.0,2/10,11.77%,SERPINE1;F2
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.35376830110437846,0.7712951151460211,0.7482758620689656,0.987208059338702,1.0,7/12,28.50%,PCGF3;SMCHD1;METTL3;HNRNPU;BRCA1;LRIF1;RBM15
prerank,regulation of interleukin-10 production (GO:0032653),-0.2250340590290279,-0.7711354804976095,0.8613861386138614,0.9913516369522711,1.0,10/44,20.57%,CD34;PLCG2;TRIB2;TNFRSF21;PRKCZ;NOD2;JAK3;TLR4;DLL1;AGER
prerank,ncRNA export from nucleus (GO:0097064),-0.23560056002359794,-0.7707732000988872,0.8668831168831169,0.9909334167938086,1.0,12/36,22.14%,NUP93;NUP35;NUP153;NUP160;NUP54;SEC13;NUP155;RANBP2;NUP88;NPM1;NUP62;NUP85
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.3606419299700272,0.7703402623272289,0.7319778188539742,0.988252430820407,1.0,1/12,2.35%,ACSL1
prerank,sister chromatid segregation (GO:0000819),0.29991329854094206,0.7702921825861208,0.7906626506024096,0.9878344106691851,1.0,10/31,22.74%,INO80;ZW10;TOP2B;CHAMP1;ZWINT;SGO1;CDCA8;DSN1;TUBG2;TUBG1
prerank,RNA splicing (GO:0008380),-0.19483960340180378,-0.7702395021732696,0.9414893617021277,0.9907533785828505,1.0,20/95,19.90%,MBNL1;IVNS1ABP;SNRPB;PPARGC1A;ZCRB1;SRPK1;RBM8A;SNRPD1;SNRNP40;LSM6;SNRPA1;SRSF7;MPHOSPH10;PPIG;SNRPD3;SNRPN;SF3B4;USB1;WDR83;SRSF4
prerank,synaptic vesicle membrane organization (GO:0048499),-0.2776376681049848,-0.769950429856386,0.7790973871733967,0.9901925819541221,1.0,2/17,6.96%,STX3;SYP
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.341236531576056,0.7695671608615973,0.7249575551782682,0.9885159309307902,1.0,3/13,12.04%,RAB23;LRRK2;RHOQ
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.34627639250805703,0.7694456458652111,0.7469670710571924,0.9882272027133944,1.0,4/13,12.69%,ERLEC1;DERL3;BCAP31;UBAC2
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.2979407725857148,0.768967016832755,0.7880116959064327,0.9884953329565006,1.0,5/31,10.61%,FGFR2;PDGFRA;TGFBR1;OSR1;DYNC2I1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.26606517604406876,-0.7686880930503907,0.7989690721649485,0.99108050067497,1.0,8/21,29.32%,MECP2;RAB11A;RAD51C;CCND1;NPM1;DTL;RCC2;CDK1
prerank,oligodendrocyte development (GO:0014003),-0.2893568172431479,-0.7685894150586037,0.7932816537467701,0.9902672595352919,1.0,4/15,14.73%,B4GALT5;EIF2B5;EIF2B1;PLP1
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.33249343104834217,-0.7685820932673676,0.7795823665893271,0.9892847143610658,1.0,8/11,38.65%,IP6K1;IPMK;PPIP5K1;ITPKB;ITPKC;IPPK;IP6K3;PPIP5K2
prerank,organonitrogen compound catabolic process (GO:1901565),0.26639973642522774,0.7678895000081741,0.8201058201058201,0.9897227433024909,1.0,7/57,10.86%,CPQ;GGACT;PLA2G4A;SMPD2;NAALADL1;CLPX;RENBP
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.3587375264802912,0.7677649747502742,0.7209705372616985,0.9894509543211888,1.0,2/10,8.40%,APOA1;IRAK3
prerank,protein deneddylation (GO:0000338),0.36533578197279104,0.7677144935328049,0.7137745974955277,0.9890325779015104,1.0,3/10,16.50%,GPS1;COPS3;COPS2
prerank,UV-damage excision repair (GO:0070914),0.3557240739580356,0.7673539834542397,0.7469458987783595,0.9890992054664959,1.0,2/12,6.57%,INO80;CUL4B
prerank,regulation of glycogen metabolic process (GO:0070873),0.35436220340125113,0.76701070743364,0.7332185886402753,0.989099947787485,1.0,6/12,21.41%,PPP1R3C;PPP1R3D;AKT1;PPP1R3E;GCGR;RUBCNL
prerank,negative regulation of cell cycle process (GO:0010948),0.2588116441120351,0.7669746036688417,0.8204456094364351,0.9886652924908107,1.0,15/61,17.73%,TOM1L2;CBX3;RBBP7;PPP1R10;NME6;TERF2;L3MBTL2;YAF2;BMP4;WAPL;RNF2;CBX5;TFDP1;APAF1;CDC7
prerank,positive regulation of lipid storage (GO:0010884),-0.2725784585734287,-0.7669430015232739,0.7936507936507936,0.9908256398590554,1.0,7/21,27.50%,SCARB1;PLIN2;MSR1;OSBPL11;HILPDA;PLIN3;LPL
prerank,regulation of calcium ion transport (GO:0051924),0.2644290393850207,0.766812519438426,0.8063241106719368,0.988444391731855,1.0,10/54,16.90%,BCL2;MYLK;STIM1;CCL4;CAMK2B;ADRA2A;CD33;EGF;CASR;HRC
prerank,positive regulation of cellular protein localization (GO:1903829),0.256408983312007,0.7667354476066677,0.8010204081632653,0.988087249653718,1.0,23/69,23.49%,YAP1;CDK5RAP3;PRKAA2;SNX33;WWTR1;EIF2AK3;CROCC;SLC5A3;PRKN;F2;SYT11;SESN2;AKT1;LIF;TM9SF4;NUMA1;ABCA7;GPR137B;CEP250;GPD1L;CARD10;PARD6A;RANGRF
prerank,positive regulation of vacuole organization (GO:0044090),0.37400411287133106,0.7665713571102646,0.7370242214532872,0.9878513085425512,1.0,7/10,29.35%,RAB3GAP1;PIP4K2C;ANXA2;PIP4K2A;SH3GLB1;PIP4K2B;GRN
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.29673602770553564,0.7662303111775538,0.7776049766718507,0.9879027853746861,1.0,2/29,3.44%,SERPINE1;GAS6
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.2863153572463843,-0.7661470085538331,0.8048192771084337,0.9910620721089659,1.0,9/17,25.45%,INPP5K;CALM1;DDIT4;CALM3;DGKQ;SPRED2;PPEF2;DMTN;CALM2
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.3421400095752689,0.7659533781208941,0.7567567567567568,0.987844503884706,1.0,3/15,8.33%,APOA1;SLC45A3;LPGAT1
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.29387333928091247,0.7656424360570891,0.7635036496350365,0.9878729010402277,1.0,4/29,11.79%,SYCE2;TEX12;MAJIN;STAG3
prerank,negative regulation of ATPase activity (GO:0032780),-0.2825354956547693,-0.7654729578652233,0.783641160949868,0.9910419063490986,1.0,5/16,29.52%,PXK;SIRT1;PLN;ATP5IF1;IFIT1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.29246665633955277,0.7653855602020404,0.7689922480620155,0.9877921714596682,1.0,15/32,27.02%,SLC44A1;APOA1;CHKB;ABHD3;LCAT;SLC44A3;PCYT1A;PEMT;LPIN3;CEPT1;LPIN2;SLC27A1;SLC44A2;LPIN1;CSNK2B
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.29764562599249855,-0.7652161727907062,0.8104265402843602,0.9904351334565732,1.0,4/14,13.18%,CD55;TGFBR2;CD81;PTPN22
prerank,dendritic spine morphogenesis (GO:0060997),0.3392739825764352,0.7651386129273838,0.7445378151260504,0.98767500650453,1.0,6/15,14.00%,DOCK10;CDC42;EPHB2;EPHB3;PTEN;DLG4
prerank,mitotic metaphase plate congression (GO:0007080),0.268798383677865,0.7651169832625438,0.8106666666666666,0.987218484783248,1.0,13/51,20.48%,PIBF1;SPDL1;ZW10;CHAMP1;CENPC;EML4;CHMP5;SEH1L;BECN1;BOD1;KPNB1;CDCA8;CDC23
prerank,regulation of organelle assembly (GO:1902115),0.254978662685026,0.7645153489274265,0.828996282527881,0.9876638949820223,1.0,13/72,15.47%,GSN;USP6NL;NPRL3;TBC1D19;ALMS1;ADPRH;MTMR3;TBC1D2B;SENP6;PLK2;TBC1D20;PIKFYVE;NPRL2
prerank,regulation of telomere maintenance (GO:0032204),0.304720762018205,0.7644827864903873,0.7593167701863354,0.9872183173092223,1.0,10/26,27.28%,PML;PPP1R10;HDAC8;TERF2;RTEL1;ATRX;MRE11;RAD50;UPF1;SMG1
prerank,purine nucleotide biosynthetic process (GO:0006164),0.3427095059223451,0.7641877297797429,0.7282051282051282,0.9871940214903813,1.0,7/12,28.42%,GART;AMPD2;PRPSAP2;PPAT;ADSL;PRPSAP1;ADA
prerank,negative regulation of interleukin-8 production (GO:0032717),0.3220797112137299,0.7640371264792664,0.7463651050080775,0.9869462087610934,1.0,5/17,13.01%,MAPKBP1;TLR6;ARRB1;CD33;SSC5D
prerank,glutamate metabolic process (GO:0006536),0.3209451601369729,0.7639420700283579,0.7598684210526315,0.9866163494355221,1.0,2/19,8.64%,GLUL;ALDH18A1
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.316563563507399,0.7630607504915792,0.7496087636932708,0.9875071043119651,1.0,2/21,1.65%,DCN;BGN
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.31676472992164484,0.7630590585579623,0.7564935064935064,0.9870223410751077,1.0,1/18,1.86%,BCL2
prerank,cellular response to calcium ion (GO:0071277),0.257970858240817,0.7625587198237685,0.8257978723404256,0.9873074559159698,1.0,7/67,7.85%,ADCY1;ADGRV1;SLC25A24;PRKAA2;DPEP1;CPNE2;SYT9
prerank,positive regulation of blood coagulation (GO:0030194),-0.27590585338456386,-0.7623758900969688,0.8132992327365729,0.9937667756552558,1.0,8/17,24.34%,THBS1;THBD;ANO6;ENPP4;ST3GAL4;F3;HPSE;DMTN
prerank,gene silencing by miRNA (GO:0035195),0.2889231594419059,0.7623306515915411,0.7996987951807228,0.9871647233357992,1.0,11/32,24.63%,ZC3H7B;TNRC6B;WTIP;TNRC6A;EIF6;PRKRA;DICER1;AGO4;RBM4;AGO3;AJUBA
prerank,regulation of defense response to virus (GO:0050688),-0.2969634577452421,-0.7619341216701756,0.764018691588785,0.9934080239160006,1.0,5/14,25.30%,TNFAIP3;PCBP2;DHX9;C1QBP;IFNLR1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.3393871497407448,0.7618672412577605,0.7335581787521079,0.987410185537202,1.0,3/15,13.84%,BCL2;PRKN;TAF9
prerank,regulation of interleukin-1 production (GO:0032652),-0.2870842310967307,-0.7618644398291621,0.7702020202020202,0.9925203853842457,1.0,5/15,19.34%,SIRPA;FOXP1;CEACAM1;TLR4;ANXA1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.3173345849016437,0.7614869186565578,0.7698675496688742,0.9875077201443586,1.0,2/21,2.08%,LYN;RUNX1
prerank,response to nutrient levels (GO:0031667),-0.2816151616431236,-0.761481465614787,0.771712158808933,0.9921015755656302,1.0,9/17,40.61%,ULK1;MTOR;FAM107A;ATF4;RPS6KB1;RPTOR;SCTR;CD68;UCN2
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.23916366598222955,-0.7611827053352567,0.8391812865497076,0.991533554386485,1.0,6/30,10.92%,TAF1B;TBP;CAVIN1;GTF2H1;TAF1C;UBTF
prerank,ATP transport (GO:0015867),0.3691493493265988,0.7611676343229078,0.7398945518453427,0.9875181809289709,1.0,2/10,16.04%,SLC25A24;CD47
prerank,cellular response to unfolded protein (GO:0034620),0.30000141686510695,0.7611574028699912,0.7613104524180967,0.9870542115567822,1.0,10/26,26.14%,OPTN;PRKN;HSPA9;TM7SF3;TMBIM6;HSF1;HSPA14;HSPA5;BAG3;ABCB10
prerank,positive regulation of viral life cycle (GO:1903902),0.31543375229860837,0.7611252463140039,0.792778649921507,0.9866199919690568,1.0,6/22,21.88%,AXL;KPNA6;P4HB;KPNA2;LGALS9;TSG101
prerank,organic cation transport (GO:0015695),0.3107739717492672,0.76111921173109,0.75,0.9861479832508931,1.0,4/20,10.99%,SLC44A1;SLC22A2;SLC22A4;SLC22A18
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.37702495300341,0.7609087695911748,0.7553191489361702,0.9860142434680037,1.0,2/10,10.18%,FZD1;RYK
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.2109265051840748,-0.7602983619222702,0.9138576779026217,0.9918292928799992,1.0,24/57,30.28%,RAD17;FOXN3;TOPBP1;MDC1;HUS1;PRKDC;BABAM1;CCND1;FBXO31;NBN;CDKN1A;HMGA2;BABAM2;DTL;FANCD2;SDE2;ATF2;HUS1B;FZR1;PLK1;DONSON;CDK1;NEK11;TICRR
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.24405995842313566,-0.7601659575399281,0.845679012345679,0.9910346692224228,1.0,3/29,6.87%,ANKRD28;PPIA;HSP90AB1
prerank,mRNA export from nucleus (GO:0006406),0.24200319488868344,0.7600023709326489,0.8367103694874851,0.9869446279007671,1.0,11/102,11.98%,POLR2D;NUP107;U2AF1L4;THOC2;NUP42;DDX39A;DDX19A;WDR33;NUP98;RAE1;MAGOHB
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.32826123070628416,0.7598204652476714,0.7466887417218543,0.9867397642957728,1.0,3/15,11.82%,LARGE1;RENBP;MGAT3
prerank,snRNA 3'-end processing (GO:0034472),-0.27488770874710144,-0.7597210757495856,0.8269230769230769,0.9907184090923121,1.0,7/19,28.82%,INTS6;INTS8;EXOSC5;USB1;INTS1;EXOSC4;TUT1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.333506114378095,0.7594590221952754,0.7524752475247525,0.9868050495230615,1.0,5/15,19.98%,DCST1;STAT2;MUL1;METTL3;YTHDF2
prerank,positive regulation of immune effector process (GO:0002699),0.2980144941663582,0.7593675749692377,0.76793893129771,0.9864697538557934,1.0,4/27,7.15%,MYO18A;APPL2;IL12B;DDX60
prerank,endothelial tube morphogenesis (GO:0061154),-0.3279649565123354,-0.7592375713234136,0.7684964200477327,0.990454842992048,1.0,2/10,7.70%,ACVRL1;RHOB
prerank,zymogen activation (GO:0031638),-0.23229232147731824,-0.75908937116019,0.8375796178343949,0.9896629808927553,1.0,8/39,14.60%,GRIN2A;PERP;KLK2;PRSS12;CASP8;CYFIP2;LGMN;BAK1
prerank,fluid transport (GO:0042044),0.3473138267838831,0.7585799247699975,0.7373572593800979,0.9872031346442469,1.0,2/12,8.39%,PDPN;AQP6
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.32864878465877145,0.7585749169771193,0.7775947281713345,0.9862518493340466,1.0,3/17,8.86%,BRWD1;TSLP;STAT5B
prerank,cellular response to interleukin-7 (GO:0098761),0.32864878465877145,0.7585749169771193,0.7775947281713345,0.9862518493340466,1.0,3/17,8.86%,BRWD1;TSLP;STAT5B
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.24966887514641684,-0.7584876488793414,0.8202898550724638,0.9895818913947041,1.0,1/24,0.42%,ABCG2
prerank,pre-miRNA processing (GO:0031054),0.3417251800107084,0.7583920132556589,0.7725752508361204,0.9860612633740297,1.0,7/14,24.47%,TUT7;TUT4;PRKRA;DICER1;AGO4;DROSHA;AGO3
prerank,regulation of chromosome segregation (GO:0051983),0.3290878718085736,0.7583092501571076,0.7328767123287672,0.9857024530448624,1.0,5/16,21.24%,SMC5;SMC6;RAD18;NUMA1;RMI2
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.2611421467706921,-0.7582228254237847,0.8117977528089888,0.9889664606740116,1.0,9/23,22.07%,MTMR2;INPP5K;INPP5F;MTMR9;SACM1L;MTMR6;INPP5B;SYNJ1;TPTE
prerank,negative regulation of telomere maintenance (GO:0032205),0.33374063527249076,0.758130808263953,0.7621283255086072,0.985502941154646,1.0,6/15,26.06%,TERF2;TNKS2;RTEL1;ATM;TNKS;RAD50
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.2367241246249949,0.7579568148653639,0.8797169811320755,0.9853110242928433,1.0,5/109,4.77%,PDPK1;PIK3R1;LYN;PPP3CA;PSME4
prerank,regulation of RNA export from nucleus (GO:0046831),0.35242415822477674,0.7576776761878398,0.7412587412587412,0.9852465269344476,1.0,5/11,22.42%,NSUN2;AKAP8L;TPR;NRDE2;NCBP2
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.2640281459300282,0.7574807026880281,0.7981029810298103,0.9850559071472965,1.0,6/54,9.33%,GAS6;CFLAR;RFFL;APOA1;RNF31;PRKN
prerank,regulation of cytoplasmic translation (GO:2000765),-0.2941519564514562,-0.757255961807102,0.8004694835680751,0.9894566877562857,1.0,7/14,25.42%,YBX3;UNK;DHX9;RBM24;CPEB2;PKM;FMR1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.2928658737803721,0.7570907841446765,0.7761194029850746,0.9851758554569224,1.0,11/29,22.71%,COPB1;COG8;COPZ2;GOSR2;TRAPPC10;COPA;GOLGA5;COPG1;TRAPPC3;COG2;NAPA
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.2792471090236602,-0.7568540910407074,0.8100961538461539,0.9890536715929366,1.0,5/16,21.29%,SHLD1;KDM4D;PRKDC;PNKP;SHLD2
prerank,cellular response to interferon-gamma (GO:0071346),0.2466627765121592,0.7566523674277308,0.851010101010101,0.985352809357139,1.0,8/88,6.42%,DAPK1;SP100;CCL19;NCAM1;IRF1;OAS2;CCL4;PML
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.20527352543281172,-0.7562389824680132,0.91796875,0.9890147179282596,1.0,15/63,21.43%,CRADD;PLAGL1;CNOT6L;BTG2;RPL26;PRKDC;CCND1;EP300;FBXO31;CDKN1A;CNOT7;E2F7;TRIAP1;PLK3;CNOT8
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.1873678965803432,-0.7562038003051627,0.949238578680203,0.9880920266414583,1.0,20/95,20.82%,MEF2C;PDE4B;CYRIB;LBP;VIM;SIRPA;MAPK8;CX3CR1;TNFAIP3;CD80;GIT1;SBNO2;NOD2;CARD16;ADAM9;TLR4;HMGB2;CD86;FZD5;DAB2IP
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.21826642167545368,0.7558815133683474,0.9518828451882845,0.9860650972974195,1.0,95/341,23.63%,SPSB1;TBL1XR1;HECW2;DCST1;FBXL17;FBXL19;NEDD4;RFFL;SMURF2;PSME4;RNF213;BFAR;ZNRF3;PML;NFE2L2;UBE4B;TRIP12;SIRT2;UBXN2B;UBE2U;RNF185;UBR4;ARRB1;UBXN11;WDR81;ANAPC5;WDR91;PRKN;ITCH;IFI27;RNF6;MIB1;FBXO11;KBTBD7;ERCC8;VPS37D;FEM1C;BTRC;RNF217;COPS3;USP9X;TNFAIP1;RNF19A;RC3H2;PTPN23;APPBP2;ADRM1;AMFR;UBA6;UBE2D1;HACE1;HUWE1;RNF13;NHLRC3;SPOP;UBE2R2;UBR3;UBE3B;PSMB5;PSMC2;KAT5;RC3H1;RNF34;PSMD1;TRIM32;PSMD4;NSFL1C;PSME3;FEM1B;RNF11;KCTD13;ARIH2;DCAF11;CDC23;PSMA3;ZSWIM8;DDIT3;UCHL1;AURKA;FBXO10;BIRC2;TSG101;RNF216;RNF20;BAG6;ANAPC4;KLHL20;PSMA2;KLHL8;BIRC6;FBXW11;ATXN3;PSMC5;ARMC8;ELOC
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.23682765255182942,-0.7557779636599259,0.8567073170731707,0.9876800644219842,1.0,10/33,21.44%,SNRPB;CPSF7;CSTF3;CSTF1;CLP1;CSTF2;SNRPD3;MED18;SLBP;MAZ
prerank,positive regulation of interleukin-10 production (GO:0032733),0.28344602448281164,0.7556698677567553,0.790519877675841,0.9859206939759021,1.0,4/30,7.10%,PIBF1;IL12B;TSLP;CD28
prerank,regulation of inclusion body assembly (GO:0090083),0.34754694529976893,0.7553862803468963,0.7522123893805309,0.9858870666974416,1.0,3/11,15.10%,SNCAIP;DNAJA4;BAG5
prerank,regulation of platelet aggregation (GO:0090330),0.3209476339332349,0.7549583334318785,0.7595356550580431,0.9860525202546618,1.0,5/17,19.61%,LYN;PDPN;C1QTNF1;PRKCA;ALOX12
prerank,regulation of mRNA catabolic process (GO:0061013),0.236138103502708,0.7541255899135026,0.8875598086124402,0.986849546849702,1.0,24/121,20.65%,SAMD4A;CSDC2;IGF2BP2;PSME4;ZFP36L1;EXOSC1;PARN;SERBP1;EXOSC7;RC3H2;NUP214;MAPKAPK2;AKT1;DCP1A;PSMB5;PSMC2;RC3H1;PSMD1;PRKCA;PSMD4;PSME3;YTHDF2;ZFP36L2;PSMA3
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.2897307040374874,0.7538823680048196,0.7871720116618076,0.9867536524759597,1.0,9/32,21.34%,EML2;CDH5;KATNB1;FGF13;DYRK1A;HDGFL3;CAMSAP1;ATXN7;TAOK1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.33194401807379514,0.7537199032356902,0.7631133671742809,0.9865155295299198,1.0,4/15,10.80%,TNRC6B;CPEB3;TNRC6A;TENT4A
prerank,cellular response to UV-A (GO:0071492),0.362730966941949,0.7534993075996818,0.7783417935702199,0.9863595548355536,1.0,1/11,2.81%,MMP2
prerank,histone mRNA metabolic process (GO:0008334),0.29848519925694,0.7534584274328879,0.7844574780058651,0.9859531933932975,1.0,12/27,26.98%,TUT7;ERI1;TUT4;TENT4B;ATM;LSM10;CPSF2;NCBP2;XRN1;SNRPE;UPF1;NCBP1
prerank,regulation of gluconeogenesis (GO:0006111),0.29367337823405626,0.7534558326725623,0.7859375,0.9854805777070069,1.0,3/27,6.83%,OGT;NNMT;SIK1
prerank,actin filament polymerization (GO:0030041),0.2923938229527588,0.7532074470280178,0.7893175074183977,0.9853708818462079,1.0,3/29,6.19%,GSN;ARHGAP6;WASHC3
prerank,zinc ion transmembrane transport (GO:0071577),0.30757472657064727,0.75317573332773,0.7980922098569158,0.9849415970863559,1.0,9/22,24.06%,SLC30A8;SLC30A2;SLC30A10;SLC39A13;SLC39A1;SLC39A12;SLC39A6;SLC30A5;SLC30A4
prerank,cell cycle checkpoint signaling (GO:0000075),0.34249654346724373,0.7531674319254781,0.7513043478260869,0.9844789620732783,1.0,5/12,24.19%,ZW10;ZWINT;PLK2;PRCC;NABP2
prerank,cellular defense response (GO:0006968),0.2768997403003076,0.7528453630577446,0.8134863701578192,0.9844848481084894,1.0,3/40,5.28%,LSP1;RAB23;CCR9
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.27951357648956715,-0.7527477990854358,0.8126721763085399,0.9909529904951438,1.0,3/17,11.31%,SLC7A5;FCER1G;PRKCZ
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.27458541776916146,-0.7522474394723426,0.8204488778054863,0.9906316354369268,1.0,4/18,13.49%,ELOVL7;ELOVL5;TECR;HACD2
prerank,ether lipid biosynthetic process (GO:0008611),0.35091320784325164,0.7520762396268299,0.7545126353790613,0.9851673251664678,1.0,4/10,21.49%,PLA2G4A;PEX7;DHRS7B;PEDS1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.3036255112465771,0.7520632964306879,0.7578125,0.984712579761375,1.0,4/23,14.70%,CDK5RAP3;ZW10;ZWINT;PLK2
prerank,cell cycle G1/S phase transition (GO:0044843),-0.2062821653921349,-0.7518254064004065,0.9230769230769231,0.9902908815862839,1.0,21/61,25.63%,CDK6;CUL1;USP29;EIF4E;DBF4;BCAT1;CCND1;CUL2;INHBA;E2F3;CDKN1A;CUL3;MAP3K11;HINFP;PLK3;CDKN3;MAX;PIM2;NASP;RPS6KB1;E2F1
prerank,secondary palate development (GO:0062009),0.33936942027177847,0.7515844065752317,0.7564322469982847,0.9849322637276072,1.0,1/14,1.00%,TGFBR3
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.36127127747183563,0.750646038571242,0.756993006993007,0.985890328780983,1.0,2/11,10.18%,FZD1;RYK
prerank,regulation of cilium movement (GO:0003352),0.35008855592944077,0.7503901991134513,0.7557117750439367,0.9857842735539488,1.0,2/10,12.43%,DNAAF1;CCDC40
prerank,positive regulation of cell killing (GO:0031343),-0.2988315847329428,-0.7502915084284353,0.7795823665893271,0.9915029910095824,1.0,4/13,28.95%,MAPK8;DVL2;NOX1;NOS2
prerank,protein homotetramerization (GO:0051289),0.2680249952555922,0.7500769886934732,0.8278805120910384,0.9857768346840704,1.0,6/49,9.41%,TRPA1;TDO2;APPL2;ALDH1A2;CBY1;TRPM4
prerank,calcineurin-mediated signaling (GO:0097720),-0.31946384396374344,-0.7498282157808605,0.7762863534675615,0.9902169509919431,1.0,3/10,7.59%,NFATC2;NFATC3;NFATC1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.31946384396374344,-0.7498282157808605,0.7762863534675615,0.9902169509919431,1.0,3/10,7.59%,NFATC2;NFATC3;NFATC1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.32144468026508144,0.7497478021464111,0.7793650793650794,0.9857937759791459,1.0,1/17,1.86%,BCL2
prerank,peptidyl-lysine methylation (GO:0018022),0.29657961493153856,0.7497056575197335,0.8030075187969925,0.9853887632758056,1.0,5/26,16.48%,SETD7;SETD4;SMYD3;TRMT112;EEF2KMT
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.317722860165051,0.7493990317822031,0.7736757624398074,0.9853411047567352,1.0,3/19,9.32%,OBSL1;CUX2;CAMK2B
prerank,histone exchange (GO:0043486),-0.2307408306581681,-0.7483417660149126,0.8471760797342193,0.9912887698686053,1.0,14/37,29.15%,MIS18BP1;KNL1;RUVBL1;RSF1;VPS72;NPM1;CENPI;RNF8;CENPN;ANP32E;ZNHIT1;NASP;HJURP;ITGB3BP
prerank,lysosome localization (GO:0032418),0.2755367108836192,0.7482617582417457,0.8201754385964912,0.9864943244489578,1.0,13/37,26.23%,KIT;BLOC1S1;PLEKHM1;PLEKHM2;TMEM106B;SNAPIN;DEF8;HDAC6;VPS33B;BLOC1S2;MAP6;RAB34;MYH9
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.2772896762924353,-0.7481449873729622,0.7974358974358975,0.9906158936868681,1.0,3/16,13.52%,SIX1;SIRT1;PTGS2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.3576375713055786,0.74803195174724,0.745674740484429,0.9863659046055891,1.0,3/10,19.36%,SP100;KAT5;MUC1
prerank,positive regulation of macrophage migration (GO:1905523),0.3112096011242815,0.7476555705523863,0.7604501607717041,0.9864365010779848,1.0,2/19,4.19%,IL34;CSF1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.3219323771455312,0.7476116001416216,0.7751277683134583,0.9860287486417907,1.0,4/18,14.41%,RNF185;RNF139;UGGT2;AMFR
prerank,regulation of chromosome organization (GO:0033044),0.30345556943915136,0.7474230823474282,0.7801857585139319,0.9858259193925831,1.0,6/22,21.70%,LIG4;HDAC8;TERF2;WAPL;RMI2;CENPV
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.3122582215450018,-0.7465379924281949,0.7908045977011494,0.9918597014349231,1.0,4/10,33.84%,GNB1;PDE6A;PDE6B;SAG
prerank,mitotic spindle assembly (GO:0090307),-0.22099607316298636,-0.7459415860376051,0.9204152249134948,0.9916697455981418,1.0,22/42,41.10%,KIF2A;STAG1;RAB11A;CCDC61;LSM14A;PRC1;KIF23;MISP;CLASP1;KIF4A;SPICE1;KIF11;TOGARAM2;WRAP73;MAP10;RACGAP1;STAG2;BCCIP;AURKB;CLASP2;TOGARAM1;KIFC2
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.36126551149621833,0.7458063180361689,0.7316636851520573,0.9872268684939396,1.0,3/10,13.79%,NUPR1;NCOR1;HDAC4
prerank,negative regulation of glycolytic process (GO:0045820),0.36126551149621833,0.7458063180361689,0.7316636851520573,0.9872268684939396,1.0,3/10,13.79%,NUPR1;NCOR1;HDAC4
prerank,import into nucleus (GO:0051170),0.2478504432579145,0.745771645694094,0.8492268041237113,0.986799628035128,1.0,19/73,19.64%,RANBP17;NUP107;APPL2;FAM53C;PRICKLE1;HNRNPA1;HEATR3;CSE1L;PPP1R10;TSC2;SNRPD2;NUP214;GEMIN2;AKT1;PHB2;TPR;APPL1;KPNB1;BACH2
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.28716170757766946,0.7457109499205862,0.7877428998505231,0.9864169217493827,1.0,7/26,15.39%,SPHK2;TLR6;SLC30A10;SLC5A3;SLC18A2;ABCD2;PIKFYVE
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.26927804912788145,-0.7454396655884759,0.8379746835443038,0.9913817385658714,1.0,5/19,21.78%,IFIH1;IRF5;TLR4;DHX9;CHUK
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.3049443562725298,0.745275965061975,0.7900466562986003,0.986597276365327,1.0,3/22,12.76%,PDGFD;DDX3X;RAP2A
prerank,vitamin D metabolic process (GO:0042359),-0.2951342890095441,-0.7450077945159542,0.8,0.9909572035900012,1.0,2/13,11.55%,CUBN;LGMN
prerank,regulation of lymphocyte differentiation (GO:0045619),0.31894029849256017,0.744706989203736,0.7872,0.9869625118709766,1.0,6/18,25.79%,ZFP36L1;METTL3;ZFP36L2;PRELID1;NCKAP1L;ABL1
prerank,negative regulation of transferase activity (GO:0051348),0.28877637675034296,0.7446196680335567,0.8014925373134328,0.986598675734562,1.0,7/28,20.16%,SRC;EIF4A2;BAG5;CDKN1C;NPRL2;CDKN1B;HNRNPU
prerank,regulation of phosphatase activity (GO:0010921),0.2952245339993273,0.7445449543694054,0.78060413354531,0.9862351869357475,1.0,5/24,19.24%,CDK5RAP3;BMP2;PTPA;PPP1R26;HTT
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.3200932048741418,0.7443200896357057,0.7728055077452668,0.9860882763878663,1.0,1/17,2.69%,NOS1AP
prerank,receptor internalization (GO:0031623),0.26796834126427516,0.7442581112167463,0.8101983002832861,0.9857074878449293,1.0,8/44,12.83%,LRP1;GRK3;NEDD4;DRD3;ARRB1;PICALM;ADM;GRK4
prerank,dicarboxylic acid metabolic process (GO:0043648),0.2604796350426477,0.7442354839907361,0.8295302013422818,0.9852685856618129,1.0,8/52,9.52%,MDH2;MDH1B;MTHFR;HOGA1;ALDH1L1;ALDH18A1;ADHFE1;IDH2
prerank,protein insertion into membrane (GO:0051205),0.28504209742192943,0.7441933370927246,0.7872648335745297,0.9848523218781731,1.0,5/32,11.44%,TRAM2;COX18;CYB5A;EGFR;TRAM1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.3327581699895452,0.7441817735508143,0.7640067911714771,0.9844012088393596,1.0,3/15,10.54%,IL17D;TLR6;CARD9
prerank,membrane protein proteolysis (GO:0033619),-0.22705608597820226,-0.7435470355232651,0.8943894389438944,0.9920343321316996,1.0,11/37,19.78%,ADAM10;RET;SPPL3;BACE2;ADAM19;TGFB1;MBTPS2;RBMX;ADAM9;RHBDD1;APH1A
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.3215410951801793,-0.7433499121270841,0.8047058823529412,0.9913448361589222,1.0,4/10,25.17%,EMC3;EMC9;MMGT1;EMC4
prerank,regulation of viral genome replication (GO:0045069),-0.20805392043459034,-0.7429991376161214,0.8902439024390244,0.9908725526501849,1.0,20/56,29.88%,IFIH1;PPIA;PABPC1;SRPK1;ADAR;FAM111A;NR5A2;RAD23A;TRIM6;N4BP1;CNOT7;PPID;OASL;PLSCR1;IFITM3;HACD3;ISG15;ISG20;IFIT1;ZC3HAV1
prerank,positive regulation of viral genome replication (GO:0045070),-0.23930001430350437,-0.7429227988985222,0.868421052631579,0.9900395440280068,1.0,9/29,20.11%,PPIA;PABPC1;SRPK1;ADAR;NR5A2;TOP2A;RAD23A;CNOT7;PPID
prerank,regulation of cellular response to stress (GO:0080135),0.23075147202087865,0.7423433586115147,0.8870392390011891,0.986576768914468,1.0,29/115,20.59%,ROCK2;NUP107;NUPR1;NUAK1;NUP42;CAMK2B;PRKN;NEK6;MANF;NUP98;CEBPB;RAE1;CLN3;YWHAE;NPAS2;AMFR;NUP214;HSBP1;BAG5;SLC38A2;MAPKAPK2;CASP9;ATM;SEH1L;DYRK3;TPR;HSF1;AAAS;MLST8
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.23585281468564734,-0.7422772777166055,0.8468468468468469,0.9898940352624416,1.0,7/27,17.93%,PHF20L1;KAT2A;RUVBL1;KAT6A;EP300;MRGBP;SGF29
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.2943894328561423,0.7418533919012837,0.8049490538573508,0.9868352962445281,1.0,4/27,11.06%,AK1;NUDT13;CTPS2;AK8
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.24913034521533178,-0.7416103339440338,0.8498583569405099,0.9898644218251796,1.0,12/26,30.87%,IFIH1;NOD1;CASP8;TNFAIP3;NOD2;TAB1;UBE2V1;MAP3K7;TRAF6;UBC;RPS27A;IKBKG
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.2348028766269391,-0.7404500835864409,0.8700906344410876,0.9904396087111684,1.0,2/29,3.00%,CADM1;CYRIB
prerank,actin crosslink formation (GO:0051764),-0.29948672043910507,-0.7400169082198313,0.812807881773399,0.9900736732581705,1.0,3/12,13.21%,BAIAP2L1;GAS2;GAS2L1
prerank,response to estradiol (GO:0032355),0.2884019553282303,0.7397617920849594,0.8206997084548106,0.9893870654082157,1.0,6/31,10.01%,WNT8B;SFRP1;STRN3;EGFR;STAT5B;FOXA1
prerank,cholesterol biosynthetic process (GO:0006695),0.2829266312982026,0.7389984811501275,0.8101449275362319,0.9899996533949424,1.0,4/31,9.34%,INSIG2;APOA1;MVK;IDI1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.25446373140001843,0.7384319403880609,0.8447368421052631,0.99032362013429,1.0,6/57,9.33%,DCN;MOAP1;PDCD5;MCU;BCL2L11;PRKN
prerank,myelin assembly (GO:0032288),0.35734808386885253,0.73786007185236,0.7579505300353356,0.9906477606551325,1.0,4/10,18.90%,PMP22;EPB41L3;NCMAP;DICER1
prerank,positive regulation of reproductive process (GO:2000243),0.281428358664005,0.7364799218655691,0.8066378066378066,0.992154416819201,1.0,6/31,12.88%,SMURF2;VIP;PDE3A;SIRT2;SYDE1;ACVR1B
prerank,osteoclast differentiation (GO:0030316),0.2986329247506031,0.7362659453291982,0.8101472995090017,0.9919704226533214,1.0,5/22,17.07%,CSF1;SRC;EFNA2;OSTM1;GLO1
prerank,ERBB2 signaling pathway (GO:0038128),0.2784241186030112,0.7360534875029521,0.8082595870206489,0.9917918913033317,1.0,6/31,13.25%,PIK3R1;SRC;CUL5;EGFR;HBEGF;EGF
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.32314180774644047,0.735204397008726,0.7936772046589018,0.9925025088069851,1.0,4/17,15.29%,LYN;CARD9;TAOK3;RNF13
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.26212889345023255,-0.7349614630720593,0.8147138964577657,0.9956645466006014,1.0,3/18,9.59%,ADAM10;ABCG1;ADAM19
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.343792560096063,0.7347975737966211,0.7771929824561403,0.9925698091187096,1.0,3/11,19.36%,SP100;KAT5;MUC1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.24350182325934244,-0.7344210194351394,0.8579710144927536,0.9954178778739253,1.0,3/25,10.70%,HSPA8;GAK;DNAJB14
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.3172400533578855,0.7342615488178851,0.8115015974440895,0.9928617205569439,1.0,2/17,8.33%,PLA2G4A;LPGAT1
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.320044313272167,0.7338677945224769,0.7850953206239168,0.9929302267084926,1.0,7/16,29.48%,RECQL5;MCM2;MCMDC2;MCM6;RECQL;RPA1;MCM4
prerank,heterotypic cell-cell adhesion (GO:0034113),0.2982542249655017,0.7337885840545555,0.8159509202453987,0.9925650912999217,1.0,4/25,9.63%,PARVA;CD200;ITGB3;ITGAV
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.3462708780937827,0.7337313370918793,0.7546125461254612,0.9921648260521436,1.0,2/10,9.95%,PIBF1;PARP14
prerank,positive regulation of myelination (GO:0031643),0.3434305660040753,0.7334045281852042,0.7750865051903114,0.992155939373952,1.0,4/11,18.90%,RNF10;PARD3;NCMAP;DICER1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.3300566112577225,0.7333420981021529,0.787085514834206,0.9917849819773121,1.0,3/13,12.33%,NEDD4;EMILIN1;NIBAN2
prerank,regulation of mRNA processing (GO:0050684),0.27870769139478174,0.7332685172087239,0.8335766423357664,0.991411023869455,1.0,14/32,27.30%,SON;ZFP36L1;SF1;SAFB2;RBM39;SRSF10;SRSF3;PAPOLA;METTL16;CWC22;CDK11B;AHCYL1;NCBP1;PABPN1
prerank,regulation of supramolecular fiber organization (GO:1902903),0.29602543525645686,0.7332350925211764,0.8132045088566827,0.990991483814791,1.0,6/22,18.99%,AEBP1;APOE;ARL2;AKAP13;CAMSAP1;EFEMP2
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.22594909796084434,0.7322618481796658,0.9045401629802096,0.9918990407839627,1.0,30/125,22.74%,DYNLL1;NUP107;EFHC1;DYNC1H1;SPC24;SPDL1;ZW10;DCTN6;PMF1;ZWINT;CENPC;NEK6;CENPH;NUP98;DYNC1I2;EML4;PLK2;SGO1;PTPA;SEH1L;CENPA;KPNB1;CDCA8;CENPM;DSN1;AURKA;TAOK1;NDE1;TUBG2;TUBG1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.34417349741844117,0.7320115553978852,0.7714285714285715,0.9917851321402149,1.0,2/10,5.54%,SERPINE1;CYP1B1
prerank,negative regulation of platelet activation (GO:0010544),0.3111180698769698,0.7311575267078143,0.7945859872611465,0.9925232698565923,1.0,4/16,12.07%,PDGFRA;APOE;F2;C1QTNF1
prerank,signal transduction by p53 class mediator (GO:0072331),-0.23543476784163192,-0.7311383701856291,0.8896797153024911,0.9987337896137207,1.0,2/30,1.35%,PPP1R13B;ACER2
prerank,regulation of mRNA metabolic process (GO:1903311),-0.30453087825232794,-0.7311369596686187,0.8186157517899761,0.9977762722445316,1.0,4/11,22.93%,SRPK1;PTCD2;DHX9;SRPK3
prerank,regulation of cholesterol storage (GO:0010885),0.32084731330948135,0.7309338071049315,0.7941653160453809,0.9923809968544293,1.0,1/15,1.73%,ABCA1
prerank,spinal cord development (GO:0021510),0.3386804679917447,0.7305861606154025,0.7783687943262412,0.9923954326200608,1.0,1/12,1.96%,GLI2
prerank,cilium organization (GO:0044782),0.21586610651896768,0.7304842921619553,0.9375684556407448,0.9920687014462835,1.0,16/209,7.64%,ASAP1;GSN;DYNLL1;PARVA;WDPCP;DZIP1L;RAB23;CYS1;CPLANE1;PIBF1;TTC39C;B9D1;WDR35;IFT43;DNAAF1;FBF1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.2804176246602995,0.7302298161568507,0.829971181556196,0.9919573654596817,1.0,3/30,4.27%,SERPINE1;CFLAR;RFFL
prerank,leukotriene metabolic process (GO:0006691),0.3059580758772438,0.7301437169676096,0.7958199356913184,0.9916096964629989,1.0,9/19,27.00%,PLA2G4A;DPEP1;DPEP2;MAPKAPK2;ALOX12;ALOX5AP;LTA4H;MGST3;MGST2
prerank,magnesium ion transport (GO:0015693),0.3316992966199691,0.7300695076100682,0.7715827338129496,0.9912361486533896,1.0,2/12,9.02%,SLC41A1;NIPAL4
prerank,regulation of interleukin-6 production (GO:0032675),0.23343206319230153,0.729838393659547,0.8969325153374234,0.9910786889770923,1.0,14/96,13.47%,IL6R;IL17D;GAS6;TSLP;SPHK2;TLR6;IRAK3;ARRB1;CD200;RAB7B;CARD9;SETD4;SELENOS;SYT11
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.3126174085249688,0.728819479423384,0.8,0.9920285938905179,1.0,4/18,11.95%,SFRP1;PRKN;ADRA2A;REST
prerank,DNA recombination (GO:0006310),0.27075451439797327,0.7286423422916839,0.8250355618776671,0.9918114358616652,1.0,15/37,28.43%,LIG4;RAD51B;DMC1;RECQL5;RAD51D;RTEL1;XRCC2;RAD54L;MRE11;HMGB3;RAD50;RPAIN;HMGB1;RECQL;RPA1
prerank,DNA damage checkpoint signaling (GO:0000077),-0.23427534795974705,-0.7286179093099677,0.8855421686746988,0.9999501213518974,1.0,12/28,34.66%,RAD17;RAD1;HUS1;NBN;CEP63;HINFP;E2F1;RHNO1;DONSON;RAD9A;DOT1L;FBXO6
prerank,cellular response to chemical stress (GO:0062197),0.22994973549669073,0.7279933322934636,0.8951807228915662,0.9922365023548103,1.0,23/96,20.80%,PYCR1;NUDT2;MT3;SLC25A24;PRKAA2;GPX8;LRRK2;NFE2L2;SIRT2;DDX3X;MGAT3;FANCC;SELENOS;GPX3;NOX4;SESN2;LONP1;ATM;FOXO3;SOD3;BRF2;ATP13A2;PRDX6
prerank,cellular response to topologically incorrect protein (GO:0035967),0.2774924715734957,0.7278904708989989,0.832579185520362,0.9919253315649404,1.0,11/31,24.70%,OPTN;PRKN;HSPA9;TM7SF3;TMBIM6;HSF1;HSPA14;HDAC6;HSPA5;ATXN3;BAG3
prerank,ribosomal subunit export from nucleus (GO:0000054),0.3330889076169187,0.7275525051556401,0.7680412371134021,0.9919318360809978,1.0,4/13,13.37%,EIF6;ABCE1;NMD3;SDAD1
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.21462515460975398,-0.7274645777781795,0.9047619047619048,1.0,1.0,19/43,30.28%,RAD17;FOXN3;TOPBP1;HUS1;BABAM1;NBN;CDKN1A;CHFR;HMGA2;BABAM2;DTL;NABP1;HUS1B;FZR1;PLK1;DONSON;CDK1;CDC6;TICRR
prerank,positive regulation of immune response (GO:0050778),-0.1981529605081456,-0.7272547796928192,0.968609865470852,0.9997071869566951,1.0,21/64,32.15%,IL15;TGFB2;GBP5;SKAP1;IFI35;SIRT1;CD81;KARS1;NOD2;PTPRC;DHX9;PLSCR1;EIF2AK4;POLR3C;SLC15A4;LILRB1;XBP1;NLRP3;SASH3;FCGR2B;TLR8
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.33189193837517933,0.7260755890878406,0.774597495527728,0.9934618224297272,1.0,2/13,5.09%,SP100;RAB23
prerank,regulation of cell killing (GO:0031341),-0.27018666714454376,-0.7259556641439533,0.8134328358208955,1.0,1.0,3/16,9.71%,TGFB2;CD55;MAPK8
prerank,lipid droplet formation (GO:0140042),-0.31607237742420047,-0.7258802236544136,0.8100961538461539,0.9994800633504094,1.0,6/10,37.21%,PLA2G4C;ZFYVE1;FITM2;CDS1;CDS2;BSCL2
prerank,regulation of protein metabolic process (GO:0051246),0.25841715329525244,0.7258147432588313,0.8388888888888889,0.9933475073864959,1.0,3/44,5.02%,ROCK2;APOE;LDLR
prerank,histone H3-K9 demethylation (GO:0033169),0.3455487234931004,0.7248301349132036,0.7915129151291513,0.9942068876846992,1.0,6/11,23.23%,KDM7A;PHF8;KDM3B;KDM4A;KDM4C;KDM3A
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.3254150519346625,0.7248016046499618,0.8048,0.9937817062843847,1.0,5/14,24.19%,TERF2;TNKS2;ATRX;TNKS;NABP2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.32761214449080517,0.7245652583070775,0.8069883527454242,0.9936631358907603,1.0,3/13,14.90%,NFIB;REST;BMP4
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.24161287213902405,-0.724369361570442,0.8717201166180758,1.0,1.0,5/28,15.60%,CYRIB;SIRPA;SH3KBP1;NOD2;PRKDC
prerank,nucleocytoplasmic transport (GO:0006913),0.2645792462176725,0.7241711647282809,0.8229166666666666,0.993742248047569,1.0,8/40,20.11%,ATXN1;PHAX;HNRNPA1;NUP98;SNRPD2;GEMIN2;BACH2;AAAS
prerank,peripheral nervous system development (GO:0007422),0.29968357774813736,0.7241501099696167,0.804953560371517,0.9933027251386161,1.0,3/23,7.02%,GDNF;NTF3;PMP22
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.3418412937048432,0.7241309010601711,0.7882960413080895,0.9928659793689508,1.0,1/12,1.86%,BCL2
prerank,positive regulation of heart contraction (GO:0045823),0.30964642672975673,0.7241142202321625,0.8103727714748784,0.9924197054742674,1.0,3/19,11.11%,ATP1A2;TRPM4;ADM
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.2539862195313138,-0.7237626890735478,0.8594594594594595,1.0,1.0,13/22,34.51%,GATA2;KDM1A;TAFA1;ID2;DLL4;SHCBP1;TOX;PTPRZ1;FZD9;DISP3;NAP1L1;RASSF10;TRIM71
prerank,negative regulation of cell communication (GO:0010648),-0.251013536521987,-0.7237610074051671,0.8549618320610687,0.9992954143923237,1.0,2/21,4.48%,UBASH3B;GLRA1
prerank,chondroitin sulfate metabolic process (GO:0030204),0.28674581774954994,0.7235758095741731,0.834597875569044,0.992684630395184,1.0,4/30,8.05%,DCN;BGN;DSE;CSPG5
prerank,double-strand break repair (GO:0006302),0.21998279757894604,0.7234347226439983,0.9263873159682899,0.9924109158462425,1.0,42/158,24.39%,EYA1;ZSWIM7;HPF1;LIG4;INO80;RAD51B;SMC5;DCLRE1C;POLL;RECQL5;UBE2V2;NHEJ1;SMC6;BAZ1B;ACTR8;TENT4A;TDP2;DCLRE1A;RAD51D;XRCC2;RNF138;KPNA2;AP5Z1;ATM;KAT5;DDX1;KDM4A;SUMO1;UIMC1;BRCC3;NSMCE2;FAN1;EXD2;EME2;APLF;SMARCAD1;BRCA1;SFPQ;SETX;NABP2;RAD51AP2;MRE11
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.19127501198936542,-0.7231304813122814,0.9626556016597511,0.999147007537239,1.0,15/68,18.14%,TAF1B;SNRPB;TBP;CPSF7;CAVIN1;GTF2H1;TAF1C;CSTF3;CSTF1;UBTF;CLP1;CSTF2;SNRPD3;POLR2E;MED18
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.2712734818833106,-0.722923912481515,0.8389610389610389,0.9984398045374994,1.0,4/16,19.40%,CELF4;RBM17;DDX5;DHX9
prerank,tRNA 5'-leader removal (GO:0001682),0.3310494306778625,0.7229151767183426,0.7956081081081081,0.992647722322917,1.0,4/13,15.60%,RPP25L;PRORP;RPP30;RPP38
prerank,microvillus organization (GO:0032528),0.3280533752282888,0.7222741680096827,0.7958477508650519,0.993071790820104,1.0,4/13,14.95%,RAPGEF2;MAP4K4;RAP2A;RAPGEF6
prerank,cardiolipin metabolic process (GO:0032048),-0.28970147228557475,-0.7220719662275862,0.8235294117647058,0.9985162828329615,1.0,4/13,17.67%,PGS1;PNPLA8;CRLS1;PTPMT1
prerank,lymphocyte proliferation (GO:0046651),-0.24704478084337322,-0.7220058919760138,0.8994565217391305,0.9976558141430273,1.0,12/22,37.51%,MEF2C;MSN;CD40;PTPRC;PIK3CG;ELF4;FLT3;CR2;MS4A1;TNFRSF4;CD79A;LMBR1L
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.28253358574968956,-0.7220007247895857,0.8337236533957846,0.9967139106645572,1.0,9/14,37.26%,NT5E;NT5C1A;UPB1;NT5C;UPP1;DPYS;DHODH;ERH;CAD
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.3065600531507899,0.7219107337468759,0.785,0.9930885758648336,1.0,4/17,22.45%,APOA1;NR1H3;LMF1;SORT1
prerank,autophagy of peroxisome (GO:0030242),0.33197333341889557,0.7218989933241879,0.7934426229508197,0.9926439161926629,1.0,3/12,17.39%,USP30;PIK3R4;ATM
prerank,positive regulation of JUN kinase activity (GO:0043507),0.29553186866010045,0.7218310575566884,0.8297872340425532,0.9922793687736439,1.0,4/23,12.37%,SASH1;TLR6;TAOK3;DUSP19
prerank,DNA packaging (GO:0006323),0.3113950774074179,0.7216193453615377,0.8073701842546064,0.9921154926472499,1.0,2/16,8.95%,CHAF1B;AIFM1
prerank,hexose metabolic process (GO:0019318),-0.2191581540470749,-0.7214914581763131,0.9010238907849829,0.996388844768013,1.0,5/39,10.91%,PPARD;APOD;ALDOA;GDPGP1;SLC35A2
prerank,folic acid metabolic process (GO:0046655),0.3051694730546005,0.7208381500506119,0.8070444104134763,0.9927004280234286,1.0,3/18,12.65%,MTHFR;ALDH1L1;FOLR2
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.33675049134048346,0.7205532196981665,0.7631578947368421,0.9926358752806115,1.0,5/12,23.43%,H6PD;SREBF1;KPNB1;SEC14L2;SREBF2
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.20780483831944063,-0.7205211467618282,0.9146757679180887,0.9965987145038244,1.0,20/45,32.82%,P2RX7;GBP5;AIM2;JAK2;TRIM16;CASP8;APP;NOD2;TLR4;FZD5;AGER;MALT1;TMEM106A;CD36;EGR1;LPL;NLRP3;HSPB1;TLR8;STAT3
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.32829880897749053,0.720079760637295,0.8035087719298246,0.9928006200466784,1.0,3/13,8.47%,TNRC6B;CPEB3;TNRC6A
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.2039520065226418,-0.7198478977936231,0.9346938775510204,0.9964648895147451,1.0,11/56,18.63%,NOD1;PLCG2;LBP;CTSB;S100A1;LGMN;UNC93B1;NOD2;TAB1;TLR4;CTSS
prerank,glutathione metabolic process (GO:0006749),0.268683654132177,0.7190599515859968,0.835195530726257,0.9937001255294297,1.0,5/38,9.39%,CHAC2;GSTM4;GSTM2;DPEP1;GSTT1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.27317742293726943,0.7189981691491572,0.8383233532934131,0.9933116483215415,1.0,5/32,7.22%,DTNBP1;MCTP2;BAIAP3;LRRK2;SNCAIP
prerank,histone H2A monoubiquitination (GO:0035518),0.30458308321884386,0.7188934766871864,0.8042414355628059,0.9930062617026654,1.0,3/17,8.78%,BCOR;CUL4B;PCGF3
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.3166258174992338,0.7187697610746104,0.7918032786885246,0.9922343170191967,1.0,2/15,9.56%,DTNBP1;BLOC1S1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.3166258174992338,0.7187697610746104,0.7918032786885246,0.9922343170191967,1.0,2/15,9.56%,DTNBP1;BLOC1S1
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.2742505727747403,-0.7185485809537577,0.8395061728395061,0.9970034702037355,1.0,4/14,15.04%,TFB2M;PNPT1;SLC25A33;FASTKD1
prerank,vitamin transport (GO:0051180),0.28144138912161154,0.7176989147514728,0.8423423423423423,0.9932136791626343,1.0,4/29,5.40%,SLC2A10;APOA1;SLC35F3;PDPN
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.3132324406890957,0.7176622970140109,0.8204697986577181,0.9928103734697662,1.0,7/17,25.28%,IL12B;EBI3;IL18BP;IL18;BACH2;MYO1G;JAG1
prerank,negative regulation of histone modification (GO:0031057),-0.2845037025781394,-0.7176572767054674,0.835,0.9970771255805362,1.0,6/14,28.28%,CTBP1;PRMT6;THAP7;TWIST1;AASS;SET
prerank,calcium ion transport into cytosol (GO:0060402),0.293626815154726,0.7170995237895923,0.8311897106109325,0.9931001123995868,1.0,2/21,6.67%,SLC8A1;CACNA1C
prerank,regulation of cellular protein metabolic process (GO:0032268),0.25770045131356356,0.7170398779101245,0.8547717842323651,0.9927131697980719,1.0,10/47,17.93%,APOE;CSF1;AGTR1;WDR91;EIF2B4;MTPN;NR1H3;RBM4B;AKT1;FOXO3
prerank,protein hydroxylation (GO:0018126),0.32293939854068954,0.7166334802870866,0.7958477508650519,0.9927590458471262,1.0,3/15,13.84%,ASPH;P3H3;JMJD7
prerank,translesion synthesis (GO:0019985),-0.20835569771649556,-0.7166071987097817,0.9442622950819672,0.9972332403142347,1.0,15/42,30.77%,REV3L;TRIM25;POLH;POLN;UFD1;POLD4;POLK;DTL;RCHY1;FAAP20;VCP;ISG15;UBC;RPS27A;POLD2
prerank,reticulophagy (GO:0061709),0.32891714991038457,0.716446367696591,0.8017391304347826,0.9925369992856178,1.0,4/12,18.10%,ULK2;UFL1;UFC1;ATG2B
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.2764005097368791,-0.7157828495333156,0.8181818181818182,0.9972405235244027,1.0,2/13,6.87%,STX3;HSP90AB1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.21628241470299508,0.715770026998662,0.9325084364454443,0.9930042095890468,1.0,10/163,7.10%,PDPK1;THEMIS;PIK3R1;FYB1;BCL2;RFTN1;PSME4;CD247;RNF31;CD28
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.29669281761556776,-0.7157647004705945,0.8299776286353467,0.99633084629415,1.0,2/11,7.29%,PLCG2;CDH13
prerank,negative regulation of viral release from host cell (GO:1902187),0.3248573110377879,0.7157027117081681,0.783303730017762,0.992631126405077,1.0,4/13,19.79%,PML;TRIM32;TRIM26;TRIM21
prerank,RNA biosynthetic process (GO:0032774),-0.22636808705732164,-0.7156942497667628,0.8906752411575563,0.9954906046451891,1.0,13/31,31.18%,TBP;TAF10;RSF1;HELB;TAF5;GTF2B;TAF4;TCEA2;PRIM1;TBPL1;SMN1;POLA1;TERT
prerank,negative regulation of response to stimulus (GO:0048585),0.24217897666732785,0.715200206958893,0.8914728682170543,0.9928434476112309,1.0,13/60,14.80%,LYN;APOA1;APPL2;ACVR1;CASK;AKT3;SLC30A10;ZKSCAN3;IGFBP3;ADRA2A;TERF2;COL3A1;NR1H3
prerank,regulation of protein-containing complex assembly (GO:0043254),0.22504894666284633,0.7150825393294968,0.9125748502994012,0.992528279944616,1.0,7/110,6.32%,TRABD2B;GSN;ABCA1;APOE;CDH5;CDC42;SRC
prerank,positive regulation of histone deacetylation (GO:0031065),-0.29168413297923673,-0.7150074685863681,0.8387850467289719,0.9953705893418693,1.0,3/12,13.50%,CTBP1;VEGFA;APLNR
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.26830301428921466,-0.7146394926804114,0.8677494199535963,0.994847055664944,1.0,5/15,21.60%,PLCG2;EZH2;CUL3;NPM1;DDRGK1
prerank,regulation of T cell proliferation (GO:0042129),-0.19256668145902017,-0.714554407041646,0.952755905511811,0.9940178748460249,1.0,14/61,22.62%,SLC7A1;IL15;TFRC;TNFRSF21;CD80;PTPRC;JAK3;NCK2;PNP;CD86;ANXA1;CD276;AIF1;VCAM1
prerank,response to UV-A (GO:0070141),0.3267675163604042,0.7141997418267185,0.8255813953488372,0.9932119010434446,1.0,2/14,8.61%,MMP2;EGFR
prerank,regulation of phospholipid metabolic process (GO:1903725),0.3428427551511169,0.7137263389373102,0.7969018932874354,0.9933461347271355,1.0,4/10,18.45%,GNB3;MTMR3;ABCA3;PHB2
prerank,positive regulation of transmembrane transport (GO:0034764),0.32221836425117734,0.7137060550138408,0.7839285714285714,0.9929163349971184,1.0,2/13,10.64%,ACSL1;BRAF
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.29183400870021836,-0.7136608418609341,0.85,0.9940965134104431,1.0,3/12,22.62%,MFSD2A;LPCAT3;ACSL3
prerank,negative regulation of myoblast differentiation (GO:0045662),0.3227025199148882,0.7132915458627329,0.7906197654941374,0.9929749922863769,1.0,2/13,5.51%,PRICKLE1;TBX3
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.30670943120570254,0.7130600805372236,0.8155668358714044,0.9928358490913346,1.0,2/16,4.55%,DPYSL3;DPYD
prerank,positive regulation of T cell migration (GO:2000406),-0.25172840087181086,-0.7125242336758761,0.8770491803278688,0.9944974559583575,1.0,1/20,1.02%,ADAM10
prerank,regulation of store-operated calcium entry (GO:2001256),-0.3037608733156743,-0.7122156325077146,0.8163265306122449,0.9939175488846073,1.0,5/10,23.45%,HOMER1;HOMER3;EFHB;GRAMD2A;CASQ1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.3433941939251181,0.7120870890011706,0.7915966386554621,0.9936431566641954,1.0,4/10,21.45%,INO80;CDC7;ATRX;STOML2
prerank,positive regulation of calcium ion transport (GO:0051928),0.2680532687413837,0.7119892841780241,0.8443804034582133,0.9933151226661016,1.0,5/36,11.47%,MYLK;PDGFRB;CCL4;SPHK2;P2RX5
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.26919652894381907,0.7117766522779773,0.8571428571428571,0.9931219890675497,1.0,11/39,22.42%,PIK3R1;TTC7B;EFR3A;PI4KA;TMEM150A;PIK3R2;PIP4K2C;ITPKA;SOCS4;SOCS7;PIK3C2A
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.28903912388831426,0.7115553220285835,0.8287461773700305,0.9929527746838139,1.0,6/25,22.45%,LEPROT;CHMP5;LAPTM4B;TMEM50B;RILP;SORT1
prerank,peroxisome organization (GO:0007031),0.28345216347582913,0.7113776756756545,0.8463901689708141,0.9927227595940258,1.0,8/25,21.51%,LONP2;PEX6;PEX2;ABCD2;PEX11B;SEC16B;PEX7;PEX1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.24658501276595404,0.7110094780055326,0.877914951989026,0.9927217845709195,1.0,9/59,16.33%,ROCK2;IRAK2;RNF31;TBK1;RIPK2;CD14;TNFRSF1A;PRDX4;AKT1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.29320367632306676,0.710898932075963,0.8208,0.9924153800563674,1.0,3/22,8.21%,NOS1AP;CACNB1;DRD3
prerank,fatty acid metabolic process (GO:0006631),0.22286403913759312,0.7107690959068146,0.917743830787309,0.9921231965905082,1.0,25/115,22.98%,SLC27A5;ACSL1;ACOT11;ACOT6;CPT1C;ACOT2;ALOXE3;AASDH;PEX2;ACSF2;ACSF3;ABCD2;FASN;OXSM;ACADSB;NUDT19;CYP1A1;ACSL4;LPIN3;ALOX12;ALOX5AP;LPIN2;CPT1A;HPGD;ACADM
prerank,response to growth factor (GO:0070848),0.25985471946507527,0.710436189109413,0.8416666666666667,0.9921067059007163,1.0,8/41,16.33%,BMPR1A;TGFBR1;ACVR1;SFRP1;STAT5B;ACVR1B;GATA6;AKT1
prerank,mRNA processing (GO:0006397),0.20761836238164377,0.7101109363141311,0.9671957671957672,0.9920568044669933,1.0,75/287,23.72%,POLR2D;SON;RBMXL2;U2AF1L4;SNRNP70;THOC2;GTF2H5;SF1;PNN;RBM22;HNRNPR;METTL14;HNRNPA1;NONO;DDX39A;RAVER2;POLR2C;WDR33;SMU1;DDX23;PRMT9;SUGP1;RBM19;MAGOHB;MNAT1;MTREX;SNRPD2;TCERG1;SRSF5;AKAP8L;PCF11;GPKOW;RBM5;RNPC3;RBM6;CMTR2;RBM4B;PSPC1;GEMIN2;LSM8;SRRM2;SYNCRIP;HNRNPC;PRPF6;RBM41;SF3B2;SF3B1;SRSF10;PPIE;CPSF2;METTL3;PRKACA;POLR2L;FIP1L1;USP49;HNRNPU;GCFC2;HNRNPH1;PPWD1;PRCC;SRSF3;ERCC3;PAPOLA;RBM4;IK;NCBP2;ESS2;CDK7;ZRSR2;SART1;ERCC2;PRPF8;SFPQ;CWC22;CASC3
prerank,neurotrophin signaling pathway (GO:0038179),0.2904120269980193,0.7099935315447263,0.8099688473520249,0.991735952047188,1.0,4/21,9.37%,RAPGEF2;NTF3;FRS2;RAPGEF1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.31952679294476255,0.7097908353923206,0.8156996587030717,0.9915230001397938,1.0,3/14,11.49%,BFAR;BCL2L11;UFL1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.24140511659263936,0.7097640390524205,0.8989501312335958,0.9911030088485203,1.0,17/62,21.18%,BCL2;SRC;LRRK2;NFE2L2;PRKN;CREB3;DDX3X;SELENOS;NOL3;VNN1;BAG5;TMBIM6;AKT1;TRIM32;CREB3L1;PPIF;OPA1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.294317240439334,0.7094673009780835,0.8304552590266876,0.9910147318430308,1.0,6/22,19.02%,DYNLL1;CDA;BMP4;CDKN1C;CDKN2C;CDKN1B
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.28525872243955086,-0.7094000838721505,0.8293838862559242,0.9961426238403078,1.0,8/12,55.05%,CCT8;GNL3;CCT6A;CCT7;CCT2;TCP1;WRAP53;DKC1
prerank,phagolysosome assembly (GO:0001845),0.3224057464676014,0.7086843664211018,0.7781512605042017,0.991558323161504,1.0,3/12,15.39%,RAB7B;CLN3;PIKFYVE
prerank,early endosome to late endosome transport (GO:0045022),0.2961977791954441,0.7077436593015478,0.8070175438596491,0.9922616077245825,1.0,10/20,27.73%,WDR81;WDR91;PTPN23;HOOK2;BECN1;RILP;STX8;ANKRD27;HOOK1;RAB5A
prerank,endoderm development (GO:0007492),0.3226569472882727,0.7076204338714143,0.8101694915254237,0.9919470936520837,1.0,1/13,2.67%,LAMC1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.25189638733133735,0.7075601899532574,0.8803894297635605,0.9915681090527256,1.0,16/50,24.01%,CCNA2;CDK5RAP3;CCNK;TTBK1;MNAT1;CNPPD1;CDKN1C;CDKN2C;CCNT2;CDKN1B;SERTAD1;CCND2;CCNT1;CCNG2;CDK7;CCNE2
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.25391237517478504,0.7072298004100048,0.8842398884239888,0.9915089488165851,1.0,6/45,9.32%,SP100;NCAM1;IRF1;OAS2;PML;CAMK2B
prerank,thymus development (GO:0048538),0.32270343988494304,0.7068525780698708,0.8079584775086506,0.9915140788385055,1.0,4/13,16.72%,TGFBR1;ZBTB1;EPHB3;SHH
prerank,glial cell differentiation (GO:0010001),0.2732856420902085,0.7066157549986309,0.858806404657933,0.9913603032505163,1.0,2/28,3.19%,SLC8A3;NFIB
prerank,regulation of response to biotic stimulus (GO:0002831),0.2726469663303993,0.7064638989671528,0.8562874251497006,0.9910990890553218,1.0,11/28,22.80%,APPL2;IRF1;GATA6;RNF135;CX3CL1;DHX58;APPL1;TIRAP;BIRC2;BIRC3;XIAP
prerank,organophosphate biosynthetic process (GO:0090407),-0.21443858962868645,-0.7060925136970927,0.9055374592833876,0.9987759196678206,1.0,11/37,25.99%,LPCAT1;MBOAT1;TPI1;IP6K1;IPMK;AGPAT5;GPHN;PPIP5K1;ITPKB;MOCS2;ITPKC
prerank,regulation of receptor recycling (GO:0001919),-0.26113668569131177,-0.7057241595352706,0.8564705882352941,0.9982136066609825,1.0,4/16,11.54%,INPP5F;KIF16B;SCRIB;NSF
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.30885590055109535,0.7054114764305744,0.7899159663865546,0.9919692511680739,1.0,2/15,11.18%,RIPOR2;CD53
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.26441681901410335,-0.7050448335053512,0.8778409090909091,0.9980512604349574,1.0,2/17,4.12%,MEF2C;PRKG1
prerank,microvillus assembly (GO:0030033),0.31487087963908406,0.7048420127525119,0.8094435075885329,0.9921918917207503,1.0,4/14,14.95%,RAPGEF2;MAP4K4;RAP2A;RAPGEF6
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.2662574677908387,0.7047883015751206,0.8651851851851852,0.9917983254504867,1.0,7/36,13.48%,DACT1;NCOR1;PRKN;ITCH;TAOK3;DUSP19;IGBP1
prerank,autophagy of nucleus (GO:0044804),-0.2676902968684838,-0.7045217169352003,0.8635235732009926,0.9976990017172883,1.0,6/16,21.83%,ULK1;WDR45B;ATG3;WIPI2;ATG13;ATG7
prerank,base-excision repair (GO:0006284),0.24910030272660116,0.7044995445357928,0.8807854137447405,0.9917079095454188,1.0,12/48,23.94%,OGG1;USP47;NEIL1;POLG;POLL;MBD4;HUWE1;XPA;RFC5;MUTYH;LIG1;TDG
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.1848668116071539,-0.7039570732038429,0.975,0.9973917411714057,1.0,21/72,23.95%,CUL1;REL;CARD14;PSMF1;PSMB8;RELB;PSMA4;PSMB10;PSMB2;PSMC4;TNFRSF10B;PSMA6;PSMD9;PSMD11;PSMD5;TRAF2;CHUK;MAP3K7;MALT1;PSMA8;PSMB1
prerank,regulation of translation (GO:0006417),0.2137474034182988,0.7037592177625857,0.9379157427937915,0.9921966280733693,1.0,28/173,18.52%,SAMD4A;DAPK1;PLD1;IGF2BP2;IGFBP5;CPEB3;CD28;EIF2AK3;RNF139;METTL14;EIF4A2;EIF6;EIF2B4;DDX3X;EIF5B;IMPACT;LARP1;MTPN;ENC1;PLXNB2;NSUN5;RBM4B;SYNCRIP;FOXO3;ALKBH1;METTL3;EIF3C;DDX1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.31818199406453923,0.7037134538762962,0.799660441426146,0.9917971495052658,1.0,6/14,27.75%,MRNIP;TIMELESS;ARID2;FUS;MMS19;FANCB
prerank,peptidyl-lysine acetylation (GO:0018394),0.33463456219245,0.7036260272927731,0.784070796460177,0.9914587857994854,1.0,5/10,24.13%,KAT2B;BLOC1S1;KAT5;BAG6;ESCO1
prerank,superoxide metabolic process (GO:0006801),-0.2270656111304563,-0.7035231498782808,0.9090909090909091,0.9969792724585197,1.0,2/29,2.34%,SH3PXD2A;NOS3
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.28339769234574086,0.7031144275226626,0.8382126348228043,0.9916235474767723,1.0,2/24,3.47%,EPHA4;APOE
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.20265815470973364,-0.7029481162438832,0.927797833935018,0.9966768649652021,1.0,8/45,14.93%,EIF4E;GRM5;LARP4;TDRD7;ATG14;PER1;YTHDC1;APP
prerank,positive regulation of cellular respiration (GO:1901857),0.32478955571258983,0.7028638375973222,0.7858439201451906,0.9914593838034618,1.0,1/11,3.59%,NUPR1
prerank,regulation of RNA splicing (GO:0043484),0.2361967014130648,0.7026962026406046,0.9016393442622951,0.991215395432,1.0,13/69,15.61%,PIK3R1;SON;HNRNPLL;SNRNP70;SF1;RBM22;CLK4;RBM39;TMBIM6;METTL4;CLK3;DYRK1A;SLC38A2
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.3088576441634898,0.7026799342435811,0.8021015761821366,0.9907860266276417,1.0,9/17,30.58%,DOLPP1;ALG6;DHDDS;SRD5A3;DPAGT1;MPDU1;ALG9;ALG2;ALG3
prerank,peptidyl-proline modification (GO:0018208),-0.23237513149721592,-0.7021326112959986,0.8760330578512396,0.9966285996429028,1.0,9/25,23.37%,PPIA;FKBP5;PPIG;P3H2;PPID;PPIL1;FKBP1A;PPIB;PPIL6
prerank,cellular response to reactive oxygen species (GO:0034614),0.2379978056685324,0.7007457309622859,0.8955823293172691,0.9926470855176063,1.0,7/59,8.61%,TPM1;PDGFRA;CYP1B1;NFE2L2;ERCC6L2;OSER1;EGFR
prerank,protein-DNA complex assembly (GO:0065004),0.21738456889914354,0.7006817471591815,0.936094674556213,0.9922720776037373,1.0,6/116,6.57%,TCF4;PSME4;CHAF1B;DMC1;GTF2H5;CUL4B
prerank,response to cholesterol (GO:0070723),0.3032012677272876,0.700570832436205,0.8238255033557047,0.991954298541421,1.0,2/17,3.64%,TGFBR1;SMO
prerank,positive regulation of bone resorption (GO:0045780),-0.2975432902887247,-0.7004907985922415,0.841991341991342,0.9974297168687708,1.0,2/11,11.79%,TNFRSF11A;SPP1
prerank,negative regulation of cellular senescence (GO:2000773),0.3234015957245694,0.7004600014601783,0.8153846153846154,0.9916395584035592,1.0,4/13,12.18%,AKT3;SLC30A10;ZKSCAN3;TERF2
prerank,positive regulation of mRNA processing (GO:0050685),-0.24093883743728645,-0.7003725841376941,0.8798955613577023,0.9966224123228319,1.0,5/21,18.99%,CELF4;SNW1;THRAP3;RBMX;SF3B4
prerank,cellular component maintenance (GO:0043954),0.324326949983867,0.7003543793609516,0.8104347826086956,0.991315477043646,1.0,2/12,12.56%,ITGA3;INSR
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.28012804418779813,-0.6998132880772168,0.8498845265588915,0.9953979906465124,1.0,11/11,72.01%,CCT8;CCT6A;CCT7;CCT2;LARP7;TCP1;DKC1;CCT4;CCT3;CCT5;MEPCE
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.28012804418779813,-0.6998132880772168,0.8498845265588915,0.9953979906465124,1.0,11/11,72.01%,CCT8;CCT6A;CCT7;CCT2;LARP7;TCP1;DKC1;CCT4;CCT3;CCT5;MEPCE
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.2109045701530624,-0.6993096822177335,0.9238410596026491,0.9949882365495324,1.0,14/36,34.66%,RAD17;RAD1;HUS1;NBN;CEP63;HINFP;E2F1;RHNO1;HUS1B;DONSON;CDC6;RAD9A;DOT1L;FBXO6
prerank,activation of phospholipase C activity (GO:0007202),0.27655556605217735,0.6990062310932045,0.8579881656804734,0.9925114191229562,1.0,3/29,8.61%,ARHGAP6;LPAR1;EGFR
prerank,positive regulation of interleukin-6 production (GO:0032755),0.23365230680478236,0.698452094512339,0.8977719528178244,0.9927473184174314,1.0,8/68,11.02%,IL6R;IL17D;TSLP;SPHK2;TLR6;RAB7B;CARD9;SETD4
prerank,regulation of T cell activation (GO:0050863),-0.2051373890129895,-0.6978178801598024,0.9590443686006825,0.9957090940643317,1.0,15/42,38.43%,CYRIB;SIRPA;KAT2A;PTPN22;JAK3;CCL2;LAX1;DUSP3;IL4I1;LAT;TNFSF8;PRKCQ;CRTAM;CCDC88B;TNFSF11
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.2847237436263649,0.6965100138566069,0.8414442700156985,0.994571398866628,1.0,3/22,9.41%,APOA1;SPHK2;TRPM4
prerank,pyroptosis (GO:0070269),-0.26395197817666977,-0.6961918002339511,0.8807785888077859,0.9964824172600434,1.0,5/15,23.90%,AIM2;CASP8;APIP;DHX9;TREM2
prerank,neutrophil mediated immunity (GO:0002446),0.19952626639180443,0.6961686138232024,0.9928789420142421,0.9945384924737851,1.0,70/432,16.21%,AMPD3;GSN;AHSG;PLD1;DYNLL1;CRISPLD2;PLEKHO2;PIGR;CLEC12A;CNN2;TXNDC5;FGL2;GALNS;IQGAP2;CTSH;FAF2;STXBP3;TOM1;DYNC1H1;CST3;PDXK;VCL;B4GALT1;KCMF1;TIMP2;CD63;CAMP;COPB1;SPTAN1;GAA;UBR4;DNAJC3;ANXA3;ARHGAP9;AGL;APEH;IGF2R;MGST1;S100A11;ITGAV;AP1M1;NFAM1;VPS35L;DNASE1L1;CARD9;DDX3X;TMEM179B;CD53;LAMTOR2;TNFAIP6;CD33;CDA;CTSZ;CD14;DDOST;KMT2E;MVP;FRK;ATP6AP2;VNN1;HUWE1;PRDX4;GNS;GSDMD;LAMP2;PYGB;AGA;ERP44;CD47;NHLRC3
prerank,response to ionizing radiation (GO:0010212),0.2355681430857365,0.6961003712737414,0.9058064516129032,0.9941790767689804,1.0,8/70,10.59%,EYA1;LIG4;IKBIP;INO80;BRSK1;NHEJ1;STK11;MRNIP
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.2583357344257604,-0.6960497325681798,0.8618266978922716,0.9957118020470219,1.0,3/16,11.55%,MEF2C;SMYD1;RANBP3L
prerank,response to amino acid starvation (GO:1990928),0.22807351883964577,0.6955560375444212,0.9121287128712872,0.99436808562813,1.0,19/72,21.58%,NPRL3;EIF2AK3;SLC38A9;ATP6V1E1;RNF152;CEBPB;CASTOR2;LAMTOR2;RRAGD;IMPACT;LARP1;ITFG2;SESN2;NPRL2;SEH1L;RHEB;SZT2;MLST8;ATP6V1B2
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.2746482468793089,0.695342354954372,0.8480825958702065,0.9941708222284337,1.0,5/28,15.05%,BCL2;MOAP1;DDX3X;CASP8AP2;TNFRSF1A
prerank,DNA-dependent DNA replication (GO:0006261),-0.16939812243347357,-0.695339831481199,1.0,0.9955538523695957,1.0,39/128,30.77%,REV3L;DBF4;TOPBP1;ORC4;POLE4;PSMF1;POLB;PSMB8;PSMA4;MCM8;PSMB10;RAD51;PSMB2;MCMBP;LRWD1;GINS3;PNKP;PSMC4;MCM3;POLD4;PSMA6;PSMD9;PSMD11;PSMD5;WRNIP1;HELB;MCM5;PSMA8;PSMB1;ORC5;PRIM1;PSMD10;CDC6;GINS2;BAZ1A;POLA1;UBC;RPS27A;POLD2
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.27077314152344945,-0.6941747156970131,0.844059405940594,0.9958325239183735,1.0,2/13,13.52%,SIX1;PTGS2
prerank,positive regulation of interleukin-12 production (GO:0032735),0.26212799878766485,0.6938724064724088,0.8513931888544891,0.9954315852123723,1.0,8/31,21.58%,CCL19;IL12B;RIPK2;MDK;IL23A;PLCB1;TIRAP;LGALS9
prerank,negative regulation of organelle assembly (GO:1902116),0.259930440036976,0.6936574096031819,0.8726207906295754,0.995224433817972,1.0,5/35,11.57%,YAP1;NUPR1;LRRK2;KAT2B;MDM1
prerank,positive regulation of telomere maintenance (GO:0032206),-0.21556968808963867,-0.6935306441328714,0.9470198675496688,0.9955648779409002,1.0,9/31,22.34%,NEK7;PKIB;HNRNPD;MAPK3;HNRNPA2B1;PNKP;NBN;SLX4;MAPK1
prerank,modification-dependent protein catabolic process (GO:0019941),0.20914371469846638,0.6934278378300488,0.9669239250275634,0.995054429860421,1.0,41/193,18.74%,SPSB1;DCST1;NEDD4;RFFL;SMURF2;RNF213;BFAR;ZNRF3;UBE4B;TRIP12;RNF185;UBR4;ARRB1;WDR81;ANAPC5;WDR91;PRKN;ITCH;RNF6;MIB1;FBXO11;FEM1C;BTRC;RNF217;COPS3;RNF19A;RC3H2;ADRM1;AMFR;UBA6;UBE2D1;HACE1;RNF13;UBE2R2;UBR3;LONP1;UBE3B;PSMC2;RC3H1;RNF34;TRIM32
prerank,defense response to fungus (GO:0050832),-0.25677405791070607,-0.6930672222295301,0.8795811518324608,0.9950978084338005,1.0,2/17,11.16%,PLCG2;CX3CR1
prerank,regulation of spindle organization (GO:0090224),0.2942187736279938,0.6929904456775674,0.8242811501597445,0.99510259615964,1.0,5/18,19.34%,DYNC1H1;RAE1;SENP6;GNAI1;NUMA1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.23126842395580272,-0.6921723693895638,0.8876404494382022,0.9951273584625728,1.0,8/22,27.02%,ERBB2;PWP1;UBTF;MTOR;UTP15;ATF4;SMARCA4;PIH1D1
prerank,protein K11-linked ubiquitination (GO:0070979),-0.22248666808865097,-0.6920160496530805,0.9136904761904762,0.9943720225750793,1.0,11/27,32.44%,UBE2H;ANAPC7;UBE2D3;UBE2B;UBE2S;RNF4;UBE2A;FZR1;ANAPC11;ANAPC13;UBE2C
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3183547161226758,0.6918157095740564,0.8173758865248227,0.9960005131459949,1.0,8/13,30.58%,ALG11;ALG6;SRD5A3;DPAGT1;MPDU1;ALG9;ALG2;ALG3
prerank,fatty acid beta-oxidation (GO:0006635),0.247464312920176,0.6917816756418645,0.9087301587301587,0.9955934291582209,1.0,11/51,19.96%,IVD;ECHDC2;ECI1;ECHS1;PEX2;DECR1;ABCD2;ETFDH;DECR2;ETFA;ETFB
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.25798551060364766,-0.6917482637874183,0.8831521739130435,0.9937026225705938,1.0,9/17,29.37%,KDM1A;PTTG1IP;SIRT1;CD44;SNAI2;TWIST1;MIF;SNAI1;PSMD10
prerank,mitotic spindle organization (GO:0007052),0.2100463120730932,0.6916127379359013,0.9589509692132269,0.9953356556499884,1.0,36/153,22.74%,DYNLL1;NUP107;EFHC1;DYNC1H1;SPC24;PIBF1;SPDL1;ZW10;DCTN6;PMF1;ZWINT;CENPC;NEK6;CENPH;NUP98;ARHGEF10;DYNC1I2;EML4;FLNA;PLK2;CEP192;SGO1;PTPA;SEH1L;CENPA;KPNB1;CDCA8;CENPM;AAAS;DSN1;AURKA;TAOK1;NDE1;ABRAXAS2;TUBG2;TUBG1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.2463248774574334,0.6914105968213382,0.8863013698630137,0.9951309265758208,1.0,8/47,13.48%,TGFBR3;MAP2K1;EGFR;MAP4K4;CARD9;TAOK3;RAP2A;IGBP1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.27025861007922747,0.6913005696677993,0.85949177877429,0.9948185274192115,1.0,8/27,21.73%,IRAK2;TLR6;IRAK3;CD14;TNIP1;TLR5;TIRAP;MYD88
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.20403086032839635,0.691265025980678,0.9742212674543501,0.9944140688570094,1.0,62/241,23.72%,POLR2D;RBMXL2;U2AF1L4;SNRNP70;SF1;PNN;RBM22;HNRNPR;METTL14;HNRNPA1;NONO;DDX39A;RAVER2;POLR2C;WDR33;SMU1;DDX23;SUGP1;RBM19;MAGOHB;MTREX;SNRPD2;SRSF5;PCF11;GPKOW;RBM5;RNPC3;RBM6;RBM4B;PSPC1;LSM8;SRRM2;SYNCRIP;HNRNPC;PRPF6;RBM41;SF3B2;SF3B1;SRSF10;PPIE;CPSF2;METTL3;POLR2L;FIP1L1;USP49;HNRNPU;GCFC2;HNRNPH1;PPWD1;PRCC;SRSF3;PAPOLA;RBM4;IK;NCBP2;ESS2;ZRSR2;SART1;PRPF8;SFPQ;CWC22;CASC3
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.32980032593160175,0.6911254089016123,0.8032200357781754,0.9941286422832948,1.0,1/10,4.43%,APPL2
prerank,tRNA processing (GO:0008033),0.23719401787558725,0.6906774361350219,0.9015544041450777,0.9941811410401332,1.0,14/61,19.91%,PUS3;ADAT2;ZBTB8OS;NSUN2;ADAT1;TRMT9B;URM1;RPP30;ELP5;DTWD1;DDX1;ANKRD16;TRUB1;METTL1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.237915750631213,0.6904504405010903,0.891156462585034,0.9940200886625902,1.0,18/56,20.59%,RAD51B;EGFR;ANAPC5;DDX3X;RGCC;KMT2E;UBE2E2;AKT1;ADAMTS1;TFDP1;LSM10;CDC7;KLHL18;PHB2;NSMCE2;CDC23;PLCB1;CCND2
prerank,sensory perception of taste (GO:0050909),-0.2910973489094639,-0.6900996224160182,0.8558139534883721,0.9943753789219164,1.0,5/10,44.03%,PKD2L1;CD36;TAS1R1;TAS1R2;GNAT3
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.22225896201620635,-0.68972353128696,0.9221183800623053,0.9938484550632078,1.0,7/30,21.70%,DACH1;ACVRL1;CTC1;BMPR2;CDKN1A;DCP2;TEN1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.2914989416626525,0.6895736083884133,0.8408037094281299,0.9946288132400901,1.0,3/19,12.65%,MTHFR;ALDH1L1;FOLR2
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.24800063909419356,-0.6890096998683609,0.8828125,0.9936233858592501,1.0,9/18,38.19%,CCT8;RUVBL1;DCP2;RUVBL2;SHQ1;NHP2;CCT6A;EXOSC10;NOP10
prerank,regulation of myelination (GO:0031641),-0.230325671891767,-0.6879687562551382,0.9208211143695014,0.9937614195168836,1.0,4/25,11.15%,JAM2;TENM4;PTN;TNFRSF21
prerank,regulation of protein localization to centrosome (GO:1904779),-0.29378292839436204,-0.6873359773379373,0.8222222222222222,0.9934544448239457,1.0,1/10,1.66%,BICD1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.300697604554475,0.6860985100639992,0.8358714043993232,0.99809856340994,1.0,2/17,8.33%,PLA2G4A;LPGAT1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.2794571033407704,0.6860386091409983,0.848,0.9977191277043779,1.0,3/22,12.38%,APOA1;MYADM;WNK1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.2897667852148629,0.6860187614551467,0.8533123028391167,0.9972996742130656,1.0,1/20,1.77%,LYN
prerank,mRNA methylation (GO:0080009),0.3038456960780026,0.6858491170959414,0.8561872909698997,0.9970374197808974,1.0,6/15,24.75%,NSUN2;METTL14;WTAP;METTL3;METTL16;PCIF1
prerank,neutrophil degranulation (GO:0043312),0.19653739938103842,0.6857127966734633,0.9929006085192698,0.9967459517132913,1.0,68/425,16.21%,AMPD3;GSN;AHSG;PLD1;DYNLL1;CRISPLD2;PLEKHO2;PIGR;CLEC12A;CNN2;TXNDC5;FGL2;GALNS;IQGAP2;CTSH;FAF2;STXBP3;TOM1;DYNC1H1;CST3;PDXK;VCL;B4GALT1;KCMF1;TIMP2;CD63;CAMP;COPB1;SPTAN1;GAA;UBR4;DNAJC3;ANXA3;ARHGAP9;AGL;APEH;IGF2R;MGST1;S100A11;ITGAV;AP1M1;NFAM1;VPS35L;DNASE1L1;DDX3X;TMEM179B;CD53;LAMTOR2;TNFAIP6;CD33;CDA;CTSZ;CD14;DDOST;MVP;FRK;ATP6AP2;VNN1;HUWE1;PRDX4;GNS;GSDMD;LAMP2;PYGB;AGA;ERP44;CD47;NHLRC3
prerank,establishment of protein localization to organelle (GO:0072594),0.230202549333664,0.6853972424593167,0.9127604166666666,0.9966481083113163,1.0,16/72,18.84%,RANBP17;NUP107;APPL2;FAM53C;PRICKLE1;HEATR3;CSE1L;PPP1R10;TSC2;NUP214;LAMP2;AKT1;PHB2;TPR;APPL1;KPNB1
prerank,protein targeting to peroxisome (GO:0006625),0.26591971518005975,0.68538744075106,0.8556067588325653,0.9962163027281022,1.0,10/29,23.71%,PXMP2;LONP2;PEX6;PEX2;ABCD2;PEX11B;PEX7;ZFAND6;PEX1;ATAD1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.24272542255819696,0.6849322267711649,0.8913043478260869,0.9962613014892623,1.0,15/48,21.41%,OGT;PRKAG2;NUP107;NUP42;EIF6;NUP98;RAE1;NUP214;GCK;SEH1L;TPR;PRKAG1;AAAS;GCGR;RUBCNL
prerank,neutrophil activation involved in immune response (GO:0002283),0.19608383959963638,0.6842480957156103,0.9949290060851927,0.9965717237392078,1.0,68/428,16.21%,AMPD3;GSN;AHSG;PLD1;DYNLL1;CRISPLD2;PLEKHO2;PIGR;CLEC12A;CNN2;TXNDC5;FGL2;GALNS;IQGAP2;CTSH;FAF2;STXBP3;TOM1;DYNC1H1;CST3;PDXK;VCL;B4GALT1;KCMF1;TIMP2;CD63;CAMP;COPB1;SPTAN1;GAA;UBR4;DNAJC3;ANXA3;ARHGAP9;AGL;APEH;IGF2R;MGST1;S100A11;ITGAV;AP1M1;NFAM1;VPS35L;DNASE1L1;DDX3X;TMEM179B;CD53;LAMTOR2;TNFAIP6;CD33;CDA;CTSZ;CD14;DDOST;MVP;FRK;ATP6AP2;VNN1;HUWE1;PRDX4;GNS;GSDMD;LAMP2;PYGB;AGA;ERP44;CD47;NHLRC3
prerank,cellular response to superoxide (GO:0071451),-0.2878203767065329,-0.6830159063755283,0.8442437923250564,0.9966417661286109,1.0,5/10,27.59%,NOS3;ATP7A;SOD2;CCS;SOD1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.19957081487498796,-0.6829190264789766,0.9351535836177475,0.9958268768868566,1.0,17/42,35.23%,KDM1A;SHLD1;CGAS;RAD51;PARPBP;PARP1;POLQ;HELB;SHLD2;RAD51AP1;KLHL15;WDR48;FIGNL1;WAS;RPA2;SIRT6;RADX
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.30023668223454447,0.6825852130745297,0.8341307814992025,0.9979893580080391,1.0,6/17,16.33%,NFE2L2;NOL3;P4HB;VNN1;BAG5;AKT1
prerank,DNA geometric change (GO:0032392),-0.23016743627712535,-0.6819593575502627,0.9252873563218391,0.9958166191474084,1.0,7/24,19.40%,ZRANB3;SUPV3L1;HNRNPA2B1;NBN;HMGB2;ANXA1;DHX9
prerank,myelination in peripheral nervous system (GO:0022011),0.3038915444935933,0.6815210264037966,0.8608247422680413,0.9986949926365385,1.0,7/13,20.81%,SKI;SIRT2;ARHGEF10;PARD3;NCMAP;DICER1;PRX
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.19315816189788254,-0.68137588451948,0.9803921568627451,0.9954471004948695,1.0,12/54,21.43%,CRADD;PLAGL1;CNOT6L;BTG2;RPL26;EP300;CDKN1A;CNOT7;E2F7;TRIAP1;PLK3;CNOT8
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.3194752554025324,0.6813188395665025,0.8263888888888888,0.9975804687896876,1.0,6/11,28.20%,PANK1;COASY;SLC25A16;DCAKD;ACOT7;PANK2
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.3194752554025324,0.6813188395665025,0.8263888888888888,0.9975804687896876,1.0,6/11,28.20%,PANK1;COASY;SLC25A16;DCAKD;ACOT7;PANK2
prerank,coenzyme A biosynthetic process (GO:0015937),0.3194752554025324,0.6813188395665025,0.8263888888888888,0.9975804687896876,1.0,6/11,28.20%,PANK1;COASY;SLC25A16;DCAKD;ACOT7;PANK2
prerank,cytosolic transport (GO:0016482),0.21381695919430224,0.6812999072085225,0.9536019536019537,0.9971570016233345,1.0,19/108,15.39%,DENND2A;BAIAP3;RHOBTB3;MON2;STX16;RBSN;DENND5A;EPS15;GOSR2;HEATR5A;WDR81;WDR91;ARL1;CLN3;TMEM87B;PTPN23;HOOK2;BET1L;PIKFYVE
prerank,endochondral bone morphogenesis (GO:0060350),-0.28611772374081906,-0.6806385600993884,0.8430913348946136,0.9952043712799766,1.0,1/11,0.57%,MEF2C
prerank,protein deacylation (GO:0035601),0.27316801323088846,0.6803458891746135,0.8778280542986425,0.9977532383103012,1.0,9/23,25.04%,ABHD17C;LYPLAL1;SIRT2;HDAC4;SIRT5;NOTUM;HDAC6;HDAC5;HDAC1
prerank,mitotic cytokinetic process (GO:1902410),0.28832920440324383,0.6800401419596722,0.8582930756843801,0.9976486661221997,1.0,3/20,13.17%,KIF20A;KLHDC8B;CHMP5
prerank,response to peptide (GO:1901652),0.2540480983296727,0.6799337802043292,0.8808864265927978,0.9973171702652854,1.0,7/33,15.71%,MMP2;STAT5B;STAT2;EIF2B4;STAT6;STAT4;EIF2B3
prerank,protein K63-linked ubiquitination (GO:0070534),0.24559892172290196,0.6796365215245653,0.8984034833091437,0.997216486421269,1.0,11/41,20.64%,NEDD4;BFAR;UBE2V2;PRKN;ITCH;RNF152;UBE2E2;RNF135;TRIM21;ARIH2;UBE2T
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.22538423010115496,-0.6796284797361536,0.9299191374663073,0.9952546240213829,1.0,8/24,27.54%,LPCAT1;PGS1;PNPLA8;CRLS1;PLA2G4F;PLA2G4B;PLA2G5;LPCAT4
prerank,regulation of cell aging (GO:0090342),0.32172387637608074,0.6796242943017747,0.82,0.9967882702061833,1.0,2/11,10.63%,NUAK1;NEK6
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.30739169347737283,0.6794471123948972,0.8410714285714286,0.9965309196041824,1.0,3/12,13.80%,GORASP1;BTRC;PTEN
prerank,nuclear membrane disassembly (GO:0051081),-0.25676379563227436,-0.6787267915293603,0.8776470588235294,0.9951199118158066,1.0,7/14,29.32%,VRK1;DCTN1;CCNB2;CNEP1R1;CTDNEP1;PLK1;CDK1
prerank,protein alkylation (GO:0008213),-0.23748790646245643,-0.6787211513920917,0.9209039548022598,0.9942281463621482,1.0,11/22,42.60%,SNRPB;FAM98B;SNRPD3;PRMT3;LCMT1;CAMKMT;PRMT2;EEF1AKMT1;ETF1;EEF1AKMT2;FAM98A
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.2675189703589141,-0.6785453167229633,0.8581081081081081,0.9935032003829402,1.0,6/12,29.32%,VRK1;CCNB2;CNEP1R1;CTDNEP1;PLK1;CDK1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.31215700605602426,0.6770777501485763,0.8496376811594203,0.9987332773711753,1.0,6/13,23.51%,BFAR;UFL1;ABCA7;WFS1;HSPA5;PPP1R15A
prerank,mitochondrion organization (GO:0007005),0.20191470515383186,0.6770400328092011,0.9688195991091314,0.998331025279103,1.0,36/165,20.40%,PID1;PYROXD2;COX7A2;MIGA2;TIMM17B;LRRK2;AKT3;AIFM1;WDR81;BCAP31;PRKN;TIMM44;RHOT1;TIMM9;TFAM;TSPO;NUBPL;POLRMT;USP30;SLC25A36;MUL1;IFIT2;RAB5IF;WASF1;TOMM22;FMC1;VPS13D;LONP1;VPS13C;RAB32;YME1L1;PHB2;SIRT5;AFG3L2;MTFP1;TOMM5
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.2313168336217462,-0.6763608150779546,0.9119318181818182,0.9945109134435887,1.0,9/21,31.19%,TNFAIP3;PTPN22;JAK3;LST1;LAX1;DUSP3;IL4I1;FOXJ1;FCGR2B
prerank,monoacylglycerol metabolic process (GO:0046462),0.3027214675763711,0.6760460653122867,0.8436426116838488,0.9989780870623991,1.0,3/13,14.61%,PLA2G4A;MOGAT3;DGAT2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.2786367087855596,0.676041641788319,0.8430769230769231,0.9985410582407097,1.0,5/22,17.39%,PLA2R1;CDK5RAP3;SPRED3;SPRED1;ATM
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.27075977158976694,0.6752747911287448,0.8705357142857143,0.9989244371118323,1.0,6/25,17.82%,B3GALT1;B3GALNT1;EXT1;NDST1;EXT2;HS2ST1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.3159064802315749,0.6751836113698909,0.8345070422535211,0.9985779946115406,1.0,4/10,18.29%,ERLEC1;DERL3;UBAC2;INSIG1
prerank,regulation of dephosphorylation (GO:0035303),0.30238399266950106,0.6751577160196305,0.850328947368421,0.9981578663656929,1.0,4/15,13.48%,CDK5RAP3;SRC;MTMR3;IGBP1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.28332387341605586,0.6747541739285793,0.8569157392686805,0.9981460073533225,1.0,3/20,9.16%,BCL2;PML;BCAP31
prerank,nucleosome organization (GO:0034728),-0.18575008715066785,-0.6735469622155755,0.9652509652509652,0.99607907592293,1.0,23/55,29.47%,NAP1L4;NAP1L2;H3-3A;CHAF1A;NAA60;RSF1;HMGB2;VPS72;NPM1;MCM3AP;RNF8;ANP32E;ZNHIT1;NASP;LIN54;ASF1A;SMARCA4;ARID1A;BPTF;SET;GRWD1;H1-0;NAP1L3
prerank,positive regulation of protein sumoylation (GO:0033235),-0.28275543756994587,-0.6735003455618607,0.8824833702882483,0.9952238409753562,1.0,5/10,30.67%,SAE1;RWDD3;UBA2;GNL3;RASD2
prerank,regulation of JUN kinase activity (GO:0043506),0.25556977942709624,0.6729054250236827,0.892128279883382,0.999614487051209,1.0,5/33,12.63%,SASH1;TLR6;TAOK3;DUSP19;PDCD4
prerank,negative regulation of centrosome duplication (GO:0010826),-0.2830582761933643,-0.6728199068448508,0.8594847775175644,0.9949550433096206,1.0,4/11,18.90%,RBM14;KAT2A;CDK5RAP2;NPM1
prerank,organelle assembly (GO:0070925),0.19241653119509355,0.6722125636721169,0.992798353909465,0.9998948846714831,1.0,74/384,20.30%,ASAP1;GSN;DYNLL1;PARVA;TMOD4;WDPCP;GORASP2;SH3PXD2B;DZIP1L;RAB23;CYS1;CPLANE1;DYNC1H1;PIBF1;INO80;ULK2;TTC39C;B9D1;WDR35;IFT43;UBXN2B;DNAAF1;FBF1;NCOR1;IFT81;MAPRE2;CENPC;DYNC2I1;NEK6;CFAP44;DDX3X;EMC6;CFAP410;VPS37D;WIPI1;HAUS1;GOLGA8B;CHMP5;PTPDC1;ABCA3;ARF4;SYNPO;PTPN23;HAUS7;FLNA;HAUS3;CEP164;PRRC2C;IFT74;POGZ;AUP1;RAB19;DZIP1;ABCB6;MAP1LC3A;INTU;PATL1;TMEM67;RAB32;RP2;BECN1;ATG2B;AHI1;RC3H1;CENPA;TTC36;HPS4;HYLS1;TMEM231;NSFL1C;EHD1;YTHDF2;WDR45;OCRL
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.29835033254679966,0.67167233813042,0.8403361344537815,1.0,1.0,5/16,19.21%,KAT2B;NAA40;NAA20;NAA80;NAA50
prerank,pre-replicative complex assembly (GO:0036388),-0.1818927600747563,-0.671633312549155,0.9830508474576272,0.9950978879615439,1.0,22/64,31.88%,ORC4;PSMF1;PSMB8;PSMA4;MCM8;PSMB10;PSMB2;PSMC4;MCM3;PSMA6;PSMD9;PSMD11;PSMD5;MCM5;PSMA8;PSMB1;ORC5;PSMD10;CDC6;UBC;RPS27A;PSMC3
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.24294452841301473,0.6712125852784433,0.8912429378531074,1.0,1.0,7/38,16.33%,DAG1;DRD3;PHLPP2;MUL1;TSC2;PTEN;AKT1
prerank,double-strand break repair via break-induced replication (GO:0000727),0.30782657346867937,0.6710275277477954,0.8540925266903915,0.9997877635883368,1.0,5/12,24.86%,MCM2;CDC7;GINS4;MCMDC2;MCM6
prerank,endoplasmic reticulum organization (GO:0007029),0.22085080398949755,0.6709686012689855,0.9346153846153846,0.9994108687079815,1.0,16/72,19.83%,LMAN2L;SEC31A;TRAM2;LMAN1;LRRK2;EIF2AK3;CYB5A;MIA3;TRAM1;TOR1B;TOR1AIP2;REEP4;SEC16B;MOSPD3;SMPD4;CCDC47
prerank,regulation of microtubule depolymerization (GO:0031114),-0.2200536143218687,-0.6708478569132279,0.913946587537092,0.9949083486753529,1.0,5/25,18.87%,NAV3;ARHGEF2;TRPV4;MAP1B;CLASP1
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.25461131598661957,-0.6707430906603917,0.8915094339622641,0.9941148726060274,1.0,9/15,40.09%,PLIN2;PNPLA2;OSBPL11;TREM2;PLIN3;LPL;FITM2;PLIN5;APOC4
prerank,regulation of nervous system development (GO:0051960),0.24966823060070165,0.6705044604979852,0.9193324061196105,0.9994610539590598,1.0,9/37,19.98%,ASCL1;YAP1;HES7;SIRT2;BHLHE41;NSUN5;CX3CL1;WNT3;YTHDF2
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.2873469725359329,0.6704794743696866,0.8661417322834646,0.99905113559912,1.0,9/18,28.95%,EIF2AK3;WDR43;FLNA;PHF8;POLR2L;MAF1;HEATR1;SIRT7;LYAR
prerank,negative regulation of secretion (GO:0051048),-0.28882189626063437,-0.6702506525799176,0.8806941431670282,0.9936342855001801,1.0,2/10,12.76%,VAMP8;ERBB3
prerank,cochlea morphogenesis (GO:0090103),-0.28227735272053717,-0.6702277583722621,0.8842794759825328,0.9927570803444283,1.0,6/10,40.14%,TBX1;MYO3B;MYO3A;TBX18;HOXA1;PAX2
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.2830338341073393,0.6675752767587387,0.867109634551495,1.0,1.0,5/18,13.79%,FRS2;BMP2;BHLHE41;TMEM119;HDAC4
prerank,regulation of protein transport (GO:0051223),0.2610233220469856,0.6673454425590863,0.8904109589041096,1.0,1.0,9/27,25.72%,DNAJC1;SNX12;LLGL1;RHBDF2;ATP13A2;LLGL2;DNAJA1;SCFD1;P3H1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.3104217876212879,0.6671620488455505,0.8509212730318257,1.0,1.0,3/11,14.80%,LDLR;SREBF1;NR1H3
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.27456404592011074,-0.6670352266141941,0.8716814159292036,0.994481912238426,1.0,2/12,11.18%,NOTCH1;HES1
prerank,negative regulation of cell aging (GO:0090344),0.2916363824766693,0.6669209660708353,0.8495297805642633,1.0,1.0,4/16,12.18%,AKT3;SLC30A10;ZKSCAN3;TERF2
prerank,metanephros development (GO:0001656),0.26278370556363684,0.666461908786129,0.8695652173913043,1.0,1.0,3/26,7.90%,GDNF;CTSH;OSR1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.21093150792165868,0.6656864152176866,0.9501779359430605,1.0,1.0,5/104,6.92%,PDPK1;LYN;PSME4;SRC;KLRD1
prerank,cellular response to lectin (GO:1990858),0.21093150792165868,0.6656864152176866,0.9501779359430605,1.0,1.0,5/104,6.92%,PDPK1;LYN;PSME4;SRC;KLRD1
prerank,microtubule depolymerization (GO:0007019),0.28518879198325564,0.6649091007758464,0.8486312399355878,1.0,1.0,5/17,22.00%,NCKAP5;KATNB1;KIF19;KIF24;CCSAP
prerank,regulation of response to stress (GO:0080134),-0.28542855222990104,-0.6645284235979594,0.8879310344827587,0.9957494604009145,1.0,3/10,21.53%,ADCY8;MLC1;CORO2B
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.2779343132534396,0.664526308911936,0.8642172523961661,1.0,1.0,1/18,1.77%,LYN
prerank,nuclear membrane organization (GO:0071763),0.2789998576729883,0.6642035550693299,0.8700475435816165,1.0,1.0,5/19,19.67%,UBXN2B;TOR1AIP1;TOR1B;AKAP8L;NSFL1C
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.2100588410223232,0.6637048177776971,0.9539007092198581,1.0,1.0,5/105,6.92%,PDPK1;LYN;PSME4;SRC;KLRD1
prerank,myeloid cell development (GO:0061515),0.2794967508896097,0.6634191929255293,0.8522920203735145,1.0,1.0,2/18,6.32%,KIT;SRC
prerank,phospholipid metabolic process (GO:0006644),0.2206328636095105,0.6630252816102891,0.9515923566878981,1.0,1.0,5/71,6.05%,PLPP3;PLCD1;PLA2G4A;SMPD2;AGPAT3
prerank,mRNA catabolic process (GO:0006402),-0.19667860737582543,-0.6625779744315413,0.9638989169675091,0.9964305527105587,1.0,12/44,19.44%,PNPT1;LSM2;LSM6;THRAP3;SUPV3L1;DIS3L2;ERN1;NBAS;AGO1;RNH1;DDX5;DCP2
prerank,positive regulation of protein acetylation (GO:1901985),0.3045335777211709,0.6624451785945303,0.8547297297297297,1.0,1.0,4/12,21.34%,PRKAA2;DDX3X;KAT5;TAOK1
prerank,glucose import (GO:0046323),0.2983478061058711,0.6619460686541677,0.8412698412698413,1.0,1.0,5/13,22.91%,SLC2A10;TRARG1;SLC2A4;SORT1;SLC27A1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.20607228900810343,-0.6619022564510985,0.9526813880126183,0.996065560861979,1.0,13/35,26.58%,ITGA1;HSP90AB1;PPP1R15B;CALM1;CALM3;MTOR;FKBP1A;CD300A;GSK3B;PPP1R11;PPP6R3;CALM2;PPP1R1B
prerank,cilium-dependent cell motility (GO:0060285),0.27416569702381244,0.6618036800038225,0.8841269841269841,1.0,1.0,3/22,10.78%,EFHC1;DNAI3;CFAP44
prerank,regulation of interferon-beta production (GO:0032648),0.23416022689085397,0.6617865773558285,0.9199457259158752,1.0,1.0,10/46,18.23%,IRF1;PTPRS;OAS2;POLR3A;DDX3X;TBK1;RIPK2;RIOK3;RNF135;DHX58
prerank,negative regulation of interleukin-17 production (GO:0032700),0.3201540562441263,0.6617127935954737,0.8526863084922011,1.0,1.0,3/10,22.81%,IL12B;DDIT3;NCKAP1L
prerank,regulation of synapse maturation (GO:0090128),0.31159774439749643,0.6614044971265021,0.8581818181818182,0.9999040753401576,1.0,2/10,9.32%,ADGRL1;CAMK2B
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.24305011360012607,-0.6613342378794437,0.9027431421446384,0.9956205176636956,1.0,7/16,32.50%,GSK3A;GPER1;ACP3;CHGA;NECAB2;GRP;SLC39A14
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.1742997120859125,-0.6612015271550872,0.9747899159663865,0.9948312019253369,1.0,17/67,23.95%,B2M;VAMP8;NCF2;PSMF1;PSMB8;PSMA4;PSMB10;PSMB2;PSMC4;FCGR1A;PSMA6;PSMD9;PSMD11;PSMD5;CHUK;PSMA8;PSMB1
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.2295439016036513,-0.6609917159599776,0.9162011173184358,0.9941004642582167,1.0,4/20,19.39%,HSP90AB1;BBS12;PFDN6;CLU
prerank,regulation of organelle organization (GO:0033043),0.21309496797140137,0.6609038457915675,0.9585427135678392,0.9999482718992743,1.0,14/80,16.12%,ZEB2;USP6NL;LMAN1;RBSN;SYDE1;PRKN;RHOT1;NEXN;CLN3;MUL1;SYT11;MARK2;ARMH3;GOLPH3
prerank,regulation of innate immune response (GO:0045088),0.22821135147770857,0.6608656712754497,0.9322493224932249,0.9995476516592006,1.0,17/57,22.80%,APPL2;IRF1;NMI;IRAK3;RNASEL;IFNK;ABCE1;MUL1;RIOK3;RNF135;DHX58;APPL1;TRIM21;TIRAP;BIRC2;BIRC3;XIAP
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.24968547821316403,0.6608300566946962,0.899856938483548,0.9991478233727864,1.0,9/31,18.32%,DACT1;RBL2;JADE1;PTEN;KANK2;CDK2AP2;CDKN2C;MYO16;CDC73
prerank,myelin maintenance (GO:0043217),0.3118747038296542,0.6605368623359615,0.8483754512635379,0.9990034813239994,1.0,4/10,20.81%,PTEN;ABCD2;EPB41L3;PRX
prerank,snRNA processing (GO:0016180),-0.24955014618974247,-0.660301783122157,0.8992248062015504,0.993736250976146,1.0,6/16,33.28%,INTS6;INTS8;INTS1;INTS10;TUT1;INTS11
prerank,DNA dealkylation (GO:0035510),0.31822924472570746,0.6599513964187647,0.843585237258348,0.9986612757191502,1.0,6/10,31.64%,ASCC3;ALKBH1;FTO;MPG;ASCC2;ALKBH3
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.31822924472570746,0.6599513964187647,0.843585237258348,0.9986612757191502,1.0,6/10,31.64%,ASCC3;ALKBH1;FTO;MPG;ASCC2;ALKBH3
prerank,negative regulation of phagocytosis (GO:0050765),-0.24315431454048778,-0.6596522545118214,0.9325,0.9933657682618208,1.0,6/17,24.08%,DYSF;SIRPA;RACK1;CD300A;CD300LF;PLSCR1
prerank,epidermal cell differentiation (GO:0009913),0.23784352126378747,0.658969268126848,0.9132290184921764,0.999154123709959,1.0,12/41,26.38%,TXNIP;USH2A;KRT10;GLI1;GATA6;ST14;ERCC3;ERCC2;ACER1;HDAC1;JAG1;CASP3
prerank,eosinophil migration (GO:0072677),0.2957827496586881,0.6587602700424824,0.8569078947368421,0.9984808795647564,1.0,2/14,17.52%,CCL4;CX3CL1
prerank,eosinophil chemotaxis (GO:0048245),0.2957827496586881,0.6587602700424824,0.8569078947368421,0.9984808795647564,1.0,2/14,17.52%,CCL4;CX3CL1
prerank,response to light stimulus (GO:0009416),0.22694591156389532,0.6587542307510978,0.9308093994778068,0.9980514198913398,1.0,7/55,12.96%,SLC24A1;PCLAF;SPRTN;UBE4B;BRSK1;ERCC8;COPS3
prerank,regulation of intracellular transport (GO:0032386),0.2375062520209541,0.6580970841296603,0.8942028985507247,0.9982461132219069,1.0,13/38,25.25%,ATP9A;DYNC1H1;LRRK2;RNF139;NUP214;GAS1;NUMA1;AAAS;ATP13A2;RBM4;RINT1;TTC21B;SCFD1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.2566382995277948,-0.6572112143809948,0.9128205128205128,0.9944222739788717,1.0,8/14,31.21%,LIMS2;EMP2;LIMS1;ITGB1BP1;DMTN;PRKD1;BST1;PHACTR4
prerank,regulation of peptidase activity (GO:0052547),0.27088341294257,0.6568715823032466,0.8867924528301887,0.9989650013412676,1.0,7/19,25.04%,CTSH;CST3;RCN3;PSMA3;ATP13A2;MAPK12;HDAC1
prerank,mitochondrion disassembly (GO:0061726),0.25029726840248173,0.6568229024642676,0.8890510948905109,0.9985702461887949,1.0,12/34,22.94%,ULK2;PRKN;USP30;WIPI1;MARK2;MAP1LC3A;BECN1;ATG2B;WDR45;ATG9A;FUNDC2;AMBRA1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.2117801123087821,0.6564348817847647,0.9609571788413098,0.9984870972224092,1.0,19/88,20.65%,FBXO48;FBXL17;PSME4;CUL4B;CUL5;FBXL3;FBXO9;FBXO4;FBXL12;BTRC;FBXO38;AMN1;PSMB5;PSMC2;PSMD1;PSMD4;PSME3;FBXL18;PSMA3
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.2674092686791346,0.656421041604342,0.8830963665086888,0.9980629675202525,1.0,5/24,12.85%,IRAK2;AAMP;ITCH;RIPK2;MAP2K6
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.21297414164319511,-0.655927948368629,0.9476744186046512,0.9944954999131389,1.0,14/28,39.79%,MAP2;GAS2L1;MAP1B;CLASP1;SKA3;PRUNE1;MAPRE1;STMN4;CAMSAP2;STMN1;MAPT;MAP1A;CLASP2;SKA1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.2520849697870009,-0.6552499736105193,0.9063291139240506,0.9941572379757802,1.0,6/15,27.01%,GBP5;NLRP2B;TLR4;TREM2;CPTP;CD36
prerank,nuclear envelope organization (GO:0006998),0.2780605531744915,0.6549071952856285,0.8823529411764706,0.9990454937360179,1.0,5/20,18.33%,DMPK;LEMD3;TOR1AIP1;TOR1B;REEP4
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.2796315235746529,-0.6526773741822303,0.8855721393034826,0.995205924074368,1.0,4/10,25.35%,DHFR;TYMS;MTHFD2;SHMT1
prerank,negative regulation of insulin secretion (GO:0046676),0.2792226432907659,0.6523917595870492,0.8706070287539937,1.0,1.0,4/17,11.95%,SFRP1;PRKN;ADRA2A;REST
prerank,cellular response to amino acid starvation (GO:0034198),0.21492515963680445,0.6520140838467526,0.956140350877193,1.0,1.0,18/71,21.58%,NPRL3;EIF2AK3;SLC38A9;ATP6V1E1;RNF152;CEBPB;CASTOR2;LAMTOR2;RRAGD;IMPACT;ITFG2;SESN2;NPRL2;SEH1L;RHEB;SZT2;MLST8;ATP6V1B2
prerank,hexose transmembrane transport (GO:0008645),0.2673831020780737,0.6517922127571318,0.877221324717286,1.0,1.0,5/21,17.57%,SLC2A10;SLC45A3;SLC5A3;SLC2A4;SLC2A8
prerank,regulation of interleukin-12 production (GO:0032655),0.22969847972612872,0.6510510033328457,0.9310344827586207,1.0,1.0,9/47,16.20%,CCL19;PIBF1;IL12B;MAST2;IRAK3;RIPK2;MDK;CD47;IL23A
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.242653107639208,-0.6508732806726276,0.9101654846335697,0.9957069685481869,1.0,7/15,29.29%,RYR2;ZFAND2B;SPCS1;RAB3GAP2;EDEM1;SRPRA;SEC61G
prerank,heterochromatin assembly (GO:0031507),-0.22635729910795582,-0.6508392484223249,0.9128205128205128,0.994849894628644,1.0,5/20,14.36%,ZNFX1;BAZ2A;SUV39H1;SIRT1;H3-3A
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.21550966637464639,0.6505644338655753,0.9583875162548765,1.0,1.0,16/70,20.65%,RUNX1;YAP1;PSME4;SETD1A;ITCH;KMT2A;TCF12;PSMB5;PSMC2;METTL3;PSMD1;PSMD4;PSME3;YTHDF2;FOXC1;PSMA3
prerank,motile cilium assembly (GO:0044458),0.3015633738928296,0.6504894477070549,0.8617021276595744,1.0,1.0,2/12,12.43%,DNAAF1;CCDC40
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.2602142236180479,0.6499333294899138,0.8829953198127926,1.0,1.0,8/23,26.16%,MYO10;DYNC1I2;HOOK2;MAP6D1;KIF1C;MAP6;KIF5C;HOOK1
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.22587086196340678,-0.6497442458073098,0.9378531073446328,0.9948184391436793,1.0,2/21,5.99%,NAV3;ARHGEF2
prerank,respiratory chain complex IV assembly (GO:0008535),0.26981948672361467,0.6491741777030425,0.8883572567783095,1.0,1.0,5/21,19.38%,COX18;COX10;COA6;PET100;FASTKD3
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.24937123129003888,-0.6483724164584888,0.9179954441913439,0.9949587545257046,1.0,4/14,21.76%,TFRC;SHLD1;SHLD2;NECTIN2
prerank,positive regulation of protein depolymerization (GO:1901881),0.30562868471123494,0.6481724867416004,0.8639575971731449,1.0,1.0,2/11,9.55%,SEMA5A;KATNB1
prerank,autophagosome assembly (GO:0000045),0.2289319030828525,0.6477114947668288,0.9392265193370166,1.0,1.0,15/52,22.94%,RAB23;ULK2;UBXN2B;EMC6;WIPI1;RAB19;MAP1LC3A;BECN1;ATG2B;NSFL1C;WDR45;STX17;ATG9A;STX12;AMBRA1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.24562514115124545,-0.6471919365947983,0.9079903147699758,0.9949255428483026,1.0,6/15,30.83%,ZC3H12C;RNASEH1;NUDT16;POP7;RPP40;ZC3H12D
prerank,nucleoside salvage (GO:0043174),0.3074727038918227,0.6471903346675293,0.8665480427046264,1.0,1.0,3/10,17.31%,CDA;UPP2;DCK
prerank,regulation of centriole replication (GO:0046599),0.2746471306165012,0.646475384340598,0.879045996592845,1.0,1.0,4/17,14.70%,ALMS1;KAT2B;MDM1;PLK2
prerank,positive regulation of actin filament polymerization (GO:0030838),0.23605800303608865,0.646110813100012,0.9307909604519774,1.0,1.0,7/44,18.37%,GSN;CDC42EP4;CARMIL1;SNX9;ARF6;FCHSD2;CDC42EP3
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.290960907279517,0.6457429120764211,0.8556521739130435,1.0,1.0,7/14,25.56%,ADK;GART;PPAT;PFAS;ADSS1;ADSL;LHPP
prerank,cellular lipid catabolic process (GO:0044242),0.2547798399557191,0.6454559228678559,0.8998482549317147,1.0,1.0,10/27,27.00%,MT3;CYP1B1;SIRT2;NUDT19;SMPDL3B;LPIN3;LPIN2;LPIN1;PLBD2;MGST2
prerank,transcription by RNA polymerase III (GO:0006383),0.2530332257210204,0.6448201036483001,0.9027777777777778,1.0,1.0,12/27,28.90%,BRF1;GTF3C1;SNAPC1;SNAPC5;SNAPC4;POLR2L;GTF3C3;ICE1;GTF3C5;ICE2;POLR3K;POLR3GL
prerank,tRNA metabolic process (GO:0006399),-0.23594759287226336,-0.6447452783306192,0.9276139410187667,0.9957777350138411,1.0,4/17,15.62%,YARS2;KARS1;RPP21;FARS2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.19910879102685097,0.644315435857351,0.9851428571428571,1.0,1.0,40/148,25.66%,PDPK1;PRKAG2;RFFL;CDK5RAP3;PRKAA2;NUAK1;PML;ING5;PPP1R13L;MTA2;STK11;RBBP7;L3MBTL1;MAP2K6;BANP;TAF9;AKT1;ATM;KAT5;RNF34;RICTOR;TAF2;RFC5;PRKAG1;MDM4;MLST8;AURKA;RMI2;MAPKAP1;MEAF6;BRCA1;HEXIM1;TAF4B;PRKAB2;MRE11;TAF15;PRKAG3;HDAC1;PIP4K2A;ATRIP
prerank,positive regulation of interleukin-8 production (GO:0032757),0.22838160126722262,0.6440951568723116,0.926530612244898,1.0,1.0,2/49,2.77%,SERPINE1;IL17D
prerank,sensory perception of smell (GO:0007608),-0.27033908266299683,-0.6440815738136677,0.9134615384615384,0.9953670851689047,1.0,1/11,11.11%,ADCY3
prerank,L-serine metabolic process (GO:0006563),0.303216568899489,0.6439662402213983,0.842391304347826,1.0,1.0,4/10,21.20%,PSPH;SERINC3;PHGDH;CBS
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.2125941463606596,-0.6439290550327307,0.9526627218934911,0.9945824259522925,1.0,13/27,41.60%,CYRIB;SIRPA;SKAP1;CD44;CCL2;TRAF6;HAS2;NR4A3;PRKCQ;CCDC88B;TNFSF11;TNF;ITGB2
prerank,regulation of myoblast differentiation (GO:0045661),0.24439226966550373,0.6433545070672962,0.9191919191919192,1.0,1.0,7/32,15.81%,RIPOR2;TBX3;ZFP36L1;IGFBP3;TRIP4;BMP4;LRRC8A
prerank,regulation of multicellular organismal development (GO:2000026),-0.21257649193265032,-0.6423625504281852,0.9507246376811594,0.9947659267102628,1.0,4/25,11.69%,SOX17;SPAAR;PTN;KAT2A
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.2579111903344046,0.6420813584821153,0.9041095890410958,1.0,1.0,4/24,10.35%,DNMT3A;RBBP7;PHF1;PPHLN1
prerank,protein palmitoylation (GO:0018345),0.24918239221684255,0.6419285130599349,0.9097633136094675,1.0,1.0,1/30,1.26%,GLUL
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.273732664632537,0.6417470998596974,0.8874388254486134,1.0,1.0,6/17,21.67%,ARFIP2;DNAI3;WASF1;FCHSD2;CORO1B;BRK1
prerank,regulation of interferon-alpha production (GO:0032647),0.2601854377558359,0.6417159241385415,0.9024,1.0,1.0,4/23,12.68%,PTPRS;DDX3X;TBK1;RIPK2
prerank,GTP metabolic process (GO:0046039),0.2775839612798542,0.6414687722104384,0.880672268907563,1.0,1.0,3/15,12.04%,RAB23;LRRK2;RHOQ
prerank,innate immune response (GO:0045087),0.1923585037243229,0.6412351078307833,0.9935135135135135,1.0,1.0,19/217,11.80%,MFAP4;COLEC12;LYN;SP100;WFDC3;CXCL16;COLEC11;SRC;PML;KYNU;KLRD1;CAMP;POLR3A;MASP1;IFI27;CARD9;DDX3X;RNASE7;TBK1
prerank,keratinocyte differentiation (GO:0030216),0.24993232234159588,0.6411769782358252,0.9041095890410958,0.9998281176062561,1.0,1/29,1.01%,TXNIP
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.20989722182598824,0.6411370791808655,0.9590570719602978,0.9994356302590204,1.0,8/88,9.90%,TRABD2B;SMAD3;SYNPO2;CDH5;SDC1;EMILIN1;BCL2L11;SYNPO2L
prerank,maintenance of protein localization in organelle (GO:0072595),0.26786297463761743,0.6410493287125152,0.8839869281045751,0.9990886580680197,1.0,8/19,28.51%,PML;ARL2;AKT1;HNRNPU;TAF8;HSPA5;HK1;TAPT1
prerank,postreplication repair (GO:0006301),0.22947546457640156,0.6402143257836613,0.9386590584878745,0.9993842030683954,1.0,7/45,13.02%,PCLAF;SPRTN;UBE2V2;ZBTB1;WDR33;RAD18;USP10
prerank,negative regulation of double-strand break repair (GO:2000780),0.23922530370078604,0.64012007962648,0.9219440353460973,0.9990401541973501,1.0,8/30,21.24%,OGG1;TRIP12;NUDT16L1;UBR5;SHLD3;SMCHD1;HSF1;RMI2
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.239567780929144,0.640029185244941,0.9176136363636364,0.9986859872614215,1.0,9/33,18.32%,DACT1;RBL2;JADE1;PTEN;KANK2;CDK2AP2;CDKN2C;MYO16;CDC73
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.2793716861456406,0.6396666830182655,0.8755980861244019,0.99856066667058,1.0,7/17,23.43%,APOE;SREBF1;ERLIN1;KPNB1;SEC14L2;ERLIN2;SREBF2
prerank,positive regulation of organelle organization (GO:0010638),-0.20150556673109832,-0.6395564154963009,0.9615384615384616,0.9958450031007999,1.0,9/32,23.90%,P2RX7;PPARGC1A;SORBS3;ADRB2;SYNJ1;ANXA1;RAB3GAP2;GSK3B;TREM2
prerank,tRNA 5'-end processing (GO:0099116),0.2810639743603036,0.6381655706862,0.8698517298187809,0.999398219521668,1.0,4/15,15.60%,RPP25L;PRORP;RPP30;RPP38
prerank,microtubule polymerization or depolymerization (GO:0031109),0.2549636490305813,0.6377186917710894,0.9156441717791411,0.9993376963688669,1.0,3/24,10.17%,NCKAP5;KATNB1;FGF13
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.21333002747163438,0.637496068988237,0.9612403100775194,0.9990953175036541,1.0,18/72,19.54%,SP100;NDRG1;PML;BATF;RBL2;RGCC;USP10;PLK2;CNOT3;SESN2;TFDP1;ATM;KAT5;CARM1;ATRX;CDKN1B;MUC1;MDM4
prerank,regulation of stem cell population maintenance (GO:2000036),0.2724772625000063,0.6370504433916739,0.9021207177814029,0.9990514266335179,1.0,5/18,14.97%,REST;WDR43;NCOA3;TAF5L;CNOT3
prerank,regulation of centrosome duplication (GO:0010824),-0.19999815969475904,-0.6362876020680636,0.9452449567723343,0.9971960939711539,1.0,10/29,29.11%,PDCD6IP;SIRT1;STIL;NPM1;CHMP2B;CEP131;CHMP4B;GEN1;SPICE1;CHMP4C
prerank,lipid droplet organization (GO:0034389),-0.2181241905456433,-0.6360971477305066,0.9442896935933147,0.99645350601645,1.0,11/22,37.23%,PPIA;PNPLA3;PLA2G4C;PPID;ZFYVE1;HILPDA;FITM2;CDS1;CDS2;BSCL2;PLIN5
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.2587807844987253,0.6358176224159292,0.9086687306501547,0.9996501968743785,1.0,6/22,22.83%,PSME4;NFE2L2;ENC1;PSMB5;PSMA3;PSMA2
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.18549678525033825,0.6349965128655691,0.9968119022316685,0.9999093302938242,1.0,66/264,23.90%,POLR2D;RBMXL2;U2AF1L4;SNRNP70;SF1;PNN;DDX17;RBM22;HNRNPR;METTL14;HNRNPA1;NONO;DDX39A;RAVER2;POLR2C;WDR33;SMU1;DDX23;SUGP1;RBM19;MAGOHB;MTREX;SNRPD2;SRSF5;PCF11;GPKOW;RBM5;RNPC3;RBM6;RBM4B;PSPC1;GEMIN2;LSM8;SRRM2;SYNCRIP;HNRNPC;PRPF6;RBM41;SF3B2;SF3B1;SRSF10;PPIE;CPSF2;METTL3;DDX1;POLR2L;FIP1L1;USP49;HNRNPU;GCFC2;HNRNPH1;PPWD1;PRCC;SRSF3;PAPOLA;RBM4;IK;NCBP2;ESS2;ZRSR2;SART1;PRPF8;SFPQ;CWC22;CASC3;CDK13
prerank,regulation of telomerase activity (GO:0051972),-0.18711978871484314,-0.634813790323698,0.9809160305343512,0.9964379568544548,1.0,7/45,16.68%,NEK7;HSP90AB1;PKIB;KLF4;NVL;MAPK3;PNKP
prerank,cell-cell junction maintenance (GO:0045217),-0.26314856938175424,-0.6344866825396125,0.8981042654028436,0.9957637158175324,1.0,1/11,2.91%,TJP1
prerank,androgen metabolic process (GO:0008209),0.27226760535547934,0.6344780804704344,0.8973063973063973,0.9999027649953529,1.0,2/18,7.56%,HSD3B2;SRD5A1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.2729365842140731,-0.63370404187669,0.9082774049217002,0.9953882643478749,1.0,6/10,37.81%,RUVBL1;ZNHIT3;RUVBL2;PIH1D1;SHQ1;PIH1D2
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.24434583865437703,-0.6334904519694278,0.9237875288683602,0.9946498531252007,1.0,2/13,12.44%,CYRIB;PVR
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.2130625682667015,-0.6330663217903608,0.9254658385093167,0.994068067306473,1.0,8/25,24.29%,HMGN1;ALYREF;LDB1;EAF2;ZNF326;EAF1;CCAR2;TCEA2
prerank,intracellular lipid transport (GO:0032365),0.2620258700401587,0.6328592796617477,0.9036697247706422,1.0,1.0,3/21,6.03%,PRKAG2;PRKAA2;PLEKHA8
prerank,negative regulation of signaling (GO:0023057),0.24851844164577575,0.6326678129524944,0.9135802469135802,1.0,1.0,5/25,17.98%,OPTN;ACVR1;IGFBP3;LIF;HHIP
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.2580331944115175,-0.6315902297739926,0.9064748201438849,0.9941632227511236,1.0,6/12,40.75%,NBN;WRNIP1;WDR18;TICRR;KAT7;CDT1
prerank,mitochondrial fusion (GO:0008053),0.26522767252764506,0.6313539194422438,0.9011164274322169,1.0,1.0,5/18,21.45%,MIGA2;USP30;AFG3L2;OPA1;STOML2
prerank,regulation of cell cycle phase transition (GO:1901987),-0.1592510926394109,-0.6309960758345381,1.0,0.9936676104783795,1.0,21/91,20.60%,CUL1;ANAPC16;TAF1;ANAPC15;ATP2B4;ANAPC7;DBF4;PSMF1;PSMB8;PSMA4;PSMB10;PSMB2;UBE2S;BUB1B;TFAP4;CDKN1A;PSMC4;PSMA6;PSMD9;PSMD11;PSMD5
prerank,mitochondrial genome maintenance (GO:0000002),0.29642888188981104,0.630925619829366,0.8820422535211268,1.0,1.0,4/11,21.18%,AKT3;SLC25A36;LONP1;OPA1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.2328370306375215,0.6305418279967312,0.9118065433854907,1.0,1.0,5/37,11.09%,BCL2;NUPR1;BCL2L11;BCAP31;GSDME
prerank,cellular response to interleukin-15 (GO:0071350),-0.24884751073616235,-0.6304439889915605,0.9213197969543148,0.9922695712543151,1.0,7/13,34.05%,IL15;STAT5A;JAK3;IL2RG;SHC1;STAT3;GRB2
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.24884751073616235,-0.6304439889915605,0.9213197969543148,0.9922695712543151,1.0,7/13,34.05%,IL15;STAT5A;JAK3;IL2RG;SHC1;STAT3;GRB2
prerank,nuclear transport (GO:0051169),-0.2332986494918614,-0.6301179038035364,0.9329896907216495,0.9915858973776509,1.0,8/16,38.55%,NXT2;PSIP1;NPM1;NUTF2;NXT1;RBM15B;HMGA1;XPO1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.27210837407014876,-0.6295695863029467,0.9004424778761062,0.9910621593442434,1.0,3/10,26.22%,DLGAP2;BEGAIN;CACNG5
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.22077232349083067,0.6295023780063771,0.9433701657458563,1.0,1.0,8/46,16.33%,TIMM17B;AIFM1;BCAP31;TIMM44;TIMM9;TSPO;TOMM22;AKT1
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.1784888693023964,-0.62929828046944,0.9887640449438202,0.990369752783971,1.0,18/51,30.04%,P2RX7;GBP5;AIM2;JAK2;TRIM16;CASP8;APP;NOD2;TLR4;FZD5;AGER;MALT1;TMEM106A;CD36;EGR1;LPL;NLRP3;HSPB1
prerank,cellular macromolecule catabolic process (GO:0044265),0.22412008784259466,0.6288516089895672,0.9473684210526315,1.0,1.0,9/49,16.23%,SND1;ADAMTS9;PRKN;NGLY1;DNASE1L1;EXOSC7;MTREX;RNASEH2C;NEU4
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.2577295090299194,0.6282337161720465,0.9080645161290323,1.0,1.0,5/21,23.73%,NOS1AP;FLNA;SCN1B;SNTA1;ANK2
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.2997454541283121,0.6274440232373487,0.8836363636363637,1.0,1.0,1/10,4.38%,SLC45A3
prerank,myeloid dendritic cell activation (GO:0001773),-0.2567725285302086,-0.6268471133905498,0.9176470588235294,0.991082883484128,1.0,2/12,9.68%,CAMK4;TGFBR2
prerank,positive regulation of keratinocyte migration (GO:0051549),0.2995239236971825,0.6265257134158811,0.8883161512027491,1.0,1.0,3/10,15.37%,MAP4K4;MAPRE2;ARF6
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.27257013525130575,0.6264734553914918,0.9049235993208828,1.0,1.0,2/16,7.82%,SHOC1;TOP2B
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.24630739037453167,-0.6260248130776884,0.9020100502512562,0.9907150670218358,1.0,5/13,28.46%,SORL1;CD81;TMEM30A;EDEM1;TMEM30B
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.24571746796120478,-0.6258957813015248,0.9451371571072319,0.9899422944649197,1.0,7/13,40.32%,BOLA2;GLRX5;CIAO2B;CIAO2A;ISCA1;LTO1;ISCA2
prerank,snRNA metabolic process (GO:0016073),-0.23179881966792829,-0.6248421529385653,0.9276139410187667,0.9897165065062433,1.0,7/17,33.28%,INTS6;INTS8;INTS1;INTS10;TUT1;ZCCHC8;INTS11
prerank,glial cell development (GO:0021782),0.2537478938481415,0.6247776969264953,0.9246676514032496,1.0,1.0,8/25,19.08%,MT3;CSPG5;EIF2B4;MDK;NSUN5;EIF2B3;SOX11;MXRA8
prerank,negative regulation of macroautophagy (GO:0016242),0.24401357656978342,0.6232702142393347,0.9166666666666666,1.0,1.0,4/26,16.33%,NUPR1;LRRK2;TSC2;AKT1
prerank,spermatid development (GO:0007286),0.23431399311596315,0.6220332741471467,0.9328358208955224,1.0,1.0,3/32,12.27%,GALNTL5;ZMYND15;SYCP3
prerank,natural killer cell mediated immunity (GO:0002228),0.268963562383088,0.621909869143896,0.909688013136289,1.0,1.0,2/15,10.14%,KLRD1;PLEKHM2
prerank,cellular response to ionizing radiation (GO:0071479),0.22200355002904842,0.6216340290389242,0.9479305740987984,1.0,1.0,4/47,6.30%,YAP1;LIG4;MAP3K20;INO80
prerank,cell junction maintenance (GO:0034331),0.2736892581547987,0.6205996500983509,0.9031719532554258,1.0,1.0,2/14,9.41%,CBLN1;MYADM
prerank,cellular response to tumor necrosis factor (GO:0071356),0.18809628244495302,0.6204695626632996,0.9932279909706546,1.0,1.0,12/175,9.62%,ADAMTS12;PID1;CCL19;EDAR;PSME4;SFRP1;ZFP36L1;CCL4;NFE2L2;NR1D1;ACTN4;LTBR
prerank,autophagy of mitochondrion (GO:0000422),0.22840408142416957,0.6169924267001923,0.9418439716312057,1.0,1.0,13/38,22.94%,ULK2;PRKN;USP30;WIPI1;MARK2;MAP1LC3A;BECN1;ATG2B;PHB2;WDR45;ATG9A;FUNDC2;AMBRA1
prerank,regulation of protein sumoylation (GO:0033233),-0.22198960965630693,-0.6169714124219015,0.9401041666666666,0.9934241043884059,1.0,8/17,30.67%,SAE1;RWDD3;EGR1;CAPN3;UBA2;GNL3;CTNNB1;RASD2
prerank,regulation of macroautophagy (GO:0016241),0.19453051376123212,0.6165062161973468,0.9847775175644028,1.0,1.0,31/105,25.11%,DCN;PRKAG2;NEDD4;PRKAA2;LRRK2;SLC38A9;ATP6V1E1;LAMTOR2;RRAGD;TBK1;CLN3;LARP1;TSC2;SESN2;AKT1;WAC;PRKACA;PRKAG1;GPSM1;RHEB;MLST8;ATP13A2;SNX6;UCHL1;ATP6V1B2;HDAC6;ATP6V0D1;PRKAB2;ATP6V1G1;PRKAG3;VPS35
prerank,mitotic DNA replication (GO:1902969),0.28959903224742994,0.6158407278557327,0.8542805100182149,1.0,1.0,6/10,29.91%,MCM2;MCMDC2;LIG1;MCM6;MCM4;GINS1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.2762148204289548,0.6149609894650714,0.8988391376451078,1.0,1.0,2/14,11.06%,AK1;AK8
prerank,serine family amino acid metabolic process (GO:0009069),0.2695977177825481,0.6145609811084203,0.8984238178633975,1.0,1.0,5/16,24.07%,CDO1;PSPH;CBS;SARS1;SEPSECS
prerank,establishment of spindle localization (GO:0051293),0.27313980454936215,0.6145169567738642,0.8807947019867549,1.0,1.0,4/14,22.02%,DYNC1H1;LLGL1;KPNB1;LLGL2
prerank,atrial septum development (GO:0003283),-0.24595311884650833,-0.6135857036617021,0.9320388349514563,0.9945335426804913,1.0,5/13,21.70%,TGFB2;HEY2;ZFPM1;BMPR2;GJA5
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.2827318604266003,0.6132845560177672,0.8867595818815331,1.0,1.0,4/13,14.48%,ATG10;UBA7;SENP6;UBA6
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.2705302471166464,0.6132677132466867,0.882051282051282,1.0,1.0,2/15,8.40%,APOA1;IRAK3
prerank,retinal metabolic process (GO:0042574),0.2859665610187299,0.6125740291643205,0.9006734006734006,1.0,1.0,1/12,5.54%,CYP1B1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.2188249216255334,0.6125618574901003,0.9518413597733711,1.0,1.0,5/42,13.54%,CCL19;CCL4;OXSR1;WNK1;CXCL13
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.26531530707463263,0.6122143760409843,0.9121405750798722,1.0,1.0,6/16,26.37%,IRAK3;CLN3;INSR;GSPT1;HDAC6;UPF1
prerank,macroautophagy (GO:0016236),0.19437268013071116,0.6113074611265283,0.9905325443786982,1.0,1.0,34/118,25.60%,DYNLL1;PRKAG2;PRKAA2;SRC;ATG10;MTMR3;PRKN;PLEKHM1;VPS37D;CLN3;UVRAG;WIPI1;VDAC1;PIK3R4;TOMM22;LAMP2;MAP1LC3A;BECN1;EPG5;PRKAG1;ATG4B;TOMM5;STX17;ATP13A2;RUBCNL;LIX1;TSG101;AMBRA1;PRKAB2;VPS16;PRKAG3;CHMP2A;PIP4K2A;VPS33B
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.2603300970962077,0.6110342244999116,0.8956386292834891,1.0,1.0,4/18,18.60%,MIA3;WNK1;AKT1;VTCN1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.26207999362326395,-0.6101773287451177,0.9197247706422018,0.9955479846603327,1.0,5/10,31.19%,CX3CR1;CEACAM1;PTPRC;LILRB1;FCGR2B
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.20184029380827623,-0.6095517785467741,0.976401179941003,0.995013164588378,1.0,9/27,25.77%,NAAA;PLAAT3;PNPLA8;ETNK1;SELENOI;PLA2G4E;CHKA;ABHD4;PLAAT1
prerank,histone H4 acetylation (GO:0043967),0.2217832183458299,0.6095182758972857,0.9656121045392022,1.0,1.0,10/47,17.85%,OGT;ING3;BRD8;ING5;JADE1;KMT2A;WDR5;TADA3;MSL2;NAA40
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.23832572159347343,0.6094112336141498,0.9221556886227545,1.0,1.0,3/27,8.21%,AGTR1;LPAR1;DRD3
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.15497496213205852,-0.6092561322812539,0.9946524064171123,0.9943068169353445,1.0,33/84,35.80%,ANAPC16;ANAPC15;ANAPC7;PSMF1;PSMB8;PSMA4;PSMB10;PSMB2;UBE2S;BUB1B;FBXO31;PSMC4;CUL3;PSMA6;PSMD9;PSMD11;PSMD5;PSMA8;PSMB1;FZR1;PLK1;CDK1;PSMD10;UBC;RPS27A;CDC20;ANAPC11;PSMC3;UBE2C;PSMD13;SKP2;BUB3;ECRG4
prerank,mitotic sister chromatid segregation (GO:0000070),0.19345228521279742,0.6091026971395365,0.9903730445246691,1.0,1.0,22/98,20.74%,PDS5B;PIBF1;INO80;SPDL1;ZW10;ZWINT;TENT4A;EML4;CHMP5;AKAP8L;PHF8;POGZ;SGO1;SEH1L;NIPBL;BECN1;BOD1;KPNB1;CDCA8;NAA50;CDC23;DSN1
prerank,positive regulation of cilium assembly (GO:0045724),-0.22937319325000846,-0.6087945844695775,0.9405684754521964,0.9937028906507586,1.0,6/18,26.21%,CCDC88A;KCTD17;CEP135;FUZ;HAP1;CCP110
prerank,cellular response to arsenic-containing substance (GO:0071243),0.2694326561044273,0.6084906557816303,0.8943661971830986,1.0,1.0,4/15,20.94%,HNRNPA1;DDX3X;HSF1;PPIF
prerank,proteasome assembly (GO:0043248),-0.2527670027598534,-0.6077390866839605,0.9272727272727272,0.9934100442677011,1.0,6/11,34.81%,PSMD9;PSMD11;PSMD5;POMP;PSMD10;PSMD13
prerank,regulation of lipid storage (GO:0010883),-0.20870815196693146,-0.6076340166656419,0.9476584022038568,0.9926150473213043,1.0,7/22,27.50%,NFKBIA;PTPN2;SIRT1;HILPDA;ALKBH7;MEST;LPL
prerank,regulation of nuclear division (GO:0051783),0.2552565713348991,0.6070759191556383,0.9098639455782312,1.0,1.0,1/20,2.03%,OBSL1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.24134225137779,0.6063468783327418,0.9375,1.0,1.0,4/28,9.33%,NUPR1;CDK5RAP3;RNF139;PRKN
prerank,global genome nucleotide-excision repair (GO:0070911),-0.2007019460218803,-0.6059096952448154,0.9752747252747253,0.9926348150379107,1.0,10/26,31.29%,RBX1;GTF2H1;DDB2;CETN2;PARP1;RNF111;CHD1L;UBC;RPS27A;XPC
prerank,positive regulation of DNA recombination (GO:0045911),0.23631355619293926,0.6052035271224553,0.9385560675883257,1.0,1.0,10/27,27.75%,KMT5B;MRNIP;HMCES;SHLD3;TIMELESS;ARID2;ERCC2;FUS;MMS19;FANCB
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.241692784357728,-0.6051390935364863,0.9424778761061947,0.9921777635200777,1.0,7/13,39.70%,NOL9;RPS21;RRS1;TSR1;RPP40;UTP20;NOP9
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.2843730376158564,0.6044243911553594,0.8947368421052632,1.0,1.0,6/11,30.80%,EBI3;STAT4;CANX;STAT1;IL6ST;IL12RB2
prerank,positive regulation of interleukin-17 production (GO:0032740),0.24797090284239603,0.6042971174076465,0.9448946515397083,1.0,1.0,5/22,17.97%,RFTN1;IL12B;CARD9;IL23A;IL18
prerank,regulation of B cell differentiation (GO:0045577),0.2612589455267334,0.604109694654003,0.9284552845528455,1.0,1.0,2/17,5.78%,SFRP1;ZFP36L1
prerank,V(D)J recombination (GO:0033151),-0.25531949606543747,-0.6026755878694013,0.9548693586698337,0.9926084555423041,1.0,4/11,23.07%,TCF3;PRKDC;HMGB2;DCAF1
prerank,protein-containing complex disassembly (GO:0032984),0.2096399636052846,0.6024427375544018,0.9759679572763685,1.0,1.0,14/54,21.88%,WNT8B;FZD2;FZD1;CLN3;UVRAG;LAMP2;MAP1LC3A;CSNK1A1;EPG5;FRAT1;STX17;RUBCNL;LIX1;TSG101
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.21351321590195652,-0.6016973413797974,0.9539295392953929,0.992253727060356,1.0,2/21,5.76%,GPI;HK2
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.2210015890761254,0.6008989567203857,0.9622093023255814,1.0,1.0,3/39,6.57%,OGG1;GTF2H5;CUL4B
prerank,defense response to symbiont (GO:0140546),0.19281562820186318,0.6004593020244664,0.9854545454545455,1.0,1.0,14/92,17.17%,BCL2;MLKL;IRF1;OAS2;STAT2;RNASEL;IFI27;ABCE1;IFIT2;FLNA;SERINC3;IFI44L;TTC4;IRF2
prerank,apoptotic DNA fragmentation (GO:0006309),0.26092642477578365,0.5994567940547282,0.9351701782820098,1.0,1.0,5/16,18.90%,DNASE2;CECR2;KPNA1;KPNB1;DICER1
prerank,exit from mitosis (GO:0010458),-0.23582280524523033,-0.5994320905048943,0.9254807692307693,0.9925023716813942,1.0,4/12,32.44%,UBE2S;CLASP1;CHMP4B;UBE2C
prerank,regulation of interleukin-8 production (GO:0032677),0.2023273425719899,0.5993732848705575,0.973753280839895,1.0,1.0,8/69,13.01%,SERPINE1;IL17D;MAPKBP1;TLR6;ARRB1;CD33;CD14;SSC5D
prerank,regulation of lysosomal lumen pH (GO:0035751),0.27098683909645016,0.5992899868845516,0.9165217391304348,1.0,1.0,3/12,14.77%,LRRK2;CLN3;ATP6AP2
prerank,mismatch repair (GO:0006298),-0.19260596645752986,-0.5989189537803068,0.9691011235955056,0.9918933180842872,1.0,10/27,34.32%,MSH3;PMS2;PMS1;POLD4;MSH2;EXO1;POLD2;XPC;RPA2;MLH3
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.1952292402581738,0.5984863701000885,0.9850187265917603,1.0,1.0,6/85,6.16%,FZD2;SMURF2;PRICKLE1;PSME4;FZD1;CDC42
prerank,mRNA metabolic process (GO:0016071),0.19199787973306526,0.5974811954191492,0.986318407960199,1.0,1.0,28/90,25.49%,SON;DXO;HNRNPR;NONO;PRMT9;TCERG1;SRSF5;AKAP8L;NUDT16L1;PCF11;GEMIN2;SF3B2;LSM10;METTL3;PRKACA;HSF1;YTHDF2;AGO4;ZFP36L2;NUDT12;NCBP2;PRPF8;SFPQ;METTL16;AGO3;SNRPE;CNOT10;RNASE4
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.22836939989551364,0.5964006461765078,0.9468085106382979,1.0,1.0,6/28,19.35%,KMT5B;MRNIP;NUDT16L1;SHLD3;SMCHD1;HSF1
prerank,positive regulation of cell cycle (GO:0045787),0.20213209322091188,0.5949704817413616,0.9747003994673769,1.0,1.0,15/62,21.06%,FGFR2;NUPR1;SMOC2;TBX3;EGFR;FOXA1;RGCC;AKT1;PRKCA;TRIM32;CDKN1B;HSF1;TRIM21;CCND2;PKN2
prerank,positive regulation of type I interferon production (GO:0032481),-0.15585345697771127,-0.5949180522151073,1.0,0.9929784673513258,1.0,16/73,22.14%,IFIH1;TOMM70;LRRFIP1;POLR3H;CGAS;G3BP1;PTPN22;PRKDC;IRF5;EP300;DDX41;TLR4;POLR2E;DHX9;CHUK;CRCP
prerank,regulation of lipase activity (GO:0060191),0.2685499058380414,0.5944820169676106,0.9211908931698775,1.0,1.0,13/13,73.17%,LMF1;PCSK5;FURIN;ANGPTL3;RHOA;SNCA;APOA2;ANGPTL8;PLIN5;RHOC;PCSK6;LPL;LIPC
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.26158382502171834,-0.5940455473726385,0.9311163895486936,0.9925267795630172,1.0,2/10,11.74%,KDM1A;SIRT1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.20769220080613748,-0.5937167443812676,0.9546599496221663,0.9918140348889843,1.0,4/19,17.73%,LBP;PIK3AP1;PRKCE;TLR4
prerank,defense response to virus (GO:0051607),0.18856482654333126,0.5930371601446307,0.9904191616766467,1.0,1.0,28/100,26.09%,BCL2;MLKL;IRF1;OAS2;STAT2;RNASEL;IFI27;ABCE1;IFIT2;FLNA;SERINC3;IFI44L;TTC4;IRF2;RNF135;PHB2;NDUFAF4;RSAD2;MYD88;AGBL5;ZBP1;ZDHHC1;PMAIP1;STAT1;FADD;MAVS;AKAP1;RELA
prerank,protein localization to centrosome (GO:0071539),0.26131390736735993,0.5929398198565085,0.9239669421487603,1.0,1.0,2/17,6.20%,GOLGB1;PIBF1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.19566203759698728,0.5906181566805566,0.9895697522816167,1.0,1.0,17/73,20.65%,RUNX1;YAP1;PSME4;SETD1A;METTL14;ITCH;KMT2A;TCF12;PSMB5;PSMC2;METTL3;PSMD1;PSMD4;PSME3;YTHDF2;FOXC1;PSMA3
prerank,CENP-A containing chromatin organization (GO:0061641),-0.18956941264049976,-0.5897659855901588,0.9815384615384616,0.9919207697730207,1.0,10/29,29.15%,MIS18BP1;KNL1;RUVBL1;RSF1;NPM1;CENPI;CENPN;NASP;HJURP;ITGB3BP
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.18956941264049976,-0.5897659855901588,0.9815384615384616,0.9919207697730207,1.0,10/29,29.15%,MIS18BP1;KNL1;RUVBL1;RSF1;NPM1;CENPI;CENPN;NASP;HJURP;ITGB3BP
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.2313886326730171,0.5889059439920011,0.9423368740515933,1.0,1.0,5/28,12.85%,IRAK2;AAMP;ITCH;RIPK2;MAP2K6
prerank,cilium movement (GO:0003341),0.20936923188506187,0.5888384745741274,0.967741935483871,1.0,1.0,8/47,16.15%,CFAP73;DNAAF1;DNAI3;CCDC40;CABYR;CFAP53;DNAAF5;SPEF2
prerank,negative regulation of T cell proliferation (GO:0042130),-0.188251376377696,-0.5887181207157343,0.9798850574712644,0.9915194520057715,1.0,8/28,27.14%,PRKAR1A;SCRIB;TNFRSF21;CD80;CD86;LILRB1;IL4I1;PRNP
prerank,dopaminergic neuron differentiation (GO:0071542),0.24603191031509303,0.5885077644666348,0.9350237717908082,1.0,1.0,4/19,16.72%,FOXA1;RYK;MANF;SHH
prerank,Golgi to lysosome transport (GO:0090160),0.27857423760704203,0.5881989849812869,0.905693950177936,1.0,1.0,2/11,11.91%,RBSN;CLN3
prerank,cytoplasmic microtubule organization (GO:0031122),0.20418668555029265,0.5873615779145324,0.9815303430079155,1.0,1.0,3/54,5.66%,FIGN;CLIP4;DYNC1H1
prerank,necroptotic process (GO:0070266),0.2524265433936783,0.5865870885839818,0.9282218597063622,1.0,1.0,2/16,12.98%,MLKL;CD14
prerank,cellular response to leucine starvation (GO:1990253),0.2800400089385563,0.5865649196492934,0.9277777777777778,1.0,1.0,3/10,15.24%,RRAGD;IMPACT;SESN2
prerank,apoptotic nuclear changes (GO:0030262),0.23638342873942453,0.5861638671740356,0.9476923076923077,1.0,1.0,6/24,18.90%,CDK5RAP3;DNASE2;CECR2;KPNA1;KPNB1;DICER1
prerank,aromatic amino acid family metabolic process (GO:0009072),0.281389087626553,0.5850871740189637,0.9353146853146853,1.0,1.0,1/10,6.78%,KYNU
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.21532011142968843,0.5842182522681241,0.9618768328445748,1.0,1.0,9/36,17.73%,CBX3;RBBP7;L3MBTL2;YAF2;RNF2;CBX5;TFDP1;APAF1;CDC7
prerank,cellular response to estradiol stimulus (GO:0071392),-0.21682456729173005,-0.5832361595292199,0.9754098360655737,0.993016391238311,1.0,2/18,5.60%,ESR1;NRIP1
prerank,protein catabolic process (GO:0030163),0.20225935489957417,0.5824730266802642,0.9710144927536232,1.0,1.0,7/59,9.86%,APOE;ADAMTS9;CUL4B;NR1D1;CLPX;PRKN;NGLY1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.20238826126397347,0.5822865677388513,0.9774535809018567,1.0,1.0,10/51,17.56%,SRC;HNRNPA1;PARN;FBXO4;TERF2;TNKS2;TENT4B;HNRNPC;ATM;NAF1
prerank,receptor recycling (GO:0001881),-0.2472819885651591,-0.5815764590799571,0.9494252873563218,0.9928672899660338,1.0,3/10,20.90%,SORL1;LMTK2;EHD3
prerank,protein acylation (GO:0043543),0.21734782642206976,0.5815655394838957,0.9659574468085106,1.0,1.0,3/38,8.84%,GLUL;ING5;KAT2B
prerank,telomere maintenance (GO:0000723),0.2069985402623258,0.581532867718181,0.9707446808510638,1.0,1.0,7/50,14.38%,SP100;SMC5;SMC6;TERF2;TEP1;RAD51D;RTEL1
prerank,protein acetylation (GO:0006473),0.22184070721155796,0.5797886770984332,0.9646017699115044,1.0,1.0,7/30,19.21%,ING5;KAT2B;BLOC1S1;KAT5;NAA40;NAA80;NAA50
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.2339598332273396,-0.5788732998653491,0.9333333333333333,0.9931264948311102,1.0,1/11,5.10%,TOMM70
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.20544372914378278,-0.577919158444228,0.9676616915422885,0.9927057480306027,1.0,6/19,29.11%,CEP97;PDCD6IP;CHMP2B;CHMP4B;PLK1;CHMP4C
prerank,carboxylic acid catabolic process (GO:0046395),0.26834473667691916,0.5774115729044197,0.9090909090909091,1.0,1.0,12/12,73.19%,RENBP;BCKDK;NAGK;GNPDA1;NPL;ACOT4;PON1;ACOT8;AMDHD2;GNPDA2;PON3;IL4I1
prerank,RNA interference (GO:0016246),0.24583440193369585,0.5761470517408701,0.9301948051948052,1.0,1.0,7/17,24.47%,PRKRA;TSNAX;DICER1;NRDE2;AGO4;DROSHA;AGO3
prerank,Golgi to endosome transport (GO:0006895),0.24721167849696016,0.5757468919844456,0.9191419141914191,1.0,1.0,6/16,22.60%,MON2;EPS15;WIPI1;VPS13C;SORT1;KLHL20
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.21784252252596903,0.5756759146029093,0.963855421686747,1.0,1.0,5/31,12.72%,TIMM17B;AIFM1;TIMM44;PEX6;PEX2
prerank,ubiquinone biosynthetic process (GO:0006744),0.2542870881945209,0.5750450933416655,0.9265442404006677,1.0,1.0,4/15,19.53%,UBIAD1;COQ10B;NDUFA9;COQ7
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.2754141639571339,0.5744955820013153,0.9129662522202486,1.0,1.0,2/10,12.30%,TUT7;TUT4
prerank,DNA conformation change (GO:0071103),0.24671189681420896,0.5734974999685898,0.931323283082077,1.0,1.0,2/17,7.82%,TOP3B;TOP2B
prerank,peptidyl-methionine modification (GO:0018206),0.2632280237958394,0.5730673038811115,0.924114671163575,1.0,1.0,1/12,4.31%,APOA1
prerank,regulation of lymphocyte proliferation (GO:0050670),0.25279481198956916,0.5724580063470545,0.9363784665579119,1.0,1.0,5/16,25.88%,IL12B;SOX11;TNFSF9;AHR;TNFRSF1B
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.2248518964960887,0.5718583738195061,0.9537313432835821,1.0,1.0,5/29,13.03%,DCST1;STAT2;RNASEL;ABCE1;MUL1
prerank,centromere complex assembly (GO:0034508),-0.17618636908597102,-0.5717170891110733,0.9867109634551495,0.9943052426195779,1.0,12/36,29.15%,MIS18BP1;KNL1;RUVBL1;RSF1;NPM1;CENPI;CENPN;CENPF;NASP;HJURP;DLGAP5;ITGB3BP
prerank,histone deubiquitination (GO:0016578),0.24139690480104087,0.5710543388600974,0.9317073170731708,1.0,1.0,6/18,21.33%,ATXN7L3;UIMC1;USP49;BRCC3;USP3;ATXN7
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.1955084914979963,0.5704096007431136,0.9919246298788694,1.0,1.0,22/61,29.39%,FGFR4;PRKAG2;PSME4;NCOR2;PSMB5;PSMC2;OAZ3;PSMD1;SIRT5;PSMD4;PSME3;PSMA3;PSMA2;PSMC5;PDK4;PSMB9;PSMD12;PSMB4;PANK2;PPARA;ODC1;PSMB7
prerank,regulation of biosynthetic process (GO:0009889),0.26631913969632404,0.5694374665640765,0.9289520426287744,1.0,1.0,2/11,15.39%,SPHK2;PIKFYVE
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.26189377627545246,0.5678454026448649,0.9380378657487092,1.0,1.0,2/13,12.23%,OAS2;EBI3
prerank,DNA replication (GO:0006260),0.17922523555916126,0.5661489669882973,0.9987878787878788,1.0,1.0,7/105,9.81%,RBMS1;PCLAF;ING5;POLG;POLL;RECQL5;POLE3
prerank,signal peptide processing (GO:0006465),0.262297398668607,0.5659248629610322,0.9337979094076655,1.0,1.0,6/11,31.44%,SEC11C;SEC11A;SPCS2;PCSK5;HM13;FURIN
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.24408990145252324,0.5659168950361316,0.9406919275123559,1.0,1.0,5/18,18.74%,SFRP1;SKI;PEX2;CDC73;TRIM32
prerank,leukotriene biosynthetic process (GO:0019370),-0.2175640856065822,-0.5657460066862103,0.9605911330049262,0.9956791989624828,1.0,6/14,31.69%,GGT5;GGTA1;GGT1;PLA2G5;ALOX5;GGT7
prerank,regulation of oxidoreductase activity (GO:0051341),0.2595902539887168,0.5655451258121704,0.9334500875656743,1.0,1.0,1/13,4.57%,MT3
prerank,tyrosine metabolic process (GO:0006570),0.2683278935475773,0.564436958370734,0.9347079037800687,1.0,1.0,11/11,73.19%,FAH;GSTZ1;TYR;HGD;TAT;TH;PAH;THAP4;IYD;DCT;IL4I1
prerank,protein import into peroxisome membrane (GO:0045046),-0.1920038386302739,-0.5642442645126546,0.97911227154047,0.9953641644595839,1.0,8/22,26.76%,RAB8B;PEX26;ABCD3;PEX12;FIS1;PEX16;PEX5;PXMP4
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.24556783210415592,0.5638800306079975,0.9414634146341463,1.0,1.0,4/16,22.99%,RBM22;DDX23;NCBP2;SART1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.27071228419730453,0.5634463389299414,0.9253996447602132,1.0,1.0,1/10,4.94%,KLF15
prerank,sulfur amino acid catabolic process (GO:0000098),-0.24148448739391754,-0.5633373928133277,0.9474885844748858,0.9948551162253567,1.0,3/10,25.57%,BLMH;MPST;MTRR
prerank,cellular response to lipopolysaccharide (GO:0071222),0.17921284047018968,0.5618643261709771,0.9927095990279465,1.0,1.0,16/101,18.62%,SERPINE1;LYN;AXL;NR1D1;TNIP2;SELENOS;PDCD4;PAF1;CD14;CHMP5;CXCL13;NR1H3;IL18;CASP1;CDC73;TRIM41
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.21717341951709432,0.5616636822416047,0.9670658682634731,1.0,1.0,4/27,12.66%,MAP3K20;MAP3K8;TNIP2;BTRC
prerank,metallo-sulfur cluster assembly (GO:0031163),0.23376651135414825,0.5605888263060071,0.951937984496124,1.0,1.0,5/22,16.13%,IBA57;NUBPL;HSPA9;NFU1;LYRM4
prerank,regulation of G0 to G1 transition (GO:0070316),0.20413416867701978,0.5605664745926285,0.9711815561959655,1.0,1.0,9/38,17.73%,CBX3;RBBP7;L3MBTL2;YAF2;RNF2;CBX5;TFDP1;APAF1;CDC7
prerank,axoneme assembly (GO:0035082),0.2127606103204976,0.559902171762829,0.9663250366032211,1.0,1.0,4/30,12.43%,SPAG1;DNAAF1;CFAP46;CCDC40
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.25875691620388985,0.5598445971336284,0.9431616341030196,1.0,1.0,3/12,17.31%,CDA;UPP2;DCK
prerank,mitotic nuclear division (GO:0140014),0.18748453537813545,0.5590798917681518,0.9936708860759493,1.0,1.0,18/71,22.74%,PIBF1;INO80;ZW10;ZWINT;KLHDC8B;ARHGEF10;FLNA;CEP192;SGO1;KPNB1;CDCA8;AAAS;DSN1;NDE1;EPS8;ABRAXAS2;TUBG2;TUBG1
prerank,organelle transport along microtubule (GO:0072384),0.21392094444638407,0.5590123590305148,0.9698795180722891,1.0,1.0,9/31,23.45%,ARHGAP21;CDC42;RHOT1;CLN3;COPG1;HTT;NDE1;FBXW11;TMEM201
prerank,cellular response to misfolded protein (GO:0071218),0.2347202697737001,0.5581735744935905,0.9592833876221498,1.0,1.0,4/20,15.93%,DERL1;RNF185;UGGT2;AUP1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.23236254079839316,-0.5574416822468342,0.9574468085106383,0.9960947221864453,1.0,11/11,76.79%,CAMK4;STAP1;ITGB2;F2RL1;CD177;TYROBP;SPI1;TICAM1;MAVS;STX4;ITGAM
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.25833058646562823,0.5569937520968653,0.9226713532513181,1.0,1.0,3/11,18.66%,CTPS2;DCK;SLC25A19
prerank,RNA catabolic process (GO:0006401),0.19645037250570313,0.5566119733632215,0.9791955617198336,1.0,1.0,15/46,25.29%,SND1;DXO;EXOSC7;MTREX;NUDT16L1;RNASEH2C;METTL3;YTHDF2;AGO4;ZFP36L2;NUDT12;SIDT2;METTL16;AGO3;CNOT10
prerank,double-strand break repair via homologous recombination (GO:0000724),0.1782755058806002,0.5562948096114508,0.9987878787878788,1.0,1.0,32/95,27.75%,ZSWIM7;INO80;RAD51B;SMC5;POLL;RECQL5;SMC6;MCM2;RAD51D;XRCC2;RNF138;AP5Z1;CDC7;NIPBL;GINS4;RAD54L;MCMDC2;NSMCE2;FAN1;EXD2;BRCA1;SFPQ;NABP2;RAD51AP2;MRE11;MCM6;SWI5;RAD50;TONSL;UBE2N;RECQL;FANCB
prerank,spindle assembly (GO:0051225),0.1877162539843888,0.5545842120476198,0.9947643979057592,1.0,1.0,18/67,22.61%,PIBF1;INO80;NCOR1;MAPRE2;NEK6;ARHGEF10;HAUS1;GOLGA8B;HAUS7;FLNA;HAUS3;CEP192;KPNB1;NUMA1;AAAS;ABRAXAS2;HAUS5;HAUS6
prerank,regulation of autophagosome maturation (GO:1901096),0.25051088486826073,0.5544970020361171,0.9345335515548282,1.0,1.0,2/13,12.10%,CLN3;UVRAG
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.23376556656695147,0.5544134625201016,0.9534109816971714,1.0,1.0,2/17,6.92%,IL12B;KLRD1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.26025030838238605,0.5532198209078677,0.9489603024574669,1.0,1.0,2/10,12.09%,SIRT2;IMPACT
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.1920478555937592,-0.5526840686637517,0.9764397905759162,0.9968487419268026,1.0,9/22,31.29%,RBX1;GTF2H1;DDB2;CETN2;PARP1;CHD1L;UBC;RPS27A;XPC
prerank,regulation of interleukin-17 production (GO:0032660),0.20851042311294626,0.552071990864644,0.9683453237410072,1.0,1.0,8/31,22.81%,RFTN1;IL12B;CARD9;IL23A;IL18;DDIT3;MYD88;NCKAP1L
prerank,aerobic respiration (GO:0009060),0.2276513433360436,0.5480813517468935,0.9524590163934427,1.0,1.0,3/20,9.82%,MDH2;BLOC1S1;SDHC
prerank,P-body assembly (GO:0033962),0.25502013792216033,0.5475324226524204,0.9428571428571428,1.0,1.0,3/12,18.32%,DYNC1H1;PATL1;RC3H1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.1886640987268148,0.5469475771451712,0.9892183288409704,1.0,1.0,7/53,13.66%,APOE;NUPR1;ARAF;COMMD1;PRKN;UFL1;GLMN
prerank,cellular response to virus (GO:0098586),0.20980631618094808,0.5467306180914099,0.9744744744744744,1.0,1.0,5/30,14.23%,CCL19;VWCE;DDX3X;GSDME;RIOK3
prerank,regulation of isotype switching (GO:0045191),-0.21138195229373266,-0.5464800432732939,0.965034965034965,0.9979879620017945,1.0,4/14,25.33%,TFRC;SHLD1;SHLD2;SLC15A4
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.24340212225413113,0.5463749740106456,0.9430485762144054,1.0,1.0,3/15,12.01%,BAIAP3;CLN3;STXBP1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.1825975703426306,-0.5461492430045803,0.9867724867724867,0.9972518041096583,1.0,4/23,14.41%,RBX1;COPS7A;DDB2;CETN2
prerank,positive regulation of lipid catabolic process (GO:0050996),0.23031641949877385,0.5457157066846406,0.9623287671232876,1.0,1.0,2/19,14.23%,APOA1;ABCD2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.23073805175267087,-0.5456529031360167,0.9576470588235294,0.9965626598379709,1.0,4/11,22.32%,MBTPS2;ATF6B;ATF3;ATF4
prerank,DNA duplex unwinding (GO:0032508),0.1884186637435786,0.5447444628174405,0.986130374479889,1.0,1.0,18/50,28.43%,GTF2H5;CUL4B;RECQL5;ASCC3;MCM2;RTEL1;DDX1;XPA;MCMDC2;ERCC3;ERCC2;MRE11;MCM6;RAD23B;RAD50;RECQL;GTF2H2;RPA1
prerank,midbody abscission (GO:0061952),0.2366032339623001,0.5417585983740749,0.9543230016313213,1.0,1.0,2/17,13.17%,KIF20A;CHMP5
prerank,interstrand cross-link repair (GO:0036297),0.18718943603051277,0.5410814272732458,0.9879194630872483,1.0,1.0,15/53,25.66%,ERCC6L2;DCLRE1C;EXO5;DCLRE1A;FANCC;FANCE;FANCI;XPA;FAN1;UBE2T;FANCA;CENPX;MSH6;RAD51AP2;ATRIP
prerank,chromatin remodeling at centromere (GO:0031055),-0.17134713012335187,-0.5406486190396563,0.9938271604938271,0.997223911546927,1.0,10/31,29.15%,MIS18BP1;KNL1;RUVBL1;RSF1;NPM1;CENPI;CENPN;NASP;HJURP;ITGB3BP
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.23643391769305927,0.5406176011984415,0.9547826086956521,1.0,1.0,2/16,6.92%,IL12B;KLRD1
prerank,positive regulation of exosomal secretion (GO:1903543),-0.207280097668605,-0.539864692218131,0.9593908629441624,0.9966151042279522,1.0,5/15,26.47%,SDCBP;PDCD6IP;VPS4A;SNF8;HGS
prerank,serine family amino acid biosynthetic process (GO:0009070),0.2424511625407192,0.5385400580148656,0.9556737588652482,1.0,1.0,4/12,21.20%,PSPH;SERINC3;PHGDH;CBS
prerank,RNA 3'-end processing (GO:0031123),0.17995987763883836,0.5380158668954886,0.9961685823754789,1.0,1.0,16/69,22.42%,U2AF1L4;THOC2;TUT7;DDX39A;WDR33;TENT4A;MAGOHB;TUT4;SRSF5;PCF11;TENT4B;CPSF2;FIP1L1;SRSF3;PAPOLA;NCBP2
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.232749419225215,0.5378704727826733,0.9421221864951769,1.0,1.0,16/16,76.75%,ETS1;MDK;NFAT5;RELA;IL6;IRAK1;FUT7;RHOA;ITGB2;SELE;TNF;FUT4;ALOX5;TRAF6;SELP;ST3GAL4
prerank,telomere capping (GO:0016233),0.23616015193994733,0.5367893529020973,0.9608482871125612,1.0,1.0,3/16,12.18%,DCLRE1C;DCLRE1A;TERF2
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.21701002779981252,-0.536748096166255,0.9618834080717489,0.9966441141858186,1.0,6/12,32.95%,PAICS;IMPDH1;ATIC;IMPDH2;ADSS2;GMPS
prerank,microtubule polymerization (GO:0046785),0.20550813640379956,0.5362713548165039,0.9782608695652174,1.0,1.0,7/28,22.74%,RANBP9;FGF13;HDGFL3;SLAIN2;NDE1;TUBG2;TUBG1
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.15850940213886866,-0.5355713093565416,0.9966996699669967,0.996149238796616,1.0,15/42,30.77%,TRIM25;POLH;SIRT1;POLN;POLD4;POLK;WRNIP1;DTL;FAAP20;VCP;ISG15;POLA1;UBC;RPS27A;POLD2
prerank,regulation of exit from mitosis (GO:0007096),0.1956188344541019,0.535098091400442,0.9860917941585535,1.0,1.0,13/38,27.45%,ZW10;NPM2;SIRT2;ANAPC5;RGCC;UBE2D1;PHB2;CDC23;ANAPC4;CDC14B;UBE2E1;ANAPC2;CDC16
prerank,regulation of spindle assembly (GO:0090169),0.21396185793723338,0.5334912584635397,0.9654088050314465,1.0,1.0,7/25,22.00%,DYNC1H1;CHMP5;SENP6;TPR;NUMA1;HNRNPU;CCSAP
prerank,regulation of B cell activation (GO:0050864),0.21363410039724673,0.5331839242362646,0.9656203288490284,1.0,1.0,3/25,11.60%,ZFP36L1;THEMIS2;TNIP2
prerank,positive regulation of chemokine production (GO:0032722),0.1912417171577242,0.5322508681006224,0.9858757062146892,1.0,1.0,3/44,11.00%,IL6R;TSLP;DDX3X
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.2118385242835122,-0.5317352543180641,0.9620535714285714,0.9963023173855271,1.0,1/12,3.78%,STX3
prerank,mitochondrion transport along microtubule (GO:0047497),-0.21338262263353125,-0.5314605518085266,0.9646464646464646,0.9955434163557594,1.0,2/13,15.15%,SYBU;HIF1A
prerank,regulation of mitochondrial translation (GO:0070129),-0.18289718375946623,-0.5287250496187054,0.9840848806366048,0.9953733177385184,1.0,9/21,34.89%,MALSU1;COA3;FASTKD2;C1QBP;NSUN3;TRMT10C;MTG2;NGRN;TSFM
prerank,regulation of cell cycle process (GO:0010564),0.16699052637042514,0.5285675217982472,1.0,1.0,1.0,6/104,6.16%,OBSL1;SND1;KIF20A;SFRP1;DYNC1H1;CDC42
prerank,regulation of superoxide anion generation (GO:0032928),-0.20190951974443083,-0.5285673799884038,0.9823232323232324,0.9945872304880514,1.0,11/14,52.49%,TGFB1;SOD1;MAPT;GSTP1;ITGB2;F2RL1;CD177;SYK;TYROBP;FPR2;CRP
prerank,programmed necrotic cell death (GO:0097300),0.22199372585578842,0.5284867820232981,0.9639344262295082,1.0,1.0,1/18,3.22%,MLKL
prerank,2-oxoglutarate metabolic process (GO:0006103),0.2394538264621181,0.5280093085863594,0.9490662139219015,1.0,1.0,4/13,22.02%,ADHFE1;IDH2;PHYH;L2HGDH
prerank,protein insertion into ER membrane (GO:0045048),0.19775995074935387,0.5273894036336079,0.9885386819484241,1.0,1.0,4/37,11.44%,TRAM2;CYB5A;EMC6;TRAM1
prerank,organelle fusion (GO:0048284),0.2137438903786125,0.5253039172596464,0.9609375,1.0,1.0,6/22,25.23%,MIGA2;USP30;AFG3L2;OPA1;STX4;VPS11
prerank,microtubule nucleation (GO:0007020),0.22068495138144292,0.5248265345190681,0.9640062597809077,1.0,1.0,7/19,28.76%,RANBP9;SLAIN2;NDE1;TUBG2;TUBG1;TPPP;CCDC57
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.2462470570679718,0.5229085898764624,0.9486725663716814,1.0,1.0,3/11,22.90%,PARN;TENT4B;EXOSC2
prerank,quinone biosynthetic process (GO:1901663),0.23693811415582183,0.5223436877158383,0.9505119453924915,1.0,1.0,2/14,9.90%,UBIAD1;COQ10B
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.21303355483790148,0.521222329301843,0.968944099378882,1.0,1.0,8/20,25.73%,EGFR;TTBK1;RGCC;AKT1;CCND2;CCNY;PKD2;MAPRE3
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.21677818345707012,-0.5197631247479839,0.977116704805492,0.9959052827551955,1.0,7/11,40.18%,CRY1;EP300;C1QTNF12;C1QTNF3;CLK2;PGP;ERFE
prerank,signal transduction in response to DNA damage (GO:0042770),0.18226974887605185,0.5186843099668054,0.9892037786774629,1.0,1.0,11/49,20.24%,MAP3K20;NDRG1;BATF;USP10;SESN2;CASP9;ATM;ATRX;CLSPN;MDM4;STK33
prerank,estrogen metabolic process (GO:0008210),0.22894141382683372,0.518681671038958,0.952054794520548,1.0,1.0,1/15,5.54%,CYP1B1
prerank,mitochondrial membrane organization (GO:0007006),0.19872504797283197,0.5184176209600402,0.9777777777777777,1.0,1.0,3/32,13.86%,BCL2;MICOS10;HSPA9
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.2107579811966958,0.5180814489099539,0.9804241435562806,1.0,1.0,2/21,6.57%,GTF2H5;CUL4B
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.2107579811966958,0.5180814489099539,0.9804241435562806,1.0,1.0,2/21,6.57%,GTF2H5;CUL4B
prerank,peroxisomal membrane transport (GO:0015919),0.20584892141967745,0.5178915554617662,0.9826771653543307,1.0,1.0,8/27,23.71%,PXMP2;PEX6;PEX2;ABCD2;PEX11B;PEX7;PEX1;ATAD1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.19532424045596428,0.5170796498363831,0.9855072463768116,1.0,1.0,7/35,17.56%,HNRNPA1;PARN;FBXO4;TNKS2;RTEL1;ATM;NAF1
prerank,microtubule bundle formation (GO:0001578),0.18768557641795752,0.5161289737041553,0.9942446043165467,1.0,1.0,4/42,12.43%,NCKAP5;KIF20A;CFAP46;CCDC40
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.24066403752062404,0.5156861217291662,0.9621993127147767,1.0,1.0,4/12,25.85%,UVRAG;INSR;SETX;JMJD4
prerank,cellular response to oxygen levels (GO:0071453),-0.22255695725852004,-0.5137053493383626,0.9801324503311258,0.9964218855335026,1.0,10/10,77.76%,ATP6V0A2;PICK1;CCDC115;NDUFS2;TMEM199;ATP6V1A;ATP6AP1;ATP6V1G1;ATP6V0D1;CPEB4
prerank,positive regulation of chromatin organization (GO:1905269),-0.2079866093664134,-0.5135762659896079,0.982367758186398,0.9956134019046519,1.0,2/12,14.36%,TAL1;H3-3A
prerank,mitochondrion distribution (GO:0048311),0.2350607334010438,0.513492973880294,0.9640933572710951,1.0,1.0,1/12,6.60%,LRRK2
prerank,hydrogen peroxide catabolic process (GO:0042744),0.24484823682420864,0.5125586850306787,0.9601449275362319,1.0,1.0,3/11,23.25%,GPX3;PRDX4;PXDN
prerank,T cell activation involved in immune response (GO:0002286),0.2358811415475494,0.5125390902570476,0.949740034662045,1.0,1.0,3/12,19.44%,IFNK;MDK;ICAM1
prerank,negative regulation by host of viral transcription (GO:0043922),0.23642107594640144,0.5122144237258259,0.9505962521294719,1.0,1.0,3/12,18.57%,CCL4;REST;POU2F3
prerank,intracellular protein transmembrane transport (GO:0065002),0.18364654567374242,0.5119742375890488,0.99,1.0,1.0,14/42,27.24%,TIMM17B;AIFM1;TIMM44;PEX6;PEX2;PEX7;SEC61A1;PEX1;HSPA5;PAM16;ROMO1;RTN2;DNLZ;DNAJC15
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.22740714697511927,0.5112717530578661,0.9676320272572402,1.0,1.0,12/13,64.06%,SPHK2;ITGAM;STX4;KLRC2;GAB2;SYK;CD177;F2RL1;AP1G1;LAMP1;ITGB2;IL4
prerank,lipoxygenase pathway (GO:0019372),-0.19856488386353732,-0.5081566546976178,0.9633507853403142,0.9959222195754664,1.0,5/14,28.63%,GPX4;PTGS2;GPX1;ALOX5;PON3
prerank,iron-sulfur cluster assembly (GO:0016226),0.20862620927227413,0.5073590222621676,0.9817351598173516,1.0,1.0,9/24,26.36%,IBA57;NUBPL;HSPA9;NFU1;LYRM4;GLRX3;NUBP2;NUBP1;MMS19
prerank,ubiquinone metabolic process (GO:0006743),0.22508016284392457,0.5069643092100746,0.9586776859504132,1.0,1.0,2/15,9.90%,UBIAD1;COQ10B
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.19196391273628247,-0.5055607654394269,0.9803439803439803,0.9956087283344086,1.0,6/14,27.10%,CARD14;TNFRSF10B;TRAF2;MAP3K7;MALT1;TRAF6
prerank,replication fork processing (GO:0031297),0.1896061587012763,0.5052491112237406,0.9902777777777778,1.0,1.0,18/38,33.01%,BOD1L1;RTEL1;PRIMPOL;ATRX;ZGRF1;ETAA1;EXD2;EME2;CENPX;MRE11;TONSL;PCNA;DNA2;CDK9;DDX11;NUCKS1;THOC1;BLM
prerank,telomere organization (GO:0032200),-0.14641484970202617,-0.5048900766616373,1.0,0.994906348531644,1.0,22/43,42.43%,DCLRE1B;CTC1;H3-3A;HUS1;PRKDC;NBN;PARP1;POLD4;HUS1B;APEX1;POLD2;TERT;RPA2;STN1;DOT1L;RECQL4;RIF1;LTO1;TERF2IP;ACD;TINF2;XRCC6
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.21381685489902036,0.5034775844637803,0.9748822605965463,1.0,1.0,7/17,25.73%,EGFR;RGCC;AKT1;CCND2;CCNY;PKD2;MAPRE3
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.14459777456767922,-0.502211783328602,1.0,0.9946305472726295,1.0,12/50,23.95%,PSMF1;PSMB8;PSMA4;PSMB10;PSMB2;PSMC4;PSMA6;PSMD9;PSMD11;PSMD5;PSMA8;PSMB1
prerank,telomere maintenance via telomerase (GO:0007004),-0.1621021929764481,-0.5011874040720598,0.9969230769230769,0.9940164472671801,1.0,2/28,6.87%,ANKRD28;HSP90AB1
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.18129339144640524,-0.5003171235015118,0.987146529562982,0.9933485648558049,1.0,6/19,27.59%,ACOX1;GPX1;CAT;PRDX5;NOX1;SOD1
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.20743206720520418,0.4963801622105614,0.9837925445705025,1.0,1.0,8/21,25.91%,PPP4R4;YWHAE;BOD1L1;PTPA;BOD1;PPP1R15A;MASTL;STYXL1
prerank,positive regulation of mitochondrial translation (GO:0070131),0.22254218649335916,0.49539975668488845,0.9742268041237113,1.0,1.0,3/14,19.38%,RPUSD4;TRUB2;FASTKD3
prerank,protein localization to phagophore assembly site (GO:0034497),0.2379187694600328,0.49331115216675053,0.976068376068376,1.0,1.0,4/11,20.91%,WIPI1;WDR45;STX17;ATG9A
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.2202634622886529,0.49323172011610544,0.9786476868327402,1.0,1.0,3/14,16.33%,LONP2;ABCD2;AKT1
prerank,innate immune response in mucosa (GO:0002227),0.2338964547810706,0.49249291132059353,0.9628942486085343,1.0,1.0,1/10,7.87%,CAMP
prerank,negative regulation of T cell activation (GO:0050868),0.18416867217454724,0.4911995648877673,0.9930362116991643,1.0,1.0,4/35,13.91%,RIPOR2;CEBPB;GLMN;SDC4
prerank,negative regulation of translational initiation (GO:0045947),0.22090395480226,0.4880612926393672,0.9600694444444444,1.0,1.0,13/13,77.93%,LARP1;TPR;RBM4;EIF3E;EIF2AK1;EIF4EBP1;AGO2;PAIP2;EIF4EBP3;PAIP2B;FMR1;EIF2AK4;EIF4EBP2
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.20203863152662205,0.48723462486674685,0.9818181818181818,1.0,1.0,5/20,21.92%,ZW10;ZWINT;ATM;TPR;IK
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.20203863152662205,0.48723462486674685,0.9818181818181818,1.0,1.0,5/20,21.92%,ZW10;ZWINT;ATM;TPR;IK
prerank,spindle assembly checkpoint signaling (GO:0071173),0.20203863152662205,0.48723462486674685,0.9818181818181818,1.0,1.0,5/20,21.92%,ZW10;ZWINT;ATM;TPR;IK
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.1866444037227952,0.48661880053018347,0.986322188449848,1.0,1.0,10/29,27.01%,TLR6;IKBKE;TBK1;CD14;UBE2D1;BIRC2;BIRC3;FADD;TICAM1;RIPK1
prerank,N-terminal protein amino acid modification (GO:0031365),-0.19171235334009165,-0.48487428898751866,0.9841269841269841,0.9951675237582784,1.0,7/14,40.78%,METAP2;NAA60;NAA15;AANAT;NTMT1;PDF;NAA11
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.14838918773776885,-0.48124715666971674,0.9968354430379747,0.9949004651444066,1.0,12/37,34.18%,RBX1;GTF2H1;DDB2;PARP1;POLD4;POLK;CHD1L;UBC;RPS27A;POLD2;ERCC5;RPA2
prerank,regulation of mitotic spindle organization (GO:0060236),0.1782086276146757,0.47949626646775373,0.9913169319826338,1.0,1.0,10/35,26.04%,DYNC1H1;RAE1;CHMP5;GNAI1;TPR;NUMA1;HNRNPU;CCSAP;CHMP2A;FSD1
prerank,recombinational repair (GO:0000725),0.15811354675622713,0.4757905594909376,1.0,1.0,1.0,24/77,27.47%,ZSWIM7;INO80;RAD51B;SMC5;POLL;RECQL5;SMC6;RAD51D;XRCC2;RNF138;AP5Z1;NSMCE2;FAN1;EXD2;BRCA1;SFPQ;NABP2;RAD51AP2;MRE11;SWI5;RAD50;TONSL;UBE2N;RECQL
prerank,positive regulation of TORC1 signaling (GO:1904263),0.21007885329449777,0.47549757394012937,0.9749582637729549,1.0,1.0,4/16,20.28%,TELO2;RRAGD;SEH1L;GPR137B
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.19523166692089045,0.4754136172208494,0.9868204283360791,1.0,1.0,5/21,21.92%,ZW10;ZWINT;ATM;TPR;IK
prerank,regulation of protein acetylation (GO:1901983),0.2201844333319768,0.47467613273426873,0.9756521739130435,1.0,1.0,3/12,21.34%,DDX3X;KAT5;TAOK1
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.20837149137556138,-0.4746627096867249,0.9828326180257511,0.9949972086669067,1.0,5/10,38.02%,NDFIP2;CORO2B;WWP2;PPM1F;MAPT
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.1819613160641823,0.47451962285451,0.9941775836972343,1.0,1.0,6/32,17.56%,HNRNPA1;PARN;FBXO4;TNKS2;ATM;NAF1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.21237669405993478,0.47425972462129606,0.9790575916230366,1.0,1.0,5/14,27.72%,DDX60;DHX58;TLR5;ANKRD17;PUM1
prerank,lymphocyte mediated immunity (GO:0002449),0.21593957970603692,0.4691948330261338,0.975736568457539,1.0,1.0,1/12,6.92%,KLRD1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.17793120529085585,0.46745495167519086,0.9910179640718563,1.0,1.0,10/30,27.01%,TLR6;IKBKE;TBK1;CD14;UBE2D1;BIRC2;BIRC3;FADD;TICAM1;RIPK1
prerank,protein import into peroxisome matrix (GO:0016558),0.2223479095062404,0.4666774515751605,0.9747292418772563,1.0,1.0,4/12,21.51%,PEX6;PEX2;PEX7;PEX1
prerank,negative regulation of phosphatase activity (GO:0010923),0.1882460170832867,0.46664998514615497,0.9969325153374233,1.0,1.0,9/25,25.91%,PPP4R4;BOD1L1;PTPA;BOD1;SEMA4D;PPP1R26;PPP1R15A;MASTL;STYXL1
prerank,autophagosome maturation (GO:0097352),0.17640635352058953,0.4655363178660711,0.9971056439942113,1.0,1.0,11/32,25.60%,CLN3;UVRAG;LAMP2;MAP1LC3A;EPG5;STX17;RUBCNL;LIX1;TSG101;VPS16;VPS33B
prerank,superoxide anion generation (GO:0042554),0.20926393305244118,0.46319399604397005,0.9763513513513513,1.0,1.0,3/13,19.61%,NOX4;NOX3;ALOX12
prerank,protein localization to chromosome (GO:0034502),0.17679262628028597,0.4629347358281563,0.9911373707533235,1.0,1.0,10/34,25.61%,MRNIP;TERF2;TNKS2;WAPL;CENPA;BOD1;ATRX;CTCF;TNKS;XRCC4
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.16097154013971177,0.46216801870748164,0.998641304347826,1.0,1.0,12/53,23.34%,PSME4;PPM1K;PSMB5;PSMC2;OAZ3;PSMD1;PSMD4;PSME3;BCKDK;PSMA3;PSMA2;PSMC5
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.21206716083852645,0.45698406071262215,0.9783001808318263,1.0,1.0,1/11,6.92%,KLRD1
prerank,regulation of hormone secretion (GO:0046883),0.20156376108346735,0.45574258634732334,0.9831365935919055,1.0,1.0,4/15,22.74%,LIF;SOX11;SNX6;SCG5
prerank,regulation of double-strand break repair (GO:2000779),0.16556434754451704,0.4554353745729238,0.9971711456859972,1.0,1.0,6/39,17.13%,PML;TRIP12;MRNIP;RTEL1;UBR5;TIMELESS
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.20584554856680487,0.4415790567254097,0.9798319327731092,1.0,1.0,4/12,22.50%,ANAPC5;NSMCE2;CDC23;ANAPC4
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.20584554856680487,0.4415790567254097,0.9798319327731092,1.0,1.0,4/12,22.50%,ANAPC5;NSMCE2;CDC23;ANAPC4
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.20584554856680487,0.4415790567254097,0.9798319327731092,1.0,1.0,4/12,22.50%,ANAPC5;NSMCE2;CDC23;ANAPC4
prerank,regulation of cellular amide metabolic process (GO:0034248),0.16786655408296824,0.4368476785981601,0.9969879518072289,1.0,1.0,11/32,27.72%,PICALM;EIF2B4;MTPN;RBM4B;TMED10;FOXO3;NANOS3;PCIF1;ATXN2;METAP1;PRKCD
prerank,nucleotide biosynthetic process (GO:0009165),0.18471174522816408,0.430940887410893,0.9968253968253968,1.0,1.0,7/18,25.33%,GART;PRPSAP2;NMNAT2;PPAT;ADSL;NMNAT1;PRPSAP1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.1814847189055687,0.430742401706106,0.9950819672131147,1.0,1.0,8/18,30.78%,POLE3;GINS4;MCMDC2;LIG1;MCM4;GINS1;PCNA;POLD3
prerank,T cell homeostasis (GO:0043029),0.20780519158383598,0.43041509713957943,0.9840142095914742,1.0,1.0,4/10,24.91%,AKT1;NCKAP1L;PMAIP1;FADD
prerank,protein import into mitochondrial matrix (GO:0030150),0.18401037275301318,0.4291786545061506,0.9862778730703259,1.0,1.0,2/18,9.80%,TIMM17B;TIMM44
prerank,homologous chromosome segregation (GO:0045143),0.17670318294854276,0.4288138179242001,0.99375,0.9999949203086,1.0,3/20,16.35%,CENPC;MAJIN;SGO1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.1690300287355917,0.42504198294124806,0.9953488372093023,0.9999700540902571,1.0,10/25,29.26%,DDX23;GEMIN2;PRPF6;SF3B1;SRSF10;PRPF8;SLU7;TXNL4A;SCAF11;SF3B3
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.15969941386737885,0.41918830601764,0.996937212863706,1.0,1.0,7/29,23.02%,GTF2H5;CUL4B;MNAT1;XPA;ERCC3;CDK7;ERCC2
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.1796443626710394,0.4183345157947402,0.9933993399339934,0.9997986783708428,1.0,3/18,19.38%,COX18;PET100;FASTKD3
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.1969406009920422,0.418234507275659,0.9926605504587156,0.9994149393216705,1.0,1/11,8.07%,WTIP
prerank,error-free translesion synthesis (GO:0070987),-0.14487949580227447,-0.41805920362024884,1.0,0.999090665800372,1.0,7/22,34.18%,POLH;UFD1;RCHY1;VCP;UBC;RPS27A;RPA2
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.1548694337909307,0.4158625542447606,0.9986244841815681,0.9992188953619692,1.0,9/40,22.69%,BOD1L1;RTEL1;PRIMPOL;TIMELESS;ATRX;ETAA1;EXD2;EME2;CENPX
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.16089893453904464,0.40064258412192916,0.9984447900466563,0.9999564152472337,1.0,1/24,5.01%,LIG4
prerank,ESCRT complex disassembly (GO:1904896),0.1943764513901965,0.3968212908029603,1.0,0.9993919263529099,1.0,10/10,80.57%,CHMP5;CHMP2A;IST1;CHMP7;CHMP1B;CHMP1A;VTA1;VPS4B;CHMP2B;VPS4A
prerank,ESCRT III complex disassembly (GO:1904903),0.1943764513901965,0.3968212908029603,1.0,0.9993919263529099,1.0,10/10,80.57%,CHMP5;CHMP2A;IST1;CHMP7;CHMP1B;CHMP1A;VTA1;VPS4B;CHMP2B;VPS4A
prerank,rRNA catabolic process (GO:0016075),0.1625027891287245,0.37066901179103445,1.0,1.0,1.0,6/16,27.35%,EXOSC7;DIS3L;EXOSC2;XRN1;EXOSC8;EXOSC9
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.16783831282952552,0.3591946670638111,0.9966159052453468,1.0,1.0,11/11,83.23%,RC3H2;RC3H1;TNFSF4;SMAD7;ZC3H12A;TBX21;FOXP3;IL4;SOCS5;ANXA1;JAK3
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.13840459754306286,0.3584696508400802,1.0,0.9997427512896019,1.0,8/27,25.49%,PARN;PCF11;RPP30;DICER1;TOE1;XRN1;LACTB2;RNASE4
prerank,regulation of lymphocyte activation (GO:0051249),-0.1453940573954104,-0.355324228733286,1.0,0.9998531302517973,1.0,4/12,35.27%,KAT2A;LAT;IKZF3;CRTAM
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.16713738781146031,0.3466772933001593,0.9983498349834984,0.9995741547309381,1.0,10/10,83.30%,RC3H2;RC3H1;SMAD7;ZC3H12A;TBX21;FOXP3;IL4;NFKBID;MALT1;NFKBIZ
